<SEC-DOCUMENT>0001493152-21-007316.txt : 20210331
<SEC-HEADER>0001493152-21-007316.hdr.sgml : 20210331
<ACCEPTANCE-DATETIME>20210331093047
ACCESSION NUMBER:		0001493152-21-007316
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		112
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210331
DATE AS OF CHANGE:		20210331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Agape ATP Corp
		CENTRAL INDEX KEY:			0001713210
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				364838886
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-220144
		FILM NUMBER:		21790360

	BUSINESS ADDRESS:	
		STREET 1:		1705-1708 LEVEL 17, TOWER 2, FABER TOWER
		STREET 2:		JALAN DESA BAHAGIA, TAMAN DESA
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			58100
		BUSINESS PHONE:		(603) 27325716

	MAIL ADDRESS:	
		STREET 1:		1705-1708 LEVEL 17, TOWER 2, FABER TOWER
		STREET 2:		JALAN DESA BAHAGIA, TAMAN DESA
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			58100
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:AATP="http://agapeatp.com/20201231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_AATP_agapeatp.com_20201231 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20200101_20201231 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001713210 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DDocumentFiscalYearFocus_2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DDocumentTransitionReport_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityExTransitionPeriod_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Pure_0_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_067_RM_0_iso4217%2D%2DMYR -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityCentralIndexKey">0001713210</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:DocumentFiscalYearFocus">2020</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0034" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0036" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2019-12-31" id="xdx2ixbrl0056" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableRelatedPartiesCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl0058" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2019-12-31" id="xdx2ixbrl0065" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PrepaidTaxes" contextRef="AsOf2019-12-31" id="xdx2ixbrl0068" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2019-12-31" id="xdx2ixbrl0082" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2019-12-31" id="xdx2ixbrl0085" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2019-12-31" id="xdx2ixbrl0088" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2019-12-31" id="xdx2ixbrl0097" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl0111" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2019-12-31" id="xdx2ixbrl0115" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2019-12-31" id="xdx2ixbrl0118" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2019-12-31" id="xdx2ixbrl0135" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2019-12-31" id="xdx2ixbrl0138" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2019-12-31" id="xdx2ixbrl0141" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31" id="xdx2ixbrl0149" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2019-12-31" id="xdx2ixbrl0150" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0199" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0200" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0220" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SalesCommissionsAndFees" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0223" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SalesCommissionsAndFees" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0224" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0246" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0248" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0255" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0256" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0260" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ImpairmentLossInEquityInvestments" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0262" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ImpairmentLossInEquityInvestments" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0264" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0318" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0319" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0321" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0324" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0325" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0326" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0330" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0331" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0332" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0334" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0336" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0354" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0370" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Depreciation" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0395" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Depreciation" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0418" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ImpairmentLossInEquityInvestments" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0422" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ImpairmentLossInEquityInvestments" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0435" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0436" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0438" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0444" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0447" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidTaxes" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidTaxes" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0452" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0468" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0472" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0480" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfInvestmentProjects" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfInvestmentProjects" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0495" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0499" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0504" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0507" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:PaymentsToAcquireNonMarketableSecurities" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0510" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:PaymentsToAcquireNonMarketableSecurities" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0523" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0524" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:RepaymentsOfRelatedPartyDebts" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0528" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0530" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0532" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0536" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0559" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0560" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0562" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0564" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0570" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0572" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0575" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0576" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0579" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0580" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0583" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl0584" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_SurvivorSelectMember" id="xdx2ixbrl0728" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_SurvivorSelectMember" id="xdx2ixbrl0730" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_IonizedCalMagMember" id="xdx2ixbrl0742" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_VegeFruitFiberMember" id="xdx2ixbrl0758" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_VegeFruitFiberMember" id="xdx2ixbrl0760" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_IronMember" id="xdx2ixbrl0764" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_IronMember" id="xdx2ixbrl0766" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_YoungFormulaMember" id="xdx2ixbrl0772" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_MitogizeMember" id="xdx2ixbrl0782" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_MitogizeMember" id="xdx2ixbrl0784" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_NoOneMEDMember" id="xdx2ixbrl0790" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_TrimPlusMember" id="xdx2ixbrl0802" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableGrossCurrent" contextRef="AsOf2019-12-31" id="xdx2ixbrl1093" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableRelatedPartiesCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl1095" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2019-12-31" id="xdx2ixbrl1107" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl1113" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:ReceivablesFromSalesDistributors" contextRef="AsOf2019-12-31" id="xdx2ixbrl1117" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-12-31_custom_ComputerAndOfficeEquipmentMember" id="xdx2ixbrl1131" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember" id="xdx2ixbrl1135" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember" id="xdx2ixbrl1139" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-12-31_custom_VehicleMember" id="xdx2ixbrl1143" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-12-31" id="xdx2ixbrl1146" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2019-12-31" id="xdx2ixbrl1149" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2019-12-31" id="xdx2ixbrl1152" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Depreciation" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl1155" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2019-12-31" id="xdx2ixbrl1162" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-12-31" id="xdx2ixbrl1165" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2019-12-31" id="xdx2ixbrl1168" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:InvestmentsIncomeDividend" contextRef="AsOf2019-12-31" id="xdx2ixbrl1214" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:SaleOfInvestmentInNonmarketableSecurities" contextRef="AsOf2019-12-31_custom_DirectorsOfUnreservedInvestmentMember" id="xdx2ixbrl1261" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:InvestmentInNonmarketableSecuritiesNet" contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember" id="xdx2ixbrl1263" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:AccruedPromotionExpenses" contextRef="AsOf2019-12-31" id="xdx2ixbrl1283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2019-12-31" id="xdx2ixbrl1286" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2019-12-31" id="xdx2ixbrl1289" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableRelatedParties" contextRef="AsOf2020-12-31_custom_SeaMember" id="xdx2ixbrl1309" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableRelatedParties" contextRef="AsOf2020-09-30" id="xdx2ixbrl1313" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2019-12-31_custom_HostastaySdnBhdMember" id="xdx2ixbrl1339" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2019-12-31_custom_THThreeTechnologySdnBhdMember" id="xdx2ixbrl1351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2020-12-31_custom_MrHowKokChoongMember25849859" id="xdx2ixbrl1365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2019-12-31_custom_AgapeSuperiorLivingPtyLtdMember" id="xdx2ixbrl1379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2020-01-012020-12-31_custom_SeaMember" id="xdx2ixbrl1393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2019-07-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" id="xdx2ixbrl1411" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdOneMember" id="xdx2ixbrl1429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2019-07-012019-12-31_custom_HostastaySdnBhdOneMember" id="xdx2ixbrl1431" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl1435" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl1437" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl1511" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl1512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl1513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl1517" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl1519" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl1520" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl1521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl1524" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl1525" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2019-07-012019-12-31" id="xdx2ixbrl1529" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2019-12-31_country_MY" id="xdx2ixbrl1592" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:DeferredTaxLiabilitiesDepreciation" contextRef="AsOf2019-12-31" id="xdx2ixbrl1600" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2019-12-31" id="xdx2ixbrl1604" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="AATP:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" contextRef="AsOf2020-12-31" id="xdx2ixbrl1667" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="aatp-20201231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2020-01-01to2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AgapeATPInternationalHoldingLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AgapeATPInternationalHoldingLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-07</xbrli:startDate>
        <xbrli:endDate>2020-05-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_custom_SubsidiaryCompanyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SubsidiaryCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SubsidiaryCompanyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SubsidiaryCompanyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SubsidiaryCompanyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_HealthAndWellnessProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:HealthAndWellnessProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SurvivorSelectMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_SurvivorSelectMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_SurvivorSelectMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EnergizedMineralConcentrateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EnergizedMineralConcentrateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_EnergizedMineralConcentrateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IonizedCalMagMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_IonizedCalMagMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_IonizedCalMagMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_OmegaBlendMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_OmegaBlendMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_OmegaBlendMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_BetaMaxxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_BetaMaxxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_BetaMaxxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_VegeFruitFiberMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_VegeFruitFiberMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_VegeFruitFiberMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_IronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_IronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_YoungFormulaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_YoungFormulaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_YoungFormulaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_OrganicYouthCareCleansingBarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_OrganicYouthCareCleansingBarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-13_custom_OrganicYouthCareCleansingBarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MitogizeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_MitogizeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_MitogizeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_NoOneMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_NoOneMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_NoOneMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EnergetiqueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EnergetiqueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_EnergetiqueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-13_custom_TrimPlusMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TrimPlusMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_TrimPlusMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SocialSecurityOrganizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember_custom_MYRCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SocialSecurityOrganizationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EmployeesProvidentFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmployeesProvidentFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EmploymentInsuranceSystemMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmploymentInsuranceSystemMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EmploymentInsuranceSystemMember_custom_MYRCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmploymentInsuranceSystemMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_HumanResourceDevelopmentFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:HumanResourceDevelopmentFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PeriodEndMYRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndMYRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PeriodEndMYRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndMYRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PeriodEndHKDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndHKDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PeriodEndHKDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndHKDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_PeriodAverageMYRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_PeriodAverageMYRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_PeriodAverageMYRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_PeriodAverageHKDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_PeriodAverageHKDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_PeriodAverageHKDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SubsidiaryCompanyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-292020-07-02_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-29</xbrli:startDate>
        <xbrli:endDate>2020-07-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-13_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-13_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ComputerAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ComputerAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_VehicleMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:VehicleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_VehicleMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:VehicleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-05-17_custom_GreenproCapitalCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-05-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-07-30_custom_GreenproCapitalCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-16_custom_GreenproCapitalCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-03_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-09_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_DirectorMember_custom_MYRCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-10_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-10_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-03_custom_UnreservedSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:UnreservedSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_MrHowKokChoongMember25848312">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-03_custom_PhoenixPlusCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-03_custom_PhoenixPlusCorpMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:DirectorsOfUnreservedInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_DirectorsOfUnreservedInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:DirectorsOfUnreservedInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PhoenixPlusCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PhoenixPlusCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SeaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_SeaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_SeaMember25849703">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="AATP:RelatedPartiesNatureDescriptionAxis">AATP:SeaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SeaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SeaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_AgapeATPAsiaLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AgapeATPAsiaLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AgapeATPAsiaLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_HostastaySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_HostastaySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_HostastaySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_HostastaySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_THThreeTechnologySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_THThreeTechnologySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_THThreeTechnologySdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_MrHowKokChoongMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MrHowKokChoongMember25849859">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_MrHowKokChoongMember25849875">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_SeaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_HostastaySdnBhdOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_HostastaySdnBhdOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-012020-05-31_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-292020-07-31_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-29</xbrli:startDate>
        <xbrli:endDate>2020-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_country_HK">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_country_HK">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-12-31_country_HK">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_IfUnutilizedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AATP:IfUnutilizedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IfUnutilizedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AATP:IfUnutilizedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-282019-01-02_custom_LabuanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">AATP:LabuanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-28</xbrli:startDate>
        <xbrli:endDate>2019-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_country_HK">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeATPInternationalHoldingLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AgapeATPInternationalHoldingLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgapeATPCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AgapeATPCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_country_MY">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:NoCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_OneCustomerMember_us-gaap_RevenueFromContractWithCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:OneCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_OneCustomerMember_us-gaap_RevenueFromContractWithCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:OneCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:ECommerceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:ECommerceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_VendorOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_VendorTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012020-11-30_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2020-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-31_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-30_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DSwissIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_VendorOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_VendorTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_VendorOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-12-31_custom_VendorTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_NoSalesMember_us-gaap_AccountsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">AATP:NoSalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-02_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-282020-04-02_custom_AgapeSuperiorLivingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-28</xbrli:startDate>
        <xbrli:endDate>2020-04-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-25_us-gaap_SubsequentEventMember_custom_SellersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:SellersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_VettonsSdnBhdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:VettonsSdnBhdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_VettonsSdnBhdMember_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001713210</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:VettonsSdnBhdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="RM">
      <xbrli:measure>iso4217:MYR</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001572" toRefs="Footnote001579"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>FORM
<span id="xdx_901_edei--DocumentType_c20200101__20201231_zmTjbX4lYLr2"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_905_edei--DocumentAnnualReport_c20200101__20201231_zloReDFXopde"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">[X]</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>ANNUAL
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
The Fiscal Year Ended <span id="xdx_905_edei--DocumentPeriodEndDate_c20200101__20201231_zMlPpjUOXcc4"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 31, 2020</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>or</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>[&#160;&#160;]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
the transition period from _____________________________</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Commission
File Number <span id="xdx_907_edei--EntityFileNumber_c20200101__20201231_zdUv9aMRDiud"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityFileNumber">333-220144</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="xdx_908_edei--EntityRegistrantName_c20200101__20201231_zdQGoPR9cqG9"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityRegistrantName">AGAPE
ATP CORPORATION</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Exact
name of registrant issuer as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20200101__20201231_zoUgBh20UEGa"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20200101__20201231_zpd96LAZeyOd"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityTaxIdentificationNumber">36-4838886</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State
                                         or other jurisdiction of</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">incorporation
        or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S.
                                         Employer</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Identification
        No.)</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>1705
&#8211; 1708, Level 17, <span id="xdx_903_edei--EntityAddressAddressLine1_c20200101__20201231_zMPa9DhHqJrj"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityAddressAddressLine1">Tower 2</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20200101__20201231_z2NoPaYfWZse"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityAddressAddressLine2">Faber Towers</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine3_c20200101__20201231_zxCcCkgaBU5h"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityAddressAddressLine3">Jalan Desa Bahagia</ix:nonNumeric></span>,</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span>Taman
Desa</span>, <span><span id="xdx_90D_edei--EntityAddressPostalZipCode_c20200101__20201231_zy4zYE0uJdla"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityAddressPostalZipCode">58100</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressCityOrTown_c20200101__20201231_zOE2n8qzZN8c"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityAddressCityOrTown">Kuala Lumpur</ix:nonNumeric></span></span>, <span id="xdx_90F_edei--EntityAddressCountry_c20200101__20201231_zgpYMhN6T8C1"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Malaysia</ix:nonNumeric></span>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address
of principal executive offices, including zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Registrant&#8217;s
phone number, including area code</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(<span id="xdx_90E_edei--CityAreaCode_c20200101__20201231_zZSmghupfame"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:CityAreaCode">60)</ix:nonNumeric></span>
<span id="xdx_90A_edei--LocalPhoneNumber_c20200101__20201231_zpMP8o36ZBoc"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:LocalPhoneNumber">192230099</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Securities Exchange Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Common
Stock, $0.0001 par value</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(Title
of Class)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">The
OTC Market &#8211; Pink Sheets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(Name
of exchange on which registered)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(g) of the Securities Exchange Act: <b><span style="text-decoration: underline">None</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [&#160;&#160;]
<span id="xdx_908_edei--EntityWellKnownSeasonedIssuer_c20200101__20201231_zJLBuQJI8g33"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> [X]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [&#160;&#160;]
<span id="xdx_903_edei--EntityVoluntaryFilers_c20200101__20201231_z2Vai3v3oNe2"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> [X]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. <span id="xdx_90C_edei--EntityCurrentReportingStatus_c20200101__20201231" title="Entity Current Reporting Status"><span style="-sec-ix-hidden: xdx2ixbrl0034">YES</span></span> [X] NO [&#160;&#160;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the
registrant was required to submit and post such files). <span id="xdx_90B_edei--EntityInteractiveDataCurrent_c20200101__20201231" title="Entity Interactive Data Current"><span style="-sec-ix-hidden: xdx2ixbrl0036">YES</span></span> [X] NO [&#160;&#160;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (&#167; 229.405 of this chapter) is not
contained herein, and will not be contained, to the best of registrant&#8217;s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller
reporting company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Large
Accelerated Filer [&#160;&#160;] Accelerated Filer [&#160;&#160;] <span id="xdx_905_edei--EntityFilerCategory_c20200101__20201231_zUHkUUV5qer4"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="dei:EntityFilerCategory">Non-accelerated Filer</ix:nonNumeric></span> [X] Smaller reporting company <span id="xdx_90C_edei--EntitySmallBusiness_c20200101__20201231_zvEBp6VWiSsb"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">[X]</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [&#160;&#160;] <span id="xdx_90D_edei--EntityShellCompany_c20200101__20201231_zPQf3NibY118"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> [X]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
growth Company [<span style="background-color: white"><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20200101__20201231_z03y65Hh3MYk"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">X</ix:nonNumeric></span></span>]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&#160;&#160;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
aggregate market value of the Company&#8217;s common stock held by non-affiliates computed by reference to the closing bid price
of the Company&#8217;s common stock, as of the last business day of the registrant&#8217;s most recently completed second fiscal
quarter:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">$<span id="xdx_908_edei--EntityPublicFloat_iI_pip0_c20200630_z7ry4RYA1W1f"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">913,908,750</ix:nonFraction></span></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding
    at March 29, 2021</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Common
    Stock, $0.0001 par value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--EntityCommonStockSharesOutstanding_iI_c20210329_zQVdp3ATNstg"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>FORM
10-K</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
the Fiscal Year Ended December 31, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Index</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Page
    #</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_001">PART I</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_002">Business</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    1A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_003">Risk Factors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">22</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    1B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_004">Unresolved Staff Comments</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">29</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_005">Properties</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">29</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_006">Legal Proceedings</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">29</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_007">Mine Safety Disclosure</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">29</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_008">PART II</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_009">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">30</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_010">Selected Financial Data</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">30</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_011">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">31</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    7A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_012">Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">40</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_013">Financial Statements and Supplementary Data</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">40</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_014">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">40</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    9A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_015">Controls and Procedures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">40</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    9B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_016">Other Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">42</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_017">PART III</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    10.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_018">Directors, Executive Officers and Corporate Governance</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    11.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_019">Executive Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">46</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    12.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_020">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    13.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#c_021">Certain Relationships and Related Transactions, and Director Independence</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">48</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    14.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_001">Principal Accounting Fees and Services</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">51</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_002">PART IV</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Item
    15.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_003">Exhibits, Financial Statement Schedules</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">52</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_004">SIGNATURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">53</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>This
Annual Report on Form 10-K contains forward-looking statements. These forward-looking statements are not historical facts but
rather are based on current expectations, estimates and projections. We may use words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221;
&#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;foresee,&#8221; &#8220;estimate&#8221; and variations
of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance
and are subject to certain risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict
and could cause actual results to differ materially from those expressed or forecasted. These risks and uncertainties include
the following:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>The
    availability and adequacy of our cash flow to meet our requirements;</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Economic,
    competitive, demographic, business and other conditions in our local and regional markets;</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Changes
    or developments in laws, regulations or taxes in our industry;</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Actions
    taken or omitted to be taken by third parties including our suppliers and competitors, as well as legislative, regulatory,
    judicial and other governmental authorities;</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Competition
    in our industry;</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>The
    loss of or failure to obtain any license or permit necessary or desirable in the operation of our business;</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Changes
    in our business strategy, capital improvements or development plans;</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>The
    availability of additional capital to support capital improvements and development; and</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Other
    risks identified in this report and in our other filings with the Securities and Exchange Commission or the SEC.</i></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>This
report should be read completely and with the understanding that actual future results may be materially different from what we
expect. The forward-looking statements included in this report are made as of the date of this report and should be evaluated
with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even
though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as
a result of new information, future events or otherwise.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Use
of Defined Terms</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Except
as otherwise indicated by the context, references in this Report to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
    &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our,&#8221; &#8220;Agape&#8221; are references to Agape
    ATP Corporation, a Nevada corporation.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8220;Common
    Stock&#8221; refers to the common stock, par value $0.0001, of the Company;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8220;Malaysia&#8221;
    is Malaysia;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8220;U.S.
    dollar,&#8221; &#8220;$&#8221; and &#8220;US$&#8221; refer to the legal currency of the United States;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8220;RM&#8221;
    and &#8220;Ringgit&#8221; are to the legal currency of Malaysia;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8220;Securities
    Act&#8221; refers to the Securities Act of 1933, as amended; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8220;Exchange
    Act&#8221; refers to the Securities Exchange Act of 1934, as amended.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="c_001"></span>PART
I</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_002"></span>ITEM
1. BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>1.
ORGANIZATION AND BUSINESS BACKGROUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation, a Nevada corporation (&#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on June
1, 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn.
Bhd., an entity incorporated in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
Superior Living Sdn. Bhd. (&#8220;ASL&#8221;) is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (&#8220;WATP&#8221;), a wholly owned
subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by
providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.
Upon the establishment of WATP, WATP starts collaborating with ASL to carry out its Wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company
is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood
circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements reflect the activities of the Company, Agape ATP Corporation (&#8220;AATP LB&#8221;),
Agape ATP International Holding Limited (&#8220;AATP HK&#8221;), Wellness ATP International Holdings Sdn, Bhd. (&#8220;Wellness
ATP&#8221;), ASL and its variable interest entity (&#8220;VIE&#8221;), Agape S.E.A. Sdn. Bhd. (&#8220;SEA&#8221;) (See Note 3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Details
of the Company&#8217;s subsidiaries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Subsidiary
                                                                                             company name</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Place
                                                                                             and date of incorporation</b></span></p></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Particulars
    of issued capital</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Principal
    activities</span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Proportional
                                                                                                         of ownership interest and voting power held</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 3%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">1.
                                         </span></td><td style="vertical-align: top; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape ATP Corporation</span></td><td style="text-align: left; width: 2%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Labuan, <br /> March 6,
    2017</span></td><td style="text-align: left; width: 2%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">100 shares of ordinary
    share of US$1 each</span></td><td style="text-align: left; width: 2%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Investment holding</span></td><td style="text-align: left; width: 2%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="vertical-align: top; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2.
                                         </span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape ATP International Holding Limited</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Hong Kong,<br /> June 1, 2017</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1,000,000 shares of ordinary share
    of HK$1 each</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Wholesaling of health and wellness
    products; and health solution advisory services</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">3.</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape Superior Living Sdn. Bhd.</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Malaysia, <br /> August 8, 2003</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">9,590,598 shares of ordinary share
    of RM1 each</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Health and wellness products and health
    solution advisory services via network marketing</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">99.99</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">4.</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape S.E.A. Sdn. Bhd.</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Malaysia, <br /> March 4, 2004</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2 shares of ordinary share of RM1
    each</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">VIE of Agape Superior Living Sdn.
    Bhd.</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">VIE</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Wellness ATP International Holdings
    Sdn, Bhd</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Malaysia, <br /> September 11, 2020</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">100 shares of ordinary share of RM1
    each</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The promotion of wellness and wellbeing
    lifestyle of the community by providing services that includes online editorials, programs, events and campaigns</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients.
The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#8220;ATP Zeta
Health Program&#8221;, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy
dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in
our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
order to strengthen the Company&#8217;s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99%
of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the
past 15 years. ASL has been offering the Company&#8217;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition
creates synergy in the Company&#8217;s operation by boosting the Company&#8217;s retail and marketing capabilities. The newly
acquired subsidiary allows the Company to fulfill its mission of &#8220;helping people to create health and wealth&#8221; by providing
a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy
lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health
solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry
out various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#201;NERG&#201;TIQUE
and BEAUNIQUE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases
caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health
and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well
as trained members and distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
&#201;NERG&#201;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level.
The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
BEAUNIQUE product series focuses on the research of our diet&#8217;s impact on modifying gene expressions in order to address
genetic variations and deliver a nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Products</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">ATP1s
Survivor Select</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ATP1s
Survivor Select contains various essential nutrients required by the human body to maintain the normal metabolism, which
includes productions of biological energy (ATP). Effective production of ATP enhances both physical as well as mental health,
and helps the body to build up resistance to diseases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_001.jpg" alt="" style="height: 166.35pt; width: 115.35pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Stimulate
    instant bio-energy production at the cellular level to ensure sufficient supply of bio energy for body cell.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Promote
    better metabolism at the cellular level.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Promote
    healthy and optimal growth of bones system, teeth structure and muscle tissue of children.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Improve
    the digestion and nutrient absorption powers of body cell.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Promote
    cell detoxification and repair capabilities in order to enhance cell self-healing ability.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">ATP2
                                         Energized Mineral Concentrate</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
ATP2 is a nutritional supplement made from the finest plant substances and also is a proprietary formulation of a super-energized
colloidal concentrate developed from a dibase solution. Its formula supports and enhances nutritional biochemical activities.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_002.jpg" alt="" style="height: 185.65pt; width: 82.2pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Support
    and enhance nutritional biochemical activities (nutrient absorption and waste metabolism). </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Break
    down or oxidised toxins and waste material to promote cellular detoxification and improve blood circulation.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Increase
    cellular respiration and energy production to reduce fatigue and maintain energy level.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Increase
    oxygen level in body cells to create a high oxygen environment in the body, which possibly help to prevent the growth of harmful
    pathogens that contribute to diseases.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Provide
    sufficient antioxidants that act as a superior scavenger of free radicals, to strengthen the body cells resistance against
    oxidative damages.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">ATP3
Ionized Cal-Mag</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">ATP3
Ionized Cal-Mag is a specialized calcium and magnesium minerals supplement that is designed to transform into ionic form completely
before entering the body. This is compatible to the cellular ion channel theory, that all cellular metabolisms are dependent on
ionic transmission to achieve the highest absorption rate. This product was tested for its nanoparticle by the National Measurement
Institute of Australian Government, with proven content of nanosized calcium and magnesium that has better absorption and bio-availability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_003.jpg" alt="" style="height: 175pt; width: 97.1pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Strengthen
    the bone system and promote better bone development.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Strengthen
    the teeth structure and prevent teeth damages.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Provide
    abundant of ionic calcium and magnesium to prevent chronic diseases through better blood circulation and acid-base regulation.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Promote
    better relaxing of nervous system and regulations of neurotransmitters which helps to enhance sleep quality.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Promote
    better relaxing of muscle to prevent muscle soreness and cramps.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">ATP4
Omega Blend</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ATP4
Omega Blend is a proprietary oil blend that is rich in undamaged polyunsaturated essential fatty acid, which is fully extracted
from plant-based ingredients. It provides a bio-effective balance of both essential fatty acids, Omega 3 and Omega 6 which are
the important structural components of cell membranes that cannot be synthesized by humans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_004.jpg" alt="" style="height: 214.85pt; width: 94.65pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Regulate
    cholesterol and triglycerides levels to promote better blood circulation.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Regulate
    inflammation, the unifying component of many diseases, and enhance cell repairing activities. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Regulate
    hormones production and functions in the body through supplies of the balanced ratio of Omega 3 and Omega 6.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Promote
    healthy functioning of the brain through the maintenance of healthy impulse transmission in brain cells that is crucial for
    memory and learning ability.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">ATP5
BetaMaxx</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ATP5
BetaMaxx is derived from the cell wall of premium food-grade baker&#8217;s yeast and is a medical breakthrough result of more
than 50 years of intensive research and studies by scientists and physicians. This product combines the immunostimulatory properties
of perfectly molecularly structured beta 1-3, 1-6-D-glucan with other immunomodulating compounds that work in perfect synergy
to make ATP5 a unique and effective natural product. It is a 100% natural immune enhancer, safe and does not cause any allergic
reactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_005.jpg" alt="" style="height: 195.9pt; width: 101.3pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Strengthen
    the function of immune cells to build up a better immune response of body for external and internal protections</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Promote
    better cell repairing and regulate inflammatory responses in wound healing. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Enhance
    the function of immune cell against damages caused by radiation. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Helps
    to normalize blood sugar levels. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">AGN-Vege
Fruit Fiber</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">AGN-Vege
Fruit Fiber is the special nutrition-based formula for intestines and stomach. It consists of four most essential components for
gastrointestinal health effects such as fiber, probiotic the &#8220;friendly bacteria&#8221;, prebiotic fructooligosaccharides
(FOS) as well as digestive enzymes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_006.jpg" alt="" style="height: 183.7pt; width: 123pt" /></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Promote
    better bowel movement and prevent low-fiber diet-induced constipation.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Maintain
    bowel health. FOS helps increase intestinal bifidobacteria and helps maintain a good intestinal environment.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Slow
    the absorption of sugar and lipid into the bloodstream which helps improve blood sugar and cholesterol level.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Induce
    better satiety, which results in reduced total food intake and helps in achieving an ideal weight management.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">AGP1-Iron</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">AGP1-Iron
is the purest and most advanced Colloidal Iron that is sourced from the remains of an ancient rainforest which contains the most
active plant-based element from nature. The colloidal nanosized iron provides high zeta potential promotes better absorptivity
and cellular iron uptake through the ion channel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<img src="image_007.jpg" alt="" style="height: 190.9pt; width: 86.25pt" /></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Promote
    better hemoglobin production to improve iron deficiency anemia.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Iron
    is a component of hemoglobin in red blood cell which carries oxygen to all part of the body. Therefore, it helps to improve
    blood circulation and prevent some oxygen deficiency symptoms through enhancement of oxygen delivery and nutrient circulation
    as well as toxins excretion.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Iron
    is a factor in red blood cell formation. It promotes hemoglobin production hence is suitable especially for women and individual
    who experienced accidental bleedings.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">YFA-Young
Formula</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">YFA-Young
Formula is a 100% natural unique formula, a combination of amino acid, vitamins, and minerals and is the best anti-aging and youthful
maintenance supplement. It stimulates the pituitary gland to release endocrine hormones such as human growth hormone (HGH) to
stimulate synergies thus achieving the efficacy of anti-ageing through the promotion of cells vitality and strengthening of organ
function.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<img src="image_008.jpg" alt="" style="height: 195.9pt; width: 177.5pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Enhance
    the production of bio-energy ATP and metabolism, which aids in reducing body fat accumulation and promote strong muscles building.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Stimulate
    the production of collagen to restore skin elasticity and reduce wrinkles.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reduce
    pigmentation and dark spots on face caused by hormonal imbalances.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">HGH
    builds and repairs tissues and thus has an effect on hair cells at the hair root to promote healthy hair growth. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Enhance
    memory and cardiovascular function and prevent various chronic diseases due to HGH deficiency.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">BEAUNIQUE
Mito+</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
BEAUNIQUE Mito+ is a strong antioxidant drink with great flavor and taste. The preeminence of BEAUNIQUE Mito+ is its ability to
further protect and stimulate mitochondria (the powerhouse of cells) in cellular energy (ATP) production with the added advantage
of less total sugars and calories. The formula comprises 11 Superfood including potent mangosteen skin extract. Backed by advanced
scientific research and tested on 88 nutrigenomic profile, the formulation revealed enhanced antioxidant properties. 96.34% DPPH
Radical Scavenging activity.</span><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_009.jpg" alt="" style="height: 240.05pt; width: 67.15pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
Promotes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Cellular
    health</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
    antioxidants to protect from cellular oxidative damages.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Immune
    health</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Enhance
    adaptive immune response.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Anti-inflammatory.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Strengthen
    immunity against bacteria and viruses.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Metabolic
    health</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reduce
    risk of obesity.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reduce
    risk of vascular diseases.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reduce
    risk of Type II Diabetic.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Brain
    health</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reduce
    risk of neurodegenerative diseases.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Skin
    health</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Systemic
    photoprotection.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reduce
    dark spot formation.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Alleviates
    skin wrinkle and inflammation induced by UV-B irradiation.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">ORYC-Organic
Youth Care Cleansing Bar</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ORYC-Organic
Youth Care Cleansing Bar is a natural, organic cleansing soap for skin. It contains pure Australian-accredited natural and organic
plant oils acting as a high quality and natural skin lubricant. It maintains the softness of the skin while promoting skin beauty
and radiance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_010.jpg" alt="" style="height: 146.85pt; width: 202.1pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">With
    its biodynamic avocado oil and vanilla extract, remove impurities, leaving skin clear, fresh and clean.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">With
    its biodynamic, coconut, almond and olive oil, moisturize and texturize the skin to prevent skin drying.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
    acting as natural anti-bacterial and anti-inflammatory agents, reduce the risks of skin infections and allergies. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">*References
alluding to the efficacy and effects of our products are based on client testimonials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Beauty
Products</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s ENERGETIQUE series aim to provide a total dermal solution for a healthy skin beginning from the cellular level.
The series is comprised of Energy Mask, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>ENERGY
MASK SERIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s Energetique Mask Series is formulated with triple action natural ingredients and advanced technologies. The innovative
combination of award-winning patented liposome encapsulating the customized fast acting patented essence, produces micro-particle
liposome which, combined with collagen peptide Tencel film, creates an effective formulation that benefits the skin at the cellular
level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
are three types of face masks in the Energetique Mask Series, each to suit a different skin requirement. They are: N&#176;1 Med-Hydration;
N&#176;2 Med-Whitening; N&#176;3 Med-Firming. Advanced genetic analysis and clinical trials conducted revealed the benefits and
efficacies of the patented functional essence. The Energetique Mask Series has clinically shown deep penetration of liposomal
essence into deep skin layers within 5 minutes of the application to deliver immediate, deep-reaching and long-lasting benefit
of skin hydration, whitening, and firming.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>N&#176;1
Med-Hydration</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Formulated
with the patented Sea Grape (Caulerpa lentillifera) extract, the <span style="background-color: white"><b>N&#176;1 Med-Hydration
</b></span>enhances skin moisture and luminosity. This treatment effectively improves the moisture content of the inner skin layer
and rejuvenate the skin barrier function to avoid moisture loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_011.jpg" alt="" style="height: 149.65pt; width: 113.4pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">locking
    the skin moisture and nutrients, strengthening the skin barrier function and boosting the skin&#8217;s moisture level.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">to
    increase the skin&#8217;s natural moisturizing factor (PCA) and skin layer glycoprotein connectivity to maintain the skin&#8217;s
    moisture.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">to
    effectively retain water, provides moisturization, restores skin elasticity, and promotes the growth of fibroblasts for moisturization,
    removes dryness, regains skin&#8217;s elasticity and smoothness.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">immensely
    in delivering an instant boost of skin moisture content up to 45.7% in just 5 minutes of application and synergistically ensuring
    a profound and long-lasting skin moisturization and hydration.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>N&#176;2
Med-Whitening</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Formulated
with patented Peach Blossom Stem Cell Extract, the <b>N&#176;2 Med-Whitening</b> has clinically shown its efficacy in inhibiting
the melanin synthesis, down-regulating the melanin synthesis gene, boosting skin moisture level and protecting skin against UV
radiation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_012.jpg" alt="" style="height: 172.35pt; width: 125pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">in
    suppressing melanin production and fight against UV radiation to protect skin cells and result in whitening effect.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">to
    stimulate interstitial hyperplasia cell and helps in increasing the moisturizing ceramide by 7.4 times in order to remove
    skin roughness and smoothing skin.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">to
    enhance the skin brightness up to 6.3% in just 5 minutes of application and synergistically rejuvenate a profound and long-lasting
    skin ability in anti-UV damage.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>N&#176;3
Med-Firming</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Formulated
with the patented Djulis (Chenopodium formosanum Koidz) Seed Extract, the native cereal plant in Taiwan and traditionally called
&#8220;ruby of cereals.&#8221; The formulation is clinically proven to be effective in stimulation of collagen secretion and anti-advances
glycation end-products (AGEs) reducing the glycation of skin collagen, provide protection and maintenance of the basal skin collagen
production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_013.jpg" alt="" style="height: 155.6pt; width: 123.85pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">to
    suppress the skin collagen glycation process, reduces collagen loss, and enhancing collagen secretion.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">repairing
    the dead skin tissue, smooth wrinkles to restore the smoothness and health of the skin.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">preventing
    wrinkles formation and providing the essential skin moisture content.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">to
    boost skin elasticity by up to 14.4%. and improve sagging skin by 135 in just 5 minutes of application.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Unique
Characteristics via Nutrigenomic</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s BEAUNIQUE product series focuses on the research of diet&#8217;s impact on modifying gene expressions to address
genetic variations and deliver a personalized nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#201;NERG&#201;TIQUE
Hyaluronic Acid (HA) Serum</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Formulated
with four functional hyaluronic acid and a unique peptide, this scientifically advanced and intensive quintuple action serum proven
to deliver 5Rs dermal benefits. Filled in an innovative yet convenient and hygienics syringe packaging, this HA serum also ensure
consumer-perceivable benefits for every skin type.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_014.jpg" alt="" style="height: 190.5pt; width: 242.25pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">REBALANCE
    - Hydrate the skin surface by forming a protection layer and keep skin moisturized even after cleansing</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">RECOVER
    &#8211; Repair the out-balanced lamellar layer to act as barrier to prevent skin moisture from evaporation</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">REGENERATE
    - Promote the production of Type I pro-collagen and boost skin&#8217;s own production of Hyaluronic Acid up to 3 times</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">REHYDRATE
    - Nano-sized particles with high capacity of water-holding allow deep penetration and bestows moisture from inside the skin.
    Long-lasting moisture retention up to 72 hours</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">REMODELLING
    - Proven to increase skin firmness +200% (cheek, under-eye and neck). Enhance skin viscoelasticity to improves skin roughness</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#201;NERG&#201;TIQUE
Mousse Facial Cleanser</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Formulated
with the mildest surface-active agents available on the market, this facial cleanser was designed to deliver a distinct A to E
cleansing benefits to consumers. </span><span style="font: 10pt Times New Roman, Times, Serif">The unique mousse
like-foam delivers a comfortable and soft feeling of the skin during and after use without compromising the moisturizing level
<span style="background-color: white">and viscoelastic properties of the skin.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><img src="image_015.jpg" alt="" style="height: 201.85pt; width: 174.9pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>A.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>All
    Skin Type</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Hypoallergenic</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Non-comedogenic</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>B.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">pH-balanced
    formula with buffer capacity at pH 5.5 of the skin.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>C.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Comfortable</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mild
    to skin and eyes without irritating or drying your skin</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Comfortable
    and soft feeling <b>&#8211; </b>prolonged comfortable to skin before and after use. Accidental consuming would not be harmful
    to your body.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>D.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Dense</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mousse-like
    foam very fine porous foam and smooth skin-feel during use</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>E.</b></span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Effortlessly</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Easily
    remove light makeup, dirt and impurities.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Easy
    to rinse with no residual.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trim+:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Trim+
is the first product launched under this series, utilizes the advanced technology to extract the patented active ingredients in
foods. Trim+ has scientifically proven to be effective in inhibiting the activities of carbohydrates digestive enzymes, which
results in a reduction of the breakdown and absorption of sugars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="image_016.jpg" alt="" style="height: 190.2pt; width: 191.35pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">It
helps to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Reduce
    total carbohydrates calories intake with the scientifically proven effect on weight management.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Regulate
    blood sugar levels with scientifically proven efficacy.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Improve
    cellular uptake of sugars for bioenergy ATP production. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Maintain
    insulin hormone balance, helps prevent diabetes.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Improve
    blood lipids composition, helps prevent cardiovascular disease.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Future
Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
at the date of this report, the number of COVID-19 cases have hit over 124 million worldwide with approximately 2.7 million lives
lost. About 17% of those who contracted the disease are still battling on.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A
year on, after the declaration of the COVID-19 pandemic, the threats brought about by the pandemic have not abated. There are
two opposing developments on COVID-19, (i) the discovery of the COVID-19 vaccines which have went into commercial production,
and first made available for patients on December 8, 2020. As at the date of this report more than 458 million doses of the vaccine
have been administered across 87 countries; and (ii) The emergence of, possibly, more virulent mutant strains of the COVID-19.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
Malaysia, where our products are mainly sold, the number of COVID-19 cases have spiked. On January 12, 2021, the local government
declared a state of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts.
On March 5, 2020, lockdowns in most part of the country was eased to a Conditional Movement Control Order.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
view of the severity of the COVID-19 pandemic, the Malaysian government had entered into several agreements to secure COVID-19
vaccines with several pharmaceutical companies. There were two agreements executed with Pfizer-BioNTech, each for the supply of
12.8 million doses of the COVID-19 vaccines, the first one million doses will be delivered as early as the first quarter of 2021.
Agreements were also signed with Russia&#8217;s Gamaleya Research Institute and China&#8217;s Sinovac Biotech for an approximate
18.4 million doses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">February
2021 was a significant month for Malaysia as all frontline staff of the country, which comprised those in healthcare, police,
the Volunteers Department of Malaysia, the Fire and Rescue Department of Malaysia and civil defence sectors were vaccinated. On
February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that a National COVID-19 Immunisation Plan will be implemented
for one year after February 2021, which 80% of the Malaysia population will be vaccinated to achieve herd immunization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
with many other corporations, as far as the challenges posed by the COVID-19 pandemic, we have encountered challenges in terms
of business and corporate developments. ASL, our newly acquired subsidiary that is principally involved in network marketing performed
marginally better in the financial year ended 2020 as compared to the preceding year. As businesses continues to be digitized,
we will further capitalize on the e-commerce trading platform provided by Vettons Sdn. Bhd. to perform e-marketing and e-trading
of our products to members, as well as online e-recruitment of new members.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
September 2020, we have also incorporated WATP to pursue the business of promoting wellness and wellbeing lifestyle of the community
by providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and
lifestyle. The establishment of WATP is a further expansion of our business into the health and wellness industry. While the COVID-19
pandemic subsists, we will concentrate our positive energy in developing our businesses in Malaysia where most of our activities
are concentrated. We anticipate expanding into the Asian markets in the future, with a particular focus, at least initially, on
expanding into Thailand, Indonesia and Taiwan. Our expansion plans constructed earlier, has to be delayed due to changes in rules
and regulations imposed by the local governments of these countries, which at this moment are still subject to continuous reviews
and changes, changes in work-methods and various other obstacles brought about as a direct result of the pandemic. We view these
challenges positively as we will now, be able to develop new methods of operations that are more cost effective. Information technology
will be deployed more extensively. We also plan to allocate funds to research new products to widen our products and services
in our ATP Zeta Super Health Program, as well as the &#201;NERG&#201;TIQUE and BEAUNIQUE series. However, such development
will require intensive research, development and testing. We cannot accurately determine a definitive timeline at present, nor
have we determined an appropriate budget, for these future activities. We may also evaluate potential acquisitions in the future
which we feel may have synergy with our current operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">When
the pandemic has subsided or is over and restrictions on travelling between nations are uplifted, we will set up offices in the
countries in which we operate to better service our customers for higher returns. It is the group&#8217;s ultimate aim to partake
in all the lucrative areas of the health and wellness ecosystem as far as possible, to carve a niche in the health and wellness
industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Marketing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Leveraging
on information technology, we will continue to build our brand image to create brand awareness to penetrate the marketplace and
attract customers. For the Company&#8217;s network marketing business, we have a corporate website which introduces and promotes
our products and services, enable e-trading and e-recruitment of members. Going forward, we will use our corporate website more
extensively to market all our products and services. We will utilize marketing related search engines to attract potential clients
to our website. In financial year 2020, we have also synched-up with Vettons Sdn. Bhd, an e-merchant to further our reach through
e-commerce. <span style="background-color: white">On February 1, 2021, </span>Mr. How Kok Choong, the CEO and director of the
Company, was appointed as the non-executive Chairman of <span style="background-color: white">Vettons Sdn Bhd.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
we will explore other online methods to enhance brand awareness that are impactful for community building for our other ventures
in the health and wellness industry such as referral programs, develop contents for guest publishing, social media contests, etc.
We will be social focus in the selection of social networks for our social media marketing, and where appropriate infographics
will be used and influence marketing will be employed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
health and wellness industry, with a focus on health supplements in particular in Malaysia, where we operate, is rather competitive.
Our focus is on the mature group of customers, i.e. adults ranging in age from 18-65 years old. We face competition from various
retail health supplement providers, pharmacies, and Multi-Level Marketing Companies which supply health supplement products, such
as Bio-Life Marketing Sdn Bhd, Elken Group, Usana Group, BMS Organics, NHF Group and their respective affiliates. These competitors
are generating significant traffic to their marketing websites; and have established brand recognition and financial resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
believe that the principal competitive factors in our type of market include the quality of health supplements, the efficacies
of the health supplements, strength and depth of relationships with clients, the ability to identify the changing needs and requirements
of prospective clients, and the scope of services. Through utilizing our competitive strengths, we believe that we have a competitive
edge over other competitors due to the breadth of our product offerings, one stop convenience, pricing, our services, our reputation
and product safety. We are confident we can develop and enlarge our market share in the Malaysian market and potentially further
into the overseas market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
all our ventures in the health and wellness industry, present and future, we will plan our inroads to ward off unnecessary competition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Customers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
customer base increased to 128,136 members as at December 31, 2020, solely brought about by the acquisition of ASL, which brought
us to a large group of customers in an established network marketing sales channel that were established in Malaysia for the past
15 years. For the year ended December 31, 2019, we were making sales, solely to Agape S.E.A. Sdn Bhd, a related party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the number of employees by function as of the date of this annual report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Function</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number
                                         of</span></p>
                                              <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">employees</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Senior Management</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Business Development Department</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Corporate Affairs Department</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance Department</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Human Resources Department</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operations Department</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product Development Department</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales &amp; Marketing
    Department</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Regulations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At
present, our products are predominately sold in Malaysia. As the contents and combination of the main ingredients in our ATP Zeta
Health Program and BEAUNIQUE series are categorized as health food rather than medicines or drugs, all of our products require
authorization from the Food Safety and Quality Division of the Ministry of Health, Malaysia according to the Food Act 1983 (ACT
281) &amp; Regulations in order to be sold in the country. Accordingly, we have obtained the appropriate authorizations from the
Food Safety and Quality Division of the Ministry of Health, Malaysia for all products in our ATP Zeta Health Program and BEAUNIQUE
series.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
&#201;NERG&#201;TIQUE series is regulated under the Control of Drugs and Cosmetics Regulations 1984, the Ministry of Health,
Malaysia. We have also obtained the appropriate authorizations for distribution and sale of the products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_003"></span>ITEM
1A. RISK FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>We
are exposed to concentration risk of heavy reliance on our major supplier for the supply of our products, and any shortage of,
or delay in, the supply may significantly impact on our business and results of operation.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, we purchased $500,747 and $174,691 from two of our major suppliers, represented 74.1%
and 25.9%, respectively, of our total purchases. Our business, financial condition and operating results depend on
the continuous supply of products from our major suppliers and our continuous supplier-customer relationships with them. Our heavy
reliance on our major suppliers for the supply of our products will have significant impact on our business and results of operation
in the event of any shortage of, or delay in the supply.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
is customary in distribution arrangements of this type, the distribution agreement with our major suppliers are terminable by
either party by giving notice. There is no assurance that our major suppliers will not terminate the distribution agreement. In
the event that they terminate the distribution agreements, we will have to source products from other suppliers and we may not
be able to secure supply of products with quantity and quality required to support our business or at all. Such termination may
therefore have a material adverse impact on our business, financial condition and operating results if we fail to engage any other
suppliers before the termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
is no assurance that our major suppliers will continue to supply their products in the quantities and timeframes required by us
to meet the needs of our customers or comply with their supply agreements with us. Our product supply may also be disrupted by
potential labor disputes, strike action, natural disasters or other accidents, epidemic and pandemic affecting the supplier. If
our major suppliers do not supply products to us in a timely manner or in sufficient quantities, our business, financial condition
and operating results may be materially and adversely affected. Furthermore, in the event of any delay in delivery of the products
to us, our cash flow or working capital may be materially and adversely affected as a result of the corresponding delay in delivery
of our products to our customers, and hence the delay in our receipt of payment from our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
major suppliers may change their existing sales or marketing strategy in respect of the products supplied to us by changing their
export strategy, reducing its sales or production volume or changing its selling prices. Consequently, there are no assurances
that our major suppliers will not appoint other dealers or distributors which may compete with us in the market where we operate.
Furthermore, any significant increase in the selling prices of the products which we source from our suppliers will increase our
costs and may adversely affect our profit margin if we are not able to pass the increased costs on to our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
are no assurances that there will be no deterioration in our relationships with our major suppliers which could affect our ability
to secure sufficient supply of products for our business. In the event that our major suppliers change their sales or marketing
strategy or otherwise appoint other dealers or distributors who may compete with us, our business, financial condition and operating
results may be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>We
could be adversely affected by a change in consumer preferences, perception and spending habits and failure to develop or enrich
our product offering or gain market acceptance of our new products could have a negative effect on our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
market we operate is subject to changes in consumer preference, perception and spending habits. Our performance depends significantly
on factors which may affect the level and pattern of consumer spending in the market we operate. Such factors include consumer
preference, consumer confidence, consumer income and consumer perception of the safety and quality of our products. Media coverage
regarding the safety or quality of, or diet or health issues relating to, our products or the raw materials, ingredients or processes
involved in their manufacturing, may damage consumer confidence in our products. A general decline in the consumption of our products
could occur as a result of change in consumer preference, perception and spending habits at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any
failure to adapt our product offering to respond to such changes may result in a decrease in our sales if such changes are related
to certain of our products. Any changes in consumer preference could result in lower sales of our products, put pressure on pricing
or lead to increased levels of selling and promotional expenses. In any event a decrease in customer demand on our products may
also result in lower sales and slow down the consumption of our inventory to a low inventory turnover level. Any of these changes
could result in a material adverse effect on our business, financial conditions or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
success of our products depends on a number of factors including our ability to accurately anticipate changes in market demand
and consumer preferences, our ability to differentiate the quality of our products from those of our competitors, and the effectiveness
of our marketing and advertising campaigns for our products. We may not be successful in identifying trends in consumer preferences
and developing products that respond to such trends in a timely manner. We also may not be able to effectively promote our products
by our marketing and advertising campaigns and gain market acceptance. If our products fail to gain market acceptance, are restricted
by regulatory requirements, or have quality problems, we may not be able to fully recover our costs and expenses incurred in our
operation, and our business prospects, financial condition or results of operations may be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>If
we fail to maintain quality products and value, our sales are likely to be negatively affected.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
success depends on the safety and quality of products that we obtain from our suppliers for our customers. Our future customers
will identify our brand name with a certain level of quality and value. If we cannot meet this perceived value or level of quality,
we may be negatively affected and our operating results may suffer. In addition, any failure on the part of our suppliers to maintain
the quality of their products, will in turn substantially harm the results of our business operations, potentially forcing us
to identify other suppliers or alter our business strategy significantly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>If
we are unable to create brand influence, we may not be able to maintain current or attract new users and customers for our products.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
operational and financial performance is highly dependent on the strength of our brand. We believe brand familiarity and preference
will continue to have a significant role in winning customers as the decision to buy our products and services. In order to further
expand our customer base, we may need to substantially increase our marketing expenditures to enhance brand awareness through
various online and offline means. Moreover, negative coverage in the media of our company could threaten the perception of our
brand, and we cannot assure you that we will be able to defuse negative press coverage about our company to the satisfaction of
our investors, customers and suppliers. If we are unable to defuse negative press coverage about our company, our brand may suffer
in the marketplace, our operational and financial performance may be negatively impacted and the price of our shares may decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Currently,
we sell our products, with or without customization, under our brand name &#8220;ATP&#8221;, to domestic customers in Malaysia
and to overseas customers. However, if our competitors initiate a lawsuit against us for infringing their trademark, we may be
forced to adopt a new brand name for our products. As a result, we may incur additional marketing cost to raise awareness of such
new brand name. We may also be ordered to pay a significant amount of damages, and our business, results of operations and financial
condition could be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>We
may incur losses resulting from product liability claims or product recalls.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
may incur losses resulting from product liability claims with respect to our products supplied by our supplier. We may face claims
or liabilities which may arise if there exist any defects in quality of these products or any of these products are deemed or
proven to be unsafe, defective or contaminated. In the event that the use or misuse of any product distributed by us results in
personal injury or death, product liability and/or indemnity claims may be brought against us, in addition to our product recalls,
and the relevant regulatory authorities in the market we operate may close down some of our related operations and take administrative
actions against us. If we experience any business disruption and litigation, we may incur additional costs and have to divert
our management&#8217;s attention and resources on such matters, which may adversely affect our business, financial condition and
results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>We
operate in a heavily regulated industry.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
business is principally regulated by various laws and regulations in the market we operate, such as in Malaysia the Food Act of
1983 (Act 281) and Regulations, Control of Drugs and Cosmetics Regulations 1984 mandate authorization from the Food Safety and
Quality Division and National Pharmaceutical Regulatory Agency of the Ministry of Health for our Company&#8217;s products to be
sold in the country. Various registrations, certificates and/or licenses for the conduct of our business are required under the
above laws, which also contain provisions for requirements on the storage, labelling, advertising and importation of some of our
products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Based
on our experience, some of the laws and regulations of the place where we operate our business are subject to amendments, uncertainty
in interpretation and administrative actions from time to time. Therefore, we cannot assure you that, for the implementation of
our business plans and the introduction of any new product, we will be able to obtain all the necessary registrations, certificates
and/or licenses. Any failure to comply with the above laws and regulations may give rise to fines, administrative penalties and/or
prosecution against us, which may adversely affect our reputation, financial condition or results of operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being
disseminated to the public.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
management is responsible for establishing and maintaining adequate internal control over our financial reporting. As defined
in Exchange Act Rule 13a-15(f), internal control over financial reporting is a process designed by, or under the supervision of,
the principal executive and principal financial officer and effected by the board of directors, management and other personnel,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:
pertain to the maintenance of records in reasonable detail accurately and fairly reflect the transactions and dispositions of
the assets of the Company; provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are
being made only in accordance with authorizations of management and/or directors of the Company; and provide reasonable assurance
regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could
have a material effect on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the audits of our consolidated financial statements as of December 31, 2020, we and our independent registered
public accounting firms identified three &#8220;material weaknesses,&#8221; and other control deficiencies including significant
deficiencies in our internal control over financial reporting. A &#8220;material weakness&#8221; is a deficiency, or a combination
of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement
of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. The material
weaknesses identified related to the Company were: (i) insufficient full-time personnel with appropriate levels of accounting
knowledge and experience to monitor the daily recording of transactions, address complex U.S. GAAP accounting issues and to prepare
and review financial statements and related disclosures under U.S. GAAP; (ii) lack of a functional internal audit department or
personnel that monitors the consistencies of the preventive internal control procedures and lack of adequate policies and procedures
in internal audit function to ensure that the Company&#8217;s policies and procedures have been carried out as planned; (iii)
lack of adequate segregation of duties and effective risk assessment, which in turn may cause the Company to face the likelihood
of fraud or theft, due to poor oversight, governance and review to detect errors; (iv) we lack of proper procedures developed
for system change management policies. Critical change management control processes and procedures, such as change request and
approval, periodic status reporting, user testing and acceptance, post-implementation review, etc., were either not performed
or formally documented; (v) we lack of the following internal control procedures in relation of System and Data Security Access:
(a) authorization of new operating system-level user accounts created was not formally documented, (b) periodic review and recertification
of application, operating system, and database users and the user access rights was not performed, (c) procedures for periodic
review and analysis of application, operating system, and database-level audit logs were not documented or performed, manually
or through the use of software tools, (d) mandatory password settings, such as minimum length, complexity, reset frequency, failed
log-in attempts, password history, etc., were not deployed; and (vi) we lack of qualified person to be able to provide the tax
provision for the U.S. income taxes in connection with the Subpart F and GILTI taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
have taken measures and plan to continue to take measures to remedy these material weaknesses. The measures that we have taken
and are planning to take which includes, but not limited to, hired a chief financial officer who possesses U.S. GAAP and
SEC reporting knowledge and hiring more qualified accounting personnel with U.S. GAAP experiences. We are also seeking a U.S.
tax professional to assist in the preparation of the Subpart F and GILTI tax provisions. We also intend to form an internal
audit function and have plans to hire internal auditors to strengthen our overall governance. All internal auditors will be independent
of our operations and will report directly to the audit committee. The implementation of these measures may not fully address
the material weaknesses in our internal control over financial reporting, and we cannot conclude that they have been fully remedied.
Our failure to correct theses material weaknesses or our failure to discover and address any other material weaknesses could result
in inaccuracies in our financial statements and could also impair our ability to comply with applicable financial reporting requirements
and related regulatory filings on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Upon
completion of this offering, we will become subject to the Sarbanes-Oxley Act of 2002. Section 404 of the Sarbanes-Oxley Act,
or SOX 404, will require that we include a report from management on the effectiveness of our internal control over financial
reporting in our annual report on Form 10-K and in our quarterly report on Form 10-Q if we are qualified as an accelerated filer.
Our management may conclude that our internal control over financial reporting is not effective. Moreover, even if our management
concludes that our internal control over financial reporting is effective, our independent registered public accounting firm,
after conducting its own independent testing, may issue a report that is qualified if it is not satisfied with our internal controls
or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements
differently from us. In addition, after we become a public company, our reporting obligations may place a significant strain on
our management, operational and financial resources and systems for the foreseeable future. We may be unable to timely complete
our evaluation testing and any required remediation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During
the course of documenting and testing our internal control procedures, in order to satisfy the requirements of SOX 404, we may
identify other weaknesses and deficiencies in our internal control over financial reporting. In addition, if we fail to maintain
the adequacy of our internal control over financial reporting, as these standards are modified, supplemented or amended from time
to time, we may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in
accordance with SOX 404. If we fail to achieve and maintain an effective internal control environment, we could suffer material
misstatements in our financial statements and fail to meet our reporting obligations, which would likely cause investors to lose
confidence in our reported financial information. This could in turn limit our access to capital markets, harm our results of
operations, and lead to a decline in the trading price of our shares. Additionally, ineffective internal control over financial
reporting could expose us to increased risk of fraud or misuse of corporate assets and subject us to potential delisting from
the stock exchange on which we list, regulatory investigations and civil or criminal sanctions. We may also be required to restate
our financial statements from prior periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Legal
disputes or proceedings could expose us to liability, divert our management&#8217;s attention and negatively impact our reputation.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
may at times be involved in potential legal disputes or proceedings during the ordinary course of business operations relating
to product or other types of liability, employees&#8217; claims, labor disputes or contract disputes that could have a material
and adverse effect on our reputation, operation and financial condition. If we become involved in material or protracted legal
proceedings or other legal disputes in the future, the outcome of such proceedings could be uncertain and could result in settlements
or outcomes which adversely affect our financial condition. In addition, any litigation or legal proceedings could incur substantial
legal expenses as well as significant time and attention of our management, diverting their attention from our business and operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>If
we are unable to successfully develop and timely introduce new products or services or enhance existing products or services,
our business, financial condition and results of operations may be materially and adversely affected.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
must continually source, develop and introduce new products and services as well as improve and enhance our existing products
and services to maintain or increase our sales. The success of new or enhanced products or services may depend on a number of
factors including, anticipating and effectively addressing user preferences and demand, the success of our sales and marketing
efforts, effective forecasting and management of products and services demands, purchase commitments, and the quality of or defects
in our products. The risk of not meeting our customers&#8217; preferences and demands through our products and services may result
in a shift in market shares, as customers instead choose products and services offered by our competitors. This may result in
lower sales revenue, materially and adversely affecting our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fluctuations
in foreign currency exchange rates could have a material adverse effect on our financial results.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
earn revenues, pay expenses, own assets and incur liabilities in countries using currencies other than the U.S. dollar, including
Australian Dollar, Malaysian Ringgit and the Hong Kong Dollar. Because our consolidated financial statements are presented in
U.S. dollars, we must translate revenues, income and expenses, as well as assets and liabilities, into U.S. dollars at exchange
rates in effect during or at the end of each reporting period. Therefore, increases or decreases in the value of the U.S. dollar
against other currencies affect our net operating revenues, operating income and the value of balance sheet items denominated
in foreign currencies. We cannot assure you that fluctuations in foreign currency exchange rates, particularly the strengthening
of the U.S. dollar against major currencies would not materially affect our financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
business depends on the continued contributions made by Mr. How Kok Choong, as our key executive officer, the loss of who may
result in a severe impediment to our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
success is dependent upon the continued contributions made by our CEO and President, Mr. How Kok Choong. We rely on his expertise
in business operations when we are developing our business. We have no &#8220;Key Man&#8221; insurance to cover the resulting
losses in the event that any of our officer or directors should die or resign.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
Mr. How Kok Choong cannot serve the Company or is no longer willing to do so, the Company may not be able to find alternatives
in a timely manner or at all. This would likely result in a severe damage to our business operations and would have an adverse
material impact on our financial position and operating results. To continue as a viable operation, the Company may have to recruit
and train replacement personnel at a higher cost. Additionally, if Mr. How Kok Choong joins our competitors or develops similar
businesses that are in competition with our Company, our business may also be negatively impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
future success depends on our ability to attract and retain qualified long-term staff to fill management, technology, sales, marketing,
and customer services positions. We have a great need for qualified talent, but we may not be successful in attracting, hiring,
developing, and retaining the talent required for our success.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>If
we are not able to achieve our overall long-term growth objectives, the value of an investment in our Company could be negatively
affected.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
have established and publicly announced certain long-term growth objectives. These objectives were based on, among other things,
our evaluation of our growth prospects, which are generally driven by the sales potential of many product types, some of which
are more profitable than others, and on an assessment of the potential price and product mix. There can be no assurance that we
will realize the sales potential and the price and product mix necessary to achieve our long-term growth objectives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>We
face risks related to health epidemics, severe weather conditions and other outbreaks.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
recent years, there have been outbreaks of epidemics in various countries, including Malaysia. Recently, there was an outbreak
of a novel strain of coronavirus (COVID-19), which has spread rapidly to many parts of the world, including Malaysia. In March
2020, the World Health Organization declared the COVID-19 a pandemic. The epidemic has resulted in quarantines, travel restrictions,
and the temporary closure of stores and facilities in Malaysia for the past few weeks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be
materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general.
Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge
regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain
the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to,
the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>We
face risks related to health epidemics, severe weather conditions and other outbreaks.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">t</span><span style="font: 10pt Times New Roman, Times, Serif">emporary
    closure of offices, travel restrictions, financial impact of our customers or suspension supplies may negatively affected,
    and could continue to negatively affect, the demand for our products;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">our
    customer may require additional time to pay us or fail to pay us at all, which could significantly increase the amount of
    accounts receivable and require us to record additional allowances for doubtful accounts. We may have to provide significant
    sales incentives to our sole customer during the outbreak, which may in turn materially adversely affect our financial condition
    and operating results;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">a</span><span style="font: 10pt Times New Roman, Times, Serif">ny
    disruption of our supply chain, logistics providers or customers could adversely impact our business and results of operations,
    including causing us or our suppliers to cease manufacturing for a period of time or materially delay delivery to our customers,
    which may also lead to loss of our customers; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">t</span><span style="font: 10pt Times New Roman, Times, Serif">he
    global stock markets have experienced, and may continue to experience, significant decline from the COVID-19 outbreak and
    the marketable securities that we have invested in could be materially adversely affected, which may lead to significant impairment
    in the fair values of our investments and in turn materially adversely affect our financial condition and operating results.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the coronavirus
cannot be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar
level year over year in the fiscal year 2021. We may have to record downward adjustments or impairment in the fair value of investments
in the fiscal year 2021, if conditions have not been significantly improved and global stock markets have not recovered from recent
declines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">In
general, our business could be adversely affected by the effects of epidemics, including, but not limited to, the COVID-19, avian
influenza, severe acute respiratory syndrome (SARS), the influenza A virus, Ebola virus, severe weather conditions such as flood
or hazardous air pollution, or other outbreaks. In response to an epidemic, severe weather conditions, or other outbreaks, government
and other organizations may adopt regulations and policies that could lead to severe disruption to our daily operations, including
temporary closure of our offices and other facilities. These severe conditions may cause us and/or our partners to make internal
adjustments, including but not limited to, temporarily closing down business, limiting business hours, and setting restrictions
on travel and/or visits with clients and partners for a prolonged period of time. Various impact arising from a severe condition
may cause business disruption, resulting in material, adverse impact to our financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Risks
Related to our Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
business and reputation may be affected by product liability claims, litigation, customer complaints, product tampering, food
safety issues, food-borne illnesses, health threats, quality control concerns or adverse publicity relating to our products. Product
liability insurance of our supplier may not cover our liability sufficiently or at all.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Like
other consumer product manufacturers, sale of our products involves an inherent risk of our products being found to be unfit for
consumption or cause illness. Products may be rendered unfit for consumption due to raw materials or product contamination or
degeneration, presence of microbials, illegal tampering of products by unauthorized third parties or other problems arising during
the various stages of the procurement, production, transportation and storage processes. The occurrence of such problems may result
in customer complaints, fines, penalties or adverse publicity causing serious damage to our reputation and brand, as well as product
liability claims, other legal disputes and loss of revenues. Under certain circumstances, we may be required to recall our products.
Even if a situation does not necessitate a product recall, we cannot assure you that product liability claims or other legal disputes
will not be asserted against us as a result. Product liability insurance of our supplier may not cover our liability sufficiently
or at all and will not cover liability that arises out of our default such as mishandling, poor storage condition and/or contamination
of the products by us. As a result, a product liability or other judgment against us, or a product recall, could have a material
adverse effect on our business, financial condition or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
business is susceptible to food-borne illnesses. We cannot assure you that we are able to effectively prevent all diseases or
illnesses caused by our products or contamination of our products. Furthermore, our reliance on third-party product suppliers
means that food-borne illness incidents could be caused by our suppliers outside of our control. New illnesses may develop in
the future, or diseases with long incubation periods could arise that could give rise to claims or allegations on a retroactive
basis. Reports in the media of instances of food-borne illnesses or health threats of our products or any of their major ingredients
could adversely and significantly affect our sales, and have significant negative impact on our results of operations. This risk
exists even if it were later determined that the illness or health threat in fact was not caused by our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
addition, adverse publicity about health and safety concerns, whether unfounded or not, may discourage consumers from buying our
products. Even if a product liability claim is unsuccessful or is not fully pursued, the negative publicity surrounding any assertion
that our products caused personal injury or illness could adversely affect our reputation and our corporate and brand image. If
consumers were to lose confidence in our brand and reputation, we could suffer long-term or even permanent declines in our sales
and results of operation. The amount of negative news, customers complaints and claims against us may also be very costly and
may divert our management&#8217;s attention from our business operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Increased
competition and capabilities in the marketplace could hurt our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
market where we operate is highly competitive. We compete with other companies that operate in multiple geographic areas, as well
as numerous companies that are primarily regional or local in operation. Our ability to gain or maintain share of sales in the
market where we operate or in various local markets may be limited as a result of actions by competitors. If we do not continue
to strengthen our capabilities in marketing and innovation to maintain our brand loyalty and market share while we selectively
expand into other product categories, our business could be negatively affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Risks
Related to our Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>The
market price of our shares is likely to be highly volatile and subject to wide fluctuations in response to factors such as:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">variations
    in our actual and perceived operating results, especially during this time when the COVID-19 pandemic poses a threat;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">news
    regarding gains or losses of customers or suppliers by us or our competitors;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">news
    regarding gains or losses of key personnel by us or our competitors;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">announcements
    of competitive developments, acquisitions or strategic alliances in our industry by us or our competitors;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">changes
    in earnings estimates or buy/sell recommendations by financial analysts;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">potential
    litigation;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    imposition of fines or penalties related to our activities in the market where we operate and failure to comply with applicable
    rules and regulations;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">general
    market conditions or other developments affecting us or our industry; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    operating and stock price performance of other companies, other industries and other events or factors beyond our control.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
addition, the securities markets have from time-to-time experienced significant price and volume fluctuations that are not related
to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market
price of the shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>We
may never be able to pay dividends and are unlikely to do so.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">To
date, we have not paid, nor do we intend to pay in the foreseeable future, dividends on our common stock, even if we become profitable.
Earnings, if any, are expected to be used to advance our activities and for working capital and general corporate purposes, rather
than to make distributions to stockholders. Since we are not in a financial position to pay dividends on our common stock and
future dividends are not presently being contemplated, investors are advised that return on investment in our common stock is
restricted to an appreciation in the share price. The potential or likelihood of an increase in share price is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
addition, under Nevada law, we may only pay dividends subject to our ability to service our debts as they become due and provided
that our assets will exceed our liabilities after the dividend. Our ability to pay dividends will therefore depend on our ability
to generate sufficient profits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Shareholders
may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Wherever
possible, our board of directors will attempt to use non-cash consideration to satisfy obligations. In many instances, we believe
that the non-cash consideration will consist of shares of our common stock, warrants to purchase shares of our common stock or
other securities. Our board of directors has authority, without action or vote of the shareholders, to issue all or part of the
authorized but unissued shares of common stock or warrants to purchase such shares of common stock. In addition, we may attempt
to raise capital by selling shares of our common stock, possibly at a discount to market in the future. These actions will result
in dilution of the ownership interests of existing shareholders and may further dilute common stock book value, and that dilution
may be material. Such issuances may also serve to enhance existing management&#8217;s ability to maintain control of us, because
the shares may be issued to parties or entities committed to supporting existing management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_004"></span>ITEM
1B. UNRESOLVED STAFF COMMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_005"></span>ITEM
2. PROPERTIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Business
support services are rendered from:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
                                         principal executive office at</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">1705
        &#8211; 1708, Level 17, Tower 2,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Faber
        Towers, Jalan Desa Bahagia,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Taman
        Desa, 58100 Kuala Lumpur, Malaysia.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Room
                                         2708-9, 2F,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
        Metropolis Tower,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">10
        Metropolis Drive, Hunghom,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Kowloon,
        Hong Kong.</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_006"></span>ITEM
3. LEGAL PROCEEDINGS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business.
Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that
may harm our business. There are currently no pending legal proceedings or claims that we believe will have a material adverse
effect on our business, financial condition or operating results. None of our directors, officers or affiliates is involved in
a proceeding adverse to our business or has a material interest adverse to our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_007"></span>ITEM
4. MINE SAFETY DISCLOSURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="c_008"></span>PART
II</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_009"></span>ITEM
5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Our
Common Stock is currently listed on the OTC Markets &#8211; Pink Sheets under the trading symbol &#8220;ATTP.&#8221; There is
no active trading market in the Company&#8217;s securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, we had 376,452,047 shares of our Common Stock par value, $0.0001 issued and outstanding. There were 1,241
record holders of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
transfer agent is VStock Transfer, LLC, with an address at 18, Lafayette Place, Woodmere, New York 11598 and telephone number
is +1 (212)828-843.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Dividend
Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any
future determination as to the declaration and payment of dividends on shares of our Common Stock will be made at the discretion
of our board of directors out of funds legally available for such purpose. We are under no contractual obligations or restrictions
to declare or pay dividends on our shares of Common Stock. In addition, we currently have no plans to pay such dividends. Our
board of directors currently intends to retain all earnings for use in the business for the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Currently,
there are no equity compensation plan in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Unregistered
Sales of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Purchases
of Equity Securities by the Registrant and Affiliated Purchasers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
have not repurchased any shares of our common stock during the twelve months ended December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_010"></span>ITEM
6. SELECTED FINANCIAL DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth selected financial data as of December 31, 2020 and 2019 and for the years ended December 31, 2020
and 2019. This selected financial data should be read in conjunction with the consolidated financial statements and related notes
included in Item 15 of this Annual Report. Financial data for the year ended December 31, 2019 was derived from the six months
audited financial statement ended December 31, 2019 and the results from the interim financial statements from January 1, 2019
to June 30, 2019 as the Company changed its fiscal year from June 30 to December 31.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years
    Ended</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2019</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,290,131</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income (loss)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">354,766</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(716,127</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income
    (loss) per share &#8211; (basic and diluted)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,210,607</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,335,274</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,285,773</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,988</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><br /></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_011"></span>ITEM
7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>The
following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated
financial statements and the notes to those financial statements appearing elsewhere in this Report.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Certain
statements in this Report constitute forward-looking statements. These forward-looking statements include statements, which involve
risks and uncertainties, regarding, among other things, (a) our projected sales, profitability, and cash flows, (b) our growth
strategy, (c) anticipated trends in our industry, (d) our future financing plans, and (e) our anticipated needs for, and use of,
working capital. They are generally identifiable by use of the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221;
&#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;continuing,&#8221;
&#8220;ongoing,&#8221; &#8220;expects,&#8221; &#8220;management believes,&#8221; &#8220;we believe,&#8221; &#8220;we intend,&#8221;
or the negative of these words or other variations on these words or comparable terminology. In light of these risks and uncertainties,
there can be no assurance that the forward-looking statements contained in this filing will in fact occur. You should not place
undue reliance on these forward-looking statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>The
forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities
laws, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date on
which the statements are made or to reflect the occurrence of unanticipated events.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Overview</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation, a Nevada corporation (&#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on June
1, 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn.
Bhd., an entity incorporated in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
Superior Living Sdn. Bhd. (&#8220;ASL&#8221;) is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (&#8220;WATP&#8221;), a wholly owned
subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by
providing services that includes online editorials, programs, events and campaigns on</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">how
to achieve positive wellness and lifestyle. Upon the establishment of WATP, WATP starts collaborating with ASL to carry out its
Wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company
is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood
circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients.
The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#8220;ATP Zeta
Health Program&#8221;, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy
dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in
our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
order to strengthen the Company&#8217;s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99%
of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the
past 15 years. ASL has been offering the Company&#8217;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition
creates synergy in the Company&#8217;s operation by boosting the Company&#8217;s retail and marketing capabilities. The newly
acquired subsidiary allows the Company to fulfill its mission of &#8220;helping people to create health and wealth&#8221; by providing
a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy
lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health
solution advisory services; and therefore incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry
out various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#201;NERG&#201;TIQUE
and BEAUNIQUE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases
caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health
and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well
as trained members and distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
&#201;NERG&#201;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level.
The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
BEAUNIQUE product series focuses on the research of our diet&#8217;s impact on modifying gene expressions in order to address
genetic variations and deliver a nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Results
of Operation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">For
the years ended December 31, 2020 and 2019</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company generated revenue of $3,452,621 for the year ended December 31, 2020 as compared to $1,290,131 for the year ended December
31, 2019, representing a significant increase of $2,162,490 or approximately 167.6%. The revenue was predominately derived from
the increased sales of health and wellness products as a result from the acquisition of ASL, which brought us to a large group
of customers in an established network marketing sales channel that were established in Malaysia for the past 15 years. For the
year ended December 31, 2019, we were only making sales to our related party, Agape S.E.A. Sdn Bhd, on wholesale basis when they
placed the purchase orders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Cost
of Revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of revenue for the year ended December 31, 2020 amounted to $775,855 as compared to $1,200,829 for the year ended December 31,
2019, representing a decrease of $424,974 or approximately 35.4%. The cost of revenue comprised cost of goods purchased and packing
materials. The cost of revenue for the current reporting year was predominately incurred by ASL for its distribution activities
to its members, while the cost of revenue for last year was related to wholesale business of the Company prior to the acquisition
of ASL. In addition, the Company also incurred less cost of revenue for 2020 due to the cost saving for adding a local supplier
rather than fully dependence on its foreign suppliers resulted from higher freight-in cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Gross
Profit</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Gross
profit for the year ended December 31, 2020 amounted to $2,676,766 as compared to $89,302 for the year ended December 31, 2019.
Gross margin for the year ended December 31, 2020 was approximately 77.5% as compared to approximately 6.9% for the year ended
December 31, 2019. The significant increase in gross profit was mainly due to the increase in revenue as a result from the operation
of ASL, which brought us to a large group of customers in an established network marketing sales channel. For the year ended December
31, 2020, we generated higher gross margins of selling our products directly to the customers in the network channel as compared
to the year ended December 31, 2019, which we generated a much lower gross margins from our sales to our related party, Agape
S.E.A. Sdn Bhd, wholesales customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Operating
Expenses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
operating expenses consist of selling expenses, commission expenses and general and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Selling
expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Selling
expenses for year ended December 31, 2020 amounted to $376,582 as compared to $7,846 for the year ended December 31, 2019, representing
a significant increase of $368,736 or approximately 4,699.7%. The significant increase was predominately due to the acquisition
of ASL which attributed additional selling expenses to our operations and resulted from the increase of approximately $254,000
salary and employee benefit expenses of our employees in ASL&#8217;s sales center for the year ended December 31, 2020. As compared
to the same period in 2019, we did not have any employees on our sales team. The significant increase was also attributable to
the increase of approximately $33,000 credit card charges of processing sales transactions from our customers, the increase of
approximately $38,000 of promotional and event expenses as we have more events and gifts to promote our products and the increase
of other miscellaneous selling expenses of approximately $43,000 as we spend more resources to expand our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Commission
expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Commission
expenses were $830,659 and $0 for the years ended December 31, 2020 and 2019, respectively, representing a significant increase
of $830,659 or 100.0%. The significant increase in commission expenses was due to the acquisition of ASL which brought us to a
new marketing channel which pays commissions to distributors and members in network sales marketing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>General
and administrative expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">General
and administrative expenses for the year ended December 31, 2020 amounted to $1,627,660, as compared to $396,048 for the year
ended December 31, 2019, representing a significant increase of $1,231,612 or approximately 311.0%. The significant increase was
predominately due to the increase of professional fees of approximately $555,000 as we have recently hired new professional firms
located in the U.S. and Hong Kong, including legal counsel, auditor, and financial reporting consultant, to strengthen our current
Securities and Exchange Commission (&#8220;SEC&#8221;) listing reporting documents and to continue to stay compliant and professional
services incurred in relation to the acquisition of ASL during the year ended December 31, 2020 as compared to the same period
in 2019, we were using local professional firms in Malaysia. Professional fee incurred by the U.S. and Hong Kong firms are generally
higher than the professional fees incurred by the Malaysia firms. The significant increase of general and administrative expenses
was also attributable to the acquisition of ASL with approximately $677,000 additional general and administrative expenses to
our operations, which mainly comprised of rental expenses, salary and employee benefit expenses and depreciation expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Other
Income (Expenses)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, other income, net was $674,482 as compared to $408,500 other expenses, net for the year ended
December 31, 2019, representing a significant increase of $1,082,982 or approximately 265.1%. The net other income of $674,482
derived during the year ended December 31, 2020 comprised of interest income of $49,203, other income of $38,051, foreign currency
gain of $77,029, unrealized holding gain on marketable securities of $350,137 and dividend income from marketable securities of
$160,062. The net other expenses of $408,500 incurred during the year ended December 31, 2019 comprised other income of $36,301,
$26,085 on loss from our equity investment, unrealized holding loss on marketable securities of $68,391, $16,509 on gain on deemed
disposal of shares in investee company and $366,834 of impairment loss in our equity investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Provision
for (Benefit of) Income Taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded provision for (benefit of) income taxes $161,581 and $(6,965) for the years ended December 31, 2020 and 2019,
respectively. During the year ended December 31, 2020, we generated taxable income in ASL that are subject to a unified 24% income taxes
rate which include current period provision as well as deferred tax assets which the Company utilized on prior periods losses in
ASL. On the other hand, during the year ended December 31, 2019, we incurred taxable losses that can be carried forward for 7 years,
which resulted in recognition of deferred tax assets on net operating loss and income taxes benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Net
Income (Loss)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net
income was $354,766 for the year ended December 31, 2020, changed from net loss of $716,127 for the year ended December
31, 2019, predominately due to reasons as discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Liquidity
and Capital Resources</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
March 11, 2020, the World Health Organization or WHO declared the corona virus or COVID-19 a pandemic. To help counter the transmission
of COVID-19, the government of Malaysia initiated movement control orders (&#8220;MCO&#8221;), the first effective March 18, 2020.
The MCO had resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia. The
first MCO was extended three times, each for a two-weeks period, until May 12, 2020. On May 13, 2020, the MCO was eased to a Conditional
Movement Control Order (&#8220;CMCO&#8221;) where most business sectors were allowed to operate under strict rules and Standard
Operating Procedures mandated by the government of Malaysia. The CMCO was further relaxed, and on June 8, 2020, Malaysia moved
into the Recovery Movement Control Order (&#8220;RMCO&#8221;). Due to a resurgence of COVID-19, CMCO was reimposed in the state
of Sabah, Selangor, Kuala Lumpur and Putrajaya effective October 14, 2020. On November 7, 2020, the CMCO was extended to a wider
geographical area to include another six states in the country. Effectively, ten of thirteen states in Malaysia were placed under
CMCO with the exceptions of Perlis, Pahang and Kelantan. On January 1, 2021, the Government of Malaysia extended the Recovery
Movement Control Order (&#8220;RMCO&#8221;) through March 31, 2021. On January 12, 2021, the Malaysian government declared a state
of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the country.
On March 5, 2021, lockdowns in most part of the country was eased to a CMCO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be
materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general.
Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge
regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain
the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to,
the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">temporary
    closure of offices, travel restrictions, disruption or suspension of supplies, our customers may be negatively impacted financially
    resulting in which the demand for our products may be adversely affected;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">we
    may have to provide significant sales incentives to our customers during the outbreak, which may in turn materially adversely
    affect our financial condition and operating results; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">any
    disruption of our supply chain, logistics providers or customers could adversely impact our business and results of operations,
    including causing us or our suppliers to cease manufacturing for a period of time or materially delay delivery to our customers,
    which may also lead to loss of our customers.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Although
some of the countries from which our products are sourced are experiencing lockdowns, industries involve in the provision of food
especially health products and pharmaceuticals are normally exempted. We may experience slight delay in products delivery lead
time but barring unforeseen circumstances, the setback should be temporary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
currently operating primarily in Malaysia and anticipate expanding into the Asian markets in the future, with a particular focus,
at least initially, on expanding into Thailand, Indonesia and Taiwan. We will explore expansion via e-commerce. When the pandemic
has subsided or is over and restrictions on travelling between nations are uplifted, we will set up offices in the countries in
which we operate to better service our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19
cannot be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar
level year over year in 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, we had working capital of $4,645,729 consisting of cash in bank of $1,112,147 and time deposits of $2,391,182
as compared to working capital of $3,452,665 consisting of cash in bank of $238,937 and time deposits of $2,505,520 as of December
31, 2019. In assessing our liquidity, we monitor and analyze our cash on-hand and our operating expenditure commitments. Our liquidity
needs are to meet our working capital requirements and operating expenses obligations. We believe we will have sufficient resource
to fund our working capital needs for the next 12 months from the date of issuance of this Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Year Ended</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Six Months Ended</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2019</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, 2019</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash used in operating
    activities</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(557,951</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(704,418</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(113,945</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash provided by (used in) investing
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,276,200</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash used in financing activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(22,091</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,573</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Effect of exchange
    rate on cash and cash equivalents</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">76,985</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,031</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">815</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net change in
    cash and cash equivalents</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">773,143</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(708,460</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(113,130</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Operating
activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net
cash used in operating activities for the year ended December 31, 2020 was $557,951 and were mainly comprised of the non-cash
income on unrealized holding gain on marketable securities of $350,137 and dividend income from marketable securities of $160,062,
the increase of accounts receivables of $165,149, the decrease of customer deposits of $1,421,886 and the payment of operating
lease liabilities of $105,009. The net cash used in operating activities was mainly offset by the net income of $354,766, the
non-cash depreciation and amortization expense of $56,912, amortization of operating right-of-use assets of $106,561, deferred
tax provision of $178,329, the decrease in inventories of $78,674, the decrease in prepaid taxes of $184,985, the decrease in
prepayments and deposits, including related party of $352,577, and the increase in other payables and accrued liabilities of $336,709.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net cash used in operating activities for
the year ended December 31, 2019 was $704,418 and were mainly comprised of net loss of $716,127, the non-cash expense of gain
on deemed disposal of shares in Investee Company of $16,509, the increase of related party accounts receivable of $518,940, the
decrease in income taxes payables of $6,965, and the decrease in customer deposits of $217,743. The net cash used in operating
activities was mainly offset by the non-cash expense of loss from equity investment of $26,085, unrealized holding loss on marketable
securities of $68,391 and the impairment loss in equity investment of $366,834, the decrease of prepayments and deposits of $241,372,
and the increase in other payables and accrued liabilities of $68,557.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net
cash used in operating activities for the six months ended December 31, 2019 was $113,945 and mainly comprised of net loss of
$338,931, the increase of accounts receivable &#8211; related party of $85,602 and the decrease of accounts payable (including
related party) of $32,308 offset by the non-cash expense on unrealized holding loss on marketable securities of $68,391, the decrease
in prepayments and deposits of $229,638, and the increase in other payables and accrued liabilities of $44,867.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Investing
activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net
cash provided by investing activities for the year ended December 31, 2020 was $1,276,200, which were in respect of cash and cash
equivalents acquired through acquisition of ASL of $1,210,818, partial proceeds collected from the sale of our non-marketable
securities of $70,173 and proceeds from sale of investment in marketable securities of $121, offset by purchase of equipment and
intangible assets of $4,912.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net
cash used in investing activities for the year ended December 31, 2019 was $1,500 which was due to the investment in non-marketable
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
were no investing activities for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financing
activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net
cash used in financing activities for the year ended December 31, 2020 was $22,091 which were mainly comprised of payment of deferred
offering cost of $249,525 offset by repayments from related parties of $227,434.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net
cash used in financing activities for the year ended December 31, 2019 was $4,573 which were due to the repayment to a director
of $5,318 offset by repayment from related parties of $745.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
were no financing activities for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Credit
Facilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
do not have any credit facilities or other access to bank credit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Off-Balance
Sheet Arrangements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current
or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations,
liquidity, capital expenditures or capital resources that are material to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Critical
Accounting Polices</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date
of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant
accounting estimates reflected in the Company&#8217;s consolidated financial statements include allowance for doubtful accounts,
allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment
of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain
tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers
(ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not
result in an adjustment to retained earnings upon adoption of this new guidance as the Company&#8217;s revenue was recognized
based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer
of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in
such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should
be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company&#8217;s
revenue streams are recognized at a point in time for the Company&#8217;s sale of health and wellness products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that
the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine
the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will
not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue
when (or as) the Company satisfies the performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including
payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive
evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability
is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred
and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted
by the customer when the products are collected by the customer at the Company&#8217;s office. Revenue is recorded net of sales
discounts, returns, allowances, and other adjustments that are based upon management&#8217;s best estimates and historical experience
and are provided for in the same period as the related revenues are recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes
in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy
for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance
and confirmed that there were no differences in the pattern of revenue recognition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Sales
of Health and Wellness products</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-
Performance obligations satisfied at a point in time</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control
of the health and wellness products are transferred to its customer at the Company&#8217;s office or shipment of the goods, which
is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after
all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products
are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the
value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash
proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction
of the health and wellness products transaction price upon such sales transactions occurred. The Company&#8217;s coupons have
a validity period of six months. If the Company&#8217;s customers did not utilize the coupons after six months, the Company would
recognize the forfeiture of the originated sales value of the coupons as net revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Sales
of Health and Wellness services</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-
Performance obligations satisfied at a point in time</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company carries out its Wellness program, where the Company&#8217;s products are bundled with health screening test and a health
camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises
to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced
by the fact that the Company provides separate services of delivering the health screening test report and allowing admission
of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues
being recognized when the test reports are completed and delivered to its customers. The Company also separately derives its revenues
from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final
day of the health camp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Fair
value of financial instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments
and requires disclosure of the fair value of financial instruments held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement
and enhance disclosure requirements for fair value measures. The three levels are defined as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
    that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
    instruments.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or
cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected
realization and their current market rates of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Recent
accounting pronouncements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption
of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations,
as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#8212;Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for
the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology.
The amendments in Update 2016-13 added Topic 326, Financial Instruments&#8212;Credit Losses, and made several consequential amendments
to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually
assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial
Instruments&#8212; Credit Losses&#8212;Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders&#8217;
concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at
amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information
by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief
also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement
users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date
of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit
losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December
15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company
is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and
investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and
purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify
that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting
when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting.
With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance
in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the
purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity
method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods
beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not
expect the adoption of this standard to have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_012"></span>ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Foreign
exchange risk</i>. Substantially most of our revenues are denominated in the U.S. dollar while most of our expenses are denominated
in Malaysian Ringgit and Hong Kong Dollar. We do not believe that we currently have any significant direct foreign exchange risk
and have not hedged exposures denominated in foreign currencies or any other derivative financial instruments. Although in general,
our exposure to foreign exchange risks should be limited, the value of an investment in our Common Stock may be affected by the
foreign exchange rate between U.S. dollar and Malaysian Ringgit; and U.S. dollar and Hong Kong Dollar because the value of our
business is effectively denominated in Malaysian Ringgit and Hong Kong Dollar, while the Common Stock is traded in U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Credit
risk</i>. Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company
believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation
process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates
the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical
trends and other information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_013"></span>ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
financial statements required by this item are located in PART IV of this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_014"></span>ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_015"></span>ITEM
9A. CONTROLS AND PROCEDURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Disclosure
Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Disclosures
Control and Procedures</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control
over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by,
or under the supervision of, the company&#8217;s principal executive and principal financial officers and effected by the company&#8217;s
board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted
in the United States of America and includes those policies and procedures that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pertain
    to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of
    the assets of the company;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Provide
    reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
    with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company
    are being made only in accordance with authorizations of management and directors of the company; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Provide
    reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company&#8217;s
    assets that could have a material effect on the financial statements.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes
in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems,
no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only
reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of
internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control
over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore,
it is possible to design into the process safeguards to reduce, though not eliminate, this risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, management assessed the effectiveness of our internal control over financial reporting based on the criteria
for effective internal control over financial reporting established in Internal Control&#8212;Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;) and SEC guidance on conducting such assessments.
Based on such evaluation, the Company&#8217;s management concluded that, during the period covered by this Report, internal controls
and procedures over financial reporting were not effective. This was due to deficiencies that existed in the design or operation
of our internal controls over financial reporting that adversely affected our internal controls and that may be considered to
be material weaknesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Identified
Material Weakness</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A
material weakness in internal control over financial reporting is a control deficiency, or combination of control deficiencies,
that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or
detected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management identified the following material
weakness during its assessment of internal controls over financial reporting as of December 31, 2020: (i) we did not have
sufficient full-time personnel with appropriate levels of accounting knowledge and experience to monitor the daily recording of
transactions, address complex U.S. GAAP accounting issues and to prepare and review financial statements and related disclosures
under U.S. GAAP; (ii) we lack of a functional internal audit department or personnel that monitors the consistencies of
the preventive internal control procedures; lack of adequate policies and procedures in internal audit function to ensure that
our policies and procedures have been carried out as planned; (iii) we do not have adequate segregation of duties and effective
risk assessment. Lack of segregation of duties and effective risk assessment may cause us to face the likelihood of fraud
or theft, due to poor oversight, governance and review to detect errors; (iv) we lack of proper procedures developed for system
change management policies. Critical change management control processes and procedures, such as change request and approval,
periodic status reporting, user testing and acceptance, post-implementation review, etc., were either not performed or formally
documented; (v) we lack of the following internal control procedures in relation of System and Data Security Access: (a) authorization
of new operating system-level user accounts created was not formally documented, (b) periodic review and recertification of application,
operating system, and database users and the user access rights was not performed, (c) procedures for periodic review and analysis
of application, operating system, and database-level audit logs were not documented or performed, manually or through the use
of software tools, (d) mandatory password settings, such as minimum length, complexity, reset frequency, failed log-in attempts,
password history, etc., were not deployed; and (vi) we lack of qualified person to be able to provide the tax provision for
the U.S. income taxes in connection with the Subpart F and GILTI taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accordingly,
the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the
annual or interim financial statements will not be prevented or detected on a timely basis by the company&#8217;s internal controls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal
control over financial reporting as of December 31, 2020 based on criteria established in Internal Control&#8212;Integrated Framework
issued by COSO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Management&#8217;s
Remediation Initiatives</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we will prepare
written policies and procedures for accounting and financial reporting with respect to the requirements and application of both
US GAAP and SEC guidelines, to establish a formal process to close our books monthly on an accrual basis and account for all transactions,
including equity and debt transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">To
further strengthen the Company&#8217;s internal controls, we have:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(i)
Hired 6 additional employees, with appropriate levels of accounting knowledge and experience to monitor the daily recording of
transactions and prepare financial statements; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(ii)
appointed a chief financial officer on January 12, 2021 with appropriate levels of accounting knowledge and experience to monitor
the recording of transactions, address complex U.S. GAAP accounting issues and to review financial statements and related disclosures
under U.S. GAAP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
plan to initiate the following measures going forward:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
    intend to establish an internal audit function with assessment of Sarbanes-Oxley compliance requirements and improvement of
    overall internal control.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Once
    we hire additional employees, we intend to initiate a comprehensive training program and development plan to provide ongoing
    company-wide trainings regarding internal control and requirements of U.S. GAAP financial statements and related disclosures,
    with particular emphasis on our accounting staff.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">3.</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">We are seeking a U.S. tax professional to assist
    in the preparation of the Subpart F and GILTI tax provisions.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
anticipate that these initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Changes
in internal controls over financial reporting</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
were no significant changes in our internal controls over financial reporting that occurred during the period covered by this
Report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">This
annual report does not include an attestation report of the Company&#8217;s registered independent public accounting firm regarding
internal control over financial reporting. Management&#8217;s report was not subject to attestation by the Company&#8217;s registered
independent public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide
only management&#8217;s report in this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_016"></span>ITEM
9B. OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="c_017"></span>PART
III</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_018"></span>ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Our
executive officer&#8217;s and director&#8217;s and their respective ages as of the date hereof are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NAME</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGE</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 57%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>POSITION</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">How
    Kok Choong</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer, President, Secretary, Treasurer, Director</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Mohd
    Shaharuddin Bin Abdullah</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Director</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Andrew
    Lee Kam Fan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Financial Officer</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Set
forth below is a brief description of the background and business experience of our executive officer and director for the past
five years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">How
Kok Choong - President, Chief Executive Officer, Secretary, Treasurer, Director</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
How Kok Choong earned a Master and Doctorate in Business Administrative from Newport University, USA. In 2004 Mr. How began to
work as Global President of AGAPE Superior Living International Group, and continues to hold this position. AGAPE Superior Living
International Group is a leading health and wellness company in nine countries. Additionally, from 2010 to present Mr. How has
served as President of TH3 Holdings Sdn Bhd, a company specialized in IT, academics, online education, mobile Apps, e-Commerce
and digital marketing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
Malaysia, Mr. How received the Outstanding Asian Community Contribution Award in 2011, Malaysia Top Team 50 Enterprise Award in
2011, The Contributor Award (Medical and Health Research) in 2012, &#8220;Man of The Year&#8221; in Worldwide Excellence Award
in 2015, &#8220;Man of The Year&#8221; in McMillan Global Award in 2016 and The Distinguished Asia Pacific Outstanding Entrepreneur
Lifetime Achievement Award in 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
How&#8217;s strong academic background and business experience and numerous qualifications have led the Board of Directors to
reach the conclusion that he should serve as our Chief Executive Officer and Director of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Mohd
Shaharuddin Bin Abdullah- Director</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mohd
Shaharuddin Bin Abdullah, was appointed as an executive director of the Board on January 12, 2021. Prior to joining the Company,
Mr. Shaharuddin has approximately 24 years of banking industry background and approximately 8 years of accounting and finance
related experience. From October 2013 to October 2016, Mr. Shaharuddin served as the assistant director and the head of consumer
credit management at Kuwait Finance House (M) Berhad. From April 2010 to October 2012, Mr. Shaharuddin served as the associate
director head of special projects at Danajamin Nasional Berhad, and was later seconded to head the corporate debt restructuring
committee, a unit incorporated by Bank Negara Malaysia. From January 2006 to April 2010, Mr. Shaharuddin served as the first vice
president and the head of the corporate loans and special assets management division at AffinBank Berhad. From January 2002 to
December 2005, Mr. Shaharuddin served as an assistant general manager of operations department at Pengurusan Danaharta Nasional
Berhad. From January 1984 to December 2001, Mr. Shaharuddin served as the internal auditor, a branch manager, a regional manager
at Interfinance Berhad, which was merged with RHB Bank Bhd. in 2000 and Mr. Abdullah served as the head of monitoring and collection
division post-merger. From January 1980 to December 1983, Mr. Shaharuddin served as an investment officer and subsequently an
assistant project accountant at Permodalan Bumiputra Sabah Berhad. From October 1976 to December 1979, Mr. Shaharuddin served
as an executive officer at Bank Negara Malaysia. Mr. Shaharuddin has been an associate member of the Asian Institute of Chartered
Bankers since April 1998. Mr. Shaharuddin received his diploma in accountancy at Universiti Teknoloji Mara in 1976, his diploma
in banking and finance and Certified Credit Professional I from the Asian Institute of Chartered Bankers in 1992 and 2001, respectively,
and his master&#8217;s degree in business administration from MBA-USA (Off Campus) in 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Andrew
Lee Kam Fan</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Lee
Kam Fan, Andrew, age 59, was appointed as the chief financial officer of the Company on January 12, 2021. Prior to joining the
Company, Mr. Lee has approximately 38 years of accounting and finance related experience. Since July 2014, Mr. Lee has been the
proprietor of Andrew Lee &amp; Company. Since June 2010, Mr. Lee served as an adjunct lecturer of the HKICPA Processional Examinations
Preparatory Programme at HKU Space. From January 2011 to October 2015, Mr. Lee served as the managing director at ANSA CPA Limited.
From September 2010 to October 2012, Mr. Lee served as an independent non-executive director at Sunrise (China) Technology Group
Limited (currently referred to as KOALA Financial Group Limited (Hong Kong stock code: 08226)). From March 2006 to April 2017,
Mr. Lee was in cooperation with Friedman LLP to oversee financial statements are prepared in accordance with U.S. GAAP. From October
2000 to December 2010, Mr. Lee served as an audit manager and subsequently a partner at Clodick &amp; Company. From April 1998
to September 2000, Mr. Lee served as a director at Nitwell Business Services Limited. From August 1994 to April 1998, Mr. Lee
was an assistant audit manager at Cheng, Kwok &amp; Chang. From July 1990 to July 1994, Mr. Lee served as an accountant at K.C.
Manufacturing Company. From April 1989 to July 1990, Mr. Lee served as an accountant at Haldane, Midgley &amp; Booth. From January
1987 to April 1989, Mr. Lee served as an audit senior at RSM Nelson Wheeler. From October 1985 to December 1986, Mr. Lee served
as an audit assistant at Andrew Ma &amp; Company. From April 1983 to September 1985, Mr. Lee served as an audit Clerk at Anthony
Y.T. Tse &amp; Company. Mr. Lee is an associate member of the Institute of Chartered Accountants in England and Wales since April
2019, a certified public accountant (practicing) of the Hong Kong Institute of Certified Public Accountants since May 2010, a
fellow member of the Association of International Accountants since December 2006, and an associate member and certified tax advisor
of the Tax Institute of Hong Kong since July 2010. Mr. Lee received his bachelor&#8217;s degree in business administration at
the Open University of Hong Kong in June 2004 and his master&#8217;s degree in professional accounting from the Hong Kong Polytechnic
University in November 2010.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Corporate
Governance</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company promotes accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely
and understandable disclosure in reports and documents that the Company files with the Securities and Exchange Commission (the
&#8220;SEC&#8221;) and in other public communications made by the Company; and strives to be compliant with applicable governmental
laws, rules and regulations. The Company has not formally adopted a written code of business conduct and ethics that governs the
Company&#8217;s employees, officers and Directors as the Company is not required to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
lieu of an Audit Committee, the Company&#8217;s Board of Directors, is responsible for reviewing and making recommendations concerning
the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of the Company&#8217;s financial
statements and other services provided by the Company&#8217;s independent public accountants. The Board of Directors and the Chief
Executive Officer of the Company review the Company&#8217;s internal accounting controls, practices and policies with advice from
third party consultants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Committees
of the Board</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
Company currently does not have nominating, compensation, or audit committees or committees performing similar functions nor does
our Company have a written nominating, compensation or audit committee charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Audit
Committee Financial Expert</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
Board of Directors has determined that we do not have a board member that qualifies as an &#8220;audit committee financial expert&#8221;
as defined in Item 407(D)(5) of Regulation S-K, nor do we have a Board member that qualifies as &#8220;independent&#8221; as the
term is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Securities Exchange Act of 1934, as amended, and as defined by Rule
4200(a)(14) of the FINRA Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
order to maintain good corporate governance and in view of the Company&#8217;s planned expansion, the Company plans to establish
a full board comprising the nominating, compensation, and audit committees during the year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Involvement
in Certain Legal Proceedings</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
Directors and our Executive officers have not been involved in any of the following events during the past ten years:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Bankruptcy
    petition filed by or against any business of which such person was a general partner or executive officer either at the time
    of the bankruptcy or within two years prior to that time;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any
    conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other
    minor offenses);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Being
    subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction,
    permanently or temporarily enjoining, barring, suspending or otherwise limiting his/her involvement in any type of business,
    securities or banking activities; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Being
    found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission
    to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Such
    person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal
    or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed,
    suspended, or vacated;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Such
    person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to
    have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading
    Commission has not been subsequently reversed, suspended or vacated;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Such
    person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding,
    not subsequently reversed, suspended or vacated, relating to an alleged violation of:</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any
                                         Federal or State securities or commodities law or regulation; or</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any
                                         law or regulation respecting financial institutions or insurance companies including,
                                         but not limited to, a temporary or permanent injunction, order of disgorgement or restitution,
                                         civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition
                                         order; or</span></td>
</tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any
                                         law or regulation prohibiting mail or wire fraud or fraud in connection with any business
                                         entity;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Such
    person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory
    organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined
    in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or
    organization that has disciplinary authority over its members or persons associated with a member.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Code
of Ethics</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
have not adopted a formal Code of Ethics. The Board of Directors evaluated the business of the Company and the number of employees
and determined that since the business is operated by a small number of persons, general rules of fiduciary duty and federal and
state criminal, business conduct and securities laws are adequate ethical guidelines. In the event our operations, employees and/or
Directors expand in the future, we may take actions to adopt a formal Code of Ethics.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Shareholder
Proposals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
Company does not have any defined policy or procedural requirements for shareholders to submit recommendations or nominations
for Directors. The Board of Directors believes that, given the stage of our development, a specific nominating policy would be
premature and of little assistance until our business operations develop to a more advanced level. Our Company does not currently
have any specific or minimum criteria for the election of nominees to the Board of Directors and we do not have any specific process
or procedure for evaluating such nominees. The Board of Directors will assess all candidates, whether submitted by management
or shareholders, and make recommendations for election or appointment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A
shareholder who wishes to communicate with our Board of Directors may do so by directing a written request addressed to our President,
at the address appearing on the first page of this Information Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_019"></span>ITEM
11. EXECUTIVE COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
How Kok Choong, the Chief Executive Officer, President, Secretary, Treasurer, Director of the Group had not received nor drawn
any (i) Salary; (ii) Bonus; (iii) Stock compensation; (iv) Option awards, (v) Non-equity incentive plan compensation, (vi) Non-qualified
deferred compensation earnings and (vii) Any other compensations in the last two fiscal years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
Mohd Shaharuddin Bin Abdullah was appointed and entered into an employment agreement with the Company on January 12, 2021 and
the employment agreement will take effect on the listing of our stock on NASDAQ Capital Market / New York Stock Exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Andrew
Lee Kam Fan was appointed and entered into an employment agreement with the Company on January 12, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Summary
of Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Stock
Option Grants</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
have not granted any stock options to our executive officers since our incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Employment
Agreements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Save
except for Mr. Mohd Shaharuddin Bin Abdullah and Mr. Andrew Lee Kam Fan, we do not have an employment or consulting agreement
with any officers or Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Compensation
Discussion and Analysis</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Director
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Save
except for Mr. Mohd Shaharuddin Bin Abdullah and Mr. Andrew Lee Kam Fan, our Board of Directors does not currently receive any
consideration for their services as members of the Board of Directors. The Board of Directors reserves the right in the future
to award the members of the Board of Directors cash or stock-based consideration for their services to the Company, which awards,
if granted shall be in the sole determination of the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
executive director of the Company, Mr. Mohd Shaharuddin Bin Abdullah will be paid a monthly salary of $3,000. He is also entitled
to receive a stock-based compensation of $60,000 per annum. His compensation, i.e., salary and stock-based compensation shall
accrue on a day-to-day basis, payable in arrears on the last day of each calendar month, provided that if his employment is terminated
prior to the end of a calendar month, his compensation for the month shall be pro-rated to reflect his period of service up to
the date of termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
Chief Financial Officer of the Company, Mr. Andrew Lee Kam Fan is paid a monthly salary of $3,870. His salary shall accrue on
a day-to-day basis, payable in arrears on the last day of each calendar month, provided that if his employment is terminated prior
to the end of a calendar month, his compensation for the month shall be pro-rated to reflect his period of service up to the date
of termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Executive
Compensation Philosophy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
Board of Directors determines the compensation given to our executive officers in their sole determination. Our Board of Directors
reserves the right to pay our executive or any future executives a salary, and/or issue them shares of common stock in consideration
for services rendered and/or to award incentive bonuses which are linked to our performance, as well as to the individual executive
officer&#8217;s performance. This package may also include long-term stock-based compensation to certain executives, which is
intended to align the performance of our executives with our long-term business strategies. Additionally, while our Board of Directors
has not granted any performance base stock options to date, the Board of Directors reserves the right to grant such options in
the future, if the Board in its sole determination believes such grants would be in the best interests of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Incentive
Bonus</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Board of Directors may grant incentive bonuses to our executive officer and/or future executive officers in its sole discretion,
if the Board of Directors believes such bonuses are in the Company&#8217;s best interest, after analyzing our current business
objectives and growth, if any, and the amount of revenue we are able to generate each month, which revenue is a direct result
of the actions and ability of such executives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Long-term,
Stock Based Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
order to attract, retain and motivate executive talent necessary to support the Company&#8217;s long-term business strategy we
may award our executive and any future executives with long-term, stock-based compensation in the future, at the sole discretion
of our Board of Directors, which we do not currently have any immediate plans to award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_020"></span>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company has 376,452,047 shares of common stock issued and outstanding, which number of issued and outstanding
shares of common stock have been used throughout this report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Name
    and Address of Beneficial&#160;Owner</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares
    of Common Stock Beneficially Owned</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock Voting Percentage Beneficially Owned</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Voting
    Shares of Preferred Stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Preferred
    Stock Voting Percentage Beneficially Owned</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total
    <br /> Voting Percentage Beneficially Owned</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Executive Officers
    and Directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 29%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">How Kok Choong, President,
    Chief Executive Officer, Secretary, Treasurer and Director; collectively this includes HKC Holdings Sdn. Bhd.*</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">254,549,547</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67.62</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">none</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">n/a</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67.62</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">5% Shareholders</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">HKC Talent Limited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13.82</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">none</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">n/a</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13.82</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">*HKC
Holdings Sdn. Bhd. is owned and controlled by How Kok Choong who is our sole officer and director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Beneficial
ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed
to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of
the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares
(for example, upon exercise of a<span style="background-color: white">n option or warrant) within 60 days of the date as of which
the information is provided. In computing the percentage ownership of any person, the amount of shares is deemed to include the
amount of shares beneficially owned by such person by reason of such acquisition rights. As a result, the percentage of outstanding
shares of any person as shown in the following table does not necessarily reflect the person&#8217;s actual voting power at any
particular date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="c_021"></span>ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
June 1, 2016, Mr. How Kok Choong was appointed as CEO, President, Secretary, Treasurer and a member of our Board of Directors.
Additionally, on June 1, 2016, the Company issued 100,000 shares of restricted common stock, each with a par value of $0.0001
per share, to Mr. How Kok Choong for initial working capital of $10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
April 5, 2017, the Company acquired Agape ATP Corporation, a company incorporated in Labuan, Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
April 10, 2017, the Company issued 245,000,000 and 70,000,000 shares of restricted common stock to Mr. How Kok Choong and HKC
Holdings Sdn Bhd respectively, each with a par value of $0.0001 per share, for total additional working capital of $31,500.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2020, the Company issued 176,547 shares of restricted common stock to Mr. How Kok Choong, with a par value of $0.0001
per share, for total consideration payable by shares by the Company for the acquisition of 99.99% of the equity interest in ASL
from Mr. How.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Vettons
Sdn Bhd <span style="background-color: white">(&#8220;Vettons&#8221;) </span>is an e-commerce company through which ASL conducts
some of its distribution activities to its members. <span style="background-color: white">On February 1, 2021, </span>Mr. How
Kok Choong, our CEO and director, was appointed as the non-executive Chairman of <span style="background-color: white">Vettons</span>.
As of December 31, 2020, the Company has accounts receivable of $172,757 from Vettons, representing 100% of our accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">*HKC
Holdings Sdn. Bhd. is owned and controlled by How Kok Choong who is our sole officer and director. As such, HKC Holdings Sdn Bhd
is regarded a related party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">With
regards to all of the above transactions we claim an exemption from registration afforded by Section 4a(2) and/or Regulation S
of the Securities Act of 1933, as amended (&#8220;Regulation S&#8221;) due to the fact that all sales of stock were made to non-U.S.
persons (as defined under Rule 902 section (k)(2)(i) of Regulation S), pursuant to offshore transactions, and no directed selling
efforts were made in the United States by the issuer, a distributor, any of their respective affiliates, or any person acting
on behalf of any of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Related
Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>The
Company&#8217;s related party list and relationship are as follows:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-style: normal; vertical-align: bottom; background-color: White; font-weight: normal">
    <td style="border-bottom: Black 1.5pt solid; font-style: normal; width: 28%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">Related
    parties</span></td>
    <td style="padding-bottom: 1.5pt; font-style: normal; width: 2%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-decoration: underline; font-style: normal; width: 70%; font-weight: normal; text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">Relationships</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-decoration: underline; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape
    S.E.A. Sdn Bhd</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-decoration: underline; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">VIE of
    Agape Superior Living Sdn Bhd, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director
    of Agape S.E.A. Sdn Bhd</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-decoration: underline; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape
    Superior Living Pty Ltd</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-decoration: underline; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Mr. How
    Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-decoration: underline; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape
    ATP (Asia) Limited</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-decoration: underline; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Mr. How
    Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-decoration: underline; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Hostastay
    Sdn. Bhd.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-decoration: underline; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Mr. How
    Kok Choong, the CEO and director of the Company is also the director of Hostastay Sdn. Bhd.</span></td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; vertical-align: top; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-decoration: underline; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font: 10pt Times New Roman, Times, Serif">Redboy
    Picture Sdn Bhd</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Mr.
    How Kok Choong, the CEO and director of the Company is also the director of Redboy Picture Sdn Bhd.</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Vettons
    Sdn Bhd</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Mr.
    How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of <span>Vettons
    Sdn Bhd</span> on February 1, 2021.</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Related
party balances as of December 31, 2020 and 2019 are as per table below:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Accounts
Receivable - Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
of Related Party</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nature</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
                                         of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December
                                         31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of <br /> December 31, 2019</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape S.E.A Sdn Bhd</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 27%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Sales
    of products </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 19%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">520,786</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">520,786</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount
due from Related Parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of Related Party</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nature</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
                                         of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December
                                         31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of <br /> December 31, 2019</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 25%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape ATP (Asia) Limited
    (&#8220;AATP Asia&#8221;)</span></td><td style="text-align: left; width: 2%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expenses paid for AATP
Asia</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,227</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,217</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Hostastay Sdn. Bhd. (&#8220;Hostastay&#8221;)</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sublease rent due from Hostastay</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">996</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TH3 Technology
    Sdn Bhd</span></td><td style="text-align: left; padding-bottom: 1.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expenses paid
    for TH3 Technology</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,235</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,217</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount
due to a Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Name
    of Related Party</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nature</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
                                         of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December
                                         31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of <br /> December 31, 2019</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 25%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mr. How Kok Choong</span></td><td style="text-align: left; width: 2%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Acquisition payment of ASL
    and expenses paid for the Company</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,952</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Agape Superior
    Living Pty Ltd</span></td><td style="text-align: left; padding-bottom: 1.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">ATP Printing
    Label fees</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,952</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Related
party transactions for years ended December 31, 2020 and 2019, and for the six months ended December 31, 2019, are as per table
below:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Related
party transactions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related&#160;Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
                                                                                 the Year </b></span><b>Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
                                                                                 the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six Months Ended<br />
 December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left">Agape S.E.A Sdn Bhd</td><td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: left">Sales of products</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,268,670</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">429,362</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Sales of products</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,060</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,461</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,060</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,290,131</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">429,362</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other
Income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Name
    of Related&#160;Party</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nature</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
                                         the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December
                                         31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
                                         the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December
                                         31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
                                         the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December
                                         31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 35%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Hostastay
    Sdn Bhd (&#8220;Hostastay&#8221;)</span></td><td style="text-align: left; width: 2%; padding-bottom: 1.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 15%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Sublease
    rental income due from Hostastay</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,881</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,881</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">*
How Kok Choong has acted as the sole promoter of the Company since inception. He has not been provided any form of compensation
as of the date of this registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Review,
Approval and Ratification of Related Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Given
our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or
ratification of transactions, such as those described above, with our executive officer(s), Director(s) and significant stockholders.
We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional
Directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an
appropriate committee thereof. Until formal policies and procedures are put in place, our Directors will continue to approve any
related party transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_001"></span>ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Total
Asia Associates PLT was our independent auditor for the quarter ended March 31, 2019, June 30, 2019, and September 30, 2019 and
incurred audit fees in the total of $15,500. Friedman LLP is our independent auditor for the year ended December 31, 2020, and
for the six months ended December 31, 2019; and incurred audit fees in the total of $325,000. Friedman LLP is also our tax accountant
for the year ended December 31, 2020, and incurred tax fees in the total of $28,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Below
is the aggregate amount of fees billed for professional services rendered by our principal accountants with respect to our last
two fiscal years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Audit fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">245,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">95,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Tax fees</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">273,000</p></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">95,500</p></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
category of &#8220;Audit fees&#8221; includes fees for our annual audit, quarterly reviews and services rendered in connection
with regulatory filings with the SEC, such as the issuance of comfort letters and consents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
category of &#8220;Tax fees&#8221; includes professional services rendered by our principal accountant for tax compliance, tax
advice, and tax planning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">All
of the professional services rendered by principal accountants for the audit of our annual financial statements that are normally
provided by the accountant in connection with statutory and regulatory filings or engagements for last two fiscal years were approved
by our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="ab_002"></span>PART
IV</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_003"></span>ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>(a)
Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following are filed as part of this report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
Statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following financial statements of AGAPE ATP Corporation. and Report of Independent Registered Public Accounting Firm are presented
in the &#8220;F&#8221; pages of this Report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Page</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_011">Index</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_005">Reports of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-2
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Financial
    Statements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_006">Consolidated Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-3</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_007">Consolidated Statements of Operations and Comprehensive Income (Loss)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_008">Consolidated Statements of Changes in Stockholders&#8217; Equity</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-5
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_009">Consolidated Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-6
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_010">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-7
    &#8211; F-33</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>(b)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following exhibits are filed or &#8220;furnished&#8221; herewith:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1713210/000169082417000101/certofinc.htm" style="-sec-extract: exhibit"><span style="font: 10pt Times New Roman, Times, Serif">Articles of Incorporation**</span></a></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1713210/000169082417000101/bylaws.htm" style="-sec-extract: exhibit"><span style="font: 10pt Times New Roman, Times, Serif">Bylaws**</span></a></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">31.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex31-1.htm">Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer and principal financial officer*</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">32.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex32-1.htm">Section 1350 Certification of principal executive officer and principal financial officer*</a></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">*
Filed herewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">**
As filed in the Registrant&#8217;s Registration Statement on Form S-1 Amendment No.8 (File No. 333-220144) on October 26, 2017.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_004"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">AGAPE
    ATP CORPORATION.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">(Name
    of Registrant)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Date:
    March 31, 2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>/s/
    How Kok Choong</i></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer, President, Secretary, Treasurer, Director</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Principal
Executive Officer</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_011"></span>INDEX
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Page</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>Financial
    Statements</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_005">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-2
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_006">Consolidated Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-3</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_007">Consolidated Statements of Operations and Comprehensive Income (Loss)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_008">Consolidated Statements of Changes in Stockholders&#8217; Equity</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_009">Consolidated Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ab_010">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-7
    - F-33</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><img src="image_017.jpg" alt="" style="width: 358px; height: 55px" />&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_005"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To the Board of Directors and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stockholders of Agape ATP Corporation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Opinion on the Consolidated Financial Statements
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have audited the accompanying consolidated
balance sheet of Agape ATP Corporation (the &#8220;Company&#8221;) as of December 31, 2020 and 2019, and the related consolidated
statements of operations and comprehensive income (loss), changes in stockholders&#8217; equity and cash flows&#160;for the year
ended December 31, 2020 and the six-month period ended December 31, 2019, and the related notes (collectively referred to as the
consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects,
the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for
the year ended December 31, 2020 and the six-month period ended December 31, 2019, in conformity with accounting principles generally
accepted in the United States of America.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis for Opinion </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These consolidated financial statements are
the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated
financial statements based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent
with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the
Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conducted our audit in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether
the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required
to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are
required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit included performing procedures to
assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing
procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and
disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe
that our audit provide a reasonable basis for our opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>/s/ Friedman LLP</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have served as the Company&#8217;s auditor
since 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">New York, New York</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">March 31, 2021</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<img src="image_018.jpg" alt="" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_006"></span>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_111_zqaOJC7fYQ8e" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20201231_zg2sc2YusyC" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20191231_zvIJCiEXxsGe" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--AssetsAbstract_iB_zOLUYR5Si1o4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--AssetsCurrentAbstract_i01B_zORJvHLWOjre" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CURRENT ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCz5gQ_maACzQbq_zsiAZ2dQpUse" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Cash and cash equivalents (Included $<span id="xdx_90A_ecustom--VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_iI_pp0p0_c20201231_zai0CyFD9Egg" title="VIE consolidated amount of cash and cash equivalents"><ix:nonFraction name="AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,387</ix:nonFraction></span> in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2020)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,517,600</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,744,457</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_i02I_maCz5gQ_maACzQbq_zFdhDpO9Wusf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,757</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0056">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AccountsReceivableRelatedPartiesCurrent_i02I_maCz5gQ_maACzQbq_zI9bCvbuOdw" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0058">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableRelatedPartiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">520,786</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--NotesReceivableRelatedPartiesCurrent_i02I_maCz5gQ_maACzQbq_zOfDrOdWbllc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amount due from related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesReceivableRelatedPartiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,235</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesReceivableRelatedPartiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,217</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--InventoryNet_i02I_maCz5gQ_maACzQbq_zeKS2aUiieXh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">589,814</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0065">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--PrepaidTaxes_i02I_maCz5gQ_maACzQbq_zy6mZNjKM3g8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepaid taxes (Included $<span id="xdx_903_ecustom--VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_iI_pp0p0_c20201231_zNUmdsv6P6a7" title="VIE consolidated amount of prepaid taxes"><ix:nonFraction name="AATP:VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,330</ix:nonFraction></span> in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2020)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidTaxes" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,104,495</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0068">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCz5gQ_maACzQbq_zTsMcDBmy9rh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepayments and deposits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">296,370</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">269,193</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_mtCz5gQ_maCzVUV_zoKnIxGDnZ9h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Current Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,684,271</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,536,653</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherAssetsAbstract_i01B_z65QjvcEJUu3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">OTHER ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentNet_i02I_maCzysI_maOAzOOL_z1sceCAIWixi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">298,309</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0082">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i02I_maCzysI_maOAzOOL_zgbfSuNsHXS9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,826</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0085">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_maCzysI_maOAzOOL_zutB7cFlfkLl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">394,141</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0088">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--MarketableSecuritiesNoncurrent_i02I_maCzysI_maOAzOOL_zfwtobloCST1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Investment in marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">577,035</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,484</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_i02I_maCzysI_maOAzOOL_zatNnamAAs4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Investment in non-marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">732,137</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredOfferingCosts_i02I_maCzysI_maOAzOOL_zIuF4ooIVFFd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deferred offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">249,525</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0097">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OtherAssets_i02TI_mtCzysI_maCzVUV_mtOAzOOL_zNCDO3xopD0c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,526,336</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">798,621</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--Assets_i01TI_mtCzVUV_zS9U4rANUQQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,210,607</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,335,274</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zM6wUia30Abk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--LiabilitiesCurrentAbstract_i01B_zfrvITiNQNz6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AccountsPayableTradeCurrent_i02I_maCzDk5_maLCzhfL_zw9z4lTCNxbe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0111">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,790</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_maLCzhfL_zbroCu1IuZwb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">236,134</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0115">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCzDk5_maLCzhfL_zM7DDfXcH2I6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,276</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0118">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_i02I_maCzDk5_maLCzhfL_zw6lqQN35RBc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other payables and accrued liabilities ($<span id="xdx_904_ecustom--VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_iI_pp0p0_c20201231_zIQJkqfmNVe4" title="VIE consolidated amount of other payables and accrued liabilities"><ix:nonFraction name="AATP:VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,904</ix:nonFraction></span> are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2020)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,246</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DueToRelatedPartiesCurrent_i02I_maCzDk5_maLCzhfL_zfi289jSYMkh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Amount due to a related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">455</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,952</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzhfL_maTLT_zUPJA0Jvfvz7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Current Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,038,542</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,988</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LiabilitiesNoncurrentAbstract_i01B_zWMu6uHFxjMc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NON-CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maLNzwNI_zeTBeUGEOnwb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241,488</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0135">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i02I_maLNzwNI_znEZ30jMbeD7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,743</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0138">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--LiabilitiesNoncurrent_i02TI_mtLNzwNI_maTLT_zMInLeAW9sB6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Non-current Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0141">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--Liabilities_i01I_mtTLT_maTL2_zsJnQ8FUJaY9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,285,773</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,988</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--StockholdersEquityAbstract_i01B_zmBVoZ1bu73h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--PreferredStockValue_i02I_maCzan3_maSEzReR_zae6ZLk6oADg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Preferred stock, $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pii_c20201231_zajiiPkrMYE5" title="Preferred stock, par value"><span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pii_c20191231_zjKFCvR7hvt9" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pii_c20201231_z5AFxBZRMlPh" title="Preferred stock, shares authorized"><span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pii_c20191231_zOVSrmBRbGi6" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_dn_c20201231_zSme3tGBBZL7" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_dn_c20191231_zYTpTgll1vz" title="Preferred stock, shares issued"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20201231_z2WSqFLGKT56" title="Preferred stock, shares outstanding"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20191231_zv2GjQP87uok" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2019-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2019-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">None</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0149">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0150">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CommonStockValue_i02I_maCzan3_maSEzReR_zhgD1amb3Ic8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Common Stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pii_c20201231_z4VcbmSphX07"><span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pii_c20191231_z6NUsO7LN9n4"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>; <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20201231_zocXMUQzjJG1"><span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_c20191231_pii"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20201231_z1BpJWI6jcc9" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20201231_zQncP2TUbDNe" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20191231_zoSQTV5oYGQl" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20191231_zvUIcczOTQGa" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,275,500</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2020 and December 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,645</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_i02I_maCzan3_maSEzReR_zCOdmPtoru04" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional paid in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,440,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,293,082</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzan3_maSEzReR_zuGWL5qKDKn7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">734,443</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,089,209</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maCzan3_maSEzReR_z4TOtmorqoV8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated other comprehensive income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">181,016</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,785</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--StockholdersEquity_i02TI_mtCzan3_mtSEzReR_maTL2_zWgFRd23pK6l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">TOTAL STOCKHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,924,834</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,251,286</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtTL2_zbkmy3QFo6Of" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,210,607</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,335,274</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_007"></span>CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_113_zXMw7WZFIZE6" summary="xdx: Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20200101__20201231_zoON3JQdYfrj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20190101__20191231_z48PgQ8EWaR7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20190701__20191231_zKTPCYTku416" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maRzJff_maRzcDT_z1aiYQbor2g3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%">REVENUE</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,434,561</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0199">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0200">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--RevenueFromRelatedParties_maRzJff_maRzcDT_zeSEpqvSFQQc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">REVENUE &#8211; RELATED PARTY</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,060</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,290,131</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">429,362</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--Revenues_iT_pp0p0_mtRzJff_maGPzjAS_mtRzcDT_zWVjQ09Q4Dv7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">TOTAL REVENUE</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,452,621</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,290,131</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">429,362</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--CostOfGoodsAndServicesSold_iN_pp0p0_di_msGPzjAS_msGPzb8a_zJcvGYCn84u2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>COST OF REVENUE</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">775,855</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,200,829</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">383,479</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--GrossProfit_iT_pp0p0_mtGPzjAS_maOILzJ3n_mtGPzb8a_zd843LLkH3c1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">GROSS PROFIT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,676,766</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,302</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45,883</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--SellingExpense_iN_pp0p0_di_maOEzkii_maOEz0p8_zMxLATdOuyB8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>SELLING</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">376,582</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,846</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0220">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--SalesCommissionsAndFees_iN_pp0p0_di_maOEzkii_maOEz0p8_z7CwUTHXuTv8" style="vertical-align: bottom; background-color: White">
    <td>COMMISSION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:SalesCommissionsAndFees" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">830,659</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0223">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0224">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--GeneralAndAdministrativeExpense_iN_pp0p0_di_maOEzkii_maOEz0p8_zUsD9N5GIobi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">GENERAL AND ADMINISTRATIVE <br /> <br /></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,627,660</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">396,048</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">312,270</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingExpenses_iNT_pp0p0_di_mtOEzkii_msOILzJ3n_mtOEz0p8_z7wLl3zdzxQe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">TOTAL OPERATING EXPENSES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,834,901</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">403,894</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">312,270</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingIncomeLoss_mtOILzJ3n_maILFCOzmaI_maILFCOzssU_maILT_zRDoVvBZNRv8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">LOSS FROM OPERATIONS</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">158,135</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">314,592</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">266,387</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">OTHER INCOME/(EXPENSES)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OtherNonoperatingIncomeExpense_i01_pp0p0_maNIEztUi_maNIEzoy5_zVVsrvIreck7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Other Income/(Expenses), Net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">164,283</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,301</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,153</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_409_eus-gaap--IncomeLossFromEquityMethodInvestments_i01_pp0p0_maNIEztUi_maNIEzoy5_ztuXsqmWCBg3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Loss from equity investment</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0246">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">26,085</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0248">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_i01_pp0p0_maNIEztUi_maNIEzoy5_zWI84PYdqlml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized holding gain (loss) on marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">350,137</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">68,391</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">68,391</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_ecustom--PreferredStockDividendIncomeStatementImpact_i01N_pp0p0_di_msNIEzoy5_zK6YPA3Cd4Gk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Dividend income from marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">160,062</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0255">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0256">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_i01_maCzqtq_maNIEzoy5_zI8Hj1n1ot7e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Gain on deemed disposal of shares in Investee Company</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0258">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,509</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0260">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--ImpairmentLossInEquityInvestments_i01_maCzqtq_maNIEzoy5_zzpDejVHhcI6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Impairment loss in equity investment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0262">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:ImpairmentLossInEquityInvestments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">366,834</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0264">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NonoperatingIncomeExpense_i01T_maCzcO8_mtNIEzoy5_maILT_zJlK9eKLYh03" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">TOTAL OTHER INCOME/(EXPENSES), NET</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">674,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">408,500</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">72,544</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILT_maNILT_zZkNB4x0qn36" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">INCOME (LOSS) BEFORE INCOME TAXES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">516,347</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">723,092</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">338,931</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msNILT_znqwPPk10Vhg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">(PROVISION FOR) BENEFIT OF INCOME TAXES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161,581</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,965</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0276">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_iT_mtNILT_maCILT_z03jk5Vqac94" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">NET INCOME (LOSS)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,766</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">716,127</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">338,931</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_iB_zl1kdhhY98ld" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">OTHER COMPREHENSIVE INCOME</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_i01_maCILT_z0fyBsj08FDg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Foreign currency translation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">171,231</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,079</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,864</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_i01T_mtCILT_zoAR1niRlnW" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">COMPREHENSIVE INCOME (LOSS)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">525,997</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">705,048</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">329,067</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB_z52ppdiqbMT2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">NET LOSS PER SHARE</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EarningsPerShareBasicAndDiluted_i01_zik3fPxla1Cd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_iB_zwxR409b4Me7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_i01_pii" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,387,778</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,275,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,275,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_008"></span>CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_114_z1gg8mH5Yw82" summary="xdx: Statement - Consolidated Statements of Changes in Stockholders&apos; Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br />
 shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zIjeVcnOoL0f" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Par<br />
 value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zYyR52Wum9ah" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PAID IN</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CAPITAL</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zYoNTWfmU6V2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ACCUMULATED DEFICIT</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zvRrCs97YVna" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>COMPREHENSIVE</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>INCOME (LOSS)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_zfNNHmQ192p3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">STOCKHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">COMMON STOCK</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ADDITIONAL</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ACCUMULATED OTHER</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">TOTAL</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br />
 shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Par<br />
 value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PAID IN</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CAPITAL</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ACCUMULATED DEFICIT</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>COMPREHENSIVE</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>INCOME (LOSS)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">STOCKHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_43F_c20190101__20191231_eus-gaap--StockholdersEquity_iS_zFkkFDbyPSLc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%">Balance as of December 31, 2018 (unaudited)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pii_uShares_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zAovd9ZNp042" title="Balance, shares" style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,275,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,628</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,293,082</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">373,082</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,294</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,956,334</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--NetIncomeLoss_zYcRgQEtn6Rk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0318">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0319">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">716,127</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0321">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">716,127</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0324">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0325">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0326">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,079</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,079</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_i_pp0p0" style="display: none; vertical-align: bottom; background-color: White">
    <td>Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pii_uShares_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyRACkZV4Ys5" title="ssuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0336">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0330">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0331">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0332">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0333">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0334">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_433_c20190101__20191231_eus-gaap--StockholdersEquity_iE_zxizJKkBNBDg" style="vertical-align: bottom; background-color: White">
    <td>Balance as of December 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pii_uShares_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgBIUW5t5WUf" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,275,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,628</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,293,082</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,089,209</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,785</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,251,286</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_43B_c20200101__20201231_eus-gaap--StockholdersEquity_iS_zSf6Dl1lOkpl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance as of December 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pii_uShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zweGCPZsCfPd" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,275,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,628</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,293,082</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,089,209</ix:nonFraction>)</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,785</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,251,286</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0354">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0355">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,766</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0357">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,766</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zv1wHuoMpLL4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pii_uShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPgmTSkQQ1W7" title="ssuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">176,547</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,147,534</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0362">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0363">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,147,551</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zVRMe2y5ZLX" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0368">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0369">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0370">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">171,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">171,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_437_c20200101__20201231_eus-gaap--StockholdersEquity_iE_z0Yvk48VuRv5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance as of December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pii_uShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwE7Du5WOhTa" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,645</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,440,616</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">734,443</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">181,016</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,924,834</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_009"></span>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_112_z1PPdPyAO3S6" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_z3jpq7Yt6FVk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20190101__20191231_zNgnenKOJgAe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20190701__20191231_zbOfjdtohax2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLoss_i01_pp0p0_maOPER1T_zK1ohuZ9Ztub" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 46%; text-align: left">Net income (loss)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">354,766</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">716,127</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">338,931</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net income (loss) to net cash (used in) operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--Depreciation_i02_pp0p0_maOPER1T_z5fzZ2y0WvYk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,407</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0395">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0396">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DepreciationDepletionAndAmortization_i02_pp0p0_maOPER1T_zRZdfG0dQ7v3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,505</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0399">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0400">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_pp0p0_maOPER1T_zUdCM8U2AbRk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amortization of operating right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,561</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0403">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0404">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncomeLossFromEquityMethodInvestments_i02N_pp0p0_di_msOPER1T_z82JjaVBWa14" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss from equity investment</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0406">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">26,085</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0408">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_i02N_pp0p0_di_msOPER1T_zuBUA4yH1cD4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Unrealized holding (gain) loss on marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">350,137</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">68,391</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">68,391</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--PreferredStockDividendIncomeStatementImpact_i02_pp0p0_maOPER1T_zjkMzu3GZ558" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Dividend income from marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AATP:PreferredStockDividendIncomeStatementImpact" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">160,062</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0416">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_i02N_pp0p0_di_msOPER1T_zQZnROBxHeph" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Gain on deemed disposal of shares in investee company</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0418">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,509</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0420">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--ImpairmentLossInEquityInvestments_i02N_di_msOPER1T_zpNJ6MgYUUCg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Impairment loss in equity investment</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0422">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:ImpairmentLossInEquityInvestments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">366,834</ix:nonFraction></td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0424">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_pp0p0_maOPER1T_zvJSEV9BqC7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deferred tax expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178,329</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0427">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0428">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_pp0p0_di_msOPER1T_z78GqXdNSf6d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">165,149</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0435">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0436">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsReceivableRelatedParties_i03N_pp0p0_di_msOPER1T_zpSQQgsr3VLa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0438">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">518,940</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">85,602</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_i03N_pp0p0_di_msOPER1T_zC3BSARbud2k" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amount due from related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,417</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,210</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0444">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--IncreaseDecreaseInInventories_i03N_pp0p0_di_msOPER1T_zjZ74yqVZGth" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">78,674</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0447">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0448">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--IncreaseDecreaseInPrepaidTaxes_i03N_pp0p0_di_msOPER1T_zsHxrGNh5OL6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepaid taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidTaxes" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">184,985</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0451">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0452">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_pp0p0_di_msOPER1T_zJJnvkPKX1uk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepayments and deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">352,577</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">241,372</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">229,638</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherAccountsPayable_i03_pp0p0_maOPER1T_zBSr0jYbU38b" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,804</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,778</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,778</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccountsPayableRelatedParties_i03_pp0p0_maOPER1T_zfWAvM80MuAf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0462">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">59</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">35,086</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_pp0p0_maOPER1T_zjbMdDbzwcqg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,421,886</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">217,743</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0468">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_pp0p0_maOPER1T_zE7GodhjvSB6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0470">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,965</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0472">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i03_pp0p0_maOPER1T_zc01XDaCLk27" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">336,709</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">68,557</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">44,867</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--IncreaseDecreaseInOperatingLeaseLiabilities_i03_pp0p0_maOPER1T_zWDv7abGFCZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Operating lease liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">105,009</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0479">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0480">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i02T_pp0p0_maCCERCzrdV_mtOPER1T_zagTyYoslKe2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">557,951</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">704,418</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">113,945</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--ProceedsFromSaleOfInvestmentProjects_i01_maNCPBUzFOl_zZVAz80HGQl2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from sale of investment in marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfInvestmentProjects" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0492">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_pp0p0_di_msNCPBUzFOl_zNCXnGypGGu5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Purchase of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,734</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0495">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0496">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_pp0p0_di_msNCPBUzFOl_z0z2Xm7MmG4h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Purchase of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0499">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0500">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CashAcquiredFromAcquisition_i01_pp0p0_maNCPBUzFOl_zPPqB39Ra6h9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash acquired through acquisition of Agape superior Living Sdn Bhd</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,210,818</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0503">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0504">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_i01_pp0p0_maNCPBUzFOl_ziTgCtmOk3cb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from sale of non-marketable securities to a related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">70,173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0507">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0508">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--PaymentsToAcquireNonMarketableSecurities_i01N_pp0p0_di_msNCPBUzFOl_z0ceAKN17oR5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Investment in non-marketable securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0510">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:PaymentsToAcquireNonMarketableSecurities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0512">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_mtNCPBUzFOl_maCCERCzrdV_zb7WJCxtA0S4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided by (used in) investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,276,200</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0516">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--PaymentsOfDebtIssuanceCosts_i01N_di_msNCPBUzCcN_zOqGWPj8fN6e" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deferred offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">249,525</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0523">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0524">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--RepaymentsOfRelatedPartyDebts_i01N_pp0p0_di_msNCPBUzCcN_zWcmEFN798Sc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Repayments from related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:RepaymentsOfRelatedPartyDebts" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">227,434</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:RepaymentsOfRelatedPartyDebts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">745</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0528">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_i01_pp0p0_maNCPBUzCcN_zonKQ9fTJqy5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Amount due to a related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0530">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,318</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0532">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUzCcN_maCCERCzrdV_zMac3kSxn0fk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">22,091</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,573</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0536">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_maCCERCzrdV_zoZi8OrtWvTi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,985</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,031</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">815</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzrdV_zdpCEFcEhrN9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">773,143</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">708,460</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">113,130</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">CASH AND CASH EQUIVALENTS, beginning of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,744,457</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,452,917</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,857,587</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of end</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,517,600</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,744,457</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,744,457</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--SupplementalCashFlowInformationAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">SUPPLEMENTAL CASH FLOWS INFORMATION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncomeTaxesPaidNet_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Income taxes paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">288,929</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0560">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--InterestPaidNet_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Interest paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0562">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0564">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">SUPPLEMENTAL NON-CASH FLOWS INFORMATION</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Amount transferred from investment in investee company to non-marketable securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">724,619</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0572">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Initial recognition of right-of-use assets and lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">483,343</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0575">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0576">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_i01_pp0p0_zkPjXFyjFcEb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Sale of non-marketable securities to a related party in exchange for acquisition payment of Agape Superior Living Sdn Bhd</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">656,495</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0579">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0580">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_i01_pp0p0_z0Df2CLt8bA6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Issuance of common stock in exchange for acquisition of Agape Superior Living Sdn Bhd</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,147,551</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0583">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0584">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ab_010"></span>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_801_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zJSi8MyvyDFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>1.
<span id="xdx_823_zJ0CruFRLV6c">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation, a Nevada corporation (&#8220;the Company&#8221; or &#8220;AATP US&#8221;) was incorporated under the laws
of the State of Nevada on June 1, 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zPAqrgj7bzDh" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-31_custom_AgapeATPInternationalHoldingLimitedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zKtfAAedHs31" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,590,596</ix:nonFraction></span> ordinary shares, no par value, equivalent to approximately <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zjjjvxYeSx34" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-05-08_custom_SubsidiaryCompanyTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.99</ix:nonFraction>%</span> of the equity interest in Agape Superior Living Sdn.
Bhd., an entity incorporated in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
Superior Living Sdn. Bhd. (&#8220;ASL&#8221;) is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd., a wholly owned
subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by
providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.
Upon the establishment of WATP, WATP starts collaborating with ASL to carry out its Wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company
and its subsidiaries is to supply high-quality health and wellness products, including supplements to assist in cell metabolism,
detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and
various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements reflect the activities of the Company, Agape ATP Corporation (&#8220;AATP LB&#8221;),
Agape ATP International Holding Limited (&#8220;AATP HK&#8221;), Wellness ATP International Holdings Sdn, Bhd. (&#8220;WATP&#8221;), ASL and its variable interest entity (&#8220;VIE&#8221;), Agape S.E.A. Sdn. Bhd. (&#8220;SEA&#8221;) (See Note 3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zw7f6w0FF1xk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Details
of the Company&#8217;s subsidiaries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_zC1Anlgtow4l" style="display: none">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Subsidiary
company name</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Place
and date of incorporation</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Particulars
    of issued&#160;capital</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Principal
    activities</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Proportional
of ownership interest and voting power held</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">1.
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 22%; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsWZZZ7j67yg" title="Subsidiary company name"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember" name="AATP:NameOftheCompany">Agape
    ATP Corporation</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zMtcK0TU6zG3" title="Place and date of incorporation" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 16%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember" name="AATP:PlaceAndDateOfIncorporation">Labuan,
    <br />
    March 6, 2017</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z3r71tizhsc9" title="Particulars of issued capital" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember" name="AATP:ParticularsOfIssuedCapital">100
    shares of ordinary share of US$1 each</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z9YBdu4Klqee" title="Principal activities" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember" name="AATP:PrincipalActivities">Investment
    holding</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zM50Vf4ndZD1" title="Proportional of ownership interest and voting power held" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">2.
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zpEX8ZyUokbf" title="Subsidiary company name" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember" name="AATP:NameOftheCompany">Agape
    ATP International Holding Limited</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98A_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zPSbyVEVQpBj" title="Place and date of incorporation" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember" name="AATP:PlaceAndDateOfIncorporation">Hong
    Kong,<br />
    June 1, 2017</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zsUJLsURrrG9" title="Particulars of issued capital" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember" name="AATP:ParticularsOfIssuedCapital">1,000,000
    shares of ordinary share of HK$1 each</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z0N1Jam9s4hh" title="Principal activities" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember" name="AATP:PrincipalActivities">Wholesaling
    of health and wellness products; and health solution advisory services</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zfkndXUXijtf" title="Proportional of ownership interest and voting power held" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zzCkeJ1IJVm1" title="Subsidiary company name" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember" name="AATP:NameOftheCompany">Agape
    Superior Living Sdn. Bhd.</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zmEPx5eMS2Tb" title="Place and date of incorporation" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember" name="AATP:PlaceAndDateOfIncorporation">Malaysia,
    <br />
    August 8, 2003</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zz4J4NcmSjr5" title="Particulars of issued capital" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember" name="AATP:ParticularsOfIssuedCapital">9,590,598
    shares of ordinary share of RM1 each</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zxZjnXi79Ywk" title="Principal activities" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember" name="AATP:PrincipalActivities">Health
    and wellness products and health solution advisory services via network marketing</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zrL824y99Ggd" title="Proportional of ownership interest and voting power held" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.99</ix:nonFraction>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zUclFrdr35C6" title="Subsidiary company name" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember" name="AATP:NameOftheCompany">Agape
    S.E.A. Sdn. Bhd.</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zxvR5Bced3Fe" title="Place and date of incorporation" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember" name="AATP:PlaceAndDateOfIncorporation">Malaysia,
    <br />
    March 4, 2004</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zwBRJGP5dGle" title="Particulars of issued capital" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember" name="AATP:ParticularsOfIssuedCapital">2
    shares of ordinary share of RM1 each</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zgBjWf04B1h4" title="Principal activities" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember" name="AATP:PrincipalActivities">VIE
    of Agape Superior Living Sdn. Bhd.</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">VIE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98E_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zZ3aOX5q2Y" title="Subsidiary company name" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember" name="AATP:NameOftheCompany">Wellness
    ATP International Holdings Sdn, Bhd</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zB0NwRqVf5hk" title="Place and date of incorporation" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember" name="AATP:PlaceAndDateOfIncorporation">Malaysia,
    <br />
    September 11, 2020</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zVrklIovqUA4" title="Particulars of issued capital" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember" name="AATP:ParticularsOfIssuedCapital">100
    shares of ordinary share of RM1 each</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zNANzG5166Ml" title="Principal activities" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember" name="AATP:PrincipalActivities">The
    promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs,
    events and campaigns</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z3e92NzKLqji" title="Proportional of ownership interest and voting power held" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyFourMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"></span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A2_z7dOJZcW7U17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>1.
ORGANIZATION AND BUSINESS BACKGROUND (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients.
The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#8220;ATP Zeta
Health Program&#8221;, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy
dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in
our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
order to strengthen the Company&#8217;s supply chain, on May 8, 2020, the Company has successfully acquired approximately <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zw0as5opirNf"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.99</ix:nonFraction>% </span></span><span style="font: 10pt Times New Roman, Times, Serif">of
ASL by issuing <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zZ5Um3AJ858l"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">176,547</ix:nonFraction> </span></span><span style="font: 10pt Times New Roman, Times, Serif">common
shares for a total value of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zNifuWGSfRne"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,147,551</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif"> and offset a loan receivable of $<span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_pp0p0_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_ziTWrJEBnEo2" title="Loan receivable"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">656,495</ix:nonFraction></span> for a total consideration
of $<span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zCySLH6HmHx9" title="Consideration amount"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,804,046</ix:nonFraction></span>, </span><span style="font: 10pt Times New Roman, Times, Serif">with the goal of securing an established network
marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the
Company&#8217;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the
Company&#8217;s operation by boosting the Company&#8217;s retail and marketing capabilities. The newly acquired subsidiary
allows the Company to fulfill its mission of &#8220;helping people to create health and wealth&#8221; by providing a
financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a
healthy lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health
solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry
out various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#201;NERG&#201;TIQUE
and BEAUNIQUE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases
caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health
and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well
as trained members and distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
&#201;NERG&#201;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level.
The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
BEAUNIQUE product series focuses on the research of our diet&#8217;s impact on modifying gene expressions in order to address
genetic variations and deliver a nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zcIMJ6haPcN8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
<span id="xdx_826_zgK8FlBMWZW6">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTR730J0sFY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_z54tMmhMAiUd">Basis
of presentation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;U.S. GAAP&#8221;) for information pursuant to the rules and regulations of the Securities
Exchange Commission (&#8220;SEC&#8221;), and include all normal and recurring adjustments that management of the Company considers
necessary for a fair presentation of its financial position and operation results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:FiscalPeriod"><p id="xdx_84F_eus-gaap--FiscalPeriod_zSP00q8ovKre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_zyIC7gncKQbh">Change
of year end</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements
consist of the unaudited financial data for the year ended December 31, 2019, which was derived from the six months audited financial
statement ended December 31, 2019 and the interim financial statements for the six months ended June 30, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zVLcAFfvvIRg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zbx6oyc4Ivu7">Principles
of consolidation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the
Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the
primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power
to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or
to cast a majority of votes at the meeting of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities
without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial
interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb
the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is
deemed to be the primary beneficiary and must consolidate the VIE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_840_eus-gaap--UseOfEstimates_zRBqtC1y0Rv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_zPD3JoKOtab9">Use
of estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date
of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant
accounting estimates reflected in the Company&#8217;s consolidated financial statements include allowance for doubtful accounts,
allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment
of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain
tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbLw5TKDzyQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_zKxM6jyQ5jj9">Cash
and cash equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_z0Jaog9bxWZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zOgNmcedxnV3">Accounts
receivable and accounts receivable &#8211; related party</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
receivable and accounts receivable &#8211; related party are recorded at the invoiced amount less an allowance for any uncollectible
accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party
e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy
of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management
also periodically evaluates individual customer&#8217;s financial condition, credit history, and the current economic conditions
to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after
all means of collection have been exhausted and the potential for recovery is considered remote. The Company&#8217;s management
continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020,
and 2019, <span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20201231_zhC0gLzsxXaj" title="Accounts Receivable, Allowance for Credit Loss"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20191231_zv9vq6cJfZ8l" title="Accounts Receivable, Allowance for Credit Loss"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2019-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> valuation allowance was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_845_eus-gaap--InventoryPolicyTextBlock_zFUs7n4p67jl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zhkqYvzJeVla">Inventories</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the
shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs
exceed expected net realizable value. As of December 31, 2020, and 2019, there are <span id="xdx_907_eus-gaap--InventoryWriteDown_do_c20200101__20201231_zgienrIUaYU3" title="Inventories write-down"><span id="xdx_90F_eus-gaap--InventoryWriteDown_do_c20190101__20191231_zCBCKFGkFpra" title="Inventories write-down"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2020-01-01to2020-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2019-01-012019-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> inventories obsolescence reserves or write-downs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:PrepaidTaxesPolicyTextBlock"><p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zMxG7BcYUaua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_z4xaDU4cq9U6">Prepaid
taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid
taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income taxes; and (ii)
goods and service tax (&#8220;GST&#8221;) that is refundable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:PrepaymentsAndDepositsPolicyTextBlock"><p id="xdx_847_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zeanCKKuhxQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_z4eTCa0GrNNg">Prepayments
and deposits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future
services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such
advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve
such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and
adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after
management has determined that the likelihood of collection is not probable. The Company&#8217;s management continues to evaluate
the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020, and 2019, there is <span id="xdx_90C_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zOoBOydnluek" title="Allowance for doubtful accounts"><span id="xdx_90D_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20191231_zRwZ81dNopmh" title="Allowance for doubtful accounts"><ix:nonFraction name="AATP:AllowanceForDoubtfulAccountsReceivablesCurrent" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="AATP:AllowanceForDoubtfulAccountsReceivablesCurrent" contextRef="AsOf2019-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span>
allowance for the doubtful accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zK7TBn5YOKXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zZcACYTGoD01">Property
and equipment, net</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock"><p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zzNtF6aagGc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the
estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BC_zCdmNN6YMpGb" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Useful Life</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Computer and office equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 22%; text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_z2fLK85JSku7" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zI6pu4GZoBA2" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> years</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Furniture &amp; fixtures</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zdgC0gag3g19" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">6</ix:nonNumeric></span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zaHBwcU8J9Jc" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> years</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_LeaseholdImprovementsMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">Lease Term</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Vehicle</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z0izDTxWgvE4" title="Estimated Useful Life of Property and Equipment"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_VehiclesMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_zW3Hoia0BIpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or
loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are
charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets,
are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances
warrant revised estimates of useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zxdQBUFNGlb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_z2GCRI0OOo6d">Intangible
assets, net</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock"><p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_z1SSSWOPprD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis
over the estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B2_zMvUZJ1WVh22" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; width: 76%; font-weight: bold">Classification</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 22%; font-weight: bold; text-align: center">Useful Life</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer software</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z1HaoclfKPk6" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonNumeric></span> years</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_z7ZQgvLZEmOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBSVMRjM1ak8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zq8BxyvJZtB">Impairment
for long-lived assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events
or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the
assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets
based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated
undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the
asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying
amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate,
to comparable market values. As of December 31, 2020 and 2019, <span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zwNmJYhcW2n4"><span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20190101__20191231_zZK7SYlBBL8l" title="Impairment of long-lived assets"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="From2020-01-01to2020-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="From2019-01-012019-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> impairment of long-lived assets was recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock"><p id="xdx_849_eus-gaap--DeferredChargesPolicyTextBlock_zcLFnJGYqLHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_z6CuZBHv5W6j">Deferred
offering costs</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred
offering costs represents costs associated with the Company&#8217;s current offering which will be netted against the proceeds
from the Company&#8217;s current offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:MarketableSecuritiesPolicy"><p id="xdx_841_eus-gaap--MarketableSecuritiesPolicy_zI3AAPKbqZS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_zNNH4dr7Jbqf">Investment
in marketable equity securities</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the
lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market
in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost
less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities
are based on the average cost of all the units of a particular security held at the time of sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair
value with changes in fair value recognized in the Company&#8217;s consolidated statements of operations and comprehensive loss
in the caption of &#8220;unrealized holding gain (loss) on marketable securities&#8221; in each reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:NonMarketableSecuritiesPolicyTextBlock"><p id="xdx_847_ecustom--NonMarketableSecuritiesPolicyTextBlock_zFnz2dhNrF4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zfsCIrUIPHYc">Investment
in non-marketable equity securities</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline
in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average
cost of all the units of a particular security held at the time of sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Due to the Company&#8217;s non-marketable equity securities (non-current) does
not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to
record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes
resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the
investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration
in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change
in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market
condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase,
an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the
carrying amount of that investment; and (v) Factors that raise significant concerns about the investee&#8217;s ability to continue
as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory
capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities
(non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair
value of the investment and its carrying amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zW3IYvpz4Alg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zMogr6vZHbe2">Customer
deposits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits
are reduced when the related sale is recognized in accordance with the Company&#8217;s revenue recognition policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zX0QGKJuKWG2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zxOAHW8oJxf">Revenue
recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers
(ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not
result in an adjustment to retained earnings upon adoption of this new guidance as the Company&#8217;s revenue was recognized
based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer
of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in
such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should
be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company&#8217;s
revenue streams are recognized at a point in time for the Company&#8217;s sale of health and wellness products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that
the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine
the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will
not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue
when (or as) the Company satisfies the performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including
payment terms, are identified, the contract has commercial substance and consideration is probable of substantial collection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive
evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability
is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred
and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted
by the customer when the products are collected by the customer at the Company&#8217;s office. Revenue is recorded net of sales
discounts, returns, allowances, and other adjustments that are based upon management&#8217;s best estimates and historical experience
and are provided for in the same period as the related revenues are recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes
in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy
for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance
and confirmed that there were no differences in the pattern of revenue recognition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sales
of Health and Wellness products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control
of the health and wellness products are transferred to its customer at the Company&#8217;s office or shipment of the goods, which
is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after
all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products
are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the
value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash
proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction
of the health and wellness products transaction price upon such sales transactions occurred. The Company&#8217;s coupons have
a validity period of six months. If the Company&#8217;s customers did not utilize the coupons after six months, the Company would
recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2020 and
2019, the Company recognized $<span id="xdx_90A_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zSpzJ5ZUN80k"><ix:nonFraction name="AATP:ForfeitedCouponIncome" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">170,431</ix:nonFraction></span>
</span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90D_ecustom--ForfeitedCouponIncome_pp0p0_c20190101__20191231_zZYzEUhVIhl2"><ix:nonFraction name="AATP:ForfeitedCouponIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">(unaudited) as forfeited coupon income.
The Company did not earn any forfeited coupon income for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_90B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200930__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_zOuTiSsaJJte" title="Revenue from sales"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30_custom_HealthAndWellnessProductsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,541</ix:nonFraction></span> which it is
expected to fulfill within 12 months from December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock"><p id="xdx_89E_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zdBXrjHSlYo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Disaggregated
information of revenues by products are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B6_zChGSZN39qXj" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Survivor Select</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" title="Total revenues" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_SurvivorSelectMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">149,897</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" title="Total revenues" style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0728">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" title="Total revenues" style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Energized Mineral Concentrate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_EnergizedMineralConcentrateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,481</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_EnergizedMineralConcentrateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,687</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_EnergizedMineralConcentrateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,270</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ionized Cal-Mag</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_IonizedCalMagMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">908,964</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_IonizedCalMagMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,718</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" title="Total revenues" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Omega Blend</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_OmegaBlendMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">495,567</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_OmegaBlendMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,752</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_OmegaBlendMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">68,927</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>BetaMaxx</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_BetaMaxxMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_BetaMaxxMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,246</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_BetaMaxxMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,789</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vege Fruit Fiber</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zbzRbBa2R2xc" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_VegeFruitFiberMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,755</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zLCVyk32GXBd" title="Total revenues" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_z4tlviO1VJ3g" title="Total revenues" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Iron</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--IronMember_zKjsOyTnGL43" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_IronMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">133,389</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--IronMember_z6jB8K3wD1ig" title="Total revenues" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--IronMember_zG3y9qjsS042" title="Total revenues" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0766">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Young Formula</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zCbbACpUD5tb" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_YoungFormulaMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">653,631</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zFBXDDEWNjg3" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_YoungFormulaMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">117,453</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zuNHdbx356e3" title="Total revenues" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Organic Youth Care Cleansing Bar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z3nhg4lmHW9i" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_OrganicYouthCareCleansingBarMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,127</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zI6wcZke4M15" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_OrganicYouthCareCleansingBarMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,917</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190701__20191213__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z6WIp5pTOix9" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-13_custom_OrganicYouthCareCleansingBarMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,206</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Mitogize</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--MitogizeMember_zAreAMX1Mll1" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_MitogizeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">162,801</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_z1oN5ObLMhp6" title="Total revenues" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0782">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_zEq44msPTLtj" title="Total revenues" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">No. 1 MED</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zlSLsCJQhFf4" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_NoOneMEDMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">46,713</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zKbFGZRdyAah" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_NoOneMEDMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,733</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_z0CCGwlOHMSj" title="Total revenues" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0790">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Energetique</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zv5rChZ4rlC" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-31_custom_EnergetiqueMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">253,396</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zRM3mj7XNsG2" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_EnergetiqueMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">174,808</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zLNcmrig4WE4" title="Total revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31_custom_EnergetiqueMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">175,170</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trim+</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20200101__20201213__srt--ProductOrServiceAxis__custom--TrimPlusMember_zcYOBTSyddxf" title="Total revenues" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-12-13_custom_TrimPlusMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">365,350</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zesbMf6lJCz3" title="Total revenues" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31_custom_TrimPlusMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,817</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zCH8cGDMuRvd" title="Total revenues" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20200101__20201231_zx6ORyFHQ275" title="Total revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,452,621</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20190101__20191231_z2fnVT2bi9k7" title="Total revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,290,131</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231_zW7lnu0jfNDb" title="Total revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">429,362</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_zI3PvwI53Oug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sales
of Health and Wellness services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company carries out its Wellness program, where the Company&#8217;s products are bundled with health screening test and a health
camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises
to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced
by the fact that the Company provides separate services of delivering the health screening test report and allowing admission
of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues
being recognized when the test reports are completed and delivered to its customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health
camp program was completed in the final day of the health camp. For the year ended December 31, 2020, revenues from health and
wellness services are immaterial to the Company&#8217;s consolidated statements of operations and comprehensive income (loss).
The Company did not earn any revenues from health and wellness services for the year ended December 31, 2019 and for the six months
ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock"><p id="xdx_846_eus-gaap--CostOfSalesPolicyTextBlock_zkmmRRTDgpw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zLrxsIRymsf8">Cost
of revenue</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:ShippingAndHandlingPolicyTextBlock"><p id="xdx_84F_ecustom--ShippingAndHandlingPolicyTextBlock_zV3CavKT9Hd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zqQ4fr4fML5i">Shipping
and handling</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Shipping
and handling charges amounted to $<span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zVbxLjvziDP1" title="Selling expenses"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,315</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--SellingExpense_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjMBI1nTDuI3" title="Selling expenses"><ix:nonFraction name="us-gaap:SellingExpense" contextRef="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> for the years ended December 31, 2020 and 2019, respectively. There was <span id="xdx_90D_eus-gaap--SellingExpense_pp0p0_do_c20190701__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zWv6ZSIDlnKd" title="Selling expenses"><span title="Selling expenses">no</span></span> shipping
and handling charges for the six months ended December 31, 2019. Shipping and handling charges are expensed as incurred and included
in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zpdnyKbHw8d6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zmLmRIvrcX3">Advertising
costs</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Advertising
costs amounted to $<span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zMIxf7tBpael" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,339</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20190101__20191231_zogSdieAsnse" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> for the years ended December 31, 2020 and 2019, respectively. There were <span id="xdx_90B_eus-gaap--AdvertisingExpense_pp0p0_do_c20190701__20191231_zwKpGThdHrBc" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2019-07-012019-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> advertising costs
for the six months ended December 31, 2019. Advertising costs are expensed as incurred and included in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:CommissionsExpensePolicyPolicyTextBlock"><p id="xdx_843_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zEVKxBI3luP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_869_zSWBTGgQNpD7">Commission
expenses</span> </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Commission
expenses are the Company&#8217;s most significant expenses. As with all companies in the network marketing industry, the Company&#8217;s
sales channel is external to the Company. The Company&#8217;s &#8220;external sales force&#8221; is stratified into two levels
based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly
or indirectly, are referred to as &#8220;sales network members&#8221;. The Company pays commission to every sales distributor
based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors
with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain
amount of the Company&#8217;s inventory on their store premises. The stockists shall account to the Company for all products sales
from their store premises as monitored through the Company&#8217;s centralized stock tracking system. The Company pays a separate
commission to stockists based on revenue generated from the stockists&#8217; physical stores. Commission expenses amounted to
$<span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zYQ1YXb97Ey3" title="Commission expenses"><ix:nonFraction name="AATP:SalesCommissionsAndFees1" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">830,659</ix:nonFraction></span> and $<span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20190101__20191231_zjJUkqSIcuPb" title="Commission expenses"><ix:nonFraction name="AATP:SalesCommissionsAndFees1" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> (unaudited) for the years ended December 31, 2020 and 2019, respectively. There were <span id="xdx_90A_ecustom--SalesCommissionsAndFees1_pp0p0_do_c20190701__20191231_zqAGdQTEnrhk" title="Commission expenses"><ix:nonFraction name="AATP:SalesCommissionsAndFees1" contextRef="From2019-07-012019-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> commission expenses for
the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:DefinedContributionPlanPolicyTextBlock"><p id="xdx_840_ecustom--DefinedContributionPlanPolicyTextBlock_zdnbUAp30fci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_86E_zoaAjV6PLZll">Defined
contribution plan</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required
to accrue and pay for these benefits based on certain percentages of the employees&#8217; respective salaries, subject to certain
ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined
contribution plan. Total expenses for the plans were $<span id="xdx_909_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_zcD48OUBTDU4" title="Defined contribution plan expense"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,802</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20190101__20191231_zScVmBNzRsja" title="Defined contribution plan expense"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> (unaudited) for the years ended December 31, 2020 and 2019,
respectively. There was <span id="xdx_903_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_do_c20190701__20191231_zwB25uwSjDv9" title="Defined contribution plan expense"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="From2019-07-012019-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> defined contribution plan expenses for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
related contribution plans include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Social
    Security Organization (&#8220;SOSCO&#8221;) &#8211; <span id="xdx_904_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_zzJ1kUxA3Xde" title="Salary percentage"><ix:nonFraction name="AATP:SalaryPercentage" contextRef="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.75</ix:nonFraction>%</span> based on employee&#8217;s monthly salary capped of RM <span id="xdx_90D_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_z5twycUgm4b7" title="Monthly salary"><ix:nonFraction name="AATP:MonthlySalary" contextRef="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember_custom_MYRCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="RM">4,000</ix:nonFraction></span>;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employees
    Provident Fund (&#8220;EPF&#8221;) &#8211; <span id="xdx_90F_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_z3vJooMIJuo2" title="Salary percentage"><ix:nonFraction name="AATP:SalaryPercentage" contextRef="From2020-01-012020-12-31_custom_EmployeesProvidentFundMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction>%</span> based on employee&#8217;s monthly salary;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employment
    Insurance System (&#8220;EIS&#8221;) &#8211; <span id="xdx_907_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zObQ2Bc6Cqgf" title="Salary percentage"><ix:nonFraction name="AATP:SalaryPercentage" contextRef="From2020-01-012020-12-31_custom_EmploymentInsuranceSystemMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction>%</span> based on employee&#8217;s monthly salary capped of RM <span id="xdx_906_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zgTOp9GhUnFd" title="Monthly salary"><ix:nonFraction name="AATP:MonthlySalary" contextRef="From2020-01-012020-12-31_custom_EmploymentInsuranceSystemMember_custom_MYRCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="RM">4,000</ix:nonFraction></span>;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Human
    Resource Development Fund (&#8220;HRDF&#8221;) &#8211; <span id="xdx_901_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zmGJg8akYI4e" title="Salary percentage"><ix:nonFraction name="AATP:SalaryPercentage" contextRef="From2020-01-012020-12-31_custom_HumanResourceDevelopmentFundMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction>% </span>based on employee&#8217;s monthly salary</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z26hosMg9bS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zWmm0JwTgGNd">Income
taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results
for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have
been enacted or substantively enacted by the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between
the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in
the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible
temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when
the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it
is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred
tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion
or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the
relevant taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">An
uncertain tax position is recognized as a benefit only if it is &#8220;more likely than not&#8221; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is <span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20200101__20201231_z6btSy8NTCP2"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement">greater than 50%</ix:nonNumeric>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">likely of being realized on examination. For
tax positions not meeting the &#8220;more likely than not&#8221; test, no tax benefit is recorded. <span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20200101__20201231_zOoWBHJPrM0g"><span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190101__20191231_zjL9HeSSY6D9"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2020-01-01to2020-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2019-01-012019-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">No</ix:nonFraction></ix:nonFraction></span>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">penalties and interest incurred related to underpayment
of income taxes for the years ended December 31, 2020 and 2019. <span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190701__20191231_zTaFbBkviXke"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2019-07-012019-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">No
</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">penalties and interest incurred related to underpayment
of income taxes for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions.
As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign
tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock"><p id="xdx_845_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zA14L2AXjhr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_z6lDNGskyQyb">Comprehensive
income (loss)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income
(loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#8217; equity
but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting
from the Company not using the U.S. dollar as its functional currencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:NoncontrollingInterestPolicyTextBlock"><p id="xdx_841_ecustom--NoncontrollingInterestPolicyTextBlock_zjA6pTuKrPnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zc3R8KYdMsN9">Non-controlling
interest</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--MinorityInterestDescription_c20200101__20201231_zuFJWaaiUBz1" title="Noncontrolling interest, description"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="us-gaap:MinorityInterestDescription">Non-controlling
interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held
by two individuals.</ix:nonNumeric></span> The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable
to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated
statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders
and the shareholders of the Company. As of December 31, 2020, the non-controlling interest balance was $<span id="xdx_90A_eus-gaap--MinorityInterest_iI_pp0p0_c20201231_zxduBUXDsSEd" title="Non-controlling interest"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and therefore not presented
in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zqg1I9qAHxok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zY3SKCpKKPQ9">Earnings
(loss) per share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company computes earnings (loss) per share (&#8220;EPS&#8221;) in accordance with ASC 260, &#8220;Earnings per Share&#8221;. ASC
260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary
share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares
(e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per
share or decrease loss per share) are excluded from the calculation of diluted EPS. For the years ended December 31, 2020 and
2019, there were <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20200101__20201231_zt4FOglj8Qxe" title="Potentially dilutive securities outstanding"><span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190101__20191231_zYfevg2dAOf8" title="Potentially dilutive securities outstanding"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-01to2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-01-012019-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span> dilutive shares. There was <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190701__20191231_z5THbyxJmJWi" title="Potentially dilutive securities outstanding"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012019-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span> dilutive shares for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOK2vIIGi7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zVe1pPjk2E0j">Foreign
currencies translation and transaction</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates
prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional
currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting
exchange differences are recorded in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have
been expressed in US$. The Company&#8217;s subsidiary in Labuan maintains its books and record in United States Dollars (&#8220;US$&#8221;)
albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the
Malaysian Ringgit (&#8220;MYR&#8221; or &#8220;RM&#8221;). The Company&#8217;s subsidiary in Hong Kong maintains its books and
record in Hong Kong Dollars (&#8220;HK$&#8221;), similar to its functional currency. The Company&#8217;s subsidiary and VIE in
Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (&#8220;MYR&#8221;
or &#8220;RM&#8221;), as its functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated
into US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate
on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses
resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other
comprehensive income within the statements of stockholders&#8217; equity. Cash flows are also translated at average translation
rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the
corresponding balances on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zyv50fNYzHIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BE_zVTTQ0AjlAuj" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Period-end MYR : US$1 exchange rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zVv6l569wlf8" title="Foreign Currency Exchange Rate, Translation" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2020-12-31_custom_PeriodEndMYRMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.02</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zAce32sO6Npd" title="Foreign Currency Exchange Rate, Translation" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2019-12-31_custom_PeriodEndMYRMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.09</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Period-end HKD : US$1 exchange rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zAgNXVkWtTEk" title="Foreign Currency Exchange Rate, Translation" style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2020-12-31_custom_PeriodEndHKDMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zfqZH1qQvpu8" title="Foreign Currency Exchange Rate, Translation" style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2019-12-31_custom_PeriodEndHKDMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.79</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Period-average MYR : US$1 exchange rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zVetDM7dEnI2" title="Foreign currency exchange rate period average" style="width: 14%; text-align: right"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2020-01-012020-12-31_custom_PeriodAverageMYRMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.20</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zjh3pkqYV8fj" title="Foreign currency exchange rate period average" style="width: 14%; text-align: right"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2019-01-012019-12-31_custom_PeriodAverageMYRMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.14</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zgvw3KqrLqk3" title="Foreign currency exchange rate period average" style="width: 14%; text-align: right"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2019-07-012019-12-31_custom_PeriodAverageMYRMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.16</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Period-average HKD : US$1 exchange rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zyaxoZRqmhx6" title="Foreign currency exchange rate period average" style="text-align: right"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2020-01-012020-12-31_custom_PeriodAverageHKDMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zI0VUIkx7qu8" title="Foreign currency exchange rate period average" style="text-align: right"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2019-01-012019-12-31_custom_PeriodAverageHKDMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.84</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zzj3XRLLV3va" title="Foreign currency exchange rate period average" style="text-align: right"><ix:nonFraction name="AATP:ForeignCurrencyExchangeRateAverage" contextRef="From2019-07-012019-12-31_custom_PeriodAverageHKDMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.83</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zGqhfLGDdP0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:RelatedPartiesPolicyTextBlock"><p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zqNQnty2NCli" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_z9BMJjyThk6j">Related
parties</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly,
to control the other party or exercise significant influence over the other party in making financial and operating decisions.
Companies are also considered to be related if they are subject to common control or common significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zx2nMC08WMI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zg5tdN22eaj1">Fair
value of financial instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments
and requires disclosure of the fair value of financial instruments held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement
and enhance disclosure requirements for fair value measures. The three levels are defined as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
    that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
    instruments.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or
cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected
realization and their current market rates of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_z0vjk6wQJWw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_zIClplFSvxVi">Leases</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
July 1, 2019, the Company adopted ASU 2016-02, &#8220;Leases&#8221; (Topic 842), and elected the practical expedients that does
not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification
for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve
months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The
Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single
lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing
leases with a lease term in excess of twelve months on July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating
lease right-of-use (&#8220;ROU&#8221;) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the
commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit
rate for the Company&#8217;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information
available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate
of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in
a similar economic environment and over a similar term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate
the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company
generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets.
The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases
with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU
asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company
reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying
value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying
value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected
to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating
lease payments in the undiscounted future pre-tax cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zbXPSSpP046l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_z8bQ1hey9MM3">Recent
accounting pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption
of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations,
as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#8212;Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for
the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology.
The amendments in Update 2016-13 added Topic 326, Financial Instruments&#8212;Credit Losses, and made several consequential amendments
to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually
assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial
Instruments&#8212; Credit Losses&#8212;Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders&#8217;
concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at
amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information
by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief
also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement
users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date
of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit
losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December
15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company
is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and
investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and
purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify
that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting
when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting.
With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance
in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the
purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity
method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods
beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this
standard on January 1, 2021 did not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:VariableInterestEntityDisclosureTextBlock"><p id="xdx_801_eus-gaap--VariableInterestEntityDisclosureTextBlock_zgUGnTSZ2Keb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>3.
<span id="xdx_82E_zwI7jzQ9wOG2">VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">SEA
is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided all of ASL&#8217;s purchases. Its
equity at risk was insufficient to finance its activities and <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zoRNSZrdRpA6" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of its business is transacted with ASL. Therefore, it was considered
to be a VIE and ASL is the primary beneficiary since it has both of the following characteristics:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
    power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
    obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from
    the VIE that could potentially be significant to the VIE</span><span style="font: 10pt Times New Roman, Times, Serif">.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accordingly,
the accounts of SEA is consolidated in the accompanying financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_zKylO7782fFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
carrying amount of the VIE&#8217;s assets and liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BF_zgXo71YX0MH" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsCurrent_iI_pp0p0_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zU8Jy1ossrzc" title="Current asset" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,717</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesCurrent_iNI_pp0p0_di_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zY2VGSD4mFZk" title="Current liabilities" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">53,573</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deficit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Net deficit" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,856</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current asset:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Cash and cash equivalents" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,387</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PrepaidTaxes_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Prepaid taxes" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidTaxes" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,330</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total current assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Total current assets" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,717</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Other payables and accrued liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,904</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other payables &#8211; intercompany</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--OtherPayablesRelatedPartyCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Other payables - intercompany" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:OtherPayablesRelatedPartyCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,669</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--LiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Total current liabilities" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">53,573</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>3.
VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
summarized operating results of the VIE&#8217;s are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left; padding-bottom: 2.5pt">Operating revenues</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Operating revenues" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">346,907</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gross profit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--GrossProfit_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Gross profit" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,442</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss from operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Loss from operations" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,752</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" title="Net loss" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">24,014</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AC_zAjTEpy5oJ6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_807_eus-gaap--BusinessCombinationDisclosureTextBlock_zw2UFQd2Jhn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>4.
<span id="xdx_82F_ziFfcT33m7Zd">BUSNINESS COMBINATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
May 8, 2020, the Company entered into a Share Exchange Agreement (&#8220;SPA&#8221;) with Mr. How Kok Choong, CEO and director
of the Company to acquire <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_pii" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,590,596</ix:nonFraction></span> ordinary shares, <span id="xdx_90D_eus-gaap--CommonStockNoParValue_iI_pii_do_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zoIqkGdxGSyd" title="Ordinary shares no par value"><ix:nonFraction name="us-gaap:CommonStockNoParValue" contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares">no</ix:nonFraction></span> par value, equivalent to approximately <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z3JXJd1ddbrh" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.99</ix:nonFraction>%</span> of the equity interest in
ASL, an entity incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration
of $<span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferred1_c20200629__20200702__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Purchase consideration value"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2020-06-292020-07-02_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,804,046</ix:nonFraction></span>, which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration
shall be satisfied by (i) the offset of the Consideration whereby the Company has a loan receivable of $<span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Loan payable"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">656,495</ix:nonFraction></span> as of March 31,
2020 due from Mr. How; and (ii) allotment and issuance of common stock of the Company. The Company shall allot and issue <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pii" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">176,547</ix:nonFraction></span>
shares of the Company&#8217;s common stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_c20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pii" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>, representing approximately <span id="xdx_907_ecustom--PercentageOfCommonStockIssuedAndOutstanding_pii_dp_uPure_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z7jb9qaYraP7" title="Percentage of common stock issued and outstanding"><ix:nonFraction name="AATP:PercentageOfCommonStockIssuedAndOutstanding" contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0469</ix:nonFraction>%</span> of the total issued and outstanding
shares in the Company after the issuance of the Shares, which is valued at $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Stock issued during period, value, acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,147,551</ix:nonFraction></span> based on the closing price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_c20200331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_pii" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-03-31_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.50</ix:nonFraction></span> of the
Company as quoted on the OTC Market on March 31, 2020. As of December 31, 2020, the Company has issued all <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pii_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z3vZ2HK501Xk" title="Issuance of common stock shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-01-012020-12-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">176,547</ix:nonFraction></span> shares of the
Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated
the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1,
2020 as ASL was under the common control of Mr. How.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zjoMFwU6vwug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date,
which represents the net purchase price allocation on the date of the acquisition of ASL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b><span id="xdx_8BA_zBmLsqF2NTUl" style="display: none">SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carry Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 82%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c20201231_pp0p0" title="Cash" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,206,493</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20201231_pp0p0" title="Other receivables" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,210</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Other receivables - related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_c20201231_pp0p0" title="Other receivables - related parties" style="text-align: right"><ix:nonFraction name="AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">219,121</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20201231_pp0p0" title="Inventories" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">616,880</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepaid taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_c20201231_pp0p0" title="Prepaid taxes" style="text-align: right"><ix:nonFraction name="AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,206,821</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepayments and other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20201231_pp0p0" title="Prepayments and other assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">318,267</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c20201231_pp0p0" title="Total current assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,600,792</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c20201231_pp0p0" title="Property and equipment, net" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">325,648</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c20201231_pp0p0" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,686</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deferred taxes asset, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c20201231_pp0p0" title="Deferred taxes asset, net" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,250</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_c20201231_pp0p0" title="Total other assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">504,584</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20201231_pp0p0" title="Total assets" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,105,376</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable - related party</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c20201231_pp0p0" title="Accounts payable - related party" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">491,628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_c20201231_pp0p0" title="Customer deposits" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,600,606</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other payables and accrued liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c20201231_pp0p0" title="Other payables and accrued liabilities" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">209,096</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_c20201231_pp0p0" title="Total current liabilities" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,301,330</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c20201231_pp0p0" title="Total liabilities" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,301,330</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total net assets acquired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20201231_pp0p0" title="Total net assets acquired" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,804,046</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zvuS4LWR3hnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>4.
BUSNINESS COMBINATION (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following unaudited pro forma combined results of operations presents the Company&#8217;s financial results as if the acquisition
of ASL had been completed on January 1, 2019. The unaudited pro forma results do not reflect operating efficiencies or potential
cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information
is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction
on January 1, 2019. Future results may vary significantly from the results in this pro forma information because of future events
and transactions, as well as other factors.</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock"><p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zSAAt6fY6ls1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zJ0F8eB5LHz9" style="display: none">SCHEDULE OF PRO FORMA BUSINESS COMBINATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the Year Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the Year Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231_pp0p0" title="Revenue" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,693,873</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190101__20191231_pp0p0" title="Revenue" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,160,820</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190701__20191231_pp0p0" title="Revenue" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,246,458</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20200101__20201231_pp0p0" title="Cost of revenue" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaCostOfRevenue" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">875,708</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190101__20191231_pp0p0" title="Cost of revenue" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaCostOfRevenue" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">789,409</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190701__20191231_pp0p0" title="Cost of revenue" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaCostOfRevenue" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">479,410</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20200101__20201231_pp0p0" title="Gross profit" style="text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaGrossProfit" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,818,165</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190101__20191231_pp0p0" title="Gross profit" style="text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaGrossProfit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,371,411</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190701__20191231_pp0p0" title="Gross profit" style="text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaGrossProfit" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,767,048</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231_pp0p0" title="Total operating expenses" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaOperatingExpenses" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,839,184</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190101__20191231_pp0p0" title="Total operating expenses" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaOperatingExpenses" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,081,917</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190701__20191231_pp0p0" title="Total operating expenses" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaOperatingExpenses" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,468,902</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income (loss) from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20200101__20201231_pp0p0" title="Income (loss) from operations" style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">21,019</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190101__20191231_pp0p0" title="Income (loss) from operations" style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,710,506</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190701__20191231_pp0p0" title="Income (loss) from operations" style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">701,854</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income (expense), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20200101__20201231_pp0p0" title="Other income (expense), net" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">267,633</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190101__20191231_pp0p0" title="Other income (expense), net" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">384,304</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190701__20191231_pp0p0" title="Other income (expense), net" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">146,649</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income (loss) before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20200101__20201231_pp0p0" title="Income (loss) before income taxes" style="text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">246,614</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190101__20191231_pp0p0" title="Income (loss) before income taxes" style="text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,094,810</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190701__20191231_pp0p0" title="Income (loss) before income taxes" style="text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">848,503</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Benefit of (provision for) income taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20200101__20201231_pp0p0" title="Benefit of (Provision for) income taxes" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">212,414</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190101__20191231_pp0p0" title="Benefit of (Provision for) income taxes" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">319,189</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190701__20191231_pp0p0" title="Benefit of (Provision for) income taxes" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">117,009</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231_pp0p0" title="Net income (loss)" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,200</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190101__20191231_pp0p0" title="Net income (loss)" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,775,621</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190701__20191231_pp0p0" title="Net income (loss)" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">731,494</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net income (loss) per common share - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20200101__20201231_pii" title="Net income (loss) per common share - basic and diluted" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190101__20191231_pii" title="Net income (loss) per common share - basic and diluted" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190701__20191231_pii" title="Net income (loss) per common share - basic and diluted" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20200101__20201231_pii" title="Weighted average number of common shares outstanding - basic and diluted" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190101__20191231_pii" title="Weighted average number of common shares outstanding - basic and diluted" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190701__20191231_pii" title="Weighted average number of common shares outstanding - basic and diluted" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_zZ49HtG0BkHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>5.
CASH AND CASH EQUIVALENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">As
of December 31, 2020, and 2019 the Company has $<span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20201231_pp0p0" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,517,600</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20191231_pp0p0" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,744,457</ix:nonFraction></span>, respectively, of cash and cash equivalents, which consists
of $<span id="xdx_909_eus-gaap--Cash_c20201231_pp0p0" title="Cash in bank"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,112,147</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--Cash_c20191231_pp0p0" title="Cash in bank"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,937</ix:nonFraction></span>, respectively, of cash in banks and </span><span style="font: 10pt Times New Roman, Times, Serif">$<span id="xdx_90A_eus-gaap--TimeDeposits_c20201231_pp0p0" title="Time deposits"><ix:nonFraction name="us-gaap:TimeDeposits" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,391,182</ix:nonFraction></span>
<span style="background-color: white">and $<span id="xdx_901_eus-gaap--TimeDeposits_c20191231_pp0p0" title="Time deposits"><ix:nonFraction name="us-gaap:TimeDeposits" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,505,520</ix:nonFraction></span>, respectively, of time deposits placed with banks or other financial institutions
and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time
deposits ranges between <span id="xdx_901_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pii_dp_uPure_c20201213__srt--RangeAxis__srt--MinimumMember_zEWSIDibomk1" title="Percentage of Interest rate for time deposits"><ix:nonFraction name="us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" contextRef="AsOf2020-12-13_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.95</ix:nonFraction>%</span> to <span id="xdx_90C_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pii_dp_uPure_c20201213__srt--RangeAxis__srt--MaximumMember_z1H8B4W9ePyg" title="Percentage of Interest rate for time deposits"><ix:nonFraction name="us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" contextRef="AsOf2020-12-13_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.25</ix:nonFraction>%</span> per annum.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_802_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_ztLkkt9z6bbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>6.
<span id="xdx_824_zoBGjeokoMPj">ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY</span></b></span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z3k4Tqe4cwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B7_z3k88x6Pg2Qb" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20201231_zjeuVyRXzvl8" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20191231_z2ligaszJJWh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zG29Ltth4Cfk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableGrossCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,757</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1093">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zmMHrdaqLIu4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accounts receivable &#8211; related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1095">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableRelatedPartiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">520,786</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zVdqhtmCi7Sh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:AccountsReceivableAndAccountsReceivableRelatedParties" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,757</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:AccountsReceivableAndAccountsReceivableRelatedParties" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">520,786</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zptH4SzfrmQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zaOdHgAewML9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>7.
<span id="xdx_82A_zcYoHdH481Oc">INVENTORIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z2viOa0MTNF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories
consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zGMyk4cKIe75" style="display: none">SCHEDULE OF INVENTORIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Finished goods</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--InventoryFinishedGoods_c20201231_pp0p0" title="Finished goods" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">589,814</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InventoryFinishedGoods_c20191231_pp0p0" title="Finished goods" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zBEpU9Yw4OIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:PrepaymentsAndDepositsTextBlock"><p id="xdx_800_ecustom--PrepaymentsAndDepositsTextBlock_zDYcL4R8KpCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>8.
<span id="xdx_827_znuDZsOzLoZ1">PREPAYMENTS AND DEPOSITS</span></b></span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock"><p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zivrAC8upLhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BF_zbrHRzStjwi6" style="display: none">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20201231_zuZCAK5AfXy3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br /> December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20191231_z2vvxHcCpeR" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br /> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzhWX_zlZfXx7hYSDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Prepaid expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1113">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,641</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_z6kTdM27P9x7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Receivables from sales distributors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:ReceivablesFromSalesDistributors" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,302</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1117">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_z4bS8sMRxkef" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Deposits to suppliers</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:DepositsToSupplier" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">261,068</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:DepositsToSupplier" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">266,552</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzhWX_zRHLu9QLIff6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">296,370</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">269,193</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zJiOVdkiElz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80A_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ztk3EbCPZZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>9.
<span id="xdx_82B_z7ylvA5fnJKc">PROPERTY AND EQUIPMENT, NET</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zcREefv8JXG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment, net consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span><span id="xdx_8B5_zEBr0QdvFIO7" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT, NET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20201231_zYmTywqIqugh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20191231_zzSGCqqUO81k" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Computer and office equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z0xxtaToXSTb" title="Subtotal" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_custom_ComputerAndOfficeEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,437</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z7OMbZxtoE7h" title="Subtotal" style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1131">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture &amp; fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zWfeAkDtAc4c" title="Subtotal" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">126,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zU4XAfvc44h3" title="Subtotal" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1135">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z8Ked0WvAgLe" title="Subtotal" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">210,496</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z2VSYwPCvgh7" title="Subtotal" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1139">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Vehicle</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_z9QUQK4gXEUc" title="Subtotal" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_custom_VehicleMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">102,564</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zgUbYAIGXk84" title="Subtotal" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1143">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzvyH_zYufVXjBCzQf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">521,463</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1146">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzvyH_zP839ta38Wv7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">223,154</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1149">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzvyH_zgpUgFs5BYKb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">298,309</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1152">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_z8hGp74JibE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense for the years ended December 31, 2020 and 2019 amounted to $<span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20200101__20201231_zZagVQ2wVNU4" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,407</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20190101__20191231_zrBwsHIB2Shb"><span style="-sec-ix-hidden: xdx2ixbrl1155">-</span></span> (unaudited), respectively. There was <span>no</span> depreciation
expense for the six months ended December 31, 2019.</span></p>

</ix:nonNumeric><p id="xdx_818_ztXtFLLcDmkh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_800_eus-gaap--IntangibleAssetsDisclosureTextBlock_zMOTLBaVM54l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>10.
<span id="xdx_821_zl7zzRPKeKIb">INTANGIBLE ASSETS, NET</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zOVb6pOQNP19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets, net, consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zf2xVuF2IrI3" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20201231_zabjW7SGYmh6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20191231_zi6e6ngPpZZ1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzwwR_maFLIANz4yv_zePWh5kLCi9k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Computer software</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,801</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzwwR_msFLIANz4yv_ze08XLW8gR7a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,975</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1165">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzwwR_mtFLIANz4yv_zetRvkWw7mkg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,826</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_z55evXnrJ0L7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Amortization
expense for the years ended December 31, 2020 and 2019 amounted to $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200101__20201231_zScbtKaKRi6c" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,505</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20190101__20191231_zrX3s2PcBHyg" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> (unaudited), respectively. There was <span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_do_c20190701__20191231_zyFnqLTjb0C2" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-07-012019-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> amortization
expense for the six months ended December 31, 2019.</span></p>

</ix:nonNumeric><p id="xdx_811_znTO0gpcH1ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:InvestmentInMarketableSecuritiesTextBlock"><p id="xdx_80C_ecustom--InvestmentInMarketableSecuritiesTextBlock_z24OoQ5pXbV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>11.
<span id="xdx_829_zS2YMS7z3Dkk">INVESTMENT IN MARKETABLE SECURITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    May 17, 2018, the Company purchased <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zmVYwPfwoHsb" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,333</ix:nonFraction></span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zpClzDTE1ome" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,000</ix:nonFraction></span> at a purchase price
    of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zlkBl5FJLctd" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6</ix:nonFraction></span> per share.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    July 30, 2018, the Company disposed <span id="xdx_904_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zfr7IOfpZgJ1" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_909_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_z3OLgb9Wvaf" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125</ix:nonFraction></span> at a purchase price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_z7kS8yVPRDse" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.2613</ix:nonFraction></span>
    per share.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    October 16, 2018, the Company purchased <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zSl4sUUxNte8" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,333</ix:nonFraction></span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_znjQghgk4P43" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000</ix:nonFraction></span> at a purchase price
    of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zwlt67wxP2qe" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per share.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    November 3, 2020, the Company received dividend of <span id="xdx_906_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_zZPBv8rJwKT4" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2020-11-03_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,667</ix:nonFraction></span> shares of common stock in DSwiss, Inc. for $<span id="xdx_907_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_zZ1myoVEiWn5" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-11-03_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">76,671</ix:nonFraction></span> at fair value
    of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_zHlSORtdssU6" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-11-03_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#8217;s shares</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    December 9, 2020, the Company received dividend of <span id="xdx_906_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zLZr23hjwIe6" title="Investment in securities, shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2020-12-09_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,663</ix:nonFraction></span> shares of common stock in DSwiss, Inc. for $<span id="xdx_90C_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zBtZWIVgqRM4" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-12-09_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,315</ix:nonFraction></span> at fair value
    of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zqjZefpIYMfb" title="Purchased price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-09_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></span> per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#8217;s shares.</span></td></tr>
</table>
<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:MarketableSecuritiesTextBlock"><p id="xdx_898_eus-gaap--MarketableSecuritiesTextBlock_z0m6ZX0jrsNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B1_zZlxQR9QRc2l" style="display: none">SCHEDULE
OF INVESTMENT IN MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20201231_zT8A2w6neZpj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20191231_z899A2mt3dA4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentOwnedAtCost_iI_maT002_maMSNzoUs_z37fFNeVkXVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cost of investment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,484</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">134,166</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--InvestmentsIncomeDividend_iNI_di_msMSNzoUs_zM7gVkETjOS7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dividend income from Greenpro Capital Corp.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:InvestmentsIncomeDividend" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">160,062</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1214">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingLoss_iI_pp0p0_msT002_msMSNzoUs_zECxHSWYdyza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unrealized holding gain (loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:MarketableSecuritiesUnrealizedHoldingLoss" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">350,137</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AATP:MarketableSecuritiesUnrealizedHoldingLoss" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">68,391</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maT002_maMSNzoUs_zZReSz2dLMWa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Exchange rate effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">352</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">709</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzoUs_zZr4ak6dsByl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Investment in marketable securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">577,035</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,484</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_z6fMpGCttcKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:InvestmentInNonMarketableSecuritiesTextBlock"><p id="xdx_80B_ecustom--InvestmentInNonMarketableSecuritiesTextBlock_zQNe1pmlBcv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>12.
<span id="xdx_826_zhFtDZkbaEk3">INVESTMENT IN NON-MARKETABLE SECURITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company invested in Unreserved Sdn Bhd with the investment amount of <span id="xdx_906_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__srt--DirectorMember_zmiphj0lm7e5" title="Investment amount">$<ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-12-31_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">863,592</ix:nonFraction></span> (RM <span id="xdx_909_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zuxMrYwybuxk" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-12-31_srt_DirectorMember_custom_MYRCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,500,000</ix:nonFraction></span>), which approximated <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--TitleOfIndividualAxis__srt--DirectorMember_z7iDElFJfpZb" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-31_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction>%</span> of the equity
interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd
issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company&#8217;s
equity interest in investee company was diluted from approximately <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190310__srt--RangeAxis__srt--MaximumMember_zuc5bTkAyVdh" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-03-10_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.0</ix:nonFraction>%</span> to approximately <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190310__srt--RangeAxis__srt--MinimumMember_zGLRomph8VF8" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-03-10_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17.86</ix:nonFraction>%</span>. Effective from March 10, 2019,
the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the
investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>12.
INVESTMENT IN NON-MARKETABLE SECURITIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unreserved
Sdn Bhd was incorporated in Malaysia with <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20201231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z7YSmvsm8048" title="Ordinary shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500,000</ix:nonFraction></span> ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David
Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company
from April 30, 2018 to March 27, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
March 3, 2020, the Company agreed to sell the <span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200303__srt--TitleOfIndividualAxis__custom--UnreservedSdnBhdMember_zacrZg8vfsu4" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-03-03_custom_UnreservedSdnBhdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17.86</ix:nonFraction>%</span> ownership interest in Unreserved Sdn Bhd at the December 31, 2019
carrying value of $7<span id="xdx_907_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z8MSf90Npslj" title="Investment amount"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2019-12-31_custom_MrHowKokChoongMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,637</ix:nonFraction></span> to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $<span id="xdx_900_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_pp0p0_c20200101__20200331_zyRj8BLE9dna" title="Proceeds from investments"><ix:nonFraction name="AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" contextRef="From2020-01-012020-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">70,173</ix:nonFraction></span>,
and had an amount due from director of $<span id="xdx_909_eus-gaap--DueFromOfficersOrStockholdersCurrent_iI_pp0p0_c20200331__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zp3qS9I8ENT3" title="Amount due from director"><ix:nonFraction name="us-gaap:DueFromOfficersOrStockholdersCurrent" contextRef="AsOf2020-03-31_custom_MrHowKokChoongMember25848312" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">660,464</ix:nonFraction></span> at March 31, 2020. In May 2020, the entire outstanding balance was settled as
part of the consideration in a transaction which the Company had acquired the CEO&#8217;s ownership interest of Agape Superior
Living Sdn. Bhd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
April 3, 2019, the Company purchased a <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zW5hQ0ECOpod" title="Equity interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction>%</span> of stock or <span id="xdx_900_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMuiSsfCa2q7" title="Shares purchased during period"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000,000</ix:nonFraction></span> shares of common stock in Phoenix Plus Corp. for $<span id="xdx_90E_eus-gaap--InvestmentOwnedAtCost_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></span> at purchase
price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pii"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share.</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:NonMarketableSecuritiesTableTextBlock"><p id="xdx_890_ecustom--NonMarketableSecuritiesTableTextBlock_zVcsiDStTTCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zwo7IHXeFEYj" style="display: none">SCHEDULE
OF INVESTMENT IN NON MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid">Unreserved Sdn Bhd</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br /> December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br /> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Investment in non-marketable securities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zy5FwsrHnnvf" title="Investment in non-marketable securities" style="width: 16%; text-align: right"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesGross" contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">730,637</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zvFRZlIhT4w9" title="Investment in non-marketable securities" style="width: 16%; text-align: right"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesGross" contextRef="AsOf2019-12-31_custom_DirectorsOfUnreservedInvestmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">730,637</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Less: Sale of investment in non-marketable securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zPHfauzcxTe5" title="Less: Sale of investment in non-marketable securities" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:SaleOfInvestmentInNonmarketableSecurities" contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">730,637</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_znBNiSMcRYXd" title="Less: Sale of investment in non-marketable securities" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1261">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Investment in non-marketable securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zRoMhr7p1lda" title="Investment in non-marketable securities" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1263">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zAOUFV0i00U2" title="Investment in non-marketable securities" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AATP:InvestmentInNonmarketableSecuritiesNet" contextRef="AsOf2019-12-31_custom_DirectorsOfUnreservedInvestmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">730,637</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left">Phoenix Plus Corporation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of investment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z6yageq06Da5" title="Cost of investment" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2020-12-31_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z3yTqDUlNzp6" title="Cost of investment" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2019-12-31_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total investment in non-marketable securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zhrdmj6iHPE3" title="Total investment in non-marketable securities" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesNoncurrent" contextRef="AsOf2020-12-31_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zNHoSPSLbmD1" title="Total investment in non-marketable securities" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:InvestmentInNonMarketableSecuritiesNoncurrent" contextRef="AsOf2019-12-31_custom_PhoenixPlusCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">732,137</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_zyqc8LlloOza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:OtherLiabilitiesDisclosureTextBlock"><p id="xdx_805_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zkPfJ73v5QSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>13.
<span id="xdx_828_zM6cgFMmVV51">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock"><p id="xdx_890_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zvevgH6ntcy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BE_zUECWJ5V8Deg" style="display: none">SCHEDULE
OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20201231_zaSsDXBRCEhd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20191231_zGkLGdcGquE1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_z0GzJp230hSf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Professional fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">297,636</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,594</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--AccruedPromotionExpenses_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zHWpQRvjZpKe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Promotion expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AATP:AccruedPromotionExpenses" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,433</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1283">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zs4HlqHau9dj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Payroll</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,976</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1286">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maOAPAAzH31_zrLNi3ewmGp2" style="vertical-align: bottom; background-color: White">
    <td>Commission</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">224,711</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1289">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_maOAPAAzr8S_maOAPAAzH31_zy64H97taSK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,921</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,652</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--OtherAccountPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzH31_zJuze8EsX2Zk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:OtherAccountPayableAndAccruedLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">647,677</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AATP:OtherAccountPayableAndAccruedLiabilities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">77,246</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zLrh4fxIfnpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zaK4JsHCB2ca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>14.
<span id="xdx_829_zhD5cTc7954l">RELATED PARTY BALANCES AND TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Related
party balances</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zixdyMYZRAHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Accounts
receivable &#8211; related party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BC_zTOqoHzErHZa" style="display: none">SCHEDULE
OF RELATED PARTIES</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 15%; padding-bottom: 1.5pt; vertical-align: top">SEA</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td title="Related parties relationship, description" style="width: 22%; text-align: center; padding-bottom: 1.5pt"><span><span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z4r0qaJJKTq6" title="Relationship"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zAc8NfDRBm8j" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SeaMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_SeaMember" name="AATP:RelatedPartiesRelationshipsDescription">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td><td style="vertical-align: top; padding-bottom: 1.5pt; width: 17%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span><span><span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zWVbZB5iVLM7" title="Nature"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__custom--RelatedPartiesNatureDescriptionAxis__custom--SeaMember_z0NZBA917z89" title="Nature"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SeaMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_SeaMember25849703" name="AATP:RelatedPartiesNatureDescription">Sales of products</ix:nonNumeric></ix:nonNumeric></span></span></span></span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zJKaZDCGbXLl" title="Accounts receivable - related party" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1309">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zakJ6nMBP6zd" title="Accounts receivable - related party" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableRelatedParties" contextRef="AsOf2019-12-31_custom_SeaMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">520,786</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20200930_z9qLb6jkgZhj" title="Accounts receivable - related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1313">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231_zN55hyFPOoAf" title="Accounts receivable - related party" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableRelatedParties" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">520,786</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount
due from related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br /> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 18%; text-align: left">Agape ATP (Asia) Limited (&#8220;AATP Asia&#8221;)</td><td style="width: 2%">&#160;</td>
    <td style="width: 20%; text-align: center"><span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zw75ccAMGFXd" title="Relationship"><span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zXhULwcfmjr5" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_AgapeATPAsiaLimitedMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span title="Nature"><span title="Nature"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zJzwpXMlsqkf" title="Nature"><span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zS9nVW5ce79" title="Nature"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_AgapeATPAsiaLimitedMember" name="AATP:RelatedPartiesNatureDescription">Expenses paid for AATP Asia</ix:nonNumeric></ix:nonNumeric></span></span></span></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zgei8Pm92EY6" title="Amount due from related parties" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2020-12-31_custom_AgapeATPAsiaLimitedMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,227</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_z4eoOUeTP8ih" title="Amount due from related parties" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2019-12-31_custom_AgapeATPAsiaLimitedMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,217</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Hostastay Sdn. Bhd.</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zr41Sjr8s5Zh" title="Relationship"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zp2wuE0fJJqj" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</ix:nonNumeric></ix:nonNumeric></span></span></td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqXkrZZrLq9h" title="Nature"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zSfJKPSZkBOb" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdMember" name="AATP:RelatedPartiesNatureDescription">Sublease rent due from Hostastay</ix:nonNumeric></ix:nonNumeric></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqyDHGPbhKEi" title="Amount due from related parties" style="text-align: right"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2020-12-31_custom_HostastaySdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">996</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoIBCiLVUBO" title="Amount due from related parties" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1339">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">TH3 Technology Sdn Bhd</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zwnrZk3jMNyh" title="Relationship"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zag0xOlzxSz4" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_THThreeTechnologySdnBhdMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span><span id="xdx_90A_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zVx5rcw72ooj" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_ztylm5j894s3" title="Nature"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_THThreeTechnologySdnBhdMember" name="AATP:RelatedPartiesNatureDescription">Expenses paid for TH3 Technology</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zzZwgyyjZze6" title="Amount due from related parties" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2020-12-31_custom_THThreeTechnologySdnBhdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zt9qfn5m2t3b" title="Amount due from related parties" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1351">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_zJyeNOxmXkT2" title="Amount due from related parties" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,235</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231_zFU5tBSekWBl" title="Amount due from related parties" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DueFromRelatedParties" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,217</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount
due to a Related Party </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br /> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 18%; text-align: left">Mr. How Kok Choong</td><td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 20%; text-align: center"><span id="xdx_90D_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zagpdtShBrnb" title="Relationship"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z7rzqqoLYiA" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_MrHowKokChoongMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_MrHowKokChoongMember" name="AATP:RelatedPartiesRelationshipsDescription">CEO and director of the Company</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zofULDJzW49l" title="Nature"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zbW6skPbsvR5" title="Nature"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_MrHowKokChoongMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_MrHowKokChoongMember" name="AATP:RelatedPartiesNatureDescription">Acquisition payment of ASL and expenses paid for the Company</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zQanBNTHZQLg" title="Amount due to a Related Party" style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1365">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zoOWyZ11kMm3" title="Amount due to a Related Party" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2019-12-31_custom_MrHowKokChoongMember25849875" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,952</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zWsafe7EuOd2" title="Relationship"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zaSkW1GuFx52" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr. How Kok Choong, the CEO and director of the Company</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z8BvKqlWyWM8" title="Nature"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4YPWKRLxzJb" title="Nature"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdMember" name="AATP:RelatedPartiesNatureDescription">ATP Printing Label fees</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4ytW8nLXkmd" title="Amount due to a Related Party" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2020-12-31_custom_AgapeSuperiorLivingPtyLtdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">455</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zk3Pafzg6zgd" title="Amount due to a Related Party" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zKvRDIes0g93" title="Amount due to a Related Party" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">455</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231_z3RySKnCB839" title="Amount due to a Related Party" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,952</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>14.
RELATED PARTY BALANCES AND TRANSACTIONS  (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Related
party transactions </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 15%; vertical-align: top">SEA</td><td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: center"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zwitaBZqCIak" title="Relationship"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zNb9Yq0kiWo9" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SeaMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_SeaMember" name="AATP:RelatedPartiesRelationshipsDescription">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="vertical-align: top; width: 13%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z71NBS1YC83i" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zrtIaUQArOy5" title="Nature"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_SeaMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_SeaMember" name="AATP:RelatedPartiesNatureDescription">Sales of products</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zl1Mwgeg7Yfh" title="Revenue" style="width: 13%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_za6sEJYzqCP7" title="Revenue" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2019-01-012019-12-31_custom_SeaMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,268,670</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zhYFfpbqSFs1" title="Revenue" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2019-07-012019-12-31_custom_SeaMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">429,362</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (&#8220;ASLPL&#8221;)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_900_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zlHsUrMdYGUj" title="Relationship"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_znbURk9VgnKj" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_ze0dRrUnKmnb" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z9K1mA3oXrTd" title="Nature"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" name="AATP:RelatedPartiesNatureDescription">Sales of products</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z1mDwTSFcI8i" title="Revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,060</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z5EFwN7Rm1G" title="Revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,461</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zMjHcT9m7sG2" title="Revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1411">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zGZIyL6cTNu8" title="Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,060</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231_zNcKogcccSO7" title="Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,290,131</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231_zzDG731xHg6f" title="Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromRelatedParties" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">429,362</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other
income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 15%; text-align: left; padding-bottom: 1.5pt">Hostastay Sdn. Bhd.</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zlx2IsTyAaUg" title="Relationship"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zGjEEcllreYf" title="Relationship"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember" name="AATP:RelatedPartiesRelationshipsDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdOneMember" name="AATP:RelatedPartiesRelationshipsDescription">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zCQ4axBg1I7j" title="Nature"><span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zYhMv2QTjPc" title="Nature"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember" name="AATP:RelatedPartiesNatureDescription"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdOneMember" name="AATP:RelatedPartiesNatureDescription">Sublease rental income due from Hostastay</ix:nonNumeric></ix:nonNumeric></span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OtherIncome_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zBTMmPFy3h12" title="Other income" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,881</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zj3DnIwsK2A6" title="Other income" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherIncome_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zO52VxQ8REB2" title="Other income" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1431">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zlL6QQCLjZqi" title="Other income" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,881</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231_zJ1OqIntLAt1" title="Other income" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20190701__20191231_zI6AgMrhyoVh" title="Other income" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1437">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_z50LwVTXkjQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zHoVyN57fMoe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>15.
<span id="xdx_824_zEjvJ3f6O5Bg">STOCKHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Preferred
stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, and 2019, there were <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_c20201231_pii" title="Preferred stock, shares authorized"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pii_c20191231_zi6jk4wOaQKd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> preferred stocks authorized but <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_c20201231_zIQMg8fKhZdd" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_c20191231_zbjKoMuYHzge" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pii_dn_c20201231_zzvy5HIz4Mv1" title="Preferred stock, shares outstanding"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pii_dn_c20191231_zgH5fN3P8O26" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2019-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2019-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Common
stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, and 2019, there were <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20201231_zbPxivfkvZPj" title="Common stock, shares authorized"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20191231_zoN9KJ0TtZof" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></ix:nonFraction></span></span> common stocks authorized, <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pii_c20201231_zK7K9hZXIKXh" title="Common stock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pii_c20201231_znk84um3p8mk" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,452,047</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_907_eus-gaap--CommonStockSharesIssued_c20191231_pii" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20191231_pii" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">376,275,500</ix:nonFraction></ix:nonFraction></span></span> shares issued and
outstanding, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2020, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200501__20200531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zy4UXmWxtw35" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-05-012020-05-31_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">162,694</ix:nonFraction></span> shares of the Company&#8217;s common stock in connection with the acquisition of ASL as part
of the acquisition payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value
increased by $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_c20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zBjfh7Bj0YI2" title="Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2020-12-31_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,043</ix:nonFraction></span>, which required the issuance of an additional <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zCEs2CDBegPi" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,853</ix:nonFraction></span> shares of the Company&#8217;s common stock to fully
satisfy the acquisition payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200629__20200731__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zrwS2BGCzZzd" title="Stock issued during period acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-06-292020-07-31_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,853</ix:nonFraction></span> additional shares were
issued in July 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
were <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_uShares_c20200101__20201231_zPl3aHIQBThj" title="Potentially dilutive securities outstanding"><span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_uShares_c20190101__20191231_zNpJWiTUHRPc" title="Potentially dilutive securities outstanding"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-01to2020-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-01-012019-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span> stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2020 and 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Non-controlling
interest</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, and for the year ended December 31, 2020, no material transactions of non-controlling interest occurred
from the operating results from ASL as the Company holds approximately <span id="xdx_901_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pii_dp_uPure_c20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zt5OHiiPpqC7" title="Business acquisition percentage of voting interests"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2020-12-31_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.99</ix:nonFraction></span>% of the equity interest in ASL, non-controlling interests
that present in ASL is $<span id="xdx_90C_eus-gaap--NoncontrollingInterestIncreaseFromBusinessCombination_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z6XiVlfioese" title="Non controlling interests"><ix:nonFraction name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and therefore not presented separately in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_z4EUw0RI8fn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>16.
<span id="xdx_828_zCkB2kBlKzdd">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
United States and foreign components of income (loss) before income taxes were comprised of the following:</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zbHvfwaLTa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B1_zzZ9wnvDeoqf" style="display: none">SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax jurisdictions from:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">- U.S.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20200101__20201231_zAbGpy29Fbej" title="Local" style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">735,159</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190101__20191231_ztiS9DrDU5ma" title="Local" style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">321,808</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190701__20191231_zwRKMI0F1QHc" title="Local" style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">279,476</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">- Foreign &#8211; Malaysia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--MY_z8DHaO1U1e1b" title="Foreign" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2020-01-012020-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,070,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--MY_z2ccxqkYJEW" title="Foreign" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2019-01-012019-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38,625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20191231__srt--StatementGeographicalAxis__country--MY_zobkAtiHFhvl" title="Foreign" style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2019-07-012019-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,174</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">- Foreign &#8211; Hong Kong</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--HK_zNrOkR70FeM7" title="Foreign" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2020-01-012020-12-31_country_HK" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">180,700</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--HK_z1s8Szjpg7t5" title="Foreign" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2019-01-012019-12-31_country_HK" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">439,909</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20201231__srt--StatementGeographicalAxis__country--HK_z8y2iKDnG2Y5" title="Foreign" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2019-07-012020-12-31_country_HK" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">55,281</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Income (loss) before income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200701__20201231_zNiGYHtEI5Gf" title="Loss before income tax" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-07-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">516,347</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190101__20191231_zSnEzu3f7kej" title="Loss before income tax" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">723,092</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190701__20191231_zizxBk9Aaz7" title="Loss before income tax" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">338,931</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zTgOP7hJyX27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>16.
INCOME TAXES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZzlmXh1kM57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
(provision for) benefit of income taxes consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BB_zaJwBfXd0tdi" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAX</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_zD6DHwvcDqLh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20190101__20191231_zI6zvqNvPTtl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20190701__20191231_zwmyScxi2la5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Years Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, </b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, </b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Current:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maT001_zNzWsoAppUkf" style="vertical-align: bottom; background-color: White">
    <td>- U.S.</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1511">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1513">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--CurrentForeignTaxExpenseBenefit_maT001_zuanHqQMqwol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%">- Foreign</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,748</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,965</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1517">&#160;</span></td><td style="width: 14%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maT001_zYRHFL9aXLi4" style="vertical-align: bottom; background-color: White">
    <td>- U.S.</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1519">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1520">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1521">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_maT001_zPBavMQDeND9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">- Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">178,329</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1524">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1525">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OtherIncomeTaxExpenseBenefitContinuingOperations_iT_pp0p0_mtT001_zK2qRy7RU0Vh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">(Provision for) benefit of income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">161,581</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,965</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1529">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zPYMD8FzKtwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply
a broad range of income taxes rates. The Company and its subsidiary that operate in various countries: United States, Malaysia
(including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>United
States of America</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a
corporate tax rate of <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zqPvD1NpFJy3" title="Tax percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-01-012020-12-31_us-gaap_StateAndLocalJurisdictionMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% on its taxable income. Agape ATP Corporation also subject to controlled foreign corporations Subpart
F income (&#8220;Subpart F&#8221;) tax, which is a tax primarily on passive income from controlled foreign corporations with a
tax rate of <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zbf14BFFp1q8"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-01-012020-12-31_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35</ix:nonFraction></span>%. <span id="xdx_90F_eus-gaap--TaxCutsAndJobsActOf2017OtherTaxEffectDescription_c20200101__20201231_zq1kTGRUqTlc" title="Tax rate description"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="us-gaap:TaxCutsAndJobsActOf2017OtherTaxEffectDescription">In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#8220;GILTI&#8221;) tax,
which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted
tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be
no U.S. corporate tax after the 80% foreign tax credits are applied.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, the Company&#8217;s foreign subsidiaries generated approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_c20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zZyzsvkfWxFl" title="Cumulative net operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">636,000</ix:nonFraction></span> taxable income that
are subject to Subpart F tax and GILTI tax. The Company has fully utilized approximately $636,000 NOL resulted in tax benefit
of approximately $<span id="xdx_90D_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zhdwQ3W4Vew4" title="Tax benefit"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">134,000</ix:nonFraction></span> for the year ended December 31, 2020. The Company did not generate any foreign taxable incomes subject
to GILTI tax for the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020 and 2019, the operations in the United States of America incurred approximately $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zJiaeiSW1rag"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">313,000</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_zanBhPaqvpvg"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2019-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">213,000</ix:nonFraction></span>, respectively,
of cumulative net operating losses (&#8220;NOL&#8221;) which can be carried forward to offset future taxable income. Approximately
$<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231_zVVmwk283852" title="Cumulative net operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementScenarioAxis__custom--IfUnutilizedMember_zie3NhvktQae" title="Cumulative net operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2019-12-31_custom_IfUnutilizedMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,000</ix:nonFraction></span> of the net operating loss carry forwards will expire in <span id="xdx_909_ecustom--OperatingLossCarryforwardsExpireYear_c20200101__20201231_zII9UGrOWbW2" title="Operating loss carryforwards expire year"><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" name="AATP:OperatingLossCarryforwardsExpireYear">2027</ix:nonNumeric></span> and <span id="xdx_905_ecustom--OperatingLossCarryforwardsExpireYear_c20200101__20201231__srt--StatementScenarioAxis__custom--IfUnutilizedMember_zujy84OOAbI7" title="Operating loss carryforwards expire year"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_IfUnutilizedMember" name="AATP:OperatingLossCarryforwardsExpireYear">2028</ix:nonNumeric></span>, respectively, if unutilized. The remaining
balance can be carried forward indefinitely. The deferred tax valuation allowance as of December 31, 2020 and 2019 were approximately
$<span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zC6BUtNr4JC3"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,000</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_zgocDCTQ7lAd"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2019-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,000</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Malaysia</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Changes
to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies
incorporated in Labuan to satisfy the &#8220;substantial activity requirements&#8221; to qualify for the preferential tax rate
of <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zwDl0Nju5Hn4"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2018-12-282019-01-02_custom_LabuanMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3</ix:nonFraction></span>% on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to
the &#8220;substantial activity requirements&#8221; was issued. As Agape ATP Corporation does not maintain a permanent establishment
in Labuan, the company is subject to tax at <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zIr2d2qfJMU"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2018-12-282019-01-02_custom_LabuanMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction></span>% on its net audited profit until such a time it satisfies the said requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>16.
INCOME TAXES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape Superior Living Sdn Bhd, Agape S.E.A
Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of Malaysia and the income
taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for
the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia,
enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential
tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. <span id="xdx_903_eus-gaap--IncomeTaxExaminationDescription_c20200101__20201231__srt--StatementGeographicalAxis__country--MY_zIwBbOtvGT9" title="Income tax examination, description"><ix:nonNumeric contextRef="From2020-01-012020-12-31_country_MY" name="us-gaap:IncomeTaxExaminationDescription">The tax rate for small and medium sized companies
(generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20200101__20200930__srt--StatementGeographicalAxis__country--MY_zh5B4oAbw7mb"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-01-012020-09-30_country_MY" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17</ix:nonFraction></span>% for the first RM 600,000 (or
approximately $150,000) for the year ended December 31, 2020 and RM 500,000 (or approximately $125,000) income for the six months
and year ended December 31, 2019, with the remaining balance being taxed at the 24% rate.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Hong
Kong</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20200101__20200930__srt--StatementGeographicalAxis__country--HK_zf09SVilgtA3"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-01-012020-09-30_country_HK" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16.5</ix:nonFraction></span>%
on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative
Region is not subject to Hong Kong Profits Tax or deduction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEAzprvvHdU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following table reconciles the local (United States) statutory rates to the Company&#8217;s effective tax rate for the periods
indicated below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BF_zeZVObx6bE45" style="display: none">SCHEDULE
OF EFFECTIVE INCOME TAX RATE</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_z2LUThGO9pX3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20190101__20191231_zqefyfFlCde3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20190701__20191231_zoZxbSfxdmy4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zYrcqMCNs3y2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">U.S. statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 2%; text-align: left">%</td>
    <td style="width: 2%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zUDvgK3s1zOk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">4.0</ix:nonFraction></td><td style="text-align: left">)%</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">21.0</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">21.0</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zAeXx6M7YG5j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Differential tax rate in Malaysia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.0</ix:nonFraction></td><td style="text-align: left">%</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zIARBUE7U4B2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Permanent difference</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2020-01-01to2020-12-31" id="Fact001572" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.3</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td>
    <td><span id="xdx_F20_zT9QkwNsyW1l">(1)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
<tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zZQx711LpOPg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">31.3</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td>
    <td>&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F06_zgsLTy4F7EQ4" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zXaXzpsaKd02" style="font: 10pt Times New Roman, Times, Serif"><ix:footnote id="Footnote001579" xml:lang="en-US"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z1QPXtoePgJ3" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.2</ix:nonFraction></span>%
    represents expenses incurred in AATP US that were not deductible in the Malaysia tax returns. <span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zUDthHbwpCje" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2020-01-012020-12-31_custom_AgapeATPInternationalHoldingLimitedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span>% represents income derived
    in AATP HK that were not taxable in the Malaysia tax returns. <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPCorporationMember_z3D4IBRUFkVf" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="From2020-01-012020-12-31_custom_AgapeATPCorporationMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.3</ix:nonFraction></span>% represents expenses incurred in AATP LB, ASL, SEA and WATP
    that are not deductible in the Malaysia tax returns.</ix:footnote></span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A8_zqNFulgTQqh9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zf0HvgM0jQhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BD_zb3y3VE0XPpb" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carry forwards in U.S.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_z5AvvsjS2uRb" title="Net operating loss carry forwards" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2020-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,648</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_z8HZFVzogH47" title="Net operating loss carry forwards" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2019-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,410</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net operating loss carry forwards in Malaysia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zFY1Y79uMQ51" title="Net operating loss carry forwards" style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2020-12-31_country_MY" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">62,678</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--MY_zpzUY7FM83X8" title="Net operating loss carry forwards" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1592">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Less: valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20201231_z22U98ovv5Qa" title="Less: valuation allowance" style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,648</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20191231_zMjGpQbIvrwh" title="Less: valuation allowance" style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,410</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20201231_zLyiBjT1QLUl" title="Depreciation" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AATP:DeferredTaxLiabilitiesDepreciation" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">68,421</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20191231_zPW4RQ9OQzQ" title="Depreciation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1600">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax liabilities, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20201231_zADFxmeWLTEf" title="Deferred tax assets, net" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,743</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20191231_zZyr63qsTkQe" title="Deferred tax assets, net" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1604">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zOwMSvdvAGga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Uncertain
tax positions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical
merits, and measure the unrecognized benefits associated with the tax positions. As of December 31, 2020, and 2019, the Company
did not have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the
years ended December 31, 2020 and 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zbkrV1KCtADh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>17.
<span id="xdx_823_zAt7kXK20Dbb">CONCENTRATIONS OF RISKS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(a)
Major customers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, no customer accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__srt--RangeAxis__srt--MaximumMember_zCxflu3X4r72" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% or more of the Company&#8217;s total revenues. For the year ended
December 31, 2019, one related party customer accounted for approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zAgmBPDu5pJ4" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_custom_OneCustomerMember_us-gaap_RevenueFromContractWithCustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">98.3</ix:nonFraction></span>% of the Company&#8217;s total revenues. For the
six months ended December 31, 2019, one related party customer accounted for approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20190701__20191231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_znA30cHspN7f" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-07-012019-12-31_custom_OneCustomerMember_us-gaap_RevenueFromContractWithCustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.0</ix:nonFraction></span>% of the Company&#8217;s total
revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, receivables from a third-party e-commerce company accounted for approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember_z8bVgR90w4Bb" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.0</ix:nonFraction></span>% of the total balance
of accounts receivable. As of December 31, 2019, one related party customer accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember_zd50vNTJDeW8" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.0</ix:nonFraction></span>% of the total balance of accounts
receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(b)
Major vendors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, two vendors accounted for approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember_zlP8f3gWp1e7" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_VendorOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">74.1</ix:nonFraction></span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorTwoMember_zJ0GXrckJKsa" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_VendorTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25.9</ix:nonFraction></span>% of the Company&#8217;s
total purchases. In November and December 2020, the Company received dividend of <span id="xdx_903_eus-gaap--ProceedsFromDividendsReceived_c20201101__20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zz0hDNXu2W3" title="Dividend received"><span id="xdx_909_eus-gaap--ProceedsFromDividendsReceived_c20201201__20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zR70pNNpRn6c" title="ividend received"><ix:nonFraction name="us-gaap:ProceedsFromDividendsReceived" contextRef="From2020-11-012020-11-30_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ProceedsFromDividendsReceived" contextRef="From2020-12-012020-12-31_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,330</ix:nonFraction></ix:nonFraction></span></span> shares of common stock of DSwiss, Inc.,
represents approximately <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zBvDHfJQ1LM8" title="Ownership percentage"><span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zGMg3DOSTRQe" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-11-30_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-31_custom_DSwissIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.01</ix:nonFraction></ix:nonFraction></span></span>% ownership that the Company accounted for as investment in marketable securities (See Note 11).
Dswiss, Inc.&#8217;s wholly owned subsidiary is the vendor that accounted for the Company&#8217;s total purchases of <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember_zrP4pAdGUej3" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_VendorOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">74.1</ix:nonFraction></span>%
for the year ended December 31, 2020. For the year ended December 31, 2019, two vendors accounted for approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--VendorOneMember_ztfyHLBHx32h" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_custom_VendorOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60.1</ix:nonFraction></span>%
and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--VendorTwoMember_zjbGAlwKecXl" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_custom_VendorTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">39.9</ix:nonFraction></span>% of the Company&#8217;s total purchases, respectively. For the six months ended December 31, 2019, two vendors accounted
for approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190701__20191231__srt--MajorCustomersAxis__custom--VendorOneMember_zsdOjrC9ed3c" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-07-012019-12-31_custom_VendorOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">59</ix:nonFraction></span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190701__20191231__srt--MajorCustomersAxis__custom--VendorTwoMember_zdRTPuIWr6h8" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-07-012019-12-31_custom_VendorTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">41</ix:nonFraction></span>% of the Company&#8217;s total purchases, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
are no accounts payable balance as of December 31, 2020. As of December 31, 2019, one vendor accounted for <span id="xdx_900_ecustom--CommissionExpensePercentage_iI_pii_dp_uPure_c20200930_zzdGrZyjH4nh"><ix:nonFraction name="AATP:CommissionExpensePercentage" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total balance
of accounts payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(c)
Commission Expenses to Sales Distributors and Stockists</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, no sales distributor accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--NoSalesMember__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--AccountsPayableMember_z2HnfHSjjSO4" title="Concentrations of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_custom_NoSalesMember_us-gaap_AccountsPayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% or more of the Company&#8217;s total commission expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(d)
Credit risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of
December 31, 2020, and 2019, $<span id="xdx_909_eus-gaap--Cash_iI_pp0p0_c20201231_zhCG3VcFeWvf" title="Cash in bank"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,112,147</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--Cash_iI_pp0p0_c20191231_z7AwyJXEDqHl" title="Cash in bank"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,937</ix:nonFraction></span> were deposited with financial institutions, respectively, $<span id="xdx_905_ecustom--DepositForInsurance_iI_pp0p0_c20201231_zUp51WqJy7U6" title="Deposit for insurance"><ix:nonFraction name="AATP:DepositForInsurance" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">563,788</ix:nonFraction></span> and $<span id="xdx_909_ecustom--DepositForInsurance_iI_pp0p0_c20191231_z8YLSL9jy6Eh" title="Deposit for insurance"><ix:nonFraction name="AATP:DepositForInsurance" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span>
of these balances are not covered by deposit insurance. While management believes that these financial institutions are of high
credit quality, it also continually monitors their credit worthiness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration
of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short
collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance
for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.
Historically, the Company did not have any bad debt on its account receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(e)
Exchange rate risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company
could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher
or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending
on changes in political and economic environments without notice.</span></p>

</ix:nonNumeric><p id="xdx_819_zEBzmXFlog5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXf5ZCxr0qQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>18.
<span id="xdx_82D_zqcH7gf1mJDh">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Lease
commitments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
April 1, 2020, the Company adopted ASC 842 for ASL&#8217;s office space lease and sales and training center as the lease commencement
date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z6Fb0mkbrjQc" title="Operating lease liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-04-02_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">506,000</ix:nonFraction></span>, with a corresponding right-of-use
(&#8220;ROU&#8221;) asset in the same amount based on the present value of the future minimum rental payments of the lease, using
an effective interest rate of <span id="xdx_902_ecustom--OperatingLeaseEffectiveInterestRate_pii_dp_uPure_c20200328__20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zz0ARfe0u7J6" title="Operating lease effective interest rate"><ix:nonFraction name="AATP:OperatingLeaseEffectiveInterestRate" contextRef="From2020-03-282020-04-02_custom_AgapeSuperiorLivingMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.5</ix:nonFraction></span>%, which was determined using the Company&#8217;s estimated incremental borrowing rate. The weighted
remaining term of the lease is approximately <span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zUxbIB3hk94d" title="Operating lease, weighted average remaining lease term"><ix:nonNumeric contextRef="AsOf2020-04-02_custom_AgapeSuperiorLivingMember" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.54</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zCzu5t3UQQJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
five-year maturity of the Company&#8217;s operating lease liabilities is as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BB_zfgyqg8maSpf" style="display: none">SCHEDULE OF LEASE COMMITMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Twelve Months Ending <br /> December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20201231_zbY0IDU060v" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Operating lease liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pp0p0_maLOLLPzA1T_zUlquhdIPMt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,191</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pp0p0_maLOLLPzA1T_zKOdfViEmfGj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">168,890</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pp0p0_maLOLLPzA1T_zMf0Qco3soI5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,259</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree_iI_pp0p0_maLOLLPzA1T_zfRziMeJGucg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1667">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_z5JPOW73pBOg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">424,340</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zH0SQNpx9GDb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,576</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">395,764</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_za8pLjqkP6k8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also leases one distribution center and one employee apartments with an expiring term of twelve months or fewer, which
were classified as operating leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy
election not to recognize lease assets and liabilities. The Company selected not to recognize lease assets and liabilities on
these leases. As of December 31, 2020, the Company&#8217;s commitment for minimum lease payments under these operating leases
within the next twelve months are $<span id="xdx_902_eus-gaap--OperatingLeasePayments_pp0p0_c20200101__20201231_zwVYYjsPFrId" title="Operating lease payments"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,654</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Rent
expense for the years ended December 31, 2020 and 2019 was $<span id="xdx_900_eus-gaap--OperatingLeaseExpense_pp0p0_c20200101__20201231_zhkZVxa7Xn26" title="Operating lease, rent expenses"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,716</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--OperatingLeaseExpense_pp0p0_c20190101__20191231_z5lcKGfHgO63" title="Operating lease, rent expenses"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">53,594</ix:nonFraction></span> (unaudited), respectively. Rent expense for the
six months ended December 31, 2019 $<span id="xdx_909_eus-gaap--OperatingLeaseExpense_pp0p0_c20190701__20191231_zTFxOEcsfuyk" title="Operating lease, rent expenses"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2019-07-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,828</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Purchase
commitments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="AATP:ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock"><p id="xdx_894_ecustom--ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_zdKVC0IHN3Jd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2020 for the next five years
and thereafter is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B6_zzRVdmpgOzH9" style="display: none">SCHEDULE OF PURCHASE COMMITMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Twelve months ending December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20201231_ziPu6rpTeRxg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Minimum</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>purchase</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PurchaseObligationDueInNextTwelveMonths_iI_pp0p0_maPOzUwc_maPOzKX0_zWrgNorC9p6k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><ix:nonFraction name="us-gaap:PurchaseObligationDueInNextTwelveMonths" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">693,900</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PurchaseObligationDueInSecondYear_iI_pp0p0_maPOzUwc_maPOzKX0_zP0w9gmHD6Zi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PurchaseObligationDueInSecondYear" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">693,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PurchaseObligationDueInThirdYear_iI_pp0p0_maPOzUwc_maPOzKX0_z1GunGTuSvke" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PurchaseObligationDueInThirdYear" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">693,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PurchaseObligationDueInFourthYear_iI_pp0p0_maPOzUwc_maPOzKX0_z4TF3eTpWShf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PurchaseObligationDueInFourthYear" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">693,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--PurchaseObligationDueInFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zsttNJWCmGK4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PurchaseObligationDueInFifthYear" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">693,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--PurchaseObligationDueAfterFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zPJksXkizzrl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PurchaseObligationDueAfterFifthYear" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,387,800</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PurchaseObligation_iTI_pp0p0_mtPOzUwc_mtPOzKX0_zXi4Wnssa8h2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total minimum purchase commitments required</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PurchaseObligation" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,857,300</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_zLA9ZkYwzEcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of the date of this report, the Company&#8217;s vendor is not able to meet the Company&#8217;s minimum purchase commitment of
the health and wellness products due to the manufacturing process was being delayed by its vendor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>18.
COMMITMENTS AND CONTINGENCIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Contingencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Legal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued,
as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are
not deemed to be material to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>COVID-19</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Since
the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Malaysia
has been put through various stages of lockdowns such as (1) full movement control orders (&#8220;MCO&#8221;), under which, quarantines,
travel restrictions, and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to
a Conditional Movement Control Order (&#8220;CMCO&#8221;) where most business sectors were allowed to operate under strict rules
and Standard Operating Procedures mandated by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement
Control Order (&#8220;RMCO&#8221;). On January 12, 2021, due to a resurgence of COVID-19 cases, the Malaysian government declared
a state of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the
country. February 2021 marked a significant month for Malaysia as all frontline staff of the country, which comprised those in
healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department of Malaysia and civil defence sectors
were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that a National COVID-19 Immunisation
Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will be vaccinated to achieve
herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO. As at the date of this report,
over 450,000 doses of the COVID-19 vaccines have been administered in the country.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be
materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general.
Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge
regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain
the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to,
the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">temporary
    closure of offices, travel restrictions, financial impact of the Company&#8217;s customers or suspension supplies may negatively
    affected, and could continue to negatively affect, the demand for the Company&#8217;s product;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially
    adversely affect its financial condition and operating results; and</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">any
disruption of the Company&#8217;s supply chain, logistics providers or customers could adversely impact its business and results
of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay
delivery to its customers, which may also lead to loss of its customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19
cannot be reasonably estimated at this time. There is no guarantee that the Company&#8217;s total revenues will grow or remain
at the similar level year over year in 2021.</span></p>

</ix:nonNumeric><p id="xdx_81D_zuehz8DeRVqj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zF2Ajqoa7KDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>19.
<span id="xdx_820_z1kNJp80P2vc">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">On
January 25, 2021, the Company and the shareholders (the &#8220;Sellers&#8221;) of DSY Wellness &amp; Longevity Center Sdn. Bhd.
and DSY Medical Education Sdn. Bhd. entered into a non-binding Letter of Intent (&#8220;LOI&#8221;) for the acquisition of <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210125__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SellersMember_zu5NZ1j4krW7" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-01-25_us-gaap_SubsequentEventMember_custom_SellersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></span>%
of the issued and outstanding capital stock of DSY Wellness &amp; Longevity Center Sdn. Bhd. and DSY Medical Education Sdn. Bhd.
(the &#8220;Target Shares&#8221;). After execution of this LOI, both parties shall proceed in good faith to complete the negotiation
and execution of the definitive transaction documents. Subject to the terms and conditions of the definitive transaction documents,
the Company will issue and allot its common stock to the Sellers and the Company will purchase the Target Shares. Except for the
provisions with regards to confidentiality, term of validity, no binding agreement, applicable law and arbitration, and miscellaneous,
the LOI is not legally binding on the parties. Any conclusion of definitive transaction documents by the Company related to such
transaction will be subject to the approval of the Board of Directors or other approval requirements, if applicable. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">On
February 1, 2021, </span><span style="font: 10pt Times New Roman, Times, Serif">Mr. How Kok Choong, the CEO
and director of the Company, is appointed as the non-executive Chairman of <span style="background-color: white">Vettons Sdn Bhd.
(&#8220;Vettons&#8221;),</span> an e-commerce company. As of December 31, 2020, the Company has accounts receivable of
$<span id="xdx_90B_eus-gaap--AccountsReceivableNetCurrent_iI_c20191231__dei--LegalEntityAxis__custom--VettonsSdnBhdMember_zBRAYs2ZHE05"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2019-12-31_custom_VettonsSdnBhdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,757</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from Vettons, representing <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20190101__20191231__dei--LegalEntityAxis__custom--VettonsSdnBhdMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zvqNsJplCXac"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_custom_VettonsSdnBhdMember_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of our accounts receivable.</span></p>

</ix:nonNumeric><p id="xdx_812_zP5RTxqa4QR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 86; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<b>&#160;</b></span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--  
       -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I,
HOW KOK CHOONG, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.
I have reviewed this annual report on Form 10-K of Agape ATP Corporation (the &ldquo;Company&rdquo;) for the period ended December
31, 2020;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.
Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
    us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed
    such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide
    reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
    purposes in accordance with generally accepted accounting principles.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
    on such evaluation; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
(or persons performing the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
    are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
    information; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:
    March 31, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    How Kok Choong</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">HOW
    KOK CHOONG</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
        Executive Officer,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">President,
        Director, Secretary, Treasurer</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Principal
    Executive Officer and Principal Financial Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I,
ANDREW LEE KAM FAN, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.
I have reviewed this annual report on Form 10-K of Agape ATP Corporation (the &ldquo;Company&rdquo;) for the period ended December
31, 2020;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.
Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
    us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed
    such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide
    reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
    purposes in accordance with generally accepted accounting principles.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
    on such evaluation; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
    affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
(or persons performing the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
    are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
    information; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:
    March 31, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Andrew Lee Kam Fan</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">LEE
    KAM FAN</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
    Financial Officer,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION
PURSUANT TO<BR>
18 U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
connection with the Annual Report of Agape ATP Corporation (the &ldquo;Company&rdquo;) on Form 10-K for the period ended December
31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), The undersigned hereby
certifies, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge and belief:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:
    March 31, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    How Kok Choong</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">HOW
    KOK CHOONG</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
        Executive Officer,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">President,
        Director, Secretary, Treasurer</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Principal
    Executive Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">A
signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise
adopting the signature that appears in typed form within the electronic version of this written statement has been provided to
the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION
PURSUANT TO<BR>
18 U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
connection with the Annual Report of Agape ATP Corporation (the &ldquo;Company&rdquo;) on Form 10-K for the period ended December
31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), The undersigned hereby
certifies, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge and belief:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:
    March 31, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Andrew Lee Kam Fan</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">LEE
    KAM FAN</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
    Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">A
signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise
adopting the signature that appears in typed form within the electronic version of this written statement has been provided to
the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '] 6 # 2(  A$! Q$!_\0
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M DHJN;VW&?WF<>@-1_VC#V24_P# : +E%46U(?PPN?TIG]IO_P ^K?\ ?0H
MT:*SO[3;_GV;_OH4G]JO_P ^K?\ ?8HN!I45FC5>>;9A_P "%/\ [5BQ\T<@
M_#- %^BJ*ZK;DX(D7W*U(-1M"?\ 7#\C0!:HJ(74!Z31_P#?0J4$$9!S0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11T
MK/N-41&*0#S''4]A0!H56EO[:$X:4%O[J\G]*P[S4%2,R7MT$C'49VBN5OO'
M^DV;F*S5KF3H!&.*7,!WK:J6_P!5;,?=R%_QJ%[ZZ(^:6*+_ '5_QKS*?Q;K
MUXI:***SA/1Y#S6+<ZS+*#]JU6XN,\,D P,_6E=A='K4^K01<SZEM/L^W^59
M=QXKT6,DO=>81Z$FO*5OX6; @"LO1KAB2:1[JZ*-L?8IZ^4@Q19BN>FR>-+%
M6VQ6LSDC(RN!^M4Y/'>$)2R"XX^=P*\ON)+I9(F-RT^?X03G\14LA,Q\P1/"
M>X)X_6BP7._?QY<^:JK]GPPZ!B2*KS>.[Q"X>:),=,*37#3.AA"%H5D!R)%Z
MC\J2XO5FA5)I49A_&J\FCE079UK_ ! NBHQ=C>3R!'Q_.I)_&%_$RE[F0(RY
M'R#FN (M0/OR'\*M2:BLD,<3%F6,87('%'*A79UT/C&]N6=8[R4M_"-HIDGC
M&^A1?,O)D?/(*#^5<<EW%%DH'!/<=:=-?K<JHEWMMZ,<9HY4%SLSXPOE*LUW
M(J$9^9!0OC6]179K]?\ 9S'_ /7KCY;V.X"^<SMM&!D5'$]NLH?((!^ZR\4<
MJ"YWJ^,]0"(PN(&W?WD(J:/QM>EV7%HX4==^,UP<\S73#,R%<].E*^Y$*6T
M3/#,"&-'*@N>A)XUGV!I-.# G'[MP:LIXWME8^;:W,3+R2%SBO+\16Y4[Y6<
M]GRH!J=)KQ)03>A W.U"6HY1W/6;?QU8L01J+H3T$G_UZU[;Q6LH'EW5M-]>
MOZ&O%QJ$\KA! ER5X >,4&:P$HBFMYK:7.287S19A<]ZC\11G_60$#U1@?\
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MV[8+<VNH790':UU<)'$WN-I9Q^(K?T_P1=0J-L>GV0(VLL2M*Y'J'.WGZJ:
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M_J9?^NA_D*J-5O3/]5(/]O/Z"F@+U%%%,04444 %%%% !1110 4444 %%%%
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M/%(#]TUEA<'-3(:0S81^F:G4J0![YK(6X>,9)! ]:M1W:_Q*1].:D#2QD/\
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M: )0:>#40IXH D%.!I@I10!(*<,5&*44 29%&:;10 _(H!IM H ?D4N:;10
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M_P"?&V_[]+_A4T5C:0_ZNVA3_=0"I0:7-,=AP51V%.&/2FYI0:8#J6FYHS0
MIZ4W-+GBF$TP%S2&DS2$T (33":<33&8*,F@!C5&I_>I_O"E8ENHP/2F9Q(F
M/[P_G3 [JBBB@ HHHH **** "BBB@ HHHH **** "OG3QR,>*=1_Z[O_ #-?
M1=?.WCL?\51J&/\ GN_\S29,MCC93R121P2W,B0P(7D8X51U-$O6MSPCM35I
M'P"ZP,4SZ_\ ZLUGU.:UW8M1ZIXC\.6R"ZA\RV&%!DYQZ#-9S:Y=ZUKUA+<L
MNU)E"(O1<L,_TJS<ZO=ZMX5NGO7#&.Z0 !0,#!XJSJ=A:-/HVM:>-L%S.B2+
MTP^?3\#GZ4/8MW>ST.NC;I5E&XJG&>E8WBC69=.L&CA1P7!W2[3A1Z ^M9T8
M.K-074N4U"-V-U#6)]4U9M+TE%,FTI)<-R%7OBL[PI96T.MW6G7\"32-D!I
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MK6?A6QM;Z.[CEN"\>-H9P1P,#M3]3\-+J>IQWOVDQM'M^4)G.#ZYJW$UYG)
MQCIBIXYK@,$*=^IJHYA5YE)WOML3["GR\O+H+=6$\V]K>ZDB9E5>'.!]X$@=
MCAOS45K*>!FLU;EP3E6."V0!VSQ^E2"^89S$1@>M9?6(=3>YI@\T\56@E$L2
MR#@&I@WO6JDFKH9,*<#Q4'F =Z<DH-5S(9/VIPIBG(IV5 Y(I@/S2CK4?F#.
M *4$GOBF!)D#J:3?_=&:3CZTM.X"'>W4X]A2!%7H.?6E)I,T[B TAH)II-,
M)II-*33<T ,:F*?WB?[P_G2L::#B5/\ >'\Z8SO****8!1110 4444 %%%%
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M: <[F9OJ:SG.,$%R])JT"'"@,<XY.?T%)%J,\@^5"HSWXK+51NPJ@?A6M8Q
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M+0TK>;3=5MI8V=;6YFP'Y )([C/!I;E;2PM;;2X9O.D>=7D.>0,YR<=.P_\
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M"-W7Z52CC4X+L=OIG%5"=RICTJ3>%/SG(] :N=1S=Y#N7EF"\1+^52*['[Y
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M+\,;*=[K^TIP<RAMN?3%7!<T[G3!7D>J4445T&X4444 %%%% !1110 4444
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E* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H[444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_002.jpg
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (W /L# 2(  A$! Q$!_\0
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M0U;BU_393@7 7_>!% &E14,5U;S@&*9'STPU34 %%%% !1110 4444 %%%%
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MP7--W_(Y*F-J3?+35OS-S3)[B^O?,F=Y97;DL<DU]">'8S%H%FAZA*\M\/\
MAI-)C\V<AYR/P7Z5ZMHG.CV_^[7%B:D92M'9'=0A*,?>W-"BBBN8W"BBB@ H
MHHH **** (+[BPN/^N;?RKY?U+_EK7T]J'_(.N?^N;?RKYBO\%I!CUKMP>[.
M3%_"86,CFHR.:?33UKV$CQ4"YS3A0M3BSN2N[[/*5]=AJM$&K(<U)'-)&=T;
MLK>JG%-VUU^D^"DU/2X[H73([]L BHJ5(4U>>Q5.$INT3!MM:U*V;=#?3J?9
MS6C%XNUV-@1J4Y]BV:U7^'5XO,5W$W^\I'^-0MX!U=.5,#_1L?S%9>UPLM[?
MU\BW3Q4=K_U\QT?C[7XP/]+4_5 :D;XA:^?^7A!_VS%5O^$(US/_ ![H?<2"
MC_A"=<_Y]5_[^"G;!_W2;XQ?S$Y^('B _P#+TO\ W[%1/XXU^3@WS+_N@"D'
M@C73_P NR_\ ?P5,G@/6VZQ1K_P,4_\ 8U_*%\8_YBI_PEFNG.=2GY_VJI2:
MSJ$KDR7LQ)Z_.:Z5/AWJ;)\T\"G\35J'X:2G!FO@#W"I1[?"1VM]W_ %[#&3
MWO\ ?_P3AGFDD.6<DGN34$A.*]3M?ASIR,IGGFEP>1D &M2'P7HD+;ELU;_>
M.:B68T5M=EPRVL]96/$TMIYWVQ1.Y]%7-;5CX)UN_(Q:^2A_BE.W_P"O7L]O
MIMI:@"&WC0#^ZH%3D =*Y:F9-_!$[89>E\3//]+^&MI;E9+^=IW_ +BC"UUU
MKI]M8Q"*VA2-!V48J^U0MS7#4K5*GQ,[:=&%/X45Y*[31AC2+<?[-<5)7;:/
M_P @FW_W:R9JB]1112&%%%% !1110 4444 5M1_Y!MS_ -<V_E7S'?C$D@]Z
M^FM3XTNZ/_3)OY5\RWQS*Y]:[<'NSEQ7PF#W--/6E;AS]:1J]E'B=1T3%)%8
M<D'(%=':7BW.LPSRW)MB,"2*0E5_#M^=8%K<-:S!U1']5=<@ULZA>1:@XGGT
MV= $ +J2!_+%8U4V[-?,VINRO?Y%F/2?.UQYK@0_8BY8N9!@C\#7>^&Q&NFA
M8<&$,0A!ZC->96L>BF4-<3W 3NNP?SKTKPN4.D)Y6?)R?+SUQ[UQXM/D5[_<
M=>%MS.WYG0IT%3**@3&*G4UYIWDBU(,5SOB#5AI<=O(6QF4 _3O6Y%<QO$KA
MAM89!SUJG!J*ET8E-.3CU18XIXQ6?<:I9VBAI[B-,] 6Z_04D>K0ORN57'WG
M^7^=+E97,C2H) %9$VLV2GYM2M8Q[R#/\Z2UO-/U"5XX=16=NI1)1Q^7-/V<
MK7:%[2-[71H27MO%.D+RJLC]%)ZU9JC_ &3:-=QW13,J#"L2>!5ZI=NA8TTP
MT\TPT@(VJ)ZE8U"QH KR5VVC?\@FW_W:XB2NWT?_ )!-O_NT,:+U%%%(8444
M4 %%%% !1110!3U4XTF[/_3)OY5\RWI^=C[U]-:L<:1=_P#7)OY5\R7XQ+(O
MUKMP>[.7%?"8<O$IIAI\G,AIAKV(['BO<?&VUU(&2#70KK=Q!K$<LRS10[0#
M$?N_4#I6!##).^V)"[>@%;%TR6ZQVFI6;AU4%724D@'Z_P JSJ<K:35S2FY)
M-IV-.VCFN[YO,@M+NV<_Z[:N5^N.:[3PV%CT[RE*D(Q7Y>G6O,!;V$@_=WS1
MGTEC/\Q7I7A)0FAPJK!@,@,.AYKBQ<;0_P" =>%E>9TB]*D!P,U"IXK"\4>(
MTT:R*QL#<.,(/3WK@A!S?*CMG-17,S!\<"-HFN)9]KJV(XRW4?2LRPMM5\6:
M;%!'-%'':\ L26-;6B>&9-4M9-1UC,MQ.O[M7_@'8X]:R?"]V^C>)'LY,JCL
M8R#QSVKTZ<OW;C!W<3S:B_>*4E92,1M'GAUG^SF?,N\)O[5U0^'-Z1EKZ+&/
M0U0O<#Q]GUF'<UU7CG5;G3]+ACMI&C:8X+KP0!5SK56X1@]T9PI4O?E-7Y69
M:?#U$'[[4E7UPM80MO[%\46\-E=><5D7YU]SR.*M:7X0U76;5;MK@(K]#(Q)
M(KJ= \"1:9>I=W4PGD3E% X!]:)5U3NISYO*PXT'4LX4^7SN=I$28P3UQ3CT
MI!P*0UXQ[0A-,)IQJ,T -:H6-2M4+F@"O(>M=QHW_()MO]RN$D.6P.G>N\TC
M_D%6_P#N"DRD7:***0PHHHH **** "BBB@"EK'_('O/^N3?RKYGU3B5FQWYK
MZ7UDXT6\_P"N+?RKYHU49>4>AKLP?Q,Y<5\)A2KMDJ(]:DD.[GO49ZU[,3QN
MI)$SI(K1DA@>"#71W!UIQ&URMK(-HQ'(%.1_.N:%;+2VE[;Q"X^UQRQC:)2-
MXQ^&*SJQU3L:4WHU<L1RK:2"6?05+#G*LVW\N17>^%I?.TH2B-8U=B1&O1?:
MO.8H9DYM-5C/MYA0_D:]"\(^9_8ZB5RSACN.<\_6N/%I<E_\_P!3IPS?/_PW
MZ&]=/+':.T$8DD ^5<XR:\]TK2KS7?%DDNI*?+MVRZYX)[ >U>@W5TEG://)
MG:@R:IVNL:<,R*1&SC<W'\S7+2G*,7RK?J=52,927,]NAN(H5 H' KSKQ9H%
M^==^UV%L[AP&)1>AKMUUFP/_ "\Q]<=:NB>-OXA4TZTJ$N8*M.-:/*V>96VD
MZS<^(8+N>QF4;U+$CIBNE\;:/>ZI!:):0^848EO:NJ6>'^^*>+B(_P 0YJI8
MV\XR5M#..%BH2BV]3%L++4;31K2"-S'(B890 1G\:U]-%V+<_;&!DSV]*D-S
M&HY-)]NCR  W/M7+*K%MMLZHI122+?:D- .12$TRA*8:<:C8A>2:8#6-597.
M=JCD]_2I#(TC?)POJ>](U %=A@5W>D_\@JW_ -P5PKDUW>E<:7;_ .X*EEHN
M4444AA1110 4444 %%%% &?KG_("OO\ KBW\J^:]3Q]KD7UKZ3UXXT"__P"N
M#?RKYMU?B[8\5V83XF<N*^$YYOO'-,/6I91B5OK41KV8GC=1RG!!]*Z.WO7O
M+ZU:&81(H59(&.T?49X-<VAP0:VKD1ZRL4D#1I<H@1X6(7=CN#WJ*JO:YI3;
M5[%N;2)+KQ%(/LS?96DR6'"X^M=YX=BAM[-H8#F)'(4YS7G5AI&HSW20RK/%
M%GYFW8 '\J]!\,PQVMD]M$_F)&Y ?/6N'%/W5'FO8Z\/\3=K7-]HTE3:ZAAZ
M&J;:%823M*\()88(SQ^575Z#K4JFN%2:V9UM)[E&/0;%2#Y6<-N!/:M VD3=
M13U-2"IG[_Q:C22V(DLHEQ\N:F6WC4Y"BG TX5'LXKH4(L,8S\HYIQAC.,J.
M*<.E.R .2!1RH8=J0U7FO8T.U<N_HHS4>V>8YD;8G]T=:NPR5[E0VQ 6;T%1
M>6[_ #2D'_9'05,L:(,* *:QH%<:PXQ4+5&EP6F,9P?I4C4K B!Z[W2O^07;
M?[@K@GKOM+XTRV_ZYBI9<2W1112*"BBB@ HHHH **** ,W7_ /D7[_\ ZX-_
M*OG#6@1.3ZU](ZX,Z%?#_IBW\J^;]</[WVKKPGQ'+BO@.?D&ZY"^I J:73Y%
MY3YAZ5"?^/I3[BMQ1P,UZKDXV/)45*Y@;&0X92/8UN7:6D-E;RQZ8[1LOSNQ
M((:I&1=ARH/L:E:W:S$:_;FA9U#B-%+  ^O:IG.]BH1:O_7YF:+BQD7:);RW
M&.@;>/Z5WO@S:ND;48NH<X8C&:Y,6\DO/EVEVH'.U-K_ %(&#79>%8#'IH "
MA2Q(5>@KGQ,E[.QOAT^<Z->@J533$0XJ555>IKSKGH68]>O>I0#522]MX#AG
M7/IFH'U@,0L,;,3Z4)-CL:H [G%))<10C+,*RD2_N?F:0QCTVXJS#IL:$,^9
M&[DT<J6[ ?\ VA+*VVW@<C^\>!2K;33<W$AQ_=4\5:6,*,*H ]J?@T770=QJ
M1)&N%4#Z4I(%.(YJ*0$$8I"97N[Q;8#<K$'N!2PR--"KE2-PS@U8VJRX(!I#
M@<47"Q!Y85BV.3UIC5,QXJ%S2&0.:[_3/^0;;_\ 7,?RK@'Z5W^F_P#(-MO^
MN8_E4LT1:HHHI#"BBB@ HHHH **** *.L#.C7@_Z9-_*OG'7$R"1U!KZ1U09
MTJZ'_3)OY5\\:HBRLRFNG#.TC#$*\3D3G[2OU%;BGH*B-M$CYV_C2O-'&.37
MIRFI'EJ#5R?R7^S&X$F<2!"A'&*D8DJJR+O5?ND'#*/ZBJ*:@8]P10Z,,,K=
MZ7S/.P([H)_L2C!_,5*\RN7L78[BSMY4EFDG!4Y * '\\UT^B:Q L,DH7 D<
ML%':N4L[ BYCEN;FV2)&#']X&)_"NLTFPM[V6:Y52(6?Y%QC/O6%=Q:U-\.N
M5FI_;4TA"PH.??)IR1:A=G+,RJ?4U)=6<D5KNL76%T&<^6&S[5BV_B"^3R?,
MN+1V=PK1!&#CGTS7/&',KP.B551=F=';:0JD&5]_MMK3AMXH1B- *2(Y -3@
MU@Y-FMQPIXJ,'FG ^](+CP:KS32*P18F;/?M5@4M "#.T9ZTUAQFER:#TH K
M&4E\*/K3@=P!I,!=P- PPX-4R%<0U"]3-4#FI+(6KT'3O^0=;_\ 7-?Y5YZU
M>A:?_P @ZV_ZYK_*DRXEFBBBI*"BBB@ HHHH **** *NH\Z;<_\ 7-OY5\Z:
MC+L=B3WZ5]&WXSI]Q_US;^5?-&I@M<-C)R:Z,/NS&ML8-U>2R38W87T%2B-Y
M<8!JO=1^7<&K,.H*"%<8^E>FH.R9YTJL4VB>VM68Y92V.R\FM"-8%   !]#U
MJO')!*-P()]1UJX(KK9%@Q,).425@2?P/^-&VYFWS$D<4>00%/X5V>@_\>0]
MCVKB?+>(D36+H1U:%R,?AR*ZOPM*TEDV2<!R%W8SCWQ6&)U@:X96F='*6^S2
M;#AMIQ]:Y73C(URAFN+[SPV&'DH5_ED"NAOKF*WM6\TL%8;<JI./RKC[-"+I
M88KBV4%U(D!96.#Z$=?QK&A&\&;5I>\CT6,\5)D<5!&2%&3S4F:YK'3<F!IP
M-0!J=N'>BPKE@'-.)J)6&T$4X\C!I6*3$<$]*7M0.!BF;3OSGCTH )%#+4*?
M*#QBIV.!4+8--">]P:H'.*26YCCD6(L-[=!4+3!I-HHL.Z$<UZ)I_P#R#K;_
M *YK_*O.2:]&T_\ Y!UM_P!<E_E42-(EFBBBI*"BBB@ HHHH **** (+P9LI
MQ_L'^5?.5ZFV5SWKZ.N_^/.;_</\J^<K[/FFNC#[LQK_  G-:FN)@?45G'AN
ME:^J+\JMZ&L@_>KV:6L4>-45IL<K$="16JTUXMO;7(D61(_E&%Y7V-9(K<MT
MN;.WA!OTC$PRL;*6!'OQ3J-*PH*]RW!JEK+<"X:YDM9"<NNTL#ZX(KKO#$L,
MRW#V[,\)D^5VZGUKA+P_9;HV]W90/)@'=$2N<UV/@ME%G,%C:-0_W6.2*X\1
M%>SYD=5"3]I9FQK[W"6D(A\X*9 )#",L%_"N=BOIXYU;S[MI!,%6.6,X*9[Y
M%=G)*(X6?&[:,XKG5\5*\BC[)E,_.0X^7)Q^?M6-%OELHW-*UN:[E8ZV-\J#
M4@:JL3 J",X-3!LUSV-N8F#8RQS2^:@&2>*@9L(1[52BR"0Q!&>E6H7)E.QM
MI(N.M.\Q?6LQ9"J9]/>F)=(TK?O.4&64<U/LP]K8UA(#3'D.WY>M5H9UF0.A
MRIJ7-3RV-.:Y#,TIB()^;VIENY*9+9%23$X) [5E_:=B.A8 ]@.U:)71DY6D
M1:A?Q)>!(PC3#@DGD"M"-A)$K@=17/V5I;2W[@'=)CYG[FN@51&@1>@%%1)6
M049.5VQ#BO1M/_Y!UM_UR7^5><&O1]/_ .0=;?\ 7-?Y5S2.R&Q9HHHJ2PHH
MHH **** "BBB@"&[_P"/.;_</\J^<[_/FFOHR[_X\YO]P_RKYTOR/,85T8?<
MQK_"8NH)NMV_.L _>KIIU#1D5S<B[964]C7K47I8\FLO>N -;%K;WQMXW>S:
M>W!RGJ/I62D3LC. ,+UYK4BNH9[".WN+B:-HSE&QP*NIJM"()7U+MY=6<U^E
MU<Q74+* /+VC!Q[UU7AV^%\;BY1?+1FP%/M7&Q?;E7%M?QS#LA<9_)JZ;PL9
M1%/YR!)-_*@ ?RKFK07(;PF^;U.L=F\IMOWL<5R$#WR7;1M;R-,9 ?FA&S.?
M6NHD/^CO_NGO7)Z>8_-7)M3)O[W)#]?3O65%>ZRJLO>6IWD3'C/!QS4JFJ\9
M/?-3J>:Y[&]Q7Y!(STJD&()J[(0J[>]4%.7Q6D-C*IN:L!$L6T+@XZU5GL72
MV=$D_>L,;R*L6[A$ [GFDN)7$L6U25)PWM6>JEH:V3CJ-L8'@M%B+ D=P,9J
M=G\L9;\:6,]<=/>B2!)XF5B<$8I-ZZCBK*R&,PD4GC&*S7GMQ)Y2@.YZCTJP
M;-H8VC$[MNY+'K7/1^(+2UU&2U=6W[]@8#K5PAS7L9U*BA;FTN:D&EK;WSW*
MO]Y<!0.E7\\<U$9<2=>#4VS(R:B=]V:TTEHAOUKT?3_^0=;?]<U_E7FSH".2
M:])T_P#Y!MM_UR7^5<\CKCL6:***DH**** "BBB@ HHHH AN_P#CSF_W#_*O
MG*_ \PFOHV[_ ./.;_</\J^<+YOWQQ71A]S"O\)2890USU\FRY;WYK?/W3]:
MQ]23]X&KU*.YYE78CLH;:;>L\QB;^'C@UH(MQ @C2>&2/M'*!_6L^S@MYRXF
MG\H@?+QUJ\+?RD -P#&>SH2*N35[7)C>U[$C0C&9M+8=]\+'']170>%#&(YQ
M$'"[NC]:Y^&V@;+1:@MNXZ .<'_"M[PNSXN?,E\UMX!?.<UG5^%_\$:W7_ .
MKR?+.?3M6 @OGE+PVZS1!O\ EXV_H16X2IA8'TKF8[9'B$=H]TB,_P Y*95N
M?TK"FM&54;T.H@O94M&EGMS$Z\%1SGZ5<T^[6\@\Q05!/ )JG=31BU9-XSMQ
MCN:FTDG[(,YSGN,5#2Y&[&B;YK7- J I.*I_QY&0 >>*T!@#FLL77GWK10C"
M(?F)&,_2IIW=QU+*Q>MG>>)F,;IAN,CJ*LA@Q!!_"G1';M7'7UJ81#DX K-R
M-8QT*[-LS@YS^E2(6?'.*BDP'(H\W:..U#5T"=F/G<)DGH!S6(]K9R.2UJF"
MVX-M&<UIRW$;(=V*SHYI'DP4^4'K5P5D3/WFK&FL88!MHZ<4X]*K&[([<5+'
M*)%-82.E1L#<"O1M/_Y!UM_UR7^5><L17HVG_P#(-MO^N2_RK*1M$LT445)0
M4444 %%%% !1110!#=C-G,/]@_RKYMNEV2LOH:^D[D9M91_L'^5?-]_Q=2KC
MHQKHP^YC6^$HM]VL^]0O"QQTJ^WW:KR+O1E/<5Z5-V/,J:F".M68II8C^[D9
M?H:;'*(69'B1UST8<_G6H;"S:P2Z>1[;><*I^<&NES2TDC!1;UBRL+L,,3V\
M4OOC:?S%=+X4*%)S&A1=PX)S7/)IDDQQ;S13>RM@_D:Z+PM&\*SQ2*0X89%9
MUN3D=AP4^97-V_O38VZR;0P9PISQP:S?.LXEFFB:=?*E PLYPV3UQ6S<M;I;
MYNE!C[@C-9J)I$M[M*VPAP".S;JY8-6V9K).^Z-(65J(WN-I<D;OO$5?TET>
MVW1KM&>?F)_G5>\98+)MJ\8P,"ET,C[(V !D\@5#5X-FBLJB2+=UJ<=O-Y&&
M:0C(P.!5:RW2W)N)0=Q]!Q6@L2ARVT$D<FFLI6,L,$D\8J8M+0<DV[LT]A*J
M0,FIUR4YZU1LW9(P';/<Y[5=#J4W \5SR36AU0=]2J5(E; X]:H75R%8K'U]
M:DN[@EB5;"BL"^U)/,\I",GO6].#D8U)**U%.H)&[ASD@U9MKB:Z<1P)]2>U
M<C=WJ6]PQ#%V/:NO\)ZC VCO-+M5D8AC6V(I\D.9(RPU7GJ<C9N06"J@,IW-
M^E-GC6$;D&/:N=O/'$*7RPPQEDW8+5T4L@EM!(.C#->?*G.-G);GHPJ0G=1=
M[$6<KFO2-/\ ^0=;?]<E_E7F:'*5Z9I__(.MO^N2_P JB1<2S1114E!1110
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MVXS'7J6G?\@VV_ZY+_*N&9WP+-%%%9EA1110 4444 %%%% "-]T_2OFG7/\
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M98C(7(I-)M_)A*EE;)['-9JW(S5WYT7VDP:SI]22WE2.08C9N6/0"M,H-IK
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MAO(0#);2C/\ LY_E2 M"G#-5 \XZPRCZH:>)9#_RS?\ [Y-%AEH8I:KAYO\
MGC+_ -\&EWS9QY,O_?!HL!8R*,XJ(0WK#(M9/RIRV.H2#(AV^S-BBP#]X]:8
MTJCJ:G31;I\>9.B#OM&2*LQ:%;+S*TDI]VP/TH$9!N#(^R)&=O11FKEOI-S<
M$-<MY2?W1RU;D<,4*[8HT0>BC%/H AM[6&UCV0H%'?U-3444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1@>E%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
4% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_003.jpg
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (6 2D# 2(  A$! Q$!_\0
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MZBJ4)XJ[&.1]?ZBD,EB_A_#_ -DJU']\?A_[-5>-<;1VX_FM3I]Z,_[O\FI
M21#_ %7_  '^1J2/[J_[J?SID7'E_5?_ $$T^,_*O^ZG\Z )/X#_ +K_ ,ZE
M'W_^!C^51?P'_=;^=2C_ %G_  ,?RH  3L_X :DYW'ZK48_U8_W#3_XC_O#^
M5 #@>GU:ES\O_ 12#M_P*E_A_P" B@!W?\?Z4#I^%'?_ (%0.GX4 +WHHHH
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M?M(H^J__ %ZKB"0=)7_$U*L4V/\ 6'\J )-DO_/1/^^#_C2^7+_STC_[X/\
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M8H ;BC%.Q28H ;BDQ3Z2@!A%-(IYIII@0L*JSKE35MJJS_=- '36TAFM(96
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MJK+XFE;BWMU'NQS_ (4TY/9&=S.A\,:G,FYQ%"<_=D?)_P#'<C]:M'PY:6C
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MNU:<S#8W8W]36A%+TK#AE!;K5^&0#WK2PR[J<G_$KFY]/YBN791(M;FJS?\
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M3D'TIA/Z5SR?,"9<!#+3 <FF1/D4[(!]J@&2BBD4BG4B1IZ4TTXU&TJ#^*D
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M>=<PQ,",]"1R?R']*Z.[E^TW4DO/S,2/85<T:V6TT0@CYF78>.YY-5I8=K9
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MHHH$%%%% !1110 4444 %%&><44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 )_$3[4M)_$?I2T %%%% !S2'=V('U%%%  -W<C\!2T44 %%%% "'/8#\
MZ!GN!^=%% !S2T44 %(3BBB@ # TPS*#C!HHH >K!AD4M%% !1110 4444 %
C%%% !1110 4444 %%%% !1110 4444 %%%% !WS1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_004.jpg
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" */ 2$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ))LP,CC.35,#/?K4;5(YYJ,]*D"&7[M1#&.E22,-M19 H NVP)Z'%37:A5
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MAO8BM9_+R?,W $'&WUJBPJ6RU$SS<'=AX%+5&982>8,'V-32-ND*LHXZ&DV
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M)A1113$%%%% !1110!E^)?\ D6=2_P"O9_Y&OG>X^^:^B/$G_(LZG_U[2?\
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M0AIA-.---,!AJ(]:E-1M0(++G4H?]ZNKKE;'_D)0_P"]7550,****!!1110
M4444 4=:&=#OAZP/_(UX5!CR"#TR:]WU4;M(O .IA;^5>&+'Y2;2>^:RJ'7A
MMF6FTYS );5A/$1]W//X'O5;[1.R&U-PZQCAHB,-CTSUQ4:7GV5R\,VQ^ZXR
M#]15M-;T^] CU"V"$=).H!]0>J_YYJ+*6VAT7E'XE=?B;6G0QK8PJJ@ #@"K
MH516#I]U*UG&(V++SM/7(R<<U>2">4_,3_P(T_9I+4XYM\S+TES%$!G!^G-0
M2:H$&%%*EC_?8_A5D6L('*!OKS7%7A?:0X-=3,_M.>0_*I(IS&YD&<[:TUMH
MC_ !]*D6U0G&2*\NI0J/:S.E5(+H9UO [L \A-75M8P<XS]:DBM=LWWJG6!N
M1D5RRH5^Q7M(D.50# IWF9XHDMY-HQS3%MY<_=_6LG0J?RLT4H]PWX-789=Y
M""J;6\N_A:MVL4BEB5YQ5T:4U/5.PJCBX[CY&Q4L9R!4+Q2,P^7BK$<3CM4*
ME4;ORLAN-MR;.%%(&-*8V- A;U%=/)6;TBS.\1ROS4P:HUA/=JE$?N:[Z$*U
MM492<>@X-1NH"@4O KT*:EU,FT YI:3-&:Z40)333LTTU:8AAJ)NM2D\5"QY
MIC'V/_(3A_WOZ5U5<K8_\A.$?[7]*ZJJ)84444 %%%% !1110!7OAFPN!_TS
M;^5?/UW<EV*Q\ '%?05X,V4X]8S_ "KY\AA#!F;LQXJ)VZG3ATW<OR&.YLET
M]8CYZ1AT?'5L9Q^(ITN@P0P%X9C)-$ 9$)!_3M2>5.)[:9(V\MVCPR\XY&<^
ME-@;R=0>4-C]\^XGG(W'BLW+NCHC%_9?F;^FHGV"%D Y7J*O"J=@IC@\MB"5
M8C]:N#BLI2.6>LF/Q3J1>13JYZG<411P:E4_.*BIX.)%K&Y9-TE!J0'YC37&
M&!I <-4W&2&G)4+-S4L9XHOJ,<3S4D7>H&/-3)PF::![$BG)J53S4(X%2)31
M+)LTH--S29YIW"Q*IS3LU&.!3LUHI65B6A0:"U)FFFJ4Q6'[J,TRE-:QF2T!
M--+4A-,)JU,5AQ-1M033">:UC.X6)K'_ )"D'^]_2NJKE+#_ )"<'^]_2NKK
M5$,****8!1110 4444 1S_\ 'O)_NFOG&:Z:UN&'5">17T?-_J)/]TU\T:G_
M ,?$G^\:QK;'?@$I2:9N:?JCQ*#"PEB[QL>1]*NK'I>HR[@S6\Y.67.-Q_D:
MX4320ONC<JWM5Z#60V%NH\C^\O\ A6"K=&>A4P+OS0_ [ZR8DW/.<3,/Y547
M4[J"4)*]O+NY 8^4^.G0\4: T3:>'A8,A8D&J_V>6Y6YF:[WS(Y#03 %  >!
MC&1D=Q4<UVSSXP2DU+H=+ Y9%8C!(!P>U3&J5E*LMI#*B[59 0OIQTJX#N -
M9-WC8YVK2L%+GYA0>E(OWJP91= W**@<[90*LI@)5"XDQ,*&5%:EEN34RG"U
M6#=#[4EO-YJLV>,T)#L3DY-3Y 4"J9D 89/6IS( *+#:)=V6 JPO JE#(&8^
MU62_%-$M$FZGBH48'FI033$29XHS3<TN:8AV:0TE+33$**0G-&:;5\S)L(:8
M33G(4<FJDURJ_=YJ9UHT_B948N6Q*332:H&ZDW9SQZ5;5MR@^M5A\1&JWRCG
M3<=RWIY_XF<'^]_0UUE<EIQ_XFD'^]_0UUM>G#8YWN%%%%4(**** "BBB@!D
MW^I?_=-?->K#%W(/>OI2;_4O_NFOF_61B[?CKS6-;X3OR_\ B&5!:RWEPL$"
M;I&Z"FWNFW=@Y6X@9/\ :QP?QK3T29K>YNIT^_';NRY]16[!XC0I917\*NES
M'DR8X!R1TKFC3BXW;LSUJF)K4ZEH1NOQ[DOA!O\ B2+_ +[5K76G:??2)]J@
MB>3^'=]ZJFD>4(IA!'Y<8F8!<8Q5/4;A#>)*I6&9"!_I68QP?X7^[SZ5DE[S
M1Y<KU*SE'2YTT:A%"J % P .U2J3NQVK.M'DCMK82R"0[ &<<@GUS6B.0#6<
MM'H<[5F/;I2)]TTCGY367>WPLK1Y7E" #JQP*YJU94VE:]RH0<MC:BNEEMR5
M8':=IK'OKU(RVYQU_*O.(?B#>P)/ T6YBQ*.,>M4(?&%[/+Y;+'([-R6'^%=
M<:;W:.A4K;L]66^$=N7,VX$<"GV^IH(JXRTU6ZD1?,MX]GH"15\:F$4%[;'H
M W6LG."TN:>P?8Z5;O[1*".$'\ZO?:&8!5ZUPS^)79A%:V3-SRV_ 'Z<TR;Q
M5<:<P:2U9@3_ '^GZ52<7I<ETI=CT6)MB $\GK4YD&W:#R:\S?XD11IN-J^>
MPWBM+2_&B7T!FD@,>/\ ;S0URJ[(5&4G9([Y" H%6$-<KI_B(7H+1I\H[FM)
M=5?IA:YY8JG%V8Y8:HNAMYI=WO6&=1F/W6'Y4T74S=7-92QT%L@6&EU-TL >
M32&9%ZL*QO,)ZL32[SBL7CW]F(?5N[-)KQ!T!-1?:V8\<50#9-3+P*PEBZLN
MMBO8QB2R2LYY-025,BY&34<@!K+5ZL%9:(JGK5^W.85JDXJ[ /W KT<O?OOT
M,Z_PEW3.=3M_][^AKKJY'3?^0G;_ .]_0UUU?2P^$\][A1115""BBB@ HHHH
M 9+_ *E_]TU\YZXN+C/K7T9+_JG^AKYY\0)B0''0D5E6^$[< _WI@PW)M96;
M;N#(R$9QP1BMC3M..N:7;I#*J3V<A&&/52<Y_.LRPM8KW4$MYI/+#Y ;W[5;
MN-(UC0I3/:EV3^_%SQ[BN6*=KM71[-:46^6,N6?2YVUK$L3RQJ<X8$GU..:S
M;^>87;>8]U;0HIVLJ*R,??@TSPI/+<:<\DSEY&D)8FK>I0M/<9@N7\V)03%&
M^#C//XXJ$^:3:/*4?9U7&70NV#>?IT+,BH2@)51@"KT61'M)Z51L1(MG%YH(
M?'.XC/XXJZK5S/<RENQY?Y#[5Q/B/6;*2VFM7"2,IYC85U<SM'.3_"R'\Z\N
M\1:M;S71M1&'=6^9B.AK.5+GG%]CHPR2;;,^W@61V:.)$'."1DU0BL38ZK&Y
M?<C'KZ592]\DX7O3+EFN(69>N,YKKCS)^3.JHH2UZH[*RN8OLYD!4A>XJG-J
M!GD\M&QNZD#H/05RL&HG[((P=JK]_GJ:GAOP#@-P>^:P^JV;8HU4]3K8G6&'
M9&5 '\3')-8>K.YBD)E4L>F!5&2\V$_,/P-5(9)=4O%MDZ'J?055.@XOF83J
MK;N9B23LY50S^PYK5LM2FLXMKP28]"*[G2]%L[2,1JBYQRQ')HU"Q@6-L!?I
MBB>,A)\O+H32H2B[\VI<T'54N;)"J>6<<BMZ*Y!P,_K7D\^IW&GNT<)P,\5T
M'A_4KB7#7,_ Z5Q5\(]9K8ZHM2TZGHB2 "IA(.U95O.KHI# U>BYYKSI1L2T
M6T))J4#CUID,9/-6#MC7FLS)L15"<FG*=QS4.2Y]JF!VC I&;)6DPN*A)IKO
MBJTUR$0Y/-6DV2H-[#Y'&:OQ_+"H]JP[:0W,^?X!U-:WF9Q7L8"DX^\S+$0M
M[IIZ6<ZG!_O?T-=?7':0?^)E;_[W]#78U[\=CSI;A1115$A1110 4444 -D_
MU3?0U\_>(4(WGT<U]!/]QOI7@OB-/WET/21OYUG5^$ZL&[5$<_HX']JA]NYD
M5F4'U XJ]I'BN\CNUAO6$T+MC<0 5_*LFRNOL6I0SG[JM\P]N];,OA.6:^2X
MLI(VM)&#@Y^Z/ZURPYK>X>Q65'F:K+1K1F_!<V\\DTUJC13Q,1-$RXW =_\
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MZA">N.*\VOAG)MK8TG)*-Y,[Q+U-F5/YU(C>;\Q-96G:?/-@LC8]ZZ"*P=5
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MXKK@QJUY_P!=G_\ 0C7M5>*ZY_R%KS_KL_\ Z$:B>QM0^(YZ=Q!J-G.<;5D
M)/;--_X2N^LK^>.X19HA(1L(P0,]JGGM5O&CB?(4R+G'UJUJ7AZQU61S:72I
M=(-K#.02/7WKGM.WNGIQG032K*ZM]VHRUFM-8N'N+1!",#>I&.:?=1VT<@5V
MC5\@!Y054\=G' /UK*L-.N](GE@N %)P05.016AOW-PP5XV&-PR#GC%8^]=W
M-'&*?N2]TW-+CCCLE"X ))_UF_/X]ZT$*Y^]6#:H\=F<2(6#DD1C 'M5JTG:
M7)/8XK&<;.YQSC>3=SH(BNW&ZN:\2Z);:E!)NDP_48]:UT<XZUS%_=;[V6%R
M<$XKDQ"EHXO8Z,'2E*;LSSJXL'MY2GFD,IJ)W=;N+S&1P.N3C]173ZKH6X&1
M.O7.:PSI:SQE2Y$B],<YKKIUHR5VSMG0:^%E81+]IDB6-7;J"AR!6W;^&KJ\
ME2<(+8%<$$D_CBCPOH[+>F0MPG4#N:ZYK@QMA3@CKFKE*VQRN;6AGC0[V&R,
M22)*<8//45<\-:2+:26XGC57'RC(I4N9!*0C[LUUEB@GT]!*N&QUJ*<;RT,Z
MM:2CJ5HT5B>,J:L@J$X  %0M:2;MBL6&>E:=O81118(R>]:JFSGE-6(+,AMS
M 9R<58<$CI4\=M$JX7(_&E>V_NFG[-D<Z;,ME82GC@]ZFCX-17-O<1Y8<CVI
MEN'"AF))]*4E;<U2NKHU8#(#U)JSE_>J*77E*6=@H'<U2G\1 $K H8^IZ5S5
M)QAN.%"I4?NHW07%,>?RQR:Y[^UKJ7EF 'H*<+N5NM<<\8U\*-E@Y+XBY=ZG
M,H(@A9CZFN0U?4]4#'>[J/8<5TIO648VBHMRW<BPM&#N.*B%:<Y)/6YU4.6A
MJX)HR-&T74]1A^U74I2WQNP>I%<^K"2=L#'->N7.RUT6=4&/+B/\J\?MS^^)
M]37M5*,*:2BC3 8F>(=2;T2V7WGHW@09U*/V!KTZO-/ (SJ(]E->EUV4O@1X
M>-_C,****T.0**** "BBB@ [5XOKPQJ]Y_UV?^9KVCM7C&OC_B<7@_Z:M_.I
MGL;4/B,;+A@4&6!&![U@:Q#=Z;JLDR[XC(V]6''7FMV0A>=VT]B*;'XDM79K
M+5H%= <"3;D$>XKEDHM6;L>K1E.+YHQYEU1GZ=J5SJ+EKE][1KM!QVK2^RK+
M(I8'<,8(."*B:TT^VN]^G/NBE3=PV0#FI#&&Q*%<,#\S1Y#8P?3KVX]JR:=[
M,U<HO6"LC8LK80VY4%FW$L2W7FK,,*IZ"J%A+++#AFD?YL*TB[21],"M&VN+
M>2=H-S>8O4%2 ?H:RFSCJ7NRR@&,5S-_#&=0<E')W=JZY0BCM6)>W82Z95C!
M.>M<6)DU%6-\%-J;LBE>6WFZ8X6W<L!D8ZUQ41D@O0)('0YZ,I%>CI>R&/&%
M'X5S?B-+BXB&P_=.3@8-<^'JM/E:W.ZGS2;BT1:$0)YHCPS'=FK\D'ES,&&[
MWKF(GN()4F5B''(KI;:]34X=PXE ^92:]#=')6IN#$MXV$F0O&:[6#Y;)2!G
M"UR4:E753D5V-L@%LH_V:WH)W9Q5GHBQ;Q!4W8RQ')IX!S4$%PJ#RW(&#P:M
M@@\YKI1S,<J\\5(%I@.*&F1!\S 51(K1@@YZ5D3O';!Y6;"+5J:^+?)&/E[D
MUEZC<V<BI;RKD$9-<N)JJ$+G7A:<I2L9%U?-?OPX$8Z+4:0XYQFM&/3;&0?N
M3M/L:D&G&-L@Y KPIU>9W9[:JPBN6.A!#%P,C\*NK%ZTL46.O6K*H*Q<CGG4
M*S0KBKNCVH-T96'RH,YIA7VJY._V#0Y'Z/(,"O0RV'-4=1[1./$U'R\BW>@S
M5+D-X8O[C/#JV#^E>5VY^?->F:M;ROX,,$"EI'"@ ?6O,X%*2[3U!P:]FO=N
M+9V90HJG42[GIWP^YO\ _@!KTFO-OA]_Q_Y_V#_2O2:Z:7P(\7&_QY!1116A
MRA1110 4444 %>->(N-;O/\ KJ:]EKQSQ*,:_>C_ *:&IEL:T?B,RU:&'S+B
M5=VW 48SS4.H:=8:Y"Y@40WBC(&,$_XTN-T#@=F!-9&J2RV<MO>0DJ\;=17/
M*5E9K0]"E3E*=XNS*FAPO%<W$3KATX(-:]PRF+RV&.<@L/ES@U=M[>.ZOA?1
MK@7$(8\=^])>Q?9=KLQ'SC9\A;GW [=:Y_AERG2ZRG+7<LV%QM@9W*EB> K9
M &/6J\-P?MLSG&[/&.U$<3>1YHD1P[$G:A4*?3!Y%009^TRDANO7M4:$.FG=
MHVXKYL<U@2:B9=8EB(Q@UIQC(X-<MJ5E=C5'GMVR V2N:QK0BXV8\-:$]3K4
MP4R*AEMVE!R !ZFF6+R?9D,@YQS4T^7C(!XKR+69VQ>NA3MM(M9$8O(K$= !
M6)=PG3[UGA9E;L ."*Z&PM91D@97VJ>>RMYE/G[OIBMH5G"6XZBBYOF=S M_
M%-G\J74;1N#U R*[J#4H9+2-HWRI7.<5P&JZ#8Q1^9!YI;/.1G/ZUUVEQ+_9
MD!4-P@R"*]6C6C)7B<&(PR23+GG;V/S<=LU:AF95^\?SK/$#[@Q4D'K[5?CM
M2J@YR#6G,8.FK$AN'/\ $:%^?DDD^]*+=L#:?KFIHX&0[@#2<KD\J0)& .1D
MURNL,IU.3'& !78;>,]*Y'4U;[?*2 1NKEQ3]U'H9?;VC]".U) R":W;4RN0
M "WK5GP_96ZV0GFB4EFP,U*'>POI8X]HRV>1VK)X**C&I4>C_I$8C%\]24(+
M5#EM)2"Y0@#N15A;2)53S9"&?H *=>R.SQ N<% 2*EF\E$ADD;E5X0#DUU4\
M/AX3DE'X;:L\V=6I))M[]BDEL3>>1G.&QGVJWJ6GR7TB0CY8D'6DT^5//FGE
M8+WR?>BY\001SI!#\[N< UTX:G1C2OTD[_Y$2=64]-T3WIBLM*?>P 1#@GZ5
MXS"=TY/J:[[XBW++IUK$&(+MDX[\5Y_:YWBKQ$KR4>Q[>44>6C*J^OZ'J?P\
MC)N6?LJ&O1JX/X=KA9S_ +(KO*Z:7P(\/&.]:04445H<P4444 %%%% !7C_B
MP!?$UZH_O _H*]@KR#XDL;3Q,DJK@-$I/OUJ9[&U!7G8Q867S=C\(XVGVJAK
M%C-]F>$QL6ZJ5&0:GCE2= ZG(-7X-5FMTV/&)0!\IS@USZ-69W)SA+FBA+'.
MG6EC!/P^PY'I5O5 KV2G!.6&"&QCWKF4U&?5=6FD=-HC7:%'.!6B;HJOER22
MA2OS':&0#W'^%<\DG.Z-'1DFI/?=EVRD"JT,K&2/.-Q'3C/]:K):B&9V0HX;
MDL#6II<<$MAA5CVY/W%(_0\@U6A@EBO)BL9:+T*D?SK)O5E4YJ\B$94\5SE[
MJ1M=9<-RO%=6T2L28_\ OD]17!>(E*ZO)VX%3-*2LSMPM.-233['7VFH02VP
M9'7<S!>O3\*T/+C;[K9!//.?PKS_ $I6GEV+(ZOC(PN1^// KL]!N7CLU\QT
MD63D84\?CC%<\J.EE&X5:#HNT66H()[9C*K$+NYXX(JX9?,A+RQJ2,<@^O2G
M+-"\14@(/<TR"ZM)@Z2$_+U'3'O7*TOMP9DYN3NUJ,EM+>1#'(C@GC\<5J67
MV:.W6,;CM7.<4WR+21PWF$_\"-:$5C;!5(S]W'7M6^$G3;:C<PK5;Q2E<K13
MQR@B($8]14T<;[N <'M4T-I;VV[;W]:F\U%X%==SG<E]E#HK8?>-6"J@=JIF
MY8<K3UF\T9'6C4S:D]Q)5Y/-<;?S,NI2)MR"U=D>1@URMY&(]6,C*64/G K#
M$VLK]ST, TI/T.H2*W@TZV6:818PWU-,U5%\^"=3E6&":P]0O3J#QED\M4&
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MW1+"6[NXH(D+R2,%51W)-?4GA_24T30[6P3&8T^<CNQZG\Z -.BBB@ HHHH
M**** "BBB@ HHHH " 00>AKYN^)W@V7P[K4ES!"W]FW3%HG X1CR4/I[>WTK
MZ1JKJ6FVFK6$ME?0K-;RC#(P_P \T ?&$JX-5W%>H>/_ (7WWAR62]T]7NM,
M/.X#+1>S>WO7FDBTP*K"FFI6%1$4 (:2@TE%@%HI*6@ S3LTVBD [-&>:;2T
M +FBDI: $S1110 N:,TF:3- "DT9I,TE #J<*:*D1: )(US6E:Q%B.*J0ID@
M 9/I7KOPU^&\FKRIJ>KPLE@G*1L,&4_X4P.@^$OA!E UZ]B95 Q:JP^]ZO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
:444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_005.jpg
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )6 38# 2(  A$! Q$!_\0
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MMSF0#GC J9=+C'5F([5H>E'\)H K+8PKGY<\8Y-2B)$!VJ!QZ5(>]![_ $H
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MM("5:>*8HJ0"@0\4\4P"G@4P'"G"F@4X T .I:04HH >G)ITJ;EP.M,YI>:
M)U "#-+\OJ*@YI<4 397UI-RU'BC% #RXII>DQ10 A8TAR:6D- #2*8:>34;
M$ 9)XH C>JLW(-66.1D=/6JLQP#C\Z -_1O^03#_ ,"_]"-7ZH:-_P @F#_@
M7_H1J_5DA1110 4444 %%%% !1110!Y;XN'_ !55Y_P#_P! 6LN,D&M7Q?\
M\C1=?1/_ $ 5DH*EE%Q"&'S#/OW_ #JTB_W7Q]1FJ<=6HZ0%M=X_@#>FT_XX
MJ=9 #@@CZ@@?G59#[U91R.](9/&ZL,J01Z@U.M5QM?&Y%;ZC-2A4.."/HQ%
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MD1AE64Y!%78\&H-BRE3I4"5.M(9,M3+4*]*E6@1,M2+40J1: )0:>#48IXH
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MCA6.>U6I*K.H=@A_B.* /4J***"0HHHH **** "BBB@ HHHH \A^-T1DDT?
MYV3G\MAKQ21VC8.C%64Y!'8U[O\ %XHM]X?WC*M]H0_B$']:\/N+.7[<]HBE
MY Y4 =ZT@SAQ,7>Z.ATR^^V^?<8(+NN1[[%!_45;N[>6=!+#(5DC5MH ZDC'
M^/YUG:9:/IWFVTC!F# DCIRH-;$3=JI::HV3;5I%1;[5+>1%,!E4Q!]N,DL
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M/6J4#].:N@\9%0T:)Z#A2$9H4\\T\U+&1XII%28IC4F(B8=:9CFI3@=\5&2
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M#=MBW#.5/6K@,<PRIVOZ>M8X?;3A,5;@FFE<2G;1FI@H<D4X?O6RW%0V]V'
M5N#Z^M2,'9\J0,]Z9JFGL+<2# 4<C/-9EY<>;)P, <"M.1%2!F)R0*QG'S&D
MA3;$0\^U=MX%.1?CT\O_ -FKB5]*[?P*/W5\?=!_.DRJ9U]%%%2:A1110 44
M44 %%%% !1110!D^*!N\)ZP/^G*8_P#CAKY^MKJWN(ULYRK,R=&[U]!^)O\
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M+54.?F)9)"">:9(^[ZU6DN-\WRJQ!/R\'GVJ9'$T:LO*D9HC%6."<G<8K?.
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M<C;B/:M+&+-0.]1Q1 @%@O/M5GRV*KC[JFHJ/F6AC.JG9'#WL:RZB4.<!\$
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MO>:I<ZG*%.0A/"+2EW9O%J,>5&RU_)J=W%9VV=A8#C^(U]%^'+;[)X=L+?\
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M9R[BWT.ZYEQ][<<4RWL+^*0+'#+D'IC(IK73O(78 DG)Q6[9:[;1K&)5D!
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MB:8?\M7_ .^C4WVZ[Q_Q]3_]_#7M7_"N/#)_Y<&'_;=_\:!\-_#/_/D__?\
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MS_A6C%#' FR)%1?11BGT6"XBJ%4*H  Z 4M%%,04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %5I].LKF0R36D#R$8+M&-V/KUJS1
M0!EMX>T\H5C66(G^)96)'_?61^E1-X>C"XCNI@WJX!_D!6S10!AKH$H'-Z#_
M -LL?^S4U]&O%/[N6%A_M9']#6]10%S &D7_ /?M_P#OIO\ "G?V3??WH/\
MOH_X5NT4#N8/]DW_ &:W_P"^V_PIO]DZD3]ZV'_ V/\ [+7044!<Q!H=R1\U
MZH/H(L_UJ1=!0C]Y=SL?]G"C^5:]% B@FC6"$$P;R.[L6_0G%7(XHX5VQ1JB
M]<*,"GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
; %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_006.jpg
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (R 7@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0NHZL!]30 M%,\
MZ+_GHG_?0IK7$"_>E0?\"% $M%5FU"S7[UU$/^!BF_VI8?\ /Y#_ -]B@"W1
M53^U+#_G\A_[[%']J6'_ #^0_P#?8H MT54_M.Q_Y^X?^^Q3Q?VC=+F(_P#
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M.?YTP.ZHKE[?Q-.G$\*R>Z\&M>UUNQNF"B7RW/\ #)QG\>E &C1110 4444
M%%%% !1110 4444 %%%% !5.^U*VL%_>OEST1>IJ'6-3&G6PV8,\G" ]O>N.
M=WED:21BSL<DGJ: -2[\07=SE8CY"'^[U_.LIBSN6=BS'JQ.2:*2D 49HHH&
M%%%% "4M%% !S12#FEH *.U%% !FEHHH *2EHH *#10: "DI<48XH 2BEHH
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MJ5JA>@"G.VW#>AS74H=T:GU -<G=Y\LXZUU4'_'O'_NC^5-")****8!1110
M4444 %%%% 'FVHOYNI7#CO(?YU6]*EE(-U-_OG^='E[L8]<4,!%J=:B",.<5
M(M2,G6IEJ%:G6@"5:E6HEJ5:0#Q3U--%/ H >#3P:8*<!3 D!-.!-,%.% #P
M:<#3!3A0 \-BG[_:HQ3J '[O84H:F8I: ';O84N[V%,IU #MWL*4-["F"EH
M?NHW&FXI<4 +N-&328HQ0 9HI:2@ HHHH 2DI:2@!*8:=330 QJA>IC32F3S
M0!3>/?D]A71PG,$9_P!D5AR86,GH *V;)M]E"WJ@IH1/1113 **** "BBB@
MJ.XE$%O)*V,(I;FI*R?$[F/PUJ#*<'R3B@#SL79-XXE.&D8LI]<]JO(V?SK+
M3R=0ME/56&01VIJS7>G\3HT\/:1/O#ZCO28&XIXY]*EVJ<\5GV=_;W8_=2JQ
MZ%>A'X5H(0:0R01C&0:D$9!Q[XIB_</T/]:L#AS]3_.@!%!J1:%Y(_X#_6I%
M[9_V?Y4  IX-(N#C(_NT\ ;<^V:0"BG@T@7G\Z<!T_#]:8#A3A30*<!0 \4H
MI *4"@!P-/S3 *=B@!U*.M-Q2@4 +2TF*6@!12BDQ2@4 +FBC%'XT %%%'%
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M-/$#[N*B;4[)/^6Z'_=Y_E2N@+5 %4CJUO\ P"1_]U#_ %IIU-S_ *NTE/\
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M\!O#W5FSR1X-5O"(XH)\]]J$ 5>ATG7XK9H+>WG4-W/'->H@ 45M'*J2W?Y
M\/?=GCR_#[Q!<2YDCB0-U9I ?Y5JV7PQNT&+B^@7WC4M_/%>F4O:NM86E:UA
MK#P1RUKX(M8HE2:ZED([H O^-:,/A?2(6#?90[#O(Q8'\.GZ5L44XX6C':*-
M%2@MD0PVEO;KMA@CC'HB@"I,4ZDK?;8TL----.IIH 8U0O4S5"] %:2MWPLO
M^BW+>LF/TK"DKH/"_P#QX3_]=C_(4#1N4444#"BBB@ HHHH *CN!FVE'JA_E
M4E(XRC#U% 'SM<#;=2CT8C]:IW@RBGWJ]??+J-R,=)&'ZU3NL^37C8CXS@J;
ME'-3V-])87/G*C,GW7!& P],],U!6A8R*^G7UM@-(5$BH<= >3^%9T%>>CU%
M#XM#7VZ)JT<69-GE@D1A]A7)R<CZT\7UI)J%I:604PPYPR=,D=!Z\?YZURPP
M>U:&D$C4X/\ >K=8US:CRV;-%6N[6.V3BI5S4*5,M=R.DF!IXZ5&*AO[HV=C
M),J;W&%1/[S$@ ?F15Q3;L@;LKLLVMPEU")(SQDK^(.#5I37G/A[Q.FF:9J?
MVW'F02F01E@I)9N0,^^:N_\ "S-/9!Y5G<LQZYP%'X]_RKKG@ZO,U%7.>.)@
MXWD['>J:D!KD;7QSI$B*9[Q8F/5/*<X_'%7D\0Z7<MNBUVWC']UBJ_\ H50\
M-5CO%_<6J]-[-'1#K4RGBLRV;[3&LL%^LT9_B3:P/XBF:=87MMJEY<37K36\
MN#'&?^6?7-1RVW9HG?5&PIYJ3-1KUJ3-24+0*0T"@!U*.E-IPI@.%.'6FBG"
M@!6ZT@%.:@"@ HHHI@)2BBE% "44M)0 4E+2&@!IIIIQIIH 8U0O4QJN[_PI
MR>Y["@""0XKH/"W_ !X3?]=C_(5SSC /K70^%O\ CPG_ .NQ_D*!HW****!A
M1110 4444 %%%% 'SQJ)SJMW_P!=6_G5.XYA8U=U,;=6NQZ2M_.JDHW1-]*\
M?$_$<%3<SC6GI.IPV#,LT;,K$$,O.*S*LV-C+?W'EQD* ,LQ'05C1<U47)N3
M!M2]TV3I^D:FQDM;H12-SM4X_'::B&F2Z7J=FS2+(DDNU2!@CCO3)O"\PBS'
M,DY'567;^55[%[@ZG;Q3RS$QRY*2,3@X]Z[*EE).I"S[HV=D_>CJ=HAJ9:KI
MTJ=:Z$SH)A7,^*/$2Z?-!8VL/VB_=@8XQT#'@9_G^M:>MZJFCZ9)<LI9APB@
M=3_A7+^!M/EU*_N/$5]\TCLR09'3^\P_E]*[*$$HNK/9;>;,JCN^1&+#I[:7
MXSMQKBQ7'GL#("OR OW_  />K?B_3+.R\06L-M"L44BKN5>_.*U?B+9?NK2_
M4<JQC8_J/ZUA:]J(U*72;LG+F$!_]X'FO7PTG4Y*B[-,\ZO:'-!^J.SG\"Z!
M%$TTLDD" <LTH"C\ZRV\(^&Y3^YUZ)?0><A_K4_Q'F<6-E$#A&<EAZX%4[#X
M>M>:9;W)OMCS1A]NS@9&:RHSDJ2J5*K5_F:5(Q=1PA33L1>"[F33_%CV$,XE
MMG9D)4Y5L=&%>L+7(>&?!D.AW)NYIO/N,%5P,!:Z\'BN/'585*EX:Z;]SIPE
M.<(6D2*>:DJ)#S4M<AU"4"@THH 6E'2DI13 <*<M-%/%,!QZTHZ44O:@!M%'
M>C-  :44VG#I0 4E%%, I#03@9) 'J:KM=*25C4R'VZ4)-@3=:ADF1#M^\W]
MU>332DTO^L?8O]U/\:>D:1KA% %/1"(B)).7.T?W13" HP!@>U3M4+TKC*\G
M0UT'A<8TZ7WE/\A7/R=ZZ/PR/^)8Q]9#_2@:-FBBB@84444 %%%% !1110!\
M^ZXGEZ[>IZ3-_.J9Y6M+Q2-OBG41_P!-VK,'*UX^+^)G#5W*$D3HN]D8(>C8
MXK2TRY:WTZ],.3, ",#D \9_#K^%+;:BUJACEA$T.>W!'^-7K*/2IYR]NVQG
M4H\6=H8'_9-:8>G!M2A+7L.G%733,."^N[>998[B7<.H9RP;Z@]?YUT<@BOE
ML-33Y&+;6![GD8_/-8\^@WL,K)$GG1_POD D>_O^E:X06=C864S_ +\2>9A1
MD#DG'ZXITH58\T:NWZE04DVI[&RAXJ9:@0U,IK=,Z2M>SV<PET^YDV>9"6))
MP-I.WKZ\C\ZLZ;;V]G8PVUMM\J)0HVU1U#2(;P/(G[NY;'[WKC!!Q].!5)?#
M,L9Q%?R*2F/,89=3C'RG/'Z_UKJBJ;C\5C%N:>US>O\ 3[75+0VMW'OB8@XR
M001WR*PV\ :6X4)/=H%.57>"!^E:D5E<Q1PA92TB* SNV2W.2.@[9':GPMJ:
MOA@&4$ EL<],D8'UK)8RK0;C"]O()4H5-9Q(?$?AP:_# GVCR3$2<[<Y_6K$
MVD79TVR@M;QHI;:,+N#,JM@8&0#R..]2)=7J(ID@#$KE@H(YQTJ>6]DADV%,
MMA3M'XYH^MMP4'LO+N4H14G-;LLZ?'<Q6JI=RB:8%LN!C(R<<?3%7ATK)35!
MO^:)]IY!QVP/\:T+:X6YB\Q00,XP:F-6$G9,NY92I:B0\U)6@P-**0T"F ZE
MI*44P'4]:8.E.7K3 DI:2B@ [TE!IK,HZFF X4X=*B$A(^1"?<\4;'?[[X'H
MO'ZT[ .>1(Q\S#/I41EE?_5I@?WFJ18T3D 9]:=1= 0?9MYS,Y<^G0?E4H55
M&%  ]J=3:&V A---.---(!C5"]2M4+4 5Y*Z;PV,:2#ZNW\ZYF3H:ZCPX/\
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M/D?Y\>U%QV$<Y%=5X?&-&B^K?S-<<T@/0UVFA#&CP>X)_6F@-&BBBF 4444
M%%%% !1110!XU\1P/^$IG/\ LI_Z"*Y6 _-75_$8?\5/<'_9C_\ 017*0 YS
MBO/KK]XCDJ?&3]J?%NB<O#(T3=RO0_4=#312A@!S2NT]!;&E!JDRG;/$D@/=
M./T-#'3Y)(G@C,,QDW,H4IN]20.#^-9;7D,1Y<$^U0'5]I!CCYSP36L9SEHU
M<I3?4[,; OS 8]Z8]_:PCYW4?C7'3ZE>3@DR-C'\/%4&%PRB0JVT]":['&VY
MU+4[:77[-5(5OFQQQFJD>NR,S,(P,].:YB-!@;W_  %:ME)##@A0Q_VN:AN"
MW'RLG:]U260B%7P<G@?XTL4-Y-EI9&7!Q\V2:UH=1MI$V2)Q["DDVHN^'=(F
M?O9Y7\*3:^R-1[D=M#!QO9F8=<G K6MS!&P$:*#6=;W<#G&0,=C5H7$ &, G
MITJ+M[L.3R-1)<G%3"88K-2:'!(R!TXJQF(IQT^M*S%REOSAC@T"?!SG-4\Q
MYX8_G44RJR;?,=?H:+,+&LDH:FRW"Q<L<5CVZR1\B9R!_>Q4C[)2-\KX'!Z5
M$N;H)HN?;P03N& >M36UX)=V#G!ZUERK#-_&1@TL!$*,J2,0>>W6H3E?4"U/
M>A;AD+<>M4I=757V*W-(T*N=S.[>Q.*@>PM2-QC);I]\_P"-'O-C+3:GM'#9
M]\TL^I$62O'QG@XYJJ+2&%0$B!!.3N)--;R;-?,\E-F><#[M4N;N%BW!?A7(
M=OWA&0M#2W4I+K$[)S@@<$U'->13()(W7!P :GAU3R(@AP:=N[!C%COYV6/R
MGCXY)'2E>*[E8*'50N0 <]*B75902J284<^]13ZB\K?>(9@0GJ:+("580LV9
M)S\IY7'>IHY[9&VH<D$GDYK+>169I7*O&N=WS8Q5"V-Y-,)+>)O*8X'RY%7%
M+H.USLK>X\]@L:[0.OI5Y&QP3FLV#;!$(]V2O4^IHDO/*4LW3/:MU'34M4S4
MW@=Z@FFVQD^@K*.IH H)^]]T^M.FNV50 C-G@X'2BR:'[(=%*5\R=N<#(J,2
MO':O,V2S= ?2G*4:)\G$8P6],#M65<7YGG$2JW/)..U96=[$\K<K%V"8MGUQ
MTKTC11C2+;_<KS*W^5A[<5Z?I'_((M?^N8K9*PIQY78NT444$!1110 4444
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M1#(X3(?:5).!P1COZBM>T)^PP'I^['\JJZO>!-+F22**0-@?O6VJ,GJ2.?\
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M.[C$T?3=W_'UKSU[-\U.;MK<YERZQDQ^N8,D#CNE99KH9HK/6U0PW/ENHX7
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M!M !'49K>$5+1GR^)<H5)-?:_(R(-,@@BA\V(&YB7;YC<M^=<[JY9;LXR,<
M&NG>XC%Y-L?<H;D9Z51U+2)=0F62';OSM<$_K2ORRLB,.U"?O&%9V,UR698B
MV1D 5H6]B]H\0E0HXY.>]=9INFQV-J$49;'S-ZU5UJ)O*5U7[AR3[5JI-O4R
MG/F9=TKD1>NX?SKTT#"@>U>7Z/)DP#/.X$_G7J-=<=C,****H HHHH ****
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MW02-CGI5IZV.-%C0I UZJCHC*/UKURO&?"FYI4D8\R2 _3FO9J[(;#"BBBK
M**** "BBB@ HHHH YSQV,^#[WZQ_^AK7C#<5[/X[./!]X?\ :C_]&+7CDRX
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M([)&@ZLS8XKEKKQ3#;KY%F/,8?QGI3=3U![]%6Y=BO!PW^%<KJ,365YM5/\
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MM0?;W=2555'YUYTJR74TEF$>Y)%9*H'RU*TUK;??D7([#DU@W-[-(Y#2MM]
M<"JY8XZUFZRZ(XJF82E\*-J;70F1!%^+5E7%_<71_>R$C^Z.E%K8W=\^VV@>
M3W X_.NBT_P1,^'OIA&.NQ.3^=:4Z5>O\*T_ YOWU8Y5(I)Y1'$C.YZ*HR:Z
M;2/!DLK++J/R*>D2]3]:[#3-%M;(^796XWGJYY/XFNCM+%;?YW.Z3U]/I7K8
M?+8P]ZIJ_P #>GA5'66I6TG2(=/A4+$J8'RJ!]W_ .O6I117J)6T1UA1110
M4444 %%%% !1110 4444 %%%% !1110!'/;PW,313QK)&W56&17,7WA>:!FD
MTY_,3_GA(>1]&[_C^==710!YV7,4IAG1HI1QLD&#_P#7J&YTK3[X?O[=&/\
M>'!_,5Z)<6EO=QF.XA25/1AFL2X\*Q<M97,D)_N2?.G^(_/\*4HQDK-":ON>
M?W/@N%^;6Y9/]F09_6LJ?PKJ=ODK$LJCNAS^E>ARZ9J=IDR6GFJ,?/ V\'\.
M#^E0K<*&*ME6!P0PQ@UQ5,NH3V5O0RE0IOI8\QELKBW)$L$B8ZY6HP*]9!20
M890P]Q4$NDZ=<DF2TB+$8SMP:X9Y0_L2^\R>%[,\O%.!(Z5Z#+X1TJ08198C
MZJ^?YYJG+X'B9LP7KH/1T#?R(KEGE>(CM9_,S>&FCC1*ZC 9A]#4T=S.O_+0
MUT$O@B]5OW5Q X]6RI_D:KMX2U5#@0H_NL@_K7//!XF.\'^9/LZL>C,]+R7^
M]G\*E%]*.R_E5@^'-6BY-J3_ +I!IG]C:F.#8S_]\&L70K+>#^X=ZJ[D1U"<
M=$0_@:DAU>>*0,$0D>N:7^RM07K9S#_@!IITV[YS:R_]\FDH58NZB_N_X <]
M7S+@\17/_/*+\C_C1_PD5YVCA_[Y/^-4AIMWVMY?^^34BZ5?MTM)C_P$UT>W
MQ?G]W_ %SU?,LGQ!>G^&(?13_C3#K=^Q_P!<%^BC_"FKHVH_\^4W_?!JS%X<
MU.0?\>S+_O$"FI8V6W-]W_ "]5]RH^J7KC#7+_@<?RJ)[F:0?/*[?[S&M=/"
M>I.<%8T]V?\ PJU%X,N&/[VZB3_=4M_A3^K8VING]_\ P1^SJOH<T93W-1M+
M7:1>"[0#]]=2N?\ 9 4?UJ_%X9TF$Y^S;S_ML36L,IQ$OBLOF4L--[GG&]Y&
MVJ"2>P%:$&FZA/'B*TE.>^W%>C16MI;C$5O&@'HH%2&4#TKJADR^W+[C185=
M6<':^"+V=M]U*D"GL/F-=#9^$]*L\%XS.X[RG(_+I6XB33_ZJ)V'KC _.K46
ME.QS/* /[J?XUZ%+ 4*6T;^NIK&A3CLB@BQQ*(X8U7T5!5V#3I93NF)C3T'4
M_P"%:4-M# ,1H![]ZEKLLD:D<4,<";8U"BI*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ IDD,4N/,C1\=-R@XI]% &<^AV#D
M%83'SG]VQ7-5WT #<8;IP2> Z@@#T[&MFB@# ?1KU&41R02+_$6)4CZ#!_G3
M/L-\KD&V) _B#K@_KFNBHH YL0W )!MY1C_8-!+(?F5AGU%=)12L!S@;VI=X
MKH2 >H!IIAB/6-/^^118#!WBC>*WO)B_YY)_WR*/)B_YY)_WR*+ 86X4N\5N
M>3%_SS3_ +Y% BC'2-/RHL!B;O:E!)Z*3^%;@4#H *6G8#%\J8](I/\ ODTX
M6MR1Q$?Q(K8HH RAI]P1G*#V)IXTMB1F;CN M:5% %$:5#D[GD8'MG&/RJ>.
MSMXCE(E!]2,U/10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_007.jpg
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )( 0@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>F,\K]/\*Z2*5)HUDC8,C<@BN)3-:NF73VD@!R8G(##T]Z8'24444""BBB@
MHHHH **** "BBB@ HHHH **** "JVH,5TZX(_P">9_E5FJ^H?\@ZZ_ZY/_(T
M <1&N.G /-6%#CI4*$]^M3Q,1UH8Q?,/<8IP<587:1R*>D$;Y)7%2!5W4NZK
M7V-#T)%)]A/9Z!E;-(2#]*L_8)/[P_*C[!+ZB@"MGBFD<U<_L^;VH_LV4^E
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M=34III% %<K385_TJ$_]-%_F*G*TU!B:+_KHG_H0IH#=HHHIB"BBB@ HHHH
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M10 4444 %%%% !4=P,VTH_V#_*I*;*,Q./\ 9- 'S[XDB#:K<,R@'!Q^!_\
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M7J1)^\8S7-Q6ZQ@,W+"NH\,G=J1;/_+,U[.'NU>6YYE5Z:'74445T',%%%%
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MUT*FH['CXF4I2UV6AB7#;Y2?>NA\)IMO,]]AKG2A\QCU7KFNE\+Y^V_\ /\
M2E"-KDU'[MCKJ***LYPHHHH **** "BBB@ HHHH **** /$_&+"/Q!>9&09G
M_G7 W9 GDKO/'7&O7@_Z:DUP=V!NSZUHMCOP^Q'76>"=51'ETN9@"3YD0/<=
MQ^=<B6"KN/3K56>8Q217$$A25#D,."*'KH=<Z:J1Y3UZ3PQH]Y/]HFL(C)G)
M/(S]0.M4_&=[#I/A>6WAVHTX\F-%XP#UQ^&:Y6S^)%[! $GM(YG QO#[<_A@
MUS>L:W=ZY>"XNB/EX1%Z**7*^IC1PE5S7M'HCJ(&W6\>>NT?RKI+)!]@CP#@
M"N7AV^1'@CA1S73:*_FVC(?X37GQ?O-#J[W'[=KX&1Z5-$&&!U'UIDJ[6 XI
MT3\ XKFJQY97023M<TK>9HOIZ5 LL5R6*D'D@BFHZLI-8]K-Y-W*IX!8\>E:
MPJ[(=."E=]2AKV@O&[7-I$#&02Z#^'W KE^03D5ZA',K+S@BLM? _P#:\TEQ
M!<+;QD\J5+<^U3*CS.\#=5E%>^<#TSZ5!(0QP*W_ !+X>?P]?+:F;SDDCWJY
M3;WP1CFMOPMX+MY[(:KK#;+;&Y8R=H*^K'TKHHT[/4TE5IQ@IWT9P+$A/3-7
M-.\/:IJQ#6EI(Z'^,C"_F:[?7]:\)IHUU:Z;;V[7!0I&5@[],[B/QSFM!;J_
ML?AWI\FF+FY944!5SG->BM%H<LZ\K)J-K]S@+W2=2T>XM[6^1E1C\@W97)/.
M*]HD'V70 H_@A _2N+\8G[3=>'K2?;]K=U,@!Z=,UVNKD1Z4R^H J9.Z1R5I
MN:A<QH2\D8S]371>%W/]J,G81G^E8<,>U/:M[PP@&ILW<H?Z5GU,)NYU]%%%
M!D%%%% !1110 4444 %%%% !1110!XC\0!M\07F?[_\ 05P5X"S A<BN_P#B
M*,:_>?[P_P#017"LV4^HK1;'=0>B*A.Z-AC/%;7BV&&6QTVXB109(CE@.O /
M^-8; +SVK>M8Y]6\/-9^1)]HM#YL6Y2-Z'L*+G5)V:EV.-8DD9&.* ,XI\Z&
M.8JW!'8]J:*L]*&J.[BM6:VBQ_<!_2M32?-M;D$@%&X;!K.LYV2WB[_(.,5K
M*4=?ERK>U>7+1W/)G+5IFQ<0 KN4\'TJJ%P,8YJYIS>;#Y$A^=>GN*DDLY,C
M"U4HJ2NA0FE[K*<9(Y[5A.^+IST^8_SKIC8R $G\JY6X1XIY PQ\QZUQSIRB
M=%"S;L:<$YV\FNUL2;#18W926(!( YY/_P!>N TMQ=7L-LIR68"NYUO7$T.T
MA98?.=CA4!QT[UT8>:LY/H8XM-N,(K<QOB'IPNM.M+G&/*E",WHK<?S IOQ
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M#WK:\,.3JS+Z1G^E<W#* -M=+X74?VFS=S&?Z5G&7,KG/-6.PHHHIF04444
M%%%% !1110 4444 %%%% 'BGQ(&/$5X/]T_^."N )RN?2O0/B5SXEO!_N?\
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M)"!U8XKI1'\I %8$VHV]M=B&Z;:9'*H<4K7LF=&'OS.QF-;L#\O6DA$L,J2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
F4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_008.jpg
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )6 AX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***IR:KI\0):]@XX(
M#@G\A0!<HK'E\3:9&N5D>4^B1G/ZXJK+XNMP/W-K*_KO(7^6: .BHKDY?%MP
MP_<VD:'U=BW\L56E\3ZE(,*88O=$_P 2: .UHK@VUW5'&#>-CV51_(57_M"^
M/6]N>?\ IJW^- 'HE,>6.(9DD1!_M,!7F[LTAW.Y8GJ6.:;@>@H ]#_M.P_Y
M_K;_ +^K_C44NM:;#]Z\B/\ N'=_+-<#@4M '<?\)'I7_/U_Y#?_  IC>)=,
M7I,[?2,_UKBN*3B@#L&\5V .!'<-]$'^-)_PEEA_SQN?^^5_QKD,TF: .P_X
M2RQ_YXW/_?*__%57?Q>@;]W9,P]6DV_T-<OFC=0!TW_"8'_GP_\ (W_V-)_P
MF)_Y\/\ R-_]C7-9I,T =2GC!,_O+)E'^S)G^@J?_A+;#',-S_WRO^-<?FDS
M0!VL?BK3G/S":/\ WD_P)J<>(]*) ^U]?6-O\*X3C%)Q0!Z*NIV#8Q>V_/0>
M:/\ &K2LKKN5@P/<'->88%&,=#0!ZA17G*:E?QXV7DX Z#S#C\JN1>)=4C<%
MIED _A9!@_E@T =U17)0^+YQGS[6-SVV,5_GFKT/BRS<*)89HV/7 # ?U_2@
M#?HK/AUO39R0MY&,?W\I_/%7D=)$#QLKJ>0RG(- #J*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJE
M=:O869VSW*!@<%5^9@?<#I0!=HKF+OQ<O*V=L2?[\O _(=?SK&N=8U&[SYER
MZJ<_+&=HQZ<=?QH [>YU"TM,_:+B.,@9VEOFQ].IK+G\5V,9(A268XX(7:I_
M/G]*XX >E.'2@#>F\6W3G]Q;Q1C'.\ECG]*SYM:U.==KW;J,Y_=X0_F.:HT9
MH 61WF??-(TC>KL2?UIO%&:3- @W#M1FDS29I .S13<T9I@/S1FF9HS0,?FD
MS3<TF: 'YHS3,T9H ?FDS3<TF: '9HS3,TF: 'YI,TW-)F@!^:,TS-&: 'YH
MS3,T9H ?FC--S2T .S1FFTN: %S1244 +2YIM+FD I-*DCQ.'C=D8=&4X(IN
M:* -&#7M3MP MTS#.<2 -^IYK3@\7S+D7%K&_/!C8KC\\US=%,#MX/%.FRYW
MM)#_ +Z9S^6:U(+JWN@3;SQR@==C X^M>:8H!*L&4D,#D$=J /4:*X&T\0:E
M:X'GF5?[LWS?KU_6MVS\5VTN%NHFA/\ >7YE_P ?YT =#14<%Q#<Q^9!*DB>
MJG-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445'//%;0/-
M,X2-!EF/:@"2L74?$MI9$QP_Z1,.,*?E'U/^&:P=5\03ZAF*#=#;8((S\S_7
MV]OYUDA<#B@"]>:SJ%_N$LQ2,C!CC^5<=P>Y_&J(4#M2Y]Z3=Z4"%SBDSS24
M4 .S29I,TF:!CLTF:3-)F@!V:3--S1F@!<TF:3-)F@!2:3-)10 [-&ZFT4 +
MFC-)10 N:,TE% "YI,T44 %%%% !1110 4444 %%%% !1FBB@!<T9I** '9H
MIM+F@!<TN:;FC- #LT4F:* %HI** %S2YIN:7- "T4E% $L-Q+;2"2&5XV'=
M3C\*Z+3_ !6ZD1WR;A_SU08/XC_#\JYBC- 'IMO<PW<0E@E61#W4]/8^AJ6O
M-K2]N+*82V\A1N_H1[CO78Z3KT.HXBE BN,?=SPWT_P_G0!L4444 %%%% !1
M110 4444 %%%% !1110 4444 (S*B,[L%51DDG  KA-:U:34[DJI(MHS^[7U
M_P!H^_\ +\ZW/%-^8;5+2-L/-R^#R%'^)_D:Y 8Q0 M!/M24A- @SVHI*4=*
M "BDI,T +FDS24F:!BYI,TE% "YI,T44 %%%% !1110 4444 %%%% !1110
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MUA01%VX'%=#X> &K./2 _P#H2T =11110 4444 %%%% !1110 4444 %%%%
M'EVH2?\ $XOL'(-Q)_Z$:%;<*J2R&2YF<G[SD_F:DC?'>FP+'>@]*%;<*#Q2
M$)1VH]*3I0 M%&:* $HI:2@!**6B@!M)3J3% Q**7%)0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%+0
ME+BBB@ HHI: $I:*6@!*6@4]4+'@4 - S4\,#2, !^-6;?3V?EN!6DD*1+A1
M2 KQPK"F.]7O#W_(7D_ZX'_T):J2=*M^'CG6)/\ K@?_ $):8'4T444 %%%%
M !1110 4444 %%%% !112,=JD^@S0!X^IZGOUJ45&E2+3$3*V#4RL&ZU6%/%
M(98\O<.#32K"A6J96!ZBD!!MQZTG2K)C5NAIIMVQTS3 @S2TYHV':F%30 M&
M*;V_G1NH$+24N:* $HQ1D9HQ0 F*,4N** &XHIU&*!C:*7%&* $HI<4F* "B
MBB@ HHHH **** "BBB@ HHI: #%%%% @I*6B@8E%%% !1110 4M)10 M+2<T
MH4GL: "BI4MI),;4)^@J[#I,S8W */>@#.P:D2!Y#A5)S6Y#I,28+Y)JXD,<
M8PJ@4@,:#2W8Y?Y16E%910C@9/K5HTPF@!IXJ)CBI#4;4 5W]ZM^'?\ D,2?
M]<#_ .A+522KGAT?\3>0_P#3 _\ H2TT!U-%%% !1110 4444 %%%% !1110
M 57OI/)T^YE_N1,WY U8JEJ__(%O_P#KWD_]!- 'E:5**C3\*D%,0]:>,9IH
M&:<*0R0<T]:8HIX]J )5/2I5;UJ%?K3QTQ2 G# ]11Y4;]1BHTXX%2 \4 ,-
MF&Z&HFL7] 15P'Z5(#[T 9;6SK_":B*,#R*VP>*-J'JHHN!AX-)SQQ6X;:%N
MJ"F'3X6]J=P,?-&:U6TQ3T;]*B;2V[,* ,_(I>*N'3)>V*C.GS _<- BO1BI
M393#^!J:;:8?PG\J (\48IQAD'8TA1QV- QM)3BK^E(58=J $HI=K>E)AAVH
M **,-Z4!6/:@ HI=K>E'EN>QH 2EIP@F/1&_*G"SG(_U;?E0!'QZT9JP-/N&
MZ1M4BZ3<G_EF1]30(I9%&:TTT2X/7:/QJ9- D/5P/PH&8U%;Z:"@^](:L)HM
MLHYY_&@#F0I-.6)V/"D_05U::=:IC]VIQZBIU@C7H@_*D!RJ:?</TC:K4>BS
MM]X@5T6T#L*6@#'CT- <NY/TJW'IMM'T0'ZU<HS0 Q8T7HH%+2FDH 0TAI::
M: $---.--- QC5&:D-,:@17<5<\/?\A>0_\ 3$_^A+522KGAT?\ $SF/I%C]
M130'3T444 %%%% !1110 4444 %%%% !5'62!H=^3_S[R#_QTU>K'\4R^3X;
MO&'4A5'XL!0!YO&:E'6HD/ J9>:8AP'%/_E313Q2&.7I4@J-:D'- #Q3Q3!V
MJ04@'BGBF*:>* 'BG@XI@IP'O0 \&G"FBG"@!XIP--%** ) :<#3!3A0 X4M
M-%+0 X#BEP/2D%** %VK_=% BC/512TH- "&"'_GF/RI/L\!_P"68_*I,T9H
M C^S0?\ /-?RH^RP?\\U_*I*6@"/[-!_SR7\J7[/"/\ EFOY5)2T ,$$6/\
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MK#"@_*/04G*VA48WU/8M)_Y UC_U[Q_^@BKE5-+_ .019?\ 7!/_ $$5;JR
MHHHH **** "BBB@ HHHH *X;XJ_\BM;_ /7XO_H#UW-</\5?^16@_P"OQ?\
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MTLHEY(W'U/-3A O0 4M0T*6+R?J1$OMR:='8QJVY\NWJW-6\4&CE[A<8% '
M I#2DU4O+ZWLXC)<3)&H[L<4]@)V:L?5M<M=,C)E?,A^[&O4US.K^-VDWQ::
MNU>GG,.?P%<K')->W!)9I97/4\FL9UDM(FT*+>LC6OM2N-6N \H^7HJ ]*VM
M.LC;6NY@-[4W2M%$"K+/S)U ]*U9>%.*=*#^*6XJLU;EB>B::NW2[1?2%!_X
MZ*M5%;+MM(5]$4?I4M;F(4444 %%%% !1110 4444 %<5\44W^$E;^Y<HWZ,
M/ZUVM<G\2$W>"[D]UDC/_CP']:3V*CNCPMN/\: Q[&E))&<TWO7GSW/1@3Q7
M(WX8]..*N, X#9PPY##J#68%._-6%D*< ]>U8MV-.6YK6NNWEG@28GC''S<-
M^=;MAX@L+P >=Y+_ -R7C]>E<@+A3PRX_E4,RK_ 1GK@=ZWAB)+S.>>'B_(]
M-23C-3K)[UYI9ZE>6B@13R1\< '*_D>*W;7Q5(I N;<..[1G!_(_XUT1Q$'O
MH<TL/-;:G:*]2*U8%KX@T^X^7S_);&2)AMQ^/3]:UHY0P!# @]"#FMDT]F8M
M-;ESY3VI#!&_WE!J,2>M2*_-,1$^F6\G\ !J :(D98P2/$6ZE&*_RK0#TX.*
M5D.YFBQU"&/9#>28]7PY_,YI7?5T4!1 V.[(>?R-:@>GA@:+#N9?]HWJ, ]@
M".Y63^F/ZTXZTJ$!K2Z]R%7'\ZT\@T;(VZJ#^%*S"Z*)UJR5 SO(N>WE,3^@
MJ9-4L70-]IC4'^^=I_(U.;:!NL:_E3#86S=8Q1J&@17]G*VV*[@<^BR FK0Y
MYZU1;2+1NL8_*HG\/V#_ 'HE/U%&H:&IFG"LE-!@BQY3-'_N,13SI$A  OKH
M ?\ 39O\:+OL%D:F1163_8TV>+^Z_&9C_6G?V7<@<7]Q^+FB[[!9&K2UE?V9
M=@ #4)_SH&FWG?4)OTHN^P6-6ES67_9ET>M_/_WU2_V5.0,WUQ^#FB[[!9&I
MFC(K-&ERYYO;G_OX:=_9>?O7,Y^LAHN^P61HYI&D5!EF"_4UG#1+8G+;F/J3
M4@TBT'6,'ZT78:%G[9;@X\^(?5Q3'U*TCZSH?]WG^5(NG6J_\L5_*I1:P+TC
M7\J>H:$!U2VQ\K,Y]%4T@U(-]R"8_5:MB-%Z(!3@HS]T4:AH5A<RMC$#TW=>
MMT5%^IJ[M/I1L:BP%$V]U)]Z? ]%% TY<Y>5VJ_L/K2%<=Z.4+E06-NO\&3[
M\U,L:(,*H%/X%)D46 *,4FZFLX Y('UIB'4F:R;[Q)I&GY%Q?1;@<%$.YA^
MR:YN^^(MK&A6RM9)&YYD.T?XU$JD8[LI0D]D=P6K-U'7-/TM"UW=(A[+G+'\
M!S7EVH^,M9U'Y3.($/58/E_7K^M8+%Y)-S%G9CR2<DFLI5U]E&L:#ZG>:I\0
M7D/EZ9#L'_/60<_@*Y*YO;J^E,EU.\C$_P 1JYIGAG4;W#>488S_ !2<?I77
M:=X5LK,!YAY\H[L.!]!6?+4J;[&EZ=/8Y/3=!O-0((3RXCU=AC-=GIVC6VFQ
M@(NZ3NYK2 "_*H  '2@UO"E&!C.JY$357F^Z:L-5>7.TULC(]-C&(D'HHIU
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MQ(<DC+'TJ?&U0*& QNE5Y3A34[&H) ",>O%" ]0HHHH **** "BBB@ HHHH
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M*:30,C/I4E@ VJV8_P"FZ?\ H0J-JDT__D+67_7=/_0A5(3/2****8@HHHH
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MY*7XXI&<'(SG%5VE/ID4A+,^<$?C7FRK':H#@Y4@ #'_ -:K23@ DD?G55%
M!WD\=!BB%A+)AEV\UFIR37F-Q3)/.W$M^&,TX3#@XIWE1L"%(^4=J0Q@]N]-
M\_<+Q S DC!'TIPEX^O6D\H#!I1&.N.?6J3F+W1PE Z9)IXD!J,)SGO3A&>
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M!6ZCI37= W=69,KH>AJK=2?/@>E/"[22#5"ZD+3E1UJ*U7E@53@G(<27(7<
M.^:KW-I,H\R(YX[5+%'ZGGU-3GS5 R<KZ5QMJ:]Y'0FXO0RH9I0=K$$]ZL@L
MP^[^M2M;H_)&#[4TIY8P.:Y'&4>NAHYI[%B.*,1DOUJNT48;(/YTUYL#&<57
M>5G.$!HG5BTDD*,)7N2&;RI@4Z@UNHPNK08/.*Y];<A-QY8]JT])=A*4)X%=
M>7591J<CV9CBH)QYET':C(+>U$0X(%<U%_Q_1_[XK9U?+S-SD9Z5E01YO(6_
MVQFNC$2YJZCVL;8:*C0;[W.AU74'LHP44'@5STVI7%T<,QP:V->&Y0!Z#O6%
M'&1T%5BZLU/D3T%@Z5/V?/):F_IA^R:89,?,YXS0+V0RJS,< ]!5<7!-ND0'
MRJ*!P.E%3$<EHP>B.=4N=N4]V37,BR3LRC@U"103Z4TD#J:YJE3GES&D(<JL
M!&*BDD5 2QP!56[U** $!LMZ"L66[GNY,9/)X44XQ;+L7;O4-Y*1?3-6]&T>
M2[E$L@.WKS4VB^'))RLLZ[4Z\UV,<,=M$$0  "N^C0ZLYJM9+2(ZPL5EN8;5
M!A2?FP>PZ_I7;UC:!9F.)KJ08:080'LO_P!?^E;-=IQA1110 4444 %%%% !
M1110 4444 %%%% !5/4].@U6PDM)U^5AE6QRC=F'O5RB@#R*[LY].O'L[I L
MJ=QT8=B/8U7FMHKB,K*H85Z9XAT"/6K4%2([N('RI#T/^RWL?T_,'SAA);3R
M6]PC1S1G:Z-U!I[@<S?Z#)"6DA&]>N*QFB*_*RX/O7HBX(Q_2JEWI%M=@G:%
M?^\!7-4PZ>L3IIXAK21P30=UQ43*5/(KH;W0KFWR47>G8@5DO&5.UE/XBN*=
M)QW.V%526A2!JY9/MN%]^*C\E2>.*5(V1P1V-0DTRF[HWTQC-2*?7@5!!*K
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M=E8RG%N39()!,<0S-$,]7;G\C5V95\N(-<,I XP?O5674K-^'7\UJ?[19S*
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M^ZI?-:]BDH<UKCH[R*5R@<\9YQQ6;(\%U,[1G.#@YJY_9DH+ ,$!4C@Y'/\
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M'6BTLY]3D(C^6('#2'H/8>IJY9:')/B2])1.HB!Y/U]/Y_2N@1%C0(BA5'
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MN)D$F?RVT:#,Q9,U*LE/D\,:S"6,<MI.HZ?,R,WX8QG\:JO8:Q A:;3)L?\
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M1ZQH$/YC!J#_ (1K2@"%MV'N)G_QK6HHN!AMX6LB<K/=(/17!_F#0/"]J/\
MEZN_Q9?_ (FMRBBX'/R>&,_ZJ]=?]] W\B*8/#-P/^8BO_?C_P"RKHZ*=P.=
M_P"$:G_Z""_]^/\ [*G?\(W-_P _Z_\ ?G_[*N@HHN!@?\(Y-_S_ (_[\_\
MV531^'D'^LNI&_W5 _QK9HHN!D_\(_;'_EO<?FO^%.30;1>KS/\ 5O\  5J4
M4@*!T73R,& G_MHW^-3)IUDB[1:Q$?[2AC^9JS10!''!%#_JHD3_ '5 J2BB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
-HH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_009.jpg
<TEXT>
begin 644 image_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "R #(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBL[4]:
MM=*P)MQ=AN"KZ5,IQ@N:3T&DWHC1HKA5^)$#S,@L)"HSSO\ 2MJP\6V5Z%RC
MQ[O7FN?Z[0O;F+]E/L=!12 @@$=#2UU&84444 %<3XO).I!<<"$8_,UVU<3X
MP=X+_P S:"#"-IQ[G-<F._@LTI?$>8I%=S79B@/S$G\JZ71?M"QH7&0O'2N.
MN+RXBO7,;%26["NNT"]N#:[7).3Z5X=1.R.U(]>MR3;QD]2HJ2H++=]A@W_>
MV#-3U]-'9'GO<****8@KD?&[A8X!_LM_2NNKB_&YW21J.R?U-<N-=J#-:/QH
M\\TSRH-72XF0,FYD((SU4BNIT= +6,@#(-<DPVR@#J'S76Z7\EJ@/<!OK7S]
M63:2['<D>E6[;[>-AW45)5/2VWZ;#[+BKE?3TY<T$_(\V2LV@HHHJQ!7#>+S
MOU KZ(!7<UP'B:3=K$P_NX'Z"N',':B:T?B.)DB)G.!P#S736QQ;6WM'M/YU
MDK 7F[\M6JHV(J^F:\"3T.T[OP_)OTP#.2K&M6L'PQ)NM)%ST(-;U?2X25Z,
M7Y'!55IL****Z" KS'Q)J5G!K5T)[F*,ACPSBO3J^=?&$27'B*^EQDM*QS^)
MK"O05:/*W8Z\)3]I-HWH]=T=78R:E"H![-5B;Q+H:'C4HR#SGDUY3*L48=2H
MSGA:O0VIN$@=N!MKE_LN#6LG^!ZGU.W4]X\#:O9:BTR6DZR[5R<?6NTKR;X7
M^7:ZDT0!!="*]9KMI4E2@H+H>3BZ?LZK04445H<PCG",?05\Y>()\ZI<$89V
M8GBOHB[?R[.=_P"[&Q_2OG6_"&]DD?KFJCN>GEMKR9S#0'<\DO4GH:W--C+J
MF[!P.!V%9SLLDDA[CO6G83*$1(^H'/M6B1[O30[OP3+]G\06X_O'!_*O7J\4
M\,S+#J]N^<G>/YU[76<MSP<SC:HGY!1114GFE+6)?)T:\D_NPL?TKYOO)#+<
MR,3QFOH;Q0XC\,Z@Q_YXD5\Y2L&D+'IGBM*9WX)VN4I"3O"\#N:N6C>5&N.X
MK,N)P-V/6IX9LB/_ '?ZULEH>RJEM#K=%N@M]$Q. &&:^@(&#P1L#D,H/Z5\
MSVEXL$R=,D\"OH[1IQ<Z+9R@@AHEZ?2L:BU/*S*7,XEZBBBLSS#GO&[A/"-^
M20!M QZ\BOG*>4EB :^@?B.Y7P?< '&Y@*^=+F41L>>:T@=F&T391G? 8DTH
MO@D<07D[2/UK-N)V<,,XIJ<0(2>1V_&M.8Z98CI$WK29GF5V/.:^FO!$QG\(
MV#$8VIM_*OERT)RIKZ0^%\YE\(1J224D85G,Y*[NKG:4445F<IQ_Q,)'@RX(
M'\2_A7S;.K.[$*S<\X&:^F/B)"9_!UT@&3N3C_@0KRWX7PJ^JZJLD:L!&O##
M/<_Y_&KB[(U@[1N>/S(RR$;6SGT-/BAEDPJ0R,V[H$)-?0'B#3K>VO[;4!!$
M(CF&?Y!@ XVG\_YU/H5K#;Z?=:O+ JB4F10$&1&O"X_G^-9*O+VCARZ6W-.=
M<O,>&I%+;.JSQ/&3R ZX)%?0WPD??X3?GI,?Y5Y1\1[E+[5K"YB4JK08P>O!
MKU?X20M%X2+E<!Y<@^O%;2UBF34=XG?4445F8&%XP0/X7O0>R@Y].:\I^&&/
M[<U1?6%3_P"/5ZSXL_Y%B^XS^[_K7BG@S5X]"U2[NYX)98I4\H>5@G.<]*TB
MKQ92^%GH(N;/6IM3TJ9 S0/Y4T9[K@$&G:GJ$%DUIH\)"W%U&^P 9\M5'7%>
M:2^(+B#XA3ZW86\[6LK 21D8+(1C\^,TZ/5KR\\;_P!M7EM.L&'C1 .44J0
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@Y)JR,YR35D6Z***R,PHHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_010.jpg
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &( AL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***BN;F"S@::YE2*)>K.<"@"6J]W?6UC'YES,L8/0'J?
MH.]8DVMW^H-Y>E6QAA[W5PN,_P"ZG7\3CZ4EOI:)+]HG=[BX/664Y/X>@^E5
MR]PM<EEU&^U#*VJFT@/_ "T<9D(]AT'XTEM816Y+8+R'[SN<L?J35DJ<8!Q0
M 1U-%RDK"]*0D*,DTZD*AA@T#&^8O]X4CLQQL(_&CR4]*4Q*>U $>Z7T!H,C
M+]Y0*?Y"^I'XTQK7)SO;Z4 -%P"?NT]ID7@BFBUP058TKV^\@C /TH !+&?X
M2*4&)^E1_96'0@TSR)E[#\#3$3%83UQ3-L4AVC^=.6)MI4@\=_6H3&V]?O#\
M* )A %;@\>E.>+/0XJ%BWRLQY!X&*&?+Y5OSR*5@'M"0O(4GW%59H5VDM$A
M]JG$K8ZC\Z?NW0@XY[CK2<4]T!C+'8S']Y%&!ZXI)-*TQ\$B/!K3.PDJ8P<=
MBM(4MG(62)>.Q%0Z%-[Q061COX:TN4'"H:SSX6T_>S('0C^(<5T_V6W(.V+[
MP['K3?L=OM$961:CZK2["LCFAX<\E?W.HW40]%F8?R-2"PUR$@V^OW@QT#3%
MA^1R*W?L$"R%OM#CV8\5.EFB$_O02>>32^K16S?WL.5& MSXNMMQ_M82@_\
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M*148CN!QYN?<BJ*ZPO4J:>NM0MV/7O0!<"3#(?8P/M3DB VN8D5^Y':JRZK
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M$16MY'=AS&& 4X.1BIZ:$VXVX ]J';;C@\GG':@"&XBFE*&&4( <D8ZU/[4
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MJG)-,ZE?L[$'WH2XDC7;]F? XZT<K'<N\EAQ^-2JU<]?Z\]K>VT"VTC"8X+
M9"_6MJ!<9;)PW.*EIH"TS';QUJ,D'Y32DTQF"C)I#&3[B%53WJD)/+\1+ST
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M/A<9,7EAC6'X5\+7.B7-Q)<.C*ZX78:QHXA0IU&G9MZ%SI\THW6A&WP[TZ0
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M_=&T>@IV[YL4Q"YI.G6FF15<(3RW3BEZGGM0 PH')W$XSQ@T_< 0M!IIZYH
M:R/N&QPJYRPQUI)HEF3:^<>QQ3BX523T%<]<^,M*M=673I)3O8A=PY )[470
MF[&]'$B-N Y(Q4I<#K48<$9[5',\ACQ 4WGINZ4QD^<TF!G.!FJMK]I$9^T,
MADS_  ],5/N]:5P' L"<G([4'DY/:D+ 4G4YS0 C8!R!DFD)!'!I"R(0"W)Z
M9-(W0@4 *9E@TJ]E;[H '%-T4![Q6'3&:1\KHTX.#E@/UJ30_P#C[Z=NM0]V
M:+9'03.R0NRXR%.,U#.0MCEP&^49!/!IUX<VT@# ''>F7"EH"O7H*S-".^'[
MD<>_TXK1^'J_\2>[?^]=-^BK6;?OMMS]#_*M+X=$GP[.QZ&[DQ^2BL'_ !X^
MC_0BIL==111728A6;XA7?X>U!?6!OY5I51UD;M%O1_TQ;^5 'B-Q_H.JC'"N
M!6C<2B>T)!Z57\30[?)F4= ,U##*LEF.W%>!B8>RJ-=!WM)Q,BX!:*=6],BL
MW2VVWF">O%7YG#2.,Y!!%9%DY%VOUJH:T91.670ZU%4C/4U$ZALC&*$;"\&D
M8DMP>*\Y)W-WL1.FU>M:WA^,M.TH&1TK%G?:#GG%=+X75?[-#=R:]# TG4JQ
M\A4UK<W6 *8/(K U>02S",<*HZ5N/*$R20 !7,2/]HNI')ZFO1S6IRTE#N:L
MT+--J[NN!3V#.2<BF(62)$4=>]2RD!#\W0<UX*6MC1:(YW4E52_.:O>&M-"R
M>>Z_,W3Z57F@$]RB@9R>:Z>QB$8"@8VC%>G@8WJ)G/&.MR\21@ @^H-.V@#B
MJ@@F%X9?-_=D?=Q5HG%?0HU!!\QXQ3Q2 \4I.*8"-CKZ56NKI;:WFF<X5%+$
MTZ0L2-HR,\\UA>,[X6'AFY=HO,#+L(';/>N><W>R$]%<\HC\SQ7XU'F*\D32
M[G &<**]MMTCAMDC0!$0 *H["O$/ VI6FF^)$EN@P$@*(P/W2?6O:Q*KJ<'G
M&<BN#%5G3D102:N32RJHW!L>]9LMXQ)V' '5JK:C?0V\6Z6547N2>E<=J'BR
MYU24Z9X>M7EE(V^8.WO7)253%SUTB:2DHD'CGQ&;L)I%FQD=F ;;W/I73>$/
M"$F@:89G;-]<*"X[+Z"G>$O L&D[;_4P+C4F^;+<B,^WO[UVA8<5[$,/3Y/9
MM:&<4[\SW.:N-6BMTN%F/[R!26'8UQ.@:S/XF\:1I.[+:1*SB,-CD=#6_P"-
M',6FWY"[3@$,.AYKE?AM$B7=]?.5_=J$&>V>37DTJ4<-3J5%NGH.4G*:B]CT
M?4M=@T>PEN+EPS0DJ0O<]JX5-7\9WLAUJTM)38J=PC/\:_2G7SOXMUYK:( V
M=KS(X/WSV%>C:>%BT]!'R0F2/4UZU.K&KY/2Z]26G)^1!HNO6VKZ6MZA\L#B
M17X*,.H-8FK?$33=.4B'=<."1N0?+GZTB^'-3UFY:76;G[/:$Y%G;'&[_>-<
M3XR\N^\06^A:;"L<<;")448 )ZU8I2DD=)HOC*_OIY]4O2EMI4:E45AS(_M6
MAX/\73>(=1OH'B CBPT;#TSWKF?B':II>CZ3I\0.V%-I.>O3J*L?":W<#4KG
M''RH/KUI"3?/RGI[J''OV/I35EW%@,[EX(JE/=3 F%82)7'R\C\Z@+)HNFS7
M=W+N=%)9B>OM3O=V1N]%=C]<U^TT*R:>Y<9Q\J9Y->=V?Q#U#4/$MG$%46LD
MP0QXSD&M30]"G\5Z@=;UN-OLA.ZVMV;@CU(]*UK;P=H>D7DFJW"CS4=G1L[5
M0'VZ<4/78Q]YN_0ZX$E<U$PD;!5E7UXS65H7B2RUQ[F.TW8MV"DGH:URJY!]
M*9HGU0[- !Q1FFL^*8#C30H5BW<T!LT9H 7O36)R#G 'ZT$XZ4UN<C-,!Q/%
M-S3,_+QS3@>*0&-XDN+VWT2XFL83)/MQ@'D#U%>#R7,WVW[1(6\T/NR>N:^C
MR58= 15&72M-N6+36$#-GJT8H>I$H<SN8?A;7+S7=,9;BUE@<)\LQ7"O]*Z&
MW+6\*13-EP.OK4R*B*%50JC@ "E8+UP,TDBUM802%G VG&.M//-&0!31P.N:
MH!"F[DGD=Z7(7BE)X[4A!XH C.';('([GM396)^4;@1W%2]^*C=UZ9YI 1S3
M?\2PQA3S(.:MZ&=DCL>PK+N)'*A"?E!R *U]#7<'XK/JS5+8U;L?N&Y/)'2E
MNE+1*HS]Y>GUIUPK-& J[OF'?H*;/(5" #.Y@*DLIZL^V(C'&P\UM?#G!\(Q
MM_>N)C_X^1_2L#6VVVSG_8-=!\.8FB\%6N[^.29Q]#(QKG7\?Y?J9U.AU=%%
M%=)D%5-4&=)O!_TP?^1JW535/^03>?\ 7!__ $$T >3:U;>=IN\'D*#7,VKE
MH&CSBNQF ETXKZI7%VZ[+EP?4UYF8P]Y2\B:NDDRHZ>5-UZFLJ%BMP>.C5L7
M(_?$^]8:MB]E4]FKGHZIF#V9UD3JR@GKBI&(4$@55A8^6N/2I'9AP:X''4TY
MM!(T\^9%QPQQ77V<*VD0C1<+7+Z<\<5XK2 X!XKL=P,8(&<U[65T_BF:4U97
M,77+LB((C?.S8(%4[-<'#5+JKQM>    =?K42N(V S7#F%7VE5]D7?4T(I58
MLJG@"DD.(RI/7O21($3-07;[5P._2N2FBI/073X/.NO,S\J]*Z&%ATSS6;8P
M&"S!_C85J01A4!/WL<U[>7T[,2V('FE-\$524'4XJX0",4G%)NKUKV >.!3"
MVXXS4<F6X!Q31\M<]2NMD!*QVKUK \2V1US1+JRA;]X5ROU%:A<LS*<[?YT*
M5084"N&K7U]T=KZ,^<;FVN+*X:&>)XY4/0C%='I6K^*;F V]B)I4^[NQP/QK
MV&2SM;ES)-;Q.W8LH-1S>7:0LR1JJCG"C%85\P5K<MV9QP]GN>?Z+X)U?6YB
MVM7;QVZM\T:MDM7I&F:'8:);>3I]ND7JV,D_4U2T'41+!(9$*8);)':MP2+(
M@93D'D&O3PTG*DI2W8^11V'#-<[XA\0IIS)!&092>1CI71*<UP'B739(M8>Z
MD#212 C/]VHQDG&EH!SOB?55?2Y0C2.\[C+_ ,/T!K"\+KJ.HSMH]@=JSG?,
MX[*.M=/?^'[W5K>TL+<Q);QCYI6ZCVKJ]$TFR\-Q1I;1#<<+)*?O'/>N'#5Z
M$8QI-ZM_\,1R2E+F-#1_#MGID06WC">NW@'Z^IK7C@6+<J@;3S^-13W@@$7R
M%O,;;QVJQNS7L*,8Z11IT([F406LLN0-B%N>G2O+_!BR>(/&]UJ]SL!MQG"]
MV/ KL?&>J'3?#5Q(NUC(/+ /H:\V\(:W#I6GWZPAY-3NF$<,:CK2D92?O(L_
M$^_2YUR.&-]PB3!QZUU'PM1%\,2.J99KAMQ!Z]*X7Q?H,NC_ &*6=B]Q/'NG
M);/SYKTGX=VQM_!]J> 9"SG'N:74F%^=MG1SQ3M('B\K(Z%EY%<3XIF?6O%-
MAX?7<UOGS+@(>JCKFNRU.\6QTVXN68#RT)_&N%\#X_XF/B;4)L"0F-6?IM'4
MBFS23NTCO6>VTRQ&2L4$*8'8 "O(?&OC-]8G-K9N5M%.,C^*NOB$_CFX9Y&>
M'18FPJKP9S_A7/\ Q,T:PT^&PDLX8X#@H508R!TH(G=J_0O_  HC\O3[ZX<X
M#RA1^ KT@X(R:\\^%E];MI%Q9A0)HI-Y]2#WKT(D"B)</A0BMD EL_ABLK7=
M>M='L9I7D4R*N53/)-96M^*62\72M(07.HR'  /RI[DUPOC72Y-,L[9[N=Y[
MZ<EIGS\N?0>PHN*<M-#N? =_>ZCI=S<W@<>;.7CW?W3Z>U=2S[>.YKBO 0EF
M\(VQ:Y+1JS@J.H&>F:ZU[B*"/=+(B1@<$FDBH_"B;J,G(SVI.!G'4UQOB7QY
M::;&8K)EFN".H/ K2\'Z[_;NB)-(X-PA*RCT-.XE)-V1T*X P*IZEJMGI-L9
M[R98TZ#/>K6:@N+6WN@HN((Y0IR Z@X-,HYX>)=0N[=I=)T6:6'DB1R$#?0'
MDUS4/Q'U!]0BM&LD5VE",#U'.*])_=PIP-JCTKS#68+8_$VT41B-2ZLVP9W-
MZTGL9RNK:GJ"DE0>A(I2,#/7%(6P.!2EN,YJC0'QLR2 .^:Y_4_&.DZ7N22<
M/*/X5KDO%'C"\O=1.CZ:"C,_EENY-:%GX%TBV@S?R&YN\ N78X!/M4M]B+N6
MQGR_%"9KC;;V6Y<X ZDUZ%IEU->:;!<7,7DRR+N,?I7-Z%X3TNSN/M4=J?.1
MSM9R< >P-=;D=*(ZZE*+6XK, ,DU@:EKGV63RHHPS?RK:F!*<*#[&N>O_*BW
M)Y#&YP0KA<YI3;MH7&U]3766.XTN"1%PY?YLUMZ"#LD)&*YC3H9X=+A,ZD%F
M) /6NHT(CR&;GK6:;:U-&K2LC1NG*1+@CE@.?2HIV_?0KWW4Z\Y$0S@F08J&
MZ8HWF'(*_= [\4%HI:^V+20_[%==X$.[P1I9]8B?_'C7$^(G46,IW MMY%=S
MX(B,/@G2$/7[,K?GS_6L(_QWZ+\S*H;]%%%=!D%5=2&[2KP>L#C_ ,=-6JAO
M!NLIQZQL/TH \RB7-J@QU05Q5RGEZC(.GS5W$ _T>/\ W17&ZO'MU1\#J:Y,
M?&]-,58R[K)<D5AJO^GR_6MVX^]6.4_TQV]ZXJ*T9S=S>@<A5'M4KN-O)JI#
MN]>.U32'"\8-<KAJ4F=#H-LLD)D=0>>]:UW<BT@+XXQ@56TA"--3 ZBL_5[A
MI7$(.0G6O6C45#")K=G3M$JC,[-(_))S2Q@/*&;HM1B3HBTJ'+$ UX33;U)3
M1H^: F2>*C@A^U762QV+40^<"-.3WK6L/*BMSMZCKFNFA3ZLI7DRP%_?(@;@
M=15\$ #FJELF09&X)J9GV#%>YAU[.GS/J6]1SGY@<TQY,=#432>]1%SSDUSU
M<7T"Q(UPJL%SR:B>X_A!J*5UV_+UJ+!V@X&>M<$Z[&65D(^4D4AD*D +D$\\
MU38_O V?;BI@3QGIZUS2JW&D2N02,' 'I56]8-&5W$$\5*'&2,Y-0QQ?;;S&
M/W<9^8^]9J+JS44/8T+&QAMK?:,G</FW'-2R(0@6-_+ /8=JDVG'!P*3KG(K
MZJ$%"*CV,[ZW$1BQW _+CIBHM0L8=0LW@ER PZJ<$5,%QD#./6G!L8!J[)KE
MEL)G.1:;-IH91^\0\(._XT6MT$;%R"/FQDCC/I72%5;/8^M0S6=O,@\U%8 Y
MY]:\RIE%.6L)-,I2L10%?,/4Y //-6A5)+7[-<Q-$'9,%<$\*#5L@LKJW /
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M)J'AQI(8D=[<^8<CYL=\5U1(# DCT%! 8$, 0>H-,;5U8\ \.>(9_#VH&XA
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M/_4 [R/4#K7H+RD1,['8%Y.?2N"\'6D>H>(]3U>526CE*QL#QSUHEM83W1Z
M..%XQZ]ZQO%FHOI6A3W,6/-QM!^M;7!.<<^M><?$^_E1;:T!PC L?>J%-VB9
M?P^TYM4U^;4;@[A ,Y/]XUZ@\<SN%18V3!W%AR3VKFOAYIOV'PZL[-EKH^9C
M'0=!76LRQ*TC$*H'))X%2EH.*LB./>I_>>6)&'134FZ-SPX)''!Z5FZ-JL>J
MFXDBCQ%'(8UD_OXJ^J0)*QC +G[RBFBAQ7<-NXLO?-5YD?[0CH@*@8/-3MN
M8+A1V-(SK'&2Y"Y]Z=D!-?\ $-HO^R36EHP(M21_>K)OR0UL"<_N\BMG2<BT
M'&0363ZFJW+4YS/ N1G<3S]*KW^&,8/J>^*L2X,T9/49P/ZU0NMLLZ;6Z-R#
M^%2:(Q/$15;:[<=2 #^5>F^$01X/T<'K]CB_]!%>5^*]T6G7;,1\W(_*O7/#
M\8A\.:;&.BVL8_\ '16%/^-/Y&-7<T:***Z#,*CN!FVE'^P?Y5)4<_\ J)/]
MT_RH \SMN;:,_P"R*Y/7%VZD3ZUUEH0;2(_[(KF_$$?^FJW8BL,6KT@K;'/W
M RU993%QGU-:]Q@5F+DS\]*X*2T.0OQ$8^E2-\S#CJ:CBP*?)]PUDXZ@CJ8=
M0BM]+VH1N P*Q@Y(9V/+57MDV1 DG%/+;FZ\4JTW4M'HC=RN.4-R<\U-$"?D
M'WS3(HGG8!!GWK:L-+\GYWY-33HN6O0<(MDVGV*P)N;ECZU:*J\FQ0 .^*)'
MV\ \]J:CB(D9^8]373%Q3MT1O:RL7051,5 \RYP&&:A:X)]ZAW!CD#FKKXQ2
M5D-$I;G!-02N5.0>*21SZ5&3SQTKRY3NP8@.X$$')J16P N>:B+YX4?6F[BI
MSQBLFP1*0!GUJ-Y3LQG\144LN02IJJTA:18XUW.>U2HML=TBUYK! BG<S'!)
MK8LH$@A")R>K&L>#2;G[4CN_RCD@=*Z!%"+\O KWLOPKIMSFO0ENX2 NI7<1
M[B@< #--8G/%-9\,H)P3V]:],1+TI!U)]:,TA% @W$&F&YC$PA+#>PR%J.&Y
M$LCIM8;3C)'6GB,&4NR*2/NGO1Z#)]_(&.*'P1DG@<UAW^M2Z7>J+RV(LWZ7
M"<A3_M#M6E!?6UU&'@GCD4C/RG-._1DW1/\ (XZ T,P5">F!0",<=*YKQ7KZ
M:;9-;0'S+R<;(XUY/- F['$Z+$FL_$MWNOW@C9I%QTR.E>KN9 A\L!CGITXK
MD?"WA^?08(IGB62ZNFS.W=1Z"NR P*E!"/*@ ^49/YTAZ]>*9,@EA>-B0&4J
M2#7,VNH3PV9:YD=8-.<QN5/,[9PH_4?C5#.H)!.,<TE94FNQ6_F+=Q/!(D8D
MVY#$J3CC'O1J&NV>FQ2&7>SQ*K%$4D_,<"BP&J>E-X8#(]^:R;;6TFU1[=V2
M*/RD90_#%FSQ6C<W4%G TT[A(UZDT /FWD81L'IR.*A\@^6,LY=3P2>:B@U.
M.XD5!#.A<;E,D9 (JPK'=M.<]>G%%@,VU%\]S-/>,8XP"$0'M6A:JR6Z*S%C
MZGK3W8!3ZU#$S9VOEF ^]C@T)6&W<F\P%RO<#-(&#=#FHYE\V/:'90Q^\M"J
M8TV@\@=<4Q$5W+L>-55V<GC [5.22,Y IK'@<9/K0&^4$\?6BP%'7)8(]'O/
M/8B,0MNP><5F>!X[>+PQ ;9) KLS$N,%CGK6^\7FDK(J-&1@JPSFGHJ+&%C4
M*HZ # %%A6UN*.">O/K7E?Q.AG&IP2N%\EDPG/.>]>I.2HR 3[5S7C#PW+XB
ML8EMY5CFB.0''!S18F<;K0;X1U.T?PG:9N(T:)-KY/W2*R[_ %.[\37G]F::
M[BSW8GN<8&/056T_X;K!;$ZCJ$I)ZI;\#_Z]=A9Z?;6MJMC;<0QX  .*C6UA
MI-[DMA:P:?:06MK&!!&O!/6KAC4@D<$G.1P32QQK'&$'0#'-1&8FZ$/E/MQD
M-C@55K(H);N*!D60D,QP!BH+RSCO0?,+#L/\:LRP12E3)&K%3D$]14>P-,9,
MDXX )Z4:C%NHC"8(2[,4A R>M=#I'.GH%/UKG]3+-><8!$:CUKHM,41V*'@9
M&3670U6X^3/VR)0>=C'^54B4,RJ#E_,W$_2IX;R"ZNPT+[U"'##H><?TJK 1
M]IQM[G\.32+1S/C&4OIES]2!^5>U:2GEZ-8H>JV\8_\ '17B/C1MEBZD@DMS
MCZU[I: +9P =!&H_2L*/\2;\U^1C4W)J***Z#,*CGY@D_P!T_P JDI&&Y2/4
M8H \ML?^/&'UVBL;Q O[U#6W;#%LH].*Q=?SO2L\3_!85=CF+S"H35*!.2QJ
MW>GG%1Q+A!7#%6B<K)8Q3RNY@M.C4 9J:"WDE8E5/-9/<<5<;N+?NU&?I5VT
MTN68@L"!Z5IV.EI$ SCDUJC;&N *%&,=9'1&EU9!:6<5M&,#FIG?L*:TJ@<G
M%49;U5R%HG.^FR-+J).\BQ DG+']*H-=EG(JO)=EB:@,H<]1Q7/.3>BV(<C3
M$X( I4D53FLR.8 X))JT6R,@$_A6#BRE(NO*H7)-023@CT%0[7?_ )9M^5(T
M$SC*Q,::I/L-R;'^=Q@=*B>4#@]#4L>G7;'D!0?6K<>DHOS2DR$=JWA@ZDWH
MA:F;#'+=/MA4JG=C6S9:?%;#"C+D<L:LQ0*%&%VBIQA1@5ZV&P,*7O3U8VP0
M;.O)-#'--W9.*.*[F[B(QY@E))!3MZBI#@X)%%(&W9]*D XW%A2\FFJNW@4;
MANV]Z %"C/O2TW #$CJ:"V.U "2Q)/$T<J!D88((R"*YRY\&6.\2V$L]E(HX
M\E^"?I72YXH."*!-)[G$KX>\532&.?6D6WZ90?,16SI/A:RTV<W+M)=7)Z2S
MG<5^GI6X  2?6C<!QUHLA**%R .:&/RG^E1LK/Q@!::OF)NWL".QIE$@'RX/
M/UK.?1[9K&:T&X++(92Q.2&SG/YUH*=R@YR#2D4".<U/1Y)5DN99S+<ML12$
MPJJ&SC'N>M1W&C7TKS7$AADDDGA?8I(&Q/X<GWYKIC32*=P.:NM,NI+>\9H
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M(Z@@;C^M*X"@Y'?\:C=!(0"",'.:ER,<U!.["/,1!8G STH 2>985&06R<
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M$9/# _C3?M,7FA3GGOCBN633KHMB&\B8>HD%(\&KPYX9@.ZG-/G\AG7+*C\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_011.jpg
<TEXT>
begin 644 image_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &? 3L# 2(  A$! Q$!_\0
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M7_O\O^-%T%F7:*I?VOIO_00M?^_J_P"-+_:VG?\ /_;?]_5_QHN@LRY15/\
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MCUFC_G0)GS&[#>:3)/:G/@-[TW-9E@">XH- !]:3GKG-,!<Y&:3K[T<TG6D
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MM>6@\]*]3^! )\:W!["U;^8I ?1M%%%6(*X#XQ@'X>W.?^>T?\Z[^N!^,?\
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M:=F@ QWHP:,>E')[T##)HH'7DTH'%, 'O7L/P!Q_PD.I_P![[*/_ $(5X\,
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M -.Z_P#H5>.<5[)^S_SJ^K'_ *8+_P"A4"/>Z***H05P/QC_ .2>W/IYT?\
M.N^K@?C'_P D\NO^NL?\Z!,^8G//%,QGK3R.<TTXSS4%AT-(31GWI/E^M !P
M.];-B<^%]6Y_CA_]"-8I /0ULV( \-:J!W>'_P!"JH;D5-ON,;%.S[48.*!T
MJ2Q#TH!R:,<T4 (0*2G8I* "K.GQP37\*7,PA@+#>[9P!^'-5L4"@#KIM3M)
MKM9IKN$30-LADB!(6,C Z@9*\?F:A5;*0V=M=ZE:LBR[Y7225PP [[A@9Z8
MKEZ7'M2L%SK1J=L^L6=]=7</GPLR,T>X@IM.W'';I572M>C-[90RHMO$DA=I
M6D=CG85SR3C\*YNDQDT[!<VY!!/>VPFGA6-1EF$KN"1Z[NF?:EN+J-KNUN&N
M$\U7"R>63@J#P?P'%9QTN_6U^U-8W(M\9\TQ-LQ]<8JK5*5E8B4;NYIQ7<:"
M^9V+[Y%P Q!89/>J=[=?:YPX38 H4#.>![FH*0C/-#DVK#44G<3O2XH'O2G&
M*D8F,4HHHQQ0 HY-!XI ?:E- R:SYO[;_KJO\Q4^M8_MR]Y_Y;-_.H;$9U"V
M.?\ EJO\ZGUH#^V[W_KLW\ZK[)'VBAQ0*-OOTI,^HJ2Q31_%TI1T%&.>* #@
MBO9?V?\ _D+:M_UP7_T*O'.1U%>Q_L_\ZMJY_P"F"#_QZFA'O5%%%4(*X'XQ
M\?#VY/\ TVC_ )UWU<!\9/\ DGES_P!=H_YT"9\QMUII([TK=::"<]*@L,CC
M -(",<BEW'THR".E !A3TK8L!CPSJO/\</\ Z%6,5'4&MC3_ /D6=5!_OQ?^
MA&JCN14V^XRNYIO%+VI*DL#UI/6E[T4 )CFE(I":4<T )BD]J=CWI/6@#:^T
M1:9*MG9Z?#-<':&FNH@Y8D X"-P!SZ9]ZZ6&ZUB]NK?3IKGP\\I(46DEL#S_
M '25C(_(URVF^(KS3YHG*6\XCP%\^!)&"^BLP)'X5+=Z@+II1:7XM8)?GDA,
M7E+GL/D&&^N!2 [2X\.6%S:W%SJF@K$%D\OS]#E,@X_Z9\CZDX^E9PT)I4_X
MHV[M+A@/F4GR[O/_  +]=N!7+Z?J*Z2Z7-M?7?V@9RL1\L _[V22#W&!6XWC
MN+4D>+6](AGC<Y\RV<PR XP/F'7'O1J/0SWL+K2[R.+4&O1=RMA(5R@W'CEF
M'//7 _&B6TMI[MK>&'3EN(S@Q"67]Z?0%CU_+VKHHO$$'V5EL?$S/ =J_8]9
MMO,X] RAL#\!5:ZNM$:Y6>]M] *+R5T\W"N?H.%S]2*+@<Q<VL%S9SW=O;FU
M>W<+-!N)49) *YY['(-91YK7U;6UOP8;:R@L[8N6*Q Y<]BQ))/\JR*8@%*:
M04O:@!,<\TX]!BDSBB@ 'UH/7%*,"D- %BP'_$PML]/-7^8J76_^0W>X_P">
MS?SJ+3_^0C:]?]<G\Q4VM@_VY??]=F_G5_9,_M_(SLD4N0:7..*3;GD5!8=*
M<"/H:09[TO!H >"*]D^ '_(4U?VA3^=>,@#UKV?]G\9U'6#V\I/YFCJ,]WHH
MHJR0K@/C(,_#RY_Z[1_SKOZX#XR?\D\N?^NT?\Z!,^8F#;CS3<-3G!W=:;R*
M@L3)SR.!2\&D#>M+M[B@!""*VK$Y\,ZK[/%_Z%6,&XP:V;#'_"-:M_OQ?S-5
M#<B>WW&/1W^M!]Z2H+#/O2=Z*,&F 4 4"@T %)1S1WH ,4N..HHQQ1GVH 3%
M%+WI * %!YX-%)T'O10 II,>XHHZ&@!0**#24 &*7MS2<XIPH$)]*.]3V]O)
M=3K!$8P[\#S)%0?BS$ 5+)I=Y%$TS1 Q*,LZNK*!DKU!]0:!C-._Y"=K_P!=
MD_F*DUK(UR]_Z[-_.F:?_P A*T_Z[)_,5)K)SKE[_P!=F_G5_9(^W\BAC<.O
M-&"/\*,'UHR:@H7<!P:.*;G/:G D]J8"\5[1^S]_Q^ZS_P!<X_YFO& ,U[5^
MS_\ \?6L].$C_F:0SW.BBBK)"N ^,G_)/+G_ *[1X_.N_K@/C*,_#RY_Z[1_
MSH$SYB8MNYI-PISJ<GFF8;';FLRP(!]J0$CKTI1QP:?@8I@,RK5LV"X\,:L>
MOSP_SK'V@BMFP4_\(SJO^_#_ .A54=R)[?<8X&2,G ]377?\(K/I>B)J5QJ&
MCBTOT\N&:42N5)Y. (S@X!&?RKDATQ7I_B0VJ_"SP]]JCF=-_ B<*0<-Z@U#
M-$<!=Z.+46DBZA:30W+,JS1"3:I7&<[D![CH#5WQ!X.U/P[:6UU=-!-;7(!2
M6!F*C(R,Y (X]JI:D(/MD9LEF73SM\KS,D;MJ[\$]\]?PKNXO$EI!KMYH.N1
M^=H]XD()/)A?RTPP_P#K<]Z&[ <)_8I_L+^UC?6OE^9Y7E'?YF[&<?=QT'K6
MC:^#+BY\/?V[_:>GQ6*ML=I#+E6]" A]1TS6OXL\/2^&_#;6C-YD#Z@'@F'(
M="C8/UK2TKR/^%+7?VCS#']K.1&0#U7UH"QPEYHT=O9"ZBU.SNH_-$9\GS 5
M)&>0Z+QQVS6K-X(FMM,L]2N-8TN*TNSB&1C-R?0@1\?C63?_ -F_9[?^SQ<;
M_F\[SB"<\8Z<8KTMM*LM9\!>$[&]OVLA)(0C^5O!/S<'D8SZ\T,$>;ZWX?U#
M0+I8;V)0)%W12HP9)%]5/I5G_A%+N#3X;[4KJTTV*?F%;IGWR#U"HK$#Z@5T
M/C;5;B;Q#I^C7-D;6UT]TC02D,9%R!O)QC! [<4GQ7,G_"40@;OL@MD\C ^3
M'?;V]*5PL<S<>'9X]+FU*&[M+FSB94:6%S]X]MK ,/Q 'UK5T?PG=#24\2?;
M-+-E&3N6Y$C -TPRA#G\,BG)X9MU\#R:\NKW*P/((GMA;#YG!XR?,P1GO^E=
M)I'DGX+W0N#(L?GMDQ@$]1V)%.X6. O=)6*S:^AU*QNT,FQA;B12I//W61>/
MI6S8_#^\U"6>&WU;3&FMXA+-'NES&I&>3Y>,^P-8M^-.6UMAILD[DJWVCS5V
MG.?EX!(Z5V_PMD>:3Q!)*[.YL^68Y)Z]Z+NP)'$W6BK:26P;5+)X;@L!.@DV
MIM.#N!0-^0-6_$/A*Y\-Q0-=WUE(\ZB2..$R%F7UY0#]<UC2DF5AD_>/6O2/
MB((CK/A@7!7R?LT8DW=-NX9S[8H"QQJ^%[E-.@OK^[M=.@G_ -3]I+[I!ZA4
M5CCW.*BU+PW>Z=8PZ@#%<Z?,<)=6[%D)]#D J?8@5U'Q9\[_ (2.V7 ^RBV7
M[/CIM[_K4WAX,_PC\0B0;E653'NY /R]/UHN%CGU\&W+>&O[?_M&P%ER.3)N
MW?W<;.N?P]ZSM%T5]:GFACN[:W>.,R?O]_S*!DXVJ>@KN%.[X'@(,E;H[L=O
MF-<UX)0MJUX0,[;"X)]ALHZ!8KZ!X6N/$6H2V>GW]EY\>642>8-ZC'S#Y.G(
MZX/M5D:9</;R:9#KVFR>6LC&%!*"V 689,8S]T]36M\(A_Q6;_\ 7K)_-:Y^
M]728FO'M+V^>\WD('@$:X).[D,Q/'THZAT,S3L?VG:?]=D_]"%2:V =;O?\
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M=\ ,?\3G'_3/_P!FKQ+CKFO;O@#@C6<?],_ZT=0/;****LD*X#XR?\D]N?\
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MM2XXK1_L+4_^?&;_ +YH_L/4_P#GQF_[YHY9=@YH]S.[\T5H?V'J9_Y<9O\
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M;!PO6@QL&VXYHY8=A\]3NSE/^$#T/_GC-_W]-)_P@.A_\\IO^_IKK/+89)'
M.#2!23@=3THY8=A.=1:7.4_X0+0^OE3?]_30/ 6A<?N9O^_IKJS&V"<=\'ZT
MIB8-@@@]*.6'8?-4[LY7_A ]#_YXR_\ ?PT?\(%H?_/&7_OX:ZLPNN[*_=Z^
MU(8V4$D< X-%H Y5.[.5_P"$"T/_ )XR_P#?PTG_  @6A_\ /*;/_74UU10[
M0V.#T-+Y+[@N.2,T<L.PN:IW9RO_  @6A@G]U+S_ --#2?\ "!Z'_P \I?\
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M>A8TGG2X(\UL8QU[5'12N%AV^0@*78J.V>*4SR''[QN.G)XIE!Q0%AYDD/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/%%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_012.jpg
<TEXT>
begin 644 image_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'V 6P# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HJ*YG6UM9KAPQ2)"[!>I &>*\L'QMMLG=I2A>Q^U#I_P!\TFTAI7/6
M**\J_P"%V6??3,?]O(_^)H_X7=8]M-S_ -O(_P#B:7.A\K/5:*\K_P"%V6&
M3IIY_P"G@?\ Q-(?C=IX(_XEI_&Y'_Q-'.@Y6>JT5Y8/C;IIS_Q+S_X$#_"G
M#XUZ9WT]O_ @?_$T<Z#E9ZC17E__  NO2\?\>#Y_Z[#_  I?^%U:5CFQ<?\
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M:;\PH.:0#@_O29SUIO3FE/- !C!ZTOS#O29(]Z,X[4 &6YYI0#CG-)N I"Q
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MJ:.,<"@!,@=J3=[4$^U+D4"%W#TH(!Z4F >E!!'2@ Y%.# CD<TFX4A0YXH
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M7)9L[ACG@BMG[RM8YXWB[\Q\^$(RY49.<$>E==\0;C=?V5KMR8XBY;_>./\
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M2@8H_2@_6C/7WI#Q0  XQ2G'2D_E2YY^E &C+<3Z7KDC12EI;27RT=NI"?*
M?; Q]*UM.U5-'O?[2L49["?Y;BVS\T+>GIZ[3W&1US69?VS7T;ZI:YD5ANN5
M4?-%)CYB1_=)R0>G..U9T4KPN2A(.,'C((]".]6FXLRLI+4]7M?%.CW<.];Z
M./ Y68["/SZ_AFL;6O%\4T;6&CDRSR @S<JL8YR<G'0 G/0#G/%<4]JLC;L+
M:EN?+E; P1D;<\X/.,\=.3FHII6B5H8XVB1PI;</F<=>?;/.![9S@&M'5DT9
M1PT$[D]U>K'9#3K4CR0VZ:4#!F?UYYVCL/J2,GBI)EK6%]BJJYC!7JQ!SD_]
M] ?A3K6TGO)UAMHFDD/\*CMZGT'O4VH^5$T5K#(DJP)M:1#\KN3EB/T7/<*#
M67FS?9V11]Z6DSCBEZU)8G:C.:,9I>E,!#1G H[]*3KUI"#M2]Z3K@TO.* $
MK;'_ ")!]]2_]IUB5MG_ )$<XX_XF7_M.E+H4C#(QQ1@]C0.M!QWJB0P?6DV
MTO7H:3'2@!PX!HR2:,"ER!TZT =5\-@?^%AZ)C_GZ3^=?6]?)'PV/_%P]$S_
M ,_*U];T(&%%%%4(**** "OBB8CS&QZU]KU\53KB5@3GYC4R&B#!-*<?C2$F
MDP>O:D,=D"D+"E %)^- "9]S6TISX+8#_H(#//\ TS-8U; ./!I&!SJ _P#1
M9J6-&/VHHZBFD'UJA!CGO2TG>C/%(0$4E*>E)3 *.II?K1C\J!BCIZTFTUL>
M'-,?4M19OLLEU#:QFXDAC4L90N $ 7GYF*J2.@)/05NF*5KZ353;8U>XA98X
M)HN1?*R;\*0!N9&,BC'WFPH) %%PL<8DDD4@DB=D=>593@@^QJP^JZC(CI)J
M%TZN,,K3,0P]^:ZFZTC5-4;3+347U.2]GDY>_M,31(JYDV?O"\B <@%>2ORX
M)8&Q'#+=>(]%O)=.DT^>VO[>%K:12K>1Y@$+<@%MH4QEC_=3N31=A8X0@CDU
M+%<W$$3QQ3RQQOC>J.0&QZXZUO3>(6GT6X@O-7U;4+B>-5\BZ&8HF#JV\,9"
M2<*1]T?>/..#L^,5UC=K+W5WXB^S?;),0RV[_8]GF_)\Y?&,8(^7K@#UHN%C
MBS>736WV=KJ=H/\ GF96*^O3.*KE3WKJ&TZ6'3ETB6S=6=!,MPT9 -QC(CW'
MC!7Y<?WJHW6J7[Z#:;[V=O,EF23]ZWS+A.#ZCD_G5N/<S4[[&$00>E+75:UJ
M9AU;48IKNZ==KQK;8S%RF 3\W&"<].U<H:4DD.+;W%XI1TIN3BCGIV]:DL![
M4N,?6BCOTI@)1C-+CUI.U( SS6T<?\(0>.FI?^TJQ",FMT<>"".W]H_^TZ4N
M@T8 QGTI:4CUI=OI3)&$ ?XTN,]*4\]11CB@8!/>E"CKFD&/6E('6@#J_AO@
M_$/1 /\ GZ7^=?6U?)/PVQ_PL/1/^OE?YU];4T)A1115""BBB@!#T-?%5P29
MG_WC7VL>E?%=R,3O_O&ID-$ &*.G>E-,)!/2D,">.E'/X4<D48:@ &X^E;'/
M_"&G/0:@/_19K'P<<_K6T.?!K]L:@I_\AFI8T8O7O0?K2>XI>AJA!WHHZBC'
M% "<=:,BE/I2$&@ _"G#D8IO;BEZ9S0 $GMQ2$Y-36UK+>7"P0)ND;)QD
M9))/   ))/  )/ K5^P:!:R(EWK-Q<-D^8+"SWH.>@>1D.>_W2/<T: 8G\J3
M QC%=+;Z;X3O96'_  D%_8(!_P O6G;]Q]C&Y_458/P_U2Z3S=&N;#5XNK&T
MN%W1@]-ZM@@GTYZ&C0+,Y+/-)QFMJYTJRT:X>WU>2>2\C($EG;#9L..C2,"
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M^+1-1FUHZ/':LU^)3"8003N&<\],#!YZ8&>E>I6.E6UGJVO>)M(W:QJ]I>W
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MT3_Q1/\ W$?_ &G2ET&C"R?2C=@T$8Z&D)/7@U1(N[ X%)DFE##&<4!L"@!
MF3R:<< <4F2>E*%SR:!G6?#+/_"Q-%.?^7@5]9U\F_#/!^(FBC_IX%?65"$P
MHHHJA!1110 5\:ZRH&LWQQ_RW?O_ +1K[*KXWUXYU_4<<C[3)S_P(U,MREL9
MI/'2DY.:< !2Y[ 4@&X/3- #9ZTI#?XT!"2>: $Z?XBM6(_\4O<<YS>1_P#H
M#UEE3ZUJ0@_\(S=<#_CZCZ?[KU+&C*H^M*?:D/2F(3O2T48[4P$ZTE*!BEQW
MH 0_C28YI>_)YHH 08';I5O2[!M4U:TL$8(]S,D08CA2Q S54?E6QX3X\7Z-
M_P!?T/\ Z&* *6HZ9=:1J,UC>Q&*XA;:RG]"/4'K^-7=8\-7NB:9I=]<2P/%
MJ,7FPB-F+*,*?FR!@_,.F:]$U/\ L_Q]J&IZ+<M%:Z_87$T=E.1@3QJ[81O7
M _$?>&?F%97Q(MYK+PSX0MKA"D\-L\<B=<,%B!'Z4KW'8PM,\#7-]I]G<3:G
M864U^<6=O<NRO-SC/3C/;KG(]16%!H]_<ZQ_9,-LS7WFF+R1UW#(.?3&#D].
M*Z/3O&\-KI]@M[H<%]J&F@K97;S,OECJH90/GVGIR/;!Y.'9:_J%CX@_MN*1
M3?&1Y"[*""S@ACCI_$:+L-#>O/AEK5M;WDD-WIM[+9KNFM[6=FE4'G[I4<XR
M<=3CC-<7ZYKT_P *>?X7TC4O&NKEO/O$,5I$Y^:=G;<6(ZX) /K@,<=,^8D^
MO>A"8PT8P*=CWHQ@TP$Q[9H_E2]0:,4P#':C.>>:._>C\>*0"4HH(XH^M !6
MT1_Q0^<==1_#_55B]:VCSX((S_S$0?\ R'2?0:,(''M2D#'6DP?6E7@CBJ$&
M"!TS1DCM3L#\:3)]:0"9- !;-*2?2@$DXQ0!UWPR&/B'HV.\XKZPKY0^&61\
M1-&)_P">XKZOIQ![!1115$A1110 5\;ZX1_;E^>I-Q)_Z$:^R*^.-=7_ (GV
MH=_](D_]"-1+<I;&;@L<]J>J@>E&#C_"CM[^M "D8SS3,X^E*<'/-!*\#% "
M;@?PK5AY\,79!Y%S%_Z"U97RD\XK6@P/#%X/6YB_]!>ID4C)_"AA0>#TH/2F
M2-//:EQ0:7L*8"&DZT[%-QS0 8I#Z4[G-'..: &^M7]%O5TS6[&^D1G2VN(Y
M65>I"L#@?E5+/;BDI :&IZDUYXAO-3MFD@:6Z>XC*MADRY8<CN..:V/%'BZ;
MQ3I.DQ7B8OK/S5EE4 +*&V8; Z'Y3D=.XZX'+D<YHH 3!&:OZ3)I\.HPRZG#
M+/:(=SPQ$ OZ GL/7OCCCJ*7>DR*8'HOB#QQX7\0Q#[7H-X\L4+1V^;ED2,]
MB%5@/3/'8>@KSK S0!W_ $I<9.*25@O<8>#0.M.([4@'O3 ,<4E.![C--Z&@
M H_2EY]:2@ Z\TF*6@9H /?FMGIX(//74?\ VG6.1[8Q6ST\$'.!G4?_ &G2
M8T89(I1CUS00#V%(4_NFF(=CTI",=*0$^E./UH 9D^M+DYZ4XK[T -3 Z[X9
MDGXB:-D?\MQ_*OJZOE'X9?\ )0]&W=//'\C7U=1'<3"BBBJ$%%%% !7QYKP/
M_"0:CZ?:9.O^\:^PZ^/-=_Y#^H_]?,G/_ C4RW*6QF_A2'&:4GMC/O2 @=JD
M!.!U%'!]:4$4G&.* #:.W%:L"L?#5UQD"YB)..GRO6201SSBM:V/_%-7F>US
M%_)Z4AHRCUZ&CIVQ3CW/--/2F(0T#/M28-*.G-, Q2=*=CFD89/(Q0 WFE'/
M>@<BEZ4 %)2FCM0 E+V]J,<4G.: #..M'7M13@.3GK0 S&!@TO3GTIW!]*0F
M@!#S3>>"*>,4F!B@!.*0^M./2D&#0 F*/PI1Q10 8ZT@P*>3Q[TW H .];)*
M_P#"$$'_ *"(X_[9UC8R!6R5#>"??^T?_:=)C1A8STI<D<4@R#3QAN:8AHPP
MHP>M!7!I0W/- "[N>:7(I.#FC;^% '6_#4_\7"T4_P#3P*^KJ^4/AH,?$/1L
M'_EX%?5].(/8****HD**** "OCO7P%\0:B/^GJ3_ -"-?8E?'WB+CQ%J7K]J
MD_\ 0C42W*6QE$@\D4N<\T=LXI>/2D A Q]:;MST-.*\T@RIYI@&.QK8M1GP
MQ?D#_EO%_)JRL!JU+7=_PC>H>GG0_P#LU2QHR#[TAX.:<>>]-QSS3$)WQ1CB
MG;3CO1CTI@)TI#[4N*"#0 F*!0!10 H Q2$=LTHHZXI '6FFG?2DQSWH 3BE
MQ^5 %+@YI@)^-&,FD-'>@ [&CK2\XI#UH ,_G1WI.M*!0 =:!CTH[T8]#UH
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M=V_QHU'H-_LG4>,V%UST_<M_A0=(U''_ "#KHCU\EO\ "E_M?5#_ ,Q*]_\
M A_\:0ZSJ8_YB5Y_W_;_ !H]X6@W^R-2_P"@?=?]^6_PI1I&I?\ 0/NS_P!L
M6_PH_MK5B>-2O!_VW;_&E_MC53UU2\_[_M_C1J&@AT?4O^@=>?\ ?AO\*#H^
MIC'_ !+KS_OPW^%+_;&IYS_:=Y_W_?\ QI/[9U3 _P")G>?]_P!_\:-0T#^Q
M]3'_ ##KO_ORW^%*-'U3&3IUW_WX;_"D_MK5?^@G>'_MLW^-+_;6J_\ 01O/
M^_[?XT]0T$.C:G_T#KO_ +\-_A6C/:W%MX,\NXAEA8Z@"%D0KD>7[UGG6-3(
M_P"0G>?]_P!O\:AGOKZZ01W-W/,@.0LDC, ?7!I6;"Z*O(I=PZ'\:3-&0:H0
M''M1\O..]!P/_K4HR!P*  #!I0 * ,$49H ZKX<9_P"%AZ*>?^/@5]7U\H?#
M8X^(6BGM]H%?5]- PHHHJB0HHHH *^0/$(!\1:D?^GJ3_P!"-?7]?(/B!?\
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MTF_X_P"G=_\ "CF069FX]J,=ZTO[ UC(QI-_UQ_Q[/\ X4+X?UH_\PB^_P#
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MDF_(;.!M]#]:)8/+F,>2><9Q18+E?%*14IA*@L#E-NY3CKR!_6E,05T!< ,
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MNM,N6,;O(PW6SCJ>W;T'<>QI;33[^R1V\)ZJE]'(WE70F(/ER?\ /4>WY_\
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M<SG_ $/3",F!_P"(L.3QV_3/4.B?PK&_]MPAYI6;$.C]UG/7"^G [8].R@U
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M42!5!!SWY--+G;M&%4XR!WIM!(HNP $J0P/0Y%+YC;64' 8Y(Z4W/O1D'O0
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M/+=.VV'2>NR<]2!Z=,=AVYP!>I.A)%I6F2V3WT6KO'X99A+-9ECO$@Q^[/\
MG/3KP:$T[3+^TEO=.U=['0V^>_M&8[D([ <_>Z8_+/ $<TWAB>?^VKB&2.]5
M]LNDXYDG[9'IUSQ]><@CS>'+Z5]5U>&2QOK?FZT_&//?^$A3SSW_ %XY)J&A
M-:Z;I6JPRW.A:E)IEBR[-1MW;!\L=#U/7'7.,$^X,=O9:3JK22>&M2?2VA4Q
MW2R,1OA[R#G_  ]\=V7%SX?UF=KO68)-*O+4#S[8 J;B/^%>@.?N^AQ[8(?+
M<^'M?5/[6M6T=X%$D) V^=;]@..>.@'X=Q2U#06TLM&U*40^&;^:PO[8>696
M)'VF,_>;Z]3V[<#@@@LM"NYQ8:#?/;ZQ:#,-V3A;@_Q#(ZC\/ID9J.2[T/76
M2TU"Q?1XHUW6-QMV[X1U4YXYY(ZC)]?O/DOM!U>*/2I[%]/TX9&GWQ7:"P^\
M<GL3U_7!Y#U#0U/"X\/V_C+2["WEDGU.&Z5WO"<B9R<."?IS_7.<^_UX#X3U
M/3G\3:1IUEIC#3X[I!:WC+R\H/S$\=Q_+\O?JTIF<PHHHK0@**** "OD'7B?
M[?U+_KZD_P#0C7U]7R!KW_(P:CGI]JD_]"-1+<I;%#%-(YR*.E&:0Q!D>U*>
MG3(]Z:>*7/:@ /-&>AI#1D4  (%.^AS33THZ=J '9(I-Q_.D)YXI3G&!0 %C
MC/6@$X/--/UI>AQVH$+DC'4>U+SC'K3<T&@8[)SC/7UH S^%-SFMK4=8\[0-
M)TR*9C%!$QE3<X"R&64CC.TG:R\XSSC/:@1CGG.>3WH!.:V8M56/PU<:?Y[!
MW(/E/N*'YU)*@<!^!\Q_AW#@XRW3;G3XM,FMKA@)+MBCOY>3"J@%#GDX+D%L
M#.$XZT#,@].#33QP:OZ==06WG_:(5FCDCV%#P?O Y5N=K#!P?S!!(-V_OM.D
M\2VEP"]UI\26J2!DV-(J1QJX(SP?E(ZD>YZT 8F3QG-(.#GN:T]7N[J[,?VC
M6/[01&81J#)MC''W0R@*#TP/[O0<4^[U&270[*R6[5X8LG[/OERC9;G!^3OV
MYY^M &4?\\4#(.?UI><8[TAXQS0 N>,#\:82>_/UI>IXI#QV'2@ #8I>1SGZ
MTA%+UH 3<?6CH<TA YH ]Z!"Y(H)XYI,]NXH_*@8&C.>M)M(&<4O8T"$I,4M
M !)]J8"CH>M'/I2 D'VIW7UH&=1\.O\ DH.BYZ?:!7U77RE\//\ DH&B<_\
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M7_XW7T7119"/G3_A0_B__G_T3_O_ "__ !NC_A0_B_M?:)_W_E_^-U]%T46
M^<_^%#>+SUO]$_[_ ,O_ ,;H_P"%"^+O^?\ T7_O_+_\;KZ,HHL.Y\Z?\*&\
M6Y/^GZ+_ -_Y?_C=)_PH7Q;_ ,_^B_\ ?^7_ .-U]&44607/G/\ X4+XN_Y_
M]$_[_P O_P ;H_X4+XN/6_T3_O\ 2_\ QNOHRBBR%<^<_P#A0OB['_(0T7_O
M_+_\;H'P%\7?\_\ HG_?^7_XW7T9119#N?.7_"A?%^?^/_1/^_TO_P ;I?\
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_013.jpg
<TEXT>
begin 644 image_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '% 6@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"?\ T%/_ "#)_P#$U\K&YE(P9#3//?\ O-1=A9'U9_PLOPG_ -!3_P @2?\
MQ-'_  LKPF?^8F?^_$G_ ,37RH;ASQEOSI#._P#?;FB["R/JS_A9?A/_ *"A
M_P"_$G_Q-(?B7X3'_,3/_@/)_P#$U\J"9S_&?SI1*XYW'\Z+L+(^JO\ A9?A
M,_\ ,3/_ (#R?_$TA^)GA(==3;_P'D_^)KY5\R3/#G\Z//E'\1HNPLCZJ_X6
M=X2_Z";?^ \G_P 32_\ "S/"?_02;_P&E_\ B:^5/M,@_B/YT>?*>[?G1=A9
M'U5_PLWPG_T$V_\  :7_ .)I1\2_"9Z:F?\ P'D_^)KY5\Z7.2[?G1Y\@ZNW
MYT7861]5_P#"RO"?_03/_@/)_P#$T?\ "R_"?_04_P#($G_Q-?*)N9CP)&Q]
M:59INOF-^=%V%D?5O_"RO"?_ $%/_($G_P 32_\ "R?"?_05'_?F3_XFOE,W
M4V,>:W'O1]KF'1V_.B["R/JP?$CPH>FJ?^09/_B:7_A8WA7_ *"G_D%__B:^
M4OMDH'$C_G2B\F/ E8_C1=A9'U9_PL;PK_T%!_WY?_"G#XB>%CTU1?\ OT_^
M%?*0NI\Y\U_SIINI\_ZUQ^-%V%D?5_\ PL/PM_T%%_[]O_A2_P#"PO"__043
M_OVW^%?)WVNXS_K'_.E%[<#_ ):/C_>HNPLCZP_X6%X7Q_R%$_[]O_A1_P +
M#\+X_P"0HO\ WZ?_  KY0%]/_P ]'_[ZI?MEP>DKX^M%Y!9'U:?B'X7 S_:B
MX]HG_P *0_$;PJO74_\ R"__ ,37RH+N<9_>M^=*+Z8#B1_SHNPLCZI7XC^%
M"ZK_ &JJ[B "T3@#/J2, >YKJ00RAE((/((KXK>XFE 5G8Y('6OL;0_^0%8?
M]>Z?R%-2=[,32+]%%%4(**** "BBB@#YS^.1_P"*\B'_ $XQ_P#H;UYGG%>F
M?'#'_">1^OV*/_T)J\Q/7WJ&4+D^E&<=*3)]*3OR*0#J,D4VEZT &1BC<,4A
M]Q2<=Z ';J7))I@QFG\8]: $VXI&/3%!):C@4P$"DFG<"F%B3@4H'K0 X/2$
MGTI-P'2C>>PI ("/3%**0,?2COR*8"Y(-*&'>D7!I=M  <8I=P%-.,<T@"\4
M *S]^]-^8]>E*Q /&*3=F@!<A10,L>*0*3R:4MMX% #BH YIN5]*3YF'/2EP
MH&: $W =J3(]*=O'84W=Z"@!0V#Q^5./(XIF[MMI0>PH 7..M)D4A%)QGIB@
M!^11N&*;@"E  % A=V: .])N '%)DM0,DC.Z>,>K@?K7V=HXQHUD/^F"?RKX
MRM5_TR >LB_SK[/TL;=)M!Z0K_*DOB![%NBBBM"0HHHH **** /G/XWG;X^B
M88R+*/J,_P 35YDS#D@?G7I7QO(/CY1_TYQ_^A-7F@'<UF4)GTHR>M'>DR30
M ISTI!0/UI<&@ IO2EY':D.* #CN*<&&.E-SFC(H <6X[TTY)YI,BC)H =PM
M-ZFE49/-+D <4P$P!2EN.*9R:<"!0 F6]*,MUI2_H*3YOI0  ^U/#5&-W6G<
MGJ* !OSHXSTHX(I3QTYH ;\M+N"]!2$CTH!44 &XGM2JOK2%L=*3YFH 4OCH
M*4 D<T@&.3UII8YXH =\J\=Z3?Z"@)W-&5% "Y/I3<^U+N)/%)\V: %W<TN.
M*9SZ4H;CTH 4X]*,@=Z#[&DZ#I0 NY>N*-V::,4N0* +%DN_4+4'O,HY^HK[
M/TX8TVV'_3)?Y5\::8-VJV6.\Z=?J*^S+$8L+<?],U_E27Q ]BQ1116A(444
M4 %%%% 'S=\;_P#D?AQTM$_FU>:D\^U>D_&[CQ^#G_ETCX_$UYMCFLR@_G10
M3Q3?QH =QFC( ZT<"D./2@!0:0@4A7OFC+"@!<#TI.@H!S0>: $SQTHW8XQ0
M<BC/M0 F2:4#UHR<=.:,$TP D <4FTDTH7 S2DG'O0 #CM0:0GBF_4YH =D#
MZ4H.:;A<4;1V- #L9H[4W#"@-18!31D =*#@TE ";A0&..E!)[K1N]!0  $T
MHPM)ECVHVD]:! 6+' Z4H ],F@ #B@F@8NXC-)33D]31M'K0 [MF@X-)M&.#
M3<$'B@!XH(ST--!QUI0<T )]11D9Z4I]:3H>13 NZ1\VM6 '_/Q'_P"A"OLV
MR&+* ?[ _E7QGHW.MV';-PG_ *$*^S;48M(1_L#^52OB^0/8FHHHK0D****
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M"E!S0 ?>I.5/M05(-*#ZT +D?C0#2$ T8P:!%_1AG7;#_KXC_P#0A7V=;_\
M'M%_NBOC+1!G7M/S_P _,?\ Z$*^SH?]1'_NBDOB&]A]%%%:$A1110 4444
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MO.2??%91V*8'/7I1@'O2<=S0-N:H!0H]:,>E!7/2F@,/>@#I_"I_XE7B+/\
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MP36OWUN\_97P6QD$?? R20H)K;L-0M7L)+/1?$$&I(<)]AUSA0@X 4D<DD<
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M<TTK[TP'#(/!I2&I #ZT8YY- &OX8!_X2;33G_ENO\Z^R$_U:_05\;^&0?\
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M^$1_Q4EK_P "_P#036=;^%+T8X_$C$NB?M<W'5V_G4?!'-2W##[3*/\ ;/\
M.HL GK6D=D2)LYSF@KCO2X'KQ28'UI@ QGD\TX'% 6C.* -?PRQ_X2?3<?\
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M'_*O.\8KT3XQL#\09QZ01_RKSWC.364=BV-Q29I>#0>*8A/7%*!GB@9I0<4
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MX".GXUI:A(=.U6W72U46[VS"6Y1MS9$+;5)[#H?>H+>)G\-S7DUC"=69TD6
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MZ:+%OYV -VX9P3P&QG!/OWQ3[)4/B>S%YY!C%Q$)@FT(1D @]OJ>G6CV5/\
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M?X=X_P"$_P!'_P"N_P#0U]65\I_#OGX@:/\ ]=_Z&OJRG'=BD%%%%62%%%%
M!1110!\Q?%S_ )*1J?':+_T6M</7;?%T@?$C4\D=(NG_ %S6N%+CUK-%C\^]
M!QT-,R#WHR#WIB'^_>DZDT@((I.YYH 7'O2 <C- :DW4 /X!HS3-V>]+GWI
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M_ CPIG_CXU+_ +_+_P#$UZ?118+GEY^!'A7_ )^=3_[_ "__ !-'_"A_"O\
MS]:G_P!_E_\ B:]0HHL!Y</@/X6'_+UJ?_?Y?_B:#\!_"Q_Y>]3_ ._J?_$U
MZC12L!Y;_P *&\+?\_>J?]_4_P#B:/\ A0WA?_G]U0?]M4_^(KU*BBP7/+/^
M%"^%_P#G]U7_ +^I_P#$4?\ "A/"_P#S_:K_ -_4_P#B*]3HHL@/*_\ A0GA
MC/\ Q_ZM_P!_4_\ B*3_ (4'X8_Y_P#5O^_L?_Q%>JT46 \J_P"%!^&/^@AJ
MW_?V/_XBC_A0?AC_ *".K?\ ?V/_ .(KU6BBP'E/_"@O#/\ T$=7_P"_L?\
M\11_PH+PS_T$M7_[^Q__ !%>K446 \H/P \,_P#03UC_ +^Q_P#Q%)_PH#PU
M_P!!36/^_D7_ ,;KUBBG8#@/#7PA\/\ AG68M4AN+^ZGB!\L7,BE5)XSA5'/
MUKOZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_014.jpg
<TEXT>
begin 644 image_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #^ 4,# 2(  A$! Q$!_\0
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MER\DL9>4%1G"*W4]23^?4U5VCT%92F[Z'H4*"47?>YKC1-3_ .?1_P#OI?\
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MZ5IB1SGY1Q[UK&G3J>]L<E2OB,._973\S$G@:%MK(4;TSD'Z&J];5^-]J7;
M*,,$?E6*?O$#H#7/6@H2LCT,)6=6%WN<?X//^E:T?6Z_QJUXP;&AMCKO7^=4
MO"#8EUC_ *^OZ5-XL??I/EJ,LTB@5F_XR-W;V;;,FPTVUO(5>=-S=-P)!Q^%
M7UT&P X60?\  S61::J+&+R70O(O4(,XJ<^(Y,\6[_E6THU+Z&"E29;GT.S
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M@KSKXM(3I-BXZ"5A^E>BUP7Q74MX<MF X%QS_P!\FLJ_\-G1A':M$\L\/_\
M'RY_V3_.NC%<YH1_TAL=PWZ$?XUT(->4SW9[CZ,TS-!:D229I,\5'FC=0%A^
M:;FD+4PM2&.+4TFFEJ86I .+8J&5L(WT-*6J*1OE8>QI#1B>&!^\U'_KLO\
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M7*9#<9'J>@JE4B]F3*A4CNC'!IP-:8\/71C9A-%P-W)P#SCK^7Y^U._X1ZY
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M!"FPTBW60?\ +61?,?\ -LUT=%;I);',]=6(    , = *6BBF 4444 %%%%
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M\_6D_P#?]_\ XBC_ (9W\8_\_6D_]_W_ /B*^HJ*5P/EW_AGCQC_ ,_6D_\
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4,Q8L,<D@8 KVFBBXK!1112&?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_015.jpg
<TEXT>
begin 644 image_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %9 2L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0G%+0: .
M=U#QSX>TN\>TN]1B2>/[R=<55_X65X5_Z"B?E7S1XXNY4\<ZU@DC[6X_4UCK
MJ,H'?%59$ZGU?_PLKPJ?^8FGY4?\+)\+9Q_::_E7RD-3GQUR*4:G/CJ2*- U
M/JO_ (65X5S_ ,A)?RI?^%D^%O\ H)+^5?*HU.X_OY^HH_M.X[-S19!=GU3_
M ,+*\*Y_Y"2_]\T?\+*\*_\ 027_ +YKY874;C^\:<-1GZ;S^-%D%V?4I^)7
MA4==27\J0_$OPJ/^8FO_ 'S7RX+Z<GACGTI?M<Q_B(]C19!=GU%_PLSPI_T$
MT_*D_P"%F^$_^@HGY5\O_:)>Y%.1Y"^2:?*@NSZKT_QSX>U2[2UM-01YI.%4
M\9KH<U\O>"6<^+-+Y_Y;BOJ&E)6"+N+1114E!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4&B@T ?&OCSGQQK7)_X_).GU-80! X
M)K>\>?\ ([ZUDX'VR3@?4U@CITQ]:;$AP.?8TX?Y(-,([]:5<$4AC\X[FE ]
M3BD QT'XFG#VY/<TQ"@>A-/![-31S[^YIV!CM3 D'/N.QIZG'<_C4*^AJ50/
M0F@0\9/TJ9.O4GZ5&/?\JD'7G\A30F=;X%!/BO3.?^6PKZ?KYC\ #/BK3C_T
MV%?3E$P@+1114%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 444&@#XV\=_\CQK6!S]LDY/U-8"]./S-;OCTC_A.-:SD_P"F2?S-
M<^"3@=J;$B7<,=<_A1D=10,#TIW&.0"/44ABC!]*=G/7GV IG(Z<BG;N.IIB
M'_7\ *>#CJ0/I40;'W1^-/4#OUI@/!![U(AIH&>@!IP'=?RH$2J<>@J0=..!
MW-0JWK4@(QW--"9VGP[&?%&GD#_EJ*^FZ^9?AQEO%%@3_P ]!7TU1,(=1:**
M*@L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBFL0H))P .: (KFX%O
M'GJQ^Z*HI<7#\E\>PIK,;J<N?NCA14RQXI@/6ZD'WN:LQSI)T.#Z&JA6HV!4
M\'F@#4H[50BNV4[7Y'K5U65ERIR*0'QMX^)_X3?6@.OVR3^9K 3I70>/<_\
M";ZU@?\ +Y)U^IKG02.JC\*;$B4$^I'UIPZ^C?SIB]/44\<CJ"/>D,</Q%.Z
M#_ZU-''_ .N@'/09I@/4$\FG]/44P9[J*<ISTX/H:8B0'U_,5(/?\Q4:]>.#
MZ&G@?A]#0(D'7U_"G]>*C!YQ4@SMX%,#N/AL/^*ELO\ KH*^EZ^:/AISXEL^
M,?O!7TO1/H*'46BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-O
MKDO*;9,_[1_I6@[!%+'H*S%'F3-)ZG- #XHPJCBIP!BF <TX@D[13&)GY6-5
M"07QFKK_ ")GM6>T;;\J01[T"+#)\F?2FQ3-$V1T]*667,.Q>7Q4T4"M;C>,
M&@#Y3^)NB:AI?B^_N+JV98;N=I89/X6!.>M<:"/;\*^O_$7A^P\1Z7-IFHQ+
M)&X^5NZ-V(KY<\6>%KWPCK3Z?=@E"<PR+TD7L:&!BCCFI!DCL:C&??\ $TX'
M'TI /QZG\!3^W/Y"F@^^/H*</;CW-,!P..N!3L9IB\=/S-/'XF@0]<GT/UJ0
M ]\"HQD5(I&,\?E3$/7';CU-2#D=/Q-1CD]S4G;GD^E,#NOAGC_A)+/I_K!7
MTK7S5\,O^1DM,G_EH.E?2M*8H]1:***DL**** "BBB@ HHHH **** "BBB@
MHHHH *"<453U"Y\J+8O^L?@>U %::Z-S,T:?ZM#@GU-2QKM6H;>(1J!5@"F
MX<#-.0=Z3&3BI.@H&-==RD5GR6SE^]7V.!2*,C)H$5X("&QCCUJQ<2"*.I5
M5<UD7\Y=L \4 0R2EGSGO7&_%70(=;\%7%T4 NK)?-C?OCN*ZV(;FS6'X_NX
M[;P9>VY<+-=+Y$2Y^\S< 4 ?*JC(R<FGCV/X&MT^#K^)S')<62LIP1YW(/Y4
MH\)7O0W=B1_UV_\ K5-T5RLQ4;'!JQ#!).2(HRY R<=A6J/"EYWN[$^_G?\
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M,/P J0=/0?SJ)?PJ1>OJ?6F(D'TQ]33STR.M1@XZ<FGY;::8CN_A@<^);/\
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M'\37+GGT/O73_$ _\5OK0X/^F2?S-<N0/0TV) 6':E49I@P?I4@(]C^-(8X
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MEQ[L+V)/]ZH[FS>V=9;20R.JAY&C'RH?8^E7_M5EX@^2^*6FI'A;H#$<I]'
MZ'WK/?[;H=P]K<QE0V,H>5< YR#T(H BOM3DOHHD=0/+'..Y]:S'-;]U:6^I
MP27MJRQL/O(3@  ?XUSTH9&*."K#J#30G<GL+BXAN@ML"9)1Y8'UJ?4YE0)8
M0MN2([I&_ON>I_#I2VH&GV#7K?Z^4%(!Z#H6_F*E\+^'KSQ3XAM=)M%+/,XW
MM_<7NQH#H>K? 3P,;R^;Q3?Q9MX"4M58?>?NWX?UKZ+%4-$TBUT+1[73+- D
M%O&$4#OCO6A0(**** "BBB@ I#2TE 'QA\0/^1XUKI_Q^2?^A&N78\^U=/\
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M"M-*LT"Q0(%X[GN:\P^!/@<Z1I#>(KV/%W>KB$$<I'_]>O9* "BBB@ HHHH
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M:,@ #O7V%0P0M%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %!HHH 88T8Y9%)]2*/)C_ .>:_E3Z* &>3'_SS7\J/)C_ .>:
M_E3Z* &>3'_SS7\J/)C_ .>:_E3Z* &>3%_SS3\J/)C_ .>:?E3Z* &>3'_S
MS3\J/)B_YYI^5/HH 9Y,?_/-/RH\F/\ YYK^5/HH 8(T4Y5%!]A3J6B@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_016.jpg
<TEXT>
begin 644 image_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $] 3\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#2I12"G"LB
MA<<4A%. J2"!KB81H.332 6VL9KLGRUX'4U*VD7:_P  _.M^R2WAC,43 L/O
M?6G'"ELG.?>MU274S<SF#8SKU2HVAD3JI%= Y5!A:J2*I))ZGBM%ATS-U68_
M\.[MZTJ,K_=(/T-3/:Q(C("<$\@FLUK9+1BUNY0]2,]:U6!OLQ?6+=#0"X'2
MG!3Z50M]:D4%)8 0#R172:3K^DWLBVNS9-TPPZUC5PLJ:N7"JI&6!3J[ V=J
MW_+)?RIATZT/_+)?RKFL:G(D4F*ZTZ7:'_ED*C;1[0_P&BP'+T@%=,=$M3T#
M5&^A0[3M+9[46 Y[%.%;HT!-H_>'-(= ])#18#&'2@BMC^PF_P">GZ4G]AR?
M\]!18#&(II%;7]AR_P#/0?E3%T21@=S@8]J+,#'(I,<5M_V"W_/4?E2_V ?^
M>HHL!A8HQ6[_ ,(^?^>OZ4HT#_IK^E%@,'%)MKH/^$?'4R_I5>?2[:!29+I5
M([$T^5O8#'QS28ILEU:HS#S0?3'>H6NF8_NHB3[UM]6JOH9^UAW+&*:13H_-
M:+<T?S>@JQ%:,Z@L,$]JEX>HN@_:1*1&:81S6PNE;AG=FI3HB;02YR:ATY(:
MDF8-**V9= <+E),GWK(DC:*0HW5:EQ:*O<2@B@4H'K4C$%/%,IR]: )!S^-=
M!I]NMI!O;'F,.<]JS+6#;B60?0&IY+Y2"0X..#@UUT:#:YC"I42T-"2X(SM(
M'T%57E8YRYK.EO<_=8KCDY%9M[K*1X F ]0O)KNAAV<SJ&Q)*,\N:IS7**"2
MV/J:Y.\\5;)#'!&\D@XY!_E52-=:U><O<VMW';-U=(]H'YX%;J$8[@E)FSJ'
MB"UMP0'WOZ UE+?ZK>8>*$1Q$_><=:UK;PGIMLL=X[SRE3EEF Q^E;-L$U:X
M:+38(YSC&2"J(OM_A3<TEY#4>VIRSWQ555,O,#C:%)WGV%=+X=T6Y>QNKG4+
M0K<R<P'^)?P[5U^EZ,-,12P5W(Q\D0POX]:V$A5!\H'/4UP5\5S:1V.BG3MJ
MREIL5PEA"+H 3A0' .>:MXJ7;1MKA>K-B/%&*DVT8I 1XJ*>9+:%I9,A5Y.!
MFI3-$'"&1=QXQFF/-$5SYB[0<'TH!C(I1-&LB*=K#()I'NH(_OR(N.O-.+01
M';N5/4 \#_"JDVGV$SO&Q(*_>"L>,T$OFMH3B^M2<"9,_6I5=7&4PP]C6:NE
M:8)>'D+A!P7/W3_^JK\-O;VL>V/Y0>V>33$G+J--U$MPL# AVZ#%6-M-"QJR
MLNT%NA SFGAQDAL9'I04GW$VT;14@ (!'0TNV@9%M'I1M]JEVT;: ,?59;F(
M1QP(V)&VM(.B"O+M9,VGZ_.;E)FA9OE>0G!KV@J#VJK/90S HT"NC_>R <?G
M6U&K[-WL3*/,CR W)*!HD#R+V![4^'7?*E"7,30G_:%=CJOAM[%C<VR1SJ!C
MRRN'(]NU8TEI;:G;K;W5NT: Y'F *WX&O5A5C-71R2A9V9+:ZG'(H,<JL*T8
MKO\ VA7+77A=X6SII:(L<(9IOE/MG&,U&UKXJTR,^?8F6-?O%"&Q^5)\DM">
M5[H[F.Z;L15R.\)QD"O.X?$J")))G$>3@@."1^%;4.M0R(A,NW=RI;C-1+#W
MV&IM;G8"578-N(]LUC:M9!9?/C'RMU]C4,>H!L?,/P-3I>K+&5<$#T-<U3"M
MHTC6U,O9BC;5N:'RVXY4\J:B*5Y[33LSJ3N5:0SQ6RB69@JYP 3C<:&9(XWD
ME;;'&I9VQG '6N U6YU37KPRP6=S]F7B)%0X"^I]S6^'I<\M=D3)V1V=YXLM
M(\[I@Q'9:P;GQHHRL$/YUFZ=X2N[M6:\\RV /&_ !^I)XKK=,^&5A<0"::^<
M1_WMXQ^8KUG4C!=$<JA%O74Y%/$5_=3X$+S#LBYQ^E:>D^&-<UB[-RI:P#'^
MZWRBN]T[PUI&@V[2VD\TX7^'<N#^=:EOJ\MVWE6]FJ.1CYW&U?>LY5I-7CK^
M [13ML4-.\/P>&]-(FECGN7.6N&3#G\ZS-6\2I-<+%I]JES*F%:1B3'$/[S'
MH*W)+$K.[L)+NZ1P5"_=SC/Y"M2RTM[G?+J<,9S]V(8VX]P.M8\\8^])W_KH
MAV;=D>=MJ;W=W"+2\ENKD':]M;C'..3R,$5W^@1/)&)C$\2[0-I(P&[]LUJ6
MVE6%I.9[:UAA<KM)C4+Q^%7,#VK&MB5-62-84N5W(T5@N&;<?7&*=BG<8SD8
MI>,9R,5R&HW%&*=D8SF@X ZT -Q1BG9 ZFE) [T 1"", @1J >3Q1Y29^XOY
M5+D#O2;E'>@!GE("3L7GKQUI0@'0 ?2G[ESC-)N4'K0 THI.2HS]*-@]!3MZ
MYQFC<N<9H 3:/2C;2[USUHWIZT )BC%'F+ZT>8G<XH ,4F*/-3UH\U/6@ Q0
M5XQ1YJ=S2>:GK0!2U"RDGM/+@(W*<J'Y!/XUPFI^']>AU,2?8X-4,@W(1B/R
MCGG)QS7I'FIZ\TGFKBMJ=>5/8B5-2/,[?2M<L;Y6658!)]ZUNI#M!]589_*N
MAANO(GD2_A8JP"L8SE&_QKHKVUM-0A$=PI(4Y&#C%9"I%;72VENQN0N=T<G3
MGL3[8S70JZJ+5:_UU,G!Q9B:GX T;5$WVD,=NS\AXP?SZUP^L^!]3TY"MM/<
MW07HBQG%=]J(A@F\MTDMBRY,:G('T(-74OWM],CE7*IO")OR3(Q/  SDGZ5J
MI2C%/=?UU(O>5CQA+?Q#:'BVNUQ_LFIAXBUFQ ,Z2!>@,B8S7JWB;4+Y1!;6
MEDUU?/R\<<.Y%7U9LC'YUSUQI'VL)_;=KI\0SQ&LCE@?H#C-:PK75_\ @CDE
M?5&-H/C,WEY%8WJJBR'"2$X"M_@:[+802",$=:Y&_L/!&F _:7>*;' 63G_O
MG)/YUU%M<PSZ?:2P!PC1 C><L1V)]\8KAQD->?N:TI)JR)8;CR-)N2(HW'ER
ME]PZX7('TX->?V'Q:D7$5Y;+&O3=&@9?^^>M=U OF1S0]G1@1^!!_G7SS+CS
MGP.-QK3!QBT[H=17/<+3Q#I^MQEE+*IZRV3A2OU4CC\J['2D_P")4L+7LMY&
MN=LSX#J#TSC@XKQ7PF;!;&+[,R?:R2+F-GVNX[;<]1[5ZCHNO06\7D3QE%Z9
M*XK>O0]V\$<\:G+/ED]"U?7,]GI[)>.\=S&VQ)8P2DPYP?;CKZ&HM"O%N=0^
MSW;;U=?E!Z%@<\^M7]2LX=<L3%%<@ \;A[^M8%QH5QI$<;I.9DAP%D_BXQR?
M3G-12Y)0<).S85.924X[(U7UB32[V22-&$ G>!X_7;@Y'YUT]K>I>6R3PR;H
MVZ5QE]+_ &E8^8JXF+[G4?W\<_F "/H:VO"C*=((5LD2'*^E8UJ2]GS/=:&E
M.;]I9;/4W][8ZT;V]33:6N,Z1VYO[QHW-ZFFTM "[CZFC<?4TE% #LGU-&3Z
MFDHH 7)]:*2B@!:*2F2RI!$TDC;449)H$2450L]8LKZX:""4F51DJR$$#\:O
MT FGJ@HHHH&%%%% "4444 %%%% !115>XO(+:2".5]KSOY<8P3N;KBA*XBGK
MU])8::9(L!V.T-Z5A:&KR/#<.Y&R=I'8]U$9!S^)%:/B:</%%8* 9)6W$G^$
M#O61>RC3K$6P;:77<W'(3K^O4_AZ5WT87I<JW?Y'+.351RZ+\RIK6I-/<7%T
M$:144[$09) ]JU]$,\NGQW$BRS31G; LC<)G_#UZ]:ET&UC73HKP6ZL[.65V
M(/R\@,I]Q_.JWB7Q.GA^,[D**.L@0D+^ JY2Y_W4%L3%<OOR>YJ:S,T-CL24
M)(PY->1>+KC5!9RRV5P(D@PMT%/SG/0[O3VXQ2ZG\1K.;<8X[FY<]V/EJ?ZU
MQNJ^([W5(C PC@MMV[R8A@$^I/4FNFA2]G&S!J4Y7L5M*Q+K%KYF7W3(&W<Y
MY'6O?KPJ;N3RU"HOR@ 8Z5X#HN3K=C@?\MT_]"%>^3$//(V,98\5PX_='3 A
MA)69<'&>,UX+J<9BU2Z7;C$K#&.G->\KPZGWKR_Q3HY76;QPIP96/ZU>71YG
M)$59*-KG%#KGH:T;77-5M %M[^=5_NEMP_(U5GMVB8\5![5WM-;BTDCW7P-%
M>#;->W?F2$X8 ;1],5UM] ESIMQ;A/WW+X.>H/!]Z\4\.>-S9+'%>%@R8 D'
M((]_>O9M#U:#5[:*>-PS*,Y!SD5R8F#3]HMC.GI[K.>T)F75/*NI$2U\D^;-
M(X3GMCWSS2W/B.'PW>/=JAGBF)BV1?=D<="I_'/XFD\7Z#;ZHTMJJA5=0^$.
M"".XKA=)AO+S3-0T*^E;%B<QR.^1'N.!@'M]/6ME%5/?>S6Q"]U6ZIGJ7@[Q
M"FM0W]Y))+$#)N$$S ^4N,<>V<UU:L&4,IR",@CO7@^C6%QX:U(Z'>WNQ[I$
MDW6TG#J>0I/IQTKVO29A-IT1  "C;@#'3V[5PXJ@H^_'9G33G=\K+U+2"EKC
M-@HHHH **6B@ HHHH *SKNZ6X62VA@DG_A8JVQ0?3<>_TK1KG;K4XX[G^S=,
M@-[=(/FC1L)&<]9&/ _G03)-Z$^E64MGO%K:6MN&.7+.SN?KP*VQTYJCI5I<
MVMLQO)Q-<RMOD*C"KZ*OL!5^AA&*BK(****"@HHHH 2BEI* "BBB@!DCE(F<
M*6*@G [UYEX[\:1-H=NUC.T=R)2':+&^%AQCGUYYKT/59#%ILSJ"2!VKQ>_N
M+*^\:6VGZK:O-8N3N"'!.5X)(]_Y5W8.DFG-]#GJS]Y1-#1_$DL.CS:SJEV9
MDC*"'S%):9<_=..AZ?K6M9:LWC&YCU!-/EM9V'E*K/D./7I7)>(8(3<Z5HH@
MDMXWFR%#@HT7\)P.0>O6O0])2&SEMW55CAB3YG8X QQ@?RKMFHQ]];G/>ZY7
MU.CB@%O:I;[MJ(H+E>Y[UR'C'5;-H9&E9-B#+$\\#_'I^-=)XA>Y736,$BHQ
MXR>?IQ7SQXBO;J?5)X9KP7*1O@&,;4S["L,+"_[QFE17?(C)D*F1BHP"3@>E
M"J7; H1#(V *WM+TIYG&%S7?&#DQRDHH/#VGLVKV;;3Q,A_45[6W+$^IS7*:
M%I,4$T+%?FWJ<UU5>;F:5XI#P\W*Y!WK%UBU2749@R@[CGGW&:VZK:K"!>%O
M[R*>/I6>72Y:C] Q2O!'G>KZ(,%XUR*Y*ZM&B8\5ZW/;JXP0*YC6]'0JTB+G
M S@5[=E-')3JN+LS@XI'@G25.'1@PSZBO9O WCK3KN1;6Y58+J3 P>A/L?3V
MK@-5TG36\/B_LD*2(X7(8G>#Z^AK.\*P07/B:QCN"0GF \''(Y%<U2GS)Q9T
MW37,NA[W>QF_N+F-(MES;#*\_P"L0\AA_+\*\YN;1;#QC#J-PF^TG'ER KN"
MG;P2/8X.?:O37)AO#=HS;;2URD2@?.#R<G\*P;]+?4=/2_M' BNDR54X*$CM
M^=<U"7V7L3/1\QS]AH^E:QK4>I-<3"4$EI@ZF.-$4D[E//:O1;&[MK+0X;C3
MQ)J$4KJ,Q+R<G&<>U>>Z#HEQIT]W),/,6?HC'(>/&UC^N#W%>E>'XX;?3VM(
M(ID2WD,8,N,MCN,=JC&-6WNNQ=!=#5I:**\PZQ:*** $I:** "EI*6@"GJJ7
M4FDW:61VW)B81G_:Q67HEG%I^DVL4*["8P\K$X8OCYBW/)SGJ*Z"J]Y;?:;.
M:%#L:12-WH30)O309ILK3V*2-T8L5_W<G'Z5;J.!2EO&A3:54#';BI,4,4=D
M%%%%!04444 %)2T4 )1WI:3% &:RWEI%J$US,ES&26ACV[0BXZ'UKSW7M=%M
MHUMJ(MA;BY0 VB*-N_<0&#8S@@9^E>F7T=Q+8S1VLBQSLN$=AD ^]>?Z]#IF
MH7T]E>72 D"0J#\P5>FT>I(_ 5WX1IRN_P"OD<U9.UC!LK1M7O8=6G='\N-8
MXDC!&".._7_Z]=F]M;R1VNDR.JM+(#,3ZKAM@]^@_.J%L\&CVK7C*OE1)\AS
M]TXSG!ZU=\-Q2MX7L9+MF,L\INF9QA@N[=D_7BNFO+33;^OR,*>KN>?_ !+\
M4ZJNK2:4@>VMU7AAU<'T/I7 :?IEWJD[1VD1D*C<QR  /<FNU\;^=XK\6_9M
M.17\A#O<G"]>>?;BL_P^)-.6_M'@+2RC81V!'K[5TTH>ZDD4YI*_4I:?HTWV
MCRI8RKJ<,".E=WI^F+;(H4<XY-1:/ISQ0[IR'F8[F8#O[5T$$!)XZ5K.:BK(
MYFW-ZC[& ^>A(X!!J]2VT>QQGFC%>)CI7DCMPRLF047J"3RF[F,#^= J649A
MB]<$?K6>$=JA==7@8<K1"[%N& F*[MOM4$T"L#D<5IS6D+3K.R*94&U7QR >
MU49I-QQ%&7*R;&!XP/7WKVX2/.DCD=8T<JI$((1CDJ.F?6LW5'TJVTZU$$?E
MZA;R<O#P2,'G/?G%=U<0!XRI.<^U<3K&G PK+Y;K)R'5NV#QBMFN=%4Y6=F=
MKX1^(=C?+#:ZDX@NE&S<_P!V0>F>U6X83X=U26R0&33KK+V<@7=C/+)GL1_*
MO%)HRC$8KT7P+#KZ!%N8GN-)=#(JNV=I'\2]QZ5Q^SY6VCIFERESQ)K-YI^H
M0+822A YFVGYAZ<CTQUKU3PY>27^@VD\JA9"@W 5Q5U9I<VLD<+1(TP$23N,
M@9Y*_CC'MFKOP_UZ>^:>P=E,5M(\:)Y>UHU!.W<>Y(K#%14X:+5%47:USNHY
MHY2PCD5BAPP!S@^AI]5+/2[2PN+JXMT(DN7#RDL3DCT]*N5Y;M?0ZE?J%%%+
M2&)12T4 %9K"YWS ;R#GUXYX_3TK2HH)DKE'_2-L9B1B$Y.21NYZ<\]*9(MQ
M*AB E4@/EAQP>F#6E247&E8S=E]YCIS\F LA/##:>?SQ2*LJS8BMYT 4%]QR
M&((]^N,UJ44#,R6*:25)3')MW$[=H)'3'?CH:TZ** $HI:* $HHHH *J:GJ$
M6E:?+>SJS1Q#)"#)JW00",$ @^M-6OJ)[%:.X%Q8K.@*^9'N4-QC(KQ6UTF]
M?Q-/>QMOC2Y9)?FRP&"<GVXKTKQW,(_#\B !V*G$.<;_ &KC-)SI6AP2W%NZ
M74D:Q3E>N1@*"#T '7WKT\'%QBY);G+6EK9]"SJA2?;+K%PD.DQ8>5F'S2D'
MB,?7'-<KXJ^)EQJ2/9Z1&;:V(VF0\,1Z =A78:IX>A\2:2ANII8HEE8HJ'@8
M'4^]>1ZGI!T[6[BR!W+&^%.<\5U1C&3]#.G:VI:T&^U&UG8V\S9D4H0>>#UQ
M7;Z;IX!\YD"N<9XQ^/UK&\.Z:R,LV,$<K776-H8H1&&9N226Y)KJE:"L85)<
MST+4$(P,=ZEN[6[D-O\ 9)1&%D#29[KW%2K9H767!$BH5#>F:N6T31Q+&TA<
M@8+'J?>N*<^I443Q ;^G:H<5:B7#9J"O+Q+O)'906C*H6I2#]G0>C&@+[5*!
M_H^,?Q?TJ,.[5$757N,ILH(JK*JJI9SM4<DFKS+C\:KW=O'<0/#*F4<88>U>
MM&1P-&7>2I;P&>0XC&"6QVK/O;9)X,C!#+D5M2VB&T\@KNBV[=K<Y%9 @EM(
MY=S>9&&RH Y5?3\*ZJ<C.2//M6TYHIR HY/ ]:Z[0_B!'IL*65_9/]I@'E!%
MX4D#'/I[U)XBTR*6UAEBY<J2<'W_ $KSV^A>.=R6+,3RWK3J14E?H=%)\RLS
MU^.4Q;)7E.^;B&';D,,?,0>G<?E56^:_\/ZL;[3#;11862;S </G !X[\C/T
MIFAZP)?!ED7"-Y)&&;JIZ'FKZW]A?7=Q8ZOOCT^1 A=>F1CDGMC%8S3Y6[$P
MLI)'H-G=7)<6]]#''.5W*T3%HY!WQGD'V-7JHW%U:Q75G#)*J%LM&2>#QC /
MXU>KP6>B%+1534-1M]-MC-<-@=AW8^@J)245>0-I*[+=9]QK=A;R>5YIFF_Y
MYPJ7;]*QK4:AXF8S3R/:Z;G"QQG#2?CZ5T5K96UE%Y=M"D2C^Z.3]3WK.,I3
MU6B,HSE/6.B,]]4U)Q_HNBS$=C-*J?IUJE+J7BE3\F@VS#_KY%=+6!K_ (B_
MLR6&QLXQ<:C<';'%GA?=J)+E5W)A-<JNY,S)O%/B*U_U_A.=@.\4NX?RJF?'
MVL.=D/A&_,G^UG'\JZ[2U(B)FOA=W(XE96&U3Z #H*T.:M)M;@HR:OS?D<WX
M?7Q!?7!U'7 MJ@&(+&,\+_M.>Y]!725QMQX^AA\21Z6MFSQ/,(3*&Y#$XSCT
MS7940E&2O$=.46M'<****LU"BBB@!**SK?5Q<:@;46DR#<ZB5L;25Z^]:-3&
M<9J\2I0<=PJO=O+L6*!@DLIVAR,[1W.*L5F:EJ*VMY9VZHK32N-NYPHQT/7J
M<9X'I6D5=Z$,X+7]&6;Q9<1M<WLKVL$5PC3SDIDEL\=.H& *MRP27.H6\$$<
M<\4H6-@YQCCELCOFL_Q3XU74[V_TJP,<4-N0LESLW-)@\@>@!-5-.N91>VT"
M-B&. DXZDYP#_.O:H0G[)-Z'!6:YSGO$WB74M+U2XTVPNV2-<>8I&1NQU7TK
M*TZR2[EAD$DDLT@W3%^S9/Y\8K/U&0WVOWDW4-*<'\<5V7AZQ$<*RE!D=_6N
MNG&WO$S?+%)&W96JVZ!"-NT<Y[5;TV6:ZO'E0K]BV[4]2X.#2B-KJ^,K "/'
M"#W]:UX((X8E2-%11V48%859]S.*(X7N3J$D308MU0%9,]3W&*T%7GI344<$
M5.BY/'2N.4KFR0]4(!8>AJ@:U0I$;8_NFLHUY]=WD=5)60"ID!,#X'<4T+4\
M0.UP!U%12=IHN>L65&7K4#+U-79%P<U X&,]J]6+.%HJNH*D#O5&:, DUJ8R
M#BJDL>36\&9R1D7$0DC(/2N#U[3S%*Q X->BNGW@?PK!URR$UNS*.5%=<'=6
M(B^65S%\(3BXTR_TQ_O8+I^7^.*75+K(D1^L\!"GT(VM_0U@6UW)I&K172?P
M-\P]5[BNL;38=3U&WCCE9$*EU*]6!!P/U _"DMFC:2M+F.H\!:P?$OAI=-N9
MY1?V3D0L,D,H&5W^H[?A7HFEZA'J=DMS&5/S,C;3D!E)!_45XCX :;2_$4UI
M Y:\N<1&U?Y0RALMSZ@#(KU'P_?V\?BK6]*CMS"69;E"$*JXP%8C/?</QKQL
M52LW;U.V$KG55Y]K$DNL>)Q9EL1K((P/3U->@UP.J12Z-XH%ZZDPM() <<'U
M%>+B]XWVOJ8XN_*NU]3NX84@A2*-0J(-J@=A4E5K74+2\A$L-Q&RD9^]R/K3
MEN5FD"PX=1]YQT'^)KJYET.E-6T(]3OH],T^:[E(VHN0/4]A7 ^'-/N]>N-3
MUAW/GD&.%CQ\QZX_#C\:N>/]1,LL&EQ$DY#.%[D]!75Z#IHTK1;>UQ\X7=)[
ML>37-;VTW?9:',_WM7EZ+\RAX5LH=.M98'<?;7;=,C<$>GU'O6^["-&=CA5&
M2?:O/]?O;G4/&=E#IA(E@<+O7OSDY]JZCQ3J0T[1)B#^]E&Q/QZFG"JHTFUT
MT'3J1C"26T0M] T2?4$UF"!))F.]) V5SZ@=,UJ37<%O)%'-($:4[4SW/I6)
MX+MI[?P['YW_ "T<R(#V4UB^(YY=8U^'3K3GRFVC!QSW-5*I[.$;+5] =50I
MJ26KZ';S3Q6T9DFD6-!W8XJ&SU*RU#?]DN8YBGW@AY%+Y4<$/G7)5V1,LS#@
M #M7"^$C->>*;^[MD"6[*0S#@+D\8'KQ52J24U'N7.JXRBNYV6IZ_I>CJ#?W
MB0^W)/Y"JT]^VI6MG=:1.\]L\A\QK8@G&/?WK*^(%Q::=X/N8C&A>X(C0$<D
M]2:A^%]A-9>%/-ER!<RF5%/9>@/XXIR3G>++A5<:MK7.@&PQ*(Q/YN]ONE0V
M>]3Z2MTM@!>;_.WM]\@G;GC./:F0:1'#J!NUN9F^=F$1(V@MUK1K+#T'#61U
M5)IJR$K@M8\00#P_JFLR*5?<]O:M(/X,[1(@^IZ^U=CJ]U)8Z/>W<,8DEAA>
M14)QD@9KRKQ3?7&G^ ]$.IQK*79LP;LK("N0QXR,9Z5Z>&@G*[.6;T/.=*G:
M,3%6!+LL?)YP6!/\J[9;P:?IEY>O@,L2HGNQR1_.LC0[.R/A^XNF5<O*JP+C
MD,.I!JKXCO&D-M8*,*JB20?[1Z?D,5[L?@.&:YIV*>CVIFN!D9+')KT>QM]D
M:J,<"N8\-V@ WD5VUO'@@$54WRQL9S?-(M6Z #IS5Y%[U%$F.15E!SBO/G*Y
MI%$J+D#-6$3FF1KBK4:Y-<TF:Q0YEQ;R?[IK&Q6Y/_Q[N!Q\IK'"UQ5=SIAL
M3[*?&O)'J*?BE5?FJ(_$BY;$$B56=,FM!UR*J.N#7I19Q215*X/3-0R(/K5E
MAGK43+QCM6\69,S98\YXK/NH@\3#L16Q,@(R*H2+E3753D9R1YAK=IY5PPQ6
MEILLQ\-I<Q2%9K5BBD?F*UM=TPW$3,D>]^@QUYJ"QT]K'3I+5,.+F7:RY^96
MQP<>G6MFM;HT4KPLREX=6XU#X@:?<VT1M[B1P[<\#Y<LWL*]0\,OJ5WXXU5[
MNY65;"W2T<^7M+N3NR/;WKD_"%I=:7\1+6*[VL[V[*6Z@@+V^F*[3PK/!=:I
MJ^NK.PMKZ=;>W63JWEY!.!^./85Y6+>K2[?F=E+:YV-1RP13H8YHUD0]F&14
ME+7F-)[FVYF+X>TE9/,%C'G\<?E5JYN(-.LI)GVI%$N< 8_"G7-W!:)NFE51
MV'<_05AW=E>>(Y464/:Z:ISM/#R_AV%83:BN6FM3*34%:"U,+PUI\NMZ]+K5
MTI\E'+)D=6[?E79ZM>?8-+GN.ZKQ]:L6]M#:6Z001A(T&%45#J=B-1TZ6U+;
M2XX/H:/9.%)QAN*%-PIM+?\ 4YKP1IXVW&J2C,LK%%)[#O5;5/\ BH?%4-DC
M[K:,X)!XP.M;6CZ3J5G8_8;B:%;<,3NCSO8'MGM22Z#<6^L)?:8\$8QM:-P<
M?I6+IRY(*VBW,/9R]E&-O4NZMJ,&D:>>55]NV)!WK%\':>S>?JDW+R,50G]3
M4VK>'+S498W\]&DQ\\C<?@!V%=#:6R6=I%;QC"1J%%7&,IU>>:LEL:*,IU>:
M2LEL<]XWU,V>E?98R?-N...R]ZN>%=*_LK1(D<8FE_>2?4]!^52ZMH<>JWEE
M/(WRV[Y9?[P]/SK6Q5P@_:2G+Y%Q@_:N<OD>5^(V?QCXXMM(B8_98&VL1Z#E
MC_2O1I"MK##8V:JLFT+&H'$:CC<?85RR>"]2T[Q')JFDW\$:R;LK/&6(#=1Q
MUKJ]/L/L:,TLS7%S)S+,XP6]@.P'855-.VNY-*,KMR6K+$,*P0K&N2!W/4GN
M34E%%:G25;^T2_T^XLY2PCGC:-BO4 C%>):KID[_  WBO?F?R;GR)"6W9B1B
MJL/[I]J]OO+D6EN96C9P" 549/)Q7DOB1!IVB>*-"MX1]DMIHKD3+U^=LE&]
M2/Y5V8633T,ZBN<AHT-S-/8([!X0K)'&.,?-SD?UJMJ2&;Q/=A03B7:!].*W
M=,LK8:%'?17:B\(.%SPH/?'M5V.PL]0N1=V,GW6VL2,LQ"@'\^M>U&VAPN5F
MV6]%MQ';*.Y&:Z2U3^(]:SK6'R@ !TXK7@7"CVK.M*YE%%I!Z5.J\]^:8@XS
M5E$SBN&3-TB6-3BK<:X%0QC@ U9 XQ7--F\4,G&8''M67LK6D&8F^E4C'STK
MEJ;FT=A*>H^<9I=N*51\P^M0MRBMJ5[!IUJ;B=L(./<^PJO!<QWENL\62K#/
M/6K.KZ9!JU@]K/NV,<AE."I'0BH+2QCT^S2WC8L%'WFZFO2@X\OF<DD[C&'K
M43#-6'7FH6':M8LR95E'!&*SYH_2M20=:H3!L$5TTV9R1FO"&CDD;I&-W'6L
MFZM;2 37QGD%PV"J,W'3 X_&M.Y25BR@#:1D'/>J<$UF;R:"X4-)'"JJS\C/
M4_TKI6UR$4M4MWT/5M/OTOKB6_&/)8$%0Q['_9Y->A^";-#I=Q),D926[,T:
M+]U7P-Q7VSFO,XTN=0EBADE1BA2("1\8,C;05'LM>VZ;806UC9HMJ(?(CV1I
MU*#TS7FXZ22MU.^@G8EU&]73K"6Z=&=8\95>IR<?UK,3Q5ITEO$Y\T/)@>6%
MY4DXP3[5MO&DL921%=&ZJPR#48LK4# MH< ;1\@Z>E>2=)BQ^(-$):2'+,I(
M+>6>",]_PJ:7Q3IL21L7<F1F5!M^\0/TK52SMD!"6\2@]0$ I?LEOG/D19SG
M.P=:$K;!HMC%N_%-M8ZB+:>&18_*$IE'(&5+8Q^%.?Q=I:0B4F?:0IQY1R W
M3^OY5M&"$OO,2%L8R5&<>E'DQ;=OEIC&,;13 QI?%6G0R(DBSJ75F3*=0#C\
M/QHB\46=W;7<EI%-*]M!YQ0KMW<= ?6M>6U@GC9)8496&""O:EAMX;>)8HHD
M1%4*%48 'I2 YJR\;VUS!+/)97$42-@97YFZ#./J?TK0O=?6QOQ!)#F/ )()
M+'*DY  Y''6MCRT_N+^5&U<@[1D>U &"_BRQ64H(KAP$,A9$R, X-3KXB@,=
M\_V:YS9!6D4)DD'T]<5K[5'\(_*EQ[4P.9;Q7))$DMOI=P5<97S1L.>>,?A2
MZSXFO-/M[.6UTJ:X^T*V5YS&P( !QVZ\UTN** ,!/$I>21%TVZ81OM9L8R..
M1GKU_2C3O$RZC-$D=E,%=RADSE1C_/-;]-CCCB39&BHO7"C H 1B I)Z#DUY
M!\046SFEG1B8;YQ<1HRG9/QA@WN.H%>PXKB_B=:Q3>$+B666.,08DCW#DOG@
M+^M=.%GRU%YD35T</%;V::5I\]K;*+IG!=(N=R$<YK3M)X5GBFAB2)6?YTVX
M/H?QKG/#JNDT=R4PL)*'!'\0W#/ZUM6TS7=U<>: A\SS%"^AKWK71YDM&;:!
M6F;9]T'BM&($@#%9=C$8R06W;FSS6S&IQQQ7+4=AQ)4R#CTJU&.<U @]:LH,
MFN21M$M1KTK \4W>IVIMO[/25F+  1KG<<]#Z"NAB%2]36,9\DKVN;<MU88N
M\VR^8 'VC<!Z]ZBVU8?B,U!FN2I\1M#87RZ-G.:L[*#'Q4%E)YD,OE -NV[L
MXX_/UJE?W,=E:O<2ABB==HR:T7VJN#@=A6?=75O"\<<LBJTIPJG^*N^GK8Y9
MD6[> PZ,,BHGYXQ5AQS@<"H&%;Q,60$Y'I5.XYSTJ\R#G%9]RZJVT@DGTK6$
M^57F92T6I1N#\N0.U<V_F6T_G'&"Y>3U/'"BMZ],GV>1H2OF%3LW' K#TC3]
M]TEF&-V\_P T\[DJ(AW -=L7:-R8K4J6D5YXB\76<%H!+*LL<LTB_<C5>V:]
M^'2N?\+Z+9Z5;/\ 8H!'"3\O'+>YKH:\3%U?:3MV/2I*T0IDSE(F8=0*BN[V
M"SC+32*OH,\FN;NO&%KITC#RY;D$9(0<@UYM2M"+Y6]PG5A#1LZ>W?S(\[]X
M_O5+6+I'BC3=6(CC<PS=HI>"?IZUI7MVEC;&XD4F)#\Y'\*]S^%:0:Y=[EPD
MI+W7<LT4R&:.X@2:%P\;J&5AT(/>GU8PHHHH&%%%% !112T"$HHHH&%%%% "
M5RGC[PQ+XG\/F"V8"YA;S(E)X8XZ5UE%5"3C)20FKGSG9/?:8?L=]:S0W&[R
MLE?ED'3!]QZUO:7)#%.ELTY,JC"K)PQ%>A^+=(DFB-U:$+)CYP0"&]__ *]>
M=76G@.'O6S+;R#;>(1E1UP:]_#U54IW1YU:-I69U5HP.<]:U4^Z*PM)O;6]#
M/;3K)L^5L=:VPZHFYV"@=2>E95=R8EF/D^]6HZK1XSP:M)@#FN21M$=<QW$M
ME(EI*(IR/D<C(!JU&&"*'.Y@/F8=S40GB2!Y"Z[5'))X%5M(O+N\MI9+JW\D
MB0A/]I>QK%IM&J:N7@D@,A+EE8Y (^[3=E-T^[:^A,A@DAP[+M<8)P>M7?+K
MEJIJ5F;0V'8HQ2TM9EF1J%A'>/$TK.IAD\Q=C8R?>L[5M-6]19$51=0Y,#GH
MK>_M6W.,.U4GKOI2:2.:HM3"GO;J"6UAF"^8Z_,PZ$^@JU=R/#:RR(ADD125
M0=SZ58E0-C*@_6HF[ UU73MH<[.<U?6;B#PS)?0QF.; X8?=R0#P:?:W,LGD
M76/-@V8\S'+&EUR:V%]IMM/(H$DV[8?XL#C]:DDEA D$+X,#<HIQ@_2L\9?V
M#LM&95-C O\ 3'U/Q%&V93:",D>6Q #9]JZNTTZ&TMQY0WJ,>8W3:O8#WJ*W
MA9T%TJC##G8<;JGBNMZQ62 #,A,BL.3Z8K/#XR#IQI\R"$E;4[:TVFUC9!A2
MH('I4LC!(V<]AFJLDHT[3 S#)C4# [FLBPNKO6;YED8);1?>5?XCZ5Y]2:YG
M%;GH.HHVCU8E[H7]O6S-<2/&<GR]G4>]<??^!_$=@&:RNDO(R?N]&Q]#7J84
M*, 8 I:R^KP9,L/"6^YXHNC^(4E_>:5<!@>&5#7H-MJ-]#X-N'U2UE2=(VC7
M>,E\C S^==56?KD2SZ)>1G&3$Q7Z@9%+V2IQ;15##QISNF53J5EX=TBSAO)0
MC+$JA%Y)('.!45OXST6>01FX,+'IYBX%8FM0V.L:-:7<=Y!YZ0+E6;AN.1GU
MK@YX,HWEMR."N?ZU@\3)3:5K'/7Q,X5&EL>XP7,-RF^"5)5SC*,"*EKP[0];
MU'P]=>;;R@Q$_O+=NC?_ %_>O:;"\BU"QANX6!25 PQV]JZZ=131O1KJIZEB
MBEHK0V"BBJSZC9Q7 MWNHEE/1"PS2;2W$VEN6:2EI*8PHHR/6EH 2BD=@BEN
MN*SAJ,L\IAC@:-AUWGG'L*F4U%:BE)+<AUK4D@MWC2-I).G R!]:XTVL$D<D
MKH=SC'3C\1787 N)0T7EK$G]X\DU@2*T#-$5PQ;=3PV-E'1;'!7;<KO8XU/^
M)--<:C!9SS>>0KQH-I4>N*T+Z*>^T=GLDDF6ZBP(I7P4;\>G_P!:M&<XW;5R
MS#EJI6%U/-/+;>2 $.02>@]:].GBI3C>"N81GIYEW34N[WPQ;0P7!BN$412.
MW4,O!_&NGC0^2$)).W!-<UH%X;J6Y2"%D2.3YV88#GN1ZUT\; $ D9)XHG)O
M1JQT0=]2G8:.SV]U#? -#,1B,'L.];<:+&H11A5& /04V,U(.M85)N3NS>*2
M1+%]ZIZKQ??JQBN2>YO'8;124M044[KB0^XJC)5Z\P''KBLZ0G/6NZC\*.:I
MN0OCM6>GVH7<XEV>1QY17K^-7VY%0N1V%=4-#!G/:[!!(_VF\\N.*!<Q3Y^=
M'^G>L"'[7JWB>.XYB@MHMK/C;YI/7BNC\3:8VK::((W"LLBN?H.M26H62SCB
MB'F,O\0],5U1LX:D-C[&Z^P2""5@;9FX;^[_ /6K5O\ 2_M,(N+8@/G<I'I5
M>PL!=S"V<#$@Y]A2@W?AS41:3$RV4A_=L>U?+9MA?93]I1)C%)>\O=_(W+JX
M:X\,":3(?:-_L1P:TM-AABL8?)(92@.X=ZS_ #83;/#)@P2@YQVSWJII=TVB
MR_8+H_Z,>89!R,&EAL1"JN;K^IU\RC-.7:USIJ*CBD\S+*ZLA^Z5-59-6M8K
MY;1G/FL<<#@5U7.AR25VRY(ZQQL['  S7&ZK-)>R,7)V'H/:NCUF0QV0 _B8
M USERRL,#TKR<PJ.4N3HCDQ4W\)SU_$HA6-54(.-HX%<I(EQI%VUQ;1+/:OD
M/!)T_#T-=A>8=2,CBLJ[17MR@Q]:Y:%3E9P1GRR-;3?"EGXBTA+[3+\\Y#1R
MKRC?W3BNO\(Z7?Z/ILMG?%3ME)B*G(VG_P"O7#?#[4&T_P 1M8LV(KM<;?\
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#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_017.jpg
<TEXT>
begin 644 image_017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !+ 8\# 2(  A$! Q$!_\0
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MU[?WKQ;XJV=[-XNMI;:UFE"VJ_,D9(!#FL\O=J_R+QZO2.I_X5%X<(&7O?\
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MZTM% "48I:* $HI:* $Q12T4 )1CFEHH 2C&*6B@!*,9I:* $HI:* $HI:*
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M"P- %Q/$-E)X>?6HM[6R1F1EQAUQU!'8CTI^K:U%I&BMJ<D,LJ#9B.,98EB
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MO;WS0!T.MZS!HFDR:C-&\J(0 D7)8DX&/SK+3Q@$N88]1T?4-/BE<1BXG4;
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84"IZ* $I:** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_018.jpg
<TEXT>
begin 644 image_018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ G # 2(  A$! Q$!_\0
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MCON \;JYVJRO@?Q#&"!@X]15B3Q;H46GPW[:G!]FF=HXV&22P^\,=>,'/'%
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M&4_0@C\*T: "BBB@ HHHH **** "BBB@ I.**R=<U>+1-/\ M4B[B9%C522
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M4=]IXM=0207N;3!C,CNS>3@]/G( 8G;@'VKH/^$O\.?]!W3O_ I/\:/^$O\
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M;J]@_L6*:::+RXRMP3()/E+9VX'F/SCG ]ZW/^$O\.?]!W3O_ I/\:/^$O\
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M+,JLJ&,*2N W)Y/' -'-+N')'L=-_8&C_P#0*L?_  '7_"C^P-'_ .@58_\
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M$$@X]<8-*]_:1QM(US$%7J=PXYQ_.CFEW#DCV*W]@:/_ - JQ_\  =?\*/[
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M'$\<BD2+N3L2/I3A<0D(1+&1)]S##YOIZT<TNX<D>Q2_L#1_^@58_P#@.O\
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M$ +M96^49XSM&??)KHJ* .:'A9&D'G7 *#8"L<>TNBAAACGDG<"3_LBG2^&
MUF(?M>YO*$1>:(,&.&!8C/).\GZUT=% &-8Z']AOY;I;EY"ZX ;/&<9[^W'I
M6S110!QNN^$]8O-1^W:-XGNK&3!_<RJ)8^?3N!46A>!);4K=:SJ]Q?7RK^[9
M#M2 ^L??\^/:NWHH R;O1TN9Q(9 H *X\I3QMP.<<8/-1W&BR7"/&;^0(0P5
M/+4A<XQP?3!Q]36U10!F#3'8.LEU(ZEB0A4;0"00,=.,?K5==$?RDBEOFEC0
D)^[>-"O!.>,=\X_"MNB@"O:0F"VBA)!*+C(7:#^%6*** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>24
<FILENAME>aatp-20201231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaiEWbP9z5Z8eekhvWBybfkqPyMse5pLhycuG3p2Mf0N -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:AATP="http://agapeatp.com/20201231" elementFormDefault="qualified" targetNamespace="http://agapeatp.com/20201231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://agapeatp.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" id="StatementsOfOperationsAndComprehensiveIncomeLoss">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" id="StatementsOfChangesInStockholdersEquity">
	  <link:definition>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackground" id="OrganizationAndBusinessBackground">
	  <link:definition>00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/VariableInterestEntityVie" id="VariableInterestEntityVie">
	  <link:definition>00000009 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BusninessCombination" id="BusninessCombination">
	  <link:definition>00000010 - Disclosure - BUSNINESS COMBINATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty" id="AccountsReceivableAndAccountsReceivableRelatedParty">
	  <link:definition>00000011 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/Inventories" id="Inventories">
	  <link:definition>00000012 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PrepaymentsAndDeposits" id="PrepaymentsAndDeposits">
	  <link:definition>00000013 - Disclosure - PREPAYMENTS AND DEPOSITS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
	  <link:definition>00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IntangibleAssetsNet" id="IntangibleAssetsNet">
	  <link:definition>00000015 - Disclosure - INTANGIBLE ASSETS, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInMarketableSecurities" id="InvestmentInMarketableSecurities">
	  <link:definition>00000016 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" id="InvestmentInNon-marketableSecurities">
	  <link:definition>00000017 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" id="OtherPayablesAndAccruedLiabilities">
	  <link:definition>00000018 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" id="RelatedPartyBalancesAndTransactions">
	  <link:definition>00000019 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StockholdersEquity" id="StockholdersEquity">
	  <link:definition>00000020 - Disclosure - STOCKHOLDERS&#8217; EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000021 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ConcentrationsOfRisks" id="ConcentrationsOfRisks">
	  <link:definition>00000022 - Disclosure - CONCENTRATIONS OF RISKS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000024 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" id="OrganizationAndBusinessBackgroundTables">
	  <link:definition>00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/VariableInterestEntityVieTables" id="VariableInterestEntityVieTables">
	  <link:definition>00000028 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BusninessCombinationTables" id="BusninessCombinationTables">
	  <link:definition>00000029 - Disclosure - BUSNINESS COMBINATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables" id="AccountsReceivableAndAccountsReceivableRelatedPartyTables">
	  <link:definition>00000030 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000031 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PrepaymentsAndDepositsTables" id="PrepaymentsAndDepositsTables">
	  <link:definition>00000032 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
	  <link:definition>00000033 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IntangibleAssetsNetTables" id="IntangibleAssetsNetTables">
	  <link:definition>00000034 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" id="InvestmentInMarketableSecuritiesTables">
	  <link:definition>00000035 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" id="InvestmentInNon-marketableSecuritiesTables">
	  <link:definition>00000036 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" id="OtherPayablesAndAccruedLiabilitiesTables">
	  <link:definition>00000037 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" id="RelatedPartyBalancesAndTransactionsTables">
	  <link:definition>00000038 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000039 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" id="ScheduleOfSubsidiariesAndAssociatesDetails">
	  <link:definition>00000041 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" id="OrganizationAndBusinessBackgroundDetailsNarrative">
	  <link:definition>00000042 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" id="ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails">
	  <link:definition>00000043 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" id="ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails">
	  <link:definition>00000044 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" id="ScheduleOfDis-aggregatedInformationOfRevenuesDetails">
	  <link:definition>00000045 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" id="ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails">
	  <link:definition>00000046 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" id="ScheduleOfVariableInterestEntityDetails">
	  <link:definition>00000048 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" id="VariableInterestEntityVieDetailsNarrative">
	  <link:definition>00000049 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" id="SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails">
	  <link:definition>00000050 - Disclosure - SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" id="ScheduleOfProFormaBusinessCombinationDetails">
	  <link:definition>00000051 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/BusninessCombinationDetailsNarrative" id="BusninessCombinationDetailsNarrative">
	  <link:definition>00000052 - Disclosure - BUSNINESS COMBINATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" id="ScheduleOfAccountsReceivables-RelatedPartyDetails">
	  <link:definition>00000053 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfInventoriesDetails" id="ScheduleOfInventoriesDetails">
	  <link:definition>00000054 - Disclosure - SCHEDULE OF INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" id="ScheduleOfPrepaidExpensesAndDepositsDetails">
	  <link:definition>00000055 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" id="ScheduleOfPropertyAndEquipmentNetDetails">
	  <link:definition>00000056 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" id="PropertyAndEquipmentNetDetailsNarrative">
	  <link:definition>00000057 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" id="ScheduleOfIntangibleAssetsNetDetails">
	  <link:definition>00000058 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" id="IntangibleAssetsNetDetailsNarrative">
	  <link:definition>00000059 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" id="ScheduleOfInvestmentInMarketableSecuritiesDetails">
	  <link:definition>00000060 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" id="InvestmentInMarketableSecuritiesDetailsNarrative">
	  <link:definition>00000061 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" id="ScheduleOfInvestmentInNonMarketableSecuritiesDetails">
	  <link:definition>00000062 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" id="InvestmentInNon-marketableSecuritiesDetailsNarrative">
	  <link:definition>00000063 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" id="ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails">
	  <link:definition>00000064 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" id="ScheduleOfRelatedPartiesDetails">
	  <link:definition>00000065 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
	  <link:definition>00000066 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" id="ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails">
	  <link:definition>00000067 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" id="ScheduleOfProvisionForIncomeTaxDetails">
	  <link:definition>00000068 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" id="ScheduleOfEffectiveIncomeTaxRateDetails">
	  <link:definition>00000069 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" id="ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical">
	  <link:definition>00000070 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" id="ScheduleOfDeferredTaxAssetsDetails">
	  <link:definition>00000071 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000072 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" id="ConcentrationsOfRisksDetailsNarrative">
	  <link:definition>00000073 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" id="ScheduleOfLeaseCommitmentsDetails">
	  <link:definition>00000074 - Disclosure - SCHEDULE OF LEASE COMMITMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails" id="ScheduleOfPurchaseCommitmentsDetails">
	  <link:definition>00000075 - Disclosure - SCHEDULE OF PURCHASE COMMITMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000076 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000077 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="aatp-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="aatp-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="aatp-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="aatp-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="AATP_AgapeATPInternationalHoldingLimitedMember" name="AgapeATPInternationalHoldingLimitedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ShareExchangeAgreementMember" name="ShareExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MrHowKokChoongMember" name="MrHowKokChoongMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyTwoMember" name="SubsidiaryCompanyTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyMember" name="SubsidiaryCompanyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyOneMember" name="SubsidiaryCompanyOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyThreeMember" name="SubsidiaryCompanyThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SubsidiaryCompanyFourMember" name="SubsidiaryCompanyFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HealthAndWellnessProductsMember" name="HealthAndWellnessProductsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SurvivorSelectMember" name="SurvivorSelectMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_EnergizedMineralConcentrateMember" name="EnergizedMineralConcentrateMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IonizedCalMagMember" name="IonizedCalMagMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OmegaBlendMember" name="OmegaBlendMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BetaMaxxMember" name="BetaMaxxMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VegeFruitFiberMember" name="VegeFruitFiberMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IronMember" name="IronMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_YoungFormulaMember" name="YoungFormulaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OrganicYouthCareCleansingBarMember" name="OrganicYouthCareCleansingBarMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MitogizeMember" name="MitogizeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NoOneMEDMember" name="NoOneMEDMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_EnergetiqueMember" name="EnergetiqueMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_TrimPlusMember" name="TrimPlusMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SocialSecurityOrganizationMember" name="SocialSecurityOrganizationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MYRCurrencyMember" name="MYRCurrencyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_EmployeesProvidentFundMember" name="EmployeesProvidentFundMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_EmploymentInsuranceSystemMember" name="EmploymentInsuranceSystemMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HumanResourceDevelopmentFundMember" name="HumanResourceDevelopmentFundMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PeriodEndMYRMember" name="PeriodEndMYRMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PeriodEndHKDMember" name="PeriodEndHKDMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PeriodAverageMYRMember" name="PeriodAverageMYRMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PeriodAverageHKDMember" name="PeriodAverageHKDMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeSuperiorLivingSdnBhdMember" name="AgapeSuperiorLivingSdnBhdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ComputerAndOfficeEquipmentMember" name="ComputerAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VehicleMember" name="VehicleMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_GreenproCapitalCorpMember" name="GreenproCapitalCorpMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DSwissIncMember" name="DSwissIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_UnreservedSdnBhdMember" name="UnreservedSdnBhdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PhoenixPlusCorpMember" name="PhoenixPlusCorpMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DirectorsOfUnreservedInvestmentMember" name="DirectorsOfUnreservedInvestmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SeaMember" name="SeaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeATPAsiaLimitedMember" name="AgapeATPAsiaLimitedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HostastaySdnBhdMember" name="HostastaySdnBhdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_THThreeTechnologySdnBhdMember" name="THThreeTechnologySdnBhdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeSuperiorLivingPtyLtdMember" name="AgapeSuperiorLivingPtyLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeSuperiorLivingPtyLtdASLPLMember" name="AgapeSuperiorLivingPtyLtdASLPLMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_HostastaySdnBhdOneMember" name="HostastaySdnBhdOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeSuperiorLivingMember" name="AgapeSuperiorLivingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IfUnutilizedMember" name="IfUnutilizedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_LabuanMember" name="LabuanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AgapeATPCorporationMember" name="AgapeATPCorporationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NoCustomerMember" name="NoCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OneCustomerMember" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ECommerceCompanyMember" name="ECommerceCompanyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VendorOneMember" name="VendorOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VendorTwoMember" name="VendorTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NoSalesMember" name="NoSalesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SellersMember" name="SellersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VettonsSdnBhdMember" name="VettonsSdnBhdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" name="InvestmentInNonMarketableSecuritiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" name="VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" name="VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" name="VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PreferredStockDividendIncomeStatementImpact" name="PreferredStockDividendIncomeStatementImpact" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ImpairmentLossInEquityInvestments" name="ImpairmentLossInEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" name="ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PaymentsToAcquireNonMarketableSecurities" name="PaymentsToAcquireNonMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_RepaymentsOfRelatedPartyDebts" name="RepaymentsOfRelatedPartyDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" name="AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" name="InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" name="SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" name="IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DisclosurePrepaymentsAndDepositsAbstract" name="DisclosurePrepaymentsAndDepositsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PrepaymentsAndDepositsTextBlock" name="PrepaymentsAndDepositsTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" name="DisclosureInvestmentInMarketableSecuritiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInMarketableSecuritiesTextBlock" name="InvestmentInMarketableSecuritiesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" name="DisclosureInvestmentInNonmarketableSecuritiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInNonMarketableSecuritiesTextBlock" name="InvestmentInNonMarketableSecuritiesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PrepaidTaxesPolicyTextBlock" name="PrepaidTaxesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PrepaymentsAndDepositsPolicyTextBlock" name="PrepaymentsAndDepositsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NonMarketableSecuritiesPolicyTextBlock" name="NonMarketableSecuritiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ShippingAndHandlingPolicyTextBlock" name="ShippingAndHandlingPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DefinedContributionPlanPolicyTextBlock" name="DefinedContributionPlanPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NoncontrollingInterestPolicyTextBlock" name="NoncontrollingInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_RelatedPartiesPolicyTextBlock" name="RelatedPartiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" name="ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" name="ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" name="ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" name="ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NonMarketableSecuritiesTableTextBlock" name="NonMarketableSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" name="ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock" name="ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_NameOftheCompany" name="NameOftheCompany" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PlaceAndDateOfIncorporation" name="PlaceAndDateOfIncorporation" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ParticularsOfIssuedCapital" name="ParticularsOfIssuedCapital" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PrincipalActivities" name="PrincipalActivities" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ForeignCurrencyExchangeRateAverage" name="ForeignCurrencyExchangeRateAverage" nillable="true" xbrli:periodType="duration" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" name="AllowanceForDoubtfulAccountsReceivablesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ForfeitedCouponIncome" name="ForfeitedCouponIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SalesCommissionsAndFees1" name="SalesCommissionsAndFees1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SalaryPercentage" name="SalaryPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MonthlySalary" name="MonthlySalary" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OtherPayablesRelatedPartyCurrent" name="OtherPayablesRelatedPartyCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaCostOfRevenue" name="BusinessAcquisitionsProFormaCostOfRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaGrossProfit" name="BusinessAcquisitionsProFormaGrossProfit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaOperatingExpenses" name="BusinessAcquisitionsProFormaOperatingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" name="BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" name="BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" name="BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" name="BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" name="BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_PercentageOfCommonStockIssuedAndOutstanding" name="PercentageOfCommonStockIssuedAndOutstanding" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" name="AccountsReceivableAndAccountsReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ReceivablesFromSalesDistributors" name="ReceivablesFromSalesDistributors" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DepositsToSupplier" name="DepositsToSupplier" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentsIncomeDividend" name="InvestmentsIncomeDividend" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_MarketableSecuritiesUnrealizedHoldingLoss" name="MarketableSecuritiesUnrealizedHoldingLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" name="ExchangeRateEffectOnInvestmentInMarketableSecurites" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInNonMarketableSecuritiesGross" name="InvestmentInNonMarketableSecuritiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SaleOfInvestmentInNonmarketableSecurities" name="SaleOfInvestmentInNonmarketableSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_InvestmentInNonmarketableSecuritiesNet" name="InvestmentInNonmarketableSecuritiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_AccruedPromotionExpenses" name="AccruedPromotionExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OtherAccountPayableAndAccruedLiabilities" name="OtherAccountPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_RelatedPartiesNatureDescriptionAxis" name="RelatedPartiesNatureDescriptionAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="AATP_RelatedPartiesNatureDescriptionDomain" name="RelatedPartiesNatureDescriptionDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_RelatedPartiesRelationshipsDescription" name="RelatedPartiesRelationshipsDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_RelatedPartiesNatureDescription" name="RelatedPartiesNatureDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DeferredTaxLiabilitiesDepreciation" name="DeferredTaxLiabilitiesDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OperatingLossCarryforwardsExpireYear" name="OperatingLossCarryforwardsExpireYear" nillable="true" xbrli:periodType="duration" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_CommissionExpensePercentage" name="CommissionExpensePercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DepositForInsurance" name="DepositForInsurance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_OperatingLeaseEffectiveInterestRate" name="OperatingLeaseEffectiveInterestRate" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_CustomerDepositcurrent" name="CustomerDepositcurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAsl" name="SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAsl" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAsl" name="IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAsl" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AATP_DeferredTaxAssetsDepreciation" name="DeferredTaxAssetsDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>25
<FILENAME>aatp-20201231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://agapeatp.com/role/Cover" xlink:href="aatp-20201231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheets" xlink:href="aatp-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:href="aatp-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:href="aatp-20201231.xsd#StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="aatp-20201231.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfCashFlows" xlink:href="aatp-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:href="aatp-20201231.xsd#OrganizationAndBusinessBackground" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVie" xlink:href="aatp-20201231.xsd#VariableInterestEntityVie" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusninessCombination" xlink:href="aatp-20201231.xsd#BusninessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty" xlink:href="aatp-20201231.xsd#AccountsReceivableAndAccountsReceivableRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Inventories" xlink:href="aatp-20201231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:href="aatp-20201231.xsd#PrepaymentsAndDeposits" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:href="aatp-20201231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNet" xlink:href="aatp-20201231.xsd#IntangibleAssetsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:href="aatp-20201231.xsd#InvestmentInMarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:href="aatp-20201231.xsd#InvestmentInNon-marketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:href="aatp-20201231.xsd#OtherPayablesAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:href="aatp-20201231.xsd#RelatedPartyBalancesAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquity" xlink:href="aatp-20201231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxes" xlink:href="aatp-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:href="aatp-20201231.xsd#ConcentrationsOfRisks" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:href="aatp-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEvents" xlink:href="aatp-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:href="aatp-20201231.xsd#OrganizationAndBusinessBackgroundTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:href="aatp-20201231.xsd#VariableInterestEntityVieTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusninessCombinationTables" xlink:href="aatp-20201231.xsd#BusninessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables" xlink:href="aatp-20201231.xsd#AccountsReceivableAndAccountsReceivableRelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InventoriesTables" xlink:href="aatp-20201231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:href="aatp-20201231.xsd#PrepaymentsAndDepositsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:href="aatp-20201231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:href="aatp-20201231.xsd#IntangibleAssetsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:href="aatp-20201231.xsd#InvestmentInMarketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:href="aatp-20201231.xsd#InvestmentInNon-marketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:href="aatp-20201231.xsd#OtherPayablesAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:href="aatp-20201231.xsd#RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesTables" xlink:href="aatp-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:href="aatp-20201231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfSubsidiariesAndAssociatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:href="aatp-20201231.xsd#OrganizationAndBusinessBackgroundDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="aatp-20201231.xsd#ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:href="aatp-20201231.xsd#ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:href="aatp-20201231.xsd#ScheduleOfVariableInterestEntityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:href="aatp-20201231.xsd#VariableInterestEntityVieDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="aatp-20201231.xsd#SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:href="aatp-20201231.xsd#ScheduleOfProFormaBusinessCombinationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusninessCombinationDetailsNarrative" xlink:href="aatp-20201231.xsd#BusninessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:href="aatp-20201231.xsd#ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:href="aatp-20201231.xsd#ScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="aatp-20201231.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:href="aatp-20201231.xsd#ScheduleOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:href="aatp-20201231.xsd#IntangibleAssetsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:href="aatp-20201231.xsd#InvestmentInMarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:href="aatp-20201231.xsd#InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:href="aatp-20201231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:href="aatp-20201231.xsd#ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:href="aatp-20201231.xsd#ScheduleOfProvisionForIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:href="aatp-20201231.xsd#ScheduleOfEffectiveIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:href="aatp-20201231.xsd#ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:href="aatp-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:href="aatp-20201231.xsd#ConcentrationsOfRisksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfLeaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfPurchaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="aatp-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:href="aatp-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapNotesReceivableRelatedPartiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapNotesReceivableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_us-gaapRevenueFromRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesCommissionsAndFees" xlink:label="loc_us-gaapSalesCommissionsAndFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSalesCommissionsAndFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="loc_AATPPreferredStockDividendIncomeStatementImpact" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_AATPPreferredStockDividendIncomeStatementImpact" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ImpairmentLossInEquityInvestments" xlink:label="loc_AATPImpairmentLossInEquityInvestments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_AATPImpairmentLossInEquityInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="loc_AATPPreferredStockDividendIncomeStatementImpact" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_AATPPreferredStockDividendIncomeStatementImpact" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ImpairmentLossInEquityInvestments" xlink:label="loc_AATPImpairmentLossInEquityInvestments" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_AATPImpairmentLossInEquityInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidTaxes" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_AATPIncreaseDecreaseInOperatingLeaseLiabilities" />
      <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_AATPIncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfInvestmentProjects" xlink:label="loc_us-gaapProceedsFromSaleOfInvestmentProjects" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfInvestmentProjects" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PaymentsToAcquireNonMarketableSecurities" xlink:label="loc_AATPPaymentsToAcquireNonMarketableSecurities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_AATPPaymentsToAcquireNonMarketableSecurities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RepaymentsOfRelatedPartyDebts" xlink:label="loc_AATPRepaymentsOfRelatedPartyDebts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_AATPRepaymentsOfRelatedPartyDebts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:title="00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVie" xlink:title="00000009 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusninessCombination" xlink:title="00000010 - Disclosure - BUSNINESS COMBINATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty" xlink:title="00000011 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:title="00000013 - Disclosure - PREPAYMENTS AND DEPOSITS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:title="00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNet" xlink:title="00000015 - Disclosure - INTANGIBLE ASSETS, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:title="00000016 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:title="00000017 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:title="00000018 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:title="00000019 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquity" xlink:title="00000020 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:title="00000022 - Disclosure - CONCENTRATIONS OF RISKS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:title="00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:title="00000028 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusninessCombinationTables" xlink:title="00000029 - Disclosure - BUSNINESS COMBINATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables" xlink:title="00000030 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InventoriesTables" xlink:title="00000031 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:title="00000032 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:title="00000033 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:title="00000034 - Disclosure - INTANGIBLE ASSETS, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:title="00000035 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:title="00000036 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:title="00000037 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:title="00000038 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesTables" xlink:title="00000039 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:title="00000040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:title="00000041 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:title="00000042 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:title="00000045 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:title="00000049 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000050 - Disclosure - SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusninessCombinationDetailsNarrative" xlink:title="00000052 - Disclosure - BUSNINESS COMBINATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:label="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="loc_us-gaapAccountsReceivableGrossCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="loc_us-gaapAccountsReceivableGrossCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:title="00000054 - Disclosure - SCHEDULE OF INVENTORIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:title="00000055 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ReceivablesFromSalesDistributors" xlink:label="loc_AATPReceivablesFromSalesDistributors" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_AATPReceivablesFromSalesDistributors" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DepositsToSupplier" xlink:label="loc_AATPDepositsToSupplier" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_AATPDepositsToSupplier" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:title="00000056 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000057 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:title="00000058 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:title="00000059 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:title="00000060 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentsIncomeDividend" xlink:label="loc_AATPInvestmentsIncomeDividend" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:to="loc_AATPInvestmentsIncomeDividend" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MarketableSecuritiesUnrealizedHoldingLoss" xlink:label="loc_AATPMarketableSecuritiesUnrealizedHoldingLoss" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:to="loc_AATPMarketableSecuritiesUnrealizedHoldingLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:label="loc_AATPExchangeRateEffectOnInvestmentInMarketableSecurites" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:to="loc_AATPExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:title="00000061 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:title="00000062 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:title="00000063 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:title="00000064 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OtherAccountPayableAndAccruedLiabilities" xlink:label="loc_AATPOtherAccountPayableAndAccruedLiabilities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPOtherAccountPayableAndAccruedLiabilities" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AccruedPromotionExpenses" xlink:label="loc_AATPAccruedPromotionExpenses" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPOtherAccountPayableAndAccruedLiabilities" xlink:to="loc_AATPAccruedPromotionExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPOtherAccountPayableAndAccruedLiabilities" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPOtherAccountPayableAndAccruedLiabilities" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AATPOtherAccountPayableAndAccruedLiabilities" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:title="00000065 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000066 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:title="00000067 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:title="00000068 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapOtherIncomeTaxExpenseBenefitContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherIncomeTaxExpenseBenefitContinuingOperations" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherIncomeTaxExpenseBenefitContinuingOperations" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherIncomeTaxExpenseBenefitContinuingOperations" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherIncomeTaxExpenseBenefitContinuingOperations" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:title="00000069 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:title="00000070 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000071 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000072 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:title="00000073 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:title="00000074 - Disclosure - SCHEDULE OF LEASE COMMITMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" xlink:label="loc_AATPLesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_AATPLesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails" xlink:title="00000075 - Disclosure - SCHEDULE OF PURCHASE COMMITMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:label="loc_us-gaapPurchaseObligationDueInNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPurchaseObligation" xlink:to="loc_us-gaapPurchaseObligationDueInNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="loc_us-gaapPurchaseObligationDueInSecondYear" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPurchaseObligation" xlink:to="loc_us-gaapPurchaseObligationDueInSecondYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="loc_us-gaapPurchaseObligationDueInThirdYear" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPurchaseObligation" xlink:to="loc_us-gaapPurchaseObligationDueInThirdYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="loc_us-gaapPurchaseObligationDueInFourthYear" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPurchaseObligation" xlink:to="loc_us-gaapPurchaseObligationDueInFourthYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear" xlink:label="loc_us-gaapPurchaseObligationDueInFifthYear" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPurchaseObligation" xlink:to="loc_us-gaapPurchaseObligationDueInFifthYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear" xlink:label="loc_us-gaapPurchaseObligationDueAfterFifthYear" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPurchaseObligation" xlink:to="loc_us-gaapPurchaseObligationDueAfterFifthYear" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000076 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000077 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>26
<FILENAME>aatp-20201231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://agapeatp.com/role/Cover" xlink:href="aatp-20201231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheets" xlink:href="aatp-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:href="aatp-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:href="aatp-20201231.xsd#StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="aatp-20201231.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfCashFlows" xlink:href="aatp-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:href="aatp-20201231.xsd#OrganizationAndBusinessBackground" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVie" xlink:href="aatp-20201231.xsd#VariableInterestEntityVie" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusninessCombination" xlink:href="aatp-20201231.xsd#BusninessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty" xlink:href="aatp-20201231.xsd#AccountsReceivableAndAccountsReceivableRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Inventories" xlink:href="aatp-20201231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:href="aatp-20201231.xsd#PrepaymentsAndDeposits" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:href="aatp-20201231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNet" xlink:href="aatp-20201231.xsd#IntangibleAssetsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:href="aatp-20201231.xsd#InvestmentInMarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:href="aatp-20201231.xsd#InvestmentInNon-marketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:href="aatp-20201231.xsd#OtherPayablesAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:href="aatp-20201231.xsd#RelatedPartyBalancesAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquity" xlink:href="aatp-20201231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxes" xlink:href="aatp-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:href="aatp-20201231.xsd#ConcentrationsOfRisks" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:href="aatp-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEvents" xlink:href="aatp-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:href="aatp-20201231.xsd#OrganizationAndBusinessBackgroundTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:href="aatp-20201231.xsd#VariableInterestEntityVieTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusninessCombinationTables" xlink:href="aatp-20201231.xsd#BusninessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables" xlink:href="aatp-20201231.xsd#AccountsReceivableAndAccountsReceivableRelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InventoriesTables" xlink:href="aatp-20201231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:href="aatp-20201231.xsd#PrepaymentsAndDepositsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:href="aatp-20201231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:href="aatp-20201231.xsd#IntangibleAssetsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:href="aatp-20201231.xsd#InvestmentInMarketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:href="aatp-20201231.xsd#InvestmentInNon-marketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:href="aatp-20201231.xsd#OtherPayablesAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:href="aatp-20201231.xsd#RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesTables" xlink:href="aatp-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:href="aatp-20201231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfSubsidiariesAndAssociatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:href="aatp-20201231.xsd#OrganizationAndBusinessBackgroundDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="aatp-20201231.xsd#ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:href="aatp-20201231.xsd#ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:href="aatp-20201231.xsd#ScheduleOfVariableInterestEntityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:href="aatp-20201231.xsd#VariableInterestEntityVieDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="aatp-20201231.xsd#SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:href="aatp-20201231.xsd#ScheduleOfProFormaBusinessCombinationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusninessCombinationDetailsNarrative" xlink:href="aatp-20201231.xsd#BusninessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:href="aatp-20201231.xsd#ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:href="aatp-20201231.xsd#ScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="aatp-20201231.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:href="aatp-20201231.xsd#ScheduleOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:href="aatp-20201231.xsd#IntangibleAssetsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:href="aatp-20201231.xsd#InvestmentInMarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:href="aatp-20201231.xsd#InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:href="aatp-20201231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:href="aatp-20201231.xsd#ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:href="aatp-20201231.xsd#ScheduleOfProvisionForIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:href="aatp-20201231.xsd#ScheduleOfEffectiveIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:href="aatp-20201231.xsd#ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:href="aatp-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:href="aatp-20201231.xsd#ConcentrationsOfRisksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfLeaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfPurchaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="aatp-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:href="aatp-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:title="00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVie" xlink:title="00000009 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusninessCombination" xlink:title="00000010 - Disclosure - BUSNINESS COMBINATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty" xlink:title="00000011 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:title="00000013 - Disclosure - PREPAYMENTS AND DEPOSITS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:title="00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNet" xlink:title="00000015 - Disclosure - INTANGIBLE ASSETS, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:title="00000016 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:title="00000017 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:title="00000018 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:title="00000019 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquity" xlink:title="00000020 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:title="00000022 - Disclosure - CONCENTRATIONS OF RISKS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:title="00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:title="00000028 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusninessCombinationTables" xlink:title="00000029 - Disclosure - BUSNINESS COMBINATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables" xlink:title="00000030 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InventoriesTables" xlink:title="00000031 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:title="00000032 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:title="00000033 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:title="00000034 - Disclosure - INTANGIBLE ASSETS, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:title="00000035 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:title="00000036 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:title="00000037 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:title="00000038 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesTables" xlink:title="00000039 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:title="00000040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:title="00000041 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:label="loc_srtCondensedCashFlowStatementsCaptionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyMember" xlink:label="loc_AATPSubsidiaryCompanyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyOneMember" xlink:label="loc_AATPSubsidiaryCompanyOneMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyOneMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="loc_AATPSubsidiaryCompanyTwoMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyTwoMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="loc_AATPSubsidiaryCompanyThreeMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyThreeMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyFourMember" xlink:label="loc_AATPSubsidiaryCompanyFourMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyFourMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NameOftheCompany" xlink:label="loc_AATPNameOftheCompany_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_AATPNameOftheCompany_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PlaceAndDateOfIncorporation" xlink:label="loc_AATPPlaceAndDateOfIncorporation_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_AATPPlaceAndDateOfIncorporation_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ParticularsOfIssuedCapital" xlink:label="loc_AATPParticularsOfIssuedCapital_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_AATPParticularsOfIssuedCapital_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PrincipalActivities" xlink:label="loc_AATPPrincipalActivities_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_AATPPrincipalActivities_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_100" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:title="00000042 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:label="loc_srtCondensedCashFlowStatementsCaptionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPInternationalHoldingLimitedMember" xlink:label="loc_AATPAgapeATPInternationalHoldingLimitedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAgapeATPInternationalHoldingLimitedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="loc_AATPSubsidiaryCompanyTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyTwoMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="loc_AATPShareExchangeAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareExchangeAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_70" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaapComputerSoftwareIntangibleAssetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapComputerSoftwareIntangibleAssetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:title="00000045 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SurvivorSelectMember" xlink:label="loc_AATPSurvivorSelectMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPSurvivorSelectMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EnergizedMineralConcentrateMember" xlink:label="loc_AATPEnergizedMineralConcentrateMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPEnergizedMineralConcentrateMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IonizedCalMagMember" xlink:label="loc_AATPIonizedCalMagMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPIonizedCalMagMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OmegaBlendMember" xlink:label="loc_AATPOmegaBlendMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPOmegaBlendMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BetaMaxxMember" xlink:label="loc_AATPBetaMaxxMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPBetaMaxxMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VegeFruitFiberMember" xlink:label="loc_AATPVegeFruitFiberMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPVegeFruitFiberMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IronMember" xlink:label="loc_AATPIronMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPIronMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_YoungFormulaMember" xlink:label="loc_AATPYoungFormulaMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPYoungFormulaMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OrganicYouthCareCleansingBarMember" xlink:label="loc_AATPOrganicYouthCareCleansingBarMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPOrganicYouthCareCleansingBarMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MitogizeMember" xlink:label="loc_AATPMitogizeMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPMitogizeMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoOneMEDMember" xlink:label="loc_AATPNoOneMEDMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPNoOneMEDMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EnergetiqueMember" xlink:label="loc_AATPEnergetiqueMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPEnergetiqueMember_330" xlink:type="arc" order="331" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_TrimPlusMember" xlink:label="loc_AATPTrimPlusMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPTrimPlusMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenues_430" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaapDerivativeLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaapVariableRateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapVariableRateAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodEndMYRMember" xlink:label="loc_AATPPeriodEndMYRMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodEndMYRMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodEndHKDMember" xlink:label="loc_AATPPeriodEndHKDMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodEndHKDMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodAverageMYRMember" xlink:label="loc_AATPPeriodAverageMYRMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodAverageMYRMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodAverageHKDMember" xlink:label="loc_AATPPeriodAverageHKDMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodAverageHKDMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateTranslation1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapForeignCurrencyExchangeRateTranslation1_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ForeignCurrencyExchangeRateAverage" xlink:label="loc_AATPForeignCurrencyExchangeRateAverage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_AATPForeignCurrencyExchangeRateAverage_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HealthAndWellnessProductsMember" xlink:label="loc_AATPHealthAndWellnessProductsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPHealthAndWellnessProductsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SocialSecurityOrganizationMember" xlink:label="loc_AATPSocialSecurityOrganizationMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPSocialSecurityOrganizationMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EmployeesProvidentFundMember" xlink:label="loc_AATPEmployeesProvidentFundMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPEmployeesProvidentFundMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EmploymentInsuranceSystemMember" xlink:label="loc_AATPEmploymentInsuranceSystemMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPEmploymentInsuranceSystemMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HumanResourceDevelopmentFundMember" xlink:label="loc_AATPHumanResourceDevelopmentFundMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPHumanResourceDevelopmentFundMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MYRCurrencyMember" xlink:label="loc_AATPMYRCurrencyMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_AATPMYRCurrencyMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapInventoryWriteDown_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:label="loc_AATPAllowanceForDoubtfulAccountsReceivablesCurrent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPAllowanceForDoubtfulAccountsReceivablesCurrent_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ForfeitedCouponIncome" xlink:label="loc_AATPForfeitedCouponIncome_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPForfeitedCouponIncome_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSellingExpense_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SalesCommissionsAndFees1" xlink:label="loc_AATPSalesCommissionsAndFees1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPSalesCommissionsAndFees1_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaapDefinedContributionPlanEmployerDiscretionaryContributionAmount_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDefinedContributionPlanEmployerDiscretionaryContributionAmount_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SalaryPercentage" xlink:label="loc_AATPSalaryPercentage_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPSalaryPercentage_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MonthlySalary" xlink:label="loc_AATPMonthlySalary_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPMonthlySalary_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement_160" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense_160" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDescription" xlink:label="loc_us-gaapMinorityInterestDescription_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterestDescription_160" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterest_160" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_160" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivityGainsAndLossesLineItems" xlink:label="loc_us-gaapTradingActivityGainsAndLossesLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivitiesGainLossByTypeTable" xlink:label="loc_us-gaapTradingActivitiesGainLossByTypeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapTradingActivitiesGainLossByTypeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivityByTypeAxis" xlink:label="loc_us-gaapTradingActivityByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapTradingActivitiesGainLossByTypeTable" xlink:to="loc_us-gaapTradingActivityByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivityByTypeDomain" xlink:label="loc_us-gaapTradingActivityByTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTradingActivityByTypeAxis" xlink:to="loc_us-gaapTradingActivityByTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivityByTypeDomain" xlink:label="loc_us-gaapTradingActivityByTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTradingActivityByTypeAxis" xlink:to="loc_us-gaapTradingActivityByTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableIncomeInterestRateMember" xlink:label="loc_us-gaapVariableIncomeInterestRateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityByTypeDomain" xlink:to="loc_us-gaapVariableIncomeInterestRateMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapAssetsCurrent_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapStockholdersEquity_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapPrepaidTaxes_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OtherPayablesRelatedPartyCurrent" xlink:label="loc_AATPOtherPayablesRelatedPartyCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_AATPOtherPayablesRelatedPartyCurrent_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapGrossProfit_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapNetIncomeLoss_30" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:title="00000049 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="loc_AATPSubsidiaryCompanyThreeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyThreeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000050 - Disclosure - SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusninessCombinationDetailsNarrative" xlink:title="00000052 - Disclosure - BUSNINESS COMBINATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="loc_AATPShareExchangeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareExchangeAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingSdnBhdMember" xlink:label="loc_AATPAgapeSuperiorLivingSdnBhdMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingSdnBhdMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPMrHowKokChoongMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaapCommonStockNoParValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockNoParValue_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:label="loc_AATPPercentageOfCommonStockIssuedAndOutstanding_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_AATPPercentageOfCommonStockIssuedAndOutstanding_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCash_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimeDeposits" xlink:label="loc_us-gaapTimeDeposits_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapTimeDeposits_120" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:label="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_120" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:title="00000054 - Disclosure - SCHEDULE OF INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:title="00000055 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:title="00000056 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ComputerAndOfficeEquipmentMember" xlink:label="loc_AATPComputerAndOfficeEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPComputerAndOfficeEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VehicleMember" xlink:label="loc_AATPVehicleMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPVehicleMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000057 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:title="00000058 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:title="00000059 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:title="00000060 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:title="00000061 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityListingsLineItems" xlink:label="loc_deiEntityListingsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityListingsLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_GreenproCapitalCorpMember" xlink:label="loc_AATPGreenproCapitalCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPGreenproCapitalCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DSwissIncMember" xlink:label="loc_AATPDSwissIncMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPDSwissIncMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityListingsLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityListingsLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityListingsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_60" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:title="00000062 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DirectorsOfUnreservedInvestmentMember" xlink:label="loc_AATPDirectorsOfUnreservedInvestmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPDirectorsOfUnreservedInvestmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="loc_AATPPhoenixPlusCorpMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPPhoenixPlusCorpMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesGross" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesGross_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesGross_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:label="loc_AATPSaleOfInvestmentInNonmarketableSecurities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_AATPSaleOfInvestmentInNonmarketableSecurities_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonmarketableSecuritiesNet" xlink:label="loc_AATPInvestmentInNonmarketableSecuritiesNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonmarketableSecuritiesNet_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:title="00000063 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:label="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_UnreservedSdnBhdMember" xlink:label="loc_AATPUnreservedSdnBhdMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPUnreservedSdnBhdMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MYRCurrencyMember" xlink:label="loc_AATPMYRCurrencyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_AATPMYRCurrencyMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="loc_AATPPhoenixPlusCorpMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPPhoenixPlusCorpMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:label="loc_us-gaapDueFromOfficersOrStockholdersCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapDueFromOfficersOrStockholdersCurrent_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_120" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:title="00000064 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:title="00000065 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SeaMember" xlink:label="loc_AATPSeaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPSeaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPAsiaLimitedMember" xlink:label="loc_AATPAgapeATPAsiaLimitedMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeATPAsiaLimitedMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HostastaySdnBhdMember" xlink:label="loc_AATPHostastaySdnBhdMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHostastaySdnBhdMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_THThreeTechnologySdnBhdMember" xlink:label="loc_AATPTHThreeTechnologySdnBhdMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPTHThreeTechnologySdnBhdMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPMrHowKokChoongMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingPtyLtdMember" xlink:label="loc_AATPAgapeSuperiorLivingPtyLtdMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingPtyLtdMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:label="loc_AATPAgapeSuperiorLivingPtyLtdASLPLMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingPtyLtdASLPLMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HostastaySdnBhdOneMember" xlink:label="loc_AATPHostastaySdnBhdOneMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHostastaySdnBhdOneMember_350" xlink:type="arc" order="351" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesNatureDescriptionAxis" xlink:label="loc_AATPRelatedPartiesNatureDescriptionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_AATPRelatedPartiesNatureDescriptionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesNatureDescriptionDomain" xlink:label="loc_AATPRelatedPartiesNatureDescriptionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_AATPRelatedPartiesNatureDescriptionAxis" xlink:to="loc_AATPRelatedPartiesNatureDescriptionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesNatureDescriptionDomain" xlink:label="loc_AATPRelatedPartiesNatureDescriptionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_AATPRelatedPartiesNatureDescriptionAxis" xlink:to="loc_AATPRelatedPartiesNatureDescriptionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SeaMember" xlink:label="loc_AATPSeaMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_AATPRelatedPartiesNatureDescriptionDomain" xlink:to="loc_AATPSeaMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesRelationshipsDescription" xlink:label="loc_AATPRelatedPartiesRelationshipsDescription_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPRelatedPartiesRelationshipsDescription_390" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesNatureDescription" xlink:label="loc_AATPRelatedPartiesNatureDescription_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPRelatedPartiesNatureDescription_390" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties" xlink:label="loc_us-gaapAccountsReceivableRelatedParties_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccountsReceivableRelatedParties_390" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="loc_us-gaapDueFromRelatedParties_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueFromRelatedParties_390" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_390" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRevenueFromRelatedParties_390" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherIncome_390" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000066 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="loc_AATPAgapeSuperiorLivingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_AATPAgapeSuperiorLivingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:label="loc_us-gaapNoncontrollingInterestIncreaseFromBusinessCombination_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapNoncontrollingInterestIncreaseFromBusinessCombination_90" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:title="00000067 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems" xlink:label="loc_srtMortgageLoansOnRealEstateLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_MY" xlink:label="loc_countryMY_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_HK" xlink:label="loc_countryHK_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryHK_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:title="00000068 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:title="00000069 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:title="00000070 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:label="loc_srtCondensedCashFlowStatementsCaptionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPInternationalHoldingLimitedMember" xlink:label="loc_AATPAgapeATPInternationalHoldingLimitedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAgapeATPInternationalHoldingLimitedMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPCorporationMember" xlink:label="loc_AATPAgapeATPCorporationMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAgapeATPCorporationMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000071 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems" xlink:label="loc_srtMortgageLoansOnRealEstateLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_countryUS_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_MY" xlink:label="loc_countryMY_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_AATPDeferredTaxLiabilitiesDepreciation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_AATPDeferredTaxLiabilitiesDepreciation_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000072 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_countryUS_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_LabuanMember" xlink:label="loc_AATPLabuanMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_AATPLabuanMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_MY" xlink:label="loc_countryMY_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_HK" xlink:label="loc_countryHK_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryHK_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IfUnutilizedMember" xlink:label="loc_AATPIfUnutilizedMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_AATPIfUnutilizedMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:label="loc_us-gaapTaxCutsAndJobsActOf2017OtherTaxEffectDescription_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapTaxCutsAndJobsActOf2017OtherTaxEffectDescription_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OperatingLossCarryforwardsExpireYear" xlink:label="loc_AATPOperatingLossCarryforwardsExpireYear_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_AATPOperatingLossCarryforwardsExpireYear_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription_140" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:title="00000073 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderAccountBalanceLineItems" xlink:label="loc_us-gaapPolicyholderAccountBalanceLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoCustomerMember" xlink:label="loc_AATPNoCustomerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPNoCustomerMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OneCustomerMember" xlink:label="loc_AATPOneCustomerMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPOneCustomerMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VendorOneMember" xlink:label="loc_AATPVendorOneMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPVendorOneMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VendorTwoMember" xlink:label="loc_AATPVendorTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPVendorTwoMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ECommerceCompanyMember" xlink:label="loc_AATPECommerceCompanyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPECommerceCompanyMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DSwissIncMember" xlink:label="loc_AATPDSwissIncMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPDSwissIncMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoSalesMember" xlink:label="loc_AATPNoSalesMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_AATPNoSalesMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis" xlink:label="loc_us-gaapExtinguishmentOfDebtAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapExtinguishmentOfDebtAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:label="loc_us-gaapExtinguishmentOfDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapExtinguishmentOfDebtAxis" xlink:to="loc_us-gaapExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:label="loc_us-gaapExtinguishmentOfDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapExtinguishmentOfDebtAxis" xlink:to="loc_us-gaapExtinguishmentOfDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapExtinguishmentOfDebtTypeDomain" xlink:to="loc_us-gaapAccountsPayableMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived" xlink:label="loc_us-gaapProceedsFromDividendsReceived_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_us-gaapProceedsFromDividendsReceived_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_CommissionExpensePercentage" xlink:label="loc_AATPCommissionExpensePercentage_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_AATPCommissionExpensePercentage_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_us-gaapCash_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DepositForInsurance" xlink:label="loc_AATPDepositForInsurance_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_AATPDepositForInsurance_200" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:title="00000074 - Disclosure - SCHEDULE OF LEASE COMMITMENTS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails" xlink:title="00000075 - Disclosure - SCHEDULE OF PURCHASE COMMITMENTS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000076 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="loc_AATPAgapeSuperiorLivingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_AATPAgapeSuperiorLivingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OperatingLeaseEffectiveInterestRate" xlink:label="loc_AATPOperatingLeaseEffectiveInterestRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_AATPOperatingLeaseEffectiveInterestRate_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000077 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SellersMember" xlink:label="loc_AATPSellersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPSellersMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VettonsSdnBhdMember" xlink:label="loc_AATPVettonsSdnBhdMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPVettonsSdnBhdMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_40" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>27
<FILENAME>aatp-20201231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPInternationalHoldingLimitedMember" xlink:label="AATP_AgapeATPInternationalHoldingLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeATPInternationalHoldingLimitedMember" xlink:to="AATP_AgapeATPInternationalHoldingLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeATPInternationalHoldingLimitedMember_lbl" xml:lang="en-US">Agape ATP International Holding Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="AATP_ShareExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareExchangeAgreementMember" xlink:to="AATP_ShareExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ShareExchangeAgreementMember_lbl" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="AATP_MrHowKokChoongMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MrHowKokChoongMember" xlink:to="AATP_MrHowKokChoongMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MrHowKokChoongMember_lbl" xml:lang="en-US">Mr.How Kok Choong [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="AATP_SubsidiaryCompanyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyTwoMember" xlink:to="AATP_SubsidiaryCompanyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyTwoMember_lbl" xml:lang="en-US">Subsidiary Company Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyMember" xlink:label="AATP_SubsidiaryCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyMember" xlink:to="AATP_SubsidiaryCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyMember_lbl" xml:lang="en-US">Subsidiary Company [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyOneMember" xlink:label="AATP_SubsidiaryCompanyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyOneMember" xlink:to="AATP_SubsidiaryCompanyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyOneMember_lbl" xml:lang="en-US">Subsidiary Company One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="AATP_SubsidiaryCompanyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyThreeMember" xlink:to="AATP_SubsidiaryCompanyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyThreeMember_lbl" xml:lang="en-US">Subsidiary Company Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyFourMember" xlink:label="AATP_SubsidiaryCompanyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyFourMember" xlink:to="AATP_SubsidiaryCompanyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SubsidiaryCompanyFourMember_lbl" xml:lang="en-US">Subsidiary Company Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HealthAndWellnessProductsMember" xlink:label="AATP_HealthAndWellnessProductsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HealthAndWellnessProductsMember" xlink:to="AATP_HealthAndWellnessProductsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HealthAndWellnessProductsMember_lbl" xml:lang="en-US">Health and Wellness Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SurvivorSelectMember" xlink:label="AATP_SurvivorSelectMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SurvivorSelectMember" xlink:to="AATP_SurvivorSelectMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SurvivorSelectMember_lbl" xml:lang="en-US">Survivor Select [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EnergizedMineralConcentrateMember" xlink:label="AATP_EnergizedMineralConcentrateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EnergizedMineralConcentrateMember" xlink:to="AATP_EnergizedMineralConcentrateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_EnergizedMineralConcentrateMember_lbl" xml:lang="en-US">Energized Mineral Concentrate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IonizedCalMagMember" xlink:label="AATP_IonizedCalMagMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IonizedCalMagMember" xlink:to="AATP_IonizedCalMagMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IonizedCalMagMember_lbl" xml:lang="en-US">Ionized Cal-Mag [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OmegaBlendMember" xlink:label="AATP_OmegaBlendMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OmegaBlendMember" xlink:to="AATP_OmegaBlendMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OmegaBlendMember_lbl" xml:lang="en-US">Omega Blend [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BetaMaxxMember" xlink:label="AATP_BetaMaxxMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BetaMaxxMember" xlink:to="AATP_BetaMaxxMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BetaMaxxMember_lbl" xml:lang="en-US">BetaMaxx [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VegeFruitFiberMember" xlink:label="AATP_VegeFruitFiberMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VegeFruitFiberMember" xlink:to="AATP_VegeFruitFiberMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VegeFruitFiberMember_lbl" xml:lang="en-US">Vege Fruit Fiber [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IronMember" xlink:label="AATP_IronMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IronMember" xlink:to="AATP_IronMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IronMember_lbl" xml:lang="en-US">Iron [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_YoungFormulaMember" xlink:label="AATP_YoungFormulaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_YoungFormulaMember" xlink:to="AATP_YoungFormulaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_YoungFormulaMember_lbl" xml:lang="en-US">Young Formula [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OrganicYouthCareCleansingBarMember" xlink:label="AATP_OrganicYouthCareCleansingBarMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OrganicYouthCareCleansingBarMember" xlink:to="AATP_OrganicYouthCareCleansingBarMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OrganicYouthCareCleansingBarMember_lbl" xml:lang="en-US">Organic Youth Care Cleansing Bar [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MitogizeMember" xlink:label="AATP_MitogizeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MitogizeMember" xlink:to="AATP_MitogizeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MitogizeMember_lbl" xml:lang="en-US">Mitogize [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoOneMEDMember" xlink:label="AATP_NoOneMEDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoOneMEDMember" xlink:to="AATP_NoOneMEDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NoOneMEDMember_lbl" xml:lang="en-US">No. 1 MED [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EnergetiqueMember" xlink:label="AATP_EnergetiqueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EnergetiqueMember" xlink:to="AATP_EnergetiqueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_EnergetiqueMember_lbl" xml:lang="en-US">Energetique [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_TrimPlusMember" xlink:label="AATP_TrimPlusMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_TrimPlusMember" xlink:to="AATP_TrimPlusMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_TrimPlusMember_lbl" xml:lang="en-US">Trim+ [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="us-gaap_ShippingAndHandlingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingMember" xlink:to="us-gaap_ShippingAndHandlingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingMember_lbl" xml:lang="en-US">Shipping and Handling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SocialSecurityOrganizationMember" xlink:label="AATP_SocialSecurityOrganizationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SocialSecurityOrganizationMember" xlink:to="AATP_SocialSecurityOrganizationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SocialSecurityOrganizationMember_lbl" xml:lang="en-US">Social Security Organization [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MYRCurrencyMember" xlink:label="AATP_MYRCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MYRCurrencyMember" xlink:to="AATP_MYRCurrencyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MYRCurrencyMember_lbl" xml:lang="en-US">MYR Currency [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EmployeesProvidentFundMember" xlink:label="AATP_EmployeesProvidentFundMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EmployeesProvidentFundMember" xlink:to="AATP_EmployeesProvidentFundMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_EmployeesProvidentFundMember_lbl" xml:lang="en-US">Employees Provident Fund [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EmploymentInsuranceSystemMember" xlink:label="AATP_EmploymentInsuranceSystemMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EmploymentInsuranceSystemMember" xlink:to="AATP_EmploymentInsuranceSystemMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_EmploymentInsuranceSystemMember_lbl" xml:lang="en-US">Employment Insurance System [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HumanResourceDevelopmentFundMember" xlink:label="AATP_HumanResourceDevelopmentFundMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HumanResourceDevelopmentFundMember" xlink:to="AATP_HumanResourceDevelopmentFundMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HumanResourceDevelopmentFundMember_lbl" xml:lang="en-US">Human Resource Development Fund [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US">Variable Rate [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodEndMYRMember" xlink:label="AATP_PeriodEndMYRMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodEndMYRMember" xlink:to="AATP_PeriodEndMYRMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PeriodEndMYRMember_lbl" xml:lang="en-US">Period-end MYR [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodEndHKDMember" xlink:label="AATP_PeriodEndHKDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodEndHKDMember" xlink:to="AATP_PeriodEndHKDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PeriodEndHKDMember_lbl" xml:lang="en-US">Period-end HKD [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodAverageMYRMember" xlink:label="AATP_PeriodAverageMYRMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodAverageMYRMember" xlink:to="AATP_PeriodAverageMYRMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PeriodAverageMYRMember_lbl" xml:lang="en-US">Period-average MYR [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodAverageHKDMember" xlink:label="AATP_PeriodAverageHKDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodAverageHKDMember" xlink:to="AATP_PeriodAverageHKDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PeriodAverageHKDMember_lbl" xml:lang="en-US">Period-average HKD [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivityByTypeAxis" xlink:label="us-gaap_TradingActivityByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingActivityByTypeAxis" xlink:to="us-gaap_TradingActivityByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingActivityByTypeAxis_lbl" xml:lang="en-US">Trading Activity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableIncomeInterestRateMember" xlink:label="us-gaap_VariableIncomeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableIncomeInterestRateMember" xlink:to="us-gaap_VariableIncomeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableIncomeInterestRateMember_lbl" xml:lang="en-US">Variable Income Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingSdnBhdMember" xlink:label="AATP_AgapeSuperiorLivingSdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingSdnBhdMember" xlink:to="AATP_AgapeSuperiorLivingSdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeSuperiorLivingSdnBhdMember_lbl" xml:lang="en-US">Agape Superior Living Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ComputerAndOfficeEquipmentMember" xlink:label="AATP_ComputerAndOfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ComputerAndOfficeEquipmentMember" xlink:to="AATP_ComputerAndOfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ComputerAndOfficeEquipmentMember_lbl" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VehicleMember" xlink:label="AATP_VehicleMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VehicleMember" xlink:to="AATP_VehicleMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VehicleMember_lbl" xml:lang="en-US">Vehicle [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_GreenproCapitalCorpMember" xlink:label="AATP_GreenproCapitalCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_GreenproCapitalCorpMember" xlink:to="AATP_GreenproCapitalCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_GreenproCapitalCorpMember_lbl" xml:lang="en-US">Greenpro Capital Corp. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DSwissIncMember" xlink:label="AATP_DSwissIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DSwissIncMember" xlink:to="AATP_DSwissIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DSwissIncMember_lbl" xml:lang="en-US">D Swiss Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_UnreservedSdnBhdMember" xlink:label="AATP_UnreservedSdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_UnreservedSdnBhdMember" xlink:to="AATP_UnreservedSdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_UnreservedSdnBhdMember_lbl" xml:lang="en-US">Unreserved Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="AATP_PhoenixPlusCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PhoenixPlusCorpMember" xlink:to="AATP_PhoenixPlusCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PhoenixPlusCorpMember_lbl" xml:lang="en-US">Phoenix Plus Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DirectorsOfUnreservedInvestmentMember" xlink:label="AATP_DirectorsOfUnreservedInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DirectorsOfUnreservedInvestmentMember" xlink:to="AATP_DirectorsOfUnreservedInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DirectorsOfUnreservedInvestmentMember_lbl" xml:lang="en-US">Directors of Unreserved Investments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SeaMember" xlink:label="AATP_SeaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SeaMember" xlink:to="AATP_SeaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SeaMember_lbl" xml:lang="en-US">Sea [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesNatureDescriptionAxis" xlink:label="AATP_RelatedPartiesNatureDescriptionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesNatureDescriptionAxis" xlink:to="AATP_RelatedPartiesNatureDescriptionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_RelatedPartiesNatureDescriptionAxis_lbl" xml:lang="en-US">Related Parties Nature Description [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPAsiaLimitedMember" xlink:label="AATP_AgapeATPAsiaLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeATPAsiaLimitedMember" xlink:to="AATP_AgapeATPAsiaLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeATPAsiaLimitedMember_lbl" xml:lang="en-US">Agape A T P Asia Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HostastaySdnBhdMember" xlink:label="AATP_HostastaySdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HostastaySdnBhdMember" xlink:to="AATP_HostastaySdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HostastaySdnBhdMember_lbl" xml:lang="en-US">Hostastay Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_THThreeTechnologySdnBhdMember" xlink:label="AATP_THThreeTechnologySdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_THThreeTechnologySdnBhdMember" xlink:to="AATP_THThreeTechnologySdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_THThreeTechnologySdnBhdMember_lbl" xml:lang="en-US">T H Three Technology Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingPtyLtdMember" xlink:label="AATP_AgapeSuperiorLivingPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingPtyLtdMember" xlink:to="AATP_AgapeSuperiorLivingPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeSuperiorLivingPtyLtdMember_lbl" xml:lang="en-US">Agape Superior Living Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:label="AATP_AgapeSuperiorLivingPtyLtdASLPLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:to="AATP_AgapeSuperiorLivingPtyLtdASLPLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeSuperiorLivingPtyLtdASLPLMember_lbl" xml:lang="en-US">Agape Superior Living Pty Ltd ASLPL [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HostastaySdnBhdOneMember" xlink:label="AATP_HostastaySdnBhdOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HostastaySdnBhdOneMember" xlink:to="AATP_HostastaySdnBhdOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_HostastaySdnBhdOneMember_lbl" xml:lang="en-US">Hostastay Sdn. Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="AATP_AgapeSuperiorLivingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingMember" xlink:to="AATP_AgapeSuperiorLivingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeSuperiorLivingMember_lbl" xml:lang="en-US">ASL [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_MY" xlink:label="country_MY" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_MY" xlink:to="country_MY_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_MY_lbl" xml:lang="en-US">MALAYSIA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_HK" xlink:label="country_HK" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_HK_lbl" xml:lang="en-US">HONG KONG</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IfUnutilizedMember" xlink:label="AATP_IfUnutilizedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IfUnutilizedMember" xlink:to="AATP_IfUnutilizedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IfUnutilizedMember_lbl" xml:lang="en-US">If Unutilized [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_LabuanMember" xlink:label="AATP_LabuanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_LabuanMember" xlink:to="AATP_LabuanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_LabuanMember_lbl" xml:lang="en-US">Labuan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPCorporationMember" xlink:label="AATP_AgapeATPCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeATPCorporationMember" xlink:to="AATP_AgapeATPCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AgapeATPCorporationMember_lbl" xml:lang="en-US">Agape A T P Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoCustomerMember" xlink:label="AATP_NoCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoCustomerMember" xlink:to="AATP_NoCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NoCustomerMember_lbl" xml:lang="en-US">No Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerMember" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_lbl" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OneCustomerMember" xlink:label="AATP_OneCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OneCustomerMember" xlink:to="AATP_OneCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OneCustomerMember_lbl" xml:lang="en-US">One Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ECommerceCompanyMember" xlink:label="AATP_ECommerceCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ECommerceCompanyMember" xlink:to="AATP_ECommerceCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ECommerceCompanyMember_lbl" xml:lang="en-US">E-commerce [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VendorOneMember" xlink:label="AATP_VendorOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VendorOneMember" xlink:to="AATP_VendorOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VendorOneMember_lbl" xml:lang="en-US">Vendor One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VendorTwoMember" xlink:label="AATP_VendorTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VendorTwoMember" xlink:to="AATP_VendorTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VendorTwoMember_lbl" xml:lang="en-US">Vendor Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoSalesMember" xlink:label="AATP_NoSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoSalesMember" xlink:to="AATP_NoSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NoSalesMember_lbl" xml:lang="en-US">No Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis" xlink:label="us-gaap_ExtinguishmentOfDebtAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtAxis_lbl" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SellersMember" xlink:label="AATP_SellersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SellersMember" xlink:to="AATP_SellersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SellersMember_lbl" xml:lang="en-US">Sellers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VettonsSdnBhdMember" xlink:label="AATP_VettonsSdnBhdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VettonsSdnBhdMember" xlink:to="AATP_VettonsSdnBhdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VettonsSdnBhdMember_lbl" xml:lang="en-US">Vettons Sdn Bhd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents (Included $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2020)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xml:lang="en-US">Accounts receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:label="us-gaap_NotesReceivableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:to="us-gaap_NotesReceivableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableRelatedPartiesCurrent_lbl" xml:lang="en-US">Amount due from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidTaxes_lbl" xml:lang="en-US">Prepaid taxes (Included $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2020)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepayments and deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl" xml:lang="en-US">OTHER ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xml:lang="en-US">Investment in marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:to="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_lbl" xml:lang="en-US">Investment in non-marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Total other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_OtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_OtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Other payables and accrued liabilities ($1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2020)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Amount due to a related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">NON-CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Non-current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,452,047 and 376,275,500 shares issued and outstanding as of December 31, 2020 and December 31, 2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_lbl" xml:lang="en-US">VIE consolidated amount of cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_lbl" xml:lang="en-US">VIE consolidated amount of prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_lbl" xml:lang="en-US">VIE consolidated amount of other payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="us-gaap_RevenueFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_RevenueFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromRelatedParties_lbl" xml:lang="en-US">REVENUE &#8211; RELATED PARTY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">TOTAL REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">COST OF REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">GROSS PROFIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingExpense" xlink:label="us-gaap_SellingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingExpense" xlink:to="us-gaap_SellingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SellingExpense_lbl" xml:lang="en-US">SELLING</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesCommissionsAndFees" xlink:label="us-gaap_SalesCommissionsAndFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesCommissionsAndFees" xlink:to="us-gaap_SalesCommissionsAndFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SalesCommissionsAndFees_lbl" xml:lang="en-US">COMMISSION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">GENERAL AND ADMINISTRATIVE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">TOTAL OPERATING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">LOSS FROM OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">OTHER INCOME/(EXPENSES)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other Income/(Expenses), Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Loss from equity investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized holding gain (loss) on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="AATP_PreferredStockDividendIncomeStatementImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PreferredStockDividendIncomeStatementImpact" xlink:to="AATP_PreferredStockDividendIncomeStatementImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AATP_PreferredStockDividendIncomeStatementImpact_lbl" xml:lang="en-US">Dividend income from marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_lbl" xml:lang="en-US">Gain on deemed disposal of shares in Investee Company</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ImpairmentLossInEquityInvestments" xlink:label="AATP_ImpairmentLossInEquityInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ImpairmentLossInEquityInvestments" xlink:to="AATP_ImpairmentLossInEquityInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ImpairmentLossInEquityInvestments_lbl" xml:lang="en-US">Impairment loss in equity investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">TOTAL OTHER INCOME/(EXPENSES), NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">INCOME (LOSS) BEFORE INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">(PROVISION FOR) BENEFIT OF INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET INCOME (LOSS)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">OTHER COMPREHENSIVE INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Foreign currency translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">NET LOSS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">ssuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash (used in) operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of operating right-of-use assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Loss from equity investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xml:lang="en-US">Unrealized holding (gain) loss on marketable securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PreferredStockDividendIncomeStatementImpact" xlink:to="AATP_PreferredStockDividendIncomeStatementImpact_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PreferredStockDividendIncomeStatementImpact_2_lbl" xml:lang="en-US">Dividend income from marketable securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2_lbl" xml:lang="en-US">Gain on deemed disposal of shares in investee company</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ImpairmentLossInEquityInvestments" xlink:to="AATP_ImpairmentLossInEquityInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AATP_ImpairmentLossInEquityInvestments_2_lbl" xml:lang="en-US">Impairment loss in equity investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl" xml:lang="en-US">Accounts receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_lbl" xml:lang="en-US">Amount due from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl" xml:lang="en-US">Prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepayments and deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl" xml:lang="en-US">Accounts payable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Other payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfInvestmentProjects" xlink:label="us-gaap_ProceedsFromSaleOfInvestmentProjects" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfInvestmentProjects" xlink:to="us-gaap_ProceedsFromSaleOfInvestmentProjects_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfInvestmentProjects_lbl" xml:lang="en-US">Proceeds from sale of investment in marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchase of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US">Cash acquired through acquisition of Agape superior Living Sdn Bhd</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:to="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_lbl" xml:lang="en-US">Proceeds from sale of non-marketable securities to a related party</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PaymentsToAcquireNonMarketableSecurities" xlink:label="AATP_PaymentsToAcquireNonMarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PaymentsToAcquireNonMarketableSecurities" xlink:to="AATP_PaymentsToAcquireNonMarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AATP_PaymentsToAcquireNonMarketableSecurities_lbl" xml:lang="en-US">Investment in non-marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RepaymentsOfRelatedPartyDebts" xlink:label="AATP_RepaymentsOfRelatedPartyDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RepaymentsOfRelatedPartyDebts" xlink:to="AATP_RepaymentsOfRelatedPartyDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AATP_RepaymentsOfRelatedPartyDebts_lbl" xml:lang="en-US">Repayments from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Amount due to a related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of end</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOWS INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL NON-CASH FLOWS INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" xlink:label="AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" xlink:to="AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities_lbl" xml:lang="en-US">Amount transferred from investment in investee company to non-marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:label="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:to="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_lbl" xml:lang="en-US">Initial recognition of right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:label="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:to="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_lbl" xml:lang="en-US">Sale of non-marketable securities to a related party in exchange for acquisition payment of Agape Superior Living Sdn Bhd</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:label="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:to="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_lbl" xml:lang="en-US">Issuance of common stock in exchange for acquisition of Agape Superior Living Sdn Bhd</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">ORGANIZATION AND BUSINESS BACKGROUND</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl" xml:lang="en-US">VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US">Business Combinations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">BUSNINESS COMBINATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:label="AATP_DisclosurePrepaymentsAndDepositsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:to="AATP_DisclosurePrepaymentsAndDepositsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DisclosurePrepaymentsAndDepositsAbstract_lbl" xml:lang="en-US">Prepayments And Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PrepaymentsAndDepositsTextBlock" xlink:label="AATP_PrepaymentsAndDepositsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaymentsAndDepositsTextBlock" xlink:to="AATP_PrepaymentsAndDepositsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PrepaymentsAndDepositsTextBlock_lbl" xml:lang="en-US">PREPAYMENTS AND DEPOSITS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">INTANGIBLE ASSETS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract_lbl" xml:lang="en-US">Investment In Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInMarketableSecuritiesTextBlock" xlink:label="AATP_InvestmentInMarketableSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInMarketableSecuritiesTextBlock" xlink:to="AATP_InvestmentInMarketableSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInMarketableSecuritiesTextBlock_lbl" xml:lang="en-US">INVESTMENT IN MARKETABLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract_lbl" xml:lang="en-US">Investment In Non-marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesTextBlock" xlink:label="AATP_InvestmentInNonMarketableSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesTextBlock" xlink:to="AATP_InvestmentInNonMarketableSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInNonMarketableSecuritiesTextBlock_lbl" xml:lang="en-US">INVESTMENT IN NON-MARKETABLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER PAYABLES AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY BALANCES AND TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">CONCENTRATIONS OF RISKS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod" xlink:label="us-gaap_FiscalPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiscalPeriod" xlink:to="us-gaap_FiscalPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiscalPeriod_lbl" xml:lang="en-US">Change of year end</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts receivable and accounts receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PrepaidTaxesPolicyTextBlock" xlink:label="AATP_PrepaidTaxesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaidTaxesPolicyTextBlock" xlink:to="AATP_PrepaidTaxesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PrepaidTaxesPolicyTextBlock_lbl" xml:lang="en-US">Prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:label="AATP_PrepaymentsAndDepositsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:to="AATP_PrepaymentsAndDepositsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_PrepaymentsAndDepositsPolicyTextBlock_lbl" xml:lang="en-US">Prepayments and deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment for long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Investment in marketable equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NonMarketableSecuritiesPolicyTextBlock" xlink:label="AATP_NonMarketableSecuritiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonMarketableSecuritiesPolicyTextBlock" xlink:to="AATP_NonMarketableSecuritiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NonMarketableSecuritiesPolicyTextBlock_lbl" xml:lang="en-US">Investment in non-marketable equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ShippingAndHandlingPolicyTextBlock" xlink:label="AATP_ShippingAndHandlingPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShippingAndHandlingPolicyTextBlock" xlink:to="AATP_ShippingAndHandlingPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ShippingAndHandlingPolicyTextBlock_lbl" xml:lang="en-US">Shipping and handling</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:label="us-gaap_CommissionsExpensePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:to="us-gaap_CommissionsExpensePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommissionsExpensePolicyPolicyTextBlock_lbl" xml:lang="en-US">Commission expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DefinedContributionPlanPolicyTextBlock" xlink:label="AATP_DefinedContributionPlanPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DefinedContributionPlanPolicyTextBlock" xlink:to="AATP_DefinedContributionPlanPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DefinedContributionPlanPolicyTextBlock_lbl" xml:lang="en-US">Defined contribution plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoncontrollingInterestPolicyTextBlock" xlink:label="AATP_NoncontrollingInterestPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoncontrollingInterestPolicyTextBlock" xlink:to="AATP_NoncontrollingInterestPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NoncontrollingInterestPolicyTextBlock_lbl" xml:lang="en-US">Non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign currencies translation and transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesPolicyTextBlock" xlink:label="AATP_RelatedPartiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesPolicyTextBlock" xlink:to="AATP_RelatedPartiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_RelatedPartiesPolicyTextBlock_lbl" xml:lang="en-US">Related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value of financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:label="us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:to="us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_lbl" xml:lang="en-US">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:to="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" xlink:to="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" xlink:label="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" xlink:to="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:label="us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:to="us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl" xml:lang="en-US">SCHEDULE OF VARIABLE INTEREST ENTITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PRO FORMA BUSINESS COMBINATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" xlink:label="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" xlink:to="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INTANGIBLE ASSETS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NonMarketableSecuritiesTableTextBlock" xlink:label="AATP_NonMarketableSecuritiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonMarketableSecuritiesTableTextBlock" xlink:to="AATP_NonMarketableSecuritiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NonMarketableSecuritiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" xlink:label="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" xlink:to="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RELATED PARTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROVISION FOR INCOME TAX</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF EFFECTIVE INCOME TAX RATE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEFERRED TAX ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF LEASE COMMITMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock" xlink:label="AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock" xlink:to="AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PURCHASE COMMITMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="srt_CondensedCashFlowStatementsCaptionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems_lbl" xml:lang="en-US">Condensed Cash Flow Statements, Captions [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NameOftheCompany" xlink:label="AATP_NameOftheCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NameOftheCompany" xlink:to="AATP_NameOftheCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_NameOftheCompany_lbl" xml:lang="en-US">Subsidiary company name</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PlaceAndDateOfIncorporation" xlink:label="AATP_PlaceAndDateOfIncorporation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PlaceAndDateOfIncorporation" xlink:to="AATP_PlaceAndDateOfIncorporation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PlaceAndDateOfIncorporation_lbl" xml:lang="en-US">Place and date of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ParticularsOfIssuedCapital" xlink:label="AATP_ParticularsOfIssuedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ParticularsOfIssuedCapital" xlink:to="AATP_ParticularsOfIssuedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ParticularsOfIssuedCapital_lbl" xml:lang="en-US">Particulars of issued capital</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PrincipalActivities" xlink:label="AATP_PrincipalActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrincipalActivities" xlink:to="AATP_PrincipalActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PrincipalActivities_lbl" xml:lang="en-US">Principal activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Proportional of ownership interest and voting power held</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xml:lang="en-US">Ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Stock issued during period acquisitions, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl" xml:lang="en-US">Loan receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Consideration amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated Useful Life of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xml:lang="en-US">Estimated Useful Lives of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated useful lives of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLineItems_lbl" xml:lang="en-US">Derivative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:to="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xml:lang="en-US">Foreign Currency Exchange Rate, Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ForeignCurrencyExchangeRateAverage" xlink:label="AATP_ForeignCurrencyExchangeRateAverage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ForeignCurrencyExchangeRateAverage" xlink:to="AATP_ForeignCurrencyExchangeRateAverage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ForeignCurrencyExchangeRateAverage_lbl" xml:lang="en-US">Foreign currency exchange rate period average</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Inventories write-down</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:label="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:to="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ForfeitedCouponIncome" xlink:label="AATP_ForfeitedCouponIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ForfeitedCouponIncome" xlink:to="AATP_ForfeitedCouponIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ForfeitedCouponIncome_lbl" xml:lang="en-US">Forfeited coupon income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Revenue from sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingExpense" xlink:to="us-gaap_SellingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingExpense_2_lbl" xml:lang="en-US">Selling expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising costs</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SalesCommissionsAndFees1" xlink:label="AATP_SalesCommissionsAndFees1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalesCommissionsAndFees1" xlink:to="AATP_SalesCommissionsAndFees1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_SalesCommissionsAndFees1_lbl" xml:lang="en-US">Commission expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xml:lang="en-US">Defined contribution plan expense</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SalaryPercentage" xlink:label="AATP_SalaryPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalaryPercentage" xlink:to="AATP_SalaryPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SalaryPercentage_lbl" xml:lang="en-US">Salary percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MonthlySalary" xlink:label="AATP_MonthlySalary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MonthlySalary" xlink:to="AATP_MonthlySalary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MonthlySalary_lbl" xml:lang="en-US">Monthly salary</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xml:lang="en-US">Income Tax Examination, Likelihood of Unfavorable Settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDescription" xlink:label="us-gaap_MinorityInterestDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDescription" xlink:to="us-gaap_MinorityInterestDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDescription_lbl" xml:lang="en-US">Noncontrolling interest, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Potentially dilutive securities outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivitiesGainLossByTypeTable" xlink:label="us-gaap_TradingActivitiesGainLossByTypeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingActivitiesGainLossByTypeTable" xlink:to="us-gaap_TradingActivitiesGainLossByTypeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingActivitiesGainLossByTypeTable_lbl" xml:lang="en-US">Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivityGainsAndLossesLineItems" xlink:label="us-gaap_TradingActivityGainsAndLossesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingActivityGainsAndLossesLineItems" xlink:to="us-gaap_TradingActivityGainsAndLossesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingActivityGainsAndLossesLineItems_lbl" xml:lang="en-US">Trading Activity, Gains and Losses, Net [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Net deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidTaxes_2_lbl" xml:lang="en-US">Prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OtherPayablesRelatedPartyCurrent" xlink:label="AATP_OtherPayablesRelatedPartyCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherPayablesRelatedPartyCurrent" xlink:to="AATP_OtherPayablesRelatedPartyCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OtherPayablesRelatedPartyCurrent_lbl" xml:lang="en-US">Other payables - intercompany</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_3_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xml:lang="en-US">Operating revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" xlink:to="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_lbl" xml:lang="en-US">Other receivables - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:to="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_lbl" xml:lang="en-US">Prepaid taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepayments and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_lbl" xml:lang="en-US">Deferred taxes asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xml:lang="en-US">Total other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accounts payable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl" xml:lang="en-US">Other payables and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Total net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:label="AATP_BusinessAcquisitionsProFormaCostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:to="AATP_BusinessAcquisitionsProFormaCostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_BusinessAcquisitionsProFormaCostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:label="AATP_BusinessAcquisitionsProFormaGrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:to="AATP_BusinessAcquisitionsProFormaGrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_BusinessAcquisitionsProFormaGrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaOperatingExpenses" xlink:label="AATP_BusinessAcquisitionsProFormaOperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaOperatingExpenses" xlink:to="AATP_BusinessAcquisitionsProFormaOperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaOperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:label="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:to="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_lbl" xml:lang="en-US">Income (loss) from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:label="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:to="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_lbl" xml:lang="en-US">Other income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:to="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_lbl" xml:lang="en-US">Income (loss) before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:to="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Benefit of (Provision for) income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:label="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:to="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_lbl" xml:lang="en-US">Net income (loss) per common share - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:label="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:to="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of common shares outstanding - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockNoParValue_lbl" xml:lang="en-US">Ordinary shares no par value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xml:lang="en-US">Purchase consideration value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2_lbl" xml:lang="en-US">Loan payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:label="AATP_PercentageOfCommonStockIssuedAndOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:to="AATP_PercentageOfCommonStockIssuedAndOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PercentageOfCommonStockIssuedAndOutstanding_lbl" xml:lang="en-US">Percentage of common stock issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Stock issued during period, value, acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Purchased price per shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Issuance of common stock shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash in bank</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimeDeposits" xlink:label="us-gaap_TimeDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimeDeposits" xlink:to="us-gaap_TimeDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TimeDeposits_lbl" xml:lang="en-US">Time deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:label="us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:to="us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_lbl" xml:lang="en-US">Percentage of Interest rate for time deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="us-gaap_AccountsReceivableGrossCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableGrossCurrent" xlink:to="us-gaap_AccountsReceivableGrossCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableGrossCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:label="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:to="AATP_DisclosurePrepaymentsAndDepositsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_DisclosurePrepaymentsAndDepositsAbstract_2_lbl" xml:lang="en-US">Schedule Of Prepaid Expenses And Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ReceivablesFromSalesDistributors" xlink:label="AATP_ReceivablesFromSalesDistributors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ReceivablesFromSalesDistributors" xlink:to="AATP_ReceivablesFromSalesDistributors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ReceivablesFromSalesDistributors_lbl" xml:lang="en-US">Receivables from sales distributors</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DepositsToSupplier" xlink:label="AATP_DepositsToSupplier" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DepositsToSupplier" xlink:to="AATP_DepositsToSupplier_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DepositsToSupplier_lbl" xml:lang="en-US">Deposits to suppliers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="us-gaap_CapitalizedComputerSoftwareGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareGross" xlink:to="us-gaap_CapitalizedComputerSoftwareGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareGross_lbl" xml:lang="en-US">Computer software</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_DisclosureInvestmentInMarketableSecuritiesAbstract_2_lbl" xml:lang="en-US">Schedule Of Investment In Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="us-gaap_InvestmentOwnedAtCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtCost" xlink:to="us-gaap_InvestmentOwnedAtCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtCost_lbl" xml:lang="en-US">Cost of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentsIncomeDividend" xlink:label="AATP_InvestmentsIncomeDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentsIncomeDividend" xlink:to="AATP_InvestmentsIncomeDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AATP_InvestmentsIncomeDividend_lbl" xml:lang="en-US">Dividend income from Greenpro Capital Corp.</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MarketableSecuritiesUnrealizedHoldingLoss" xlink:label="AATP_MarketableSecuritiesUnrealizedHoldingLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MarketableSecuritiesUnrealizedHoldingLoss" xlink:to="AATP_MarketableSecuritiesUnrealizedHoldingLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_MarketableSecuritiesUnrealizedHoldingLoss_lbl" xml:lang="en-US">Unrealized holding gain (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:label="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:to="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_lbl" xml:lang="en-US">Exchange rate effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_2_lbl" xml:lang="en-US">Investment in marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityListingsLineItems" xlink:label="dei_EntityListingsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingsLineItems_lbl" xml:lang="en-US">Entity Listings [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="us-gaap_InvestmentOwnedBalanceShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceShares" xlink:to="us-gaap_InvestmentOwnedBalanceShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalanceShares_lbl" xml:lang="en-US">Investment in securities, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtCost" xlink:to="us-gaap_InvestmentOwnedAtCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentOwnedAtCost_2_lbl" xml:lang="en-US">Investment amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_lbl" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesGross" xlink:label="AATP_InvestmentInNonMarketableSecuritiesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesGross" xlink:to="AATP_InvestmentInNonMarketableSecuritiesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_InvestmentInNonMarketableSecuritiesGross_lbl" xml:lang="en-US">Investment in non-marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:label="AATP_SaleOfInvestmentInNonmarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:to="AATP_SaleOfInvestmentInNonmarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SaleOfInvestmentInNonmarketableSecurities_lbl" xml:lang="en-US">Less: Sale of investment in non-marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonmarketableSecuritiesNet" xlink:label="AATP_InvestmentInNonmarketableSecuritiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonmarketableSecuritiesNet" xlink:to="AATP_InvestmentInNonmarketableSecuritiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_InvestmentInNonmarketableSecuritiesNet_lbl" xml:lang="en-US">Investment in non-marketable securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:to="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_2_lbl" xml:lang="en-US">Total investment in non-marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:label="srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems_lbl" xml:lang="en-US">SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_3_lbl" xml:lang="en-US">Equity interest percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Ordinary shares authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:to="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_2_lbl" xml:lang="en-US">Proceeds from investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:label="us-gaap_DueFromOfficersOrStockholdersCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:to="us-gaap_DueFromOfficersOrStockholdersCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromOfficersOrStockholdersCurrent_lbl" xml:lang="en-US">Amount due from director</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceShares" xlink:to="us-gaap_InvestmentOwnedBalanceShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentOwnedBalanceShares_2_lbl" xml:lang="en-US">Shares purchased during period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AccruedPromotionExpenses" xlink:label="AATP_AccruedPromotionExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccruedPromotionExpenses" xlink:to="AATP_AccruedPromotionExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AccruedPromotionExpenses_lbl" xml:lang="en-US">Promotion expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xml:lang="en-US">Payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="us-gaap_AccruedSalesCommissionCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalesCommissionCurrent" xlink:to="us-gaap_AccruedSalesCommissionCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalesCommissionCurrent_lbl" xml:lang="en-US">Commission</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilities_lbl" xml:lang="en-US">Others</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OtherAccountPayableAndAccruedLiabilities" xlink:label="AATP_OtherAccountPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherAccountPayableAndAccruedLiabilities" xlink:to="AATP_OtherAccountPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="AATP_OtherAccountPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesNatureDescriptionAxis" xlink:to="AATP_RelatedPartiesNatureDescriptionAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_RelatedPartiesNatureDescriptionAxis_2_lbl" xml:lang="en-US">RelatedPartiesNatureDescriptionAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesRelationshipsDescription" xlink:label="AATP_RelatedPartiesRelationshipsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesRelationshipsDescription" xlink:to="AATP_RelatedPartiesRelationshipsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_RelatedPartiesRelationshipsDescription_lbl" xml:lang="en-US">Relationship</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesNatureDescription" xlink:label="AATP_RelatedPartiesNatureDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesNatureDescription" xlink:to="AATP_RelatedPartiesNatureDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_RelatedPartiesNatureDescription_lbl" xml:lang="en-US">Nature</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties" xlink:label="us-gaap_AccountsReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableRelatedParties" xlink:to="us-gaap_AccountsReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableRelatedParties_lbl" xml:lang="en-US">Accounts receivable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="us-gaap_DueFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedParties" xlink:to="us-gaap_DueFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DueFromRelatedParties_lbl" xml:lang="en-US">Amount due from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Amount due to a Related Party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_RevenueFromRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromRelatedParties_2_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Acquired Indefinite-lived Intangible Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_3_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Business acquisition percentage of voting interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_lbl" xml:lang="en-US">Non controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems" xlink:label="srt_MortgageLoansOnRealEstateLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MortgageLoansOnRealEstateLineItems" xlink:to="srt_MortgageLoansOnRealEstateLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MortgageLoansOnRealEstateLineItems_lbl" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Local</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Loss before income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">- U.S.</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">- Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">- U.S.</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">- Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">(Provision for) benefit of income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">U.S. statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Differential tax rate in Malaysia</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Permanent difference</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US">Net operating loss carry forwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Net operating loss carry forwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DeferredTaxLiabilitiesDepreciation" xlink:label="AATP_DeferredTaxLiabilitiesDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DeferredTaxLiabilitiesDepreciation" xlink:to="AATP_DeferredTaxLiabilitiesDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AATP_DeferredTaxLiabilitiesDepreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xml:lang="en-US">Tax percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:label="us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:to="us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription_lbl" xml:lang="en-US">Tax rate description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Cumulative net operating loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OperatingLossCarryforwardsExpireYear" xlink:label="AATP_OperatingLossCarryforwardsExpireYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OperatingLossCarryforwardsExpireYear" xlink:to="AATP_OperatingLossCarryforwardsExpireYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OperatingLossCarryforwardsExpireYear_lbl" xml:lang="en-US">Operating loss carryforwards expire year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xml:lang="en-US">Income tax examination, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderAccountBalanceLineItems" xlink:label="us-gaap_PolicyholderAccountBalanceLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyholderAccountBalanceLineItems" xlink:to="us-gaap_PolicyholderAccountBalanceLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PolicyholderAccountBalanceLineItems_lbl" xml:lang="en-US">Policyholder Account Balance [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentrations of risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived" xlink:label="us-gaap_ProceedsFromDividendsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDividendsReceived" xlink:to="us-gaap_ProceedsFromDividendsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDividendsReceived_lbl" xml:lang="en-US">ividend received</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_CommissionExpensePercentage" xlink:label="AATP_CommissionExpensePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_CommissionExpensePercentage" xlink:to="AATP_CommissionExpensePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_CommissionExpensePercentage_lbl" xml:lang="en-US">[custom:CommissionExpensePercentage-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DepositForInsurance" xlink:label="AATP_DepositForInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DepositForInsurance" xlink:to="AATP_DepositForInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DepositForInsurance_lbl" xml:lang="en-US">Deposit for insurance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" xlink:label="AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" xlink:to="AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="us-gaap_PurchaseObligationDueInSecondYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInSecondYear" xlink:to="us-gaap_PurchaseObligationDueInSecondYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PurchaseObligationDueInSecondYear_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="us-gaap_PurchaseObligationDueInThirdYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInThirdYear" xlink:to="us-gaap_PurchaseObligationDueInThirdYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PurchaseObligationDueInThirdYear_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="us-gaap_PurchaseObligationDueInFourthYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInFourthYear" xlink:to="us-gaap_PurchaseObligationDueInFourthYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueInFourthYear_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear" xlink:label="us-gaap_PurchaseObligationDueInFifthYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInFifthYear" xlink:to="us-gaap_PurchaseObligationDueInFifthYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueInFifthYear_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear" xlink:label="us-gaap_PurchaseObligationDueAfterFifthYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueAfterFifthYear" xlink:to="us-gaap_PurchaseObligationDueAfterFifthYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PurchaseObligationDueAfterFifthYear_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="us-gaap_PurchaseObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligation" xlink:to="us-gaap_PurchaseObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PurchaseObligation_lbl" xml:lang="en-US">Total minimum purchase commitments required</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OperatingLeaseEffectiveInterestRate" xlink:label="AATP_OperatingLeaseEffectiveInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OperatingLeaseEffectiveInterestRate" xlink:to="AATP_OperatingLeaseEffectiveInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OperatingLeaseEffectiveInterestRate_lbl" xml:lang="en-US">Operating lease effective interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating lease, weighted average remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating lease, rent expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_2_lbl" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_2_lbl" xml:lang="en-US">Concentration Risk, Percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:to="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InvestmentInNonMarketableSecuritiesNoncurrent_doc" xml:lang="en-US">Investment in non-marketable securities.</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_CustomerDepositcurrent" xlink:label="AATP_CustomerDepositcurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_CustomerDepositcurrent" xlink:to="AATP_CustomerDepositcurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_CustomerDepositcurrent_doc" xml:lang="en-US">Customer deposits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents_doc" xml:lang="en-US">VIE consolidated amount of cash and cash equivalents.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes_doc" xml:lang="en-US">VIE consolidated amount of Prepaid taxes .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:to="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities_doc" xml:lang="en-US">VIE consolidated amount of other payables and accrued liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ImpairmentLossInEquityInvestments" xlink:to="AATP_ImpairmentLossInEquityInvestments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ImpairmentLossInEquityInvestments_doc" xml:lang="en-US">Impairment loss in equity investments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:to="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_doc" xml:lang="en-US">Proceeds from sale of non-marketable securities to a related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PaymentsToAcquireNonMarketableSecurities" xlink:to="AATP_PaymentsToAcquireNonMarketableSecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PaymentsToAcquireNonMarketableSecurities_doc" xml:lang="en-US">Investment in non-marketable securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RepaymentsOfRelatedPartyDebts" xlink:to="AATP_RepaymentsOfRelatedPartyDebts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_RepaymentsOfRelatedPartyDebts_doc" xml:lang="en-US">Repayments from related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" xlink:to="AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities_doc" xml:lang="en-US">Amount transferred from investment in investee company to investment in non-marketable securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:to="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities_doc" xml:lang="en-US">Initial recognition of right-of-use assets and lease liabilities.</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAsl" xlink:label="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAsl" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAsl" xlink:to="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAsl_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAsl_doc" xml:lang="en-US">Sale of non-marketable securities to a related party in exchange for ASL.</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAsl" xlink:label="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAsl" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAsl" xlink:to="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAsl_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAsl_doc" xml:lang="en-US">Issuance of common stock in exchange for acquisition payment of ASL.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:to="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition_doc" xml:lang="en-US">Sale of non-marketable securities to related party in exchange for acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:to="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition_doc" xml:lang="en-US">Issuance of common stock in exchange for acquisition payment of acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeATPInternationalHoldingLimitedMember" xlink:to="AATP_AgapeATPInternationalHoldingLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeATPInternationalHoldingLimitedMember_doc" xml:lang="en-US">Agape ATP International Holding Limited [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShareExchangeAgreementMember" xlink:to="AATP_ShareExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ShareExchangeAgreementMember_doc" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MrHowKokChoongMember" xlink:to="AATP_MrHowKokChoongMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MrHowKokChoongMember_doc" xml:lang="en-US">Mr.How Kok Choong [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyTwoMember" xlink:to="AATP_SubsidiaryCompanyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyTwoMember_doc" xml:lang="en-US">Subsidiary Company Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NameOftheCompany" xlink:to="AATP_NameOftheCompany_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NameOftheCompany_doc" xml:lang="en-US">Name of the company name.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyMember" xlink:to="AATP_SubsidiaryCompanyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyMember_doc" xml:lang="en-US">Subsidiary Company [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PlaceAndDateOfIncorporation" xlink:to="AATP_PlaceAndDateOfIncorporation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PlaceAndDateOfIncorporation_doc" xml:lang="en-US">Place and date of incorporation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ParticularsOfIssuedCapital" xlink:to="AATP_ParticularsOfIssuedCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ParticularsOfIssuedCapital_doc" xml:lang="en-US">Particulars of issued capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrincipalActivities" xlink:to="AATP_PrincipalActivities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PrincipalActivities_doc" xml:lang="en-US">Principal activities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyOneMember" xlink:to="AATP_SubsidiaryCompanyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyOneMember_doc" xml:lang="en-US">Subsidiary Company One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyThreeMember" xlink:to="AATP_SubsidiaryCompanyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyThreeMember_doc" xml:lang="en-US">Subsidiary Company Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SubsidiaryCompanyFourMember" xlink:to="AATP_SubsidiaryCompanyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SubsidiaryCompanyFourMember_doc" xml:lang="en-US">Subsidiary Company Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaidTaxesPolicyTextBlock" xlink:to="AATP_PrepaidTaxesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PrepaidTaxesPolicyTextBlock_doc" xml:lang="en-US">Prepaid Taxes [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:to="AATP_PrepaymentsAndDepositsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PrepaymentsAndDepositsPolicyTextBlock_doc" xml:lang="en-US">Prepayments and Deposits [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NonMarketableSecuritiesPolicyTextBlock" xlink:to="AATP_NonMarketableSecuritiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NonMarketableSecuritiesPolicyTextBlock_doc" xml:lang="en-US">Non-Marketable Securities [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ShippingAndHandlingPolicyTextBlock" xlink:to="AATP_ShippingAndHandlingPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ShippingAndHandlingPolicyTextBlock_doc" xml:lang="en-US">Shipping and Handling [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DefinedContributionPlanPolicyTextBlock" xlink:to="AATP_DefinedContributionPlanPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DefinedContributionPlanPolicyTextBlock_doc" xml:lang="en-US">Defined Contribution Plan [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoncontrollingInterestPolicyTextBlock" xlink:to="AATP_NoncontrollingInterestPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NoncontrollingInterestPolicyTextBlock_doc" xml:lang="en-US">Noncontrolling Interest [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesPolicyTextBlock" xlink:to="AATP_RelatedPartiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_RelatedPartiesPolicyTextBlock_doc" xml:lang="en-US">Related Parties [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:to="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AllowanceForDoubtfulAccountsReceivablesCurrent_doc" xml:lang="en-US">Allowance for doubtful accounts,</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ForfeitedCouponIncome" xlink:to="AATP_ForfeitedCouponIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ForfeitedCouponIncome_doc" xml:lang="en-US">Forfeited coupon income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HealthAndWellnessProductsMember" xlink:to="AATP_HealthAndWellnessProductsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HealthAndWellnessProductsMember_doc" xml:lang="en-US">Health and Wellness Products [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalesCommissionsAndFees1" xlink:to="AATP_SalesCommissionsAndFees1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SalesCommissionsAndFees1_doc" xml:lang="en-US">Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalaryPercentage" xlink:to="AATP_SalaryPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SalaryPercentage_doc" xml:lang="en-US">Salary percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SocialSecurityOrganizationMember" xlink:to="AATP_SocialSecurityOrganizationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SocialSecurityOrganizationMember_doc" xml:lang="en-US">Social Security Organization [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MonthlySalary" xlink:to="AATP_MonthlySalary_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MonthlySalary_doc" xml:lang="en-US">Monthly salary.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MYRCurrencyMember" xlink:to="AATP_MYRCurrencyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MYRCurrencyMember_doc" xml:lang="en-US">MYR Currency [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EmployeesProvidentFundMember" xlink:to="AATP_EmployeesProvidentFundMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_EmployeesProvidentFundMember_doc" xml:lang="en-US">Employees Provident Fund [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EmploymentInsuranceSystemMember" xlink:to="AATP_EmploymentInsuranceSystemMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_EmploymentInsuranceSystemMember_doc" xml:lang="en-US">Employment Insurance System [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HumanResourceDevelopmentFundMember" xlink:to="AATP_HumanResourceDevelopmentFundMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HumanResourceDevelopmentFundMember_doc" xml:lang="en-US">Human Resource Development Fund [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ComputerAndOfficeEquipmentMember" xlink:to="AATP_ComputerAndOfficeEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ComputerAndOfficeEquipmentMember_doc" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SurvivorSelectMember" xlink:to="AATP_SurvivorSelectMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SurvivorSelectMember_doc" xml:lang="en-US">Survivor Select [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EnergizedMineralConcentrateMember" xlink:to="AATP_EnergizedMineralConcentrateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_EnergizedMineralConcentrateMember_doc" xml:lang="en-US">Energized Mineral Concentrate [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IonizedCalMagMember" xlink:to="AATP_IonizedCalMagMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IonizedCalMagMember_doc" xml:lang="en-US">Ionized Cal-Mag [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OmegaBlendMember" xlink:to="AATP_OmegaBlendMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OmegaBlendMember_doc" xml:lang="en-US">Omega Blend [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BetaMaxxMember" xlink:to="AATP_BetaMaxxMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BetaMaxxMember_doc" xml:lang="en-US">BetaMaxx [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VegeFruitFiberMember" xlink:to="AATP_VegeFruitFiberMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VegeFruitFiberMember_doc" xml:lang="en-US">Vege Fruit Fiber [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IronMember" xlink:to="AATP_IronMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IronMember_doc" xml:lang="en-US">Iron [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_YoungFormulaMember" xlink:to="AATP_YoungFormulaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_YoungFormulaMember_doc" xml:lang="en-US">Young Formula [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OrganicYouthCareCleansingBarMember" xlink:to="AATP_OrganicYouthCareCleansingBarMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OrganicYouthCareCleansingBarMember_doc" xml:lang="en-US">Organic Youth Care Cleansing Bar [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MitogizeMember" xlink:to="AATP_MitogizeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MitogizeMember_doc" xml:lang="en-US">Mitogize [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoOneMEDMember" xlink:to="AATP_NoOneMEDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NoOneMEDMember_doc" xml:lang="en-US">No. 1 MED [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_EnergetiqueMember" xlink:to="AATP_EnergetiqueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_EnergetiqueMember_doc" xml:lang="en-US">Energetique [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_TrimPlusMember" xlink:to="AATP_TrimPlusMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_TrimPlusMember_doc" xml:lang="en-US">Trim+ [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodEndMYRMember" xlink:to="AATP_PeriodEndMYRMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PeriodEndMYRMember_doc" xml:lang="en-US">Period-end MYR [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodEndHKDMember" xlink:to="AATP_PeriodEndHKDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PeriodEndHKDMember_doc" xml:lang="en-US">Period-end HKD [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodAverageMYRMember" xlink:to="AATP_PeriodAverageMYRMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PeriodAverageMYRMember_doc" xml:lang="en-US">Period-average MYR [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PeriodAverageHKDMember" xlink:to="AATP_PeriodAverageHKDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PeriodAverageHKDMember_doc" xml:lang="en-US">Period-average HKD [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherPayablesRelatedPartyCurrent" xlink:to="AATP_OtherPayablesRelatedPartyCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OtherPayablesRelatedPartyCurrent_doc" xml:lang="en-US">Other payables - related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingSdnBhdMember" xlink:to="AATP_AgapeSuperiorLivingSdnBhdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeSuperiorLivingSdnBhdMember_doc" xml:lang="en-US">Agape Superior Living Sdn Bhd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:to="AATP_PercentageOfCommonStockIssuedAndOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PercentageOfCommonStockIssuedAndOutstanding_doc" xml:lang="en-US">Percentage of common stock issued and outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:to="AATP_BusinessAcquisitionsProFormaCostOfRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaCostOfRevenue_doc" xml:lang="en-US">Cost of revenue.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:to="AATP_BusinessAcquisitionsProFormaGrossProfit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaGrossProfit_doc" xml:lang="en-US">Gross profit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaOperatingExpenses" xlink:to="AATP_BusinessAcquisitionsProFormaOperatingExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaOperatingExpenses_doc" xml:lang="en-US">Total operating expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:to="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_doc" xml:lang="en-US">Other income (expense), net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:to="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_doc" xml:lang="en-US">Income (loss) before income taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:to="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_doc" xml:lang="en-US">Benefit of (Provision for) income taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:to="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_doc" xml:lang="en-US">Net income (loss) per common share - basic and diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:to="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_doc" xml:lang="en-US">Weighted average number of common shares outstanding - basic and diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ReceivablesFromSalesDistributors" xlink:to="AATP_ReceivablesFromSalesDistributors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ReceivablesFromSalesDistributors_doc" xml:lang="en-US">Receivables from sales distributors.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DepositsToSupplier" xlink:to="AATP_DepositsToSupplier_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DepositsToSupplier_doc" xml:lang="en-US">Deposits to supplier.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_doc" xml:lang="en-US">Accounts receivable and accounts receivable related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VehicleMember" xlink:to="AATP_VehicleMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VehicleMember_doc" xml:lang="en-US">Vehicle [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_GreenproCapitalCorpMember" xlink:to="AATP_GreenproCapitalCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_GreenproCapitalCorpMember_doc" xml:lang="en-US">Greenpro Capital Corp. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_MarketableSecuritiesUnrealizedHoldingLoss" xlink:to="AATP_MarketableSecuritiesUnrealizedHoldingLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_MarketableSecuritiesUnrealizedHoldingLoss_doc" xml:lang="en-US">Unrealized holding loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:to="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites_doc" xml:lang="en-US">Exchange rate effect.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_UnreservedSdnBhdMember" xlink:to="AATP_UnreservedSdnBhdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_UnreservedSdnBhdMember_doc" xml:lang="en-US">Unreserved Sdn Bhd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PhoenixPlusCorpMember" xlink:to="AATP_PhoenixPlusCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PhoenixPlusCorpMember_doc" xml:lang="en-US">Phoenix Plus Corporation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesGross" xlink:to="AATP_InvestmentInNonMarketableSecuritiesGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InvestmentInNonMarketableSecuritiesGross_doc" xml:lang="en-US">Investment in non-marketable securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DirectorsOfUnreservedInvestmentMember" xlink:to="AATP_DirectorsOfUnreservedInvestmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DirectorsOfUnreservedInvestmentMember_doc" xml:lang="en-US">Directors of Unreserved Investments [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:to="AATP_SaleOfInvestmentInNonmarketableSecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SaleOfInvestmentInNonmarketableSecurities_doc" xml:lang="en-US">Sale of investment in non-marketable securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonmarketableSecuritiesNet" xlink:to="AATP_InvestmentInNonmarketableSecuritiesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_InvestmentInNonmarketableSecuritiesNet_doc" xml:lang="en-US">Investment in non-marketable securities, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccruedPromotionExpenses" xlink:to="AATP_AccruedPromotionExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AccruedPromotionExpenses_doc" xml:lang="en-US">Accrued promotion expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherAccountPayableAndAccruedLiabilities" xlink:to="AATP_OtherAccountPayableAndAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OtherAccountPayableAndAccruedLiabilities_doc" xml:lang="en-US">Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesRelationshipsDescription" xlink:to="AATP_RelatedPartiesRelationshipsDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_RelatedPartiesRelationshipsDescription_doc" xml:lang="en-US">Related parties, relationships, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RelatedPartiesNatureDescription" xlink:to="AATP_RelatedPartiesNatureDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_RelatedPartiesNatureDescription_doc" xml:lang="en-US">Related parties nature, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:to="AATP_AgapeSuperiorLivingPtyLtdASLPLMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeSuperiorLivingPtyLtdASLPLMember_doc" xml:lang="en-US">Agape Superior Living Pty Ltd ASLPL [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_HostastaySdnBhdOneMember" xlink:to="AATP_HostastaySdnBhdOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_HostastaySdnBhdOneMember_doc" xml:lang="en-US">Hostastay Sdn. Bhd.[Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeSuperiorLivingMember" xlink:to="AATP_AgapeSuperiorLivingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeSuperiorLivingMember_doc" xml:lang="en-US">ASL [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_LabuanMember" xlink:to="AATP_LabuanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_LabuanMember_doc" xml:lang="en-US">Labuan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OperatingLossCarryforwardsExpireYear" xlink:to="AATP_OperatingLossCarryforwardsExpireYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OperatingLossCarryforwardsExpireYear_doc" xml:lang="en-US">Operating Loss Carryforwards Expire Year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AgapeATPCorporationMember" xlink:to="AATP_AgapeATPCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_AgapeATPCorporationMember_doc" xml:lang="en-US">Agape ATP Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DeferredTaxAssetsDepreciation" xlink:label="AATP_DeferredTaxAssetsDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DeferredTaxAssetsDepreciation" xlink:to="AATP_DeferredTaxAssetsDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DeferredTaxAssetsDepreciation_doc" xml:lang="en-US">Deferred Tax Assets,Depreciation,</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoCustomerMember" xlink:to="AATP_NoCustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NoCustomerMember_doc" xml:lang="en-US">No Customer [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OneCustomerMember" xlink:to="AATP_OneCustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OneCustomerMember_doc" xml:lang="en-US">One Customer [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ECommerceCompanyMember" xlink:to="AATP_ECommerceCompanyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ECommerceCompanyMember_doc" xml:lang="en-US">E-commerce [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VendorOneMember" xlink:to="AATP_VendorOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VendorOneMember_doc" xml:lang="en-US">Vendor One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VendorTwoMember" xlink:to="AATP_VendorTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VendorTwoMember_doc" xml:lang="en-US">Vendor Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_CommissionExpensePercentage" xlink:to="AATP_CommissionExpensePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_CommissionExpensePercentage_doc" xml:lang="en-US">Commission expense, percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_NoSalesMember" xlink:to="AATP_NoSalesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_NoSalesMember_doc" xml:lang="en-US">No Sales [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DepositForInsurance" xlink:to="AATP_DepositForInsurance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_DepositForInsurance_doc" xml:lang="en-US">Deposit for insurance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock" xlink:to="AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_doc" xml:lang="en-US">Schedule of purchase commitments [Table Text Block].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OperatingLeaseEffectiveInterestRate" xlink:to="AATP_OperatingLeaseEffectiveInterestRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_OperatingLeaseEffectiveInterestRate_doc" xml:lang="en-US">Operating Lease effective interest rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" xlink:to="AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree_doc" xml:lang="en-US">Lessee Operating Lease Liability Payments Due After Rolling Year Three.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_VettonsSdnBhdMember" xlink:to="AATP_VettonsSdnBhdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_VettonsSdnBhdMember_doc" xml:lang="en-US">Vettons Sdn Bhd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SellersMember" xlink:to="AATP_SellersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_SellersMember_doc" xml:lang="en-US">Sellers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_doc" xml:lang="en-US">Increase decrease in operating lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IfUnutilizedMember" xlink:to="AATP_IfUnutilizedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_IfUnutilizedMember_doc" xml:lang="en-US">If Unutilized [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PreferredStockDividendIncomeStatementImpact" xlink:to="AATP_PreferredStockDividendIncomeStatementImpact_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AATP_PreferredStockDividendIncomeStatementImpact_doc" xml:lang="en-US">The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_2_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesCommissionsAndFees" xlink:to="us-gaap_SalesCommissionsAndFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesCommissionsAndFees_2_lbl" xml:lang="en-US">Sales Commissions and Fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable, Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent_2_lbl" xml:lang="en-US">Increase (Decrease) in Due from Other Related Parties, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_IncreaseDecreaseInOperatingLeaseLiabilities_3_lbl" xml:lang="en-US">IncreaseDecreaseInOperatingLeaseLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PaymentsToAcquireNonMarketableSecurities" xlink:to="AATP_PaymentsToAcquireNonMarketableSecurities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PaymentsToAcquireNonMarketableSecurities_3_lbl" xml:lang="en-US">PaymentsToAcquireNonMarketableSecurities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_RepaymentsOfRelatedPartyDebts" xlink:to="AATP_RepaymentsOfRelatedPartyDebts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_RepaymentsOfRelatedPartyDebts_3_lbl" xml:lang="en-US">Repayments from related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Proceeds from (Repayments of) Related Party Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:to="AATP_PrepaymentsAndDepositsPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_PrepaymentsAndDepositsPolicyTextBlock_3_lbl" xml:lang="en-US">PrepaymentsAndDepositsPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_2_lbl" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_2_lbl" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_2_lbl" xml:lang="en-US">Advertising Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_SalesCommissionsAndFees1" xlink:to="AATP_SalesCommissionsAndFees1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_SalesCommissionsAndFees1_3_lbl" xml:lang="en-US">Commission expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:to="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_2_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:to="AATP_BusinessAcquisitionsProFormaCostOfRevenue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaCostOfRevenue_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaCostOfRevenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:to="AATP_BusinessAcquisitionsProFormaGrossProfit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_BusinessAcquisitionsProFormaGrossProfit_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaGrossProfit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableGrossCurrent" xlink:to="us-gaap_AccountsReceivableGrossCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableGrossCurrent_2_lbl" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:to="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_AccountsReceivableAndAccountsReceivableRelatedParties_3_lbl" xml:lang="en-US">Accounts receivable and accounts receivable related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentsIncomeDividend" xlink:to="AATP_InvestmentsIncomeDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentsIncomeDividend_2_lbl" xml:lang="en-US">InvestmentsIncomeDividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonMarketableSecuritiesGross" xlink:to="AATP_InvestmentInNonMarketableSecuritiesGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInNonMarketableSecuritiesGross_3_lbl" xml:lang="en-US">Investment in non-marketable securities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_InvestmentInNonmarketableSecuritiesNet" xlink:to="AATP_InvestmentInNonmarketableSecuritiesNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_InvestmentInNonmarketableSecuritiesNet_3_lbl" xml:lang="en-US">Investment in non-marketable securities, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_OtherAccountPayableAndAccruedLiabilities" xlink:to="AATP_OtherAccountPayableAndAccruedLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_OtherAccountPayableAndAccruedLiabilities_3_lbl" xml:lang="en-US">OtherAccountPayableAndAccruedLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedParties" xlink:to="us-gaap_DueFromRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromRelatedParties_2_lbl" xml:lang="en-US">Due from Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_2_lbl" xml:lang="en-US">Other Income Tax Expense (Benefit), Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_2_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AATP_DeferredTaxLiabilitiesDepreciation" xlink:to="AATP_DeferredTaxLiabilitiesDepreciation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AATP_DeferredTaxLiabilitiesDepreciation_2_lbl" xml:lang="en-US">DeferredTaxLiabilitiesDepreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_2_lbl" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInSecondYear" xlink:to="us-gaap_PurchaseObligationDueInSecondYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueInSecondYear_2_lbl" xml:lang="en-US">Purchase Obligation, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInThirdYear" xlink:to="us-gaap_PurchaseObligationDueInThirdYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueInThirdYear_2_lbl" xml:lang="en-US">Purchase Obligation, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueAfterFifthYear" xlink:to="us-gaap_PurchaseObligationDueAfterFifthYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueAfterFifthYear_2_lbl" xml:lang="en-US">Purchase Obligation, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligation" xlink:to="us-gaap_PurchaseObligation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligation_2_lbl" xml:lang="en-US">Purchase Obligation</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>28
<FILENAME>aatp-20201231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://agapeatp.com/role/Cover" xlink:href="aatp-20201231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheets" xlink:href="aatp-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:href="aatp-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:href="aatp-20201231.xsd#StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="aatp-20201231.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StatementsOfCashFlows" xlink:href="aatp-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:href="aatp-20201231.xsd#OrganizationAndBusinessBackground" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVie" xlink:href="aatp-20201231.xsd#VariableInterestEntityVie" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusninessCombination" xlink:href="aatp-20201231.xsd#BusninessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty" xlink:href="aatp-20201231.xsd#AccountsReceivableAndAccountsReceivableRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/Inventories" xlink:href="aatp-20201231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:href="aatp-20201231.xsd#PrepaymentsAndDeposits" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:href="aatp-20201231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNet" xlink:href="aatp-20201231.xsd#IntangibleAssetsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:href="aatp-20201231.xsd#InvestmentInMarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:href="aatp-20201231.xsd#InvestmentInNon-marketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:href="aatp-20201231.xsd#OtherPayablesAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:href="aatp-20201231.xsd#RelatedPartyBalancesAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquity" xlink:href="aatp-20201231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxes" xlink:href="aatp-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:href="aatp-20201231.xsd#ConcentrationsOfRisks" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:href="aatp-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEvents" xlink:href="aatp-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:href="aatp-20201231.xsd#OrganizationAndBusinessBackgroundTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:href="aatp-20201231.xsd#VariableInterestEntityVieTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusninessCombinationTables" xlink:href="aatp-20201231.xsd#BusninessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables" xlink:href="aatp-20201231.xsd#AccountsReceivableAndAccountsReceivableRelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InventoriesTables" xlink:href="aatp-20201231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:href="aatp-20201231.xsd#PrepaymentsAndDepositsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:href="aatp-20201231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:href="aatp-20201231.xsd#IntangibleAssetsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:href="aatp-20201231.xsd#InvestmentInMarketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:href="aatp-20201231.xsd#InvestmentInNon-marketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:href="aatp-20201231.xsd#OtherPayablesAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:href="aatp-20201231.xsd#RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesTables" xlink:href="aatp-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:href="aatp-20201231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfSubsidiariesAndAssociatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:href="aatp-20201231.xsd#OrganizationAndBusinessBackgroundDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="aatp-20201231.xsd#ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:href="aatp-20201231.xsd#ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="aatp-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:href="aatp-20201231.xsd#ScheduleOfVariableInterestEntityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:href="aatp-20201231.xsd#VariableInterestEntityVieDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="aatp-20201231.xsd#SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:href="aatp-20201231.xsd#ScheduleOfProFormaBusinessCombinationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/BusninessCombinationDetailsNarrative" xlink:href="aatp-20201231.xsd#BusninessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:href="aatp-20201231.xsd#ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:href="aatp-20201231.xsd#ScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="aatp-20201231.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:href="aatp-20201231.xsd#ScheduleOfIntangibleAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:href="aatp-20201231.xsd#IntangibleAssetsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:href="aatp-20201231.xsd#InvestmentInMarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:href="aatp-20201231.xsd#InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:href="aatp-20201231.xsd#ScheduleOfRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:href="aatp-20201231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:href="aatp-20201231.xsd#ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:href="aatp-20201231.xsd#ScheduleOfProvisionForIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:href="aatp-20201231.xsd#ScheduleOfEffectiveIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:href="aatp-20201231.xsd#ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:href="aatp-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:href="aatp-20201231.xsd#ConcentrationsOfRisksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfLeaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails" xlink:href="aatp-20201231.xsd#ScheduleOfPurchaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="aatp-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:href="aatp-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapNotesReceivableRelatedPartiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapNotesReceivableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:label="loc_AATPVariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_AATPVariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:label="loc_AATPVariableInterestEntityConsolidatedAmountOfPrepaidTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_AATPVariableInterestEntityConsolidatedAmountOfPrepaidTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:label="loc_AATPVariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_AATPVariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesCommissionsAndFees" xlink:label="loc_us-gaapSalesCommissionsAndFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSalesCommissionsAndFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="loc_AATPPreferredStockDividendIncomeStatementImpact" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_AATPPreferredStockDividendIncomeStatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ImpairmentLossInEquityInvestments" xlink:label="loc_AATPImpairmentLossInEquityInvestments" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_AATPImpairmentLossInEquityInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PreferredStockDividendIncomeStatementImpact" xlink:label="loc_AATPPreferredStockDividendIncomeStatementImpact" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_AATPPreferredStockDividendIncomeStatementImpact" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ImpairmentLossInEquityInvestments" xlink:label="loc_AATPImpairmentLossInEquityInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_AATPImpairmentLossInEquityInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidTaxes" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_AATPIncreaseDecreaseInOperatingLeaseLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_AATPIncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfInvestmentProjects" xlink:label="loc_us-gaapProceedsFromSaleOfInvestmentProjects" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfInvestmentProjects" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PaymentsToAcquireNonMarketableSecurities" xlink:label="loc_AATPPaymentsToAcquireNonMarketableSecurities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_AATPPaymentsToAcquireNonMarketableSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RepaymentsOfRelatedPartyDebts" xlink:label="loc_AATPRepaymentsOfRelatedPartyDebts" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_AATPRepaymentsOfRelatedPartyDebts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" xlink:label="loc_AATPAmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_AATPAmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_AATPInitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_AATPInitialRecognitionOfRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:label="loc_AATPSaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_AATPSaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:label="loc_AATPIssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_AATPIssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackground" xlink:title="00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVie" xlink:title="00000009 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="loc_us-gaapVariableInterestEntityDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapVariableInterestEntityDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusninessCombination" xlink:title="00000010 - Disclosure - BUSNINESS COMBINATION">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty" xlink:title="00000011 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDeposits" xlink:title="00000013 - Disclosure - PREPAYMENTS AND DEPOSITS">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:label="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PrepaymentsAndDepositsTextBlock" xlink:label="loc_AATPPrepaymentsAndDepositsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPPrepaymentsAndDepositsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNet" xlink:title="00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNet" xlink:title="00000015 - Disclosure - INTANGIBLE ASSETS, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecurities" xlink:title="00000016 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInMarketableSecuritiesTextBlock" xlink:label="loc_AATPInvestmentInMarketableSecuritiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_AATPInvestmentInMarketableSecuritiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecurities" xlink:title="00000017 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesTextBlock" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" xlink:title="00000018 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" xlink:title="00000019 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquity" xlink:title="00000020 - Disclosure - STOCKHOLDERS&#8217; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisks" xlink:title="00000022 - Disclosure - CONCENTRATIONS OF RISKS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod" xlink:label="loc_us-gaapFiscalPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFiscalPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PrepaidTaxesPolicyTextBlock" xlink:label="loc_AATPPrepaidTaxesPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPPrepaidTaxesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PrepaymentsAndDepositsPolicyTextBlock" xlink:label="loc_AATPPrepaymentsAndDepositsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPPrepaymentsAndDepositsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="loc_us-gaapDeferredChargesPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDeferredChargesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NonMarketableSecuritiesPolicyTextBlock" xlink:label="loc_AATPNonMarketableSecuritiesPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPNonMarketableSecuritiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaapCostOfSalesPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostOfSalesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ShippingAndHandlingPolicyTextBlock" xlink:label="loc_AATPShippingAndHandlingPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPShippingAndHandlingPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:label="loc_us-gaapCommissionsExpensePolicyPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommissionsExpensePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DefinedContributionPlanPolicyTextBlock" xlink:label="loc_AATPDefinedContributionPlanPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPDefinedContributionPlanPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoncontrollingInterestPolicyTextBlock" xlink:label="loc_AATPNoncontrollingInterestPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPNoncontrollingInterestPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesPolicyTextBlock" xlink:label="loc_AATPRelatedPartiesPolicyTextBlock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPRelatedPartiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" xlink:title="00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:label="loc_us-gaapScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:label="loc_AATPScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" xlink:label="loc_AATPScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" xlink:label="loc_AATPScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_AATPScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:label="loc_us-gaapScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieTables" xlink:title="00000028 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:label="loc_us-gaapScheduleOfVariableInterestEntitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusninessCombinationTables" xlink:title="00000029 - Disclosure - BUSNINESS COMBINATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables" xlink:title="00000030 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InventoriesTables" xlink:title="00000031 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PrepaymentsAndDepositsTables" xlink:title="00000032 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:label="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock" xlink:label="loc_AATPScheduleOfPrepaidExpensesAndDepositsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPScheduleOfPrepaidExpensesAndDepositsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetTables" xlink:title="00000033 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetTables" xlink:title="00000034 - Disclosure - INTANGIBLE ASSETS, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" xlink:title="00000035 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="loc_us-gaapMarketableSecuritiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" xlink:title="00000036 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NonMarketableSecuritiesTableTextBlock" xlink:label="loc_AATPNonMarketableSecuritiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="loc_AATPNonMarketableSecuritiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" xlink:title="00000037 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_AATPScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_AATPScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:title="00000038 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesTables" xlink:title="00000039 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesTables" xlink:title="00000040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock" xlink:label="loc_AATPScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_AATPScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" xlink:title="00000041 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:label="loc_srtCondensedCashFlowStatementsCaptionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCondensedCashFlowStatementsCaptionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyMember" xlink:label="loc_AATPSubsidiaryCompanyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyOneMember" xlink:label="loc_AATPSubsidiaryCompanyOneMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="loc_AATPSubsidiaryCompanyTwoMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="loc_AATPSubsidiaryCompanyThreeMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyFourMember" xlink:label="loc_AATPSubsidiaryCompanyFourMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NameOftheCompany" xlink:label="loc_AATPNameOftheCompany" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_AATPNameOftheCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PlaceAndDateOfIncorporation" xlink:label="loc_AATPPlaceAndDateOfIncorporation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_AATPPlaceAndDateOfIncorporation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ParticularsOfIssuedCapital" xlink:label="loc_AATPParticularsOfIssuedCapital" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_AATPParticularsOfIssuedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PrincipalActivities" xlink:label="loc_AATPPrincipalActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_AATPPrincipalActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" xlink:title="00000042 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:label="loc_srtCondensedCashFlowStatementsCaptionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCondensedCashFlowStatementsCaptionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPInternationalHoldingLimitedMember" xlink:label="loc_AATPAgapeATPInternationalHoldingLimitedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAgapeATPInternationalHoldingLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyTwoMember" xlink:label="loc_AATPSubsidiaryCompanyTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="loc_AATPShareExchangeAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaapComputerSoftwareIntangibleAssetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapComputerSoftwareIntangibleAssetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" xlink:title="00000045 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SurvivorSelectMember" xlink:label="loc_AATPSurvivorSelectMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPSurvivorSelectMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EnergizedMineralConcentrateMember" xlink:label="loc_AATPEnergizedMineralConcentrateMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPEnergizedMineralConcentrateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IonizedCalMagMember" xlink:label="loc_AATPIonizedCalMagMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPIonizedCalMagMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OmegaBlendMember" xlink:label="loc_AATPOmegaBlendMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPOmegaBlendMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BetaMaxxMember" xlink:label="loc_AATPBetaMaxxMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPBetaMaxxMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VegeFruitFiberMember" xlink:label="loc_AATPVegeFruitFiberMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPVegeFruitFiberMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IronMember" xlink:label="loc_AATPIronMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPIronMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_YoungFormulaMember" xlink:label="loc_AATPYoungFormulaMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPYoungFormulaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OrganicYouthCareCleansingBarMember" xlink:label="loc_AATPOrganicYouthCareCleansingBarMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPOrganicYouthCareCleansingBarMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MitogizeMember" xlink:label="loc_AATPMitogizeMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPMitogizeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoOneMEDMember" xlink:label="loc_AATPNoOneMEDMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPNoOneMEDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EnergetiqueMember" xlink:label="loc_AATPEnergetiqueMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPEnergetiqueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_TrimPlusMember" xlink:label="loc_AATPTrimPlusMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPTrimPlusMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaapDerivativeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDerivativeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaapVariableRateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapVariableRateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaapVariableRateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateAxis" xlink:to="loc_us-gaapVariableRateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodEndMYRMember" xlink:label="loc_AATPPeriodEndMYRMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodEndMYRMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodEndHKDMember" xlink:label="loc_AATPPeriodEndHKDMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodEndHKDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodAverageMYRMember" xlink:label="loc_AATPPeriodAverageMYRMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodAverageMYRMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PeriodAverageHKDMember" xlink:label="loc_AATPPeriodAverageHKDMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVariableRateDomain" xlink:to="loc_AATPPeriodAverageHKDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateTranslation1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapForeignCurrencyExchangeRateTranslation1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ForeignCurrencyExchangeRateAverage" xlink:label="loc_AATPForeignCurrencyExchangeRateAverage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_AATPForeignCurrencyExchangeRateAverage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HealthAndWellnessProductsMember" xlink:label="loc_AATPHealthAndWellnessProductsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_AATPHealthAndWellnessProductsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SocialSecurityOrganizationMember" xlink:label="loc_AATPSocialSecurityOrganizationMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPSocialSecurityOrganizationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EmployeesProvidentFundMember" xlink:label="loc_AATPEmployeesProvidentFundMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPEmployeesProvidentFundMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_EmploymentInsuranceSystemMember" xlink:label="loc_AATPEmploymentInsuranceSystemMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPEmploymentInsuranceSystemMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HumanResourceDevelopmentFundMember" xlink:label="loc_AATPHumanResourceDevelopmentFundMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPHumanResourceDevelopmentFundMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MYRCurrencyMember" xlink:label="loc_AATPMYRCurrencyMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_AATPMYRCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AllowanceForDoubtfulAccountsReceivablesCurrent" xlink:label="loc_AATPAllowanceForDoubtfulAccountsReceivablesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPAllowanceForDoubtfulAccountsReceivablesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ForfeitedCouponIncome" xlink:label="loc_AATPForfeitedCouponIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPForfeitedCouponIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingExpense" xlink:label="loc_us-gaapSellingExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSellingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SalesCommissionsAndFees1" xlink:label="loc_AATPSalesCommissionsAndFees1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPSalesCommissionsAndFees1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaapDefinedContributionPlanEmployerDiscretionaryContributionAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SalaryPercentage" xlink:label="loc_AATPSalaryPercentage" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPSalaryPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MonthlySalary" xlink:label="loc_AATPMonthlySalary" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_AATPMonthlySalary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDescription" xlink:label="loc_us-gaapMinorityInterestDescription" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterestDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivitiesGainLossByTypeTable" xlink:label="loc_us-gaapTradingActivitiesGainLossByTypeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapTradingActivitiesGainLossByTypeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivityGainsAndLossesLineItems" xlink:label="loc_us-gaapTradingActivityGainsAndLossesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivitiesGainLossByTypeTable" xlink:to="loc_us-gaapTradingActivityGainsAndLossesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivityByTypeAxis" xlink:label="loc_us-gaapTradingActivityByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivitiesGainLossByTypeTable" xlink:to="loc_us-gaapTradingActivityByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingActivityByTypeDomain" xlink:label="loc_us-gaapTradingActivityByTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityByTypeAxis" xlink:to="loc_us-gaapTradingActivityByTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableIncomeInterestRateMember" xlink:label="loc_us-gaapVariableIncomeInterestRateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityByTypeDomain" xlink:to="loc_us-gaapVariableIncomeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapPrepaidTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OtherPayablesRelatedPartyCurrent" xlink:label="loc_AATPOtherPayablesRelatedPartyCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_AATPOtherPayablesRelatedPartyCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTradingActivityGainsAndLossesLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" xlink:title="00000049 - Disclosure - VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SubsidiaryCompanyThreeMember" xlink:label="loc_AATPSubsidiaryCompanyThreeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPSubsidiaryCompanyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000050 - Disclosure - SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" xlink:label="loc_AATPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:label="loc_AATPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaCostOfRevenue" xlink:label="loc_AATPBusinessAcquisitionsProFormaCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaGrossProfit" xlink:label="loc_AATPBusinessAcquisitionsProFormaGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaOperatingExpenses" xlink:label="loc_AATPBusinessAcquisitionsProFormaOperatingExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaOperatingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:label="loc_AATPBusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:label="loc_AATPBusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:label="loc_AATPBusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessAcquisitionsProFormaIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:label="loc_AATPBusinessAcquisitionProFormaEarningsPerShareBasicDiluted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessAcquisitionProFormaEarningsPerShareBasicDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:label="loc_AATPBusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_AATPBusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/BusninessCombinationDetailsNarrative" xlink:title="00000052 - Disclosure - BUSNINESS COMBINATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ShareExchangeAgreementMember" xlink:label="loc_AATPShareExchangeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_AATPShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingSdnBhdMember" xlink:label="loc_AATPAgapeSuperiorLivingSdnBhdMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingSdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPMrHowKokChoongMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaapCommonStockNoParValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockNoParValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PercentageOfCommonStockIssuedAndOutstanding" xlink:label="loc_AATPPercentageOfCommonStockIssuedAndOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_AATPPercentageOfCommonStockIssuedAndOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimeDeposits" xlink:label="loc_us-gaapTimeDeposits" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapTimeDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:label="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="loc_us-gaapAccountsReceivableGrossCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableGrossCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AccountsReceivableAndAccountsReceivableRelatedParties" xlink:label="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_AATPAccountsReceivableAndAccountsReceivableRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInventoriesDetails" xlink:title="00000054 - Disclosure - SCHEDULE OF INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" xlink:title="00000055 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosurePrepaymentsAndDepositsAbstract" xlink:label="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ReceivablesFromSalesDistributors" xlink:label="loc_AATPReceivablesFromSalesDistributors" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPReceivablesFromSalesDistributors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DepositsToSupplier" xlink:label="loc_AATPDepositsToSupplier" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_AATPDepositsToSupplier" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosurePrepaymentsAndDepositsAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" xlink:title="00000056 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ComputerAndOfficeEquipmentMember" xlink:label="loc_AATPComputerAndOfficeEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPComputerAndOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VehicleMember" xlink:label="loc_AATPVehicleMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_AATPVehicleMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000057 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" xlink:title="00000058 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" xlink:title="00000059 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" xlink:title="00000060 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentsIncomeDividend" xlink:label="loc_AATPInvestmentsIncomeDividend" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_AATPInvestmentsIncomeDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MarketableSecuritiesUnrealizedHoldingLoss" xlink:label="loc_AATPMarketableSecuritiesUnrealizedHoldingLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_AATPMarketableSecuritiesUnrealizedHoldingLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:label="loc_AATPExchangeRateEffectOnInvestmentInMarketableSecurites" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_AATPExchangeRateEffectOnInvestmentInMarketableSecurites" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="loc_us-gaapMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:title="00000061 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInMarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInMarketableSecuritiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityListingsLineItems" xlink:label="loc_deiEntityListingsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiEntityListingsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_GreenproCapitalCorpMember" xlink:label="loc_AATPGreenproCapitalCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPGreenproCapitalCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DSwissIncMember" xlink:label="loc_AATPDSwissIncMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPDSwissIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" xlink:title="00000062 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DirectorsOfUnreservedInvestmentMember" xlink:label="loc_AATPDirectorsOfUnreservedInvestmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPDirectorsOfUnreservedInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="loc_AATPPhoenixPlusCorpMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPPhoenixPlusCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesGross" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SaleOfInvestmentInNonmarketableSecurities" xlink:label="loc_AATPSaleOfInvestmentInNonmarketableSecurities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_AATPSaleOfInvestmentInNonmarketableSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonmarketableSecuritiesNet" xlink:label="loc_AATPInvestmentInNonmarketableSecuritiesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonmarketableSecuritiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_InvestmentInNonMarketableSecuritiesNoncurrent" xlink:label="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="loc_AATPInvestmentInNonMarketableSecuritiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" xlink:title="00000063 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:label="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPDisclosureInvestmentInNonmarketableSecuritiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:label="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPMrHowKokChoongMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_UnreservedSdnBhdMember" xlink:label="loc_AATPUnreservedSdnBhdMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPUnreservedSdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MYRCurrencyMember" xlink:label="loc_AATPMYRCurrencyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_AATPMYRCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_PhoenixPlusCorpMember" xlink:label="loc_AATPPhoenixPlusCorpMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPPhoenixPlusCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:label="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_AATPProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromOfficersOrStockholdersCurrent" xlink:label="loc_us-gaapDueFromOfficersOrStockholdersCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapDueFromOfficersOrStockholdersCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" xlink:title="00000064 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AccruedPromotionExpenses" xlink:label="loc_AATPAccruedPromotionExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_AATPAccruedPromotionExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OtherAccountPayableAndAccruedLiabilities" xlink:label="loc_AATPOtherAccountPayableAndAccruedLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_AATPOtherAccountPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" xlink:title="00000065 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SeaMember" xlink:label="loc_AATPSeaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPSeaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPAsiaLimitedMember" xlink:label="loc_AATPAgapeATPAsiaLimitedMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeATPAsiaLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HostastaySdnBhdMember" xlink:label="loc_AATPHostastaySdnBhdMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHostastaySdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_THThreeTechnologySdnBhdMember" xlink:label="loc_AATPTHThreeTechnologySdnBhdMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPTHThreeTechnologySdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_MrHowKokChoongMember" xlink:label="loc_AATPMrHowKokChoongMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPMrHowKokChoongMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingPtyLtdMember" xlink:label="loc_AATPAgapeSuperiorLivingPtyLtdMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingPtyLtdASLPLMember" xlink:label="loc_AATPAgapeSuperiorLivingPtyLtdASLPLMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPAgapeSuperiorLivingPtyLtdASLPLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_HostastaySdnBhdOneMember" xlink:label="loc_AATPHostastaySdnBhdOneMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_AATPHostastaySdnBhdOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesNatureDescriptionAxis" xlink:label="loc_AATPRelatedPartiesNatureDescriptionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_AATPRelatedPartiesNatureDescriptionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesNatureDescriptionDomain" xlink:label="loc_AATPRelatedPartiesNatureDescriptionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPRelatedPartiesNatureDescriptionAxis" xlink:to="loc_AATPRelatedPartiesNatureDescriptionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SeaMember" xlink:label="loc_AATPSeaMember_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AATPRelatedPartiesNatureDescriptionDomain" xlink:to="loc_AATPSeaMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesRelationshipsDescription" xlink:label="loc_AATPRelatedPartiesRelationshipsDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPRelatedPartiesRelationshipsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_RelatedPartiesNatureDescription" xlink:label="loc_AATPRelatedPartiesNatureDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_AATPRelatedPartiesNatureDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties" xlink:label="loc_us-gaapAccountsReceivableRelatedParties" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccountsReceivableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="loc_us-gaapDueFromRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueFromRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRevenueFromRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000066 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="loc_AATPAgapeSuperiorLivingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_AATPAgapeSuperiorLivingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:label="loc_us-gaapNoncontrollingInterestIncreaseFromBusinessCombination" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapNoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" xlink:title="00000067 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems" xlink:label="loc_srtMortgageLoansOnRealEstateLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMortgageLoansOnRealEstateLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_MY" xlink:label="loc_countryMY" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_HK" xlink:label="loc_countryHK" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryHK" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" xlink:title="00000068 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapOtherIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOtherIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" xlink:title="00000069 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" xlink:title="00000070 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:label="loc_srtCondensedCashFlowStatementsCaptionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCondensedCashFlowStatementsCaptionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPInternationalHoldingLimitedMember" xlink:label="loc_AATPAgapeATPInternationalHoldingLimitedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAgapeATPInternationalHoldingLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeATPCorporationMember" xlink:label="loc_AATPAgapeATPCorporationMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_AATPAgapeATPCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCondensedCashFlowStatementsCaptionsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000071 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems" xlink:label="loc_srtMortgageLoansOnRealEstateLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMortgageLoansOnRealEstateLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_MY" xlink:label="loc_countryMY" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_AATPDeferredTaxLiabilitiesDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_AATPDeferredTaxLiabilitiesDepreciation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMortgageLoansOnRealEstateLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000072 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementGeographicalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_LabuanMember" xlink:label="loc_AATPLabuanMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_AATPLabuanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_MY" xlink:label="loc_countryMY" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryMY" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_HK" xlink:label="loc_countryHK" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryHK" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtStatementScenarioAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_IfUnutilizedMember" xlink:label="loc_AATPIfUnutilizedMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_AATPIfUnutilizedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:label="loc_us-gaapTaxCutsAndJobsActOf2017OtherTaxEffectDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapTaxCutsAndJobsActOf2017OtherTaxEffectDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OperatingLossCarryforwardsExpireYear" xlink:label="loc_AATPOperatingLossCarryforwardsExpireYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_AATPOperatingLossCarryforwardsExpireYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" xlink:title="00000073 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderAccountBalanceLineItems" xlink:label="loc_us-gaapPolicyholderAccountBalanceLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPolicyholderAccountBalanceLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoCustomerMember" xlink:label="loc_AATPNoCustomerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPNoCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OneCustomerMember" xlink:label="loc_AATPOneCustomerMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPOneCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VendorOneMember" xlink:label="loc_AATPVendorOneMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPVendorOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VendorTwoMember" xlink:label="loc_AATPVendorTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_AATPVendorTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_ECommerceCompanyMember" xlink:label="loc_AATPECommerceCompanyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPECommerceCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DSwissIncMember" xlink:label="loc_AATPDSwissIncMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPDSwissIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_NoSalesMember" xlink:label="loc_AATPNoSalesMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_AATPNoSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis" xlink:label="loc_us-gaapExtinguishmentOfDebtAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapExtinguishmentOfDebtAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:label="loc_us-gaapExtinguishmentOfDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtAxis" xlink:to="loc_us-gaapExtinguishmentOfDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtTypeDomain" xlink:to="loc_us-gaapAccountsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived" xlink:label="loc_us-gaapProceedsFromDividendsReceived" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_us-gaapProceedsFromDividendsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_CommissionExpensePercentage" xlink:label="loc_AATPCommissionExpensePercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_AATPCommissionExpensePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_DepositForInsurance" xlink:label="loc_AATPDepositForInsurance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPolicyholderAccountBalanceLineItems" xlink:to="loc_AATPDepositForInsurance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" xlink:title="00000074 - Disclosure - SCHEDULE OF LEASE COMMITMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" xlink:label="loc_AATPLesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_AATPLesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails" xlink:title="00000075 - Disclosure - SCHEDULE OF PURCHASE COMMITMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:label="loc_us-gaapPurchaseObligationDueInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPurchaseObligationDueInNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="loc_us-gaapPurchaseObligationDueInSecondYear" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPurchaseObligationDueInSecondYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="loc_us-gaapPurchaseObligationDueInThirdYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPurchaseObligationDueInThirdYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="loc_us-gaapPurchaseObligationDueInFourthYear" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPurchaseObligationDueInFourthYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear" xlink:label="loc_us-gaapPurchaseObligationDueInFifthYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPurchaseObligationDueInFifthYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear" xlink:label="loc_us-gaapPurchaseObligationDueAfterFifthYear" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPurchaseObligationDueAfterFifthYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPurchaseObligation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000076 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_AgapeSuperiorLivingMember" xlink:label="loc_AATPAgapeSuperiorLivingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_AATPAgapeSuperiorLivingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_OperatingLeaseEffectiveInterestRate" xlink:label="loc_AATPOperatingLeaseEffectiveInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_AATPOperatingLeaseEffectiveInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://agapeatp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000077 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_SellersMember" xlink:label="loc_AATPSellersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_AATPSellersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aatp-20201231.xsd#AATP_VettonsSdnBhdMember" xlink:label="loc_AATPVettonsSdnBhdMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_AATPVettonsSdnBhdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>form10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:AATP="http://agapeatp.com/20201231"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aatp-20201231.xsd" xlink:type="simple"/>
    <context id="From2020-01-01to2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AgapeATPInternationalHoldingLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AgapeATPInternationalHoldingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-07</startDate>
            <endDate>2020-05-08</endDate>
        </period>
    </context>
    <context id="AsOf2020-05-08_custom_SubsidiaryCompanyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-08</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SubsidiaryCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SubsidiaryCompanyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SubsidiaryCompanyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SubsidiaryCompanyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-08</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_HealthAndWellnessProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:HealthAndWellnessProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SurvivorSelectMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_SurvivorSelectMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_SurvivorSelectMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:SurvivorSelectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EnergizedMineralConcentrateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EnergizedMineralConcentrateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_EnergizedMineralConcentrateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergizedMineralConcentrateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IonizedCalMagMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_IonizedCalMagMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_IonizedCalMagMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IonizedCalMagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_OmegaBlendMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_OmegaBlendMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_OmegaBlendMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OmegaBlendMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_BetaMaxxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_BetaMaxxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_BetaMaxxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:BetaMaxxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_VegeFruitFiberMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_VegeFruitFiberMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_VegeFruitFiberMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:VegeFruitFiberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IronMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_IronMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_IronMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:IronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_YoungFormulaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_YoungFormulaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_YoungFormulaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:YoungFormulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_OrganicYouthCareCleansingBarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_OrganicYouthCareCleansingBarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-13_custom_OrganicYouthCareCleansingBarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:OrganicYouthCareCleansingBarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-13</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_MitogizeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_MitogizeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_MitogizeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:MitogizeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_NoOneMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_NoOneMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_NoOneMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:NoOneMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EnergetiqueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EnergetiqueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_EnergetiqueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:EnergetiqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-13_custom_TrimPlusMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-13</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TrimPlusMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_TrimPlusMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AATP:TrimPlusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SocialSecurityOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember_custom_MYRCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:SocialSecurityOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EmployeesProvidentFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmployeesProvidentFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EmploymentInsuranceSystemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmploymentInsuranceSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EmploymentInsuranceSystemMember_custom_MYRCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:EmploymentInsuranceSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_HumanResourceDevelopmentFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:HumanResourceDevelopmentFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PeriodEndMYRMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndMYRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_PeriodEndMYRMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndMYRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PeriodEndHKDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndHKDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_PeriodEndHKDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodEndHKDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_PeriodAverageMYRMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_PeriodAverageMYRMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_PeriodAverageMYRMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageMYRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_PeriodAverageHKDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_PeriodAverageHKDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_PeriodAverageHKDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">AATP:PeriodAverageHKDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SubsidiaryCompanyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:SubsidiaryCompanyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TradingActivityByTypeAxis">us-gaap:VariableIncomeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-08</instant>
        </period>
    </context>
    <context id="From2020-06-292020-07-02_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-31_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingSdnBhdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AATP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-13_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-13</instant>
        </period>
    </context>
    <context id="AsOf2020-12-13_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-13</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ComputerAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_ComputerAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_VehicleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:VehicleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_VehicleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AATP:VehicleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-05-17_custom_GreenproCapitalCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-17</instant>
        </period>
    </context>
    <context id="AsOf2018-07-30_custom_GreenproCapitalCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-30</instant>
        </period>
    </context>
    <context id="AsOf2018-10-16_custom_GreenproCapitalCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:GreenproCapitalCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-16</instant>
        </period>
    </context>
    <context id="AsOf2020-11-03_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="AsOf2020-12-09_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-09</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_DirectorMember_custom_MYRCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AATP:MYRCurrencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-03-10_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-10</instant>
        </period>
    </context>
    <context id="AsOf2019-03-10_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-10</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-03_custom_UnreservedSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:UnreservedSdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-03</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-03-31_custom_MrHowKokChoongMember25848312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="AsOf2019-04-03_custom_PhoenixPlusCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-03</instant>
        </period>
    </context>
    <context id="AsOf2019-04-03_custom_PhoenixPlusCorpMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-03</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:DirectorsOfUnreservedInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_DirectorsOfUnreservedInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:DirectorsOfUnreservedInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PhoenixPlusCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_PhoenixPlusCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:PhoenixPlusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SeaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_SeaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_SeaMember25849703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="AATP:RelatedPartiesNatureDescriptionAxis">AATP:SeaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SeaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_SeaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_AgapeATPAsiaLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AgapeATPAsiaLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_AgapeATPAsiaLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeATPAsiaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_HostastaySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_HostastaySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_HostastaySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_HostastaySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_THThreeTechnologySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_THThreeTechnologySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_THThreeTechnologySdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:THThreeTechnologySdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_MrHowKokChoongMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_MrHowKokChoongMember25849859">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_MrHowKokChoongMember25849875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:MrHowKokChoongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_AgapeSuperiorLivingPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_SeaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:SeaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:AgapeSuperiorLivingPtyLtdASLPLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_HostastaySdnBhdOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_HostastaySdnBhdOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AATP:HostastaySdnBhdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-05-012020-05-31_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-06-292020-07-31_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_country_HK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_country_HK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-12-31_country_HK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_IfUnutilizedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AATP:IfUnutilizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IfUnutilizedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AATP:IfUnutilizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2018-12-282019-01-02_custom_LabuanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">AATP:LabuanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-28</startDate>
            <endDate>2019-01-02</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_country_HK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeATPInternationalHoldingLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AgapeATPInternationalHoldingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgapeATPCorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">AATP:AgapeATPCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_country_MY">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:NoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_OneCustomerMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_OneCustomerMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:ECommerceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:ECommerceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_VendorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_VendorTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-11-012020-11-30_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-31_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-11-30_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_DSwissIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:DSwissIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_VendorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_VendorTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_VendorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-12-31_custom_VendorTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AATP:VendorTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_NoSalesMember_us-gaap_AccountsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">AATP:NoSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-04-02_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-02</instant>
        </period>
    </context>
    <context id="From2020-03-282020-04-02_custom_AgapeSuperiorLivingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AATP:AgapeSuperiorLivingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-28</startDate>
            <endDate>2020-04-02</endDate>
        </period>
    </context>
    <context id="AsOf2021-01-25_us-gaap_SubsequentEventMember_custom_SellersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AATP:SellersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-25</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_VettonsSdnBhdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:VettonsSdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_VettonsSdnBhdMember_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001713210</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AATP:VettonsSdnBhdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="RM">
        <measure>iso4217:MYR</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-12-31">0001713210</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-12-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-01-01to2020-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2020-01-01to2020-12-31">2020</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-01-01to2020-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2020-01-01to2020-12-31">false</dei:DocumentTransitionReport>
    <dei:EntityExTransitionPeriod contextRef="From2020-01-01to2020-12-31">false</dei:EntityExTransitionPeriod>
    <dei:EntityCurrentReportingStatus contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0034">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-01-01to2020-12-31" id="xdx2ixbrl0036">Yes</dei:EntityInteractiveDataCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0056"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0058"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InventoryNet
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0065"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidTaxes
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0068"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0082"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0085"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0088"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0097"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0111"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0115"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0118"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0135"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0138"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0141"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0149"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0150"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0199"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0200"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SellingExpense
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0220"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0223"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0224"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0246"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0255"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0256"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0260"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ImpairmentLossInEquityInvestments
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0262"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ImpairmentLossInEquityInvestments
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0264"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0318"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0324"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0325"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0326"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0331"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0332"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0334"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0336"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Depreciation
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Depreciation
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0406"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0416"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0418"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ImpairmentLossInEquityInvestments
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ImpairmentLossInEquityInvestments
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0424"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0436"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0438"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0444"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0447"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0468"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0472"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0480"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfInvestmentProjects
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfInvestmentProjects
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0492"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0504"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0507"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:PaymentsToAcquireNonMarketableSecurities
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:PaymentsToAcquireNonMarketableSecurities
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:RepaymentsOfRelatedPartyDebts
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0528"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0530"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0532"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0536"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0559"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0564"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl0570"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0572"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0575"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0579"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0580"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl0584"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_SurvivorSelectMember"
      id="xdx2ixbrl0728"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_SurvivorSelectMember"
      id="xdx2ixbrl0730"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_IonizedCalMagMember"
      id="xdx2ixbrl0742"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_VegeFruitFiberMember"
      id="xdx2ixbrl0758"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_VegeFruitFiberMember"
      id="xdx2ixbrl0760"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_IronMember"
      id="xdx2ixbrl0764"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_IronMember"
      id="xdx2ixbrl0766"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_YoungFormulaMember"
      id="xdx2ixbrl0772"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_MitogizeMember"
      id="xdx2ixbrl0782"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_MitogizeMember"
      id="xdx2ixbrl0784"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_NoOneMEDMember"
      id="xdx2ixbrl0790"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_TrimPlusMember"
      id="xdx2ixbrl0802"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1093"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1095"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1107"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1113"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:ReceivablesFromSalesDistributors
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1117"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-12-31_custom_ComputerAndOfficeEquipmentMember"
      id="xdx2ixbrl1131"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember"
      id="xdx2ixbrl1135"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember"
      id="xdx2ixbrl1139"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-12-31_custom_VehicleMember"
      id="xdx2ixbrl1143"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1146"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1149"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1152"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Depreciation
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl1155"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1165"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1168"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:InvestmentsIncomeDividend
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1214"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:SaleOfInvestmentInNonmarketableSecurities
      contextRef="AsOf2019-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      id="xdx2ixbrl1261"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:InvestmentInNonmarketableSecuritiesNet
      contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      id="xdx2ixbrl1263"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:AccruedPromotionExpenses
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1286"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1289"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="AsOf2020-12-31_custom_SeaMember"
      id="xdx2ixbrl1309"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="AsOf2020-09-30"
      id="xdx2ixbrl1313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2019-12-31_custom_HostastaySdnBhdMember"
      id="xdx2ixbrl1339"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2019-12-31_custom_THThreeTechnologySdnBhdMember"
      id="xdx2ixbrl1351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2020-12-31_custom_MrHowKokChoongMember25849859"
      id="xdx2ixbrl1365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2019-12-31_custom_AgapeSuperiorLivingPtyLtdMember"
      id="xdx2ixbrl1379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2020-01-012020-12-31_custom_SeaMember"
      id="xdx2ixbrl1393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2019-07-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember"
      id="xdx2ixbrl1411"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdOneMember"
      id="xdx2ixbrl1429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2019-07-012019-12-31_custom_HostastaySdnBhdOneMember"
      id="xdx2ixbrl1431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl1435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl1437"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl1511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl1512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl1513"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl1517"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2020-01-01to2020-12-31"
      id="xdx2ixbrl1519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl1520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl1521"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl1524"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl1525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2019-07-012019-12-31"
      id="xdx2ixbrl1529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2019-12-31_country_MY"
      id="xdx2ixbrl1592"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:DeferredTaxLiabilitiesDepreciation
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1600"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1604"
      unitRef="USD"
      xsi:nil="true"/>
    <AATP:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1667"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2020-01-01to2020-12-31">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2020-01-01to2020-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-01to2020-12-31">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="From2020-01-01to2020-12-31">333-220144</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-12-31">AGAPE ATP CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-01-01to2020-12-31">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-01-01to2020-12-31">36-4838886</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-01-01to2020-12-31">Tower 2</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2020-01-01to2020-12-31">Faber Towers</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2020-01-01to2020-12-31">Jalan Desa Bahagia</dei:EntityAddressAddressLine3>
    <dei:EntityAddressPostalZipCode contextRef="From2020-01-01to2020-12-31">58100</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="From2020-01-01to2020-12-31">Kuala Lumpur</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2020-01-01to2020-12-31">MY</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="From2020-01-01to2020-12-31">60)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-01-01to2020-12-31">192230099</dei:LocalPhoneNumber>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2020-01-01to2020-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2020-01-01to2020-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityShellCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityShellCompany>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-12-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityPublicFloat contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">913908750</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-03-29" decimals="INF" unitRef="Shares">376452047</dei:EntityCommonStockSharesOutstanding>
    <AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">37387</AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3517600</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2744457</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">172757</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">520786</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3235</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:NotesReceivableRelatedPartiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2217</us-gaap:NotesReceivableRelatedPartiesCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">589814</us-gaap:InventoryNet>
    <AATP:VariableInterestEntityConsolidatedAmountOfPrepaidTaxes contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11330</AATP:VariableInterestEntityConsolidatedAmountOfPrepaidTaxes>
    <us-gaap:PrepaidTaxes contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1104495</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">296370</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">269193</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5684271</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">3536653</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">298309</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5826</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">394141</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">577035</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">66484</us-gaap:MarketableSecuritiesNoncurrent>
    <AATP:InvestmentInNonMarketableSecuritiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1500</AATP:InvestmentInNonMarketableSecuritiesNoncurrent>
    <AATP:InvestmentInNonMarketableSecuritiesNoncurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">732137</AATP:InvestmentInNonMarketableSecuritiesNoncurrent>
    <us-gaap:DeferredOfferingCosts contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">249525</us-gaap:DeferredOfferingCosts>
    <us-gaap:OtherAssets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1526336</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">798621</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7210607</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4335274</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2790</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">236134</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">154276</us-gaap:OperatingLeaseLiabilityCurrent>
    <AATP:VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1904</AATP:VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">647677</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">77246</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">455</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">3952</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1038542</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">83988</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">241488</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5743</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">247231</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1285773</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">83988</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">376452047</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">376452047</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">376275500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">376275500</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">37645</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">37628</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">6440616</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">5293082</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-734443</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-1089209</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">181016</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">9785</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5924834</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4251286</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7210607</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4335274</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">3434561</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">18060</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">1290131</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">429362</us-gaap:RevenueFromRelatedParties>
    <us-gaap:Revenues
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">3452621</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">1290131</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">429362</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">775855</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">1200829</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">383479</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">2676766</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">89302</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">45883</us-gaap:GrossProfit>
    <us-gaap:SellingExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">376582</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">7846</us-gaap:SellingExpense>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">830659</us-gaap:SalesCommissionsAndFees>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">1627660</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">396048</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">312270</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">2834901</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">403894</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">312270</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-158135</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-314592</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-266387</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">164283</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">36301</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-4153</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-26085</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">350137</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-68391</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-68391</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-160062</AATP:PreferredStockDividendIncomeStatementImpact>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">16509</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <AATP:ImpairmentLossInEquityInvestments
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-366834</AATP:ImpairmentLossInEquityInvestments>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">674482</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-408500</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-72544</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">516347</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-723092</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-338931</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">161581</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-6965</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">354766</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-716127</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-338931</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">171231</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">11079</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">9864</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">525997</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-705048</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-329067</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="Shares">376387778</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">376275500</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="Shares">376275500</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">376275500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">37628</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">5293082</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-373082</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-1294</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" decimals="0" unitRef="USD">4956334</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-716127</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-716127</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2019-01-012019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">11079</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">11079</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">376275500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">37628</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">5293082</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1089209</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">9785</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4251286</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">376275500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">37628</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">5293082</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1089209</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">9785</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4251286</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">354766</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">354766</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">176547</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">17</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1147534</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">1147551</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">171231</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">171231</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">376452047</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">37645</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">6440616</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-734443</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">181016</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5924834</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">354766</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-716127</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-338931</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">55407</us-gaap:Depreciation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">1505</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">106561</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-26085</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">350137</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-68391</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-68391</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <AATP:PreferredStockDividendIncomeStatementImpact
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-160062</AATP:PreferredStockDividendIncomeStatementImpact>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">16509</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <AATP:ImpairmentLossInEquityInvestments
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-366834</AATP:ImpairmentLossInEquityInvestments>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">178329</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">165149</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">518940</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">85602</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">2417</us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">2210</us-gaap:IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-78674</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-184985</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-352577</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-241372</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-229638</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-2804</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">2778</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">2778</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">59</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-35086</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-1421886</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-217743</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-6965</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">336709</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">68557</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">44867</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <AATP:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-105009</AATP:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-557951</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-704418</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-113945</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfInvestmentProjects
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">121</us-gaap:ProceedsFromSaleOfInvestmentProjects>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">4734</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">178</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">1210818</us-gaap:CashAcquiredFromAcquisition>
    <AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">70173</AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty>
    <AATP:PaymentsToAcquireNonMarketableSecurities
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">1500</AATP:PaymentsToAcquireNonMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">1276200</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-1500</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">249525</us-gaap:PaymentsOfDebtIssuanceCosts>
    <AATP:RepaymentsOfRelatedPartyDebts
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-227434</AATP:RepaymentsOfRelatedPartyDebts>
    <AATP:RepaymentsOfRelatedPartyDebts
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-745</AATP:RepaymentsOfRelatedPartyDebts>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-5318</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-22091</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-4573</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">76985</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">2031</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">815</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">773143</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-708460</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-113130</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2744457</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-12-31" decimals="0" unitRef="USD">3452917</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-06-30" decimals="0" unitRef="USD">2857587</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3517600</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2744457</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2744457</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">288929</us-gaap:IncomeTaxesPaidNet>
    <AATP:AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">724619</AATP:AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities>
    <AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">483343</AATP:InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities>
    <AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">656495</AATP:SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition>
    <AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">1147551</AATP:IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_801_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zJSi8MyvyDFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;1.
&lt;span id="xdx_823_zJ0CruFRLV6c"&gt;ORGANIZATION AND BUSINESS BACKGROUND&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
ATP Corporation, a Nevada corporation (&#x201c;the Company&#x201d; or &#x201c;AATP US&#x201d;) was incorporated under the laws
of the State of Nevada on June 1, 2016.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with &lt;span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zPAqrgj7bzDh" title="Ownership interest percentage"&gt;100%&lt;/span&gt; equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zKtfAAedHs31" title="Stock issued during period acquisitions, shares"&gt;9,590,596&lt;/span&gt; ordinary shares, no par value, equivalent to approximately &lt;span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zjjjvxYeSx34" title="Ownership interest percentage"&gt;99.99%&lt;/span&gt; of the equity interest in Agape Superior Living Sdn.
Bhd., an entity incorporated in Malaysia.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
Superior Living Sdn. Bhd. (&#x201c;ASL&#x201d;) is a limited company incorporated on August 8, 2003, under the laws of Malaysia.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd., a wholly owned
subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by
providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.
Upon the establishment of WATP, WATP starts collaborating with ASL to carry out its Wellness programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company
and its subsidiaries is to supply high-quality health and wellness products, including supplements to assist in cell metabolism,
detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and
various wellness programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying consolidated financial statements reflect the activities of the Company, Agape ATP Corporation (&#x201c;AATP LB&#x201d;),
Agape ATP International Holding Limited (&#x201c;AATP HK&#x201d;), Wellness ATP International Holdings Sdn, Bhd. (&#x201c;WATP&#x201d;), ASL and its variable interest entity (&#x201c;VIE&#x201d;), Agape S.E.A. Sdn. Bhd. (&#x201c;SEA&#x201d;) (See Note 3).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zw7f6w0FF1xk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Details
of the Company&#x2019;s subsidiaries:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B4_zC1Anlgtow4l" style="display: none"&gt;SCHEDULE OF SUBSIDIARIES AND ASSOCIATES&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Subsidiary
company name&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Place
and date of incorporation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Particulars
    of issued&#160;capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Principal
    activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Proportional
of ownership interest and voting power held&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1.
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 22%; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsWZZZ7j67yg" title="Subsidiary company name"&gt;Agape
    ATP Corporation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zMtcK0TU6zG3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Labuan,
    &lt;br/&gt;
    March 6, 2017&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z3r71tizhsc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100
    shares of ordinary share of US$1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z9YBdu4Klqee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Investment
    holding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zM50Vf4ndZD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; text-align: right" title="Proportional of ownership interest and voting power held"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2.
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zpEX8ZyUokbf" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
    ATP International Holding Limited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zPSbyVEVQpBj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Hong
    Kong,&lt;br/&gt;
    June 1, 2017&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zsUJLsURrrG9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,000,000
    shares of ordinary share of HK$1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z0N1Jam9s4hh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Wholesaling
    of health and wellness products; and health solution advisory services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zfkndXUXijtf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zzCkeJ1IJVm1" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
    Superior Living Sdn. Bhd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zmEPx5eMS2Tb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Malaysia,
    &lt;br/&gt;
    August 8, 2003&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zz4J4NcmSjr5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,590,598
    shares of ordinary share of RM1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zxZjnXi79Ywk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Health
    and wellness products and health solution advisory services via network marketing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zrL824y99Ggd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;99.99%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;4.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zUclFrdr35C6" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
    S.E.A. Sdn. Bhd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zxvR5Bced3Fe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Malaysia,
    &lt;br/&gt;
    March 4, 2004&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zwBRJGP5dGle" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2
    shares of ordinary share of RM1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zgBjWf04B1h4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;VIE
    of Agape Superior Living Sdn. Bhd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;VIE&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zZ3aOX5q2Y" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Wellness
    ATP International Holdings Sdn, Bhd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zB0NwRqVf5hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Malaysia,
    &lt;br/&gt;
    September 11, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zVrklIovqUA4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100
    shares of ordinary share of RM1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zNANzG5166Ml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
    promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs,
    events and campaigns&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z3e92NzKLqji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A2_z7dOJZcW7U17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;1.
ORGANIZATION AND BUSINESS BACKGROUND (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Business
Overview&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients.
The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#x201c;ATP Zeta
Health Program&#x201d;, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy
dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in
our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
order to strengthen the Company&#x2019;s supply chain, on May 8, 2020, the Company has successfully acquired approximately &lt;span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zw0as5opirNf"&gt;99.99% &lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of
ASL by issuing &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zZ5Um3AJ858l"&gt;176,547 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;common
shares for a total value of $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zNifuWGSfRne"&gt;1,147,551&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt; and offset a loan receivable of $&lt;span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_pp0p0_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_ziTWrJEBnEo2" title="Loan receivable"&gt;656,495&lt;/span&gt; for a total consideration
of $&lt;span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zCySLH6HmHx9" title="Consideration amount"&gt;1,804,046&lt;/span&gt;, &lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;with the goal of securing an established network
marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the
Company&#x2019;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the
Company&#x2019;s operation by boosting the Company&#x2019;s retail and marketing capabilities. The newly acquired subsidiary
allows the Company to fulfill its mission of &#x201c;helping people to create health and wealth&#x201d; by providing a
financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a
healthy lifestyle.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health
solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry
out various wellness programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#xc9;NERG&#xc9;TIQUE
and BEAUNIQUE.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases
caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health
and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well
as trained members and distributors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
&#xc9;NERG&#xc9;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level.
The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
BEAUNIQUE product series focuses on the research of our diet&#x2019;s impact on modifying gene expressions in order to address
genetic variations and deliver a nutrigenomic solution for every individual.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-31_custom_AgapeATPInternationalHoldingLimitedMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="Shares">9590596</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-05-08_custom_SubsidiaryCompanyTwoMember"
      decimals="INF"
      unitRef="Pure">0.9999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_89C_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zw7f6w0FF1xk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Details
of the Company&#x2019;s subsidiaries:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B4_zC1Anlgtow4l" style="display: none"&gt;SCHEDULE OF SUBSIDIARIES AND ASSOCIATES&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Subsidiary
company name&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Place
and date of incorporation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Particulars
    of issued&#160;capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Principal
    activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Proportional
of ownership interest and voting power held&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1.
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 22%; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsWZZZ7j67yg" title="Subsidiary company name"&gt;Agape
    ATP Corporation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zMtcK0TU6zG3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Labuan,
    &lt;br/&gt;
    March 6, 2017&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z3r71tizhsc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100
    shares of ordinary share of US$1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z9YBdu4Klqee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Investment
    holding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zM50Vf4ndZD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; text-align: right" title="Proportional of ownership interest and voting power held"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2.
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zpEX8ZyUokbf" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
    ATP International Holding Limited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zPSbyVEVQpBj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Hong
    Kong,&lt;br/&gt;
    June 1, 2017&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zsUJLsURrrG9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,000,000
    shares of ordinary share of HK$1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z0N1Jam9s4hh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Wholesaling
    of health and wellness products; and health solution advisory services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zfkndXUXijtf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zzCkeJ1IJVm1" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
    Superior Living Sdn. Bhd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zmEPx5eMS2Tb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Malaysia,
    &lt;br/&gt;
    August 8, 2003&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zz4J4NcmSjr5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,590,598
    shares of ordinary share of RM1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zxZjnXi79Ywk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Health
    and wellness products and health solution advisory services via network marketing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zrL824y99Ggd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;99.99%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;4.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zUclFrdr35C6" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
    S.E.A. Sdn. Bhd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zxvR5Bced3Fe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Malaysia,
    &lt;br/&gt;
    March 4, 2004&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zwBRJGP5dGle" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2
    shares of ordinary share of RM1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zgBjWf04B1h4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;VIE
    of Agape Superior Living Sdn. Bhd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;VIE&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zZ3aOX5q2Y" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Wellness
    ATP International Holdings Sdn, Bhd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zB0NwRqVf5hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Malaysia,
    &lt;br/&gt;
    September 11, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zVrklIovqUA4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100
    shares of ordinary share of RM1 each&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zNANzG5166Ml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
    promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs,
    events and campaigns&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z3e92NzKLqji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock>
    <AATP:NameOftheCompany contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember">Agape
    ATP Corporation</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember">Labuan,

    March 6, 2017</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember">100
    shares of ordinary share of US$1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyMember">Investment
    holding</AATP:PrincipalActivities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <AATP:NameOftheCompany contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember">Agape
    ATP International Holding Limited</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember">Hong
    Kong,
    June 1, 2017</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember">1,000,000
    shares of ordinary share of HK$1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyOneMember">Wholesaling
    of health and wellness products; and health solution advisory services</AATP:PrincipalActivities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyOneMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <AATP:NameOftheCompany contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember">Agape
    Superior Living Sdn. Bhd.</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember">Malaysia,

    August 8, 2003</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember">9,590,598
    shares of ordinary share of RM1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyTwoMember">Health
    and wellness products and health solution advisory services via network marketing</AATP:PrincipalActivities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyTwoMember"
      decimals="INF"
      unitRef="Pure">0.9999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <AATP:NameOftheCompany contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember">Agape
    S.E.A. Sdn. Bhd.</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember">Malaysia,

    March 4, 2004</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember">2
    shares of ordinary share of RM1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyThreeMember">VIE
    of Agape Superior Living Sdn. Bhd.</AATP:PrincipalActivities>
    <AATP:NameOftheCompany contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember">Wellness
    ATP International Holdings Sdn, Bhd</AATP:NameOftheCompany>
    <AATP:PlaceAndDateOfIncorporation contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember">Malaysia,

    September 11, 2020</AATP:PlaceAndDateOfIncorporation>
    <AATP:ParticularsOfIssuedCapital contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember">100
    shares of ordinary share of RM1 each</AATP:ParticularsOfIssuedCapital>
    <AATP:PrincipalActivities contextRef="From2020-01-012020-12-31_custom_SubsidiaryCompanyFourMember">The
    promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs,
    events and campaigns</AATP:PrincipalActivities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyFourMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="Pure">0.9999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="Shares">176547</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="0"
      unitRef="USD">1147551</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="0"
      unitRef="USD">656495</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="0"
      unitRef="USD">1804046</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zcIMJ6haPcN8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
&lt;span id="xdx_826_zgK8FlBMWZW6"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTR730J0sFY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z54tMmhMAiUd"&gt;Basis
of presentation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;U.S. GAAP&#x201d;) for information pursuant to the rules and regulations of the Securities
Exchange Commission (&#x201c;SEC&#x201d;), and include all normal and recurring adjustments that management of the Company considers
necessary for a fair presentation of its financial position and operation results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--FiscalPeriod_zSP00q8ovKre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zyIC7gncKQbh"&gt;Change
of year end&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements
consist of the unaudited financial data for the year ended December 31, 2019, which was derived from the six months audited financial
statement ended December 31, 2019 and the interim financial statements for the six months ended June 30, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zVLcAFfvvIRg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zbx6oyc4Ivu7"&gt;Principles
of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the
Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the
primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power
to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or
to cast a majority of votes at the meeting of directors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities
without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial
interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb
the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is
deemed to be the primary beneficiary and must consolidate the VIE.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--UseOfEstimates_zRBqtC1y0Rv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zPD3JoKOtab9"&gt;Use
of estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date
of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant
accounting estimates reflected in the Company&#x2019;s consolidated financial statements include allowance for doubtful accounts,
allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment
of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain
tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbLw5TKDzyQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zKxM6jyQ5jj9"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_z0Jaog9bxWZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zOgNmcedxnV3"&gt;Accounts
receivable and accounts receivable &#x2013; related party&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
receivable and accounts receivable &#x2013; related party are recorded at the invoiced amount less an allowance for any uncollectible
accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party
e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy
of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management
also periodically evaluates individual customer&#x2019;s financial condition, credit history, and the current economic conditions
to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after
all means of collection have been exhausted and the potential for recovery is considered remote. The Company&#x2019;s management
continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020,
and 2019, &lt;span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20201231_zhC0gLzsxXaj" title="Accounts Receivable, Allowance for Credit Loss"&gt;&lt;span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20191231_zv9vq6cJfZ8l" title="Accounts Receivable, Allowance for Credit Loss"&gt;no&lt;/span&gt;&lt;/span&gt; valuation allowance was recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--InventoryPolicyTextBlock_zFUs7n4p67jl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zhkqYvzJeVla"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the
shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs
exceed expected net realizable value. As of December 31, 2020, and 2019, there are &lt;span id="xdx_907_eus-gaap--InventoryWriteDown_do_c20200101__20201231_zgienrIUaYU3" title="Inventories write-down"&gt;&lt;span id="xdx_90F_eus-gaap--InventoryWriteDown_do_c20190101__20191231_zCBCKFGkFpra" title="Inventories write-down"&gt;no&lt;/span&gt;&lt;/span&gt; inventories obsolescence reserves or write-downs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zMxG7BcYUaua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z4xaDU4cq9U6"&gt;Prepaid
taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prepaid
taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income taxes; and (ii)
goods and service tax (&#x201c;GST&#x201d;) that is refundable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zeanCKKuhxQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_z4eTCa0GrNNg"&gt;Prepayments
and deposits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future
services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such
advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve
such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and
adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after
management has determined that the likelihood of collection is not probable. The Company&#x2019;s management continues to evaluate
the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020, and 2019, there is &lt;span id="xdx_90C_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zOoBOydnluek" title="Allowance for doubtful accounts"&gt;&lt;span id="xdx_90D_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20191231_zRwZ81dNopmh" title="Allowance for doubtful accounts"&gt;no&lt;/span&gt;&lt;/span&gt;
allowance for the doubtful accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zK7TBn5YOKXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zZcACYTGoD01"&gt;Property
and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zzNtF6aagGc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the
estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8BC_zCdmNN6YMpGb" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Useful Life&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Computer and office equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_z2fLK85JSku7" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zI6pu4GZoBA2" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Furniture &amp;amp; fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zdgC0gag3g19" title="Estimated Useful Life of Property and Equipment"&gt;6&lt;/span&gt;-&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zaHBwcU8J9Jc" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment"&gt;Lease Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Vehicle&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z0izDTxWgvE4" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_zW3Hoia0BIpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or
loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are
charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets,
are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances
warrant revised estimates of useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zxdQBUFNGlb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_z2GCRI0OOo6d"&gt;Intangible
assets, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_z1SSSWOPprD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis
over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B2_zMvUZJ1WVh22" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 76%; font-weight: bold"&gt;Classification&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 22%; font-weight: bold; text-align: center"&gt;Useful Life&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z1HaoclfKPk6" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_z7ZQgvLZEmOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBSVMRjM1ak8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zq8BxyvJZtB"&gt;Impairment
for long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events
or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the
assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets
based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated
undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the
asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying
amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate,
to comparable market values. As of December 31, 2020 and 2019, &lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zwNmJYhcW2n4"&gt;&lt;span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20190101__20191231_zZK7SYlBBL8l" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment of long-lived assets was recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--DeferredChargesPolicyTextBlock_zcLFnJGYqLHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z6CuZBHv5W6j"&gt;Deferred
offering costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred
offering costs represents costs associated with the Company&#x2019;s current offering which will be netted against the proceeds
from the Company&#x2019;s current offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--MarketableSecuritiesPolicy_zI3AAPKbqZS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zNNH4dr7Jbqf"&gt;Investment
in marketable equity securities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prior
to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the
lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market
in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost
less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities
are based on the average cost of all the units of a particular security held at the time of sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company adopted ASU 2016-01, &lt;i&gt;Financial Instruments &#x2013; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities&lt;/i&gt;. Investments in marketable equity securities (non-current) are reported at fair
value with changes in fair value recognized in the Company&#x2019;s consolidated statements of operations and comprehensive loss
in the caption of &#x201c;unrealized holding gain (loss) on marketable securities&#x201d; in each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--NonMarketableSecuritiesPolicyTextBlock_zFnz2dhNrF4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zfsCIrUIPHYc"&gt;Investment
in non-marketable equity securities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prior
to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline
in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average
cost of all the units of a particular security held at the time of sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company adopted ASU 2016-01, &lt;i&gt;Financial Instruments &#x2013; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities&lt;/i&gt;. Due to the Company&#x2019;s non-marketable equity securities (non-current) does
not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to
record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes
resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the
investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration
in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change
in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market
condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase,
an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the
carrying amount of that investment; and (v) Factors that raise significant concerns about the investee&#x2019;s ability to continue
as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory
capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities
(non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair
value of the investment and its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zW3IYvpz4Alg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zMogr6vZHbe2"&gt;Customer
deposits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits
are reduced when the related sale is recognized in accordance with the Company&#x2019;s revenue recognition policy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zX0QGKJuKWG2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zxOAHW8oJxf"&gt;Revenue
recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09, Revenue from Contracts with Customers
(ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not
result in an adjustment to retained earnings upon adoption of this new guidance as the Company&#x2019;s revenue was recognized
based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer
of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in
such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should
be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company&#x2019;s
revenue streams are recognized at a point in time for the Company&#x2019;s sale of health and wellness products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that
the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine
the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will
not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue
when (or as) the Company satisfies the performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including
payment terms, are identified, the contract has commercial substance and consideration is probable of substantial collection.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prior
to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive
evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability
is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred
and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted
by the customer when the products are collected by the customer at the Company&#x2019;s office. Revenue is recorded net of sales
discounts, returns, allowances, and other adjustments that are based upon management&#x2019;s best estimates and historical experience
and are provided for in the same period as the related revenues are recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes
in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy
for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance
and confirmed that there were no differences in the pattern of revenue recognition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Sales
of Health and Wellness products&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
&lt;i&gt;Performance obligations satisfied at a point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control
of the health and wellness products are transferred to its customer at the Company&#x2019;s office or shipment of the goods, which
is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after
all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products
are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the
value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash
proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction
of the health and wellness products transaction price upon such sales transactions occurred. The Company&#x2019;s coupons have
a validity period of six months. If the Company&#x2019;s customers did not utilize the coupons after six months, the Company would
recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2020 and
2019, the Company recognized $&lt;span id="xdx_90A_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zSpzJ5ZUN80k"&gt;170,431&lt;/span&gt;
&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90D_ecustom--ForfeitedCouponIncome_pp0p0_c20190101__20191231_zZYzEUhVIhl2"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(unaudited) as forfeited coupon income.
The Company did not earn any forfeited coupon income for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, the Company had contracts for the sales of health and wellness products amounting to $&lt;span id="xdx_90B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200930__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_zOuTiSsaJJte" title="Revenue from sales"&gt;116,541&lt;/span&gt; which it is
expected to fulfill within 12 months from December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zdBXrjHSlYo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Disaggregated
information of revenues by products are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B6_zChGSZN39qXj" style="display: none"&gt;SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Survivor Select&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"&gt;149,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0730"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Energized Mineral Concentrate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues"&gt;81,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues"&gt;238,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues"&gt;100,270&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ionized Cal-Mag&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"&gt;908,964&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"&gt;55,718&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Omega Blend&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues"&gt;495,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues"&gt;137,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues"&gt;68,927&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;BetaMaxx&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues"&gt;156,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues"&gt;191,246&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues"&gt;67,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vege Fruit Fiber&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zbzRbBa2R2xc" style="text-align: right" title="Total revenues"&gt;1,755&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zLCVyk32GXBd" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_z4tlviO1VJ3g" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0760"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Iron&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--IronMember_zKjsOyTnGL43" style="text-align: right" title="Total revenues"&gt;133,389&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--IronMember_z6jB8K3wD1ig" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0764"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--IronMember_zG3y9qjsS042" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0766"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Young Formula&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zCbbACpUD5tb" style="text-align: right" title="Total revenues"&gt;653,631&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zFBXDDEWNjg3" style="text-align: right" title="Total revenues"&gt;117,453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zuNHdbx356e3" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0772"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Organic Youth Care Cleansing Bar&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z3nhg4lmHW9i" style="text-align: right" title="Total revenues"&gt;43,127&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zI6wcZke4M15" style="text-align: right" title="Total revenues"&gt;34,917&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190701__20191213__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z6WIp5pTOix9" style="text-align: right" title="Total revenues"&gt;17,206&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Mitogize&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--MitogizeMember_zAreAMX1Mll1" style="text-align: right" title="Total revenues"&gt;162,801&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_z1oN5ObLMhp6" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_zEq44msPTLtj" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;No. 1 MED&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zlSLsCJQhFf4" style="text-align: right" title="Total revenues"&gt;46,713&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zKbFGZRdyAah" style="text-align: right" title="Total revenues"&gt;140,733&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_z0CCGwlOHMSj" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Energetique&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zv5rChZ4rlC" style="text-align: right" title="Total revenues"&gt;253,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zRM3mj7XNsG2" style="text-align: right" title="Total revenues"&gt;174,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zLNcmrig4WE4" style="text-align: right" title="Total revenues"&gt;175,170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Trim+&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pp0p0_c20200101__20201213__srt--ProductOrServiceAxis__custom--TrimPlusMember_zcYOBTSyddxf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"&gt;365,350&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zesbMf6lJCz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"&gt;198,817&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zCH8cGDMuRvd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0802"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20200101__20201231_zx6ORyFHQ275" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues"&gt;3,452,621&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pp0p0_c20190101__20191231_z2fnVT2bi9k7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues"&gt;1,290,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231_zW7lnu0jfNDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues"&gt;429,362&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zI3PvwI53Oug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Sales
of Health and Wellness services&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
&lt;i&gt;Performance obligations satisfied at a point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company carries out its Wellness program, where the Company&#x2019;s products are bundled with health screening test and a health
camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises
to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced
by the fact that the Company provides separate services of delivering the health screening test report and allowing admission
of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues
being recognized when the test reports are completed and delivered to its customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health
camp program was completed in the final day of the health camp. For the year ended December 31, 2020, revenues from health and
wellness services are immaterial to the Company&#x2019;s consolidated statements of operations and comprehensive income (loss).
The Company did not earn any revenues from health and wellness services for the year ended December 31, 2019 and for the six months
ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--CostOfSalesPolicyTextBlock_zkmmRRTDgpw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zLrxsIRymsf8"&gt;Cost
of revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cost
of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--ShippingAndHandlingPolicyTextBlock_zV3CavKT9Hd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zqQ4fr4fML5i"&gt;Shipping
and handling&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Shipping
and handling charges amounted to $&lt;span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zVbxLjvziDP1" title="Selling expenses"&gt;9,315&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--SellingExpense_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjMBI1nTDuI3" title="Selling expenses"&gt;0&lt;/span&gt; for the years ended December 31, 2020 and 2019, respectively. There was &lt;span id="xdx_90D_eus-gaap--SellingExpense_pp0p0_do_c20190701__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zWv6ZSIDlnKd" title="Selling expenses"&gt;&lt;span title="Selling expenses"&gt;no&lt;/span&gt;&lt;/span&gt; shipping
and handling charges for the six months ended December 31, 2019. Shipping and handling charges are expensed as incurred and included
in selling expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zpdnyKbHw8d6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zmLmRIvrcX3"&gt;Advertising
costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Advertising
costs amounted to $&lt;span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zMIxf7tBpael" title="Advertising costs"&gt;14,339&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20190101__20191231_zogSdieAsnse" title="Advertising costs"&gt;0&lt;/span&gt; for the years ended December 31, 2020 and 2019, respectively. There were &lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_pp0p0_do_c20190701__20191231_zwKpGThdHrBc" title="Advertising costs"&gt;no&lt;/span&gt; advertising costs
for the six months ended December 31, 2019. Advertising costs are expensed as incurred and included in selling expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zEVKxBI3luP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zSWBTGgQNpD7"&gt;Commission
expenses&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Commission
expenses are the Company&#x2019;s most significant expenses. As with all companies in the network marketing industry, the Company&#x2019;s
sales channel is external to the Company. The Company&#x2019;s &#x201c;external sales force&#x201d; is stratified into two levels
based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly
or indirectly, are referred to as &#x201c;sales network members&#x201d;. The Company pays commission to every sales distributor
based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors
with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain
amount of the Company&#x2019;s inventory on their store premises. The stockists shall account to the Company for all products sales
from their store premises as monitored through the Company&#x2019;s centralized stock tracking system. The Company pays a separate
commission to stockists based on revenue generated from the stockists&#x2019; physical stores. Commission expenses amounted to
$&lt;span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zYQ1YXb97Ey3" title="Commission expenses"&gt;830,659&lt;/span&gt; and $&lt;span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20190101__20191231_zjJUkqSIcuPb" title="Commission expenses"&gt;0&lt;/span&gt; (unaudited) for the years ended December 31, 2020 and 2019, respectively. There were &lt;span id="xdx_90A_ecustom--SalesCommissionsAndFees1_pp0p0_do_c20190701__20191231_zqAGdQTEnrhk" title="Commission expenses"&gt;no&lt;/span&gt; commission expenses for
the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--DefinedContributionPlanPolicyTextBlock_zdnbUAp30fci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zoaAjV6PLZll"&gt;Defined
contribution plan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required
to accrue and pay for these benefits based on certain percentages of the employees&#x2019; respective salaries, subject to certain
ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined
contribution plan. Total expenses for the plans were $&lt;span id="xdx_909_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_zcD48OUBTDU4" title="Defined contribution plan expense"&gt;75,802&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20190101__20191231_zScVmBNzRsja" title="Defined contribution plan expense"&gt;0&lt;/span&gt; (unaudited) for the years ended December 31, 2020 and 2019,
respectively. There was &lt;span id="xdx_903_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_do_c20190701__20191231_zwB25uwSjDv9" title="Defined contribution plan expense"&gt;no&lt;/span&gt; defined contribution plan expenses for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
related contribution plans include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Social
    Security Organization (&#x201c;SOSCO&#x201d;) &#x2013; &lt;span id="xdx_904_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_zzJ1kUxA3Xde" title="Salary percentage"&gt;1.75%&lt;/span&gt; based on employee&#x2019;s monthly salary capped of RM &lt;span id="xdx_90D_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_z5twycUgm4b7" title="Monthly salary"&gt;4,000&lt;/span&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Employees
    Provident Fund (&#x201c;EPF&#x201d;) &#x2013; &lt;span id="xdx_90F_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_z3vJooMIJuo2" title="Salary percentage"&gt;12%&lt;/span&gt; based on employee&#x2019;s monthly salary;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Employment
    Insurance System (&#x201c;EIS&#x201d;) &#x2013; &lt;span id="xdx_907_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zObQ2Bc6Cqgf" title="Salary percentage"&gt;0.2%&lt;/span&gt; based on employee&#x2019;s monthly salary capped of RM &lt;span id="xdx_906_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zgTOp9GhUnFd" title="Monthly salary"&gt;4,000&lt;/span&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Human
    Resource Development Fund (&#x201c;HRDF&#x201d;) &#x2013; &lt;span id="xdx_901_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zmGJg8akYI4e" title="Salary percentage"&gt;1% &lt;/span&gt;based on employee&#x2019;s monthly salary&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z26hosMg9bS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zWmm0JwTgGNd"&gt;Income
taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results
for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have
been enacted or substantively enacted by the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between
the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in
the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible
temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when
the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it
is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred
tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion
or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the
relevant taxing authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;An
uncertain tax position is recognized as a benefit only if it is &#x201c;more likely than not&#x201d; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is &lt;span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20200101__20201231_z6btSy8NTCP2"&gt;greater than 50%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;likely of being realized on examination. For
tax positions not meeting the &#x201c;more likely than not&#x201d; test, no tax benefit is recorded. &lt;span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20200101__20201231_zOoWBHJPrM0g"&gt;&lt;span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190101__20191231_zjL9HeSSY6D9"&gt;No&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;penalties and interest incurred related to underpayment
of income taxes for the years ended December 31, 2020 and 2019. &lt;span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190701__20191231_zTaFbBkviXke"&gt;No
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;penalties and interest incurred related to underpayment
of income taxes for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions.
As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign
tax authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zA14L2AXjhr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_z6lDNGskyQyb"&gt;Comprehensive
income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income
(loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#x2019; equity
but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting
from the Company not using the U.S. dollar as its functional currencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--NoncontrollingInterestPolicyTextBlock_zjA6pTuKrPnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zc3R8KYdMsN9"&gt;Non-controlling
interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eus-gaap--MinorityInterestDescription_c20200101__20201231_zuFJWaaiUBz1" title="Noncontrolling interest, description"&gt;Non-controlling
interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held
by two individuals.&lt;/span&gt; The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable
to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated
statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders
and the shareholders of the Company. As of December 31, 2020, the non-controlling interest balance was $&lt;span id="xdx_90A_eus-gaap--MinorityInterest_iI_pp0p0_c20201231_zxduBUXDsSEd" title="Non-controlling interest"&gt;0&lt;/span&gt; and therefore not presented
in the accompanying consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zqg1I9qAHxok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zY3SKCpKKPQ9"&gt;Earnings
(loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company computes earnings (loss) per share (&#x201c;EPS&#x201d;) in accordance with ASC 260, &#x201c;Earnings per Share&#x201d;. ASC
260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary
share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares
(e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per
share or decrease loss per share) are excluded from the calculation of diluted EPS. For the years ended December 31, 2020 and
2019, there were &lt;span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20200101__20201231_zt4FOglj8Qxe" title="Potentially dilutive securities outstanding"&gt;&lt;span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190101__20191231_zYfevg2dAOf8" title="Potentially dilutive securities outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; dilutive shares. There was &lt;span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190701__20191231_z5THbyxJmJWi" title="Potentially dilutive securities outstanding"&gt;no&lt;/span&gt; dilutive shares for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOK2vIIGi7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zVe1pPjk2E0j"&gt;Foreign
currencies translation and transaction&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates
prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional
currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting
exchange differences are recorded in the Consolidated Statements of Operations and Comprehensive Income (Loss).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
reporting currency of the Company is United States Dollars (&#x201c;US$&#x201d;) and the accompanying financial statements have
been expressed in US$. The Company&#x2019;s subsidiary in Labuan maintains its books and record in United States Dollars (&#x201c;US$&#x201d;)
albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the
Malaysian Ringgit (&#x201c;MYR&#x201d; or &#x201c;RM&#x201d;). The Company&#x2019;s subsidiary in Hong Kong maintains its books and
record in Hong Kong Dollars (&#x201c;HK$&#x201d;), similar to its functional currency. The Company&#x2019;s subsidiary and VIE in
Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (&#x201c;MYR&#x201d;
or &#x201c;RM&#x201d;), as its functional currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated
into US$, in accordance with ASC Topic 830-30, &#x201c;&lt;i&gt;Translation of Financial Statement&#x201d;&lt;/i&gt;, using the exchange rate
on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses
resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other
comprehensive income within the statements of stockholders&#x2019; equity. Cash flows are also translated at average translation
rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the
corresponding balances on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zyv50fNYzHIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BE_zVTTQ0AjlAuj" style="display: none"&gt;SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Period-end MYR : US$1 exchange rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zVv6l569wlf8" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;4.02&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zAce32sO6Npd" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;4.09&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Period-end HKD : US$1 exchange rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zAgNXVkWtTEk" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;7.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zfqZH1qQvpu8" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;7.79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Period-average MYR : US$1 exchange rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zVetDM7dEnI2" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average"&gt;4.20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zjh3pkqYV8fj" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average"&gt;4.14&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zgvw3KqrLqk3" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average"&gt;4.16&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Period-average HKD : US$1 exchange rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zyaxoZRqmhx6" style="text-align: right" title="Foreign currency exchange rate period average"&gt;7.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zI0VUIkx7qu8" style="text-align: right" title="Foreign currency exchange rate period average"&gt;7.84&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zzj3XRLLV3va" style="text-align: right" title="Foreign currency exchange rate period average"&gt;7.83&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zGqhfLGDdP0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zqNQnty2NCli" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z9BMJjyThk6j"&gt;Related
parties&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly,
to control the other party or exercise significant influence over the other party in making financial and operating decisions.
Companies are also considered to be related if they are subject to common control or common significant influence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zx2nMC08WMI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zg5tdN22eaj1"&gt;Fair
value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments
and requires disclosure of the fair value of financial instruments held by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement
and enhance disclosure requirements for fair value measures. The three levels are defined as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
    that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
    instruments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or
cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected
realization and their current market rates of interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_z0vjk6wQJWw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zIClplFSvxVi"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
July 1, 2019, the Company adopted ASU 2016-02, &#x201c;Leases&#x201d; (Topic 842), and elected the practical expedients that does
not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification
for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve
months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The
Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single
lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing
leases with a lease term in excess of twelve months on July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Operating
lease right-of-use (&#x201c;ROU&#x201d;) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the
commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit
rate for the Company&#x2019;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information
available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate
of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in
a similar economic environment and over a similar term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate
the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company
generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets.
The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases
with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU
asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company
reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying
value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying
value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected
to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating
lease payments in the undiscounted future pre-tax cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zbXPSSpP046l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_z8bQ1hey9MM3"&gt;Recent
accounting pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption
of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations,
as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#x2014;Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for
the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology.
The amendments in Update 2016-13 added Topic 326, Financial Instruments&#x2014;Credit Losses, and made several consequential amendments
to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually
assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial
Instruments&#x2014; Credit Losses&#x2014;Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders&#x2019;
concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at
amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information
by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief
also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement
users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date
of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit
losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December
15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company
is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and
investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and
purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify
that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting
when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting.
With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance
in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the
purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity
method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods
beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this
standard on January 1, 2021 did not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTR730J0sFY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z54tMmhMAiUd"&gt;Basis
of presentation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;U.S. GAAP&#x201d;) for information pursuant to the rules and regulations of the Securities
Exchange Commission (&#x201c;SEC&#x201d;), and include all normal and recurring adjustments that management of the Company considers
necessary for a fair presentation of its financial position and operation results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:FiscalPeriod contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84F_eus-gaap--FiscalPeriod_zSP00q8ovKre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zyIC7gncKQbh"&gt;Change
of year end&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements
consist of the unaudited financial data for the year ended December 31, 2019, which was derived from the six months audited financial
statement ended December 31, 2019 and the interim financial statements for the six months ended June 30, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FiscalPeriod>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zVLcAFfvvIRg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zbx6oyc4Ivu7"&gt;Principles
of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the
Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the
primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power
to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or
to cast a majority of votes at the meeting of directors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities
without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial
interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb
the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is
deemed to be the primary beneficiary and must consolidate the VIE.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_840_eus-gaap--UseOfEstimates_zRBqtC1y0Rv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zPD3JoKOtab9"&gt;Use
of estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date
of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant
accounting estimates reflected in the Company&#x2019;s consolidated financial statements include allowance for doubtful accounts,
allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment
of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain
tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbLw5TKDzyQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zKxM6jyQ5jj9"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_z0Jaog9bxWZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zOgNmcedxnV3"&gt;Accounts
receivable and accounts receivable &#x2013; related party&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
receivable and accounts receivable &#x2013; related party are recorded at the invoiced amount less an allowance for any uncollectible
accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party
e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy
of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management
also periodically evaluates individual customer&#x2019;s financial condition, credit history, and the current economic conditions
to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after
all means of collection have been exhausted and the potential for recovery is considered remote. The Company&#x2019;s management
continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020,
and 2019, &lt;span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20201231_zhC0gLzsxXaj" title="Accounts Receivable, Allowance for Credit Loss"&gt;&lt;span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20191231_zv9vq6cJfZ8l" title="Accounts Receivable, Allowance for Credit Loss"&gt;no&lt;/span&gt;&lt;/span&gt; valuation allowance was recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_845_eus-gaap--InventoryPolicyTextBlock_zFUs7n4p67jl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zhkqYvzJeVla"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the
shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs
exceed expected net realizable value. As of December 31, 2020, and 2019, there are &lt;span id="xdx_907_eus-gaap--InventoryWriteDown_do_c20200101__20201231_zgienrIUaYU3" title="Inventories write-down"&gt;&lt;span id="xdx_90F_eus-gaap--InventoryWriteDown_do_c20190101__20191231_zCBCKFGkFpra" title="Inventories write-down"&gt;no&lt;/span&gt;&lt;/span&gt; inventories obsolescence reserves or write-downs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryWriteDown
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:InventoryWriteDown>
    <AATP:PrepaidTaxesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zMxG7BcYUaua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z4xaDU4cq9U6"&gt;Prepaid
taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prepaid
taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income taxes; and (ii)
goods and service tax (&#x201c;GST&#x201d;) that is refundable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:PrepaidTaxesPolicyTextBlock>
    <AATP:PrepaymentsAndDepositsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_847_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zeanCKKuhxQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_z4eTCa0GrNNg"&gt;Prepayments
and deposits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future
services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such
advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve
such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and
adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after
management has determined that the likelihood of collection is not probable. The Company&#x2019;s management continues to evaluate
the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020, and 2019, there is &lt;span id="xdx_90C_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zOoBOydnluek" title="Allowance for doubtful accounts"&gt;&lt;span id="xdx_90D_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20191231_zRwZ81dNopmh" title="Allowance for doubtful accounts"&gt;no&lt;/span&gt;&lt;/span&gt;
allowance for the doubtful accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:PrepaymentsAndDepositsPolicyTextBlock>
    <AATP:AllowanceForDoubtfulAccountsReceivablesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</AATP:AllowanceForDoubtfulAccountsReceivablesCurrent>
    <AATP:AllowanceForDoubtfulAccountsReceivablesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">0</AATP:AllowanceForDoubtfulAccountsReceivablesCurrent>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zK7TBn5YOKXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zZcACYTGoD01"&gt;Property
and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zzNtF6aagGc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the
estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8BC_zCdmNN6YMpGb" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Useful Life&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Computer and office equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_z2fLK85JSku7" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zI6pu4GZoBA2" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Furniture &amp;amp; fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zdgC0gag3g19" title="Estimated Useful Life of Property and Equipment"&gt;6&lt;/span&gt;-&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zaHBwcU8J9Jc" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment"&gt;Lease Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Vehicle&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z0izDTxWgvE4" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_zW3Hoia0BIpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or
loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are
charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets,
are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances
warrant revised estimates of useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zzNtF6aagGc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the
estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span id="xdx_8BC_zCdmNN6YMpGb" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Useful Life&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Computer and office equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_z2fLK85JSku7" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zI6pu4GZoBA2" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Furniture &amp;amp; fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zdgC0gag3g19" title="Estimated Useful Life of Property and Equipment"&gt;6&lt;/span&gt;-&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zaHBwcU8J9Jc" title="Estimated Useful Life of Property and Equipment"&gt;7&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment"&gt;Lease Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Vehicle&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z0izDTxWgvE4" title="Estimated Useful Life of Property and Equipment"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-01-012020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">P6Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-01-012020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2020-01-012020-12-31_us-gaap_LeaseholdImprovementsMember">Lease Term</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-01-012020-12-31_us-gaap_VehiclesMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zxdQBUFNGlb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_z2GCRI0OOo6d"&gt;Intangible
assets, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_z1SSSWOPprD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis
over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B2_zMvUZJ1WVh22" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 76%; font-weight: bold"&gt;Classification&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 22%; font-weight: bold; text-align: center"&gt;Useful Life&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z1HaoclfKPk6" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_z7ZQgvLZEmOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_z1SSSWOPprD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis
over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B2_zMvUZJ1WVh22" style="display: none"&gt;SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 76%; font-weight: bold"&gt;Classification&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 22%; font-weight: bold; text-align: center"&gt;Useful Life&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z1HaoclfKPk6" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2020-01-012020-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBSVMRjM1ak8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zq8BxyvJZtB"&gt;Impairment
for long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events
or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the
assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets
based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated
undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the
asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying
amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate,
to comparable market values. As of December 31, 2020 and 2019, &lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zwNmJYhcW2n4"&gt;&lt;span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20190101__20191231_zZK7SYlBBL8l" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment of long-lived assets was recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_849_eus-gaap--DeferredChargesPolicyTextBlock_zcLFnJGYqLHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z6CuZBHv5W6j"&gt;Deferred
offering costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred
offering costs represents costs associated with the Company&#x2019;s current offering which will be netted against the proceeds
from the Company&#x2019;s current offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_841_eus-gaap--MarketableSecuritiesPolicy_zI3AAPKbqZS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zNNH4dr7Jbqf"&gt;Investment
in marketable equity securities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prior
to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the
lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market
in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost
less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities
are based on the average cost of all the units of a particular security held at the time of sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company adopted ASU 2016-01, &lt;i&gt;Financial Instruments &#x2013; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities&lt;/i&gt;. Investments in marketable equity securities (non-current) are reported at fair
value with changes in fair value recognized in the Company&#x2019;s consolidated statements of operations and comprehensive loss
in the caption of &#x201c;unrealized holding gain (loss) on marketable securities&#x201d; in each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MarketableSecuritiesPolicy>
    <AATP:NonMarketableSecuritiesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_847_ecustom--NonMarketableSecuritiesPolicyTextBlock_zFnz2dhNrF4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zfsCIrUIPHYc"&gt;Investment
in non-marketable equity securities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prior
to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline
in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average
cost of all the units of a particular security held at the time of sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company adopted ASU 2016-01, &lt;i&gt;Financial Instruments &#x2013; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities&lt;/i&gt;. Due to the Company&#x2019;s non-marketable equity securities (non-current) does
not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to
record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes
resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the
investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration
in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change
in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market
condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase,
an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the
carrying amount of that investment; and (v) Factors that raise significant concerns about the investee&#x2019;s ability to continue
as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory
capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities
(non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair
value of the investment and its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:NonMarketableSecuritiesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zW3IYvpz4Alg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zMogr6vZHbe2"&gt;Customer
deposits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits
are reduced when the related sale is recognized in accordance with the Company&#x2019;s revenue recognition policy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zX0QGKJuKWG2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zxOAHW8oJxf"&gt;Revenue
recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09, Revenue from Contracts with Customers
(ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not
result in an adjustment to retained earnings upon adoption of this new guidance as the Company&#x2019;s revenue was recognized
based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer
of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in
such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should
be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company&#x2019;s
revenue streams are recognized at a point in time for the Company&#x2019;s sale of health and wellness products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that
the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine
the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will
not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue
when (or as) the Company satisfies the performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including
payment terms, are identified, the contract has commercial substance and consideration is probable of substantial collection.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Prior
to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive
evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability
is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred
and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted
by the customer when the products are collected by the customer at the Company&#x2019;s office. Revenue is recorded net of sales
discounts, returns, allowances, and other adjustments that are based upon management&#x2019;s best estimates and historical experience
and are provided for in the same period as the related revenues are recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes
in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy
for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance
and confirmed that there were no differences in the pattern of revenue recognition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Sales
of Health and Wellness products&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
&lt;i&gt;Performance obligations satisfied at a point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control
of the health and wellness products are transferred to its customer at the Company&#x2019;s office or shipment of the goods, which
is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after
all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products
are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the
value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash
proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction
of the health and wellness products transaction price upon such sales transactions occurred. The Company&#x2019;s coupons have
a validity period of six months. If the Company&#x2019;s customers did not utilize the coupons after six months, the Company would
recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2020 and
2019, the Company recognized $&lt;span id="xdx_90A_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zSpzJ5ZUN80k"&gt;170,431&lt;/span&gt;
&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90D_ecustom--ForfeitedCouponIncome_pp0p0_c20190101__20191231_zZYzEUhVIhl2"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(unaudited) as forfeited coupon income.
The Company did not earn any forfeited coupon income for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, the Company had contracts for the sales of health and wellness products amounting to $&lt;span id="xdx_90B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200930__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_zOuTiSsaJJte" title="Revenue from sales"&gt;116,541&lt;/span&gt; which it is
expected to fulfill within 12 months from December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zdBXrjHSlYo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Disaggregated
information of revenues by products are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B6_zChGSZN39qXj" style="display: none"&gt;SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Survivor Select&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"&gt;149,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0730"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Energized Mineral Concentrate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues"&gt;81,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues"&gt;238,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues"&gt;100,270&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ionized Cal-Mag&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"&gt;908,964&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"&gt;55,718&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Omega Blend&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues"&gt;495,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues"&gt;137,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues"&gt;68,927&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;BetaMaxx&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues"&gt;156,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues"&gt;191,246&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues"&gt;67,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vege Fruit Fiber&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zbzRbBa2R2xc" style="text-align: right" title="Total revenues"&gt;1,755&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zLCVyk32GXBd" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_z4tlviO1VJ3g" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0760"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Iron&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--IronMember_zKjsOyTnGL43" style="text-align: right" title="Total revenues"&gt;133,389&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--IronMember_z6jB8K3wD1ig" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0764"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--IronMember_zG3y9qjsS042" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0766"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Young Formula&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zCbbACpUD5tb" style="text-align: right" title="Total revenues"&gt;653,631&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zFBXDDEWNjg3" style="text-align: right" title="Total revenues"&gt;117,453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zuNHdbx356e3" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0772"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Organic Youth Care Cleansing Bar&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z3nhg4lmHW9i" style="text-align: right" title="Total revenues"&gt;43,127&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zI6wcZke4M15" style="text-align: right" title="Total revenues"&gt;34,917&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190701__20191213__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z6WIp5pTOix9" style="text-align: right" title="Total revenues"&gt;17,206&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Mitogize&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--MitogizeMember_zAreAMX1Mll1" style="text-align: right" title="Total revenues"&gt;162,801&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_z1oN5ObLMhp6" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_zEq44msPTLtj" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;No. 1 MED&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zlSLsCJQhFf4" style="text-align: right" title="Total revenues"&gt;46,713&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zKbFGZRdyAah" style="text-align: right" title="Total revenues"&gt;140,733&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_z0CCGwlOHMSj" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Energetique&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zv5rChZ4rlC" style="text-align: right" title="Total revenues"&gt;253,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zRM3mj7XNsG2" style="text-align: right" title="Total revenues"&gt;174,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zLNcmrig4WE4" style="text-align: right" title="Total revenues"&gt;175,170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Trim+&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pp0p0_c20200101__20201213__srt--ProductOrServiceAxis__custom--TrimPlusMember_zcYOBTSyddxf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"&gt;365,350&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zesbMf6lJCz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"&gt;198,817&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zCH8cGDMuRvd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0802"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20200101__20201231_zx6ORyFHQ275" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues"&gt;3,452,621&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pp0p0_c20190101__20191231_z2fnVT2bi9k7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues"&gt;1,290,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231_zW7lnu0jfNDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues"&gt;429,362&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zI3PvwI53Oug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Sales
of Health and Wellness services&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
&lt;i&gt;Performance obligations satisfied at a point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company carries out its Wellness program, where the Company&#x2019;s products are bundled with health screening test and a health
camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises
to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced
by the fact that the Company provides separate services of delivering the health screening test report and allowing admission
of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues
being recognized when the test reports are completed and delivered to its customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health
camp program was completed in the final day of the health camp. For the year ended December 31, 2020, revenues from health and
wellness services are immaterial to the Company&#x2019;s consolidated statements of operations and comprehensive income (loss).
The Company did not earn any revenues from health and wellness services for the year ended December 31, 2019 and for the six months
ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <AATP:ForfeitedCouponIncome
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">170431</AATP:ForfeitedCouponIncome>
    <AATP:ForfeitedCouponIncome
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">0</AATP:ForfeitedCouponIncome>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30_custom_HealthAndWellnessProductsMember"
      decimals="0"
      unitRef="USD">116541</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <AATP:ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_89E_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zdBXrjHSlYo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Disaggregated
information of revenues by products are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B6_zChGSZN39qXj" style="display: none"&gt;SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Survivor Select&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"&gt;149,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0730"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Energized Mineral Concentrate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues"&gt;81,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues"&gt;238,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues"&gt;100,270&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Ionized Cal-Mag&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"&gt;908,964&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"&gt;55,718&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Omega Blend&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues"&gt;495,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues"&gt;137,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues"&gt;68,927&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;BetaMaxx&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues"&gt;156,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues"&gt;191,246&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues"&gt;67,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vege Fruit Fiber&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zbzRbBa2R2xc" style="text-align: right" title="Total revenues"&gt;1,755&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zLCVyk32GXBd" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_z4tlviO1VJ3g" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0760"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Iron&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--IronMember_zKjsOyTnGL43" style="text-align: right" title="Total revenues"&gt;133,389&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--IronMember_z6jB8K3wD1ig" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0764"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--IronMember_zG3y9qjsS042" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0766"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Young Formula&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zCbbACpUD5tb" style="text-align: right" title="Total revenues"&gt;653,631&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zFBXDDEWNjg3" style="text-align: right" title="Total revenues"&gt;117,453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zuNHdbx356e3" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0772"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Organic Youth Care Cleansing Bar&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z3nhg4lmHW9i" style="text-align: right" title="Total revenues"&gt;43,127&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zI6wcZke4M15" style="text-align: right" title="Total revenues"&gt;34,917&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190701__20191213__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z6WIp5pTOix9" style="text-align: right" title="Total revenues"&gt;17,206&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Mitogize&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--MitogizeMember_zAreAMX1Mll1" style="text-align: right" title="Total revenues"&gt;162,801&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_z1oN5ObLMhp6" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_zEq44msPTLtj" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;No. 1 MED&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zlSLsCJQhFf4" style="text-align: right" title="Total revenues"&gt;46,713&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zKbFGZRdyAah" style="text-align: right" title="Total revenues"&gt;140,733&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_z0CCGwlOHMSj" style="text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Energetique&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zv5rChZ4rlC" style="text-align: right" title="Total revenues"&gt;253,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zRM3mj7XNsG2" style="text-align: right" title="Total revenues"&gt;174,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zLNcmrig4WE4" style="text-align: right" title="Total revenues"&gt;175,170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Trim+&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pp0p0_c20200101__20201213__srt--ProductOrServiceAxis__custom--TrimPlusMember_zcYOBTSyddxf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"&gt;365,350&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zesbMf6lJCz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"&gt;198,817&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zCH8cGDMuRvd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0802"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20200101__20201231_zx6ORyFHQ275" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues"&gt;3,452,621&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pp0p0_c20190101__20191231_z2fnVT2bi9k7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues"&gt;1,290,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231_zW7lnu0jfNDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues"&gt;429,362&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</AATP:ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_SurvivorSelectMember"
      decimals="0"
      unitRef="USD">149897</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_EnergizedMineralConcentrateMember"
      decimals="0"
      unitRef="USD">81481</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_EnergizedMineralConcentrateMember"
      decimals="0"
      unitRef="USD">238687</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_EnergizedMineralConcentrateMember"
      decimals="0"
      unitRef="USD">100270</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_IonizedCalMagMember"
      decimals="0"
      unitRef="USD">908964</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_IonizedCalMagMember"
      decimals="0"
      unitRef="USD">55718</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_OmegaBlendMember"
      decimals="0"
      unitRef="USD">495567</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_OmegaBlendMember"
      decimals="0"
      unitRef="USD">137752</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_OmegaBlendMember"
      decimals="0"
      unitRef="USD">68927</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_BetaMaxxMember"
      decimals="0"
      unitRef="USD">156550</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_BetaMaxxMember"
      decimals="0"
      unitRef="USD">191246</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_BetaMaxxMember"
      decimals="0"
      unitRef="USD">67789</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_VegeFruitFiberMember"
      decimals="0"
      unitRef="USD">1755</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_IronMember"
      decimals="0"
      unitRef="USD">133389</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_YoungFormulaMember"
      decimals="0"
      unitRef="USD">653631</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_YoungFormulaMember"
      decimals="0"
      unitRef="USD">117453</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_OrganicYouthCareCleansingBarMember"
      decimals="0"
      unitRef="USD">43127</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_OrganicYouthCareCleansingBarMember"
      decimals="0"
      unitRef="USD">34917</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-13_custom_OrganicYouthCareCleansingBarMember"
      decimals="0"
      unitRef="USD">17206</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_MitogizeMember"
      decimals="0"
      unitRef="USD">162801</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_NoOneMEDMember"
      decimals="0"
      unitRef="USD">46713</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_NoOneMEDMember"
      decimals="0"
      unitRef="USD">140733</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_EnergetiqueMember"
      decimals="0"
      unitRef="USD">253396</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_EnergetiqueMember"
      decimals="0"
      unitRef="USD">174808</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31_custom_EnergetiqueMember"
      decimals="0"
      unitRef="USD">175170</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-13_custom_TrimPlusMember"
      decimals="0"
      unitRef="USD">365350</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31_custom_TrimPlusMember"
      decimals="0"
      unitRef="USD">198817</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">3452621</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">1290131</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">429362</us-gaap:Revenues>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_846_eus-gaap--CostOfSalesPolicyTextBlock_zkmmRRTDgpw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zLrxsIRymsf8"&gt;Cost
of revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cost
of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CostOfSalesPolicyTextBlock>
    <AATP:ShippingAndHandlingPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84F_ecustom--ShippingAndHandlingPolicyTextBlock_zV3CavKT9Hd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zqQ4fr4fML5i"&gt;Shipping
and handling&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Shipping
and handling charges amounted to $&lt;span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zVbxLjvziDP1" title="Selling expenses"&gt;9,315&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--SellingExpense_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjMBI1nTDuI3" title="Selling expenses"&gt;0&lt;/span&gt; for the years ended December 31, 2020 and 2019, respectively. There was &lt;span id="xdx_90D_eus-gaap--SellingExpense_pp0p0_do_c20190701__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zWv6ZSIDlnKd" title="Selling expenses"&gt;&lt;span title="Selling expenses"&gt;no&lt;/span&gt;&lt;/span&gt; shipping
and handling charges for the six months ended December 31, 2019. Shipping and handling charges are expensed as incurred and included
in selling expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:ShippingAndHandlingPolicyTextBlock>
    <us-gaap:SellingExpense
      contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">9315</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">0</us-gaap:SellingExpense>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zpdnyKbHw8d6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zmLmRIvrcX3"&gt;Advertising
costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Advertising
costs amounted to $&lt;span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zMIxf7tBpael" title="Advertising costs"&gt;14,339&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20190101__20191231_zogSdieAsnse" title="Advertising costs"&gt;0&lt;/span&gt; for the years ended December 31, 2020 and 2019, respectively. There were &lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_pp0p0_do_c20190701__20191231_zwKpGThdHrBc" title="Advertising costs"&gt;no&lt;/span&gt; advertising costs
for the six months ended December 31, 2019. Advertising costs are expensed as incurred and included in selling expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">14339</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:AdvertisingExpense>
    <us-gaap:CommissionsExpensePolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_843_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zEVKxBI3luP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zSWBTGgQNpD7"&gt;Commission
expenses&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Commission
expenses are the Company&#x2019;s most significant expenses. As with all companies in the network marketing industry, the Company&#x2019;s
sales channel is external to the Company. The Company&#x2019;s &#x201c;external sales force&#x201d; is stratified into two levels
based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly
or indirectly, are referred to as &#x201c;sales network members&#x201d;. The Company pays commission to every sales distributor
based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors
with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain
amount of the Company&#x2019;s inventory on their store premises. The stockists shall account to the Company for all products sales
from their store premises as monitored through the Company&#x2019;s centralized stock tracking system. The Company pays a separate
commission to stockists based on revenue generated from the stockists&#x2019; physical stores. Commission expenses amounted to
$&lt;span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zYQ1YXb97Ey3" title="Commission expenses"&gt;830,659&lt;/span&gt; and $&lt;span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20190101__20191231_zjJUkqSIcuPb" title="Commission expenses"&gt;0&lt;/span&gt; (unaudited) for the years ended December 31, 2020 and 2019, respectively. There were &lt;span id="xdx_90A_ecustom--SalesCommissionsAndFees1_pp0p0_do_c20190701__20191231_zqAGdQTEnrhk" title="Commission expenses"&gt;no&lt;/span&gt; commission expenses for
the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommissionsExpensePolicyPolicyTextBlock>
    <AATP:SalesCommissionsAndFees1
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">830659</AATP:SalesCommissionsAndFees1>
    <AATP:SalesCommissionsAndFees1
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">0</AATP:SalesCommissionsAndFees1>
    <AATP:SalesCommissionsAndFees1
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">0</AATP:SalesCommissionsAndFees1>
    <AATP:DefinedContributionPlanPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_840_ecustom--DefinedContributionPlanPolicyTextBlock_zdnbUAp30fci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zoaAjV6PLZll"&gt;Defined
contribution plan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required
to accrue and pay for these benefits based on certain percentages of the employees&#x2019; respective salaries, subject to certain
ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined
contribution plan. Total expenses for the plans were $&lt;span id="xdx_909_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_zcD48OUBTDU4" title="Defined contribution plan expense"&gt;75,802&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20190101__20191231_zScVmBNzRsja" title="Defined contribution plan expense"&gt;0&lt;/span&gt; (unaudited) for the years ended December 31, 2020 and 2019,
respectively. There was &lt;span id="xdx_903_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_do_c20190701__20191231_zwB25uwSjDv9" title="Defined contribution plan expense"&gt;no&lt;/span&gt; defined contribution plan expenses for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
related contribution plans include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Social
    Security Organization (&#x201c;SOSCO&#x201d;) &#x2013; &lt;span id="xdx_904_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_zzJ1kUxA3Xde" title="Salary percentage"&gt;1.75%&lt;/span&gt; based on employee&#x2019;s monthly salary capped of RM &lt;span id="xdx_90D_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_z5twycUgm4b7" title="Monthly salary"&gt;4,000&lt;/span&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Employees
    Provident Fund (&#x201c;EPF&#x201d;) &#x2013; &lt;span id="xdx_90F_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_z3vJooMIJuo2" title="Salary percentage"&gt;12%&lt;/span&gt; based on employee&#x2019;s monthly salary;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Employment
    Insurance System (&#x201c;EIS&#x201d;) &#x2013; &lt;span id="xdx_907_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zObQ2Bc6Cqgf" title="Salary percentage"&gt;0.2%&lt;/span&gt; based on employee&#x2019;s monthly salary capped of RM &lt;span id="xdx_906_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zgTOp9GhUnFd" title="Monthly salary"&gt;4,000&lt;/span&gt;;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Human
    Resource Development Fund (&#x201c;HRDF&#x201d;) &#x2013; &lt;span id="xdx_901_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zmGJg8akYI4e" title="Salary percentage"&gt;1% &lt;/span&gt;based on employee&#x2019;s monthly salary&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:DefinedContributionPlanPolicyTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">75802</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <AATP:SalaryPercentage
      contextRef="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember"
      decimals="INF"
      unitRef="Pure">0.0175</AATP:SalaryPercentage>
    <AATP:MonthlySalary
      contextRef="From2020-01-012020-12-31_custom_SocialSecurityOrganizationMember_custom_MYRCurrencyMember"
      decimals="0"
      unitRef="RM">4000</AATP:MonthlySalary>
    <AATP:SalaryPercentage
      contextRef="From2020-01-012020-12-31_custom_EmployeesProvidentFundMember"
      decimals="INF"
      unitRef="Pure">0.12</AATP:SalaryPercentage>
    <AATP:SalaryPercentage
      contextRef="From2020-01-012020-12-31_custom_EmploymentInsuranceSystemMember"
      decimals="INF"
      unitRef="Pure">0.002</AATP:SalaryPercentage>
    <AATP:MonthlySalary
      contextRef="From2020-01-012020-12-31_custom_EmploymentInsuranceSystemMember_custom_MYRCurrencyMember"
      decimals="0"
      unitRef="RM">4000</AATP:MonthlySalary>
    <AATP:SalaryPercentage
      contextRef="From2020-01-012020-12-31_custom_HumanResourceDevelopmentFundMember"
      decimals="INF"
      unitRef="Pure">0.01</AATP:SalaryPercentage>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z26hosMg9bS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zWmm0JwTgGNd"&gt;Income
taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results
for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have
been enacted or substantively enacted by the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between
the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in
the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible
temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when
the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it
is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred
tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion
or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the
relevant taxing authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;An
uncertain tax position is recognized as a benefit only if it is &#x201c;more likely than not&#x201d; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is &lt;span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20200101__20201231_z6btSy8NTCP2"&gt;greater than 50%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;likely of being realized on examination. For
tax positions not meeting the &#x201c;more likely than not&#x201d; test, no tax benefit is recorded. &lt;span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20200101__20201231_zOoWBHJPrM0g"&gt;&lt;span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190101__20191231_zjL9HeSSY6D9"&gt;No&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;penalties and interest incurred related to underpayment
of income taxes for the years ended December 31, 2020 and 2019. &lt;span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190701__20191231_zTaFbBkviXke"&gt;No
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;penalties and interest incurred related to underpayment
of income taxes for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions.
As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign
tax authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement contextRef="From2020-01-01to2020-12-31">greater than 50%</us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_845_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zA14L2AXjhr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_z6lDNGskyQyb"&gt;Comprehensive
income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income
(loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#x2019; equity
but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting
from the Company not using the U.S. dollar as its functional currencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <AATP:NoncontrollingInterestPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_841_ecustom--NoncontrollingInterestPolicyTextBlock_zjA6pTuKrPnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zc3R8KYdMsN9"&gt;Non-controlling
interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eus-gaap--MinorityInterestDescription_c20200101__20201231_zuFJWaaiUBz1" title="Noncontrolling interest, description"&gt;Non-controlling
interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held
by two individuals.&lt;/span&gt; The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable
to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated
statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders
and the shareholders of the Company. As of December 31, 2020, the non-controlling interest balance was $&lt;span id="xdx_90A_eus-gaap--MinorityInterest_iI_pp0p0_c20201231_zxduBUXDsSEd" title="Non-controlling interest"&gt;0&lt;/span&gt; and therefore not presented
in the accompanying consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:NoncontrollingInterestPolicyTextBlock>
    <us-gaap:MinorityInterestDescription contextRef="From2020-01-01to2020-12-31">Non-controlling
interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held
by two individuals.</us-gaap:MinorityInterestDescription>
    <us-gaap:MinorityInterest contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</us-gaap:MinorityInterest>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zqg1I9qAHxok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zY3SKCpKKPQ9"&gt;Earnings
(loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company computes earnings (loss) per share (&#x201c;EPS&#x201d;) in accordance with ASC 260, &#x201c;Earnings per Share&#x201d;. ASC
260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary
share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares
(e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per
share or decrease loss per share) are excluded from the calculation of diluted EPS. For the years ended December 31, 2020 and
2019, there were &lt;span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20200101__20201231_zt4FOglj8Qxe" title="Potentially dilutive securities outstanding"&gt;&lt;span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190101__20191231_zYfevg2dAOf8" title="Potentially dilutive securities outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; dilutive shares. There was &lt;span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190701__20191231_z5THbyxJmJWi" title="Potentially dilutive securities outstanding"&gt;no&lt;/span&gt; dilutive shares for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOK2vIIGi7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zVe1pPjk2E0j"&gt;Foreign
currencies translation and transaction&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates
prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional
currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting
exchange differences are recorded in the Consolidated Statements of Operations and Comprehensive Income (Loss).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
reporting currency of the Company is United States Dollars (&#x201c;US$&#x201d;) and the accompanying financial statements have
been expressed in US$. The Company&#x2019;s subsidiary in Labuan maintains its books and record in United States Dollars (&#x201c;US$&#x201d;)
albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the
Malaysian Ringgit (&#x201c;MYR&#x201d; or &#x201c;RM&#x201d;). The Company&#x2019;s subsidiary in Hong Kong maintains its books and
record in Hong Kong Dollars (&#x201c;HK$&#x201d;), similar to its functional currency. The Company&#x2019;s subsidiary and VIE in
Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (&#x201c;MYR&#x201d;
or &#x201c;RM&#x201d;), as its functional currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated
into US$, in accordance with ASC Topic 830-30, &#x201c;&lt;i&gt;Translation of Financial Statement&#x201d;&lt;/i&gt;, using the exchange rate
on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses
resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other
comprehensive income within the statements of stockholders&#x2019; equity. Cash flows are also translated at average translation
rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the
corresponding balances on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zyv50fNYzHIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BE_zVTTQ0AjlAuj" style="display: none"&gt;SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Period-end MYR : US$1 exchange rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zVv6l569wlf8" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;4.02&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zAce32sO6Npd" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;4.09&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Period-end HKD : US$1 exchange rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zAgNXVkWtTEk" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;7.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zfqZH1qQvpu8" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;7.79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Period-average MYR : US$1 exchange rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zVetDM7dEnI2" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average"&gt;4.20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zjh3pkqYV8fj" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average"&gt;4.14&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zgvw3KqrLqk3" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average"&gt;4.16&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Period-average HKD : US$1 exchange rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zyaxoZRqmhx6" style="text-align: right" title="Foreign currency exchange rate period average"&gt;7.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zI0VUIkx7qu8" style="text-align: right" title="Foreign currency exchange rate period average"&gt;7.84&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zzj3XRLLV3va" style="text-align: right" title="Foreign currency exchange rate period average"&gt;7.83&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zGqhfLGDdP0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zyv50fNYzHIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BE_zVTTQ0AjlAuj" style="display: none"&gt;SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Period-end MYR : US$1 exchange rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zVv6l569wlf8" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;4.02&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zAce32sO6Npd" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;4.09&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Period-end HKD : US$1 exchange rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zAgNXVkWtTEk" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;7.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zfqZH1qQvpu8" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"&gt;7.79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Period-average MYR : US$1 exchange rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zVetDM7dEnI2" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average"&gt;4.20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zjh3pkqYV8fj" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average"&gt;4.14&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zgvw3KqrLqk3" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average"&gt;4.16&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Period-average HKD : US$1 exchange rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zyaxoZRqmhx6" style="text-align: right" title="Foreign currency exchange rate period average"&gt;7.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zI0VUIkx7qu8" style="text-align: right" title="Foreign currency exchange rate period average"&gt;7.84&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zzj3XRLLV3va" style="text-align: right" title="Foreign currency exchange rate period average"&gt;7.83&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2020-12-31_custom_PeriodEndMYRMember"
      decimals="INF"
      unitRef="Pure">4.02</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2019-12-31_custom_PeriodEndMYRMember"
      decimals="INF"
      unitRef="Pure">4.09</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2020-12-31_custom_PeriodEndHKDMember"
      decimals="INF"
      unitRef="Pure">7.75</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2019-12-31_custom_PeriodEndHKDMember"
      decimals="INF"
      unitRef="Pure">7.79</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2020-01-012020-12-31_custom_PeriodAverageMYRMember"
      decimals="INF"
      unitRef="Pure">4.20</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2019-01-012019-12-31_custom_PeriodAverageMYRMember"
      decimals="INF"
      unitRef="Pure">4.14</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2019-07-012019-12-31_custom_PeriodAverageMYRMember"
      decimals="INF"
      unitRef="Pure">4.16</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2020-01-012020-12-31_custom_PeriodAverageHKDMember"
      decimals="INF"
      unitRef="Pure">7.76</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2019-01-012019-12-31_custom_PeriodAverageHKDMember"
      decimals="INF"
      unitRef="Pure">7.84</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:ForeignCurrencyExchangeRateAverage
      contextRef="From2019-07-012019-12-31_custom_PeriodAverageHKDMember"
      decimals="INF"
      unitRef="Pure">7.83</AATP:ForeignCurrencyExchangeRateAverage>
    <AATP:RelatedPartiesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zqNQnty2NCli" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z9BMJjyThk6j"&gt;Related
parties&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly,
to control the other party or exercise significant influence over the other party in making financial and operating decisions.
Companies are also considered to be related if they are subject to common control or common significant influence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:RelatedPartiesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zx2nMC08WMI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zg5tdN22eaj1"&gt;Fair
value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments
and requires disclosure of the fair value of financial instruments held by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement
and enhance disclosure requirements for fair value measures. The three levels are defined as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
    that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
    instruments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or
cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected
realization and their current market rates of interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_z0vjk6wQJWw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zIClplFSvxVi"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
July 1, 2019, the Company adopted ASU 2016-02, &#x201c;Leases&#x201d; (Topic 842), and elected the practical expedients that does
not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification
for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve
months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The
Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single
lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing
leases with a lease term in excess of twelve months on July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Operating
lease right-of-use (&#x201c;ROU&#x201d;) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the
commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit
rate for the Company&#x2019;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information
available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate
of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in
a similar economic environment and over a similar term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate
the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company
generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets.
The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases
with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU
asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company
reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying
value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying
value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected
to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating
lease payments in the undiscounted future pre-tax cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zbXPSSpP046l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_z8bQ1hey9MM3"&gt;Recent
accounting pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption
of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations,
as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#x2014;Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for
the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology.
The amendments in Update 2016-13 added Topic 326, Financial Instruments&#x2014;Credit Losses, and made several consequential amendments
to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually
assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial
Instruments&#x2014; Credit Losses&#x2014;Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders&#x2019;
concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at
amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information
by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief
also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement
users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date
of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit
losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December
15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company
is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and
investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and
purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify
that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting
when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting.
With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance
in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the
purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity
method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods
beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this
standard on January 1, 2021 did not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:VariableInterestEntityDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_801_eus-gaap--VariableInterestEntityDisclosureTextBlock_zgUGnTSZ2Keb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;3.
&lt;span id="xdx_82E_zwI7jzQ9wOG2"&gt;VARIABLE INTEREST ENTITY (&#x201c;VIE&#x201d;)&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;SEA
is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided all of ASL&#x2019;s purchases. Its
equity at risk was insufficient to finance its activities and &lt;span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zoRNSZrdRpA6" title="Ownership interest percentage"&gt;100%&lt;/span&gt; of its business is transacted with ASL. Therefore, it was considered
to be a VIE and ASL is the primary beneficiary since it has both of the following characteristics:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;a.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;The
    power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;b.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;The
    obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from
    the VIE that could potentially be significant to the VIE&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accordingly,
the accounts of SEA is consolidated in the accompanying financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_zKylO7782fFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
carrying amount of the VIE&#x2019;s assets and liabilities were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BF_zgXo71YX0MH" style="display: none"&gt;SCHEDULE OF VARIABLE INTEREST ENTITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsCurrent_iI_pp0p0_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zU8Jy1ossrzc" style="width: 16%; text-align: right" title="Current asset"&gt;48,717&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesCurrent_iNI_pp0p0_di_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zY2VGSD4mFZk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current liabilities"&gt;(53,573&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deficit&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net deficit"&gt;(4,856&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current asset:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="width: 16%; text-align: right" title="Cash and cash equivalents"&gt;37,387&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Prepaid taxes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PrepaidTaxes_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepaid taxes"&gt;11,330&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total current assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current assets"&gt;48,717&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other payables and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Other payables and accrued liabilities"&gt;1,904&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other payables &#x2013; intercompany&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OtherPayablesRelatedPartyCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables - intercompany"&gt;51,669&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current liabilities"&gt;53,573&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;3.
VARIABLE INTEREST ENTITY (&#x201c;VIE&#x201d;) (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
summarized operating results of the VIE&#x2019;s are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left; padding-bottom: 2.5pt"&gt;Operating revenues&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Operating revenues"&gt;346,907&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Gross profit&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GrossProfit_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross profit"&gt;4,442&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss from operations"&gt;(10,752&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss"&gt;(24,014&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AC_zAjTEpy5oJ6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-31_custom_SubsidiaryCompanyThreeMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_zKylO7782fFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
carrying amount of the VIE&#x2019;s assets and liabilities were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BF_zgXo71YX0MH" style="display: none"&gt;SCHEDULE OF VARIABLE INTEREST ENTITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsCurrent_iI_pp0p0_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zU8Jy1ossrzc" style="width: 16%; text-align: right" title="Current asset"&gt;48,717&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesCurrent_iNI_pp0p0_di_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zY2VGSD4mFZk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current liabilities"&gt;(53,573&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deficit&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net deficit"&gt;(4,856&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current asset:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="width: 16%; text-align: right" title="Cash and cash equivalents"&gt;37,387&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Prepaid taxes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PrepaidTaxes_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepaid taxes"&gt;11,330&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total current assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current assets"&gt;48,717&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other payables and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Other payables and accrued liabilities"&gt;1,904&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other payables &#x2013; intercompany&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OtherPayablesRelatedPartyCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables - intercompany"&gt;51,669&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current liabilities"&gt;53,573&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;3.
VARIABLE INTEREST ENTITY (&#x201c;VIE&#x201d;) (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
summarized operating results of the VIE&#x2019;s are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left; padding-bottom: 2.5pt"&gt;Operating revenues&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Operating revenues"&gt;346,907&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Gross profit&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GrossProfit_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross profit"&gt;4,442&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss from operations"&gt;(10,752&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss"&gt;(24,014&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">48717</us-gaap:AssetsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">53573</us-gaap:LiabilitiesCurrent>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-4856</us-gaap:StockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">37387</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidTaxes
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">11330</us-gaap:PrepaidTaxes>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">48717</us-gaap:AssetsCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">1904</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <AATP:OtherPayablesRelatedPartyCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">51669</AATP:OtherPayablesRelatedPartyCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">53573</us-gaap:LiabilitiesCurrent>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">346907</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">4442</us-gaap:GrossProfit>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-10752</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_VariableIncomeInterestRateMember"
      decimals="0"
      unitRef="USD">-24014</us-gaap:NetIncomeLoss>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_807_eus-gaap--BusinessCombinationDisclosureTextBlock_zw2UFQd2Jhn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;4.
&lt;span id="xdx_82F_ziFfcT33m7Zd"&gt;BUSNINESS COMBINATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
May 8, 2020, the Company entered into a Share Exchange Agreement (&#x201c;SPA&#x201d;) with Mr. How Kok Choong, CEO and director
of the Company to acquire &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_pii" title="Stock issued during period acquisitions, shares"&gt;9,590,596&lt;/span&gt; ordinary shares, &lt;span id="xdx_90D_eus-gaap--CommonStockNoParValue_iI_pii_do_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zoIqkGdxGSyd" title="Ordinary shares no par value"&gt;no&lt;/span&gt; par value, equivalent to approximately &lt;span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z3JXJd1ddbrh" title="Ownership interest percentage"&gt;99.99%&lt;/span&gt; of the equity interest in
ASL, an entity incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration
of $&lt;span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferred1_c20200629__20200702__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Purchase consideration value"&gt;1,804,046&lt;/span&gt;, which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration
shall be satisfied by (i) the offset of the Consideration whereby the Company has a loan receivable of $&lt;span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Loan payable"&gt;656,495&lt;/span&gt; as of March 31,
2020 due from Mr. How; and (ii) allotment and issuance of common stock of the Company. The Company shall allot and issue &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pii" title="Stock issued during period acquisitions, shares"&gt;176,547&lt;/span&gt;
shares of the Company&#x2019;s common stock, par value $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_c20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pii" title="Common stock par value"&gt;0.0001&lt;/span&gt;, representing approximately &lt;span id="xdx_907_ecustom--PercentageOfCommonStockIssuedAndOutstanding_pii_dp_uPure_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z7jb9qaYraP7" title="Percentage of common stock issued and outstanding"&gt;0.0469%&lt;/span&gt; of the total issued and outstanding
shares in the Company after the issuance of the Shares, which is valued at $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Stock issued during period, value, acquisitions"&gt;1,147,551&lt;/span&gt; based on the closing price of $&lt;span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_c20200331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_pii" title="Purchased price per shares"&gt;6.50&lt;/span&gt; of the
Company as quoted on the OTC Market on March 31, 2020. As of December 31, 2020, the Company has issued all &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pii_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z3vZ2HK501Xk" title="Issuance of common stock shares"&gt;176,547&lt;/span&gt; shares of the
Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated
the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1,
2020 as ASL was under the common control of Mr. How.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zjoMFwU6vwug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date,
which represents the net purchase price allocation on the date of the acquisition of ASL.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BA_zBmLsqF2NTUl" style="display: none"&gt;SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carry Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;ASSETS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 82%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c20201231_pp0p0" style="width: 14%; text-align: right" title="Cash"&gt;1,206,493&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20201231_pp0p0" style="text-align: right" title="Other receivables"&gt;33,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Other receivables - related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_c20201231_pp0p0" style="text-align: right" title="Other receivables - related parties"&gt;219,121&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20201231_pp0p0" style="text-align: right" title="Inventories"&gt;616,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_c20201231_pp0p0" style="text-align: right" title="Prepaid taxes"&gt;1,206,821&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Prepayments and other assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepayments and other assets"&gt;318,267&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total current assets"&gt;3,600,792&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Other assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Property and equipment, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c20201231_pp0p0" style="text-align: right" title="Property and equipment, net"&gt;325,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Intangible assets, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c20201231_pp0p0" style="text-align: right" title="Intangible assets, net"&gt;6,686&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Deferred taxes asset, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Deferred taxes asset, net"&gt;172,250&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total other assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total other assets"&gt;504,584&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;Total assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets"&gt;4,105,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;LIABILITIES AND SHAREHOLDERS&#x2019; EQUITY&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accounts payable - related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c20201231_pp0p0" style="text-align: right" title="Accounts payable - related party"&gt;491,628&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Customer deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_c20201231_pp0p0" style="text-align: right" title="Customer deposits"&gt;1,600,606&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Other payables and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables and accrued liabilities"&gt;209,096&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total current liabilities"&gt;2,301,330&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total liabilities"&gt;2,301,330&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total net assets acquired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net assets acquired"&gt;1,804,046&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zvuS4LWR3hnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;4.
BUSNINESS COMBINATION (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following unaudited pro forma combined results of operations presents the Company&#x2019;s financial results as if the acquisition
of ASL had been completed on January 1, 2019. The unaudited pro forma results do not reflect operating efficiencies or potential
cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information
is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction
on January 1, 2019. Future results may vary significantly from the results in this pro forma information because of future events
and transactions, as well as other factors.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zSAAt6fY6ls1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zJ0F8eB5LHz9" style="display: none"&gt;SCHEDULE OF PRO FORMA BUSINESS COMBINATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the Year Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the Year Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231_pp0p0" style="width: 16%; text-align: right" title="Revenue"&gt;4,693,873&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190101__20191231_pp0p0" style="width: 16%; text-align: right" title="Revenue"&gt;4,160,820&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190701__20191231_pp0p0" style="width: 16%; text-align: right" title="Revenue"&gt;2,246,458&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue"&gt;(875,708&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue"&gt;(789,409&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue"&gt;(479,410&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Gross profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20200101__20201231_pp0p0" style="text-align: right" title="Gross profit"&gt;3,818,165&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190101__20191231_pp0p0" style="text-align: right" title="Gross profit"&gt;3,371,411&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190701__20191231_pp0p0" style="text-align: right" title="Gross profit"&gt;1,767,048&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses"&gt;(3,839,184&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses"&gt;(5,081,917&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses"&gt;(2,468,902&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income (loss) from operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20200101__20201231_pp0p0" style="text-align: right" title="Income (loss) from operations"&gt;(21,019&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190101__20191231_pp0p0" style="text-align: right" title="Income (loss) from operations"&gt;(1,710,506&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190701__20191231_pp0p0" style="text-align: right" title="Income (loss) from operations"&gt;(701,854&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other income (expense), net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net"&gt;267,633&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net"&gt;(384,304&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net"&gt;(146,649&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income (loss) before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20200101__20201231_pp0p0" style="text-align: right" title="Income (loss) before income taxes"&gt;246,614&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190101__20191231_pp0p0" style="text-align: right" title="Income (loss) before income taxes"&gt;(2,094,810&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190701__20191231_pp0p0" style="text-align: right" title="Income (loss) before income taxes"&gt;(848,503&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Benefit of (provision for) income taxes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes"&gt;(212,414&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes"&gt;319,189&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes"&gt;117,009&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)"&gt;34,200&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)"&gt;(1,775,621&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190701__20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)"&gt;(731,494&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net income (loss) per common share - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20200101__20201231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190101__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190701__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Weighted average number of common shares outstanding - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20200101__20201231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted"&gt;376,452,047&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190101__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted"&gt;376,452,047&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190701__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted"&gt;376,452,047&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_zZ49HtG0BkHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;5.
CASH AND CASH EQUIVALENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;As
of December 31, 2020, and 2019 the Company has $&lt;span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20201231_pp0p0" title="Cash and cash equivalents"&gt;3,517,600&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20191231_pp0p0" title="Cash and cash equivalents"&gt;2,744,457&lt;/span&gt;, respectively, of cash and cash equivalents, which consists
of $&lt;span id="xdx_909_eus-gaap--Cash_c20201231_pp0p0" title="Cash in bank"&gt;1,112,147&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--Cash_c20191231_pp0p0" title="Cash in bank"&gt;238,937&lt;/span&gt;, respectively, of cash in banks and &lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;span id="xdx_90A_eus-gaap--TimeDeposits_c20201231_pp0p0" title="Time deposits"&gt;2,391,182&lt;/span&gt;
&lt;span style="background-color: white"&gt;and $&lt;span id="xdx_901_eus-gaap--TimeDeposits_c20191231_pp0p0" title="Time deposits"&gt;2,505,520&lt;/span&gt;, respectively, of time deposits placed with banks or other financial institutions
and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time
deposits ranges between &lt;span id="xdx_901_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pii_dp_uPure_c20201213__srt--RangeAxis__srt--MinimumMember_zEWSIDibomk1" title="Percentage of Interest rate for time deposits"&gt;2.95%&lt;/span&gt; to &lt;span id="xdx_90C_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pii_dp_uPure_c20201213__srt--RangeAxis__srt--MaximumMember_z1H8B4W9ePyg" title="Percentage of Interest rate for time deposits"&gt;3.25%&lt;/span&gt; per annum.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="Shares">9590596</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockNoParValue
      contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:CommonStockNoParValue>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="Pure">0.9999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2020-06-292020-07-02_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="0"
      unitRef="USD">1804046</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="0"
      unitRef="USD">656495</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="Shares">176547</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <AATP:PercentageOfCommonStockIssuedAndOutstanding
      contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="Pure">0.000469</AATP:PercentageOfCommonStockIssuedAndOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="0"
      unitRef="USD">1147551</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-03-31_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="USDPShares">6.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-01-012020-12-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember"
      decimals="INF"
      unitRef="Shares">176547</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zjoMFwU6vwug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date,
which represents the net purchase price allocation on the date of the acquisition of ASL.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BA_zBmLsqF2NTUl" style="display: none"&gt;SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carry Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;ASSETS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 82%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c20201231_pp0p0" style="width: 14%; text-align: right" title="Cash"&gt;1,206,493&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20201231_pp0p0" style="text-align: right" title="Other receivables"&gt;33,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Other receivables - related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_c20201231_pp0p0" style="text-align: right" title="Other receivables - related parties"&gt;219,121&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20201231_pp0p0" style="text-align: right" title="Inventories"&gt;616,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_c20201231_pp0p0" style="text-align: right" title="Prepaid taxes"&gt;1,206,821&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Prepayments and other assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepayments and other assets"&gt;318,267&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total current assets"&gt;3,600,792&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Other assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Property and equipment, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c20201231_pp0p0" style="text-align: right" title="Property and equipment, net"&gt;325,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Intangible assets, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c20201231_pp0p0" style="text-align: right" title="Intangible assets, net"&gt;6,686&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Deferred taxes asset, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Deferred taxes asset, net"&gt;172,250&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total other assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total other assets"&gt;504,584&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"&gt;Total assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets"&gt;4,105,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;LIABILITIES AND SHAREHOLDERS&#x2019; EQUITY&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accounts payable - related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c20201231_pp0p0" style="text-align: right" title="Accounts payable - related party"&gt;491,628&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Customer deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_c20201231_pp0p0" style="text-align: right" title="Customer deposits"&gt;1,600,606&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Other payables and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables and accrued liabilities"&gt;209,096&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total current liabilities"&gt;2,301,330&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total liabilities"&gt;2,301,330&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total net assets acquired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net assets acquired"&gt;1,804,046&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1206493</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">33210</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">219121</AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">616880</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1206821</AATP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">318267</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3600792</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">325648</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">6686</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">172250</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">504584</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4105376</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">491628</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1600606</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">209096</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2301330</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2301330</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1804046</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zSAAt6fY6ls1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zJ0F8eB5LHz9" style="display: none"&gt;SCHEDULE OF PRO FORMA BUSINESS COMBINATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the Year Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the Year Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231_pp0p0" style="width: 16%; text-align: right" title="Revenue"&gt;4,693,873&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190101__20191231_pp0p0" style="width: 16%; text-align: right" title="Revenue"&gt;4,160,820&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190701__20191231_pp0p0" style="width: 16%; text-align: right" title="Revenue"&gt;2,246,458&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue"&gt;(875,708&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue"&gt;(789,409&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue"&gt;(479,410&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Gross profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20200101__20201231_pp0p0" style="text-align: right" title="Gross profit"&gt;3,818,165&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190101__20191231_pp0p0" style="text-align: right" title="Gross profit"&gt;3,371,411&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190701__20191231_pp0p0" style="text-align: right" title="Gross profit"&gt;1,767,048&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses"&gt;(3,839,184&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses"&gt;(5,081,917&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses"&gt;(2,468,902&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income (loss) from operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20200101__20201231_pp0p0" style="text-align: right" title="Income (loss) from operations"&gt;(21,019&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190101__20191231_pp0p0" style="text-align: right" title="Income (loss) from operations"&gt;(1,710,506&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190701__20191231_pp0p0" style="text-align: right" title="Income (loss) from operations"&gt;(701,854&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other income (expense), net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net"&gt;267,633&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net"&gt;(384,304&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net"&gt;(146,649&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income (loss) before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20200101__20201231_pp0p0" style="text-align: right" title="Income (loss) before income taxes"&gt;246,614&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190101__20191231_pp0p0" style="text-align: right" title="Income (loss) before income taxes"&gt;(2,094,810&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190701__20191231_pp0p0" style="text-align: right" title="Income (loss) before income taxes"&gt;(848,503&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Benefit of (provision for) income taxes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes"&gt;(212,414&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes"&gt;319,189&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes"&gt;117,009&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)"&gt;34,200&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)"&gt;(1,775,621&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190701__20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)"&gt;(731,494&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net income (loss) per common share - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20200101__20201231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190101__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190701__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Weighted average number of common shares outstanding - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20200101__20201231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted"&gt;376,452,047&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190101__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted"&gt;376,452,047&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190701__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted"&gt;376,452,047&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">4693873</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">4160820</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">2246458</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <AATP:BusinessAcquisitionsProFormaCostOfRevenue
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-875708</AATP:BusinessAcquisitionsProFormaCostOfRevenue>
    <AATP:BusinessAcquisitionsProFormaCostOfRevenue
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-789409</AATP:BusinessAcquisitionsProFormaCostOfRevenue>
    <AATP:BusinessAcquisitionsProFormaCostOfRevenue
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-479410</AATP:BusinessAcquisitionsProFormaCostOfRevenue>
    <AATP:BusinessAcquisitionsProFormaGrossProfit
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">3818165</AATP:BusinessAcquisitionsProFormaGrossProfit>
    <AATP:BusinessAcquisitionsProFormaGrossProfit
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">3371411</AATP:BusinessAcquisitionsProFormaGrossProfit>
    <AATP:BusinessAcquisitionsProFormaGrossProfit
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">1767048</AATP:BusinessAcquisitionsProFormaGrossProfit>
    <AATP:BusinessAcquisitionsProFormaOperatingExpenses
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-3839184</AATP:BusinessAcquisitionsProFormaOperatingExpenses>
    <AATP:BusinessAcquisitionsProFormaOperatingExpenses
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-5081917</AATP:BusinessAcquisitionsProFormaOperatingExpenses>
    <AATP:BusinessAcquisitionsProFormaOperatingExpenses
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-2468902</AATP:BusinessAcquisitionsProFormaOperatingExpenses>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-21019</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-1710506</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-701854</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">267633</AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet>
    <AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-384304</AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet>
    <AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-146649</AATP:BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet>
    <AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">246614</AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes>
    <AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-2094810</AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes>
    <AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-848503</AATP:BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes>
    <AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-212414</AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit>
    <AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">319189</AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit>
    <AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">117009</AATP:BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">34200</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-1775621</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-731494</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00</AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted>
    <AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00</AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted>
    <AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00</AATP:BusinessAcquisitionProFormaEarningsPerShareBasicDiluted>
    <AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="Shares">376452047</AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted>
    <AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">376452047</AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted>
    <AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="Shares">376452047</AATP:BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3517600</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2744457</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:Cash contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1112147</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">238937</us-gaap:Cash>
    <us-gaap:TimeDeposits contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2391182</us-gaap:TimeDeposits>
    <us-gaap:TimeDeposits contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2505520</us-gaap:TimeDeposits>
    <us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits
      contextRef="AsOf2020-12-13_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.0295</us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits>
    <us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits
      contextRef="AsOf2020-12-13_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.0325</us-gaap:PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_802_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_ztLkkt9z6bbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;6.
&lt;span id="xdx_824_zoBGjeokoMPj"&gt;ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#x2013; RELATED PARTY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z3k4Tqe4cwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B7_z3k88x6Pg2Qb" style="display: none"&gt;SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20201231_zjeuVyRXzvl8" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20191231_z2ligaszJJWh" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zG29Ltth4Cfk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;172,757&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1093"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zmMHrdaqLIu4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accounts receivable &#x2013; related party&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1095"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;520,786&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zVdqhtmCi7Sh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;172,757&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;520,786&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zptH4SzfrmQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z3k4Tqe4cwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B7_z3k88x6Pg2Qb" style="display: none"&gt;SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20201231_zjeuVyRXzvl8" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20191231_z2ligaszJJWh" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zG29Ltth4Cfk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;172,757&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1093"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zmMHrdaqLIu4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accounts receivable &#x2013; related party&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1095"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;520,786&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zVdqhtmCi7Sh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;172,757&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;520,786&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">172757</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">520786</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <AATP:AccountsReceivableAndAccountsReceivableRelatedParties contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">172757</AATP:AccountsReceivableAndAccountsReceivableRelatedParties>
    <AATP:AccountsReceivableAndAccountsReceivableRelatedParties contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">520786</AATP:AccountsReceivableAndAccountsReceivableRelatedParties>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zaOdHgAewML9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;7.
&lt;span id="xdx_82A_zcYoHdH481Oc"&gt;INVENTORIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z2viOa0MTNF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventories
consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B1_zGMyk4cKIe75" style="display: none"&gt;SCHEDULE OF INVENTORIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;Finished goods&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InventoryFinishedGoods_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Finished goods"&gt;589,814&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InventoryFinishedGoods_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Finished goods"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1107"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_zBEpU9Yw4OIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z2viOa0MTNF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventories
consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B1_zGMyk4cKIe75" style="display: none"&gt;SCHEDULE OF INVENTORIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;Finished goods&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InventoryFinishedGoods_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Finished goods"&gt;589,814&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InventoryFinishedGoods_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Finished goods"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1107"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">589814</us-gaap:InventoryFinishedGoods>
    <AATP:PrepaymentsAndDepositsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_800_ecustom--PrepaymentsAndDepositsTextBlock_zDYcL4R8KpCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;8.
&lt;span id="xdx_827_znuDZsOzLoZ1"&gt;PREPAYMENTS AND DEPOSITS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zivrAC8upLhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BF_zbrHRzStjwi6" style="display: none"&gt;SCHEDULE OF PREPAID EXPENSES AND DEPOSITS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20201231_zuZCAK5AfXy3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt; December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20191231_z2vvxHcCpeR" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt; December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzhWX_zlZfXx7hYSDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1113"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,641&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_z6kTdM27P9x7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Receivables from sales distributors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1117"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_z4bS8sMRxkef" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deposits to suppliers&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;261,068&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;266,552&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzhWX_zRHLu9QLIff6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;296,370&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;269,193&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zJiOVdkiElz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</AATP:PrepaymentsAndDepositsTextBlock>
    <AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zivrAC8upLhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BF_zbrHRzStjwi6" style="display: none"&gt;SCHEDULE OF PREPAID EXPENSES AND DEPOSITS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20201231_zuZCAK5AfXy3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt; December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20191231_z2vvxHcCpeR" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt; December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzhWX_zlZfXx7hYSDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1113"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,641&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_z6kTdM27P9x7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Receivables from sales distributors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1117"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_z4bS8sMRxkef" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deposits to suppliers&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;261,068&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;266,552&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzhWX_zRHLu9QLIff6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;296,370&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;269,193&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2641</us-gaap:PrepaidExpenseCurrent>
    <AATP:ReceivablesFromSalesDistributors contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">35302</AATP:ReceivablesFromSalesDistributors>
    <AATP:DepositsToSupplier contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">261068</AATP:DepositsToSupplier>
    <AATP:DepositsToSupplier contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">266552</AATP:DepositsToSupplier>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">296370</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">269193</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_80A_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ztk3EbCPZZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9.
&lt;span id="xdx_82B_z7ylvA5fnJKc"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zcREefv8JXG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment, net consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zEBr0QdvFIO7" style="display: none"&gt;SCHEDULE
OF PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20201231_zYmTywqIqugh" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20191231_zzSGCqqUO81k" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Computer and office equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z0xxtaToXSTb" style="width: 16%; text-align: right" title="Subtotal"&gt;81,437&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z7OMbZxtoE7h" style="width: 16%; text-align: right" title="Subtotal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1131"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Furniture &amp;amp; fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zWfeAkDtAc4c" style="text-align: right" title="Subtotal"&gt;126,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zU4XAfvc44h3" style="text-align: right" title="Subtotal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1135"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z8Ked0WvAgLe" style="text-align: right" title="Subtotal"&gt;210,496&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z2VSYwPCvgh7" style="text-align: right" title="Subtotal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1139"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vehicle&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_z9QUQK4gXEUc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal"&gt;102,564&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zgUbYAIGXk84" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1143"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzvyH_zYufVXjBCzQf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;521,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1146"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzvyH_zP839ta38Wv7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(223,154&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1149"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzvyH_zgpUgFs5BYKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;298,309&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1152"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_z8hGp74JibE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation
expense for the years ended December 31, 2020 and 2019 amounted to $&lt;span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20200101__20201231_zZagVQ2wVNU4" title="Depreciation"&gt;55,407&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20190101__20191231_zrBwsHIB2Shb"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1155"&gt;-&lt;/span&gt;&lt;/span&gt; (unaudited), respectively. There was &lt;span&gt;no&lt;/span&gt; depreciation
expense for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zcREefv8JXG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment, net consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zEBr0QdvFIO7" style="display: none"&gt;SCHEDULE
OF PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20201231_zYmTywqIqugh" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20191231_zzSGCqqUO81k" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Computer and office equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z0xxtaToXSTb" style="width: 16%; text-align: right" title="Subtotal"&gt;81,437&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z7OMbZxtoE7h" style="width: 16%; text-align: right" title="Subtotal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1131"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Furniture &amp;amp; fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zWfeAkDtAc4c" style="text-align: right" title="Subtotal"&gt;126,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zU4XAfvc44h3" style="text-align: right" title="Subtotal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1135"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z8Ked0WvAgLe" style="text-align: right" title="Subtotal"&gt;210,496&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z2VSYwPCvgh7" style="text-align: right" title="Subtotal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1139"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vehicle&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_z9QUQK4gXEUc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal"&gt;102,564&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zgUbYAIGXk84" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1143"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzvyH_zYufVXjBCzQf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;521,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1146"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzvyH_zP839ta38Wv7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(223,154&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1149"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzvyH_zgpUgFs5BYKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;298,309&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1152"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_custom_ComputerAndOfficeEquipmentMember"
      decimals="0"
      unitRef="USD">81437</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">126966</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">210496</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_custom_VehicleMember"
      decimals="0"
      unitRef="USD">102564</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">521463</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">223154</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">298309</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">55407</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_800_eus-gaap--IntangibleAssetsDisclosureTextBlock_zMOTLBaVM54l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;10.
&lt;span id="xdx_821_zl7zzRPKeKIb"&gt;INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zOVb6pOQNP19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible
assets, net, consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zf2xVuF2IrI3" style="display: none"&gt;SCHEDULE
OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231_zabjW7SGYmh6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20191231_zi6e6ngPpZZ1" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzwwR_maFLIANz4yv_zePWh5kLCi9k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Computer software&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;35,801&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzwwR_msFLIANz4yv_ze08XLW8gR7a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,975&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1165"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzwwR_mtFLIANz4yv_zetRvkWw7mkg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,826&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_z55evXnrJ0L7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization
expense for the years ended December 31, 2020 and 2019 amounted to $&lt;span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200101__20201231_zScbtKaKRi6c" title="Amortization expense"&gt;1,505&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20190101__20191231_zrX3s2PcBHyg" title="Amortization expense"&gt;0&lt;/span&gt; (unaudited), respectively. There was &lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_do_c20190701__20191231_zyFnqLTjb0C2" title="Amortization expense"&gt;no&lt;/span&gt; amortization
expense for the six months ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_89D_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zOVb6pOQNP19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible
assets, net, consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zf2xVuF2IrI3" style="display: none"&gt;SCHEDULE
OF INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231_zabjW7SGYmh6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20191231_zi6e6ngPpZZ1" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzwwR_maFLIANz4yv_zePWh5kLCi9k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Computer software&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;35,801&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzwwR_msFLIANz4yv_ze08XLW8gR7a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,975&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1165"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzwwR_mtFLIANz4yv_zetRvkWw7mkg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,826&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">35801</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">29975</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5826</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">1505</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <AATP:InvestmentInMarketableSecuritiesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_80C_ecustom--InvestmentInMarketableSecuritiesTextBlock_z24OoQ5pXbV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;11.
&lt;span id="xdx_829_zS2YMS7z3Dkk"&gt;INVESTMENT IN MARKETABLE SECURITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
    May 17, 2018, the Company purchased &lt;span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zmVYwPfwoHsb" title="Investment in securities, shares"&gt;83,333&lt;/span&gt; shares of common stock in Greenpro Capital Corp. for $&lt;span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zpClzDTE1ome" title="Investment amount"&gt;500,000&lt;/span&gt; at a purchase price
    of $&lt;span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zlkBl5FJLctd" title="Purchased price per shares"&gt;6&lt;/span&gt; per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
    July 30, 2018, the Company disposed &lt;span id="xdx_904_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zfr7IOfpZgJ1" title="Investment in securities, shares"&gt;20&lt;/span&gt; shares of common stock in Greenpro Capital Corp. for $&lt;span id="xdx_909_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_z3OLgb9Wvaf" title="Investment amount"&gt;125&lt;/span&gt; at a purchase price of $&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_z7kS8yVPRDse" title="Purchased price per shares"&gt;6.2613&lt;/span&gt;
    per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
    October 16, 2018, the Company purchased &lt;span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zSl4sUUxNte8" title="Investment in securities, shares"&gt;33,333&lt;/span&gt; shares of common stock in Greenpro Capital Corp. for $&lt;span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_znjQghgk4P43" title="Investment amount"&gt;1,000&lt;/span&gt; at a purchase price
    of $&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zwlt67wxP2qe" title="Purchased price per shares"&gt;0.03&lt;/span&gt; per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
    November 3, 2020, the Company received dividend of &lt;span id="xdx_906_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_zZPBv8rJwKT4" title="Investment in securities, shares"&gt;6,667&lt;/span&gt; shares of common stock in DSwiss, Inc. for $&lt;span id="xdx_907_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_zZ1myoVEiWn5" title="Investment amount"&gt;76,671&lt;/span&gt; at fair value
    of $&lt;span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_zHlSORtdssU6" title="Purchased price per shares"&gt;11.50&lt;/span&gt; per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#x2019;s shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(v)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
    December 9, 2020, the Company received dividend of &lt;span id="xdx_906_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zLZr23hjwIe6" title="Investment in securities, shares"&gt;16,663&lt;/span&gt; shares of common stock in DSwiss, Inc. for $&lt;span id="xdx_90C_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zBtZWIVgqRM4" title="Investment amount"&gt;83,315&lt;/span&gt; at fair value
    of $&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zqjZefpIYMfb" title="Purchased price per shares"&gt;5.00&lt;/span&gt; per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#x2019;s shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_898_eus-gaap--MarketableSecuritiesTextBlock_z0m6ZX0jrsNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B1_zZlxQR9QRc2l" style="display: none"&gt;SCHEDULE
OF INVESTMENT IN MARKETABLE SECURITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20201231_zT8A2w6neZpj" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20191231_z899A2mt3dA4" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentOwnedAtCost_iI_maT002_maMSNzoUs_z37fFNeVkXVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Cost of investment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;66,484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;134,166&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--InvestmentsIncomeDividend_iNI_di_msMSNzoUs_zM7gVkETjOS7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Dividend income from Greenpro Capital Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,062&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1214"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingLoss_iI_pp0p0_msT002_msMSNzoUs_zECxHSWYdyza" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unrealized holding gain (loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(68,391&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maT002_maMSNzoUs_zZReSz2dLMWa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Exchange rate effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;352&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;709&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzoUs_zZr4ak6dsByl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Investment in marketable securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;577,035&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;66,484&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_z6fMpGCttcKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</AATP:InvestmentInMarketableSecuritiesTextBlock>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="Shares">83333</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember"
      decimals="0"
      unitRef="USD">500000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2018-05-17_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="USDPShares">6</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="Shares">20</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember"
      decimals="0"
      unitRef="USD">125</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2018-07-30_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="USDPShares">6.2613</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="Shares">33333</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember"
      decimals="0"
      unitRef="USD">1000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2018-10-16_custom_GreenproCapitalCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2020-11-03_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Shares">6667</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2020-11-03_custom_DSwissIncMember"
      decimals="0"
      unitRef="USD">76671</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-11-03_custom_DSwissIncMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2020-12-09_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Shares">16663</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2020-12-09_custom_DSwissIncMember"
      decimals="0"
      unitRef="USD">83315</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-09_custom_DSwissIncMember"
      decimals="INF"
      unitRef="USDPShares">5.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_898_eus-gaap--MarketableSecuritiesTextBlock_z0m6ZX0jrsNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B1_zZlxQR9QRc2l" style="display: none"&gt;SCHEDULE
OF INVESTMENT IN MARKETABLE SECURITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20201231_zT8A2w6neZpj" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20191231_z899A2mt3dA4" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--InvestmentOwnedAtCost_iI_maT002_maMSNzoUs_z37fFNeVkXVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Cost of investment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;66,484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;134,166&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--InvestmentsIncomeDividend_iNI_di_msMSNzoUs_zM7gVkETjOS7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Dividend income from Greenpro Capital Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,062&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1214"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingLoss_iI_pp0p0_msT002_msMSNzoUs_zECxHSWYdyza" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unrealized holding gain (loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(68,391&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maT002_maMSNzoUs_zZReSz2dLMWa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Exchange rate effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;352&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;709&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzoUs_zZr4ak6dsByl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Investment in marketable securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;577,035&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;66,484&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:InvestmentOwnedAtCost contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">66484</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">134166</us-gaap:InvestmentOwnedAtCost>
    <AATP:InvestmentsIncomeDividend contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-160062</AATP:InvestmentsIncomeDividend>
    <AATP:MarketableSecuritiesUnrealizedHoldingLoss contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">350137</AATP:MarketableSecuritiesUnrealizedHoldingLoss>
    <AATP:MarketableSecuritiesUnrealizedHoldingLoss contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-68391</AATP:MarketableSecuritiesUnrealizedHoldingLoss>
    <AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">352</AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites>
    <AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">709</AATP:ExchangeRateEffectOnInvestmentInMarketableSecurites>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">577035</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">66484</us-gaap:MarketableSecuritiesNoncurrent>
    <AATP:InvestmentInNonMarketableSecuritiesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_80B_ecustom--InvestmentInNonMarketableSecuritiesTextBlock_zQNe1pmlBcv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;12.
&lt;span id="xdx_826_zhFtDZkbaEk3"&gt;INVESTMENT IN NON-MARKETABLE SECURITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company invested in Unreserved Sdn Bhd with the investment amount of &lt;span id="xdx_906_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__srt--DirectorMember_zmiphj0lm7e5" title="Investment amount"&gt;$863,592&lt;/span&gt; (RM &lt;span id="xdx_909_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zuxMrYwybuxk" title="Investment amount"&gt;3,500,000&lt;/span&gt;), which approximated &lt;span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--TitleOfIndividualAxis__srt--DirectorMember_z7iDElFJfpZb" title="Equity interest percentage"&gt;20%&lt;/span&gt; of the equity
interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd
issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company&#x2019;s
equity interest in investee company was diluted from approximately &lt;span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190310__srt--RangeAxis__srt--MaximumMember_zuc5bTkAyVdh" title="Equity interest percentage"&gt;20.0%&lt;/span&gt; to approximately &lt;span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190310__srt--RangeAxis__srt--MinimumMember_zGLRomph8VF8" title="Equity interest percentage"&gt;17.86%&lt;/span&gt;. Effective from March 10, 2019,
the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the
investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable
securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;12.
INVESTMENT IN NON-MARKETABLE SECURITIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Unreserved
Sdn Bhd was incorporated in Malaysia with &lt;span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20201231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z7YSmvsm8048" title="Ordinary shares authorized"&gt;2,500,000&lt;/span&gt; ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David
Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company
from April 30, 2018 to March 27, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
March 3, 2020, the Company agreed to sell the &lt;span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200303__srt--TitleOfIndividualAxis__custom--UnreservedSdnBhdMember_zacrZg8vfsu4" title="Equity interest percentage"&gt;17.86%&lt;/span&gt; ownership interest in Unreserved Sdn Bhd at the December 31, 2019
carrying value of $7&lt;span id="xdx_907_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z8MSf90Npslj" title="Investment amount"&gt;30,637&lt;/span&gt; to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $&lt;span id="xdx_900_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_pp0p0_c20200101__20200331_zyRj8BLE9dna" title="Proceeds from investments"&gt;70,173&lt;/span&gt;,
and had an amount due from director of $&lt;span id="xdx_909_eus-gaap--DueFromOfficersOrStockholdersCurrent_iI_pp0p0_c20200331__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zp3qS9I8ENT3" title="Amount due from director"&gt;660,464&lt;/span&gt; at March 31, 2020. In May 2020, the entire outstanding balance was settled as
part of the consideration in a transaction which the Company had acquired the CEO&#x2019;s ownership interest of Agape Superior
Living Sdn. Bhd.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
April 3, 2019, the Company purchased a &lt;span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zW5hQ0ECOpod" title="Equity interest percentage"&gt;5%&lt;/span&gt; of stock or &lt;span id="xdx_900_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMuiSsfCa2q7" title="Shares purchased during period"&gt;15,000,000&lt;/span&gt; shares of common stock in Phoenix Plus Corp. for $&lt;span id="xdx_90E_eus-gaap--InvestmentOwnedAtCost_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0"&gt;1,500&lt;/span&gt; at purchase
price of $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pii"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--NonMarketableSecuritiesTableTextBlock_zVcsiDStTTCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zwo7IHXeFEYj" style="display: none"&gt;SCHEDULE
OF INVESTMENT IN NON MARKETABLE SECURITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;Unreserved Sdn Bhd&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt; December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt; December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Investment in non-marketable securities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zy5FwsrHnnvf" style="width: 16%; text-align: right" title="Investment in non-marketable securities"&gt;730,637&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zvFRZlIhT4w9" style="width: 16%; text-align: right" title="Investment in non-marketable securities"&gt;730,637&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1.5pt"&gt;Less: Sale of investment in non-marketable securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zPHfauzcxTe5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"&gt;(730,637&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_znBNiSMcRYXd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Investment in non-marketable securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zRoMhr7p1lda" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1263"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zAOUFV0i00U2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"&gt;730,637&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;Phoenix Plus Corporation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Cost of investment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z6yageq06Da5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment"&gt;1,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z3yTqDUlNzp6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment"&gt;1,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total investment in non-marketable securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zhrdmj6iHPE3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"&gt;1,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zNHoSPSLbmD1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"&gt;732,137&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zyqc8LlloOza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AATP:InvestmentInNonMarketableSecuritiesTextBlock>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2020-12-31_srt_DirectorMember"
      decimals="0"
      unitRef="USD">863592</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2020-12-31_srt_DirectorMember_custom_MYRCurrencyMember"
      decimals="0"
      unitRef="USD">3500000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-31_srt_DirectorMember"
      decimals="INF"
      unitRef="Pure">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-03-10_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.200</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-03-10_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.1786</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2020-12-31_custom_MrHowKokChoongMember"
      decimals="INF"
      unitRef="Shares">2500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-03-03_custom_UnreservedSdnBhdMember"
      decimals="INF"
      unitRef="Pure">0.1786</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2019-12-31_custom_MrHowKokChoongMember"
      decimals="0"
      unitRef="USD">30637</us-gaap:InvestmentOwnedAtCost>
    <AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty
      contextRef="From2020-01-012020-03-31"
      decimals="0"
      unitRef="USD">70173</AATP:ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty>
    <us-gaap:DueFromOfficersOrStockholdersCurrent
      contextRef="AsOf2020-03-31_custom_MrHowKokChoongMember25848312"
      decimals="0"
      unitRef="USD">660464</us-gaap:DueFromOfficersOrStockholdersCurrent>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember"
      decimals="INF"
      unitRef="Pure">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">15000000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">1500</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2019-04-03_custom_PhoenixPlusCorpMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:SharesIssuedPricePerShare>
    <AATP:NonMarketableSecuritiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_890_ecustom--NonMarketableSecuritiesTableTextBlock_zVcsiDStTTCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zwo7IHXeFEYj" style="display: none"&gt;SCHEDULE
OF INVESTMENT IN NON MARKETABLE SECURITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;Unreserved Sdn Bhd&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt; December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt; December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Investment in non-marketable securities&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zy5FwsrHnnvf" style="width: 16%; text-align: right" title="Investment in non-marketable securities"&gt;730,637&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zvFRZlIhT4w9" style="width: 16%; text-align: right" title="Investment in non-marketable securities"&gt;730,637&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1.5pt"&gt;Less: Sale of investment in non-marketable securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zPHfauzcxTe5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"&gt;(730,637&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_znBNiSMcRYXd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Investment in non-marketable securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zRoMhr7p1lda" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1263"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zAOUFV0i00U2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"&gt;730,637&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;Phoenix Plus Corporation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Cost of investment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z6yageq06Da5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment"&gt;1,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z3yTqDUlNzp6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment"&gt;1,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total investment in non-marketable securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zhrdmj6iHPE3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"&gt;1,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zNHoSPSLbmD1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"&gt;732,137&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</AATP:NonMarketableSecuritiesTableTextBlock>
    <AATP:InvestmentInNonMarketableSecuritiesGross
      contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      decimals="0"
      unitRef="USD">730637</AATP:InvestmentInNonMarketableSecuritiesGross>
    <AATP:InvestmentInNonMarketableSecuritiesGross
      contextRef="AsOf2019-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      decimals="0"
      unitRef="USD">730637</AATP:InvestmentInNonMarketableSecuritiesGross>
    <AATP:SaleOfInvestmentInNonmarketableSecurities
      contextRef="AsOf2020-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      decimals="0"
      unitRef="USD">-730637</AATP:SaleOfInvestmentInNonmarketableSecurities>
    <AATP:InvestmentInNonmarketableSecuritiesNet
      contextRef="AsOf2019-12-31_custom_DirectorsOfUnreservedInvestmentMember"
      decimals="0"
      unitRef="USD">730637</AATP:InvestmentInNonmarketableSecuritiesNet>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2020-12-31_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">1500</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2019-12-31_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">1500</us-gaap:InvestmentOwnedAtCost>
    <AATP:InvestmentInNonMarketableSecuritiesNoncurrent
      contextRef="AsOf2020-12-31_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">1500</AATP:InvestmentInNonMarketableSecuritiesNoncurrent>
    <AATP:InvestmentInNonMarketableSecuritiesNoncurrent
      contextRef="AsOf2019-12-31_custom_PhoenixPlusCorpMember"
      decimals="0"
      unitRef="USD">732137</AATP:InvestmentInNonMarketableSecuritiesNoncurrent>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_805_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zkPfJ73v5QSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;13.
&lt;span id="xdx_828_zM6cgFMmVV51"&gt;OTHER PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zvevgH6ntcy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BE_zUECWJ5V8Deg" style="display: none"&gt;SCHEDULE
OF OTHER PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20201231_zaSsDXBRCEhd" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20191231_zGkLGdcGquE1" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As
of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_z0GzJp230hSf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Professional fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;297,636&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;58,594&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--AccruedPromotionExpenses_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zHWpQRvjZpKe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Promotion expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,433&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1283"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zs4HlqHau9dj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Payroll&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1286"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maOAPAAzH31_zrLNi3ewmGp2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Commission&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;224,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1289"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_maOAPAAzr8S_maOAPAAzH31_zy64H97taSK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;63,921&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,652&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--OtherAccountPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzH31_zJuze8EsX2Zk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;647,677&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;77,246&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zLrh4fxIfnpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_890_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zvevgH6ntcy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BE_zUECWJ5V8Deg" style="display: none"&gt;SCHEDULE
OF OTHER PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20201231_zaSsDXBRCEhd" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20191231_zGkLGdcGquE1" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As
of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_z0GzJp230hSf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Professional fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;297,636&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;58,594&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--AccruedPromotionExpenses_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zHWpQRvjZpKe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Promotion expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,433&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1283"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zs4HlqHau9dj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Payroll&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1286"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maOAPAAzH31_zrLNi3ewmGp2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Commission&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;224,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1289"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_maOAPAAzr8S_maOAPAAzH31_zy64H97taSK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;63,921&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,652&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--OtherAccountPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzH31_zJuze8EsX2Zk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;647,677&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;77,246&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">297636</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">58594</us-gaap:AccruedProfessionalFeesCurrent>
    <AATP:AccruedPromotionExpenses contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">37433</AATP:AccruedPromotionExpenses>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">23976</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">224711</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">63921</us-gaap:AccountsPayableAndOtherAccruedLiabilities>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilities contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">18652</us-gaap:AccountsPayableAndOtherAccruedLiabilities>
    <AATP:OtherAccountPayableAndAccruedLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">647677</AATP:OtherAccountPayableAndAccruedLiabilities>
    <AATP:OtherAccountPayableAndAccruedLiabilities contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">77246</AATP:OtherAccountPayableAndAccruedLiabilities>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zaK4JsHCB2ca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;14.
&lt;span id="xdx_829_zhD5cTc7954l"&gt;RELATED PARTY BALANCES AND TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Related
party balances&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zixdyMYZRAHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accounts
receivable &#x2013; related party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BC_zTOqoHzErHZa" style="display: none"&gt;SCHEDULE
OF RELATED PARTIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 15%; padding-bottom: 1.5pt; vertical-align: top"&gt;SEA&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; text-align: center; padding-bottom: 1.5pt" title="Related parties relationship, description"&gt;&lt;span&gt;&lt;span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z4r0qaJJKTq6" title="Relationship"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zAc8NfDRBm8j" title="Relationship"&gt;VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; padding-bottom: 1.5pt; width: 17%; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zWVbZB5iVLM7" title="Nature"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__custom--RelatedPartiesNatureDescriptionAxis__custom--SeaMember_z0NZBA917z89" title="Nature"&gt;Sales of products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zJKaZDCGbXLl" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Accounts receivable - related party"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1309"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zakJ6nMBP6zd" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Accounts receivable - related party"&gt;520,786&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20200930_z9qLb6jkgZhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - related party"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1313"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231_zN55hyFPOoAf" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - related party"&gt;520,786&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount
due from related parties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: left"&gt;Agape ATP (Asia) Limited (&#x201c;AATP Asia&#x201d;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: center"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zw75ccAMGFXd" title="Relationship"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zXhULwcfmjr5" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: center"&gt;&lt;span title="Nature"&gt;&lt;span title="Nature"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zJzwpXMlsqkf" title="Nature"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zS9nVW5ce79" title="Nature"&gt;Expenses paid for AATP Asia&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zgei8Pm92EY6" style="width: 16%; text-align: right" title="Amount due from related parties"&gt;2,227&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_z4eoOUeTP8ih" style="width: 16%; text-align: right" title="Amount due from related parties"&gt;2,217&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;Hostastay Sdn. Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zr41Sjr8s5Zh" title="Relationship"&gt;&lt;span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zp2wuE0fJJqj" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqXkrZZrLq9h" title="Nature"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zSfJKPSZkBOb" title="Relationship"&gt;Sublease rent due from Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqyDHGPbhKEi" style="text-align: right" title="Amount due from related parties"&gt;996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoIBCiLVUBO" style="text-align: right" title="Amount due from related parties"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1339"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"&gt;TH3 Technology Sdn Bhd&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zwnrZk3jMNyh" title="Relationship"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zag0xOlzxSz4" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span&gt;&lt;span id="xdx_90A_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zVx5rcw72ooj" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_ztylm5j894s3" title="Nature"&gt;Expenses paid for TH3 Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zzZwgyyjZze6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"&gt;12&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zt9qfn5m2t3b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1351"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_zJyeNOxmXkT2" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;3,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231_zFU5tBSekWBl" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;2,217&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount
due to a Related Party &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: left"&gt;Mr. How Kok Choong&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 20%; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zagpdtShBrnb" title="Relationship"&gt;&lt;span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z7rzqqoLYiA" title="Relationship"&gt;CEO and director of the Company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zofULDJzW49l" title="Nature"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zbW6skPbsvR5" title="Nature"&gt;Acquisition payment of ASL and expenses paid for the Company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zQanBNTHZQLg" style="width: 16%; text-align: right" title="Amount due to a Related Party"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1365"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zoOWyZ11kMm3" style="width: 16%; text-align: right" title="Amount due to a Related Party"&gt;3,952&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"&gt;Agape Superior Living Pty Ltd&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zWsafe7EuOd2" title="Relationship"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zaSkW1GuFx52" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z8BvKqlWyWM8" title="Nature"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4YPWKRLxzJb" title="Nature"&gt;ATP Printing Label fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4ytW8nLXkmd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due to a Related Party"&gt;455&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zk3Pafzg6zgd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due to a Related Party"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zKvRDIes0g93" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party"&gt;455&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231_z3RySKnCB839" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party"&gt;3,952&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;14.
RELATED PARTY BALANCES AND TRANSACTIONS  (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Related
party transactions &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 15%; vertical-align: top"&gt;SEA&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 15%; text-align: center"&gt;&lt;span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zwitaBZqCIak" title="Relationship"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zNb9Yq0kiWo9" title="Relationship"&gt;VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; width: 13%; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z71NBS1YC83i" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zrtIaUQArOy5" title="Nature"&gt;Sales of products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zl1Mwgeg7Yfh" style="width: 13%; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_za6sEJYzqCP7" style="width: 13%; text-align: right" title="Revenue"&gt;1,268,670&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zhYFfpbqSFs1" style="width: 13%; text-align: right" title="Revenue"&gt;429,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"&gt;Agape Superior Living Pty Ltd (&#x201c;ASLPL&#x201d;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_900_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zlHsUrMdYGUj" title="Relationship"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_znbURk9VgnKj" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_ze0dRrUnKmnb" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z9K1mA3oXrTd" title="Nature"&gt;Sales of products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z1mDwTSFcI8i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;18,060&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z5EFwN7Rm1G" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;21,461&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zMjHcT9m7sG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1411"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zGZIyL6cTNu8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;18,060&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231_zNcKogcccSO7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;1,290,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231_zzDG731xHg6f" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;429,362&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other
income&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 15%; text-align: left; padding-bottom: 1.5pt"&gt;Hostastay Sdn. Bhd.&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zlx2IsTyAaUg" title="Relationship"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zGjEEcllreYf" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zCQ4axBg1I7j" title="Nature"&gt;&lt;span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zYhMv2QTjPc" title="Nature"&gt;Sublease rental income due from Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OtherIncome_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zBTMmPFy3h12" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"&gt;2,881&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zj3DnIwsK2A6" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1429"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherIncome_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zO52VxQ8REB2" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1431"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zlL6QQCLjZqi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"&gt;2,881&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231_zJ1OqIntLAt1" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1435"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20190701__20191231_zI6AgMrhyoVh" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1437"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_z50LwVTXkjQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_893_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zixdyMYZRAHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accounts
receivable &#x2013; related party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BC_zTOqoHzErHZa" style="display: none"&gt;SCHEDULE
OF RELATED PARTIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 15%; padding-bottom: 1.5pt; vertical-align: top"&gt;SEA&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; text-align: center; padding-bottom: 1.5pt" title="Related parties relationship, description"&gt;&lt;span&gt;&lt;span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z4r0qaJJKTq6" title="Relationship"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zAc8NfDRBm8j" title="Relationship"&gt;VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; padding-bottom: 1.5pt; width: 17%; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zWVbZB5iVLM7" title="Nature"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__custom--RelatedPartiesNatureDescriptionAxis__custom--SeaMember_z0NZBA917z89" title="Nature"&gt;Sales of products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zJKaZDCGbXLl" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Accounts receivable - related party"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1309"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zakJ6nMBP6zd" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Accounts receivable - related party"&gt;520,786&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20200930_z9qLb6jkgZhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - related party"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1313"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231_zN55hyFPOoAf" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - related party"&gt;520,786&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount
due from related parties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: left"&gt;Agape ATP (Asia) Limited (&#x201c;AATP Asia&#x201d;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: center"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zw75ccAMGFXd" title="Relationship"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zXhULwcfmjr5" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: center"&gt;&lt;span title="Nature"&gt;&lt;span title="Nature"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zJzwpXMlsqkf" title="Nature"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zS9nVW5ce79" title="Nature"&gt;Expenses paid for AATP Asia&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zgei8Pm92EY6" style="width: 16%; text-align: right" title="Amount due from related parties"&gt;2,227&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_z4eoOUeTP8ih" style="width: 16%; text-align: right" title="Amount due from related parties"&gt;2,217&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;Hostastay Sdn. Bhd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zr41Sjr8s5Zh" title="Relationship"&gt;&lt;span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zp2wuE0fJJqj" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqXkrZZrLq9h" title="Nature"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zSfJKPSZkBOb" title="Relationship"&gt;Sublease rent due from Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqyDHGPbhKEi" style="text-align: right" title="Amount due from related parties"&gt;996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoIBCiLVUBO" style="text-align: right" title="Amount due from related parties"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1339"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"&gt;TH3 Technology Sdn Bhd&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zwnrZk3jMNyh" title="Relationship"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zag0xOlzxSz4" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span&gt;&lt;span id="xdx_90A_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zVx5rcw72ooj" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_ztylm5j894s3" title="Nature"&gt;Expenses paid for TH3 Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zzZwgyyjZze6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"&gt;12&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zt9qfn5m2t3b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1351"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_zJyeNOxmXkT2" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;3,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231_zFU5tBSekWBl" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"&gt;2,217&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount
due to a Related Party &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt; December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: left"&gt;Mr. How Kok Choong&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 20%; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zagpdtShBrnb" title="Relationship"&gt;&lt;span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z7rzqqoLYiA" title="Relationship"&gt;CEO and director of the Company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 18%; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zofULDJzW49l" title="Nature"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zbW6skPbsvR5" title="Nature"&gt;Acquisition payment of ASL and expenses paid for the Company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zQanBNTHZQLg" style="width: 16%; text-align: right" title="Amount due to a Related Party"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1365"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zoOWyZ11kMm3" style="width: 16%; text-align: right" title="Amount due to a Related Party"&gt;3,952&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"&gt;Agape Superior Living Pty Ltd&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zWsafe7EuOd2" title="Relationship"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zaSkW1GuFx52" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z8BvKqlWyWM8" title="Nature"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4YPWKRLxzJb" title="Nature"&gt;ATP Printing Label fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4ytW8nLXkmd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due to a Related Party"&gt;455&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zk3Pafzg6zgd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due to a Related Party"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zKvRDIes0g93" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party"&gt;455&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231_z3RySKnCB839" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party"&gt;3,952&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;14.
RELATED PARTY BALANCES AND TRANSACTIONS  (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Related
party transactions &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 15%; vertical-align: top"&gt;SEA&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 15%; text-align: center"&gt;&lt;span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zwitaBZqCIak" title="Relationship"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zNb9Yq0kiWo9" title="Relationship"&gt;VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: top; width: 13%; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z71NBS1YC83i" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zrtIaUQArOy5" title="Nature"&gt;Sales of products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zl1Mwgeg7Yfh" style="width: 13%; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_za6sEJYzqCP7" style="width: 13%; text-align: right" title="Revenue"&gt;1,268,670&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zhYFfpbqSFs1" style="width: 13%; text-align: right" title="Revenue"&gt;429,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"&gt;Agape Superior Living Pty Ltd (&#x201c;ASLPL&#x201d;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_900_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zlHsUrMdYGUj" title="Relationship"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_znbURk9VgnKj" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_ze0dRrUnKmnb" title="Nature"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z9K1mA3oXrTd" title="Nature"&gt;Sales of products&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z1mDwTSFcI8i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;18,060&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z5EFwN7Rm1G" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;21,461&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zMjHcT9m7sG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1411"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zGZIyL6cTNu8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;18,060&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231_zNcKogcccSO7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;1,290,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231_zzDG731xHg6f" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"&gt;429,362&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other
income&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of Related Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Relationship&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nature&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 15%; text-align: left; padding-bottom: 1.5pt"&gt;Hostastay Sdn. Bhd.&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zlx2IsTyAaUg" title="Relationship"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zGjEEcllreYf" title="Relationship"&gt;Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zCQ4axBg1I7j" title="Nature"&gt;&lt;span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zYhMv2QTjPc" title="Nature"&gt;Sublease rental income due from Hostastay&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OtherIncome_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zBTMmPFy3h12" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"&gt;2,881&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zj3DnIwsK2A6" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1429"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherIncome_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zO52VxQ8REB2" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1431"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zlL6QQCLjZqi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"&gt;2,881&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231_zJ1OqIntLAt1" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1435"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20190701__20191231_zI6AgMrhyoVh" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1437"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_SeaMember">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2019-01-012019-12-31_custom_SeaMember">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_SeaMember">Sales of products</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2019-01-012019-12-31_custom_SeaMember25849703">Sales of products</AATP:RelatedPartiesNatureDescription>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="AsOf2019-12-31_custom_SeaMember"
      decimals="0"
      unitRef="USD">520786</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:AccountsReceivableRelatedParties contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">520786</us-gaap:AccountsReceivableRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2019-01-012019-12-31_custom_AgapeATPAsiaLimitedMember">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_AgapeATPAsiaLimitedMember">Expenses paid for AATP Asia</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2019-01-012019-12-31_custom_AgapeATPAsiaLimitedMember">Expenses paid for AATP Asia</AATP:RelatedPartiesNatureDescription>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2020-12-31_custom_AgapeATPAsiaLimitedMember"
      decimals="0"
      unitRef="USD">2227</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2019-12-31_custom_AgapeATPAsiaLimitedMember"
      decimals="0"
      unitRef="USD">2217</us-gaap:DueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdMember">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdMember">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdMember">Sublease rent due from Hostastay</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdMember">Sublease rent due from Hostastay</AATP:RelatedPartiesNatureDescription>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2020-12-31_custom_HostastaySdnBhdMember"
      decimals="0"
      unitRef="USD">996</us-gaap:DueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember">Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2019-01-012019-12-31_custom_THThreeTechnologySdnBhdMember">Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_THThreeTechnologySdnBhdMember">Expenses paid for TH3 Technology</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2019-01-012019-12-31_custom_THThreeTechnologySdnBhdMember">Expenses paid for TH3 Technology</AATP:RelatedPartiesNatureDescription>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2020-12-31_custom_THThreeTechnologySdnBhdMember"
      decimals="0"
      unitRef="USD">12</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3235</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2217</us-gaap:DueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_MrHowKokChoongMember">CEO and director of the Company</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2019-01-012019-12-31_custom_MrHowKokChoongMember">CEO and director of the Company</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_MrHowKokChoongMember">Acquisition payment of ASL and expenses paid for the Company</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2019-01-012019-12-31_custom_MrHowKokChoongMember">Acquisition payment of ASL and expenses paid for the Company</AATP:RelatedPartiesNatureDescription>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2019-12-31_custom_MrHowKokChoongMember25849875"
      decimals="0"
      unitRef="USD">3952</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">Mr. How Kok Choong, the CEO and director of the Company</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdMember">Mr. How Kok Choong, the CEO and director of the Company</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdMember">ATP Printing Label fees</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdMember">ATP Printing Label fees</AATP:RelatedPartiesNatureDescription>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2020-12-31_custom_AgapeSuperiorLivingPtyLtdMember"
      decimals="0"
      unitRef="USD">455</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">455</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">3952</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_SeaMember">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2019-01-012019-12-31_custom_SeaMember">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_SeaMember">Sales of products</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2019-01-012019-12-31_custom_SeaMember">Sales of products</AATP:RelatedPartiesNatureDescription>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2019-01-012019-12-31_custom_SeaMember"
      decimals="0"
      unitRef="USD">1268670</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2019-07-012019-12-31_custom_SeaMember"
      decimals="0"
      unitRef="USD">429362</us-gaap:RevenueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">Sales of products</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember">Sales of products</AATP:RelatedPartiesNatureDescription>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember"
      decimals="0"
      unitRef="USD">18060</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2019-01-012019-12-31_custom_AgapeSuperiorLivingPtyLtdASLPLMember"
      decimals="0"
      unitRef="USD">21461</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">18060</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">1290131</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">429362</us-gaap:RevenueFromRelatedParties>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesRelationshipsDescription contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdOneMember">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</AATP:RelatedPartiesRelationshipsDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember">Sublease rental income due from Hostastay</AATP:RelatedPartiesNatureDescription>
    <AATP:RelatedPartiesNatureDescription contextRef="From2019-01-012019-12-31_custom_HostastaySdnBhdOneMember">Sublease rental income due from Hostastay</AATP:RelatedPartiesNatureDescription>
    <us-gaap:OtherIncome
      contextRef="From2020-01-012020-12-31_custom_HostastaySdnBhdOneMember"
      decimals="0"
      unitRef="USD">2881</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">2881</us-gaap:OtherIncome>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zHoVyN57fMoe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;15.
&lt;span id="xdx_824_zEjvJ3f6O5Bg"&gt;STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Preferred
stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, and 2019, there were &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_c20201231_pii" title="Preferred stock, shares authorized"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pii_c20191231_zi6jk4wOaQKd" title="Preferred stock, shares authorized"&gt;200,000,000&lt;/span&gt;&lt;/span&gt; preferred stocks authorized but &lt;span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_c20201231_zIQMg8fKhZdd" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_c20191231_zbjKoMuYHzge" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pii_dn_c20201231_zzvy5HIz4Mv1" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pii_dn_c20191231_zgH5fN3P8O26" title="Preferred stock, shares outstanding"&gt;none&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; were issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Common
stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, and 2019, there were &lt;span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20201231_zbPxivfkvZPj" title="Common stock, shares authorized"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20191231_zoN9KJ0TtZof" title="Common stock, shares authorized"&gt;1,000,000,000&lt;/span&gt;&lt;/span&gt; common stocks authorized, &lt;span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pii_c20201231_zK7K9hZXIKXh" title="Common stock, shares issued"&gt;&lt;span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pii_c20201231_znk84um3p8mk" title="Common stock, shares outstanding"&gt;376,452,047&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_907_eus-gaap--CommonStockSharesIssued_c20191231_pii" title="Common stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20191231_pii" title="Common stock, shares outstanding"&gt;376,275,500&lt;/span&gt;&lt;/span&gt; shares issued and
outstanding, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
May 2020, the Company issued &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200501__20200531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zy4UXmWxtw35" title="Stock issued during period acquisitions, shares"&gt;162,694&lt;/span&gt; shares of the Company&#x2019;s common stock in connection with the acquisition of ASL as part
of the acquisition payment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value
increased by $&lt;span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_c20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zBjfh7Bj0YI2" title="Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets"&gt;90,043&lt;/span&gt;, which required the issuance of an additional &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zCEs2CDBegPi" title="Stock issued during period acquisitions, shares"&gt;13,853&lt;/span&gt; shares of the Company&#x2019;s common stock to fully
satisfy the acquisition payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200629__20200731__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zrwS2BGCzZzd" title="Stock issued during period acquisitions, shares"&gt;13,853&lt;/span&gt; additional shares were
issued in July 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;There
were &lt;span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_uShares_c20200101__20201231_zPl3aHIQBThj" title="Potentially dilutive securities outstanding"&gt;&lt;span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_uShares_c20190101__20191231_zNpJWiTUHRPc" title="Potentially dilutive securities outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2020 and 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Non-controlling
interest&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, and for the year ended December 31, 2020, no material transactions of non-controlling interest occurred
from the operating results from ASL as the Company holds approximately &lt;span id="xdx_901_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pii_dp_uPure_c20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zt5OHiiPpqC7" title="Business acquisition percentage of voting interests"&gt;99.99&lt;/span&gt;% of the equity interest in ASL, non-controlling interests
that present in ASL is $&lt;span id="xdx_90C_eus-gaap--NoncontrollingInterestIncreaseFromBusinessCombination_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z6XiVlfioese" title="Non controlling interests"&gt;0&lt;/span&gt; and therefore not presented separately in the accompanying consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">376452047</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">376452047</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">376275500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">376275500</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-05-012020-05-31_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Shares">162694</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2020-12-31_custom_AgapeSuperiorLivingMember"
      decimals="0"
      unitRef="USD">90043</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Shares">13853</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-06-292020-07-31_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Shares">13853</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2020-12-31_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Pure">0.9999</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="From2020-01-012020-12-31_custom_AgapeSuperiorLivingMember"
      decimals="0"
      unitRef="USD">0</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_z4EUw0RI8fn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;16.
&lt;span id="xdx_828_zCkB2kBlKzdd"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
United States and foreign components of income (loss) before income taxes were comprised of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zbHvfwaLTa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B1_zzZ9wnvDeoqf" style="display: none"&gt;SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax jurisdictions from:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;- U.S.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20200101__20201231_zAbGpy29Fbej" style="width: 14%; text-align: right" title="Local"&gt;(735,159&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190101__20191231_ztiS9DrDU5ma" style="width: 14%; text-align: right" title="Local"&gt;(321,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190701__20191231_zwRKMI0F1QHc" style="width: 14%; text-align: right" title="Local"&gt;(279,476&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;- Foreign &#x2013; Malaysia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--MY_z8DHaO1U1e1b" style="text-align: right" title="Foreign"&gt;1,070,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--MY_z2ccxqkYJEW" style="text-align: right" title="Foreign"&gt;38,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20191231__srt--StatementGeographicalAxis__country--MY_zobkAtiHFhvl" style="text-align: right" title="Foreign"&gt;(4,174&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;- Foreign &#x2013; Hong Kong&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--HK_zNrOkR70FeM7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign"&gt;180,700&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--HK_z1s8Szjpg7t5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign"&gt;(439,909&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20201231__srt--StatementGeographicalAxis__country--HK_z8y2iKDnG2Y5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign"&gt;(55,281&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Income (loss) before income taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200701__20201231_zNiGYHtEI5Gf" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax"&gt;516,347&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190101__20191231_zSnEzu3f7kej" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax"&gt;(723,092&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190701__20191231_zizxBk9Aaz7" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax"&gt;(338,931&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zTgOP7hJyX27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;16.
INCOME TAXES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZzlmXh1kM57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
(provision for) benefit of income taxes consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BB_zaJwBfXd0tdi" style="display: none"&gt;SCHEDULE OF PROVISION FOR INCOME TAX&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20200101__20201231_zD6DHwvcDqLh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20190101__20191231_zI6zvqNvPTtl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20190701__20191231_zwmyScxi2la5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Years Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Current:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maT001_zNzWsoAppUkf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;- U.S.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1511"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1513"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--CurrentForeignTaxExpenseBenefit_maT001_zuanHqQMqwol" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%"&gt;- Foreign&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;16,748&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;6,965&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1517"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maT001_zYRHFL9aXLi4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;- U.S.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1519"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1521"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_maT001_zPBavMQDeND9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;- Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(178,329&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1524"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1525"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OtherIncomeTaxExpenseBenefitContinuingOperations_iT_pp0p0_mtT001_zK2qRy7RU0Vh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;(Provision for) benefit of income taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(161,581&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,965&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1529"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zPYMD8FzKtwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply
a broad range of income taxes rates. The Company and its subsidiary that operate in various countries: United States, Malaysia
(including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;United
States of America&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a
corporate tax rate of &lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zqPvD1NpFJy3" title="Tax percentage"&gt;21&lt;/span&gt;% on its taxable income. Agape ATP Corporation also subject to controlled foreign corporations Subpart
F income (&#x201c;Subpart F&#x201d;) tax, which is a tax primarily on passive income from controlled foreign corporations with a
tax rate of &lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zbf14BFFp1q8"&gt;35&lt;/span&gt;%. &lt;span id="xdx_90F_eus-gaap--TaxCutsAndJobsActOf2017OtherTaxEffectDescription_c20200101__20201231_zq1kTGRUqTlc" title="Tax rate description"&gt;In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#x201c;GILTI&#x201d;) tax,
which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted
tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be
no U.S. corporate tax after the 80% foreign tax credits are applied.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2020, the Company&#x2019;s foreign subsidiaries generated approximately $&lt;span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_c20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zZyzsvkfWxFl" title="Cumulative net operating loss"&gt;636,000&lt;/span&gt; taxable income that
are subject to Subpart F tax and GILTI tax. The Company has fully utilized approximately $636,000 NOL resulted in tax benefit
of approximately $&lt;span id="xdx_90D_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zhdwQ3W4Vew4" title="Tax benefit"&gt;134,000&lt;/span&gt; for the year ended December 31, 2020. The Company did not generate any foreign taxable incomes subject
to GILTI tax for the year ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020 and 2019, the operations in the United States of America incurred approximately $&lt;span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zJiaeiSW1rag"&gt;313,000&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_zanBhPaqvpvg"&gt;213,000&lt;/span&gt;, respectively,
of cumulative net operating losses (&#x201c;NOL&#x201d;) which can be carried forward to offset future taxable income. Approximately
$&lt;span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231_zVVmwk283852" title="Cumulative net operating loss"&gt;10,000&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementScenarioAxis__custom--IfUnutilizedMember_zie3NhvktQae" title="Cumulative net operating loss"&gt;24,000&lt;/span&gt; of the net operating loss carry forwards will expire in &lt;span id="xdx_909_ecustom--OperatingLossCarryforwardsExpireYear_c20200101__20201231_zII9UGrOWbW2" title="Operating loss carryforwards expire year"&gt;2027&lt;/span&gt; and &lt;span id="xdx_905_ecustom--OperatingLossCarryforwardsExpireYear_c20200101__20201231__srt--StatementScenarioAxis__custom--IfUnutilizedMember_zujy84OOAbI7" title="Operating loss carryforwards expire year"&gt;2028&lt;/span&gt;, respectively, if unutilized. The remaining
balance can be carried forward indefinitely. The deferred tax valuation allowance as of December 31, 2020 and 2019 were approximately
$&lt;span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zC6BUtNr4JC3"&gt;66,000&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_zgocDCTQ7lAd"&gt;43,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Malaysia&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Changes
to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies
incorporated in Labuan to satisfy the &#x201c;substantial activity requirements&#x201d; to qualify for the preferential tax rate
of &lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zwDl0Nju5Hn4"&gt;3&lt;/span&gt;% on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to
the &#x201c;substantial activity requirements&#x201d; was issued. As Agape ATP Corporation does not maintain a permanent establishment
in Labuan, the company is subject to tax at &lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zIr2d2qfJMU"&gt;24&lt;/span&gt;% on its net audited profit until such a time it satisfies the said requirements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;16.
INCOME TAXES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Agape Superior Living Sdn Bhd, Agape S.E.A
Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of Malaysia and the income
taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for
the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia,
enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential
tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. &lt;span id="xdx_903_eus-gaap--IncomeTaxExaminationDescription_c20200101__20201231__srt--StatementGeographicalAxis__country--MY_zIwBbOtvGT9" title="Income tax examination, description"&gt;The tax rate for small and medium sized companies
(generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is &lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20200101__20200930__srt--StatementGeographicalAxis__country--MY_zh5B4oAbw7mb"&gt;17&lt;/span&gt;% for the first RM 600,000 (or
approximately $150,000) for the year ended December 31, 2020 and RM 500,000 (or approximately $125,000) income for the six months
and year ended December 31, 2019, with the remaining balance being taxed at the 24% rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Hong
Kong&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Agape
ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of &lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20200101__20200930__srt--StatementGeographicalAxis__country--HK_zf09SVilgtA3"&gt;16.5&lt;/span&gt;%
on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative
Region is not subject to Hong Kong Profits Tax or deduction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEAzprvvHdU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table reconciles the local (United States) statutory rates to the Company&#x2019;s effective tax rate for the periods
indicated below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BF_zeZVObx6bE45" style="display: none"&gt;SCHEDULE
OF EFFECTIVE INCOME TAX RATE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20200101__20201231_z2LUThGO9pX3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20190101__20191231_zqefyfFlCde3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20190701__20191231_zoZxbSfxdmy4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zYrcqMCNs3y2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;U.S. statutory rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 2%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zUDvgK3s1zOk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zAeXx6M7YG5j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Differential tax rate in Malaysia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zIARBUE7U4B2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Permanent difference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11.3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_F20_zT9QkwNsyW1l"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zZQx711LpOPg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;31.3&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F06_zgsLTy4F7EQ4" style="font: 10pt Times New Roman, Times, Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_zXaXzpsaKd02" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z1QPXtoePgJ3"&gt;10.2&lt;/span&gt;%
    represents expenses incurred in AATP US that were not deductible in the Malaysia tax returns. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zUDthHbwpCje"&gt;0.2&lt;/span&gt;% represents income derived
    in AATP HK that were not taxable in the Malaysia tax returns. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPCorporationMember_z3D4IBRUFkVf"&gt;1.3&lt;/span&gt;% represents expenses incurred in AATP LB, ASL, SEA and WATP
    that are not deductible in the Malaysia tax returns.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A8_zqNFulgTQqh9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zf0HvgM0jQhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BD_zb3y3VE0XPpb" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Net operating loss carry forwards in U.S.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_z5AvvsjS2uRb" style="width: 16%; text-align: right" title="Net operating loss carry forwards"&gt;65,648&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_z8HZFVzogH47" style="width: 16%; text-align: right" title="Net operating loss carry forwards"&gt;43,410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Net operating loss carry forwards in Malaysia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zFY1Y79uMQ51" style="text-align: right" title="Net operating loss carry forwards"&gt;62,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--MY_zpzUY7FM83X8" style="text-align: right" title="Net operating loss carry forwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1592"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Less: valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20201231_z22U98ovv5Qa" style="text-align: right" title="Less: valuation allowance"&gt;(65,648&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20191231_zMjGpQbIvrwh" style="text-align: right" title="Less: valuation allowance"&gt;(43,410&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20201231_zLyiBjT1QLUl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation"&gt;(68,421&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20191231_zPW4RQ9OQzQ" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1600"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Deferred tax liabilities, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20201231_zADFxmeWLTEf" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net"&gt;(5,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20191231_zZyr63qsTkQe" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1604"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zOwMSvdvAGga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Uncertain
tax positions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical
merits, and measure the unrecognized benefits associated with the tax positions. As of December 31, 2020, and 2019, the Company
did not have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the
years ended December 31, 2020 and 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zbHvfwaLTa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B1_zzZ9wnvDeoqf" style="display: none"&gt;SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax jurisdictions from:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;- U.S.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20200101__20201231_zAbGpy29Fbej" style="width: 14%; text-align: right" title="Local"&gt;(735,159&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190101__20191231_ztiS9DrDU5ma" style="width: 14%; text-align: right" title="Local"&gt;(321,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190701__20191231_zwRKMI0F1QHc" style="width: 14%; text-align: right" title="Local"&gt;(279,476&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;- Foreign &#x2013; Malaysia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--MY_z8DHaO1U1e1b" style="text-align: right" title="Foreign"&gt;1,070,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--MY_z2ccxqkYJEW" style="text-align: right" title="Foreign"&gt;38,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20191231__srt--StatementGeographicalAxis__country--MY_zobkAtiHFhvl" style="text-align: right" title="Foreign"&gt;(4,174&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;- Foreign &#x2013; Hong Kong&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--HK_zNrOkR70FeM7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign"&gt;180,700&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--HK_z1s8Szjpg7t5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign"&gt;(439,909&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20201231__srt--StatementGeographicalAxis__country--HK_z8y2iKDnG2Y5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign"&gt;(55,281&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Income (loss) before income taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200701__20201231_zNiGYHtEI5Gf" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax"&gt;516,347&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190101__20191231_zSnEzu3f7kej" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax"&gt;(723,092&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190701__20191231_zizxBk9Aaz7" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax"&gt;(338,931&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-735159</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-321808</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-279476</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2020-01-012020-12-31_country_MY"
      decimals="0"
      unitRef="USD">1070806</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2019-01-012019-12-31_country_MY"
      decimals="0"
      unitRef="USD">38625</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2019-07-012019-12-31_country_MY"
      decimals="0"
      unitRef="USD">-4174</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2020-01-012020-12-31_country_HK"
      decimals="0"
      unitRef="USD">180700</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2019-01-012019-12-31_country_HK"
      decimals="0"
      unitRef="USD">-439909</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2019-07-012020-12-31_country_HK"
      decimals="0"
      unitRef="USD">-55281</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-07-012020-12-31"
      decimals="0"
      unitRef="USD">516347</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-723092</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">-338931</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZzlmXh1kM57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
(provision for) benefit of income taxes consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BB_zaJwBfXd0tdi" style="display: none"&gt;SCHEDULE OF PROVISION FOR INCOME TAX&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20200101__20201231_zD6DHwvcDqLh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20190101__20191231_zI6zvqNvPTtl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20190701__20191231_zwmyScxi2la5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Years Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For the Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Current:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maT001_zNzWsoAppUkf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;- U.S.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1511"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1513"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--CurrentForeignTaxExpenseBenefit_maT001_zuanHqQMqwol" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%"&gt;- Foreign&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;16,748&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;6,965&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1517"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maT001_zYRHFL9aXLi4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;- U.S.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1519"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1521"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_maT001_zPBavMQDeND9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;- Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(178,329&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1524"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1525"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OtherIncomeTaxExpenseBenefitContinuingOperations_iT_pp0p0_mtT001_zK2qRy7RU0Vh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;(Provision for) benefit of income taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(161,581&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,965&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1529"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">16748</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">6965</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-178329</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">-161581</us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">6965</us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-012020-12-31_us-gaap_StateAndLocalJurisdictionMember"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-012020-12-31_us-gaap_ForeignCountryMember"
      decimals="INF"
      unitRef="Pure">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:TaxCutsAndJobsActOf2017OtherTaxEffectDescription contextRef="From2020-01-01to2020-12-31">In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#x201c;GILTI&#x201d;) tax,
which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted
tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be
no U.S. corporate tax after the 80% foreign tax credits are applied.</us-gaap:TaxCutsAndJobsActOf2017OtherTaxEffectDescription>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2020-12-31_us-gaap_ForeignCountryMember"
      decimals="0"
      unitRef="USD">636000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31_us-gaap_ForeignCountryMember"
      decimals="0"
      unitRef="USD">134000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2020-12-31_country_US"
      decimals="0"
      unitRef="USD">313000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2019-12-31_country_US"
      decimals="0"
      unitRef="USD">213000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">10000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2019-12-31_custom_IfUnutilizedMember"
      decimals="0"
      unitRef="USD">24000</us-gaap:OperatingLossCarryforwards>
    <AATP:OperatingLossCarryforwardsExpireYear contextRef="From2020-01-01to2020-12-31">2027</AATP:OperatingLossCarryforwardsExpireYear>
    <AATP:OperatingLossCarryforwardsExpireYear contextRef="From2020-01-012020-12-31_custom_IfUnutilizedMember">2028</AATP:OperatingLossCarryforwardsExpireYear>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2020-12-31_country_US"
      decimals="0"
      unitRef="USD">66000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2019-12-31_country_US"
      decimals="0"
      unitRef="USD">43000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2018-12-282019-01-02_custom_LabuanMember"
      decimals="INF"
      unitRef="Pure">0.03</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2018-12-282019-01-02_custom_LabuanMember"
      decimals="INF"
      unitRef="Pure">0.24</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxExaminationDescription contextRef="From2020-01-012020-12-31_country_MY">The tax rate for small and medium sized companies
(generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or
approximately $150,000) for the year ended December 31, 2020 and RM 500,000 (or approximately $125,000) income for the six months
and year ended December 31, 2019, with the remaining balance being taxed at the 24% rate.</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-012020-09-30_country_MY"
      decimals="INF"
      unitRef="Pure">0.17</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-012020-09-30_country_HK"
      decimals="INF"
      unitRef="Pure">0.165</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEAzprvvHdU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table reconciles the local (United States) statutory rates to the Company&#x2019;s effective tax rate for the periods
indicated below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BF_zeZVObx6bE45" style="display: none"&gt;SCHEDULE
OF EFFECTIVE INCOME TAX RATE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20200101__20201231_z2LUThGO9pX3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20190101__20191231_zqefyfFlCde3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20190701__20191231_zoZxbSfxdmy4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;For the years ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the six months ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;(Unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zYrcqMCNs3y2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;U.S. statutory rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 2%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zUDvgK3s1zOk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zAeXx6M7YG5j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Differential tax rate in Malaysia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zIARBUE7U4B2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Permanent difference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11.3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_F20_zT9QkwNsyW1l"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zZQx711LpOPg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;31.3&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F06_zgsLTy4F7EQ4" style="font: 10pt Times New Roman, Times, Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_zXaXzpsaKd02" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z1QPXtoePgJ3"&gt;10.2&lt;/span&gt;%
    represents expenses incurred in AATP US that were not deductible in the Malaysia tax returns. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zUDthHbwpCje"&gt;0.2&lt;/span&gt;% represents income derived
    in AATP HK that were not taxable in the Malaysia tax returns. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPCorporationMember_z3D4IBRUFkVf"&gt;1.3&lt;/span&gt;% represents expenses incurred in AATP LB, ASL, SEA and WATP
    that are not deductible in the Malaysia tax returns.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="Pure">-0.040</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">-0.210</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="Pure">-0.210</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="Pure">0.030</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      id="Fact001572"
      unitRef="Pure">0.113</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="Pure">0.313</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.010</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2019-07-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      unitRef="Pure">0.102</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2020-01-012020-12-31_custom_AgapeATPInternationalHoldingLimitedMember"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2020-01-012020-12-31_custom_AgapeATPCorporationMember"
      decimals="INF"
      unitRef="Pure">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zf0HvgM0jQhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BD_zb3y3VE0XPpb" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Net operating loss carry forwards in U.S.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_z5AvvsjS2uRb" style="width: 16%; text-align: right" title="Net operating loss carry forwards"&gt;65,648&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_z8HZFVzogH47" style="width: 16%; text-align: right" title="Net operating loss carry forwards"&gt;43,410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Net operating loss carry forwards in Malaysia&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zFY1Y79uMQ51" style="text-align: right" title="Net operating loss carry forwards"&gt;62,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--MY_zpzUY7FM83X8" style="text-align: right" title="Net operating loss carry forwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1592"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Less: valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20201231_z22U98ovv5Qa" style="text-align: right" title="Less: valuation allowance"&gt;(65,648&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20191231_zMjGpQbIvrwh" style="text-align: right" title="Less: valuation allowance"&gt;(43,410&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20201231_zLyiBjT1QLUl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation"&gt;(68,421&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20191231_zPW4RQ9OQzQ" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1600"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Deferred tax liabilities, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20201231_zADFxmeWLTEf" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net"&gt;(5,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20191231_zZyr63qsTkQe" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1604"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2020-12-31_country_US"
      decimals="0"
      unitRef="USD">65648</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2019-12-31_country_US"
      decimals="0"
      unitRef="USD">43410</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2020-12-31_country_MY"
      decimals="0"
      unitRef="USD">62678</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">65648</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">43410</us-gaap:DeferredTaxAssetsValuationAllowance>
    <AATP:DeferredTaxLiabilitiesDepreciation contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-68421</AATP:DeferredTaxLiabilitiesDepreciation>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5743</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zbkrV1KCtADh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;17.
&lt;span id="xdx_823_zAt7kXK20Dbb"&gt;CONCENTRATIONS OF RISKS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(a)
Major customers&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the year ended December 31, 2020, no customer accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__srt--RangeAxis__srt--MaximumMember_zCxflu3X4r72" title="Concentrations of risk percentage"&gt;10&lt;/span&gt;% or more of the Company&#x2019;s total revenues. For the year ended
December 31, 2019, one related party customer accounted for approximately &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zAgmBPDu5pJ4" title="Concentrations of risk percentage"&gt;98.3&lt;/span&gt;% of the Company&#x2019;s total revenues. For the
six months ended December 31, 2019, one related party customer accounted for approximately &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20190701__20191231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_znA30cHspN7f" title="Concentrations of risk percentage"&gt;100.0&lt;/span&gt;% of the Company&#x2019;s total
revenues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, receivables from a third-party e-commerce company accounted for approximately &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember_z8bVgR90w4Bb" title="Concentrations of risk percentage"&gt;100.0&lt;/span&gt;% of the total balance
of accounts receivable. As of December 31, 2019, one related party customer accounted for &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember_zd50vNTJDeW8" title="Concentrations of risk percentage"&gt;100.0&lt;/span&gt;% of the total balance of accounts
receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(b)
Major vendors&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the year ended December 31, 2020, two vendors accounted for approximately &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember_zlP8f3gWp1e7" title="Concentrations of risk percentage"&gt;74.1&lt;/span&gt;% and &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorTwoMember_zJ0GXrckJKsa" title="Concentrations of risk percentage"&gt;25.9&lt;/span&gt;% of the Company&#x2019;s
total purchases. In November and December 2020, the Company received dividend of &lt;span id="xdx_903_eus-gaap--ProceedsFromDividendsReceived_c20201101__20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zz0hDNXu2W3" title="Dividend received"&gt;&lt;span id="xdx_909_eus-gaap--ProceedsFromDividendsReceived_c20201201__20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zR70pNNpRn6c" title="ividend received"&gt;23,330&lt;/span&gt;&lt;/span&gt; shares of common stock of DSwiss, Inc.,
represents approximately &lt;span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zBvDHfJQ1LM8" title="Ownership percentage"&gt;&lt;span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zGMg3DOSTRQe" title="Ownership percentage"&gt;0.01&lt;/span&gt;&lt;/span&gt;% ownership that the Company accounted for as investment in marketable securities (See Note 11).
Dswiss, Inc.&#x2019;s wholly owned subsidiary is the vendor that accounted for the Company&#x2019;s total purchases of &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember_zrP4pAdGUej3" title="Concentrations of risk percentage"&gt;74.1&lt;/span&gt;%
for the year ended December 31, 2020. For the year ended December 31, 2019, two vendors accounted for approximately &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--VendorOneMember_ztfyHLBHx32h" title="Concentrations of risk percentage"&gt;60.1&lt;/span&gt;%
and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--VendorTwoMember_zjbGAlwKecXl" title="Concentrations of risk percentage"&gt;39.9&lt;/span&gt;% of the Company&#x2019;s total purchases, respectively. For the six months ended December 31, 2019, two vendors accounted
for approximately &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190701__20191231__srt--MajorCustomersAxis__custom--VendorOneMember_zsdOjrC9ed3c" title="Concentrations of risk percentage"&gt;59&lt;/span&gt;% and &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190701__20191231__srt--MajorCustomersAxis__custom--VendorTwoMember_zdRTPuIWr6h8" title="Concentrations of risk percentage"&gt;41&lt;/span&gt;% of the Company&#x2019;s total purchases, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;There
are no accounts payable balance as of December 31, 2020. As of December 31, 2019, one vendor accounted for &lt;span id="xdx_900_ecustom--CommissionExpensePercentage_iI_pii_dp_uPure_c20200930_zzdGrZyjH4nh"&gt;100&lt;/span&gt;% of the total balance
of accounts payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(c)
Commission Expenses to Sales Distributors and Stockists&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the year ended December 31, 2020, no sales distributor accounted for &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--NoSalesMember__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--AccountsPayableMember_z2HnfHSjjSO4" title="Concentrations of risk percentage"&gt;10&lt;/span&gt;% or more of the Company&#x2019;s total commission expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(d)
Credit risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Financial
instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of
December 31, 2020, and 2019, $&lt;span id="xdx_909_eus-gaap--Cash_iI_pp0p0_c20201231_zhCG3VcFeWvf" title="Cash in bank"&gt;1,112,147&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--Cash_iI_pp0p0_c20191231_z7AwyJXEDqHl" title="Cash in bank"&gt;238,937&lt;/span&gt; were deposited with financial institutions, respectively, $&lt;span id="xdx_905_ecustom--DepositForInsurance_iI_pp0p0_c20201231_zUp51WqJy7U6" title="Deposit for insurance"&gt;563,788&lt;/span&gt; and $&lt;span id="xdx_909_ecustom--DepositForInsurance_iI_pp0p0_c20191231_z8YLSL9jy6Eh" title="Deposit for insurance"&gt;0&lt;/span&gt;
of these balances are not covered by deposit insurance. While management believes that these financial institutions are of high
credit quality, it also continually monitors their credit worthiness.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Financial
instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration
of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short
collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance
for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.
Historically, the Company did not have any bad debt on its account receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(e)
Exchange rate risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;The
Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company
could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher
or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending
on changes in political and economic environments without notice.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_NoCustomerMember_us-gaap_RevenueFromContractWithCustomerMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_custom_OneCustomerMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      unitRef="Pure">0.983</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-07-012019-12-31_custom_OneCustomerMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      unitRef="Pure">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember"
      decimals="INF"
      unitRef="Pure">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_ECommerceCompanyMember"
      decimals="INF"
      unitRef="Pure">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_VendorOneMember"
      decimals="INF"
      unitRef="Pure">0.741</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_VendorTwoMember"
      decimals="INF"
      unitRef="Pure">0.259</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="From2020-11-012020-11-30_custom_DSwissIncMember"
      decimals="0"
      unitRef="USD">23330</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="From2020-12-012020-12-31_custom_DSwissIncMember"
      decimals="0"
      unitRef="USD">23330</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-11-30_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Pure">0.0001</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-12-31_custom_DSwissIncMember"
      decimals="INF"
      unitRef="Pure">0.0001</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_VendorOneMember"
      decimals="INF"
      unitRef="Pure">0.741</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_custom_VendorOneMember"
      decimals="INF"
      unitRef="Pure">0.601</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_custom_VendorTwoMember"
      decimals="INF"
      unitRef="Pure">0.399</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-07-012019-12-31_custom_VendorOneMember"
      decimals="INF"
      unitRef="Pure">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-07-012019-12-31_custom_VendorTwoMember"
      decimals="INF"
      unitRef="Pure">0.41</us-gaap:ConcentrationRiskPercentage1>
    <AATP:CommissionExpensePercentage contextRef="AsOf2020-09-30" decimals="INF" unitRef="Pure">1</AATP:CommissionExpensePercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_custom_NoSalesMember_us-gaap_AccountsPayableMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Cash contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1112147</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">238937</us-gaap:Cash>
    <AATP:DepositForInsurance contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">563788</AATP:DepositForInsurance>
    <AATP:DepositForInsurance contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">0</AATP:DepositForInsurance>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXf5ZCxr0qQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;18.
&lt;span id="xdx_82D_zqcH7gf1mJDh"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Lease
commitments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
April 1, 2020, the Company adopted ASC 842 for ASL&#x2019;s office space lease and sales and training center as the lease commencement
date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $&lt;span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z6Fb0mkbrjQc" title="Operating lease liability"&gt;506,000&lt;/span&gt;, with a corresponding right-of-use
(&#x201c;ROU&#x201d;) asset in the same amount based on the present value of the future minimum rental payments of the lease, using
an effective interest rate of &lt;span id="xdx_902_ecustom--OperatingLeaseEffectiveInterestRate_pii_dp_uPure_c20200328__20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zz0ARfe0u7J6" title="Operating lease effective interest rate"&gt;5.5&lt;/span&gt;%, which was determined using the Company&#x2019;s estimated incremental borrowing rate. The weighted
remaining term of the lease is approximately &lt;span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zUxbIB3hk94d" title="Operating lease, weighted average remaining lease term"&gt;2.54&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zCzu5t3UQQJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
five-year maturity of the Company&#x2019;s operating lease liabilities is as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BB_zfgyqg8maSpf" style="display: none"&gt;SCHEDULE OF LEASE COMMITMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Twelve Months Ending &lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20201231_zbY0IDU060v" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Operating lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pp0p0_maLOLLPzA1T_zUlquhdIPMt5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;172,191&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pp0p0_maLOLLPzA1T_zKOdfViEmfGj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,890&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pp0p0_maLOLLPzA1T_zMf0Qco3soI5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83,259&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree_iI_pp0p0_maLOLLPzA1T_zfRziMeJGucg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1667"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_z5JPOW73pBOg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;424,340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zH0SQNpx9GDb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,576&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Present value of lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;395,764&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_za8pLjqkP6k8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also leases one distribution center and one employee apartments with an expiring term of twelve months or fewer, which
were classified as operating leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy
election not to recognize lease assets and liabilities. The Company selected not to recognize lease assets and liabilities on
these leases. As of December 31, 2020, the Company&#x2019;s commitment for minimum lease payments under these operating leases
within the next twelve months are $&lt;span id="xdx_902_eus-gaap--OperatingLeasePayments_pp0p0_c20200101__20201231_zwVYYjsPFrId" title="Operating lease payments"&gt;4,654&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Rent
expense for the years ended December 31, 2020 and 2019 was $&lt;span id="xdx_900_eus-gaap--OperatingLeaseExpense_pp0p0_c20200101__20201231_zhkZVxa7Xn26" title="Operating lease, rent expenses"&gt;156,716&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--OperatingLeaseExpense_pp0p0_c20190101__20191231_z5lcKGfHgO63" title="Operating lease, rent expenses"&gt;53,594&lt;/span&gt; (unaudited), respectively. Rent expense for the
six months ended December 31, 2019 $&lt;span id="xdx_909_eus-gaap--OperatingLeaseExpense_pp0p0_c20190701__20191231_zTFxOEcsfuyk" title="Operating lease, rent expenses"&gt;26,828&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Purchase
commitments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_zdKVC0IHN3Jd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2020 for the next five years
and thereafter is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B6_zzRVdmpgOzH9" style="display: none"&gt;SCHEDULE OF PURCHASE COMMITMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;Twelve months ending December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20201231_ziPu6rpTeRxg" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Minimum&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;purchase&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--PurchaseObligationDueInNextTwelveMonths_iI_pp0p0_maPOzUwc_maPOzKX0_zWrgNorC9p6k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PurchaseObligationDueInSecondYear_iI_pp0p0_maPOzUwc_maPOzKX0_zP0w9gmHD6Zi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--PurchaseObligationDueInThirdYear_iI_pp0p0_maPOzUwc_maPOzKX0_z1GunGTuSvke" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PurchaseObligationDueInFourthYear_iI_pp0p0_maPOzUwc_maPOzKX0_z4TF3eTpWShf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--PurchaseObligationDueInFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zsttNJWCmGK4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--PurchaseObligationDueAfterFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zPJksXkizzrl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,387,800&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PurchaseObligation_iTI_pp0p0_mtPOzUwc_mtPOzKX0_zXi4Wnssa8h2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total minimum purchase commitments required&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,857,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_zLA9ZkYwzEcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of the date of this report, the Company&#x2019;s vendor is not able to meet the Company&#x2019;s minimum purchase commitment of
the health and wellness products due to the manufacturing process was being delayed by its vendor.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;AGAPE
ATP CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Currency
expressed in United States Dollars (&#x201c;US$&#x201d;), except for number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;18.
COMMITMENTS AND CONTINGENCIES (CONT&#x2019;D)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Legal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;From
time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued,
as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are
not deemed to be material to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;COVID-19&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Since
the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Malaysia
has been put through various stages of lockdowns such as (1) full movement control orders (&#x201c;MCO&#x201d;), under which, quarantines,
travel restrictions, and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to
a Conditional Movement Control Order (&#x201c;CMCO&#x201d;) where most business sectors were allowed to operate under strict rules
and Standard Operating Procedures mandated by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement
Control Order (&#x201c;RMCO&#x201d;). On January 12, 2021, due to a resurgence of COVID-19 cases, the Malaysian government declared
a state of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the
country. February 2021 marked a significant month for Malaysia as all frontline staff of the country, which comprised those in
healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department of Malaysia and civil defence sectors
were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that a National COVID-19 Immunisation
Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will be vaccinated to achieve
herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO. As at the date of this report,
over 450,000 doses of the COVID-19 vaccines have been administered in the country.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be
materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general.
Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge
regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain
the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to,
the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;temporary
    closure of offices, travel restrictions, financial impact of the Company&#x2019;s customers or suspension supplies may negatively
    affected, and could continue to negatively affect, the demand for the Company&#x2019;s product;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;the
    Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially
    adversely affect its financial condition and operating results; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;any
disruption of the Company&#x2019;s supply chain, logistics providers or customers could adversely impact its business and results
of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay
delivery to its customers, which may also lead to loss of its customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19
cannot be reasonably estimated at this time. There is no guarantee that the Company&#x2019;s total revenues will grow or remain
at the similar level year over year in 2021.&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2020-04-02_custom_AgapeSuperiorLivingMember"
      decimals="0"
      unitRef="USD">506000</us-gaap:OperatingLeaseLiability>
    <AATP:OperatingLeaseEffectiveInterestRate
      contextRef="From2020-03-282020-04-02_custom_AgapeSuperiorLivingMember"
      decimals="INF"
      unitRef="Pure">0.055</AATP:OperatingLeaseEffectiveInterestRate>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2020-04-02_custom_AgapeSuperiorLivingMember">P2Y6M14D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zCzu5t3UQQJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
five-year maturity of the Company&#x2019;s operating lease liabilities is as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BB_zfgyqg8maSpf" style="display: none"&gt;SCHEDULE OF LEASE COMMITMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Twelve Months Ending &lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20201231_zbY0IDU060v" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Operating lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pp0p0_maLOLLPzA1T_zUlquhdIPMt5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;172,191&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pp0p0_maLOLLPzA1T_zKOdfViEmfGj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,890&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pp0p0_maLOLLPzA1T_zMf0Qco3soI5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83,259&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree_iI_pp0p0_maLOLLPzA1T_zfRziMeJGucg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1667"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_z5JPOW73pBOg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;424,340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zH0SQNpx9GDb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,576&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Present value of lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;395,764&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">172191</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">168890</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">83259</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">424340</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">28576</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">395764</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeasePayments
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">4654</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">156716</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">53594</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2019-07-012019-12-31"
      decimals="0"
      unitRef="USD">26828</us-gaap:OperatingLeaseExpense>
    <AATP:ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_894_ecustom--ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_zdKVC0IHN3Jd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2020 for the next five years
and thereafter is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B6_zzRVdmpgOzH9" style="display: none"&gt;SCHEDULE OF PURCHASE COMMITMENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;Twelve months ending December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20201231_ziPu6rpTeRxg" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Minimum&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;purchase&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--PurchaseObligationDueInNextTwelveMonths_iI_pp0p0_maPOzUwc_maPOzKX0_zWrgNorC9p6k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PurchaseObligationDueInSecondYear_iI_pp0p0_maPOzUwc_maPOzKX0_zP0w9gmHD6Zi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--PurchaseObligationDueInThirdYear_iI_pp0p0_maPOzUwc_maPOzKX0_z1GunGTuSvke" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PurchaseObligationDueInFourthYear_iI_pp0p0_maPOzUwc_maPOzKX0_z4TF3eTpWShf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--PurchaseObligationDueInFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zsttNJWCmGK4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--PurchaseObligationDueAfterFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zPJksXkizzrl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,387,800&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--PurchaseObligation_iTI_pp0p0_mtPOzUwc_mtPOzKX0_zXi4Wnssa8h2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total minimum purchase commitments required&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,857,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</AATP:ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">693900</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">693900</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">693900</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligationDueInFourthYear contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">693900</us-gaap:PurchaseObligationDueInFourthYear>
    <us-gaap:PurchaseObligationDueInFifthYear contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">693900</us-gaap:PurchaseObligationDueInFifthYear>
    <us-gaap:PurchaseObligationDueAfterFifthYear contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1387800</us-gaap:PurchaseObligationDueAfterFifthYear>
    <us-gaap:PurchaseObligation contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4857300</us-gaap:PurchaseObligation>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zF2Ajqoa7KDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;19.
&lt;span id="xdx_820_z1kNJp80P2vc"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;On
January 25, 2021, the Company and the shareholders (the &#x201c;Sellers&#x201d;) of DSY Wellness &amp;amp; Longevity Center Sdn. Bhd.
and DSY Medical Education Sdn. Bhd. entered into a non-binding Letter of Intent (&#x201c;LOI&#x201d;) for the acquisition of &lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210125__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SellersMember_zu5NZ1j4krW7" title="Ownership percentage"&gt;51&lt;/span&gt;%
of the issued and outstanding capital stock of DSY Wellness &amp;amp; Longevity Center Sdn. Bhd. and DSY Medical Education Sdn. Bhd.
(the &#x201c;Target Shares&#x201d;). After execution of this LOI, both parties shall proceed in good faith to complete the negotiation
and execution of the definitive transaction documents. Subject to the terms and conditions of the definitive transaction documents,
the Company will issue and allot its common stock to the Sellers and the Company will purchase the Target Shares. Except for the
provisions with regards to confidentiality, term of validity, no binding agreement, applicable law and arbitration, and miscellaneous,
the LOI is not legally binding on the parties. Any conclusion of definitive transaction documents by the Company related to such
transaction will be subject to the approval of the Board of Directors or other approval requirements, if applicable. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;On
February 1, 2021, &lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Mr. How Kok Choong, the CEO
and director of the Company, is appointed as the non-executive Chairman of &lt;span style="background-color: white"&gt;Vettons Sdn Bhd.
(&#x201c;Vettons&#x201d;),&lt;/span&gt; an e-commerce company. As of December 31, 2020, the Company has accounts receivable of
$&lt;span id="xdx_90B_eus-gaap--AccountsReceivableNetCurrent_iI_c20191231__dei--LegalEntityAxis__custom--VettonsSdnBhdMember_zBRAYs2ZHE05"&gt;172,757
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;from Vettons, representing &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20190101__20191231__dei--LegalEntityAxis__custom--VettonsSdnBhdMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zvqNsJplCXac"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of our accounts receivable.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-01-25_us-gaap_SubsequentEventMember_custom_SellersMember"
      decimals="INF"
      unitRef="Pure">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2019-12-31_custom_VettonsSdnBhdMember"
      decimals="0"
      unitRef="USD">172757</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_custom_VettonsSdnBhdMember_us-gaap_AccountsReceivableMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001572"
          xlink:label="Fact001572"
          xlink:type="locator"/>
        <link:footnote id="Footnote001579" xlink:label="Footnote001579" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z1QPXtoePgJ3">10.2</xhtml:span>%
    represents expenses incurred in AATP US that were not deductible in the Malaysia tax returns. <xhtml:span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zUDthHbwpCje">0.2</xhtml:span>% represents income derived
    in AATP HK that were not taxable in the Malaysia tax returns. <xhtml:span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPCorporationMember_z3D4IBRUFkVf">1.3</xhtml:span>% represents expenses incurred in AATP LB, ASL, SEA and WATP
    that are not deductible in the Malaysia tax returns.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001572"
          xlink:to="Footnote001579"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581791720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 29, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">333-220144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AGAPE
ATP CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001713210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-4838886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Tower 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Faber Towers<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Jalan Desa Bahagia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kuala Lumpur<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">MY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">58100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">192230099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 913,908,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,452,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581502024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents (Included $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2020)</a></td>
<td class="nump">$ 3,517,600<span></span>
</td>
<td class="nump">$ 2,744,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">172,757<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Accounts receivable &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">520,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedPartiesCurrent', window );">Amount due from related parties</a></td>
<td class="nump">3,235<span></span>
</td>
<td class="nump">2,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">589,814<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes (Included $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2020)</a></td>
<td class="nump">1,104,495<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and deposits</a></td>
<td class="nump">296,370<span></span>
</td>
<td class="nump">269,193<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">5,684,271<span></span>
</td>
<td class="nump">3,536,653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">298,309<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">5,826<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right-of-use assets</a></td>
<td class="nump">394,141<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Investment in marketable securities</a></td>
<td class="nump">577,035<span></span>
</td>
<td class="nump">66,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent', window );">Investment in non-marketable securities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">732,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">249,525<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Total other assets</a></td>
<td class="nump">1,526,336<span></span>
</td>
<td class="nump">798,621<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">7,210,607<span></span>
</td>
<td class="nump">4,335,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Customer deposits</a></td>
<td class="nump">236,134<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">154,276<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Other payables and accrued liabilities ($1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2020)</a></td>
<td class="nump">647,677<span></span>
</td>
<td class="nump">77,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Amount due to a related party</a></td>
<td class="nump">455<span></span>
</td>
<td class="nump">3,952<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">1,038,542<span></span>
</td>
<td class="nump">83,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>NON-CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">241,488<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">5,743<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Non-current Liabilities</a></td>
<td class="nump">247,231<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">1,285,773<span></span>
</td>
<td class="nump">83,988<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,452,047 and 376,275,500 shares issued and outstanding as of December 31, 2020 and December 31, 2019</a></td>
<td class="nump">37,645<span></span>
</td>
<td class="nump">37,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">6,440,616<span></span>
</td>
<td class="nump">5,293,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(734,443)<span></span>
</td>
<td class="num">(1,089,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">181,016<span></span>
</td>
<td class="nump">9,785<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">5,924,834<span></span>
</td>
<td class="nump">4,251,286<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 7,210,607<span></span>
</td>
<td class="nump">$ 4,335,274<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonMarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011391&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504847416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents', window );">VIE consolidated amount of cash and cash equivalents</a></td>
<td class="nump">$ 37,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes', window );">VIE consolidated amount of prepaid taxes</a></td>
<td class="nump">11,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities', window );">VIE consolidated amount of other payables and accrued liabilities</a></td>
<td class="nump">$ 1,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">376,452,047<span></span>
</td>
<td class="nump">376,275,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">376,452,047<span></span>
</td>
<td class="nump">376,275,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>VIE consolidated amount of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>VIE consolidated amount of other payables and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>VIE consolidated amount of Prepaid taxes .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826587687624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">REVENUE</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,434,561<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">REVENUE &#8211; RELATED PARTY</a></td>
<td class="nump">429,362<span></span>
</td>
<td class="nump">18,060<span></span>
</td>
<td class="nump">1,290,131<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUE</a></td>
<td class="nump">429,362<span></span>
</td>
<td class="nump">3,452,621<span></span>
</td>
<td class="nump">1,290,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">COST OF REVENUE</a></td>
<td class="num">(383,479)<span></span>
</td>
<td class="num">(775,855)<span></span>
</td>
<td class="num">(1,200,829)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS PROFIT</a></td>
<td class="nump">45,883<span></span>
</td>
<td class="nump">2,676,766<span></span>
</td>
<td class="nump">89,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">SELLING</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(376,582)<span></span>
</td>
<td class="num">(7,846)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">COMMISSION</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(830,659)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">GENERAL AND ADMINISTRATIVE</a></td>
<td class="num">(312,270)<span></span>
</td>
<td class="num">(1,627,660)<span></span>
</td>
<td class="num">(396,048)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">TOTAL OPERATING EXPENSES</a></td>
<td class="num">(312,270)<span></span>
</td>
<td class="num">(2,834,901)<span></span>
</td>
<td class="num">(403,894)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">LOSS FROM OPERATIONS</a></td>
<td class="num">(266,387)<span></span>
</td>
<td class="num">(158,135)<span></span>
</td>
<td class="num">(314,592)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME/(EXPENSES)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Income/(Expenses), Net</a></td>
<td class="num">(4,153)<span></span>
</td>
<td class="nump">164,283<span></span>
</td>
<td class="nump">36,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity investment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(26,085)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized holding gain (loss) on marketable securities</a></td>
<td class="num">(68,391)<span></span>
</td>
<td class="nump">350,137<span></span>
</td>
<td class="num">(68,391)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PreferredStockDividendIncomeStatementImpact', window );">Dividend income from marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">160,062<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Gain on deemed disposal of shares in Investee Company</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ImpairmentLossInEquityInvestments', window );">Impairment loss in equity investment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(366,834)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">TOTAL OTHER INCOME/(EXPENSES), NET</a></td>
<td class="num">(72,544)<span></span>
</td>
<td class="nump">674,482<span></span>
</td>
<td class="num">(408,500)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">INCOME (LOSS) BEFORE INCOME TAXES</a></td>
<td class="num">(338,931)<span></span>
</td>
<td class="nump">516,347<span></span>
</td>
<td class="num">(723,092)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">(PROVISION FOR) BENEFIT OF INCOME TAXES</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(161,581)<span></span>
</td>
<td class="nump">6,965<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME (LOSS)</a></td>
<td class="num">(338,931)<span></span>
</td>
<td class="nump">354,766<span></span>
</td>
<td class="num">(716,127)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>OTHER COMPREHENSIVE INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">9,864<span></span>
</td>
<td class="nump">171,231<span></span>
</td>
<td class="nump">11,079<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="num">$ (329,067)<span></span>
</td>
<td class="nump">$ 525,997<span></span>
</td>
<td class="num">$ (705,048)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>NET LOSS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="nump">376,275,500<span></span>
</td>
<td class="nump">376,387,778<span></span>
</td>
<td class="nump">376,275,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ImpairmentLossInEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment loss in equity investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ImpairmentLossInEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PreferredStockDividendIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PreferredStockDividendIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesCommissionsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesCommissionsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized in the period that are directly related to the selling and distribution of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826509454536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2018</a></td>
<td class="nump">$ 37,628<span></span>
</td>
<td class="nump">$ 5,293,082<span></span>
</td>
<td class="num">$ (373,082)<span></span>
</td>
<td class="num">$ (1,294)<span></span>
</td>
<td class="nump">$ 4,956,334<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="nump">376,275,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(716,127)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(716,127)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,079<span></span>
</td>
<td class="nump">11,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">ssuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 37,628<span></span>
</td>
<td class="nump">5,293,082<span></span>
</td>
<td class="num">(1,089,209)<span></span>
</td>
<td class="nump">9,785<span></span>
</td>
<td class="nump">4,251,286<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="nump">376,275,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">354,766<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">354,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">171,231<span></span>
</td>
<td class="nump">171,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">1,147,534<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,147,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">ssuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares</a></td>
<td class="nump">176,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 37,645<span></span>
</td>
<td class="nump">$ 6,440,616<span></span>
</td>
<td class="num">$ (734,443)<span></span>
</td>
<td class="nump">$ 181,016<span></span>
</td>
<td class="nump">$ 5,924,834<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">376,452,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504619224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (338,931)<span></span>
</td>
<td class="nump">$ 354,766<span></span>
</td>
<td class="num">$ (716,127)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">55,407<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,505<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating right-of-use assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">106,561<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity investment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized holding (gain) loss on marketable securities</a></td>
<td class="nump">68,391<span></span>
</td>
<td class="num">(350,137)<span></span>
</td>
<td class="nump">68,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PreferredStockDividendIncomeStatementImpact', window );">Dividend income from marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(160,062)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Gain on deemed disposal of shares in investee company</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(16,509)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ImpairmentLossInEquityInvestments', window );">Impairment loss in equity investment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">366,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">178,329<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(165,149)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties', window );">Accounts receivable &#8211; related party</a></td>
<td class="num">(85,602)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(518,940)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent', window );">Amount due from related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,417)<span></span>
</td>
<td class="num">(2,210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">78,674<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">184,985<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepayments and deposits</a></td>
<td class="nump">229,638<span></span>
</td>
<td class="nump">352,577<span></span>
</td>
<td class="nump">241,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,778<span></span>
</td>
<td class="num">(2,804)<span></span>
</td>
<td class="nump">2,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties', window );">Accounts payable &#8211; related party</a></td>
<td class="num">(35,086)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Customer deposits</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,421,886)<span></span>
</td>
<td class="num">(217,743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,965)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Other payables and accrued liabilities</a></td>
<td class="nump">44,867<span></span>
</td>
<td class="nump">336,709<span></span>
</td>
<td class="nump">68,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(105,009)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(113,945)<span></span>
</td>
<td class="num">(557,951)<span></span>
</td>
<td class="num">(704,418)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfInvestmentProjects', window );">Proceeds from sale of investment in marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(4,734)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired through acquisition of Agape superior Living Sdn Bhd</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,210,818<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty', window );">Proceeds from sale of non-marketable securities to a related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">70,173<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PaymentsToAcquireNonMarketableSecurities', window );">Investment in non-marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,276,200<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Deferred offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(249,525)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RepaymentsOfRelatedPartyDebts', window );">Repayments from related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">227,434<span></span>
</td>
<td class="nump">745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Amount due to a related party</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,318)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(22,091)<span></span>
</td>
<td class="num">(4,573)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">76,985<span></span>
</td>
<td class="nump">2,031<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(113,130)<span></span>
</td>
<td class="nump">773,143<span></span>
</td>
<td class="num">(708,460)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS, beginning of year</a></td>
<td class="nump">2,857,587<span></span>
</td>
<td class="nump">2,744,457<span></span>
</td>
<td class="nump">3,452,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS, end of end</a></td>
<td class="nump">2,744,457<span></span>
</td>
<td class="nump">3,517,600<span></span>
</td>
<td class="nump">2,744,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL CASH FLOWS INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">288,929<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>SUPPLEMENTAL NON-CASH FLOWS INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities', window );">Amount transferred from investment in investee company to non-marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">724,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities', window );">Initial recognition of right-of-use assets and lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">483,343<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition', window );">Sale of non-marketable securities to a related party in exchange for acquisition payment of Agape Superior Living Sdn Bhd</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">656,495<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition', window );">Issuance of common stock in exchange for acquisition of Agape Superior Living Sdn Bhd</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,147,551<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount transferred from investment in investee company to investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ImpairmentLossInEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment loss in equity investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ImpairmentLossInEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial recognition of right-of-use assets and lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in exchange for acquisition payment of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PaymentsToAcquireNonMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PaymentsToAcquireNonMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PreferredStockDividendIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PreferredStockDividendIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of non-marketable securities to a related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_RepaymentsOfRelatedPartyDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments from related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_RepaymentsOfRelatedPartyDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of non-marketable securities to related party in exchange for acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in related party receivables classified as other, due within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfInvestmentProjects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of investment projects held by an entity in hopes of getting a future return or interest from it.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfInvestmentProjects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826502132808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS BACKGROUND<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">ORGANIZATION AND BUSINESS BACKGROUND</a></td>
<td class="text"><p id="xdx_801_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zJSi8MyvyDFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>1.
<span id="xdx_823_zJ0CruFRLV6c">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation, a Nevada corporation (&#8220;the Company&#8221; or &#8220;AATP US&#8221;) was incorporated under the laws
of the State of Nevada on June 1, 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zPAqrgj7bzDh" title="Ownership interest percentage">100%</span> equity interest in Agape ATP International
Holding Limited, a company incorporated in Hong Kong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire
<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zKtfAAedHs31" title="Stock issued during period acquisitions, shares">9,590,596</span> ordinary shares, no par value, equivalent to approximately <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zjjjvxYeSx34" title="Ownership interest percentage">99.99%</span> of the equity interest in Agape Superior Living Sdn.
Bhd., an entity incorporated in Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
Superior Living Sdn. Bhd. (&#8220;ASL&#8221;) is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd., a wholly owned
subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by
providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.
Upon the establishment of WATP, WATP starts collaborating with ASL to carry out its Wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company
and its subsidiaries is to supply high-quality health and wellness products, including supplements to assist in cell metabolism,
detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and
various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements reflect the activities of the Company, Agape ATP Corporation (&#8220;AATP LB&#8221;),
Agape ATP International Holding Limited (&#8220;AATP HK&#8221;), Wellness ATP International Holdings Sdn, Bhd. (&#8220;WATP&#8221;), ASL and its variable interest entity (&#8220;VIE&#8221;), Agape S.E.A. Sdn. Bhd. (&#8220;SEA&#8221;) (See Note 3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zw7f6w0FF1xk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Details
of the Company&#8217;s subsidiaries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_zC1Anlgtow4l" style="display: none">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Subsidiary
company name</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Place
and date of incorporation</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Particulars
    of issued&#160;capital</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Principal
    activities</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Proportional
of ownership interest and voting power held</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">1.
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 22%; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsWZZZ7j67yg" title="Subsidiary company name">Agape
    ATP Corporation</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zMtcK0TU6zG3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Labuan,
    <br/>
    March 6, 2017</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z3r71tizhsc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">100
    shares of ordinary share of US$1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z9YBdu4Klqee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">Investment
    holding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zM50Vf4ndZD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; text-align: right" title="Proportional of ownership interest and voting power held"><span style="font: 10pt Times New Roman, Times, Serif">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"/></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">2.
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zpEX8ZyUokbf" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"><span style="font: 10pt Times New Roman, Times, Serif">Agape
    ATP International Holding Limited</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98A_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zPSbyVEVQpBj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Hong
    Kong,<br/>
    June 1, 2017</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zsUJLsURrrG9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">1,000,000
    shares of ordinary share of HK$1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z0N1Jam9s4hh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">Wholesaling
    of health and wellness products; and health solution advisory services</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zfkndXUXijtf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"><span style="font: 10pt Times New Roman, Times, Serif">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"/></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zzCkeJ1IJVm1" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"><span style="font: 10pt Times New Roman, Times, Serif">Agape
    Superior Living Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zmEPx5eMS2Tb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Malaysia,
    <br/>
    August 8, 2003</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zz4J4NcmSjr5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">9,590,598
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zxZjnXi79Ywk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">Health
    and wellness products and health solution advisory services via network marketing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zrL824y99Ggd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"><span style="font: 10pt Times New Roman, Times, Serif">99.99%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zUclFrdr35C6" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"><span style="font: 10pt Times New Roman, Times, Serif">Agape
    S.E.A. Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zxvR5Bced3Fe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Malaysia,
    <br/>
    March 4, 2004</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zwBRJGP5dGle" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">2
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zgBjWf04B1h4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">VIE
    of Agape Superior Living Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">VIE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98E_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zZ3aOX5q2Y" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"><span style="font: 10pt Times New Roman, Times, Serif">Wellness
    ATP International Holdings Sdn, Bhd</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zB0NwRqVf5hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Malaysia,
    <br/>
    September 11, 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zVrklIovqUA4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">100
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zNANzG5166Ml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">The
    promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs,
    events and campaigns</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z3e92NzKLqji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"><span style="font: 10pt Times New Roman, Times, Serif">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"/></td></tr>
</table>
<p id="xdx_8A2_z7dOJZcW7U17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>1.
ORGANIZATION AND BUSINESS BACKGROUND (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients.
The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the &#8220;ATP Zeta
Health Program&#8221;, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy
dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in
our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
order to strengthen the Company&#8217;s supply chain, on May 8, 2020, the Company has successfully acquired approximately <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zw0as5opirNf">99.99% </span></span><span style="font: 10pt Times New Roman, Times, Serif">of
ASL by issuing <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zZ5Um3AJ858l">176,547 </span></span><span style="font: 10pt Times New Roman, Times, Serif">common
shares for a total value of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zNifuWGSfRne">1,147,551</span></span><span style="font: 10pt Times New Roman, Times, Serif"> and offset a loan receivable of $<span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_pp0p0_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_ziTWrJEBnEo2" title="Loan receivable">656,495</span> for a total consideration
of $<span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zCySLH6HmHx9" title="Consideration amount">1,804,046</span>, </span><span style="font: 10pt Times New Roman, Times, Serif">with the goal of securing an established network
marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the
Company&#8217;s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the
Company&#8217;s operation by boosting the Company&#8217;s retail and marketing capabilities. The newly acquired subsidiary
allows the Company to fulfill its mission of &#8220;helping people to create health and wealth&#8221; by providing a
financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a
healthy lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health
solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry
out various wellness programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, &#201;NERG&#201;TIQUE
and BEAUNIQUE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases
caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health
and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well
as trained members and distributors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
&#201;NERG&#201;TIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level.
The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
BEAUNIQUE product series focuses on the research of our diet&#8217;s impact on modifying gene expressions in order to address
genetic variations and deliver a nutrigenomic solution for every individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826502107608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zcIMJ6haPcN8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
<span id="xdx_826_zgK8FlBMWZW6">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTR730J0sFY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_z54tMmhMAiUd">Basis
of presentation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;U.S. GAAP&#8221;) for information pursuant to the rules and regulations of the Securities
Exchange Commission (&#8220;SEC&#8221;), and include all normal and recurring adjustments that management of the Company considers
necessary for a fair presentation of its financial position and operation results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84F_eus-gaap--FiscalPeriod_zSP00q8ovKre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_zyIC7gncKQbh">Change
of year end</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements
consist of the unaudited financial data for the year ended December 31, 2019, which was derived from the six months audited financial
statement ended December 31, 2019 and the interim financial statements for the six months ended June 30, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zVLcAFfvvIRg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zbx6oyc4Ivu7">Principles
of consolidation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the
Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the
primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power
to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or
to cast a majority of votes at the meeting of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities
without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial
interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb
the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is
deemed to be the primary beneficiary and must consolidate the VIE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_840_eus-gaap--UseOfEstimates_zRBqtC1y0Rv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_zPD3JoKOtab9">Use
of estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date
of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant
accounting estimates reflected in the Company&#8217;s consolidated financial statements include allowance for doubtful accounts,
allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment
of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain
tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbLw5TKDzyQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_zKxM6jyQ5jj9">Cash
and cash equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_z0Jaog9bxWZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zOgNmcedxnV3">Accounts
receivable and accounts receivable &#8211; related party</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
receivable and accounts receivable &#8211; related party are recorded at the invoiced amount less an allowance for any uncollectible
accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party
e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy
of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management
also periodically evaluates individual customer&#8217;s financial condition, credit history, and the current economic conditions
to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after
all means of collection have been exhausted and the potential for recovery is considered remote. The Company&#8217;s management
continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020,
and 2019, <span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20201231_zhC0gLzsxXaj" title="Accounts Receivable, Allowance for Credit Loss"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20191231_zv9vq6cJfZ8l" title="Accounts Receivable, Allowance for Credit Loss">no</span></span> valuation allowance was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--InventoryPolicyTextBlock_zFUs7n4p67jl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zhkqYvzJeVla">Inventories</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the
shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs
exceed expected net realizable value. As of December 31, 2020, and 2019, there are <span id="xdx_907_eus-gaap--InventoryWriteDown_do_c20200101__20201231_zgienrIUaYU3" title="Inventories write-down"><span id="xdx_90F_eus-gaap--InventoryWriteDown_do_c20190101__20191231_zCBCKFGkFpra" title="Inventories write-down">no</span></span> inventories obsolescence reserves or write-downs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zMxG7BcYUaua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_z4xaDU4cq9U6">Prepaid
taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid
taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income taxes; and (ii)
goods and service tax (&#8220;GST&#8221;) that is refundable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_847_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zeanCKKuhxQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_z4eTCa0GrNNg">Prepayments
and deposits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future
services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such
advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve
such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and
adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after
management has determined that the likelihood of collection is not probable. The Company&#8217;s management continues to evaluate
the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020, and 2019, there is <span id="xdx_90C_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zOoBOydnluek" title="Allowance for doubtful accounts"><span id="xdx_90D_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20191231_zRwZ81dNopmh" title="Allowance for doubtful accounts">no</span></span>
allowance for the doubtful accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zK7TBn5YOKXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zZcACYTGoD01">Property
and equipment, net</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zzNtF6aagGc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the
estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BC_zCdmNN6YMpGb" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Useful Life</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Computer and office equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 22%; text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_z2fLK85JSku7" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zI6pu4GZoBA2" title="Estimated Useful Life of Property and Equipment">7</span> years</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Furniture &amp; fixtures</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zdgC0gag3g19" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zaHBwcU8J9Jc" title="Estimated Useful Life of Property and Equipment">7</span> years</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment">Lease Term</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Vehicle</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z0izDTxWgvE4" title="Estimated Useful Life of Property and Equipment">5</span> years</td></tr>
</table>

<p id="xdx_8AD_zW3Hoia0BIpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or
loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are
charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets,
are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances
warrant revised estimates of useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zxdQBUFNGlb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_z2GCRI0OOo6d">Intangible
assets, net</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_z1SSSWOPprD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis
over the estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B2_zMvUZJ1WVh22" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; width: 76%; font-weight: bold">Classification</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 22%; font-weight: bold; text-align: center">Useful Life</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer software</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z1HaoclfKPk6" title="Estimated useful lives of intangible assets">5</span> years</td></tr>
</table>

<p id="xdx_8A2_z7ZQgvLZEmOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBSVMRjM1ak8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zq8BxyvJZtB">Impairment
for long-lived assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events
or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the
assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets
based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated
undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the
asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying
amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate,
to comparable market values. As of December 31, 2020 and 2019, <span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zwNmJYhcW2n4"><span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20190101__20191231_zZK7SYlBBL8l" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets was recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_849_eus-gaap--DeferredChargesPolicyTextBlock_zcLFnJGYqLHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_z6CuZBHv5W6j">Deferred
offering costs</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred
offering costs represents costs associated with the Company&#8217;s current offering which will be netted against the proceeds
from the Company&#8217;s current offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_eus-gaap--MarketableSecuritiesPolicy_zI3AAPKbqZS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_zNNH4dr7Jbqf">Investment
in marketable equity securities</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the
lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market
in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost
less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities
are based on the average cost of all the units of a particular security held at the time of sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair
value with changes in fair value recognized in the Company&#8217;s consolidated statements of operations and comprehensive loss
in the caption of &#8220;unrealized holding gain (loss) on marketable securities&#8221; in each reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_847_ecustom--NonMarketableSecuritiesPolicyTextBlock_zFnz2dhNrF4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zfsCIrUIPHYc">Investment
in non-marketable equity securities</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline
in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average
cost of all the units of a particular security held at the time of sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Due to the Company&#8217;s non-marketable equity securities (non-current) does
not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to
record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes
resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the
investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration
in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change
in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market
condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase,
an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the
carrying amount of that investment; and (v) Factors that raise significant concerns about the investee&#8217;s ability to continue
as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory
capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities
(non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair
value of the investment and its carrying amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zW3IYvpz4Alg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zMogr6vZHbe2">Customer
deposits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits
are reduced when the related sale is recognized in accordance with the Company&#8217;s revenue recognition policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zX0QGKJuKWG2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zxOAHW8oJxf">Revenue
recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers
(ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not
result in an adjustment to retained earnings upon adoption of this new guidance as the Company&#8217;s revenue was recognized
based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer
of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in
such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should
be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company&#8217;s
revenue streams are recognized at a point in time for the Company&#8217;s sale of health and wellness products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that
the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine
the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will
not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue
when (or as) the Company satisfies the performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including
payment terms, are identified, the contract has commercial substance and consideration is probable of substantial collection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive
evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability
is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred
and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted
by the customer when the products are collected by the customer at the Company&#8217;s office. Revenue is recorded net of sales
discounts, returns, allowances, and other adjustments that are based upon management&#8217;s best estimates and historical experience
and are provided for in the same period as the related revenues are recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes
in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy
for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance
and confirmed that there were no differences in the pattern of revenue recognition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sales
of Health and Wellness products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control
of the health and wellness products are transferred to its customer at the Company&#8217;s office or shipment of the goods, which
is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after
all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products
are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the
value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash
proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction
of the health and wellness products transaction price upon such sales transactions occurred. The Company&#8217;s coupons have
a validity period of six months. If the Company&#8217;s customers did not utilize the coupons after six months, the Company would
recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2020 and
2019, the Company recognized $<span id="xdx_90A_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zSpzJ5ZUN80k">170,431</span>
</span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90D_ecustom--ForfeitedCouponIncome_pp0p0_c20190101__20191231_zZYzEUhVIhl2">0
</span></span><span style="font: 10pt Times New Roman, Times, Serif">(unaudited) as forfeited coupon income.
The Company did not earn any forfeited coupon income for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_90B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200930__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_zOuTiSsaJJte" title="Revenue from sales">116,541</span> which it is
expected to fulfill within 12 months from December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zdBXrjHSlYo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Disaggregated
information of revenues by products are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B6_zChGSZN39qXj" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Survivor Select</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues">149,897</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0728">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Energized Mineral Concentrate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">81,481</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">238,687</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">100,270</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ionized Cal-Mag</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues">908,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues">55,718</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Omega Blend</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">495,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">137,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">68,927</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>BetaMaxx</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues">156,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues">191,246</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues">67,789</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vege Fruit Fiber</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zbzRbBa2R2xc" style="text-align: right" title="Total revenues">1,755</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zLCVyk32GXBd" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_z4tlviO1VJ3g" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Iron</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--IronMember_zKjsOyTnGL43" style="text-align: right" title="Total revenues">133,389</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--IronMember_z6jB8K3wD1ig" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--IronMember_zG3y9qjsS042" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0766">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Young Formula</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zCbbACpUD5tb" style="text-align: right" title="Total revenues">653,631</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zFBXDDEWNjg3" style="text-align: right" title="Total revenues">117,453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zuNHdbx356e3" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Organic Youth Care Cleansing Bar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z3nhg4lmHW9i" style="text-align: right" title="Total revenues">43,127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zI6wcZke4M15" style="text-align: right" title="Total revenues">34,917</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190701__20191213__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z6WIp5pTOix9" style="text-align: right" title="Total revenues">17,206</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Mitogize</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--MitogizeMember_zAreAMX1Mll1" style="text-align: right" title="Total revenues">162,801</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_z1oN5ObLMhp6" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0782">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_zEq44msPTLtj" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">No. 1 MED</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zlSLsCJQhFf4" style="text-align: right" title="Total revenues">46,713</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zKbFGZRdyAah" style="text-align: right" title="Total revenues">140,733</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_z0CCGwlOHMSj" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0790">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Energetique</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zv5rChZ4rlC" style="text-align: right" title="Total revenues">253,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zRM3mj7XNsG2" style="text-align: right" title="Total revenues">174,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zLNcmrig4WE4" style="text-align: right" title="Total revenues">175,170</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trim+</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20200101__20201213__srt--ProductOrServiceAxis__custom--TrimPlusMember_zcYOBTSyddxf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">365,350</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zesbMf6lJCz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">198,817</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zCH8cGDMuRvd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20200101__20201231_zx6ORyFHQ275" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">3,452,621</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20190101__20191231_z2fnVT2bi9k7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">1,290,131</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231_zW7lnu0jfNDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">429,362</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AE_zI3PvwI53Oug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sales
of Health and Wellness services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company carries out its Wellness program, where the Company&#8217;s products are bundled with health screening test and a health
camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises
to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced
by the fact that the Company provides separate services of delivering the health screening test report and allowing admission
of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues
being recognized when the test reports are completed and delivered to its customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health
camp program was completed in the final day of the health camp. For the year ended December 31, 2020, revenues from health and
wellness services are immaterial to the Company&#8217;s consolidated statements of operations and comprehensive income (loss).
The Company did not earn any revenues from health and wellness services for the year ended December 31, 2019 and for the six months
ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_846_eus-gaap--CostOfSalesPolicyTextBlock_zkmmRRTDgpw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zLrxsIRymsf8">Cost
of revenue</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84F_ecustom--ShippingAndHandlingPolicyTextBlock_zV3CavKT9Hd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zqQ4fr4fML5i">Shipping
and handling</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Shipping
and handling charges amounted to $<span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zVbxLjvziDP1" title="Selling expenses">9,315</span> and $<span id="xdx_90C_eus-gaap--SellingExpense_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjMBI1nTDuI3" title="Selling expenses">0</span> for the years ended December 31, 2020 and 2019, respectively. There was <span id="xdx_90D_eus-gaap--SellingExpense_pp0p0_do_c20190701__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zWv6ZSIDlnKd" title="Selling expenses"><span title="Selling expenses">no</span></span> shipping
and handling charges for the six months ended December 31, 2019. Shipping and handling charges are expensed as incurred and included
in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zpdnyKbHw8d6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zmLmRIvrcX3">Advertising
costs</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Advertising
costs amounted to $<span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zMIxf7tBpael" title="Advertising costs">14,339</span> and $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20190101__20191231_zogSdieAsnse" title="Advertising costs">0</span> for the years ended December 31, 2020 and 2019, respectively. There were <span id="xdx_90B_eus-gaap--AdvertisingExpense_pp0p0_do_c20190701__20191231_zwKpGThdHrBc" title="Advertising costs">no</span> advertising costs
for the six months ended December 31, 2019. Advertising costs are expensed as incurred and included in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_843_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zEVKxBI3luP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_869_zSWBTGgQNpD7">Commission
expenses</span> </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Commission
expenses are the Company&#8217;s most significant expenses. As with all companies in the network marketing industry, the Company&#8217;s
sales channel is external to the Company. The Company&#8217;s &#8220;external sales force&#8221; is stratified into two levels
based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly
or indirectly, are referred to as &#8220;sales network members&#8221;. The Company pays commission to every sales distributor
based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors
with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain
amount of the Company&#8217;s inventory on their store premises. The stockists shall account to the Company for all products sales
from their store premises as monitored through the Company&#8217;s centralized stock tracking system. The Company pays a separate
commission to stockists based on revenue generated from the stockists&#8217; physical stores. Commission expenses amounted to
$<span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zYQ1YXb97Ey3" title="Commission expenses">830,659</span> and $<span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20190101__20191231_zjJUkqSIcuPb" title="Commission expenses">0</span> (unaudited) for the years ended December 31, 2020 and 2019, respectively. There were <span id="xdx_90A_ecustom--SalesCommissionsAndFees1_pp0p0_do_c20190701__20191231_zqAGdQTEnrhk" title="Commission expenses">no</span> commission expenses for
the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_840_ecustom--DefinedContributionPlanPolicyTextBlock_zdnbUAp30fci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_86E_zoaAjV6PLZll">Defined
contribution plan</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required
to accrue and pay for these benefits based on certain percentages of the employees&#8217; respective salaries, subject to certain
ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined
contribution plan. Total expenses for the plans were $<span id="xdx_909_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_zcD48OUBTDU4" title="Defined contribution plan expense">75,802</span> and $<span id="xdx_901_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20190101__20191231_zScVmBNzRsja" title="Defined contribution plan expense">0</span> (unaudited) for the years ended December 31, 2020 and 2019,
respectively. There was <span id="xdx_903_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_do_c20190701__20191231_zwB25uwSjDv9" title="Defined contribution plan expense">no</span> defined contribution plan expenses for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
related contribution plans include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Social
    Security Organization (&#8220;SOSCO&#8221;) &#8211; <span id="xdx_904_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_zzJ1kUxA3Xde" title="Salary percentage">1.75%</span> based on employee&#8217;s monthly salary capped of RM <span id="xdx_90D_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_z5twycUgm4b7" title="Monthly salary">4,000</span>;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employees
    Provident Fund (&#8220;EPF&#8221;) &#8211; <span id="xdx_90F_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_z3vJooMIJuo2" title="Salary percentage">12%</span> based on employee&#8217;s monthly salary;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employment
    Insurance System (&#8220;EIS&#8221;) &#8211; <span id="xdx_907_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zObQ2Bc6Cqgf" title="Salary percentage">0.2%</span> based on employee&#8217;s monthly salary capped of RM <span id="xdx_906_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zgTOp9GhUnFd" title="Monthly salary">4,000</span>;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Human
    Resource Development Fund (&#8220;HRDF&#8221;) &#8211; <span id="xdx_901_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zmGJg8akYI4e" title="Salary percentage">1% </span>based on employee&#8217;s monthly salary</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z26hosMg9bS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zWmm0JwTgGNd">Income
taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results
for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have
been enacted or substantively enacted by the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between
the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in
the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible
temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when
the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it
is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred
tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion
or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the
relevant taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">An
uncertain tax position is recognized as a benefit only if it is &#8220;more likely than not&#8221; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is <span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20200101__20201231_z6btSy8NTCP2">greater than 50%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">likely of being realized on examination. For
tax positions not meeting the &#8220;more likely than not&#8221; test, no tax benefit is recorded. <span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20200101__20201231_zOoWBHJPrM0g"><span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190101__20191231_zjL9HeSSY6D9">No</span>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">penalties and interest incurred related to underpayment
of income taxes for the years ended December 31, 2020 and 2019. <span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190701__20191231_zTaFbBkviXke">No
</span></span><span style="font: 10pt Times New Roman, Times, Serif">penalties and interest incurred related to underpayment
of income taxes for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions.
As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign
tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zA14L2AXjhr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_z6lDNGskyQyb">Comprehensive
income (loss)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income
(loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#8217; equity
but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting
from the Company not using the U.S. dollar as its functional currencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_ecustom--NoncontrollingInterestPolicyTextBlock_zjA6pTuKrPnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zc3R8KYdMsN9">Non-controlling
interest</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--MinorityInterestDescription_c20200101__20201231_zuFJWaaiUBz1" title="Noncontrolling interest, description">Non-controlling
interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held
by two individuals.</span> The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable
to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated
statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders
and the shareholders of the Company. As of December 31, 2020, the non-controlling interest balance was $<span id="xdx_90A_eus-gaap--MinorityInterest_iI_pp0p0_c20201231_zxduBUXDsSEd" title="Non-controlling interest">0</span> and therefore not presented
in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zqg1I9qAHxok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zY3SKCpKKPQ9">Earnings
(loss) per share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company computes earnings (loss) per share (&#8220;EPS&#8221;) in accordance with ASC 260, &#8220;Earnings per Share&#8221;. ASC
260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary
share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares
(e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per
share or decrease loss per share) are excluded from the calculation of diluted EPS. For the years ended December 31, 2020 and
2019, there were <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20200101__20201231_zt4FOglj8Qxe" title="Potentially dilutive securities outstanding"><span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190101__20191231_zYfevg2dAOf8" title="Potentially dilutive securities outstanding">no</span></span> dilutive shares. There was <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190701__20191231_z5THbyxJmJWi" title="Potentially dilutive securities outstanding">no</span> dilutive shares for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOK2vIIGi7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zVe1pPjk2E0j">Foreign
currencies translation and transaction</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates
prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional
currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting
exchange differences are recorded in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have
been expressed in US$. The Company&#8217;s subsidiary in Labuan maintains its books and record in United States Dollars (&#8220;US$&#8221;)
albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the
Malaysian Ringgit (&#8220;MYR&#8221; or &#8220;RM&#8221;). The Company&#8217;s subsidiary in Hong Kong maintains its books and
record in Hong Kong Dollars (&#8220;HK$&#8221;), similar to its functional currency. The Company&#8217;s subsidiary and VIE in
Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (&#8220;MYR&#8221;
or &#8220;RM&#8221;), as its functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated
into US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate
on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses
resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other
comprehensive income within the statements of stockholders&#8217; equity. Cash flows are also translated at average translation
rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the
corresponding balances on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zyv50fNYzHIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BE_zVTTQ0AjlAuj" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Period-end MYR : US$1 exchange rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zVv6l569wlf8" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.02</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zAce32sO6Npd" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.09</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Period-end HKD : US$1 exchange rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zAgNXVkWtTEk" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zfqZH1qQvpu8" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.79</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Period-average MYR : US$1 exchange rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zVetDM7dEnI2" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average">4.20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zjh3pkqYV8fj" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average">4.14</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zgvw3KqrLqk3" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average">4.16</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Period-average HKD : US$1 exchange rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zyaxoZRqmhx6" style="text-align: right" title="Foreign currency exchange rate period average">7.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zI0VUIkx7qu8" style="text-align: right" title="Foreign currency exchange rate period average">7.84</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zzj3XRLLV3va" style="text-align: right" title="Foreign currency exchange rate period average">7.83</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A4_zGqhfLGDdP0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zqNQnty2NCli" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_z9BMJjyThk6j">Related
parties</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly,
to control the other party or exercise significant influence over the other party in making financial and operating decisions.
Companies are also considered to be related if they are subject to common control or common significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zx2nMC08WMI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zg5tdN22eaj1">Fair
value of financial instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments
and requires disclosure of the fair value of financial instruments held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement
and enhance disclosure requirements for fair value measures. The three levels are defined as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
    that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
    instruments.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or
cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected
realization and their current market rates of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_z0vjk6wQJWw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_zIClplFSvxVi">Leases</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
July 1, 2019, the Company adopted ASU 2016-02, &#8220;Leases&#8221; (Topic 842), and elected the practical expedients that does
not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification
for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve
months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The
Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single
lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing
leases with a lease term in excess of twelve months on July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating
lease right-of-use (&#8220;ROU&#8221;) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the
commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit
rate for the Company&#8217;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information
available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate
of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in
a similar economic environment and over a similar term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate
the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company
generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets.
The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases
with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU
asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company
reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying
value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying
value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected
to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating
lease payments in the undiscounted future pre-tax cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zbXPSSpP046l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_z8bQ1hey9MM3">Recent
accounting pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption
of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations,
as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#8212;Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for
the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology.
The amendments in Update 2016-13 added Topic 326, Financial Instruments&#8212;Credit Losses, and made several consequential amendments
to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually
assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial
Instruments&#8212; Credit Losses&#8212;Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders&#8217;
concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at
amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information
by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief
also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement
users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date
of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit
losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December
15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company
is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and
investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and
purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify
that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting
when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting.
With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance
in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the
purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity
method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods
beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this
standard on January 1, 2021 did not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826502044696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</a></td>
<td class="text"><p id="xdx_801_eus-gaap--VariableInterestEntityDisclosureTextBlock_zgUGnTSZ2Keb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>3.
<span id="xdx_82E_zwI7jzQ9wOG2">VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">SEA
is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided all of ASL&#8217;s purchases. Its
equity at risk was insufficient to finance its activities and <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zoRNSZrdRpA6" title="Ownership interest percentage">100%</span> of its business is transacted with ASL. Therefore, it was considered
to be a VIE and ASL is the primary beneficiary since it has both of the following characteristics:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
    power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
    obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from
    the VIE that could potentially be significant to the VIE</span><span style="font: 10pt Times New Roman, Times, Serif">.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accordingly,
the accounts of SEA is consolidated in the accompanying financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_zKylO7782fFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
carrying amount of the VIE&#8217;s assets and liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BF_zgXo71YX0MH" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsCurrent_iI_pp0p0_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zU8Jy1ossrzc" style="width: 16%; text-align: right" title="Current asset">48,717</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesCurrent_iNI_pp0p0_di_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zY2VGSD4mFZk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current liabilities">(53,573</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deficit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net deficit">(4,856</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current asset:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="width: 16%; text-align: right" title="Cash and cash equivalents">37,387</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PrepaidTaxes_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepaid taxes">11,330</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total current assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current assets">48,717</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Other payables and accrued liabilities">1,904</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other payables &#8211; intercompany</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--OtherPayablesRelatedPartyCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables - intercompany">51,669</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--LiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current liabilities">53,573</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>3.
VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
summarized operating results of the VIE&#8217;s are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left; padding-bottom: 2.5pt">Operating revenues</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Operating revenues">346,907</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gross profit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--GrossProfit_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross profit">4,442</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss from operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss from operations">(10,752</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(24,014</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

<p id="xdx_8AC_zAjTEpy5oJ6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826591860024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSNINESS COMBINATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSNINESS COMBINATION</a></td>
<td class="text"><p id="xdx_807_eus-gaap--BusinessCombinationDisclosureTextBlock_zw2UFQd2Jhn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>4.
<span id="xdx_82F_ziFfcT33m7Zd">BUSNINESS COMBINATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
May 8, 2020, the Company entered into a Share Exchange Agreement (&#8220;SPA&#8221;) with Mr. How Kok Choong, CEO and director
of the Company to acquire <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_pii" title="Stock issued during period acquisitions, shares">9,590,596</span> ordinary shares, <span id="xdx_90D_eus-gaap--CommonStockNoParValue_iI_pii_do_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zoIqkGdxGSyd" title="Ordinary shares no par value">no</span> par value, equivalent to approximately <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z3JXJd1ddbrh" title="Ownership interest percentage">99.99%</span> of the equity interest in
ASL, an entity incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration
of $<span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferred1_c20200629__20200702__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Purchase consideration value">1,804,046</span>, which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration
shall be satisfied by (i) the offset of the Consideration whereby the Company has a loan receivable of $<span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Loan payable">656,495</span> as of March 31,
2020 due from Mr. How; and (ii) allotment and issuance of common stock of the Company. The Company shall allot and issue <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pii" title="Stock issued during period acquisitions, shares">176,547</span>
shares of the Company&#8217;s common stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_c20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pii" title="Common stock par value">0.0001</span>, representing approximately <span id="xdx_907_ecustom--PercentageOfCommonStockIssuedAndOutstanding_pii_dp_uPure_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z7jb9qaYraP7" title="Percentage of common stock issued and outstanding">0.0469%</span> of the total issued and outstanding
shares in the Company after the issuance of the Shares, which is valued at $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Stock issued during period, value, acquisitions">1,147,551</span> based on the closing price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_c20200331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_pii" title="Purchased price per shares">6.50</span> of the
Company as quoted on the OTC Market on March 31, 2020. As of December 31, 2020, the Company has issued all <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pii_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z3vZ2HK501Xk" title="Issuance of common stock shares">176,547</span> shares of the
Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated
the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1,
2020 as ASL was under the common control of Mr. How.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zjoMFwU6vwug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date,
which represents the net purchase price allocation on the date of the acquisition of ASL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b><span id="xdx_8BA_zBmLsqF2NTUl" style="display: none">SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carry Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 82%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c20201231_pp0p0" style="width: 14%; text-align: right" title="Cash">1,206,493</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20201231_pp0p0" style="text-align: right" title="Other receivables">33,210</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Other receivables - related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_c20201231_pp0p0" style="text-align: right" title="Other receivables - related parties">219,121</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20201231_pp0p0" style="text-align: right" title="Inventories">616,880</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepaid taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_c20201231_pp0p0" style="text-align: right" title="Prepaid taxes">1,206,821</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepayments and other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepayments and other assets">318,267</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total current assets">3,600,792</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c20201231_pp0p0" style="text-align: right" title="Property and equipment, net">325,648</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c20201231_pp0p0" style="text-align: right" title="Intangible assets, net">6,686</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deferred taxes asset, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Deferred taxes asset, net">172,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total other assets">504,584</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">4,105,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable - related party</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c20201231_pp0p0" style="text-align: right" title="Accounts payable - related party">491,628</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_c20201231_pp0p0" style="text-align: right" title="Customer deposits">1,600,606</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other payables and accrued liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables and accrued liabilities">209,096</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total current liabilities">2,301,330</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total liabilities">2,301,330</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total net assets acquired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net assets acquired">1,804,046</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zvuS4LWR3hnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>4.
BUSNINESS COMBINATION (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following unaudited pro forma combined results of operations presents the Company&#8217;s financial results as if the acquisition
of ASL had been completed on January 1, 2019. The unaudited pro forma results do not reflect operating efficiencies or potential
cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information
is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction
on January 1, 2019. Future results may vary significantly from the results in this pro forma information because of future events
and transactions, as well as other factors.</span></p>

<p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zSAAt6fY6ls1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zJ0F8eB5LHz9" style="display: none">SCHEDULE OF PRO FORMA BUSINESS COMBINATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the Year Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the Year Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231_pp0p0" style="width: 16%; text-align: right" title="Revenue">4,693,873</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190101__20191231_pp0p0" style="width: 16%; text-align: right" title="Revenue">4,160,820</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190701__20191231_pp0p0" style="width: 16%; text-align: right" title="Revenue">2,246,458</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue">(875,708</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue">(789,409</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue">(479,410</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20200101__20201231_pp0p0" style="text-align: right" title="Gross profit">3,818,165</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190101__20191231_pp0p0" style="text-align: right" title="Gross profit">3,371,411</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190701__20191231_pp0p0" style="text-align: right" title="Gross profit">1,767,048</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses">(3,839,184</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses">(5,081,917</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses">(2,468,902</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income (loss) from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20200101__20201231_pp0p0" style="text-align: right" title="Income (loss) from operations">(21,019</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190101__20191231_pp0p0" style="text-align: right" title="Income (loss) from operations">(1,710,506</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190701__20191231_pp0p0" style="text-align: right" title="Income (loss) from operations">(701,854</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income (expense), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net">267,633</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net">(384,304</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net">(146,649</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income (loss) before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20200101__20201231_pp0p0" style="text-align: right" title="Income (loss) before income taxes">246,614</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190101__20191231_pp0p0" style="text-align: right" title="Income (loss) before income taxes">(2,094,810</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190701__20191231_pp0p0" style="text-align: right" title="Income (loss) before income taxes">(848,503</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Benefit of (provision for) income taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes">(212,414</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes">319,189</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes">117,009</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)">34,200</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)">(1,775,621</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190701__20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)">(731,494</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net income (loss) per common share - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20200101__20201231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted">0.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190101__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted">0.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190701__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted">0.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20200101__20201231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190101__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190701__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AD_zZ49HtG0BkHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>5.
CASH AND CASH EQUIVALENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">As
of December 31, 2020, and 2019 the Company has $<span id="xdx_908_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20201231_pp0p0" title="Cash and cash equivalents">3,517,600</span> and $<span id="xdx_900_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20191231_pp0p0" title="Cash and cash equivalents">2,744,457</span>, respectively, of cash and cash equivalents, which consists
of $<span id="xdx_909_eus-gaap--Cash_c20201231_pp0p0" title="Cash in bank">1,112,147</span> and $<span id="xdx_901_eus-gaap--Cash_c20191231_pp0p0" title="Cash in bank">238,937</span>, respectively, of cash in banks and </span><span style="font: 10pt Times New Roman, Times, Serif">$<span id="xdx_90A_eus-gaap--TimeDeposits_c20201231_pp0p0" title="Time deposits">2,391,182</span>
<span style="background-color: white">and $<span id="xdx_901_eus-gaap--TimeDeposits_c20191231_pp0p0" title="Time deposits">2,505,520</span>, respectively, of time deposits placed with banks or other financial institutions
and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time
deposits ranges between <span id="xdx_901_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pii_dp_uPure_c20201213__srt--RangeAxis__srt--MinimumMember_zEWSIDibomk1" title="Percentage of Interest rate for time deposits">2.95%</span> to <span id="xdx_90C_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pii_dp_uPure_c20201213__srt--RangeAxis__srt--MaximumMember_z1H8B4W9ePyg" title="Percentage of Interest rate for time deposits">3.25%</span> per annum.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826502096840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY</a></td>
<td class="text"><p id="xdx_802_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_ztLkkt9z6bbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>6.
<span id="xdx_824_zoBGjeokoMPj">ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY</span></b></span></p>

<p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z3k4Tqe4cwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B7_z3k88x6Pg2Qb" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20201231_zjeuVyRXzvl8" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20191231_z2ligaszJJWh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zG29Ltth4Cfk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">172,757</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1093">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zmMHrdaqLIu4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accounts receivable &#8211; related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1095">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">520,786</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zVdqhtmCi7Sh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">172,757</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">520,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_zptH4SzfrmQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505350648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zaOdHgAewML9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>7.
<span id="xdx_82A_zcYoHdH481Oc">INVENTORIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z2viOa0MTNF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories
consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zGMyk4cKIe75" style="display: none">SCHEDULE OF INVENTORIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Finished goods</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--InventoryFinishedGoods_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Finished goods">589,814</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InventoryFinishedGoods_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Finished goods"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A1_zBEpU9Yw4OIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826502018104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAYMENTS AND DEPOSITS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosurePrepaymentsAndDepositsAbstract', window );"><strong>Prepayments And Deposits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrepaymentsAndDepositsTextBlock', window );">PREPAYMENTS AND DEPOSITS</a></td>
<td class="text"><p id="xdx_800_ecustom--PrepaymentsAndDepositsTextBlock_zDYcL4R8KpCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>8.
<span id="xdx_827_znuDZsOzLoZ1">PREPAYMENTS AND DEPOSITS</span></b></span></p>

<p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zivrAC8upLhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BF_zbrHRzStjwi6" style="display: none">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20201231_zuZCAK5AfXy3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20191231_z2vvxHcCpeR" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzhWX_zlZfXx7hYSDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Prepaid expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1113">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,641</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_z6kTdM27P9x7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Receivables from sales distributors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,302</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1117">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_z4bS8sMRxkef" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Deposits to suppliers</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">261,068</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">266,552</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzhWX_zRHLu9QLIff6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">296,370</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">269,193</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A4_zJiOVdkiElz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosurePrepaymentsAndDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosurePrepaymentsAndDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PrepaymentsAndDepositsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PrepaymentsAndDepositsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503702616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ztk3EbCPZZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>9.
<span id="xdx_82B_z7ylvA5fnJKc">PROPERTY AND EQUIPMENT, NET</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zcREefv8JXG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment, net consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span><span id="xdx_8B5_zEBr0QdvFIO7" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT, NET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20201231_zYmTywqIqugh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20191231_zzSGCqqUO81k" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Computer and office equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z0xxtaToXSTb" style="width: 16%; text-align: right" title="Subtotal">81,437</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z7OMbZxtoE7h" style="width: 16%; text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1131">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture &amp; fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zWfeAkDtAc4c" style="text-align: right" title="Subtotal">126,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zU4XAfvc44h3" style="text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1135">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z8Ked0WvAgLe" style="text-align: right" title="Subtotal">210,496</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z2VSYwPCvgh7" style="text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1139">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Vehicle</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_z9QUQK4gXEUc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal">102,564</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zgUbYAIGXk84" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1143">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzvyH_zYufVXjBCzQf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">521,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1146">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzvyH_zP839ta38Wv7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(223,154</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1149">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzvyH_zgpUgFs5BYKb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">298,309</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1152">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AD_z8hGp74JibE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense for the years ended December 31, 2020 and 2019 amounted to $<span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20200101__20201231_zZagVQ2wVNU4" title="Depreciation">55,407</span> and $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20190101__20191231_zrBwsHIB2Shb"><span style="-sec-ix-hidden: xdx2ixbrl1155">-</span></span> (unaudited), respectively. There was <span>no</span> depreciation
expense for the six months ended December 31, 2019.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503273720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS, NET</a></td>
<td class="text"><p id="xdx_800_eus-gaap--IntangibleAssetsDisclosureTextBlock_zMOTLBaVM54l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>10.
<span id="xdx_821_zl7zzRPKeKIb">INTANGIBLE ASSETS, NET</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zOVb6pOQNP19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets, net, consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zf2xVuF2IrI3" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20201231_zabjW7SGYmh6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20191231_zi6e6ngPpZZ1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzwwR_maFLIANz4yv_zePWh5kLCi9k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Computer software</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">35,801</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzwwR_msFLIANz4yv_ze08XLW8gR7a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,975</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1165">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzwwR_mtFLIANz4yv_zetRvkWw7mkg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,826</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A4_z55evXnrJ0L7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Amortization
expense for the years ended December 31, 2020 and 2019 amounted to $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200101__20201231_zScbtKaKRi6c" title="Amortization expense">1,505</span> and $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20190101__20191231_zrX3s2PcBHyg" title="Amortization expense">0</span> (unaudited), respectively. There was <span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_do_c20190701__20191231_zyFnqLTjb0C2" title="Amortization expense">no</span> amortization
expense for the six months ended December 31, 2019.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504645096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN MARKETABLE SECURITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract', window );"><strong>Investment In Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInMarketableSecuritiesTextBlock', window );">INVESTMENT IN MARKETABLE SECURITIES</a></td>
<td class="text"><p id="xdx_80C_ecustom--InvestmentInMarketableSecuritiesTextBlock_z24OoQ5pXbV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>11.
<span id="xdx_829_zS2YMS7z3Dkk">INVESTMENT IN MARKETABLE SECURITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    May 17, 2018, the Company purchased <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zmVYwPfwoHsb" title="Investment in securities, shares">83,333</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zpClzDTE1ome" title="Investment amount">500,000</span> at a purchase price
    of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zlkBl5FJLctd" title="Purchased price per shares">6</span> per share.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    July 30, 2018, the Company disposed <span id="xdx_904_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zfr7IOfpZgJ1" title="Investment in securities, shares">20</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_909_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_z3OLgb9Wvaf" title="Investment amount">125</span> at a purchase price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_z7kS8yVPRDse" title="Purchased price per shares">6.2613</span>
    per share.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    October 16, 2018, the Company purchased <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zSl4sUUxNte8" title="Investment in securities, shares">33,333</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_znjQghgk4P43" title="Investment amount">1,000</span> at a purchase price
    of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zwlt67wxP2qe" title="Purchased price per shares">0.03</span> per share.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    November 3, 2020, the Company received dividend of <span id="xdx_906_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_zZPBv8rJwKT4" title="Investment in securities, shares">6,667</span> shares of common stock in DSwiss, Inc. for $<span id="xdx_907_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_zZ1myoVEiWn5" title="Investment amount">76,671</span> at fair value
    of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_zHlSORtdssU6" title="Purchased price per shares">11.50</span> per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#8217;s shares</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
    December 9, 2020, the Company received dividend of <span id="xdx_906_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zLZr23hjwIe6" title="Investment in securities, shares">16,663</span> shares of common stock in DSwiss, Inc. for $<span id="xdx_90C_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zBtZWIVgqRM4" title="Investment amount">83,315</span> at fair value
    of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pii_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zqjZefpIYMfb" title="Purchased price per shares">5.00</span> per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.&#8217;s shares.</span></td></tr>
</table>
<p id="xdx_898_eus-gaap--MarketableSecuritiesTextBlock_z0m6ZX0jrsNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B1_zZlxQR9QRc2l" style="display: none">SCHEDULE
OF INVESTMENT IN MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20201231_zT8A2w6neZpj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20191231_z899A2mt3dA4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentOwnedAtCost_iI_maT002_maMSNzoUs_z37fFNeVkXVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cost of investment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">66,484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">134,166</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--InvestmentsIncomeDividend_iNI_di_msMSNzoUs_zM7gVkETjOS7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dividend income from Greenpro Capital Corp.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,062</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1214">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingLoss_iI_pp0p0_msT002_msMSNzoUs_zECxHSWYdyza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unrealized holding gain (loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350,137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(68,391</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maT002_maMSNzoUs_zZReSz2dLMWa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Exchange rate effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">352</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">709</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzoUs_zZr4ak6dsByl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Investment in marketable securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">577,035</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">66,484</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_z6fMpGCttcKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInMarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505418568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN NON-MARKETABLE SECURITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract', window );"><strong>Investment In Non-marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesTextBlock', window );">INVESTMENT IN NON-MARKETABLE SECURITIES</a></td>
<td class="text"><p id="xdx_80B_ecustom--InvestmentInNonMarketableSecuritiesTextBlock_zQNe1pmlBcv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>12.
<span id="xdx_826_zhFtDZkbaEk3">INVESTMENT IN NON-MARKETABLE SECURITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company invested in Unreserved Sdn Bhd with the investment amount of <span id="xdx_906_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__srt--DirectorMember_zmiphj0lm7e5" title="Investment amount">$863,592</span> (RM <span id="xdx_909_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zuxMrYwybuxk" title="Investment amount">3,500,000</span>), which approximated <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--TitleOfIndividualAxis__srt--DirectorMember_z7iDElFJfpZb" title="Equity interest percentage">20%</span> of the equity
interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd
issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company&#8217;s
equity interest in investee company was diluted from approximately <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190310__srt--RangeAxis__srt--MaximumMember_zuc5bTkAyVdh" title="Equity interest percentage">20.0%</span> to approximately <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190310__srt--RangeAxis__srt--MinimumMember_zGLRomph8VF8" title="Equity interest percentage">17.86%</span>. Effective from March 10, 2019,
the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the
investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>12.
INVESTMENT IN NON-MARKETABLE SECURITIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unreserved
Sdn Bhd was incorporated in Malaysia with <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20201231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z7YSmvsm8048" title="Ordinary shares authorized">2,500,000</span> ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David
Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company
from April 30, 2018 to March 27, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
March 3, 2020, the Company agreed to sell the <span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200303__srt--TitleOfIndividualAxis__custom--UnreservedSdnBhdMember_zacrZg8vfsu4" title="Equity interest percentage">17.86%</span> ownership interest in Unreserved Sdn Bhd at the December 31, 2019
carrying value of $7<span id="xdx_907_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z8MSf90Npslj" title="Investment amount">30,637</span> to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $<span id="xdx_900_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_pp0p0_c20200101__20200331_zyRj8BLE9dna" title="Proceeds from investments">70,173</span>,
and had an amount due from director of $<span id="xdx_909_eus-gaap--DueFromOfficersOrStockholdersCurrent_iI_pp0p0_c20200331__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zp3qS9I8ENT3" title="Amount due from director">660,464</span> at March 31, 2020. In May 2020, the entire outstanding balance was settled as
part of the consideration in a transaction which the Company had acquired the CEO&#8217;s ownership interest of Agape Superior
Living Sdn. Bhd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
April 3, 2019, the Company purchased a <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zW5hQ0ECOpod" title="Equity interest percentage">5%</span> of stock or <span id="xdx_900_eus-gaap--InvestmentOwnedBalanceShares_iI_pii_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMuiSsfCa2q7" title="Shares purchased during period">15,000,000</span> shares of common stock in Phoenix Plus Corp. for $<span id="xdx_90E_eus-gaap--InvestmentOwnedAtCost_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0">1,500</span> at purchase
price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pii">0.0001</span> per share.</span></p>

<p id="xdx_890_ecustom--NonMarketableSecuritiesTableTextBlock_zVcsiDStTTCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zwo7IHXeFEYj" style="display: none">SCHEDULE
OF INVESTMENT IN NON MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid">Unreserved Sdn Bhd</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Investment in non-marketable securities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zy5FwsrHnnvf" style="width: 16%; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zvFRZlIhT4w9" style="width: 16%; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Less: Sale of investment in non-marketable securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zPHfauzcxTe5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities">(730,637</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_znBNiSMcRYXd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1261">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Investment in non-marketable securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zRoMhr7p1lda" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1263">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zAOUFV0i00U2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left">Phoenix Plus Corporation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of investment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z6yageq06Da5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment">1,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z3yTqDUlNzp6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment">1,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total investment in non-marketable securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zhrdmj6iHPE3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities">1,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zNHoSPSLbmD1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities">732,137</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AE_zyqc8LlloOza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826592101512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER PAYABLES AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">OTHER PAYABLES AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_805_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zkPfJ73v5QSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>13.
<span id="xdx_828_zM6cgFMmVV51">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p>

<p id="xdx_890_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zvevgH6ntcy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BE_zUECWJ5V8Deg" style="display: none">SCHEDULE
OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20201231_zaSsDXBRCEhd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20191231_zGkLGdcGquE1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_z0GzJp230hSf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Professional fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">297,636</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">58,594</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--AccruedPromotionExpenses_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zHWpQRvjZpKe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Promotion expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,433</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1283">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zs4HlqHau9dj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Payroll</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,976</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1286">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maOAPAAzH31_zrLNi3ewmGp2" style="vertical-align: bottom; background-color: White">
    <td>Commission</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">224,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1289">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_maOAPAAzr8S_maOAPAAzH31_zy64H97taSK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,921</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,652</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--OtherAccountPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzH31_zJuze8EsX2Zk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">647,677</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,246</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_zLrh4fxIfnpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504950680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY BALANCES AND TRANSACTIONS</a></td>
<td class="text"><p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zaK4JsHCB2ca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>14.
<span id="xdx_829_zhD5cTc7954l">RELATED PARTY BALANCES AND TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Related
party balances</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zixdyMYZRAHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Accounts
receivable &#8211; related party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BC_zTOqoHzErHZa" style="display: none">SCHEDULE
OF RELATED PARTIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 15%; padding-bottom: 1.5pt; vertical-align: top">SEA</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 22%; text-align: center; padding-bottom: 1.5pt" title="Related parties relationship, description"><span><span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z4r0qaJJKTq6" title="Relationship"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zAc8NfDRBm8j" title="Relationship">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td><td style="vertical-align: top; padding-bottom: 1.5pt; width: 17%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span><span><span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zWVbZB5iVLM7" title="Nature"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__custom--RelatedPartiesNatureDescriptionAxis__custom--SeaMember_z0NZBA917z89" title="Nature">Sales of products</span></span></span></span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zJKaZDCGbXLl" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Accounts receivable - related party"><span style="-sec-ix-hidden: xdx2ixbrl1309">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zakJ6nMBP6zd" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Accounts receivable - related party">520,786</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20200930_z9qLb6jkgZhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - related party"><span style="-sec-ix-hidden: xdx2ixbrl1313">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231_zN55hyFPOoAf" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - related party">520,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount
due from related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 18%; text-align: left">Agape ATP (Asia) Limited (&#8220;AATP Asia&#8221;)</td><td style="width: 2%">&#160;</td>
    <td style="width: 20%; text-align: center"><span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zw75ccAMGFXd" title="Relationship"><span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zXhULwcfmjr5" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</span></span></td><td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span title="Nature"><span title="Nature"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zJzwpXMlsqkf" title="Nature"><span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zS9nVW5ce79" title="Nature">Expenses paid for AATP Asia</span></span></span></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zgei8Pm92EY6" style="width: 16%; text-align: right" title="Amount due from related parties">2,227</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_z4eoOUeTP8ih" style="width: 16%; text-align: right" title="Amount due from related parties">2,217</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Hostastay Sdn. Bhd.</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zr41Sjr8s5Zh" title="Relationship"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zp2wuE0fJJqj" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqXkrZZrLq9h" title="Nature"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zSfJKPSZkBOb" title="Relationship">Sublease rent due from Hostastay</span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqyDHGPbhKEi" style="text-align: right" title="Amount due from related parties">996</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoIBCiLVUBO" style="text-align: right" title="Amount due from related parties"><span style="-sec-ix-hidden: xdx2ixbrl1339">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">TH3 Technology Sdn Bhd</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zwnrZk3jMNyh" title="Relationship"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zag0xOlzxSz4" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span><span id="xdx_90A_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zVx5rcw72ooj" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_ztylm5j894s3" title="Nature">Expenses paid for TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zzZwgyyjZze6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties">12</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zt9qfn5m2t3b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="-sec-ix-hidden: xdx2ixbrl1351">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_zJyeNOxmXkT2" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties">3,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231_zFU5tBSekWBl" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties">2,217</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount
due to a Related Party </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 18%; text-align: left">Mr. How Kok Choong</td><td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 20%; text-align: center"><span id="xdx_90D_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zagpdtShBrnb" title="Relationship"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z7rzqqoLYiA" title="Relationship">CEO and director of the Company</span></span></td><td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zofULDJzW49l" title="Nature"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zbW6skPbsvR5" title="Nature">Acquisition payment of ASL and expenses paid for the Company</span></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zQanBNTHZQLg" style="width: 16%; text-align: right" title="Amount due to a Related Party"><span style="-sec-ix-hidden: xdx2ixbrl1365">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zoOWyZ11kMm3" style="width: 16%; text-align: right" title="Amount due to a Related Party">3,952</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zWsafe7EuOd2" title="Relationship"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zaSkW1GuFx52" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z8BvKqlWyWM8" title="Nature"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4YPWKRLxzJb" title="Nature">ATP Printing Label fees</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4ytW8nLXkmd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due to a Related Party">455</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zk3Pafzg6zgd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due to a Related Party"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zKvRDIes0g93" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party">455</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231_z3RySKnCB839" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party">3,952</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>14.
RELATED PARTY BALANCES AND TRANSACTIONS  (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Related
party transactions </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 15%; vertical-align: top">SEA</td><td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: center"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zwitaBZqCIak" title="Relationship"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zNb9Yq0kiWo9" title="Relationship">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="vertical-align: top; width: 13%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z71NBS1YC83i" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zrtIaUQArOy5" title="Nature">Sales of products</span></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zl1Mwgeg7Yfh" style="width: 13%; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_za6sEJYzqCP7" style="width: 13%; text-align: right" title="Revenue">1,268,670</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zhYFfpbqSFs1" style="width: 13%; text-align: right" title="Revenue">429,362</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (&#8220;ASLPL&#8221;)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_900_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zlHsUrMdYGUj" title="Relationship"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_znbURk9VgnKj" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_ze0dRrUnKmnb" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z9K1mA3oXrTd" title="Nature">Sales of products</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z1mDwTSFcI8i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">18,060</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z5EFwN7Rm1G" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">21,461</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zMjHcT9m7sG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1411">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zGZIyL6cTNu8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">18,060</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231_zNcKogcccSO7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">1,290,131</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231_zzDG731xHg6f" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">429,362</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other
income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 15%; text-align: left; padding-bottom: 1.5pt">Hostastay Sdn. Bhd.</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zlx2IsTyAaUg" title="Relationship"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zGjEEcllreYf" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zCQ4axBg1I7j" title="Nature"><span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zYhMv2QTjPc" title="Nature">Sublease rental income due from Hostastay</span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OtherIncome_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zBTMmPFy3h12" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income">2,881</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zj3DnIwsK2A6" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherIncome_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zO52VxQ8REB2" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1431">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zlL6QQCLjZqi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income">2,881</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231_zJ1OqIntLAt1" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20190701__20191231_zI6AgMrhyoVh" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1437">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A3_z50LwVTXkjQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504675768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zHoVyN57fMoe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>15.
<span id="xdx_824_zEjvJ3f6O5Bg">STOCKHOLDERS&#8217; EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Preferred
stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, and 2019, there were <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_c20201231_pii" title="Preferred stock, shares authorized"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pii_c20191231_zi6jk4wOaQKd" title="Preferred stock, shares authorized">200,000,000</span></span> preferred stocks authorized but <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_c20201231_zIQMg8fKhZdd" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_c20191231_zbjKoMuYHzge" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pii_dn_c20201231_zzvy5HIz4Mv1" title="Preferred stock, shares outstanding"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pii_dn_c20191231_zgH5fN3P8O26" title="Preferred stock, shares outstanding">none</span></span></span></span> were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Common
stock</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, and 2019, there were <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20201231_zbPxivfkvZPj" title="Common stock, shares authorized"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20191231_zoN9KJ0TtZof" title="Common stock, shares authorized">1,000,000,000</span></span> common stocks authorized, <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pii_c20201231_zK7K9hZXIKXh" title="Common stock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pii_c20201231_znk84um3p8mk" title="Common stock, shares outstanding">376,452,047</span></span> and <span id="xdx_907_eus-gaap--CommonStockSharesIssued_c20191231_pii" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20191231_pii" title="Common stock, shares outstanding">376,275,500</span></span> shares issued and
outstanding, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2020, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200501__20200531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zy4UXmWxtw35" title="Stock issued during period acquisitions, shares">162,694</span> shares of the Company&#8217;s common stock in connection with the acquisition of ASL as part
of the acquisition payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value
increased by $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_c20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zBjfh7Bj0YI2" title="Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets">90,043</span>, which required the issuance of an additional <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zCEs2CDBegPi" title="Stock issued during period acquisitions, shares">13,853</span> shares of the Company&#8217;s common stock to fully
satisfy the acquisition payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200629__20200731__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zrwS2BGCzZzd" title="Stock issued during period acquisitions, shares">13,853</span> additional shares were
issued in July 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
were <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_uShares_c20200101__20201231_zPl3aHIQBThj" title="Potentially dilutive securities outstanding"><span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_uShares_c20190101__20191231_zNpJWiTUHRPc" title="Potentially dilutive securities outstanding">no</span></span> stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2020 and 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Non-controlling
interest</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, and for the year ended December 31, 2020, no material transactions of non-controlling interest occurred
from the operating results from ASL as the Company holds approximately <span id="xdx_901_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pii_dp_uPure_c20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zt5OHiiPpqC7" title="Business acquisition percentage of voting interests">99.99</span>% of the equity interest in ASL, non-controlling interests
that present in ASL is $<span id="xdx_90C_eus-gaap--NoncontrollingInterestIncreaseFromBusinessCombination_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z6XiVlfioese" title="Non controlling interests">0</span> and therefore not presented separately in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826501897464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_z4EUw0RI8fn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>16.
<span id="xdx_828_zCkB2kBlKzdd">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
United States and foreign components of income (loss) before income taxes were comprised of the following:</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zbHvfwaLTa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B1_zzZ9wnvDeoqf" style="display: none">SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax jurisdictions from:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">- U.S.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20200101__20201231_zAbGpy29Fbej" style="width: 14%; text-align: right" title="Local">(735,159</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190101__20191231_ztiS9DrDU5ma" style="width: 14%; text-align: right" title="Local">(321,808</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190701__20191231_zwRKMI0F1QHc" style="width: 14%; text-align: right" title="Local">(279,476</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">- Foreign &#8211; Malaysia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--MY_z8DHaO1U1e1b" style="text-align: right" title="Foreign">1,070,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--MY_z2ccxqkYJEW" style="text-align: right" title="Foreign">38,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20191231__srt--StatementGeographicalAxis__country--MY_zobkAtiHFhvl" style="text-align: right" title="Foreign">(4,174</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">- Foreign &#8211; Hong Kong</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--HK_zNrOkR70FeM7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">180,700</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--HK_z1s8Szjpg7t5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(439,909</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20201231__srt--StatementGeographicalAxis__country--HK_z8y2iKDnG2Y5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(55,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Income (loss) before income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200701__20201231_zNiGYHtEI5Gf" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">516,347</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190101__20191231_zSnEzu3f7kej" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(723,092</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190701__20191231_zizxBk9Aaz7" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(338,931</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

<p id="xdx_8A7_zTgOP7hJyX27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>16.
INCOME TAXES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZzlmXh1kM57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
(provision for) benefit of income taxes consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BB_zaJwBfXd0tdi" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAX</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_zD6DHwvcDqLh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20190101__20191231_zI6zvqNvPTtl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20190701__20191231_zwmyScxi2la5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Years Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, </b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, </b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Current:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maT001_zNzWsoAppUkf" style="vertical-align: bottom; background-color: White">
    <td>- U.S.</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1511">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1513">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--CurrentForeignTaxExpenseBenefit_maT001_zuanHqQMqwol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%">- Foreign</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">16,748</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">6,965</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1517">&#160;</span></td><td style="width: 14%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maT001_zYRHFL9aXLi4" style="vertical-align: bottom; background-color: White">
    <td>- U.S.</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1519">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1520">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1521">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_maT001_zPBavMQDeND9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">- Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(178,329</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1524">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1525">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OtherIncomeTaxExpenseBenefitContinuingOperations_iT_pp0p0_mtT001_zK2qRy7RU0Vh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">(Provision for) benefit of income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(161,581</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,965</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1529">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_zPYMD8FzKtwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply
a broad range of income taxes rates. The Company and its subsidiary that operate in various countries: United States, Malaysia
(including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>United
States of America</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a
corporate tax rate of <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zqPvD1NpFJy3" title="Tax percentage">21</span>% on its taxable income. Agape ATP Corporation also subject to controlled foreign corporations Subpart
F income (&#8220;Subpart F&#8221;) tax, which is a tax primarily on passive income from controlled foreign corporations with a
tax rate of <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zbf14BFFp1q8">35</span>%. <span id="xdx_90F_eus-gaap--TaxCutsAndJobsActOf2017OtherTaxEffectDescription_c20200101__20201231_zq1kTGRUqTlc" title="Tax rate description">In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#8220;GILTI&#8221;) tax,
which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted
tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be
no U.S. corporate tax after the 80% foreign tax credits are applied.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, the Company&#8217;s foreign subsidiaries generated approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_c20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zZyzsvkfWxFl" title="Cumulative net operating loss">636,000</span> taxable income that
are subject to Subpart F tax and GILTI tax. The Company has fully utilized approximately $636,000 NOL resulted in tax benefit
of approximately $<span id="xdx_90D_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zhdwQ3W4Vew4" title="Tax benefit">134,000</span> for the year ended December 31, 2020. The Company did not generate any foreign taxable incomes subject
to GILTI tax for the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020 and 2019, the operations in the United States of America incurred approximately $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zJiaeiSW1rag">313,000</span> and $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_zanBhPaqvpvg">213,000</span>, respectively,
of cumulative net operating losses (&#8220;NOL&#8221;) which can be carried forward to offset future taxable income. Approximately
$<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231_zVVmwk283852" title="Cumulative net operating loss">10,000</span> and $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementScenarioAxis__custom--IfUnutilizedMember_zie3NhvktQae" title="Cumulative net operating loss">24,000</span> of the net operating loss carry forwards will expire in <span id="xdx_909_ecustom--OperatingLossCarryforwardsExpireYear_c20200101__20201231_zII9UGrOWbW2" title="Operating loss carryforwards expire year">2027</span> and <span id="xdx_905_ecustom--OperatingLossCarryforwardsExpireYear_c20200101__20201231__srt--StatementScenarioAxis__custom--IfUnutilizedMember_zujy84OOAbI7" title="Operating loss carryforwards expire year">2028</span>, respectively, if unutilized. The remaining
balance can be carried forward indefinitely. The deferred tax valuation allowance as of December 31, 2020 and 2019 were approximately
$<span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zC6BUtNr4JC3">66,000</span> and $<span id="xdx_901_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_zgocDCTQ7lAd">43,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Malaysia</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Changes
to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies
incorporated in Labuan to satisfy the &#8220;substantial activity requirements&#8221; to qualify for the preferential tax rate
of <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zwDl0Nju5Hn4">3</span>% on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to
the &#8220;substantial activity requirements&#8221; was issued. As Agape ATP Corporation does not maintain a permanent establishment
in Labuan, the company is subject to tax at <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zIr2d2qfJMU">24</span>% on its net audited profit until such a time it satisfies the said requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>16.
INCOME TAXES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape Superior Living Sdn Bhd, Agape S.E.A
Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of Malaysia and the income
taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for
the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia,
enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential
tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. <span id="xdx_903_eus-gaap--IncomeTaxExaminationDescription_c20200101__20201231__srt--StatementGeographicalAxis__country--MY_zIwBbOtvGT9" title="Income tax examination, description">The tax rate for small and medium sized companies
(generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20200101__20200930__srt--StatementGeographicalAxis__country--MY_zh5B4oAbw7mb">17</span>% for the first RM 600,000 (or
approximately $150,000) for the year ended December 31, 2020 and RM 500,000 (or approximately $125,000) income for the six months
and year ended December 31, 2019, with the remaining balance being taxed at the 24% rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Hong
Kong</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape
ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20200101__20200930__srt--StatementGeographicalAxis__country--HK_zf09SVilgtA3">16.5</span>%
on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative
Region is not subject to Hong Kong Profits Tax or deduction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEAzprvvHdU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following table reconciles the local (United States) statutory rates to the Company&#8217;s effective tax rate for the periods
indicated below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BF_zeZVObx6bE45" style="display: none">SCHEDULE
OF EFFECTIVE INCOME TAX RATE</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_z2LUThGO9pX3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20190101__20191231_zqefyfFlCde3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20190701__20191231_zoZxbSfxdmy4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zYrcqMCNs3y2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">U.S. statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">21.0</td><td style="width: 2%; text-align: left">%</td>
    <td style="width: 2%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zUDvgK3s1zOk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.0</td><td style="text-align: left">)%</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21.0</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21.0</td><td style="text-align: left">)%</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zAeXx6M7YG5j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Differential tax rate in Malaysia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.0</td><td style="text-align: left">%</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
<tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zIARBUE7U4B2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Permanent difference</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td>
    <td><span id="xdx_F20_zT9QkwNsyW1l">(1)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
<tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zZQx711LpOPg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">31.3</td><td style="padding-bottom: 2.5pt; text-align: left">%</td>
    <td>&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F06_zgsLTy4F7EQ4" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zXaXzpsaKd02" style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z1QPXtoePgJ3">10.2</span>%
    represents expenses incurred in AATP US that were not deductible in the Malaysia tax returns. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zUDthHbwpCje">0.2</span>% represents income derived
    in AATP HK that were not taxable in the Malaysia tax returns. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPCorporationMember_z3D4IBRUFkVf">1.3</span>% represents expenses incurred in AATP LB, ASL, SEA and WATP
    that are not deductible in the Malaysia tax returns.</span></td></tr>
</table>
<p id="xdx_8A8_zqNFulgTQqh9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zf0HvgM0jQhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BD_zb3y3VE0XPpb" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carry forwards in U.S.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_z5AvvsjS2uRb" style="width: 16%; text-align: right" title="Net operating loss carry forwards">65,648</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_z8HZFVzogH47" style="width: 16%; text-align: right" title="Net operating loss carry forwards">43,410</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net operating loss carry forwards in Malaysia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zFY1Y79uMQ51" style="text-align: right" title="Net operating loss carry forwards">62,678</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--MY_zpzUY7FM83X8" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl1592">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Less: valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20201231_z22U98ovv5Qa" style="text-align: right" title="Less: valuation allowance">(65,648</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20191231_zMjGpQbIvrwh" style="text-align: right" title="Less: valuation allowance">(43,410</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20201231_zLyiBjT1QLUl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation">(68,421</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20191231_zPW4RQ9OQzQ" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation"><span style="-sec-ix-hidden: xdx2ixbrl1600">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax liabilities, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20201231_zADFxmeWLTEf" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net">(5,743</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20191231_zZyr63qsTkQe" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net"><span style="-sec-ix-hidden: xdx2ixbrl1604">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A6_zOwMSvdvAGga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Uncertain
tax positions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical
merits, and measure the unrecognized benefits associated with the tax positions. As of December 31, 2020, and 2019, the Company
did not have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the
years ended December 31, 2020 and 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826591083336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS OF RISKS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CONCENTRATIONS OF RISKS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zbkrV1KCtADh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>17.
<span id="xdx_823_zAt7kXK20Dbb">CONCENTRATIONS OF RISKS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(a)
Major customers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, no customer accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__srt--RangeAxis__srt--MaximumMember_zCxflu3X4r72" title="Concentrations of risk percentage">10</span>% or more of the Company&#8217;s total revenues. For the year ended
December 31, 2019, one related party customer accounted for approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zAgmBPDu5pJ4" title="Concentrations of risk percentage">98.3</span>% of the Company&#8217;s total revenues. For the
six months ended December 31, 2019, one related party customer accounted for approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20190701__20191231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_znA30cHspN7f" title="Concentrations of risk percentage">100.0</span>% of the Company&#8217;s total
revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, receivables from a third-party e-commerce company accounted for approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember_z8bVgR90w4Bb" title="Concentrations of risk percentage">100.0</span>% of the total balance
of accounts receivable. As of December 31, 2019, one related party customer accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember_zd50vNTJDeW8" title="Concentrations of risk percentage">100.0</span>% of the total balance of accounts
receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(b)
Major vendors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, two vendors accounted for approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember_zlP8f3gWp1e7" title="Concentrations of risk percentage">74.1</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorTwoMember_zJ0GXrckJKsa" title="Concentrations of risk percentage">25.9</span>% of the Company&#8217;s
total purchases. In November and December 2020, the Company received dividend of <span id="xdx_903_eus-gaap--ProceedsFromDividendsReceived_c20201101__20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zz0hDNXu2W3" title="Dividend received"><span id="xdx_909_eus-gaap--ProceedsFromDividendsReceived_c20201201__20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zR70pNNpRn6c" title="ividend received">23,330</span></span> shares of common stock of DSwiss, Inc.,
represents approximately <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zBvDHfJQ1LM8" title="Ownership percentage"><span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zGMg3DOSTRQe" title="Ownership percentage">0.01</span></span>% ownership that the Company accounted for as investment in marketable securities (See Note 11).
Dswiss, Inc.&#8217;s wholly owned subsidiary is the vendor that accounted for the Company&#8217;s total purchases of <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember_zrP4pAdGUej3" title="Concentrations of risk percentage">74.1</span>%
for the year ended December 31, 2020. For the year ended December 31, 2019, two vendors accounted for approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--VendorOneMember_ztfyHLBHx32h" title="Concentrations of risk percentage">60.1</span>%
and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--VendorTwoMember_zjbGAlwKecXl" title="Concentrations of risk percentage">39.9</span>% of the Company&#8217;s total purchases, respectively. For the six months ended December 31, 2019, two vendors accounted
for approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190701__20191231__srt--MajorCustomersAxis__custom--VendorOneMember_zsdOjrC9ed3c" title="Concentrations of risk percentage">59</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190701__20191231__srt--MajorCustomersAxis__custom--VendorTwoMember_zdRTPuIWr6h8" title="Concentrations of risk percentage">41</span>% of the Company&#8217;s total purchases, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
are no accounts payable balance as of December 31, 2020. As of December 31, 2019, one vendor accounted for <span id="xdx_900_ecustom--CommissionExpensePercentage_iI_pii_dp_uPure_c20200930_zzdGrZyjH4nh">100</span>% of the total balance
of accounts payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(c)
Commission Expenses to Sales Distributors and Stockists</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, no sales distributor accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--NoSalesMember__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--AccountsPayableMember_z2HnfHSjjSO4" title="Concentrations of risk percentage">10</span>% or more of the Company&#8217;s total commission expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(d)
Credit risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of
December 31, 2020, and 2019, $<span id="xdx_909_eus-gaap--Cash_iI_pp0p0_c20201231_zhCG3VcFeWvf" title="Cash in bank">1,112,147</span> and $<span id="xdx_905_eus-gaap--Cash_iI_pp0p0_c20191231_z7AwyJXEDqHl" title="Cash in bank">238,937</span> were deposited with financial institutions, respectively, $<span id="xdx_905_ecustom--DepositForInsurance_iI_pp0p0_c20201231_zUp51WqJy7U6" title="Deposit for insurance">563,788</span> and $<span id="xdx_909_ecustom--DepositForInsurance_iI_pp0p0_c20191231_z8YLSL9jy6Eh" title="Deposit for insurance">0</span>
of these balances are not covered by deposit insurance. While management believes that these financial institutions are of high
credit quality, it also continually monitors their credit worthiness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration
of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short
collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance
for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.
Historically, the Company did not have any bad debt on its account receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(e)
Exchange rate risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company
could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher
or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending
on changes in political and economic environments without notice.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503704456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXf5ZCxr0qQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>18.
<span id="xdx_82D_zqcH7gf1mJDh">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Lease
commitments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
April 1, 2020, the Company adopted ASC 842 for ASL&#8217;s office space lease and sales and training center as the lease commencement
date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z6Fb0mkbrjQc" title="Operating lease liability">506,000</span>, with a corresponding right-of-use
(&#8220;ROU&#8221;) asset in the same amount based on the present value of the future minimum rental payments of the lease, using
an effective interest rate of <span id="xdx_902_ecustom--OperatingLeaseEffectiveInterestRate_pii_dp_uPure_c20200328__20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zz0ARfe0u7J6" title="Operating lease effective interest rate">5.5</span>%, which was determined using the Company&#8217;s estimated incremental borrowing rate. The weighted
remaining term of the lease is approximately <span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zUxbIB3hk94d" title="Operating lease, weighted average remaining lease term">2.54</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zCzu5t3UQQJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
five-year maturity of the Company&#8217;s operating lease liabilities is as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BB_zfgyqg8maSpf" style="display: none">SCHEDULE OF LEASE COMMITMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Twelve Months Ending <br/> December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20201231_zbY0IDU060v" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Operating lease liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pp0p0_maLOLLPzA1T_zUlquhdIPMt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">172,191</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pp0p0_maLOLLPzA1T_zKOdfViEmfGj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,890</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pp0p0_maLOLLPzA1T_zMf0Qco3soI5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,259</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree_iI_pp0p0_maLOLLPzA1T_zfRziMeJGucg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1667">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_z5JPOW73pBOg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">424,340</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zH0SQNpx9GDb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,576</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">395,764</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A4_za8pLjqkP6k8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also leases one distribution center and one employee apartments with an expiring term of twelve months or fewer, which
were classified as operating leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy
election not to recognize lease assets and liabilities. The Company selected not to recognize lease assets and liabilities on
these leases. As of December 31, 2020, the Company&#8217;s commitment for minimum lease payments under these operating leases
within the next twelve months are $<span id="xdx_902_eus-gaap--OperatingLeasePayments_pp0p0_c20200101__20201231_zwVYYjsPFrId" title="Operating lease payments">4,654</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Rent
expense for the years ended December 31, 2020 and 2019 was $<span id="xdx_900_eus-gaap--OperatingLeaseExpense_pp0p0_c20200101__20201231_zhkZVxa7Xn26" title="Operating lease, rent expenses">156,716</span> and $<span id="xdx_90E_eus-gaap--OperatingLeaseExpense_pp0p0_c20190101__20191231_z5lcKGfHgO63" title="Operating lease, rent expenses">53,594</span> (unaudited), respectively. Rent expense for the
six months ended December 31, 2019 $<span id="xdx_909_eus-gaap--OperatingLeaseExpense_pp0p0_c20190701__20191231_zTFxOEcsfuyk" title="Operating lease, rent expenses">26,828</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Purchase
commitments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_894_ecustom--ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_zdKVC0IHN3Jd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2020 for the next five years
and thereafter is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B6_zzRVdmpgOzH9" style="display: none">SCHEDULE OF PURCHASE COMMITMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Twelve months ending December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20201231_ziPu6rpTeRxg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Minimum</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>purchase</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PurchaseObligationDueInNextTwelveMonths_iI_pp0p0_maPOzUwc_maPOzKX0_zWrgNorC9p6k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">693,900</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PurchaseObligationDueInSecondYear_iI_pp0p0_maPOzUwc_maPOzKX0_zP0w9gmHD6Zi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,900</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PurchaseObligationDueInThirdYear_iI_pp0p0_maPOzUwc_maPOzKX0_z1GunGTuSvke" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,900</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PurchaseObligationDueInFourthYear_iI_pp0p0_maPOzUwc_maPOzKX0_z4TF3eTpWShf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,900</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--PurchaseObligationDueInFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zsttNJWCmGK4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,900</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--PurchaseObligationDueAfterFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zPJksXkizzrl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,387,800</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PurchaseObligation_iTI_pp0p0_mtPOzUwc_mtPOzKX0_zXi4Wnssa8h2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total minimum purchase commitments required</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,857,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A2_zLA9ZkYwzEcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of the date of this report, the Company&#8217;s vendor is not able to meet the Company&#8217;s minimum purchase commitment of
the health and wellness products due to the manufacturing process was being delayed by its vendor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>18.
COMMITMENTS AND CONTINGENCIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Contingencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Legal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued,
as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are
not deemed to be material to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>COVID-19</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Since
the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Malaysia
has been put through various stages of lockdowns such as (1) full movement control orders (&#8220;MCO&#8221;), under which, quarantines,
travel restrictions, and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to
a Conditional Movement Control Order (&#8220;CMCO&#8221;) where most business sectors were allowed to operate under strict rules
and Standard Operating Procedures mandated by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement
Control Order (&#8220;RMCO&#8221;). On January 12, 2021, due to a resurgence of COVID-19 cases, the Malaysian government declared
a state of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the
country. February 2021 marked a significant month for Malaysia as all frontline staff of the country, which comprised those in
healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department of Malaysia and civil defence sectors
were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that a National COVID-19 Immunisation
Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will be vaccinated to achieve
herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO. As at the date of this report,
over 450,000 doses of the COVID-19 vaccines have been administered in the country.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Substantially
all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be
materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general.
Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge
regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain
the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to,
the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">temporary
    closure of offices, travel restrictions, financial impact of the Company&#8217;s customers or suspension supplies may negatively
    affected, and could continue to negatively affect, the demand for the Company&#8217;s product;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially
    adversely affect its financial condition and operating results; and</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">any
disruption of the Company&#8217;s supply chain, logistics providers or customers could adversely impact its business and results
of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay
delivery to its customers, which may also lead to loss of its customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Because
of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19
cannot be reasonably estimated at this time. There is no guarantee that the Company&#8217;s total revenues will grow or remain
at the similar level year over year in 2021.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581574008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zF2Ajqoa7KDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>19.
<span id="xdx_820_z1kNJp80P2vc">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">On
January 25, 2021, the Company and the shareholders (the &#8220;Sellers&#8221;) of DSY Wellness &amp; Longevity Center Sdn. Bhd.
and DSY Medical Education Sdn. Bhd. entered into a non-binding Letter of Intent (&#8220;LOI&#8221;) for the acquisition of <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210125__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SellersMember_zu5NZ1j4krW7" title="Ownership percentage">51</span>%
of the issued and outstanding capital stock of DSY Wellness &amp; Longevity Center Sdn. Bhd. and DSY Medical Education Sdn. Bhd.
(the &#8220;Target Shares&#8221;). After execution of this LOI, both parties shall proceed in good faith to complete the negotiation
and execution of the definitive transaction documents. Subject to the terms and conditions of the definitive transaction documents,
the Company will issue and allot its common stock to the Sellers and the Company will purchase the Target Shares. Except for the
provisions with regards to confidentiality, term of validity, no binding agreement, applicable law and arbitration, and miscellaneous,
the LOI is not legally binding on the parties. Any conclusion of definitive transaction documents by the Company related to such
transaction will be subject to the approval of the Board of Directors or other approval requirements, if applicable. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">On
February 1, 2021, </span><span style="font: 10pt Times New Roman, Times, Serif">Mr. How Kok Choong, the CEO
and director of the Company, is appointed as the non-executive Chairman of <span style="background-color: white">Vettons Sdn Bhd.
(&#8220;Vettons&#8221;),</span> an e-commerce company. As of December 31, 2020, the Company has accounts receivable of
$<span id="xdx_90B_eus-gaap--AccountsReceivableNetCurrent_iI_c20191231__dei--LegalEntityAxis__custom--VettonsSdnBhdMember_zBRAYs2ZHE05">172,757
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from Vettons, representing <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20190101__20191231__dei--LegalEntityAxis__custom--VettonsSdnBhdMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zvqNsJplCXac">100</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of our accounts receivable.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826580947000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTR730J0sFY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_z54tMmhMAiUd">Basis
of presentation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;U.S. GAAP&#8221;) for information pursuant to the rules and regulations of the Securities
Exchange Commission (&#8220;SEC&#8221;), and include all normal and recurring adjustments that management of the Company considers
necessary for a fair presentation of its financial position and operation results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Change of year end</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--FiscalPeriod_zSP00q8ovKre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_zyIC7gncKQbh">Change
of year end</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements
consist of the unaudited financial data for the year ended December 31, 2019, which was derived from the six months audited financial
statement ended December 31, 2019 and the interim financial statements for the six months ended June 30, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zVLcAFfvvIRg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zbx6oyc4Ivu7">Principles
of consolidation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the
Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the
primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power
to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or
to cast a majority of votes at the meeting of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities
without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial
interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb
the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is
deemed to be the primary beneficiary and must consolidate the VIE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><p id="xdx_840_eus-gaap--UseOfEstimates_zRBqtC1y0Rv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_zPD3JoKOtab9">Use
of estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date
of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant
accounting estimates reflected in the Company&#8217;s consolidated financial statements include allowance for doubtful accounts,
allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment
of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain
tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbLw5TKDzyQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_zKxM6jyQ5jj9">Cash
and cash equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash
and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts receivable and accounts receivable &#8211; related party</a></td>
<td class="text"><p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_z0Jaog9bxWZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zOgNmcedxnV3">Accounts
receivable and accounts receivable &#8211; related party</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
receivable and accounts receivable &#8211; related party are recorded at the invoiced amount less an allowance for any uncollectible
accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party
e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy
of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management
also periodically evaluates individual customer&#8217;s financial condition, credit history, and the current economic conditions
to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after
all means of collection have been exhausted and the potential for recovery is considered remote. The Company&#8217;s management
continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020,
and 2019, <span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20201231_zhC0gLzsxXaj" title="Accounts Receivable, Allowance for Credit Loss"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20191231_zv9vq6cJfZ8l" title="Accounts Receivable, Allowance for Credit Loss">no</span></span> valuation allowance was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_845_eus-gaap--InventoryPolicyTextBlock_zFUs7n4p67jl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zhkqYvzJeVla">Inventories</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories
consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management
reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the
shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs
exceed expected net realizable value. As of December 31, 2020, and 2019, there are <span id="xdx_907_eus-gaap--InventoryWriteDown_do_c20200101__20201231_zgienrIUaYU3" title="Inventories write-down"><span id="xdx_90F_eus-gaap--InventoryWriteDown_do_c20190101__20191231_zCBCKFGkFpra" title="Inventories write-down">no</span></span> inventories obsolescence reserves or write-downs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrepaidTaxesPolicyTextBlock', window );">Prepaid taxes</a></td>
<td class="text"><p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zMxG7BcYUaua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_z4xaDU4cq9U6">Prepaid
taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid
taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income taxes; and (ii)
goods and service tax (&#8220;GST&#8221;) that is refundable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrepaymentsAndDepositsPolicyTextBlock', window );">Prepayments and deposits</a></td>
<td class="text"><p id="xdx_847_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zeanCKKuhxQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_z4eTCa0GrNNg">Prepayments
and deposits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepayments
and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future
services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such
advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve
such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and
adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after
management has determined that the likelihood of collection is not probable. The Company&#8217;s management continues to evaluate
the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2020, and 2019, there is <span id="xdx_90C_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zOoBOydnluek" title="Allowance for doubtful accounts"><span id="xdx_90D_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20191231_zRwZ81dNopmh" title="Allowance for doubtful accounts">no</span></span>
allowance for the doubtful accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment, net</a></td>
<td class="text"><p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zK7TBn5YOKXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zZcACYTGoD01">Property
and equipment, net</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zzNtF6aagGc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the
estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BC_zCdmNN6YMpGb" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Useful Life</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Computer and office equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 22%; text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_z2fLK85JSku7" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zI6pu4GZoBA2" title="Estimated Useful Life of Property and Equipment">7</span> years</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Furniture &amp; fixtures</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zdgC0gag3g19" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zaHBwcU8J9Jc" title="Estimated Useful Life of Property and Equipment">7</span> years</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment">Lease Term</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Vehicle</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z0izDTxWgvE4" title="Estimated Useful Life of Property and Equipment">5</span> years</td></tr>
</table>

<p id="xdx_8AD_zW3Hoia0BIpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or
loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are
charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets,
are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances
warrant revised estimates of useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible assets, net</a></td>
<td class="text"><p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zxdQBUFNGlb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_z2GCRI0OOo6d">Intangible
assets, net</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_z1SSSWOPprD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis
over the estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B2_zMvUZJ1WVh22" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; width: 76%; font-weight: bold">Classification</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 22%; font-weight: bold; text-align: center">Useful Life</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer software</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z1HaoclfKPk6" title="Estimated useful lives of intangible assets">5</span> years</td></tr>
</table>

<p id="xdx_8A2_z7ZQgvLZEmOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment for long-lived assets</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zBSVMRjM1ak8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zq8BxyvJZtB">Impairment
for long-lived assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Long-lived
assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events
or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the
assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets
based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated
undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the
asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying
amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate,
to comparable market values. As of December 31, 2020 and 2019, <span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zwNmJYhcW2n4"><span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20190101__20191231_zZK7SYlBBL8l" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets was recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred offering costs</a></td>
<td class="text"><p id="xdx_849_eus-gaap--DeferredChargesPolicyTextBlock_zcLFnJGYqLHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_z6CuZBHv5W6j">Deferred
offering costs</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred
offering costs represents costs associated with the Company&#8217;s current offering which will be netted against the proceeds
from the Company&#8217;s current offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investment in marketable equity securities</a></td>
<td class="text"><p id="xdx_841_eus-gaap--MarketableSecuritiesPolicy_zI3AAPKbqZS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_zNNH4dr7Jbqf">Investment
in marketable equity securities</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the
lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market
in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost
less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities
are based on the average cost of all the units of a particular security held at the time of sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair
value with changes in fair value recognized in the Company&#8217;s consolidated statements of operations and comprehensive loss
in the caption of &#8220;unrealized holding gain (loss) on marketable securities&#8221; in each reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NonMarketableSecuritiesPolicyTextBlock', window );">Investment in non-marketable equity securities</a></td>
<td class="text"><p id="xdx_847_ecustom--NonMarketableSecuritiesPolicyTextBlock_zFnz2dhNrF4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zfsCIrUIPHYc">Investment
in non-marketable equity securities</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline
in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average
cost of all the units of a particular security held at the time of sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments &#8211; Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities</i>. Due to the Company&#8217;s non-marketable equity securities (non-current) does
not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to
record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes
resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At
each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the
investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration
in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change
in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market
condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase,
an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the
carrying amount of that investment; and (v) Factors that raise significant concerns about the investee&#8217;s ability to continue
as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory
capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities
(non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair
value of the investment and its carrying amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Customer deposits</a></td>
<td class="text"><p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zW3IYvpz4Alg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zMogr6vZHbe2">Customer
deposits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Customer
deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits
are reduced when the related sale is recognized in accordance with the Company&#8217;s revenue recognition policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zX0QGKJuKWG2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zxOAHW8oJxf">Revenue
recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers
(ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not
result in an adjustment to retained earnings upon adoption of this new guidance as the Company&#8217;s revenue was recognized
based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer
of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in
such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should
be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company&#8217;s
revenue streams are recognized at a point in time for the Company&#8217;s sale of health and wellness products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that
the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine
the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will
not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue
when (or as) the Company satisfies the performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including
payment terms, are identified, the contract has commercial substance and consideration is probable of substantial collection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior
to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive
evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability
is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred
and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted
by the customer when the products are collected by the customer at the Company&#8217;s office. Revenue is recorded net of sales
discounts, returns, allowances, and other adjustments that are based upon management&#8217;s best estimates and historical experience
and are provided for in the same period as the related revenues are recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes
in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy
for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance
and confirmed that there were no differences in the pattern of revenue recognition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sales
of Health and Wellness products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control
of the health and wellness products are transferred to its customer at the Company&#8217;s office or shipment of the goods, which
is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after
all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products
are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the
value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash
proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction
of the health and wellness products transaction price upon such sales transactions occurred. The Company&#8217;s coupons have
a validity period of six months. If the Company&#8217;s customers did not utilize the coupons after six months, the Company would
recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2020 and
2019, the Company recognized $<span id="xdx_90A_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zSpzJ5ZUN80k">170,431</span>
</span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90D_ecustom--ForfeitedCouponIncome_pp0p0_c20190101__20191231_zZYzEUhVIhl2">0
</span></span><span style="font: 10pt Times New Roman, Times, Serif">(unaudited) as forfeited coupon income.
The Company did not earn any forfeited coupon income for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_90B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200930__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_zOuTiSsaJJte" title="Revenue from sales">116,541</span> which it is
expected to fulfill within 12 months from December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zdBXrjHSlYo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Disaggregated
information of revenues by products are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B6_zChGSZN39qXj" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Survivor Select</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues">149,897</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0728">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Energized Mineral Concentrate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">81,481</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">238,687</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">100,270</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ionized Cal-Mag</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues">908,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues">55,718</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Omega Blend</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">495,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">137,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">68,927</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>BetaMaxx</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues">156,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues">191,246</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues">67,789</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vege Fruit Fiber</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zbzRbBa2R2xc" style="text-align: right" title="Total revenues">1,755</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zLCVyk32GXBd" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_z4tlviO1VJ3g" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Iron</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--IronMember_zKjsOyTnGL43" style="text-align: right" title="Total revenues">133,389</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--IronMember_z6jB8K3wD1ig" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--IronMember_zG3y9qjsS042" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0766">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Young Formula</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zCbbACpUD5tb" style="text-align: right" title="Total revenues">653,631</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zFBXDDEWNjg3" style="text-align: right" title="Total revenues">117,453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zuNHdbx356e3" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Organic Youth Care Cleansing Bar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z3nhg4lmHW9i" style="text-align: right" title="Total revenues">43,127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zI6wcZke4M15" style="text-align: right" title="Total revenues">34,917</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190701__20191213__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z6WIp5pTOix9" style="text-align: right" title="Total revenues">17,206</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Mitogize</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--MitogizeMember_zAreAMX1Mll1" style="text-align: right" title="Total revenues">162,801</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_z1oN5ObLMhp6" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0782">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_zEq44msPTLtj" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">No. 1 MED</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zlSLsCJQhFf4" style="text-align: right" title="Total revenues">46,713</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zKbFGZRdyAah" style="text-align: right" title="Total revenues">140,733</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_z0CCGwlOHMSj" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0790">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Energetique</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zv5rChZ4rlC" style="text-align: right" title="Total revenues">253,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zRM3mj7XNsG2" style="text-align: right" title="Total revenues">174,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zLNcmrig4WE4" style="text-align: right" title="Total revenues">175,170</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trim+</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20200101__20201213__srt--ProductOrServiceAxis__custom--TrimPlusMember_zcYOBTSyddxf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">365,350</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zesbMf6lJCz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">198,817</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zCH8cGDMuRvd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20200101__20201231_zx6ORyFHQ275" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">3,452,621</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20190101__20191231_z2fnVT2bi9k7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">1,290,131</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231_zW7lnu0jfNDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">429,362</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AE_zI3PvwI53Oug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sales
of Health and Wellness services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-
<i>Performance obligations satisfied at a point in time</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company carries out its Wellness program, where the Company&#8217;s products are bundled with health screening test and a health
camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises
to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced
by the fact that the Company provides separate services of delivering the health screening test report and allowing admission
of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues
being recognized when the test reports are completed and delivered to its customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health
camp program was completed in the final day of the health camp. For the year ended December 31, 2020, revenues from health and
wellness services are immaterial to the Company&#8217;s consolidated statements of operations and comprehensive income (loss).
The Company did not earn any revenues from health and wellness services for the year ended December 31, 2019 and for the six months
ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of revenue</a></td>
<td class="text"><p id="xdx_846_eus-gaap--CostOfSalesPolicyTextBlock_zkmmRRTDgpw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zLrxsIRymsf8">Cost
of revenue</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ShippingAndHandlingPolicyTextBlock', window );">Shipping and handling</a></td>
<td class="text"><p id="xdx_84F_ecustom--ShippingAndHandlingPolicyTextBlock_zV3CavKT9Hd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zqQ4fr4fML5i">Shipping
and handling</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Shipping
and handling charges amounted to $<span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zVbxLjvziDP1" title="Selling expenses">9,315</span> and $<span id="xdx_90C_eus-gaap--SellingExpense_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjMBI1nTDuI3" title="Selling expenses">0</span> for the years ended December 31, 2020 and 2019, respectively. There was <span id="xdx_90D_eus-gaap--SellingExpense_pp0p0_do_c20190701__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zWv6ZSIDlnKd" title="Selling expenses"><span title="Selling expenses">no</span></span> shipping
and handling charges for the six months ended December 31, 2019. Shipping and handling charges are expensed as incurred and included
in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising costs</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zpdnyKbHw8d6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zmLmRIvrcX3">Advertising
costs</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Advertising
costs amounted to $<span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zMIxf7tBpael" title="Advertising costs">14,339</span> and $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20190101__20191231_zogSdieAsnse" title="Advertising costs">0</span> for the years ended December 31, 2020 and 2019, respectively. There were <span id="xdx_90B_eus-gaap--AdvertisingExpense_pp0p0_do_c20190701__20191231_zwKpGThdHrBc" title="Advertising costs">no</span> advertising costs
for the six months ended December 31, 2019. Advertising costs are expensed as incurred and included in selling expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommissionsExpensePolicyPolicyTextBlock', window );">Commission expenses</a></td>
<td class="text"><p id="xdx_843_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zEVKxBI3luP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_869_zSWBTGgQNpD7">Commission
expenses</span> </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Commission
expenses are the Company&#8217;s most significant expenses. As with all companies in the network marketing industry, the Company&#8217;s
sales channel is external to the Company. The Company&#8217;s &#8220;external sales force&#8221; is stratified into two levels
based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly
or indirectly, are referred to as &#8220;sales network members&#8221;. The Company pays commission to every sales distributor
based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors
with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain
amount of the Company&#8217;s inventory on their store premises. The stockists shall account to the Company for all products sales
from their store premises as monitored through the Company&#8217;s centralized stock tracking system. The Company pays a separate
commission to stockists based on revenue generated from the stockists&#8217; physical stores. Commission expenses amounted to
$<span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zYQ1YXb97Ey3" title="Commission expenses">830,659</span> and $<span id="xdx_903_ecustom--SalesCommissionsAndFees1_pp0p0_c20190101__20191231_zjJUkqSIcuPb" title="Commission expenses">0</span> (unaudited) for the years ended December 31, 2020 and 2019, respectively. There were <span id="xdx_90A_ecustom--SalesCommissionsAndFees1_pp0p0_do_c20190701__20191231_zqAGdQTEnrhk" title="Commission expenses">no</span> commission expenses for
the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DefinedContributionPlanPolicyTextBlock', window );">Defined contribution plan</a></td>
<td class="text"><p id="xdx_840_ecustom--DefinedContributionPlanPolicyTextBlock_zdnbUAp30fci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_86E_zoaAjV6PLZll">Defined
contribution plan</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required
to accrue and pay for these benefits based on certain percentages of the employees&#8217; respective salaries, subject to certain
ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined
contribution plan. Total expenses for the plans were $<span id="xdx_909_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_zcD48OUBTDU4" title="Defined contribution plan expense">75,802</span> and $<span id="xdx_901_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20190101__20191231_zScVmBNzRsja" title="Defined contribution plan expense">0</span> (unaudited) for the years ended December 31, 2020 and 2019,
respectively. There was <span id="xdx_903_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_do_c20190701__20191231_zwB25uwSjDv9" title="Defined contribution plan expense">no</span> defined contribution plan expenses for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
related contribution plans include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Social
    Security Organization (&#8220;SOSCO&#8221;) &#8211; <span id="xdx_904_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_zzJ1kUxA3Xde" title="Salary percentage">1.75%</span> based on employee&#8217;s monthly salary capped of RM <span id="xdx_90D_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_z5twycUgm4b7" title="Monthly salary">4,000</span>;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employees
    Provident Fund (&#8220;EPF&#8221;) &#8211; <span id="xdx_90F_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_z3vJooMIJuo2" title="Salary percentage">12%</span> based on employee&#8217;s monthly salary;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employment
    Insurance System (&#8220;EIS&#8221;) &#8211; <span id="xdx_907_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zObQ2Bc6Cqgf" title="Salary percentage">0.2%</span> based on employee&#8217;s monthly salary capped of RM <span id="xdx_906_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zgTOp9GhUnFd" title="Monthly salary">4,000</span>;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Human
    Resource Development Fund (&#8220;HRDF&#8221;) &#8211; <span id="xdx_901_ecustom--SalaryPercentage_pii_dp_uPure_c20200101__20201231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zmGJg8akYI4e" title="Salary percentage">1% </span>based on employee&#8217;s monthly salary</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z26hosMg9bS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zWmm0JwTgGNd">Income
taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results
for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have
been enacted or substantively enacted by the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred
taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between
the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in
the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible
temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when
the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it
is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred
tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion
or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the
relevant taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">An
uncertain tax position is recognized as a benefit only if it is &#8220;more likely than not&#8221; that the tax position would be sustained
in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that
is <span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20200101__20201231_z6btSy8NTCP2">greater than 50%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">likely of being realized on examination. For
tax positions not meeting the &#8220;more likely than not&#8221; test, no tax benefit is recorded. <span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20200101__20201231_zOoWBHJPrM0g"><span id="xdx_900_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190101__20191231_zjL9HeSSY6D9">No</span>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">penalties and interest incurred related to underpayment
of income taxes for the years ended December 31, 2020 and 2019. <span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190701__20191231_zTaFbBkviXke">No
</span></span><span style="font: 10pt Times New Roman, Times, Serif">penalties and interest incurred related to underpayment
of income taxes for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions.
As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign
tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive income (loss)</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zA14L2AXjhr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_z6lDNGskyQyb">Comprehensive
income (loss)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Comprehensive
income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income
(loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders&#8217; equity
but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting
from the Company not using the U.S. dollar as its functional currencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NoncontrollingInterestPolicyTextBlock', window );">Non-controlling interest</a></td>
<td class="text"><p id="xdx_841_ecustom--NoncontrollingInterestPolicyTextBlock_zjA6pTuKrPnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zc3R8KYdMsN9">Non-controlling
interest</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--MinorityInterestDescription_c20200101__20201231_zuFJWaaiUBz1" title="Noncontrolling interest, description">Non-controlling
interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held
by two individuals.</span> The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable
to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated
statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders
and the shareholders of the Company. As of December 31, 2020, the non-controlling interest balance was $<span id="xdx_90A_eus-gaap--MinorityInterest_iI_pp0p0_c20201231_zxduBUXDsSEd" title="Non-controlling interest">0</span> and therefore not presented
in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (loss) per share</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zqg1I9qAHxok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zY3SKCpKKPQ9">Earnings
(loss) per share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company computes earnings (loss) per share (&#8220;EPS&#8221;) in accordance with ASC 260, &#8220;Earnings per Share&#8221;. ASC
260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary
share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares
(e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per
share or decrease loss per share) are excluded from the calculation of diluted EPS. For the years ended December 31, 2020 and
2019, there were <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20200101__20201231_zt4FOglj8Qxe" title="Potentially dilutive securities outstanding"><span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190101__20191231_zYfevg2dAOf8" title="Potentially dilutive securities outstanding">no</span></span> dilutive shares. There was <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190701__20191231_z5THbyxJmJWi" title="Potentially dilutive securities outstanding">no</span> dilutive shares for the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currencies translation and transaction</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOK2vIIGi7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zVe1pPjk2E0j">Foreign
currencies translation and transaction</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates
prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional
currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting
exchange differences are recorded in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have
been expressed in US$. The Company&#8217;s subsidiary in Labuan maintains its books and record in United States Dollars (&#8220;US$&#8221;)
albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the
Malaysian Ringgit (&#8220;MYR&#8221; or &#8220;RM&#8221;). The Company&#8217;s subsidiary in Hong Kong maintains its books and
record in Hong Kong Dollars (&#8220;HK$&#8221;), similar to its functional currency. The Company&#8217;s subsidiary and VIE in
Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (&#8220;MYR&#8221;
or &#8220;RM&#8221;), as its functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated
into US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate
on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses
resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other
comprehensive income within the statements of stockholders&#8217; equity. Cash flows are also translated at average translation
rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the
corresponding balances on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zyv50fNYzHIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BE_zVTTQ0AjlAuj" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Period-end MYR : US$1 exchange rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zVv6l569wlf8" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.02</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zAce32sO6Npd" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.09</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Period-end HKD : US$1 exchange rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zAgNXVkWtTEk" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zfqZH1qQvpu8" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.79</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Period-average MYR : US$1 exchange rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zVetDM7dEnI2" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average">4.20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zjh3pkqYV8fj" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average">4.14</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zgvw3KqrLqk3" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average">4.16</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Period-average HKD : US$1 exchange rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zyaxoZRqmhx6" style="text-align: right" title="Foreign currency exchange rate period average">7.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zI0VUIkx7qu8" style="text-align: right" title="Foreign currency exchange rate period average">7.84</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zzj3XRLLV3va" style="text-align: right" title="Foreign currency exchange rate period average">7.83</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A4_zGqhfLGDdP0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesPolicyTextBlock', window );">Related parties</a></td>
<td class="text"><p id="xdx_840_ecustom--RelatedPartiesPolicyTextBlock_zqNQnty2NCli" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_z9BMJjyThk6j">Related
parties</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly,
to control the other party or exercise significant influence over the other party in making financial and operating decisions.
Companies are also considered to be related if they are subject to common control or common significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zx2nMC08WMI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zg5tdN22eaj1">Fair
value of financial instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments
and requires disclosure of the fair value of financial instruments held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement
and enhance disclosure requirements for fair value measures. The three levels are defined as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs
    that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial
    instruments.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
    3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial
instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or
cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected
realization and their current market rates of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_z0vjk6wQJWw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_zIClplFSvxVi">Leases</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
July 1, 2019, the Company adopted ASU 2016-02, &#8220;Leases&#8221; (Topic 842), and elected the practical expedients that does
not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification
for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve
months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The
Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single
lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing
leases with a lease term in excess of twelve months on July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating
lease right-of-use (&#8220;ROU&#8221;) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the
commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit
rate for the Company&#8217;s leases is not readily determinable, the Company use its incremental borrowing rate based on the information
available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate
of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in
a similar economic environment and over a similar term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Lease
terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate
the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company
generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets.
The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases
with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU
asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company
reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying
value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying
value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected
to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating
lease payments in the undiscounted future pre-tax cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent accounting pronouncements</a></td>
<td class="text"><p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zbXPSSpP046l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_z8bQ1hey9MM3">Recent
accounting pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption
of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations,
as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments&#8212;Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for
the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology.
The amendments in Update 2016-13 added Topic 326, Financial Instruments&#8212;Credit Losses, and made several consequential amendments
to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually
assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial
Instruments&#8212; Credit Losses&#8212;Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders&#8217;
concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at
amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information
by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief
also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement
users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date
of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit
losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December
15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company
is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and
investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and
purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify
that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting
when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting.
With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance
in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the
purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity
method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods
beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this
standard on January 1, 2021 did not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DefinedContributionPlanPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DefinedContributionPlanPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NonMarketableSecuritiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Marketable Securities [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NonMarketableSecuritiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NoncontrollingInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NoncontrollingInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PrepaidTaxesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Taxes [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PrepaidTaxesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PrepaymentsAndDepositsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepayments and Deposits [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PrepaymentsAndDepositsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_RelatedPartiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Parties [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_RelatedPartiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ShippingAndHandlingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shipping and Handling [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ShippingAndHandlingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommissionsExpensePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commissions incurred in relation to revenue generating activities or operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommissionsExpensePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504766568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS BACKGROUND (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock', window );">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zw7f6w0FF1xk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Details
of the Company&#8217;s subsidiaries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_zC1Anlgtow4l" style="display: none">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Subsidiary
company name</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Place
and date of incorporation</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Particulars
    of issued&#160;capital</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Principal
    activities</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Proportional
of ownership interest and voting power held</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">1.
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 22%; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsWZZZ7j67yg" title="Subsidiary company name">Agape
    ATP Corporation</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zMtcK0TU6zG3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Labuan,
    <br/>
    March 6, 2017</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z3r71tizhsc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">100
    shares of ordinary share of US$1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_z9YBdu4Klqee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">Investment
    holding</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zM50Vf4ndZD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; text-align: right" title="Proportional of ownership interest and voting power held"><span style="font: 10pt Times New Roman, Times, Serif">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"/></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">2.
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zpEX8ZyUokbf" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"><span style="font: 10pt Times New Roman, Times, Serif">Agape
    ATP International Holding Limited</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98A_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zPSbyVEVQpBj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Hong
    Kong,<br/>
    June 1, 2017</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zsUJLsURrrG9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">1,000,000
    shares of ordinary share of HK$1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z0N1Jam9s4hh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">Wholesaling
    of health and wellness products; and health solution advisory services</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zfkndXUXijtf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"><span style="font: 10pt Times New Roman, Times, Serif">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"/></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zzCkeJ1IJVm1" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"><span style="font: 10pt Times New Roman, Times, Serif">Agape
    Superior Living Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zmEPx5eMS2Tb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Malaysia,
    <br/>
    August 8, 2003</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zz4J4NcmSjr5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">9,590,598
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zxZjnXi79Ywk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">Health
    and wellness products and health solution advisory services via network marketing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zrL824y99Ggd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"><span style="font: 10pt Times New Roman, Times, Serif">99.99%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zUclFrdr35C6" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"><span style="font: 10pt Times New Roman, Times, Serif">Agape
    S.E.A. Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zxvR5Bced3Fe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Malaysia,
    <br/>
    March 4, 2004</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zwBRJGP5dGle" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">2
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zgBjWf04B1h4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">VIE
    of Agape Superior Living Sdn. Bhd.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">VIE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98E_ecustom--NameOftheCompany_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zZ3aOX5q2Y" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top" title="Subsidiary company name"><span style="font: 10pt Times New Roman, Times, Serif">Wellness
    ATP International Holdings Sdn, Bhd</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zB0NwRqVf5hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Place and date of incorporation"><span style="font: 10pt Times New Roman, Times, Serif">Malaysia,
    <br/>
    September 11, 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--ParticularsOfIssuedCapital_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zVrklIovqUA4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Particulars of issued capital"><span style="font: 10pt Times New Roman, Times, Serif">100
    shares of ordinary share of RM1 each</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zNANzG5166Ml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Principal activities"><span style="font: 10pt Times New Roman, Times, Serif">The
    promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs,
    events and campaigns</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20201231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z3e92NzKLqji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held"><span style="font: 10pt Times New Roman, Times, Serif">100%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"/></td></tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504819224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock', window );">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zzNtF6aagGc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the
estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><span id="xdx_8BC_zCdmNN6YMpGb" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Useful Life</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Computer and office equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 22%; text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_z2fLK85JSku7" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zI6pu4GZoBA2" title="Estimated Useful Life of Property and Equipment">7</span> years</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Furniture &amp; fixtures</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zdgC0gag3g19" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zaHBwcU8J9Jc" title="Estimated Useful Life of Property and Equipment">7</span> years</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment">Lease Term</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Vehicle</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z0izDTxWgvE4" title="Estimated Useful Life of Property and Equipment">5</span> years</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock', window );">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</a></td>
<td class="text"><p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_z1SSSWOPprD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis
over the estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B2_zMvUZJ1WVh22" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; width: 76%; font-weight: bold">Classification</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 22%; font-weight: bold; text-align: center">Useful Life</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer software</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z1HaoclfKPk6" title="Estimated useful lives of intangible assets">5</span> years</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock', window );">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</a></td>
<td class="text"><p id="xdx_89E_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zdBXrjHSlYo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Disaggregated
information of revenues by products are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B6_zChGSZN39qXj" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Survivor Select</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues">149,897</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0728">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="width: 14%; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Energized Mineral Concentrate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">81,481</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">238,687</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">100,270</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ionized Cal-Mag</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues">908,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues">55,718</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Omega Blend</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">495,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">137,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">68,927</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>BetaMaxx</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_c20200101__20201231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues">156,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20190101__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues">191,246</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_c20190701__20191231__srt--ProductOrServiceAxis__custom--BetaMaxxMember_pp0p0" style="text-align: right" title="Total revenues">67,789</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vege Fruit Fiber</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zbzRbBa2R2xc" style="text-align: right" title="Total revenues">1,755</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zLCVyk32GXBd" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_z4tlviO1VJ3g" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Iron</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--IronMember_zKjsOyTnGL43" style="text-align: right" title="Total revenues">133,389</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--IronMember_z6jB8K3wD1ig" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--IronMember_zG3y9qjsS042" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0766">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Young Formula</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zCbbACpUD5tb" style="text-align: right" title="Total revenues">653,631</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zFBXDDEWNjg3" style="text-align: right" title="Total revenues">117,453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--YoungFormulaMember_zuNHdbx356e3" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Organic Youth Care Cleansing Bar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z3nhg4lmHW9i" style="text-align: right" title="Total revenues">43,127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zI6wcZke4M15" style="text-align: right" title="Total revenues">34,917</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20190701__20191213__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_z6WIp5pTOix9" style="text-align: right" title="Total revenues">17,206</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Mitogize</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--MitogizeMember_zAreAMX1Mll1" style="text-align: right" title="Total revenues">162,801</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_z1oN5ObLMhp6" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0782">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--MitogizeMember_zEq44msPTLtj" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">No. 1 MED</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zlSLsCJQhFf4" style="text-align: right" title="Total revenues">46,713</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_zKbFGZRdyAah" style="text-align: right" title="Total revenues">140,733</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--NoOneMEDMember_z0CCGwlOHMSj" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0790">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Energetique</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zv5rChZ4rlC" style="text-align: right" title="Total revenues">253,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zRM3mj7XNsG2" style="text-align: right" title="Total revenues">174,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--EnergetiqueMember_zLNcmrig4WE4" style="text-align: right" title="Total revenues">175,170</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trim+</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20200101__20201213__srt--ProductOrServiceAxis__custom--TrimPlusMember_zcYOBTSyddxf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">365,350</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zesbMf6lJCz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">198,817</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_pp0p0_c20190701__20191231__srt--ProductOrServiceAxis__custom--TrimPlusMember_zCH8cGDMuRvd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20200101__20201231_zx6ORyFHQ275" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">3,452,621</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20190101__20191231_z2fnVT2bi9k7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">1,290,131</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20190701__20191231_zW7lnu0jfNDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">429,362</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock', window );">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zyv50fNYzHIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Translation
of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BE_zVTTQ0AjlAuj" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Period-end MYR : US$1 exchange rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zVv6l569wlf8" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.02</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zAce32sO6Npd" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.09</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Period-end HKD : US$1 exchange rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zAgNXVkWtTEk" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pii_uPure_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zfqZH1qQvpu8" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.79</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Period-average MYR : US$1 exchange rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zVetDM7dEnI2" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average">4.20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zjh3pkqYV8fj" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average">4.14</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zgvw3KqrLqk3" style="width: 14%; text-align: right" title="Foreign currency exchange rate period average">4.16</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Period-average HKD : US$1 exchange rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zyaxoZRqmhx6" style="text-align: right" title="Foreign currency exchange rate period average">7.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190101__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zI0VUIkx7qu8" style="text-align: right" title="Foreign currency exchange rate period average">7.84</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ForeignCurrencyExchangeRateAverage_pii_uPure_c20190701__20191231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zzj3XRLLV3va" style="text-align: right" title="Foreign currency exchange rate period average">7.83</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505399448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">SCHEDULE OF VARIABLE INTEREST ENTITY</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_zKylO7782fFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
carrying amount of the VIE&#8217;s assets and liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BF_zgXo71YX0MH" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsCurrent_iI_pp0p0_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zU8Jy1ossrzc" style="width: 16%; text-align: right" title="Current asset">48,717</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesCurrent_iNI_pp0p0_di_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zY2VGSD4mFZk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current liabilities">(53,573</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deficit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net deficit">(4,856</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current asset:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="width: 16%; text-align: right" title="Cash and cash equivalents">37,387</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PrepaidTaxes_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepaid taxes">11,330</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total current assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current assets">48,717</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other payables and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Other payables and accrued liabilities">1,904</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other payables &#8211; intercompany</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--OtherPayablesRelatedPartyCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables - intercompany">51,669</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--LiabilitiesCurrent_c20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current liabilities">53,573</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>3.
VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
summarized operating results of the VIE&#8217;s are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left; padding-bottom: 2.5pt">Operating revenues</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Operating revenues">346,907</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gross profit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--GrossProfit_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross profit">4,442</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss from operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss from operations">(10,752</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(24,014</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505176520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSNINESS COMBINATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zjoMFwU6vwug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date,
which represents the net purchase price allocation on the date of the acquisition of ASL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b><span id="xdx_8BA_zBmLsqF2NTUl" style="display: none">SUMMARY
OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carry Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 82%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c20201231_pp0p0" style="width: 14%; text-align: right" title="Cash">1,206,493</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20201231_pp0p0" style="text-align: right" title="Other receivables">33,210</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Other receivables - related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_c20201231_pp0p0" style="text-align: right" title="Other receivables - related parties">219,121</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20201231_pp0p0" style="text-align: right" title="Inventories">616,880</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepaid taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_c20201231_pp0p0" style="text-align: right" title="Prepaid taxes">1,206,821</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepayments and other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepayments and other assets">318,267</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total current assets">3,600,792</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c20201231_pp0p0" style="text-align: right" title="Property and equipment, net">325,648</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c20201231_pp0p0" style="text-align: right" title="Intangible assets, net">6,686</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deferred taxes asset, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Deferred taxes asset, net">172,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total other assets">504,584</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">4,105,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable - related party</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c20201231_pp0p0" style="text-align: right" title="Accounts payable - related party">491,628</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_c20201231_pp0p0" style="text-align: right" title="Customer deposits">1,600,606</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other payables and accrued liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables and accrued liabilities">209,096</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total current liabilities">2,301,330</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total liabilities">2,301,330</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total net assets acquired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total net assets acquired">1,804,046</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">SCHEDULE OF PRO FORMA BUSINESS COMBINATION</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zSAAt6fY6ls1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zJ0F8eB5LHz9" style="display: none">SCHEDULE OF PRO FORMA BUSINESS COMBINATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the Year Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the Year Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231_pp0p0" style="width: 16%; text-align: right" title="Revenue">4,693,873</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190101__20191231_pp0p0" style="width: 16%; text-align: right" title="Revenue">4,160,820</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20190701__20191231_pp0p0" style="width: 16%; text-align: right" title="Revenue">2,246,458</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue">(875,708</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue">(789,409</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of revenue">(479,410</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20200101__20201231_pp0p0" style="text-align: right" title="Gross profit">3,818,165</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190101__20191231_pp0p0" style="text-align: right" title="Gross profit">3,371,411</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaGrossProfit_c20190701__20191231_pp0p0" style="text-align: right" title="Gross profit">1,767,048</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses">(3,839,184</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses">(5,081,917</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total operating expenses">(2,468,902</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income (loss) from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20200101__20201231_pp0p0" style="text-align: right" title="Income (loss) from operations">(21,019</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190101__20191231_pp0p0" style="text-align: right" title="Income (loss) from operations">(1,710,506</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_c20190701__20191231_pp0p0" style="text-align: right" title="Income (loss) from operations">(701,854</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income (expense), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net">267,633</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net">(384,304</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other income (expense), net">(146,649</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income (loss) before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20200101__20201231_pp0p0" style="text-align: right" title="Income (loss) before income taxes">246,614</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190101__20191231_pp0p0" style="text-align: right" title="Income (loss) before income taxes">(2,094,810</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_c20190701__20191231_pp0p0" style="text-align: right" title="Income (loss) before income taxes">(848,503</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Benefit of (provision for) income taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes">(212,414</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes">319,189</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_c20190701__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Benefit of (Provision for) income taxes">117,009</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)">34,200</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)">(1,775,621</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20190701__20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss)">(731,494</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net income (loss) per common share - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20200101__20201231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted">0.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190101__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted">0.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_c20190701__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income (loss) per common share - basic and diluted">0.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20200101__20201231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190101__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_c20190701__20191231_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average number of common shares outstanding - basic and diluted">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503333384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE &#8211; RELATED PARTY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z3k4Tqe4cwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B7_z3k88x6Pg2Qb" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20201231_zjeuVyRXzvl8" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20191231_z2ligaszJJWh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zG29Ltth4Cfk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">172,757</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1093">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zmMHrdaqLIu4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accounts receivable &#8211; related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1095">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">520,786</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zVdqhtmCi7Sh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">172,757</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">520,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503413688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">SCHEDULE OF INVENTORIES</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z2viOa0MTNF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories
consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zGMyk4cKIe75" style="display: none">SCHEDULE OF INVENTORIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Finished goods</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--InventoryFinishedGoods_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Finished goods">589,814</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InventoryFinishedGoods_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Finished goods"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503334664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAYMENTS AND DEPOSITS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosurePrepaymentsAndDepositsAbstract', window );"><strong>Prepayments And Deposits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock', window );">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</a></td>
<td class="text"><p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zivrAC8upLhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BF_zbrHRzStjwi6" style="display: none">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20201231_zuZCAK5AfXy3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20191231_z2vvxHcCpeR" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzhWX_zlZfXx7hYSDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Prepaid expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1113">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,641</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_z6kTdM27P9x7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Receivables from sales distributors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,302</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1117">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_z4bS8sMRxkef" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Deposits to suppliers</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">261,068</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">266,552</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzhWX_zRHLu9QLIff6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">296,370</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">269,193</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosurePrepaymentsAndDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosurePrepaymentsAndDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826502035144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zcREefv8JXG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment, net consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span><span id="xdx_8B5_zEBr0QdvFIO7" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT, NET</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20201231_zYmTywqIqugh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20191231_zzSGCqqUO81k" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Computer and office equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z0xxtaToXSTb" style="width: 16%; text-align: right" title="Subtotal">81,437</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z7OMbZxtoE7h" style="width: 16%; text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1131">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture &amp; fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zWfeAkDtAc4c" style="text-align: right" title="Subtotal">126,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zU4XAfvc44h3" style="text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1135">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z8Ked0WvAgLe" style="text-align: right" title="Subtotal">210,496</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z2VSYwPCvgh7" style="text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1139">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Vehicle</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_z9QUQK4gXEUc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal">102,564</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zgUbYAIGXk84" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1143">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzvyH_zYufVXjBCzQf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">521,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1146">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzvyH_zP839ta38Wv7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(223,154</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1149">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzvyH_zgpUgFs5BYKb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">298,309</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1152">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826501988584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">SCHEDULE OF INTANGIBLE ASSETS, NET</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zOVb6pOQNP19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets, net, consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zf2xVuF2IrI3" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS, NET</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20201231_zabjW7SGYmh6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20191231_zi6e6ngPpZZ1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzwwR_maFLIANz4yv_zePWh5kLCi9k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Computer software</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">35,801</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzwwR_msFLIANz4yv_ze08XLW8gR7a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,975</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1165">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzwwR_mtFLIANz4yv_zetRvkWw7mkg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,826</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826501979656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN MARKETABLE SECURITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract', window );"><strong>Investment In Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</a></td>
<td class="text"><p id="xdx_898_eus-gaap--MarketableSecuritiesTextBlock_z0m6ZX0jrsNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B1_zZlxQR9QRc2l" style="display: none">SCHEDULE
OF INVESTMENT IN MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20201231_zT8A2w6neZpj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20191231_z899A2mt3dA4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InvestmentOwnedAtCost_iI_maT002_maMSNzoUs_z37fFNeVkXVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cost of investment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">66,484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">134,166</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--InvestmentsIncomeDividend_iNI_di_msMSNzoUs_zM7gVkETjOS7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dividend income from Greenpro Capital Corp.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,062</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1214">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingLoss_iI_pp0p0_msT002_msMSNzoUs_zECxHSWYdyza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unrealized holding gain (loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350,137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(68,391</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maT002_maMSNzoUs_zZReSz2dLMWa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Exchange rate effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">352</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">709</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzoUs_zZr4ak6dsByl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Investment in marketable securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">577,035</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">66,484</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInMarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505239784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract', window );"><strong>Investment In Non-marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NonMarketableSecuritiesTableTextBlock', window );">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</a></td>
<td class="text"><p id="xdx_890_ecustom--NonMarketableSecuritiesTableTextBlock_zVcsiDStTTCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zwo7IHXeFEYj" style="display: none">SCHEDULE
OF INVESTMENT IN NON MARKETABLE SECURITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid">Unreserved Sdn Bhd</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Investment in non-marketable securities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zy5FwsrHnnvf" style="width: 16%; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zvFRZlIhT4w9" style="width: 16%; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Less: Sale of investment in non-marketable securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zPHfauzcxTe5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities">(730,637</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_znBNiSMcRYXd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1261">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Investment in non-marketable securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zRoMhr7p1lda" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1263">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zAOUFV0i00U2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left">Phoenix Plus Corporation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of investment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z6yageq06Da5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment">1,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z3yTqDUlNzp6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment">1,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total investment in non-marketable securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zhrdmj6iHPE3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities">1,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zNHoSPSLbmD1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities">732,137</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NonMarketableSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NonMarketableSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505402136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock', window );">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_890_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zvevgH6ntcy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BE_zUECWJ5V8Deg" style="display: none">SCHEDULE
OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20201231_zaSsDXBRCEhd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20191231_zGkLGdcGquE1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_z0GzJp230hSf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Professional fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">297,636</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">58,594</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--AccruedPromotionExpenses_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zHWpQRvjZpKe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Promotion expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,433</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1283">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maOAPAAzRsB_maOAPAAzr8S_maOAPAAzH31_zs4HlqHau9dj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Payroll</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,976</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1286">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maOAPAAzH31_zrLNi3ewmGp2" style="vertical-align: bottom; background-color: White">
    <td>Commission</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">224,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1289">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_maOAPAAzr8S_maOAPAAzH31_zy64H97taSK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,921</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,652</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--OtherAccountPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzH31_zJuze8EsX2Zk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">647,677</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,246</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581574008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">SCHEDULE OF RELATED PARTIES</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zixdyMYZRAHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Accounts
receivable &#8211; related party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BC_zTOqoHzErHZa" style="display: none">SCHEDULE
OF RELATED PARTIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 15%; padding-bottom: 1.5pt; vertical-align: top">SEA</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 22%; text-align: center; padding-bottom: 1.5pt" title="Related parties relationship, description"><span><span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z4r0qaJJKTq6" title="Relationship"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zAc8NfDRBm8j" title="Relationship">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td><td style="vertical-align: top; padding-bottom: 1.5pt; width: 17%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span><span><span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zWVbZB5iVLM7" title="Nature"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__custom--RelatedPartiesNatureDescriptionAxis__custom--SeaMember_z0NZBA917z89" title="Nature">Sales of products</span></span></span></span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zJKaZDCGbXLl" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Accounts receivable - related party"><span style="-sec-ix-hidden: xdx2ixbrl1309">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zakJ6nMBP6zd" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Accounts receivable - related party">520,786</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20200930_z9qLb6jkgZhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - related party"><span style="-sec-ix-hidden: xdx2ixbrl1313">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20191231_zN55hyFPOoAf" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - related party">520,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount
due from related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 18%; text-align: left">Agape ATP (Asia) Limited (&#8220;AATP Asia&#8221;)</td><td style="width: 2%">&#160;</td>
    <td style="width: 20%; text-align: center"><span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zw75ccAMGFXd" title="Relationship"><span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zXhULwcfmjr5" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</span></span></td><td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span title="Nature"><span title="Nature"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zJzwpXMlsqkf" title="Nature"><span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zS9nVW5ce79" title="Nature">Expenses paid for AATP Asia</span></span></span></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zgei8Pm92EY6" style="width: 16%; text-align: right" title="Amount due from related parties">2,227</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_z4eoOUeTP8ih" style="width: 16%; text-align: right" title="Amount due from related parties">2,217</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Hostastay Sdn. Bhd.</td><td>&#160;</td>
    <td style="text-align: center"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zr41Sjr8s5Zh" title="Relationship"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zp2wuE0fJJqj" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></td><td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqXkrZZrLq9h" title="Nature"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zSfJKPSZkBOb" title="Relationship">Sublease rent due from Hostastay</span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zqyDHGPbhKEi" style="text-align: right" title="Amount due from related parties">996</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoIBCiLVUBO" style="text-align: right" title="Amount due from related parties"><span style="-sec-ix-hidden: xdx2ixbrl1339">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">TH3 Technology Sdn Bhd</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_905_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zwnrZk3jMNyh" title="Relationship"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zag0xOlzxSz4" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span><span id="xdx_90A_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zVx5rcw72ooj" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_ztylm5j894s3" title="Nature">Expenses paid for TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zzZwgyyjZze6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties">12</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zt9qfn5m2t3b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="-sec-ix-hidden: xdx2ixbrl1351">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_zJyeNOxmXkT2" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties">3,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20191231_zFU5tBSekWBl" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties">2,217</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount
due to a Related Party </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 18%; text-align: left">Mr. How Kok Choong</td><td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 20%; text-align: center"><span id="xdx_90D_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zagpdtShBrnb" title="Relationship"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z7rzqqoLYiA" title="Relationship">CEO and director of the Company</span></span></td><td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: center"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zofULDJzW49l" title="Nature"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zbW6skPbsvR5" title="Nature">Acquisition payment of ASL and expenses paid for the Company</span></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zQanBNTHZQLg" style="width: 16%; text-align: right" title="Amount due to a Related Party"><span style="-sec-ix-hidden: xdx2ixbrl1365">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zoOWyZ11kMm3" style="width: 16%; text-align: right" title="Amount due to a Related Party">3,952</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zWsafe7EuOd2" title="Relationship"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zaSkW1GuFx52" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z8BvKqlWyWM8" title="Nature"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4YPWKRLxzJb" title="Nature">ATP Printing Label fees</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_z4ytW8nLXkmd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due to a Related Party">455</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zk3Pafzg6zgd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due to a Related Party"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zKvRDIes0g93" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party">455</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20191231_z3RySKnCB839" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party">3,952</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE
ATP CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency
expressed in United States Dollars (&#8220;US$&#8221;), except for number of shares)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>14.
RELATED PARTY BALANCES AND TRANSACTIONS  (CONT&#8217;D)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Related
party transactions </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 15%; vertical-align: top">SEA</td><td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: center"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zwitaBZqCIak" title="Relationship"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zNb9Yq0kiWo9" title="Relationship">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="vertical-align: top; width: 13%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_z71NBS1YC83i" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zrtIaUQArOy5" title="Nature">Sales of products</span></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zl1Mwgeg7Yfh" style="width: 13%; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_za6sEJYzqCP7" style="width: 13%; text-align: right" title="Revenue">1,268,670</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zhYFfpbqSFs1" style="width: 13%; text-align: right" title="Revenue">429,362</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (&#8220;ASLPL&#8221;)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_900_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zlHsUrMdYGUj" title="Relationship"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_znbURk9VgnKj" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_ze0dRrUnKmnb" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z9K1mA3oXrTd" title="Nature">Sales of products</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z1mDwTSFcI8i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">18,060</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z5EFwN7Rm1G" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">21,461</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zMjHcT9m7sG2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1411">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zGZIyL6cTNu8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">18,060</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190101__20191231_zNcKogcccSO7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">1,290,131</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromRelatedParties_pp0p0_c20190701__20191231_zzDG731xHg6f" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">429,362</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other
income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 15%; text-align: left; padding-bottom: 1.5pt">Hostastay Sdn. Bhd.</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_908_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zlx2IsTyAaUg" title="Relationship"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zGjEEcllreYf" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: top; width: 15%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zCQ4axBg1I7j" title="Nature"><span id="xdx_906_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zYhMv2QTjPc" title="Nature">Sublease rental income due from Hostastay</span></span></td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OtherIncome_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zBTMmPFy3h12" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income">2,881</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zj3DnIwsK2A6" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherIncome_pp0p0_c20190701__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zO52VxQ8REB2" style="border-bottom: Black 1.5pt solid; width: 13%; text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1431">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zlL6QQCLjZqi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income">2,881</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherIncome_pp0p0_c20190101__20191231_zJ1OqIntLAt1" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20190701__20191231_zI6AgMrhyoVh" style="border-bottom: Black 2.5pt double; text-align: right" title="Other income"><span style="-sec-ix-hidden: xdx2ixbrl1437">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503234584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zbHvfwaLTa7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B1_zzZ9wnvDeoqf" style="display: none">SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax jurisdictions from:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">- U.S.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20200101__20201231_zAbGpy29Fbej" style="width: 14%; text-align: right" title="Local">(735,159</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190101__20191231_ztiS9DrDU5ma" style="width: 14%; text-align: right" title="Local">(321,808</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190701__20191231_zwRKMI0F1QHc" style="width: 14%; text-align: right" title="Local">(279,476</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">- Foreign &#8211; Malaysia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--MY_z8DHaO1U1e1b" style="text-align: right" title="Foreign">1,070,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--MY_z2ccxqkYJEW" style="text-align: right" title="Foreign">38,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20191231__srt--StatementGeographicalAxis__country--MY_zobkAtiHFhvl" style="text-align: right" title="Foreign">(4,174</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">- Foreign &#8211; Hong Kong</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--HK_zNrOkR70FeM7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">180,700</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190101__20191231__srt--StatementGeographicalAxis__country--HK_z1s8Szjpg7t5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(439,909</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pp0p0_c20190701__20201231__srt--StatementGeographicalAxis__country--HK_z8y2iKDnG2Y5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(55,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Income (loss) before income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200701__20201231_zNiGYHtEI5Gf" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">516,347</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190101__20191231_zSnEzu3f7kej" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(723,092</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190701__20191231_zizxBk9Aaz7" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(338,931</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF PROVISION FOR INCOME TAX</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZzlmXh1kM57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
(provision for) benefit of income taxes consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BB_zaJwBfXd0tdi" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAX</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_zD6DHwvcDqLh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20190101__20191231_zI6zvqNvPTtl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20190701__20191231_zwmyScxi2la5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Years Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, </b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, </b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Current:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maT001_zNzWsoAppUkf" style="vertical-align: bottom; background-color: White">
    <td>- U.S.</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1511">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1513">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--CurrentForeignTaxExpenseBenefit_maT001_zuanHqQMqwol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%">- Foreign</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">16,748</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">6,965</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1517">&#160;</span></td><td style="width: 14%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maT001_zYRHFL9aXLi4" style="vertical-align: bottom; background-color: White">
    <td>- U.S.</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1519">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1520">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1521">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_maT001_zPBavMQDeND9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">- Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(178,329</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1524">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1525">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OtherIncomeTaxExpenseBenefitContinuingOperations_iT_pp0p0_mtT001_zK2qRy7RU0Vh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">(Provision for) benefit of income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(161,581</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,965</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1529">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">SCHEDULE OF EFFECTIVE INCOME TAX RATE</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEAzprvvHdU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following table reconciles the local (United States) statutory rates to the Company&#8217;s effective tax rate for the periods
indicated below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BF_zeZVObx6bE45" style="display: none">SCHEDULE
OF EFFECTIVE INCOME TAX RATE</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20200101__20201231_z2LUThGO9pX3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20190101__20191231_zqefyfFlCde3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20190701__20191231_zoZxbSfxdmy4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zYrcqMCNs3y2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">U.S. statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">21.0</td><td style="width: 2%; text-align: left">%</td>
    <td style="width: 2%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zUDvgK3s1zOk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.0</td><td style="text-align: left">)%</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21.0</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21.0</td><td style="text-align: left">)%</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zAeXx6M7YG5j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Differential tax rate in Malaysia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.0</td><td style="text-align: left">%</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
<tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zIARBUE7U4B2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Permanent difference</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td>
    <td><span id="xdx_F20_zT9QkwNsyW1l">(1)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
<tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zZQx711LpOPg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">31.3</td><td style="padding-bottom: 2.5pt; text-align: left">%</td>
    <td>&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F06_zgsLTy4F7EQ4" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zXaXzpsaKd02" style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z1QPXtoePgJ3">10.2</span>%
    represents expenses incurred in AATP US that were not deductible in the Malaysia tax returns. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zUDthHbwpCje">0.2</span>% represents income derived
    in AATP HK that were not taxable in the Malaysia tax returns. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPCorporationMember_z3D4IBRUFkVf">1.3</span>% represents expenses incurred in AATP LB, ASL, SEA and WATP
    that are not deductible in the Malaysia tax returns.</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF DEFERRED TAX ASSETS</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zf0HvgM0jQhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BD_zb3y3VE0XPpb" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carry forwards in U.S.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_z5AvvsjS2uRb" style="width: 16%; text-align: right" title="Net operating loss carry forwards">65,648</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_z8HZFVzogH47" style="width: 16%; text-align: right" title="Net operating loss carry forwards">43,410</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net operating loss carry forwards in Malaysia</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zFY1Y79uMQ51" style="text-align: right" title="Net operating loss carry forwards">62,678</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--MY_zpzUY7FM83X8" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl1592">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Less: valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20201231_z22U98ovv5Qa" style="text-align: right" title="Less: valuation allowance">(65,648</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20191231_zMjGpQbIvrwh" style="text-align: right" title="Less: valuation allowance">(43,410</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20201231_zLyiBjT1QLUl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation">(68,421</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pp0p0_c20191231_zPW4RQ9OQzQ" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation"><span style="-sec-ix-hidden: xdx2ixbrl1600">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax liabilities, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20201231_zADFxmeWLTEf" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net">(5,743</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_pp0p0_di_c20191231_zZyr63qsTkQe" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net"><span style="-sec-ix-hidden: xdx2ixbrl1604">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503925864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">SCHEDULE OF LEASE COMMITMENTS</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zCzu5t3UQQJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
five-year maturity of the Company&#8217;s operating lease liabilities is as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BB_zfgyqg8maSpf" style="display: none">SCHEDULE OF LEASE COMMITMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Twelve Months Ending <br/> December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20201231_zbY0IDU060v" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Operating lease liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pp0p0_maLOLLPzA1T_zUlquhdIPMt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">172,191</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pp0p0_maLOLLPzA1T_zKOdfViEmfGj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,890</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pp0p0_maLOLLPzA1T_zMf0Qco3soI5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,259</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree_iI_pp0p0_maLOLLPzA1T_zfRziMeJGucg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1667">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_z5JPOW73pBOg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">424,340</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zH0SQNpx9GDb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,576</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">395,764</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock', window );">SCHEDULE OF PURCHASE COMMITMENTS</a></td>
<td class="text"><p id="xdx_894_ecustom--ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_zdKVC0IHN3Jd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2020 for the next five years
and thereafter is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B6_zzRVdmpgOzH9" style="display: none">SCHEDULE OF PURCHASE COMMITMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Twelve months ending December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20201231_ziPu6rpTeRxg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Minimum</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>purchase</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PurchaseObligationDueInNextTwelveMonths_iI_pp0p0_maPOzUwc_maPOzKX0_zWrgNorC9p6k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">693,900</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PurchaseObligationDueInSecondYear_iI_pp0p0_maPOzUwc_maPOzKX0_zP0w9gmHD6Zi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,900</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PurchaseObligationDueInThirdYear_iI_pp0p0_maPOzUwc_maPOzKX0_z1GunGTuSvke" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,900</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PurchaseObligationDueInFourthYear_iI_pp0p0_maPOzUwc_maPOzKX0_z4TF3eTpWShf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,900</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--PurchaseObligationDueInFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zsttNJWCmGK4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,900</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--PurchaseObligationDueAfterFifthYear_iI_pp0p0_maPOzUwc_maPOzKX0_zPJksXkizzrl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,387,800</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PurchaseObligation_iTI_pp0p0_mtPOzUwc_mtPOzKX0_zXi4Wnssa8h2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total minimum purchase commitments required</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,857,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of purchase commitments [Table Text Block].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826509441352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 08, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyMember', window );">Subsidiary Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Agape
    ATP Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Labuan,

    March 6, 2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">100
    shares of ordinary share of US$1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Investment
    holding<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyOneMember', window );">Subsidiary Company One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Agape
    ATP International Holding Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Hong
    Kong,
    June 1, 2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">1,000,000
    shares of ordinary share of HK$1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Wholesaling
    of health and wellness products; and health solution advisory services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember', window );">Subsidiary Company Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Agape
    Superior Living Sdn. Bhd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Malaysia,

    August 8, 2003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">9,590,598
    shares of ordinary share of RM1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Health
    and wellness products and health solution advisory services via network marketing<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">99.99%<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember', window );">Subsidiary Company Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Agape
    S.E.A. Sdn. Bhd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Malaysia,

    March 4, 2004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">2
    shares of ordinary share of RM1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">VIE
    of Agape Superior Living Sdn. Bhd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFourMember', window );">Subsidiary Company Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_NameOftheCompany', window );">Subsidiary company name</a></td>
<td class="text">Wellness
    ATP International Holdings Sdn, Bhd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PlaceAndDateOfIncorporation', window );">Place and date of incorporation</a></td>
<td class="text">Malaysia,

    September 11, 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ParticularsOfIssuedCapital', window );">Particulars of issued capital</a></td>
<td class="text">100
    shares of ordinary share of RM1 each<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">The
    promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs,
    events and campaigns<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_NameOftheCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the company name.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_NameOftheCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ParticularsOfIssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Particulars of issued capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ParticularsOfIssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PlaceAndDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Place and date of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PlaceAndDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PrincipalActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PrincipalActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedCashFlowStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedCashFlowStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826509490824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 08, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,147,551<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Mr.How Kok Choong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period acquisitions, shares</a></td>
<td class="nump">9,590,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">176,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 1,147,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Loan receivable</a></td>
<td class="nump">656,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration amount</a></td>
<td class="nump">$ 1,804,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_AgapeATPInternationalHoldingLimitedMember', window );">Agape ATP International Holding Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember', window );">Subsidiary Company Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="nump">99.99%<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedCashFlowStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedCashFlowStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_AgapeATPInternationalHoldingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_AgapeATPInternationalHoldingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581659896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated Useful Lives of Property and Equipment</a></td>
<td class="text">Lease Term<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826502096840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer Software, Intangible Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505314968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 13, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 13, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 429,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,452,621<span></span>
</td>
<td class="nump">$ 1,290,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_SurvivorSelectMember', window );">Survivor Select [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,897<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_EnergizedMineralConcentrateMember', window );">Energized Mineral Concentrate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,481<span></span>
</td>
<td class="nump">238,687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_IonizedCalMagMember', window );">Ionized Cal-Mag [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">908,964<span></span>
</td>
<td class="nump">55,718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_OmegaBlendMember', window );">Omega Blend [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">495,567<span></span>
</td>
<td class="nump">137,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_BetaMaxxMember', window );">BetaMaxx [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,550<span></span>
</td>
<td class="nump">191,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_VegeFruitFiberMember', window );">Vege Fruit Fiber [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_IronMember', window );">Iron [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,389<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_YoungFormulaMember', window );">Young Formula [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">653,631<span></span>
</td>
<td class="nump">117,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_OrganicYouthCareCleansingBarMember', window );">Organic Youth Care Cleansing Bar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 17,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,127<span></span>
</td>
<td class="nump">34,917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_MitogizeMember', window );">Mitogize [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,801<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_NoOneMEDMember', window );">No. 1 MED [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,713<span></span>
</td>
<td class="nump">140,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_EnergetiqueMember', window );">Energetique [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 253,396<span></span>
</td>
<td class="nump">174,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_TrimPlusMember', window );">Trim+ [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 365,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198,817<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_SurvivorSelectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_SurvivorSelectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_EnergizedMineralConcentrateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_EnergizedMineralConcentrateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_IonizedCalMagMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_IonizedCalMagMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_OmegaBlendMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_OmegaBlendMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_BetaMaxxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_BetaMaxxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_VegeFruitFiberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_VegeFruitFiberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_IronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_IronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_YoungFormulaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_YoungFormulaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_OrganicYouthCareCleansingBarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_OrganicYouthCareCleansingBarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_MitogizeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_MitogizeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_NoOneMEDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_NoOneMEDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_EnergetiqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_EnergetiqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_TrimPlusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_TrimPlusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505868072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=AATP_PeriodEndMYRMember', window );">Period-end MYR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Foreign Currency Exchange Rate, Translation</a></td>
<td class="nump">4.09<span></span>
</td>
<td class="nump">4.02<span></span>
</td>
<td class="nump">4.09<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=AATP_PeriodEndHKDMember', window );">Period-end HKD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Foreign Currency Exchange Rate, Translation</a></td>
<td class="nump">7.79<span></span>
</td>
<td class="nump">7.75<span></span>
</td>
<td class="nump">7.79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=AATP_PeriodAverageMYRMember', window );">Period-average MYR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ForeignCurrencyExchangeRateAverage', window );">Foreign currency exchange rate period average</a></td>
<td class="nump">4.16<span></span>
</td>
<td class="nump">4.20<span></span>
</td>
<td class="nump">4.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=AATP_PeriodAverageHKDMember', window );">Period-average HKD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ForeignCurrencyExchangeRateAverage', window );">Foreign currency exchange rate period average</a></td>
<td class="nump">7.83<span></span>
</td>
<td class="nump">7.76<span></span>
</td>
<td class="nump">7.84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ForeignCurrencyExchangeRateAverage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ForeignCurrencyExchangeRateAverage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateTranslation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32618-110901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateTranslation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=AATP_PeriodEndMYRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=AATP_PeriodEndMYRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=AATP_PeriodEndHKDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=AATP_PeriodEndHKDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=AATP_PeriodAverageMYRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=AATP_PeriodAverageMYRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=AATP_PeriodAverageHKDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=AATP_PeriodAverageHKDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504579448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>MYR (RM) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventories write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_AllowanceForDoubtfulAccountsReceivablesCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ForfeitedCouponIncome', window );">Forfeited coupon income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from sales</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,434,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Selling expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalesCommissionsAndFees1', window );">Commission expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">830,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined contribution plan expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement', window );">Income Tax Examination, Likelihood of Unfavorable Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">greater than 50%<span></span>
</td>
<td class="text">greater than 50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income Tax Examination, Penalties and Interest Expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDescription', window );">Noncontrolling interest, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Non-controlling
interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held
by two individuals.<span></span>
</td>
<td class="text">Non-controlling
interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held
by two individuals.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_SocialSecurityOrganizationMember', window );">Social Security Organization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalaryPercentage', window );">Salary percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_SocialSecurityOrganizationMember', window );">Social Security Organization [Member] | MYR Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_MonthlySalary', window );">Monthly salary | RM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">RM 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_EmployeesProvidentFundMember', window );">Employees Provident Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalaryPercentage', window );">Salary percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_EmploymentInsuranceSystemMember', window );">Employment Insurance System [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalaryPercentage', window );">Salary percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_EmploymentInsuranceSystemMember', window );">Employment Insurance System [Member] | MYR Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_MonthlySalary', window );">Monthly salary | RM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">RM 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_HumanResourceDevelopmentFundMember', window );">Human Resource Development Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SalaryPercentage', window );">Salary percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AATP_HealthAndWellnessProductsMember', window );">Health and Wellness Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Selling expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_AllowanceForDoubtfulAccountsReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for doubtful accounts,</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_AllowanceForDoubtfulAccountsReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ForfeitedCouponIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forfeited coupon income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ForfeitedCouponIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_MonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly salary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_MonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_SalaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Salary percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_SalaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_SalesCommissionsAndFees1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_SalesCommissionsAndFees1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 15<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877542&amp;loc=d3e27249-109313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized in the period that are directly related to the selling and distribution of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_SocialSecurityOrganizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_SocialSecurityOrganizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AATP_MYRCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AATP_MYRCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_EmployeesProvidentFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_EmployeesProvidentFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_EmploymentInsuranceSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_EmploymentInsuranceSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_HumanResourceDevelopmentFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_HumanResourceDevelopmentFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AATP_HealthAndWellnessProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AATP_HealthAndWellnessProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581426776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF VARIABLE INTEREST ENTITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingActivityGainsAndLossesLineItems', window );"><strong>Trading Activity, Gains and Losses, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">$ 3,536,653<span></span>
</td>
<td class="nump">$ 5,684,271<span></span>
</td>
<td class="nump">$ 3,536,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(83,988)<span></span>
</td>
<td class="num">(1,038,542)<span></span>
</td>
<td class="num">(83,988)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Net deficit</a></td>
<td class="nump">4,251,286<span></span>
</td>
<td class="nump">5,924,834<span></span>
</td>
<td class="nump">4,251,286<span></span>
</td>
<td class="nump">$ 4,956,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">2,744,457<span></span>
</td>
<td class="nump">3,517,600<span></span>
</td>
<td class="nump">2,744,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,104,495<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">83,988<span></span>
</td>
<td class="nump">1,038,542<span></span>
</td>
<td class="nump">83,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Operating revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,434,561<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">45,883<span></span>
</td>
<td class="nump">2,676,766<span></span>
</td>
<td class="nump">89,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(266,387)<span></span>
</td>
<td class="num">(158,135)<span></span>
</td>
<td class="num">(314,592)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (338,931)<span></span>
</td>
<td class="nump">354,766<span></span>
</td>
<td class="num">$ (716,127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingActivityByTypeAxis=us-gaap_VariableIncomeInterestRateMember', window );">Variable Income Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingActivityGainsAndLossesLineItems', window );"><strong>Trading Activity, Gains and Losses, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,573)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Net deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,856)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Other payables and accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_OtherPayablesRelatedPartyCurrent', window );">Other payables - intercompany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Operating revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,014)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_OtherPayablesRelatedPartyCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other payables - related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_OtherPayablesRelatedPartyCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingActivityGainsAndLossesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingActivityGainsAndLossesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingActivityByTypeAxis=us-gaap_VariableIncomeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingActivityByTypeAxis=us-gaap_VariableIncomeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503311880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>VARIABLE INTEREST ENTITY (&#8220;VIE&#8221;) (Details Narrative)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember', window );">Subsidiary Company Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_SubsidiaryCompanyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826509468664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 1,206,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Other receivables</a></td>
<td class="nump">33,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties', window );">Other receivables - related parties</a></td>
<td class="nump">219,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">616,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">1,206,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepayments and other assets</a></td>
<td class="nump">318,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Total current assets</a></td>
<td class="nump">3,600,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">325,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">6,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred taxes asset, net</a></td>
<td class="nump">172,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total other assets</a></td>
<td class="nump">504,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">4,105,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable - related party</a></td>
<td class="nump">491,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Customer deposits</a></td>
<td class="nump">1,600,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other payables and accrued liabilities</a></td>
<td class="nump">209,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">2,301,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="nump">2,301,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total net assets acquired</a></td>
<td class="nump">$ 1,804,046<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504505800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 2,246,458<span></span>
</td>
<td class="nump">$ 4,693,873<span></span>
</td>
<td class="nump">$ 4,160,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaCostOfRevenue', window );">Cost of revenue</a></td>
<td class="num">(479,410)<span></span>
</td>
<td class="num">(875,708)<span></span>
</td>
<td class="num">(789,409)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaGrossProfit', window );">Gross profit</a></td>
<td class="nump">1,767,048<span></span>
</td>
<td class="nump">3,818,165<span></span>
</td>
<td class="nump">3,371,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaOperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(2,468,902)<span></span>
</td>
<td class="num">(3,839,184)<span></span>
</td>
<td class="num">(5,081,917)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax', window );">Income (loss) from operations</a></td>
<td class="num">(701,854)<span></span>
</td>
<td class="num">(21,019)<span></span>
</td>
<td class="num">(1,710,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet', window );">Other income (expense), net</a></td>
<td class="num">(146,649)<span></span>
</td>
<td class="nump">267,633<span></span>
</td>
<td class="num">(384,304)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes', window );">Income (loss) before income taxes</a></td>
<td class="num">(848,503)<span></span>
</td>
<td class="nump">246,614<span></span>
</td>
<td class="num">(2,094,810)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit', window );">Benefit of (Provision for) income taxes</a></td>
<td class="nump">117,009<span></span>
</td>
<td class="num">(212,414)<span></span>
</td>
<td class="nump">319,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (731,494)<span></span>
</td>
<td class="nump">$ 34,200<span></span>
</td>
<td class="num">$ (1,775,621)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted', window );">Net income (loss) per common share - basic and diluted</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted', window );">Weighted average number of common shares outstanding - basic and diluted</a></td>
<td class="nump">376,452,047<span></span>
</td>
<td class="nump">376,452,047<span></span>
</td>
<td class="nump">376,452,047<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income (loss) per common share - basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of common shares outstanding - basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaCostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaCostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaGrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross profit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaGrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (loss) before income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Benefit of (Provision for) income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other income (expense), net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505041816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSNINESS COMBINATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 02, 2020</div></th>
<th class="th"><div>May 08, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 13, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 10, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,517,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,744,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash in bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,112,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimeDeposits', window );">Time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,391,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,505,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.86%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits', window );">Percentage of Interest rate for time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits', window );">Percentage of Interest rate for time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_MrHowKokChoongMember', window );">Mr.How Kok Choong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchased price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Mr.How Kok Choong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period acquisitions, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,590,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,804,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Loan payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 656,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Mr.How Kok Choong [Member] | Agape Superior Living Sdn Bhd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period acquisitions, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Ordinary shares no par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration value</a></td>
<td class="nump">$ 1,804,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Loan payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 656,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_PercentageOfCommonStockIssuedAndOutstanding', window );">Percentage of common stock issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0469%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock issued during period, value, acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,147,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_PercentageOfCommonStockIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_PercentageOfCommonStockIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of interest-bearing domestic time deposit liabilities to total deposit liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimeDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of time deposit liabilities, including certificates of deposit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116652737&amp;loc=d3e64164-112818<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimeDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AATP_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingSdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingSdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826589998712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 172,757<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Accounts receivable &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">520,786<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_AccountsReceivableAndAccountsReceivableRelatedParties', window );">Total</a></td>
<td class="nump">$ 172,757<span></span>
</td>
<td class="nump">$ 520,786<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_AccountsReceivableAndAccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable and accounts receivable related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_AccountsReceivableAndAccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503438456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INVENTORIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 589,814<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503417960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosurePrepaymentsAndDepositsAbstract', window );"><strong>Prepayments And Deposits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ReceivablesFromSalesDistributors', window );">Receivables from sales distributors</a></td>
<td class="nump">35,302<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DepositsToSupplier', window );">Deposits to suppliers</a></td>
<td class="nump">261,068<span></span>
</td>
<td class="nump">266,552<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 296,370<span></span>
</td>
<td class="nump">$ 269,193<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DepositsToSupplier">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deposits to supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DepositsToSupplier</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosurePrepaymentsAndDepositsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosurePrepaymentsAndDepositsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ReceivablesFromSalesDistributors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables from sales distributors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ReceivablesFromSalesDistributors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505661208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">$ 521,463<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(223,154)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">298,309<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_ComputerAndOfficeEquipmentMember', window );">Computer and Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">81,437<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">126,966<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">210,496<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_VehicleMember', window );">Vehicle [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">$ 102,564<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_ComputerAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_ComputerAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_VehicleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AATP_VehicleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503357784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 55,407<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503313592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INTANGIBLE ASSETS, NET (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Computer software</a></td>
<td class="nump">$ 35,801<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(29,975)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 5,826<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504925848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,505<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503356648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract', window );"><strong>Investment In Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">$ 66,484<span></span>
</td>
<td class="nump">$ 134,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentsIncomeDividend', window );">Dividend income from Greenpro Capital Corp.</a></td>
<td class="nump">160,062<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_MarketableSecuritiesUnrealizedHoldingLoss', window );">Unrealized holding gain (loss)</a></td>
<td class="nump">350,137<span></span>
</td>
<td class="num">(68,391)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites', window );">Exchange rate effect</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">709<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Investment in marketable securities</a></td>
<td class="nump">$ 577,035<span></span>
</td>
<td class="nump">$ 66,484<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DisclosureInvestmentInMarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DisclosureInvestmentInMarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange rate effect.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentsIncomeDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentsIncomeDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_MarketableSecuritiesUnrealizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrealized holding loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_MarketableSecuritiesUnrealizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826589546808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 09, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Oct. 16, 2018</div></th>
<th class="th"><div>Jul. 30, 2018</div></th>
<th class="th"><div>May 17, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="nump">$ 66,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_GreenproCapitalCorpMember', window );">Greenpro Capital Corp. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment in securities, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,333<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">83,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchased price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 6.2613<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_DSwissIncMember', window );">D Swiss Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment in securities, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,663<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,315<span></span>
</td>
<td class="nump">$ 76,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchased price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_GreenproCapitalCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_GreenproCapitalCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_DSwissIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_DSwissIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581209816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 03, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">$ 66,484<span></span>
</td>
<td class="nump">$ 134,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent', window );">Total investment in non-marketable securities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">732,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember', window );">Phoenix Plus Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent', window );">Total investment in non-marketable securities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">732,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AATP_DirectorsOfUnreservedInvestmentMember', window );">Directors of Unreserved Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonMarketableSecuritiesGross', window );">Investment in non-marketable securities</a></td>
<td class="nump">730,637<span></span>
</td>
<td class="nump">730,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_SaleOfInvestmentInNonmarketableSecurities', window );">Less: Sale of investment in non-marketable securities</a></td>
<td class="num">(730,637)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_InvestmentInNonmarketableSecuritiesNet', window );">Investment in non-marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 730,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonMarketableSecuritiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonMarketableSecuritiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonMarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonMarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_InvestmentInNonmarketableSecuritiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in non-marketable securities, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_InvestmentInNonmarketableSecuritiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_SaleOfInvestmentInNonmarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of investment in non-marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_SaleOfInvestmentInNonmarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_DirectorsOfUnreservedInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_DirectorsOfUnreservedInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826500506776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 03, 2020</div></th>
<th class="th"><div>Apr. 03, 2019</div></th>
<th class="th"><div>Mar. 10, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems', window );"><strong>SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,166<span></span>
</td>
<td class="nump">$ 66,484<span></span>
</td>
<td class="nump">$ 134,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty', window );">Proceeds from investments</a></td>
<td class="nump">$ 70,173<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 70,173<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember', window );">Phoenix Plus Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems', window );"><strong>SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember', window );">Phoenix Plus Corporation [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems', window );"><strong>SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Shares purchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems', window );"><strong>SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems', window );"><strong>SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.86%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems', window );"><strong>SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 863,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member] | MYR Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems', window );"><strong>SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember', window );">Mr.How Kok Choong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems', window );"><strong>SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromOfficersOrStockholdersCurrent', window );">Amount due from director</a></td>
<td class="nump">$ 660,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AATP_UnreservedSdnBhdMember', window );">Unreserved Sdn Bhd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems', window );"><strong>SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of non-marketable securities to a related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromOfficersOrStockholdersCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are usually due within 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39599-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromOfficersOrStockholdersCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AATP_MYRCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AATP_MYRCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_UnreservedSdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_UnreservedSdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826501928328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">$ 297,636<span></span>
</td>
<td class="nump">$ 58,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_AccruedPromotionExpenses', window );">Promotion expenses</a></td>
<td class="nump">37,433<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Payroll</a></td>
<td class="nump">23,976<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commission</a></td>
<td class="nump">224,711<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities', window );">Others</a></td>
<td class="nump">63,921<span></span>
</td>
<td class="nump">18,652<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_OtherAccountPayableAndAccruedLiabilities', window );">Total</a></td>
<td class="nump">$ 647,677<span></span>
</td>
<td class="nump">$ 77,246<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_AccruedPromotionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued promotion expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_AccruedPromotionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_OtherAccountPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_OtherAccountPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504167272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF RELATED PARTIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Accounts receivable - related party</a></td>
<td class="nump">$ 520,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 520,786<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount due from related parties</a></td>
<td class="nump">2,217<span></span>
</td>
<td class="nump">$ 3,235<span></span>
</td>
<td class="nump">2,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Amount due to a Related Party</a></td>
<td class="nump">3,952<span></span>
</td>
<td class="nump">455<span></span>
</td>
<td class="nump">3,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue</a></td>
<td class="nump">429,362<span></span>
</td>
<td class="nump">18,060<span></span>
</td>
<td class="nump">1,290,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,881<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescriptionAxis=AATP_SeaMember', window );">Sea [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sales of products<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_SeaMember', window );">Sea [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA<span></span>
</td>
<td class="text">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sales of products<span></span>
</td>
<td class="text">Sales of products<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Accounts receivable - related party</a></td>
<td class="nump">520,786<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 520,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue</a></td>
<td class="nump">429,362<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,268,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeATPAsiaLimitedMember', window );">Agape A T P Asia Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Expenses paid for AATP Asia<span></span>
</td>
<td class="text">Expenses paid for AATP Asia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount due from related parties</a></td>
<td class="nump">2,217<span></span>
</td>
<td class="nump">$ 2,227<span></span>
</td>
<td class="nump">$ 2,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdMember', window );">Hostastay Sdn Bhd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sublease rent due from Hostastay<span></span>
</td>
<td class="text">Sublease rent due from Hostastay<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount due from related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 996<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_THThreeTechnologySdnBhdMember', window );">T H Three Technology Sdn Bhd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Expenses paid for TH3 Technology<span></span>
</td>
<td class="text">Expenses paid for TH3 Technology<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount due from related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_MrHowKokChoongMember', window );">Mr.How Kok Choong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">CEO and director of the Company<span></span>
</td>
<td class="text">CEO and director of the Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Acquisition payment of ASL and expenses paid for the Company<span></span>
</td>
<td class="text">Acquisition payment of ASL and expenses paid for the Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Amount due to a Related Party</a></td>
<td class="nump">3,952<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdMember', window );">Agape Superior Living Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">ATP Printing Label fees<span></span>
</td>
<td class="text">ATP Printing Label fees<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Amount due to a Related Party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 455<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdASLPLMember', window );">Agape Superior Living Pty Ltd ASLPL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sales of products<span></span>
</td>
<td class="text">Sales of products<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 18,060<span></span>
</td>
<td class="nump">$ 21,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdOneMember', window );">Hostastay Sdn. Bhd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesRelationshipsDescription', window );">Relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay<span></span>
</td>
<td class="text">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_RelatedPartiesNatureDescription', window );">Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sublease rental income due from Hostastay<span></span>
</td>
<td class="text">Sublease rental income due from Hostastay<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,881<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_RelatedPartiesNatureDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related parties nature, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_RelatedPartiesNatureDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_RelatedPartiesRelationshipsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related parties, relationships, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_RelatedPartiesRelationshipsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables arising from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_RelatedPartiesNatureDescriptionAxis=AATP_SeaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_RelatedPartiesNatureDescriptionAxis=AATP_SeaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_SeaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_SeaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeATPAsiaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeATPAsiaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_THThreeTechnologySdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_THThreeTechnologySdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_MrHowKokChoongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_MrHowKokChoongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdASLPLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_AgapeSuperiorLivingPtyLtdASLPLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AATP_HostastaySdnBhdOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581804376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,275,500<span></span>
</td>
<td class="nump">376,452,047<span></span>
</td>
<td class="nump">376,275,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,275,500<span></span>
</td>
<td class="nump">376,452,047<span></span>
</td>
<td class="nump">376,275,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,105,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember', window );">ASL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period acquisitions, shares</a></td>
<td class="nump">13,853<span></span>
</td>
<td class="nump">162,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition percentage of voting interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Non controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826589989880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (279,476)<span></span>
</td>
<td class="num">$ (735,159)<span></span>
</td>
<td class="num">$ (321,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax</a></td>
<td class="nump">$ 516,347<span></span>
</td>
<td class="num">(338,931)<span></span>
</td>
<td class="nump">516,347<span></span>
</td>
<td class="num">(723,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MY', window );">MALAYSIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,174)<span></span>
</td>
<td class="nump">1,070,806<span></span>
</td>
<td class="nump">38,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_HK', window );">HONG KONG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,700<span></span>
</td>
<td class="num">$ (439,909)<span></span>
</td>
<td class="num">$ (55,281)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826505771768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF PROVISION FOR INCOME TAX (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">- U.S.</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">- Foreign</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16,748<span></span>
</td>
<td class="nump">6,965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">- U.S.</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">- Foreign</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(178,329)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations', window );">(Provision for) benefit of income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (161,581)<span></span>
</td>
<td class="nump">$ 6,965<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other current and other deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826501852728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(21.00%)<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Differential tax rate in Malaysia</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Permanent difference</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">11.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">31.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z1QPXtoePgJ3">10.2</span>%
    represents expenses incurred in AATP US that were not deductible in the Malaysia tax returns. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zUDthHbwpCje">0.2</span>% represents income derived
    in AATP HK that were not taxable in the Malaysia tax returns. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEVGRkVDVElWRSBJTkNPTUUgVEFYIFJBVEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPCorporationMember_z3D4IBRUFkVf">1.3</span>% represents expenses incurred in AATP LB, ASL, SEA and WATP
    that are not deductible in the Malaysia tax returns.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581165256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</a></td>
<td class="nump">10.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_AgapeATPInternationalHoldingLimitedMember', window );">Agape ATP International Holding Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=AATP_AgapeATPCorporationMember', window );">Agape A T P Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</a></td>
<td class="nump">1.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedCashFlowStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedCashFlowStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_AgapeATPInternationalHoldingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_AgapeATPInternationalHoldingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=AATP_AgapeATPCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=AATP_AgapeATPCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826504739768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">$ (65,648)<span></span>
</td>
<td class="num">$ (43,410)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DeferredTaxLiabilitiesDepreciation', window );">Depreciation</a></td>
<td class="num">(68,421)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets, net</a></td>
<td class="num">(5,743)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Net operating loss carry forwards</a></td>
<td class="nump">65,648<span></span>
</td>
<td class="nump">43,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(66,000)<span></span>
</td>
<td class="num">(43,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MY', window );">MALAYSIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Net operating loss carry forwards</a></td>
<td class="nump">$ 62,678<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DeferredTaxLiabilitiesDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DeferredTaxLiabilitiesDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503975176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 02, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription', window );">Tax rate description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (&#8220;GILTI&#8221;) tax,
which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted
tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be
no U.S. corporate tax after the 80% foreign tax credits are applied.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Cumulative net operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161,581<span></span>
</td>
<td class="num">$ (6,965)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_OperatingLossCarryforwardsExpireYear', window );">Operating loss carryforwards expire year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,648<span></span>
</td>
<td class="nump">$ 43,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.30%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=AATP_IfUnutilizedMember', window );">If Unutilized [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Cumulative net operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_OperatingLossCarryforwardsExpireYear', window );">Operating loss carryforwards expire year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Cumulative net operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 313,000<span></span>
</td>
<td class="nump">213,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66,000<span></span>
</td>
<td class="nump">$ 43,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=AATP_LabuanMember', window );">Labuan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MY', window );">MALAYSIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income tax examination, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The tax rate for small and medium sized companies
(generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or
approximately $150,000) for the year ended December 31, 2020 and RM 500,000 (or approximately $125,000) income for the six months
and year ended December 31, 2019, with the remaining balance being taxed at the 24% rate.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_HK', window );">HONG KONG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Cumulative net operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 636,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_OperatingLossCarryforwardsExpireYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards Expire Year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_OperatingLossCarryforwardsExpireYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of other income tax effect related to application of Tax Cuts and Jobs Act that are reclassified from accumulated other comprehensive income to retained earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL116659650-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659663-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=AATP_IfUnutilizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=AATP_IfUnutilizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=AATP_LabuanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=AATP_LabuanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826507291784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS OF RISKS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 10, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceLineItems', window );"><strong>Policyholder Account Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_CommissionExpensePercentage', window );">[custom:CommissionExpensePercentage-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash in bank</a></td>
<td class="nump">$ 1,112,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238,937<span></span>
</td>
<td class="nump">$ 1,112,147<span></span>
</td>
<td class="nump">$ 238,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_DepositForInsurance', window );">Deposit for insurance</a></td>
<td class="nump">563,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 563,788<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=AATP_NoSalesMember', window );">No Sales [Member] | Accounts Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceLineItems', window );"><strong>Policyholder Account Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_DSwissIncMember', window );">D Swiss Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceLineItems', window );"><strong>Policyholder Account Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDividendsReceived', window );">ividend received</a></td>
<td class="nump">$ 23,330<span></span>
</td>
<td class="nump">$ 23,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="nump">0.01%<span></span>
</td>
<td class="nump">0.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceLineItems', window );"><strong>Policyholder Account Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | E-commerce [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceLineItems', window );"><strong>Policyholder Account Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_NoCustomerMember', window );">No Customer [Member] | Revenue from Contract with Customer Benchmark [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceLineItems', window );"><strong>Policyholder Account Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_OneCustomerMember', window );">One Customer [Member] | Revenue from Contract with Customer Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceLineItems', window );"><strong>Policyholder Account Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_VendorOneMember', window );">Vendor One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceLineItems', window );"><strong>Policyholder Account Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">74.10%<span></span>
</td>
<td class="nump">60.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=AATP_VendorTwoMember', window );">Vendor Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceLineItems', window );"><strong>Policyholder Account Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">25.90%<span></span>
</td>
<td class="nump">39.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_CommissionExpensePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission expense, percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_CommissionExpensePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_DepositForInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deposit for insurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_DepositForInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends received on equity and other investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=AATP_NoSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=AATP_NoSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_DSwissIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_DSwissIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_ECommerceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_ECommerceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_NoCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_NoCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_VendorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_VendorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AATP_VendorTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AATP_VendorTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503307080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF LEASE COMMITMENTS (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths', window );">2021</a></td>
<td class="nump">$ 172,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo', window );">2022</a></td>
<td class="nump">168,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree', window );">2023</a></td>
<td class="nump">83,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">424,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: interest</a></td>
<td class="num">(28,576)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 395,764<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Liability Payments Due After Rolling Year Three.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503297528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PURCHASE COMMITMENTS (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 693,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">2022</a></td>
<td class="nump">693,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">2023</a></td>
<td class="nump">693,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">2024</a></td>
<td class="nump">693,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFifthYear', window );">2025</a></td>
<td class="nump">693,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueAfterFifthYear', window );">Thereafter</a></td>
<td class="nump">1,387,800<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Total minimum purchase commitments required</a></td>
<td class="nump">$ 4,857,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826581223272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 02, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease, rent expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,828<span></span>
</td>
<td class="nump">$ 156,716<span></span>
</td>
<td class="nump">$ 53,594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember', window );">ASL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">$ 506,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_AATP_OperatingLeaseEffectiveInterestRate', window );">Operating lease effective interest rate</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted average remaining lease term</a></td>
<td class="text">2 years 6 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AATP_OperatingLeaseEffectiveInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease effective interest rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AATP_OperatingLeaseEffectiveInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AATP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AATP_AgapeSuperiorLivingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139826503600344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 25, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_VettonsSdnBhdMember', window );">Vettons Sdn Bhd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="nump">$ 172,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=AATP_VettonsSdnBhdMember', window );">Vettons Sdn Bhd [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Sellers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Proportional of ownership interest and voting power held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AATP_VettonsSdnBhdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AATP_VettonsSdnBhdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AATP_SellersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AATP_SellersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>107
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M^@#<WPBA#R?I"XJ-^/&_4$L#!!0    ( --+?U)IIH!C<0<  .@?   8
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MI=8%1+-5/K6"K@>,JYX>=;@E/S:C?YY)ECW'*O.S:B>';:&:/$3<KB7&Y7[
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M=5')PC O(;OMV(;>O\/CP+(1RSEDZZ9X-Q;M2O(UEFM12M4XBC('=T'A7HV
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M*?+ZLW)](\6F^C+[)"0TA-7EFK.(YTH ?E\)(=]NU,?>[<?]JW\ 4$L#!!0
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M$HK]]V5:)Z1J(WG +E]I=KW3$@:0,"P<$BF2HB -2:ECW-ZP%,3 E)!AG)9
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M*Y=!V/S$5[O82BR7_0%VM^E]4LV2[M-8Z%'ZNC%QI!QT34Y5N>A;%5C-6GE
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MNBU1-%XDC[$:"\X;%P:9FGU38+NJ23!-K Q6]!#[<4X%\YY2:&$>TZI&7VJ
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M776E8\( ["Z^T\S4])J'=E_\G]B*^J>V$@0CW"MLUC;F.'HCUE'9.E:KV=S
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MP2G";@7\0KMQU*5;V1>3M<W+@[E%P1[& U,*%4D1(->I/C^>XS6\.#66X!R
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MI*W.%6V0L:!*L!5"J00M(I>;,[B_^+R\?+Q>#KY>P0'TP<*X8+H*K->H^^N
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M=[H.;'#+CH5>BM,CGNMI&;Q<%,K^PJGVC9H.Y$>E17D.)@8EK^HO>S[WX55
M]ZV X!P06-YU(LMRS#0;]*0X@33>A&8$6ZJ-)G*\,I>2:DFGG.+T8)X]3I:P
MB'^/A]-)"O%L#/%HM%Q-QC!-XF$R3;)DDO8\3;E,A)>?<8<U;O &KA_ DZCT
M7L&DVN#FWP >D;PR#2Y,A\&[B&/,;R'T70B:0?,=O/!:>6CQPK<JUWN4,.5L
MS0NN.2H8<Y470ATEPA_Q6FE)3^;/=S)%UTR1S13]]!Z_BVOF]5X=6(Y]AP92
MH?R.SL /;QL_EA#2T>-DO)I.&O,'^+&01JQ ;(&N LLU=>]R'1"KQG_M_EUC
M(<46E9E@5L 6J<DW$-QUW';8)JG5=5MWD7$JA9U1?*9EH\@K[+A1&,*GQH*]
M2%$4$(3N7:=-AI$H2VX1(0@BM^/[9+1WJ:!-3H$/?M=MMX)&)C0EO8%V1/DZ
M'9(Z'3>(VA#_%B\FC3A;P&B^7,R7<9;,9S";9U1@-B?C+)U/DW&<4?$/R2R>
MC9)X"FE&AJ?)+$OAP^@H)5;Y2X,(4^<5;H!7L*JX)BG53)O71+09D?KPZR_=
M(&A^7J4W5O(_?W2IT!P/&FBI0G6T+:/VJ3TCL(_P?T_.>S7B)<J=760*<G&L
M=#WM5^MU5\;UBOC'O5ZT3TSN>*6@P"V%-F\[+0=DO;QJ18N#71AKH6G]6'%/
M^QZE<:#SK1#ZHI@$UW^0P=]02P,$%     @ TTM_4G3$_F_>!   .P\  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3DN>&ULU5?K;]LV$/^NO^+@=4,"J+8E
M/V+G84"QG<:88QN6TJ$8]H&6:(NH)*HDE<=_OR/E*':2INT68!T01^+QGK\[
M'G6GMUQ\EC&E"N[2))-GM5BI_+C1D&%,4R+K/*<9[JRY2(G"I=@T9"XHB8Q0
MFC3<9K/;2 G+:H-30UN(P2DO5,(RNA @BS0EXOZ<)OSVK.;4'@A+MHF5)C0&
MISG94)^JZWPA<-6HM$0LI9ED/ -!UV<USSD^;VM^P_"1T5NY\PXZDA7GG_5B
M$IW5FMHAFM!0:0T$'S=T2)-$*T(WOFQUUBJ36G#W_4'[A8D=8UD128<\^8-%
M*CZK]6H0T34I$K7DMY=T&T]'ZPMY(LU_N"UYV\T:A(54/-T*HP<IR\HGN=OB
ML"/0^YJ NQ5PC=^E(>/EB"@R.!7\%H3F1FWZQ81JI-$YENFD^$K@+D,Y-5B.
MIUXP'L'"6P:?X-R;>K/AV =O-H)@Z<U\;QA,YC/_M*'0F!9IA%O%YZ5B]RN*
M'1>N>*9B">,LHM&^@@9Z6;GJ/KAZ[KZJ<43#.K0<&]RFVWQ%7ZL*O67TM;X6
M.DV(HA$LB%#W$ B226)*1<*?WDHJ@:N_7K'3KNRTC9WVVT/\JF)]7H]E3D)Z
M5L,#*:FXH;6!TZY;WVD1M@A8N4%@11*2A52"%X:\R)2T! TINR&KA,)OO_1<
MQSG!<UB"5HKXP\OQZ'HZMN87L&MT,O:M&4DI\#7LPVQ6&N.8Y3 CJA 4/*GY
M,+TT75%1I?AENM.W_+$''R=CO>GY4QNN1!TN,2>_\\\PC#G/-C:HF,)P/ >2
M11 Q#$1QH04,G:<YR>Z!2;.4'..3,1$TYDF$AI[*:'L^2:AQ)Q<\*D(EX1V\
MQU_';=I'O:X5<$62?1IXJ8;1B@H*:\'3/>P8E6^%D.5M2(X\P0(./,G((4Q9
MRK3" YTUMWGBZ3V]9=;.R>&_@8PDDG\?;I59&-_A)2(1P)RP"/ JV=E[!Z[M
MND?ETSFR+KE4!/^PNJ*L#N=Q5'\3=W=Y=FP46-W8U3$YF8(J58\,_7X7WEO!
M90L"&L893_C&>*8=>W._GIAY#ML3!FRR[ZO2:]ENJ_, XV[Q*0YDO\C>K/2>
M _#-V+WP2\$D,W=R3NY3C7MYDHT8?1;SKG!YP%IVO^-NR]XO<BH8LDW9#4/S
M"XQCJOYY:G1=+@3+E%8V)2N:P)JB.^U.9P=KO=KZ =X';S&VM-QPOES,EYYN
MKC";!]@$@SD29_Y\.AF9YG@QF6$OGGA3\ ,D7(UG@0\'PT)@^87W%@:/C5QB
M0E@&UYDYQ+["#$D8\20A0E9G^MI_]W":;00MI+DR:&6%R1-&98ZF/(0?N1$.
MT-O ]/JCD]'ADPM"[5Z12WI#LX+^0"5=;'/YB1)1?A2\4%;?9G+Z%9//[O8^
M,EZX*PZN,U)$&LC#G^K><&RWV[.[1TU=3&[?;G6_5=!5,_>GB^F;-'+H.+\^
M"X#LMW!M[(4@G)[=[#;!=>QVU]DY%UNZB:_?M)V6\Q@?S-$!8;$LY.G_JF[^
MPQL)02WQ>NEJTJV^UW.V%?68A#WJ3]^>7OK";NP,-"D5&S.V23"?I>5L4U&K
MR= K!Z)']G*LO")BP[!?)72-HLWZ4:<&HAS5RH7BN1F/5ESAL&5>8YQNJ= ,
MN+_F7#TLM(%J7A[\#5!+ P04    " #32W]2:[['/3,#  #P!@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970R,"YX;6RM54MSVC 0OO,K=MQ.3RY^ "&DP PD
MZ21MTJ0A::?3Z4'8"U9C2XXDA_#ONY+!368"ATX/MEZ[WSZT^VFXDNI>9X@&
MGHI<Z)&7&5,>!8%.,BR8;LL2!9TLI"J8H:5:!KI4R%*G5.1!'(8'0<&X\,9#
MMW>MQD-9F9P+O%:@JZ)@:CW%7*Y&7N1M-V[X,C-V(Q@/2[;$&9J[\EK1*FA0
M4EZ@T%P*4+@8>9/H:-JU\D[@&\>5?C8'&\E<RGN[.$]'7F@=PAP38Q$8#8]X
MC'EN@<B-APVFUYBTBL_G6_2/+G:*9<XT'LO\.T]--O(./4AQP:K<W,C5&6[B
MZ5F\1.;:_6%5R\9D,:FTD<5&F=8%%_7(GC9Y>*9P&.Y0B#<*L?.[-N2\/&&&
MC8=*KD!9:4*S$Q>JTR;GN+"7,C.*3CGIF?'L]NKX\]G5Q<GIS>S=F\,XZG^
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M=F625*XV%DH6S@C1N6+&"M5)T.".;'Z9?G$?F<Q32E99*OG$K>E\#8-!>S"
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MXY>6SYQ;49U/#+_BV(_RS7/3C+<\CPR1EL?$?L_MXTCXCL:4KN_]-=DZ<?W
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M+B3X4P3H?[V*F,V2G12>,GO?/(/4=4J4EA+?.B)>6ZHX#%I"2 6?YY)7D=D
MKS,9<+,#0:,L$(#0ME%=XAH#G^3@6M+4E=&&JCZP#N4T$NQ)QZ5,L)6TJ8A-
MKM<6IA0P&0X-")6Q0KO"96%)L,%^#1TJ&($N'"H# 3X&&V2@%/K641PY53IP
M_^_7E^_!; L-OF&0Q@H&$[GZ7H>=6Z^2<"Y(*M41&%_<2B!=]!IJ!QQI]1_&
M)K'X[K$^LVN)\E&)L^*/[S.PA01^G9;!AB&M,B0-)94UY7J#BF^U*1WIN?;M
M4V*BQ]AL,^<=A4UO>^_ J/!]:I[8%L^-F$R,!8GNT7D[G>W1Z0F6ZW4H_BQA
M)>%+N3  K3ZIA$*"7H&+*('$LR9J=0J6P#0HZK:;0%T86W652-6F^\H:XP1W
M!*F,.9\1!&-W(1J<=P(Z^2^I=%'P DE0C[F_1(!N:YNFE4TSLJDQ:=JR"<;P
M*0:]T[)TFBG% 57&.G^&))+W$/%%4U5N\)8*6Z+/X *!_(::-FYU@'/*F;@D
M0[T-GG3(*6LH:;.*W?9&DZ"W Z1N8^2JM%1ZX-M$_O2*W*.IP.Y=8VGPO*7W
M+4L[F W$WT&,%(=>GS$'Y%6L*2ETI26JX.@TB(VH._ 44>N8M77W:%<Q0L!Y
M09NA$DO:B8QQBV&7#P&A+V71R.Z(:VHFN3.#I#U(V6P-S%3\V0)T44'&-Z5$
M^SZW ^[E[ XMHEI:MI$K:"KM(U&2<!I=&*8;(-;78>;8O=L=!5JL++ZB.8S.
M6JWJ_*V$5ZTJV8$9BZ&W@8Y0(?"5*8(G0M]-5K3ZNTFP55%&7:JZ1VX'W"_[
MIJT?M>Z5BQ"1Y]?RB@C4EM"5!(>J@JKOGI_ K& I@(R#W7BB=U9'>VZ)^*G9
M< 4UR0\(YL)J<5MN=CH&MXM_4 ,.,L\RV!RQB0B9%'>R2JX&&==I6D(.OP_F
M"21M-5RXY- E#$NB37B9)@6>RWPS<A"AVJ?C[M]J;S?FYB8O$\]\M>B]B8S:
M:*/5DX+WD76:]?%,R?9[>AW5MN_Q!?LXX<G'1R'F)J&F%9A-:<C-N"Q>;'X"
MR@8Q''5Y)(V-\Z1[0/Q>;WRQ 4]ZRI9Q6L5!-16J0?&B7 *!8%>J80%!$Q)-
M22R ;J54OB4'9]- 9MD?+>KL$/,YM''X,@%L_497)@5K5C7_AE*-_)KH1QJK
MX5X9PQ2,,#M/WJFDMT%=%_GU:L7S35@7273*!%.&R8')AL9$C.!,7BK7ONRA
ME4G=89CII'5BE@ 7>"TSZ8YL 8% RZ033#*J_W0(%5]@2_J:WS:*S8@59A*:
M2T,?._#2NM8OK.>'&/Y+3+Z_&LK4%L?YBT_-UQ4PA SW+!90QV"Y8>?XEU5E
MYWL1R#JX9FC*?%7XI*^$HL#(F1'QMXA3EB /ZZL>C]/>3["27S%=9M18!<=>
M+= 8%=RX>F<@* GCN8*)3RC"QU+M#(F&IZKRWA'S(U=2.D1)&8.P,./S-FJ,
M$IUJGV4A*^"'';CA0_#K+Q=GYQ<?]V4]:)5U?X5$%>.YCF#?1%5Q?.&"QM^)
M$FL:NEMV>75![,H\3S174Q07ZN4PHU&"-*ADBC1E$K/%.O/E;;^T K"G74"2
M^X]JZCO6HAHM/NXM;EV3D :<S!"/A4]4X]I%QE^::4Y0G,P1I9CM38O]>$(G
MF[)8(JJ/-1N2<**$TF9BGWU!DYZ5%2QP[].H[H$\H)HNI,J2C_P:N@>HGK;,
M#SK4(]/9T>C7-@ @4><:1*4C5UOJ [,WQ7M\KUX575*OZ:KH\$J3X("$P@J!
M?*\H:?GZ8"2A&;)P=>RMSPV^VCB<\RB,DNYZM(G9+JIUQK8<Z >_ '\UMT_'
M(6F[O[X&XT) 8P>)/%C=$5\5Z:OJR9@*)L]"H 3D [KQK"&.?0(WH>:T.DX(
MZO*JZM8&!E^">@?F1.WU][78(***71"'M\8FY![?F<:^?*%DD4_XPLHJ/YB+
MM6_CE6I1^!$8_&#65!XFVS7=C1MB8/I1**AV.K &:!=^H]SGFL_%D3\!T%2)
M.\_=M)^V?MQ@WJ6?<)ROA_YWCN9M\RO1Q/\XLE_N?V)"V5]KD&ZB5MC:[9R/
M3H3U/]OXA\+D_%/)TA0()']$^P90TP)\OS*@R.J!#FA^._OR'U!+ P04
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MX<QX?C.9S[[>S+Y\@]DM/>?#P!"MW0R2AF)24\0O4$0Q7$AA,@TSD6+Z)T%
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M-4ND",/R'O:[3GE6.V8A,#&$:E+M6=ZC?@+&!TCJ!4E0/"W-#+0707YPB!H
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MI^!1\(Z2'RL49FEEU;T(VNPM-<C6\\(I<D/]3C3 S1XPPA^HTP&DX/5MY'U
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M0IQ\2@"KTJPPA^K>2O>AOD#OZB)EF""O03$&W(AY+GN8$E!&<;7*&G#( 1*
M:WY'_E\8"TT,BA*F*'<DW()Q#> )#V#3BBRJD4'AVD)W@E/E<-BOM1&+SE$0
M*YKBA%3L"=ND=4)Z2\2WV.-0F@-O,X?>8HQ.A4B*N#UP;=*0,'QHF%NC%UK0
M,$]+P#3 %KFV>DC*,A$Q@XJN=S+#%"'E__LF9XQ])M2X/Q7J<M>7O8_Q?D,R
ME!]=!:/K[J\''4QWL,MU0=DJ:[ WF.N>!9]LL((5,=%CG"$4,]\9IVD)[]W'
M.F/>^_N9Z.75[=G5SY=OX+FSFYN+VYN!OKJX5><9C$CA$EIV)T^MBF7]@  Y
MZD6T3\,9]^?A7/H8 -+B3HBB$^7?D);CYU&=\^CW[AN'?&:IG,/6K0QP2EB+
M5%D8HBN@-H&L8_73L#T>A#Y0,S2(<.8L"G[E="".!(8\1C^W$>-$5SZTA<8$
M6 )&WN-X(-KT@0LOL/IP;HD#BJW15-9LE[V_(+?BG#U<HC1BI(%R!-D_@=PW
MYQW#;%NK[HN3;4=[I"<IV,S:H3R%D:)M3,]J%OH)P"1(*Q)]"#E>+EE32R3X
MZ!BTI 8G&]968 7V0P!\DIZDF[NCIAZ9,IR#8U!>2GM "F0V65,1;P$*0A=%
M\#J]!#.YD%B( 1]FQVT1LZ$DD6Y$N/F&^G+9VB&J!@OT@BY3%,:19461,Y#1
MS=Q$(RNQ'*.MP';10/(LB;(4>0T.98D.8!< +=D  !*@W:(4QTURGZ29#W#@
M[YLR12N*<DO(_40_"RG31-5>6T!'_M$^UN23O\;]V5]O;32TP- B9\=6>SC2
M-Z1^V>%5/+S>][V+ZE7R!:"E0*W%!O$ZP]?BU'=C2?(>\@$XK3DJ7XO([VX)
M53FB?FS,?@>.3\D8]^=D7$;QW\ I*4DW/@3<B8%O2-?P,ZI'9@1S+.6DI[\T
MV5:[5,C."'6DBJ=/WI5^CC%O >Z+7;^QVO$;R\FP@9B[N]+<)1C*^$A*:_?B
M'IEEUSO-PZCV+"+[?.R70\?$I7JWB68+/1J^W+<J7(B2F.4VDGL+,R>M"7WC
MGAF)I+%)1L&ZP ;:%"6Y%*X-FPID1TD"BR1#^:@AZ<0^4QR7%0FG!&78G1%0
M+2DXSD(KE9P:BLJF<_(FR4A;O3*9 S?%Y'&:! 7FQUS%!!:RZV118,H\J&R?
M\=?C@Q$\]LZ%^"[A!)<-@]/&AC_>4[Z]?G[3S.IBD\[UR>3H8#QZ\1H 0!+1
M)6-\ /NV8;<^QCS]N&<^Q<=_^3[(\N@[_3Z]8MR?7W'9E_WQ- [P#5D7,0=X
M;-9]7" DY*<,\QBQZSYB5_\SQ*[W$;OZEQ'[']H*_O_R))_5RJ"2QNEW9/B0
MEZ3#(<_I /JW!B@+:U3N+2E:OS"%UW&(4!=EHP(39\,@NO6RH) +Y64E[UJ'
MSI[)@E%%\@[TK*DEB@>G*5VGK*^_UL_'+_19ZUAATF[!"9I6RCE'%NR?*HPH
M,4\R)SC=;2!J,2]J2R&,&?I4\>R"$E6AFN],==Z6,=]3O*RUA-A\LVN0JB7*
MT; Y&31+;>:KO,B*.THI,?E]6A9Y6& 43?;(;%9[D-(L*^V=X4AILJE%#SQ6
MW)7)9D53 X 3+3DW@(0&J'8;Y\';E4B6(,8,GZ?WN*)9D2=@(R\,JY&4Q"UQ
M+LQUD&]GVW@8#):9+",P)&0D9(889\/Q"U)>JZ!&)%E30+,"$LB24.60E*<H
M)<I:6,I96*$=A'%+][K$/F$K[Y(Y$S0^4";HRPVA#8"<&\S.3F88N ]WXQ1J
M:P:3W<,!%44V/B<3R1 ^73Q'!0P/06!@D;;NZL#0E5J47^AM=HMB;B?ERW,U
M #*\(B< IKYJ#\50@Q2G[%M1L)\R1&>XIWOT!6-,_Y(I[BDGD_T)013J,3FI
M8CF98BPK2!ZWO*';IK7F/@&\9>]CM"ZS98*<.$K9$#-3/V B$7E&X T5&=@!
M[=@"DA:=]!M"/IMQW)_.>"YI7/TA[&_(3[0#*Q?MW/W&YX[:U&L7J8;#:#/,
M2'&0S Z-N8:E3Q07X]_!KLFI0 C] 046U@#5[.Q0L8,,'1$+=@\P!V37*FDG
ML?.TH^2TRU25G''[)O,(BC?VXFKBTXPF_6E&U[L3=&&K?Y1N;,G0*ES[T[0*
MG^@..E"^2#"GYC.'5JT6!)J'2\F D0X/1C"8W0SQDG.LZ4CFUIUI40:G\NSF
M7-^2"G(\.GX1Q!'7Q8*\3!C,$@&(#$$"BLAPYVY0=D<:$=$!)R>1V2KEHVR&
M1;K 9Y7XW%)*N/0)B>R.PT1SC+U8^4V57 08YV'#&+%YT'=-RL0C557[2 ?K
M'#WAQ<Y)+QZLPN,=_MY%R+4[*7XM,A=!4<&CU7(;%"]812.HVZ%,#E2Y2^/K
MJ-$G:LK,O=I%Y':GJ&%2J#W:I*Q+6.2!&X%EF/<SD<Z.I7; (5&5W$GS(3W.
M,P7!"4-%!J/ZBLJ%)#V0X,W= D&&7"4LG@J2,CKNG-=A(2@D(:DA)*+:^Q.G
MY];1'/+\/5"6%)!VU,^"I5JA4%$S$W(@+*C17$^'*E3*B@9';N##P!M/DJ?&
M=9-[H"A IHTG#J*=^1?*+:L&_6M=N93O_0MK)48[&K=FWPKLPYK+&QY O;(J
MK.3M(04B';G2H\#3G=!96@*!'X!*LT$68+*8O,J0J]B=>4[ >VR/$,R5U"I$
M+::U.=P*5=%(7@K820:L;$=/[Z, 'S6GP0:B.CNB4.XL)%;53-$F\#$B5S&W
M0^9D46 ,VQ8PDFUCDVSXNSB@(U$'!%T)2")"5\@HBSGH0P-6HO%<SVT2\L[2
M7!L$XQCQD_=N==L=)"JBY>>H.E<OHA/'["SUP?6.F?[@)O]M4##MTC668JF$
M-.H/N-=UW!.<HK-.:RE*PT0P,C<)F509:C52<K>8,%"I)*F-ZB\J#AZUHS]N
MIA6G^6*%!5>[SCC,*(DA(1&'Y(K@XD?K-"II&.[SC[5S?(FDJI@Q<)&&XXX.
M+AS9IL+2HO$L>8Z)P7#>.,G2U&S9 ]E538*I+,I@=B21'\<I,3=#DM;,U[2J
MT1*=X/G& &W)E>ETN$ +A9^F+\C0E/XEG.:W3+]R[J9E"@@.,00/7UA B#&G
M2%^5'#B*?C;DQXAT+$G\K![CP2WEEX&#DI%CFVGU15-Y7\7"P$H3#"))@K9/
M:A8+DRI. AX@W"*0/&Y\)KSJBVVF\D *)4Q8/.0 \%6Z<3.2^.)Z)6[O(@;\
M+KV[K5'J#H..;8SH>3$5VX*+L[H\- 4^5/2$T5;Q,5;*&B24=41ETD'-8\6<
MCGVF.XU;O .4E$B?]>A6,</BYKCH-JCU056F1(/;*%L'($F[D@)@7:]KFXQD
M55%K]_B*UZ"HB^6Q]%P(XL9=0CC4#JVV$";V,R+@S'IM6+1L[;7LR)O!B0G6
M1?60;'<.-R7PU^YT#\'RB%3PO(<Y6(_@(ARAPWBC%(Z$=+]X<\A>+5SGQ<;9
M[JB^D-:,B;_W5)=0.=.(,D^#:HL8C/P:^2L"JT$)CURB7\'[-#!QEVV:P*_@
M!.PFP52W/"AF#O<VU#>)] 'YQ?."O^WP@@/U:8\<MS*X4P?L-1VYD4N$N"KD
MR_/8&"3?A]/ZZ2OWULQ0J7"+6XGZ:ZOI>IE=BX79Q(.G\03R]JTDUU-F(Y$B
MR87(EWT;*NL7)%N$JM>J;I$@QZ0EVO1-,U_M'M/]BK@O9=MKB6 TR.*1=>-R
M/Y/SR1B.T0F31EX7<#J4S0Q><K7<P0YS,-_U(ME64APG321*9V15/J^%? =8
MBBXNVJ'^Q3&Z;#L(23_-0X;!Y".##V,5"=,R4<A6UC'4QC2OC)R<!,O N\1"
M.<@J=Q]VG$SHILNI20TQ*]7UM*AIY(%BA2??HU53.<V.E(J*;JMH)"N*I%<3
M%G.[7"!FLF&:K[7([+K:)!4< ^>R0U]/%NV&K6?K=HL7]*0CN+MODH%D@TLY
M;=B!QYZ2[GH!NRJLU%0)8BM=H*=7A!X"R+5R<A[EW:03BTTKH:1(*=HXG:]@
MN [?L(I]PX#XI>%<< &,U*Y;QV/525[LAJ_=V><"&GQ@2[4UG1VN.$M)]2C%
M"_V='K\:#0ZG8\+,=WJDGKMV72\XU9,6[-RI-FE;W8;\7&"$?C *).]Y:W\S
MK9WF7)AYI;JK,,*MK))%("U\'"9[@I;+CB,2Q 4"8GP\.#H<_[&-QK=IY5)J
ML!NB[V<8MCR9;6/QN"_E]^WES<'9SS]?7_Q,T+B\>O?Q^@/#"WZ]OOCUXNHS
M0*V+5M_MH82X=5WX01%%DQS$?]3SSXY0U4U3WJ?W,.0-=5=%;!Z>#DY.7\%?
M!_B?N@ 9?$<D_R'ET.,YQKF0<D#6G(P'AR=C/9F>#(Y/7NGQ:#28O!JIRX)/
MR7F2'7Q([O3IZ&1P>GRHCXX&K\8G,.K'-4!2O\FP7N#P]&AP= PO3U\-7AU-
M]#$\.WFEWI@Z^9!\_:K'1T!?1R,]/AT/)H?'^A@>.SE5OYH[H]^535KK=REN
M=0QO'\&J#]1E"7@93Z>#Z<DI??%W(-@[!!UF@>OCH^G@&$[N>/QJ<'@TQ>64
M=TF>SC4\ASYT1-UYAD7L2.1O0/$XG [&DU=Z>C@X'<-*7PTFHV/U(:T+!(T>
M'T\&)Z,Q3755#/58?P"L'A[#9J< T-'@U71J06GJ]#=@4Q-8P_3T&(8ZA%=/
MX/]' ^ HZK9,U_]+3X^/!E/:\LG@!"8\4+<%A_F$T+[34UCZ9' \&2/.!I/3
MT6 \Q;\/)Z>#Z?&D7TEU#LUO5%)#_8 [FP#7:&K2"D)-^*Y,UK;]7)>TB [+
M#%3XS"9)"@.JYJ4Q.;$:(^4[B?RFYLEZ8R=AB;;_I4"2AJ]9L]8U&4@0-M0&
MJM_5CP.LL=&>HCH4TD3#25I+X$0-MQ*T+W*):M0[:R/54A8!NI#U"W'%95!Y
M(YX39[PO.5L\5KNM+1OLRR&?2FIHZ=:H>G3UB?7R) OIP>J:1CG!C[Z%VE4"
M!3N+$\W_=;:,ZK9E2#'TZ[>X=A$LBB70]G>-EVX=V.'DO]T.\Y"+R)RB7'X+
MJ6\JB)U!78)^!/-0B.S3=P:M77CQKQYV> 8Y*]=HSI2IC\_W-N2*Z]I\^L/>
MVC;]'+UD+Q[1EO8M6N\N^BDM4[7MPA#+5[57T^H+3?O& Y/^Q@/GDJ<GF^D,
M2W]#ZP$<5@4>C/9G2<%"V%&_\X,T]_U8Q'QT";/ !!MD+^@;%<\OQT8S$T46
M_^"1@SY\^P8(D_X&"#>K=+,A%HI^2/@'O=>=6/^&[@=V<!4.KKN_Y8)0J\XS
M#_Q.@_8P/M*C1ZHS)KX^>])?GWV&:6R@2O369?2/L:>+EQ]8<:'%[C?QUL:'
M@^GT]/&]^>K'27_U8]")W#8Z[-S=-Y0^^J&5ZZ'8]5VR1[-:X\D-/3SV#:K,
MX?!6EK&7.4^][Q.,9<Q(D_Q"R@N5C,%!USQ*Y!T056XR='UA +7,=^1"M\M!
MCJ][AT>#DSLW<IYQ2"R]Y,@8%O'!L ^%SH"-94$-&OG]T%L!DA1M A0V(/NP
M$T_8+88G6*0P9#IKN-/M#69M+BC>X)KJRB@<Z4AV7_,=@U6K8S![@KQ+-'&[
MY$$<@'DFV6:L&FW0VS?WQ$5)N.CJW%E'  #7?62=+ PNF_HI=\TI2J23 )PU
MMS!83([N6-Z,O"OO##&5R*K$2!8A#)4-Z:<E!IOT9K6M*+:"OD=:D:A0,T/"
M';Z>?\'@WD[3:S(56)_=@IC^1V$;SE)O:$ZKI")W^(]XJ+9=*^-2N#:A1=V6
M>*&T-HPSD![/"/ + WF196'?DE"GMF$-9[YP$,MZ!W<&IU6#28Q?HH1U'>YV
MM28RK+D(@!:##KPY)8A6VPITJ Y"29QFJF*:\;MQ5&*EORVZ#%V:]FE93!N+
M0]W![D(.J[[3)]/1X/CH"2S6UQU/^NN.WP+N<R.^*B0W<G5F27?ZWC<4',L$
M:F<",@"6398=D,EK0.DNML:T:99M,9L )83"';\IMH&]N*3%Q)Z=Q"BEZ $E
MU2S0M@0*+!N.[P*RK79:&7\L'&[E). A13)*[H*.T7;Q%K=!M@G0;B)M?IK9
M/ZCS<.%.U=RDJ"M0[D)G)F=I@!.C? FV'-SCP9%;*D*@^$"X^>H)T-I%"S*B
M6L*V1(%68<<?*XYM?*=?'0U.1A.F0\2C#=7N#.=J$5ZK WU34./O&UL3PVXA
MZ0[@[AKY>'/^T25EVKJ/\?#5T9_TX6 T&L% %Q;>ZA.;W["U=PTF(,@@%Y_>
M[0XQ^9-[E8I"+O.J*0G<-W3V_=N7-SMOCX83/_\O#0!279NJ:+ MYUL4E@7'
MVJ)E_'+]MF,=?_KWU>)]T?&DO^CX,FBPULF*OJ'2F,>4]G![LY2B'G$=I]+W
M(&\_+:$M4OOYV"1?7=[0+.[Z1SV;E3U;X5TG&*:B' R;'\&]"+UC"JL!N+C
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M^)^N6T35_;(>&%FZ'K62!CN>>\1]E(&R ?A^+:4Y#JQ \Z=E^"]02P,$%
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MZ1?$%W?FB]D\6>1?(9Z.(?G',IU/DFE^"/#CTN8"LU:H)XO4*Z#?&K;#/%)
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M[X(+$_1J/T1C?034L2/??X&2*O:MH>"A#OXP1%9])!W@?V"[B%PN6/5W\,/
M]HW) WN  D^MG"N$?A]H'\!'U3T[]%SM,]L;.K;KZW'?&]I^Z,&19(OVR1;]
M<+)A@";8#<%HN5@D4]/]Y(MXFMVV49O\:_09"T0""PSH@SEW5-3AG,L%>J T
M669AEF'*84=98P\H!*U-0\)JQ;%6?7!A2^ZQ%E):8RNXHKKJZB1IDT\[D3X6
M6RS5%'38ZJQLLPAE[:AI@P'; \97WR7J3YEMQ;K0ODU$DWO?K6 .SHVP4QW^
MDZ\+.&N->*,D]+N.IS]O3G_^=7SX=-2- OT90GP3SQ,KSN<PFBWFLT6KZG2F
M-<QGN#C-L($=F\ISG4YC-"N^A2S'!7WW8UL[:A%^LO >0H0D9C+#ZE[KF@&9
M,@B.$5I=E3[^\K>!YSF?4"4S<C^=V%HUNE,&Y;HQEJ/_Y!;S2IZ U[5^IL=&
M?7/-V8T^C4_^3R7Q&6",(8'OKF,N0;)^U^WK3_@]V3'?8"?4'?3UQS^8FKU7
M#Y9*EPG]+-/=)?;@[=MEO[I_^<7M@^?/X^VS<4*P8-<2&XXUDCH8%QT0[5.L
MG2B^,\^?.Z[P,66&6WR]4J$/X/Z:<_4RT0+V[^'+/P!02P,$%     @ TTM_
M4FY7PV#< P  -0@  !D   !X;"]W;W)K<VAE971S+W-H965T,C@N>&ULE59M
M;^(X$/Z>7S'*5:<B1<TKI=M2I!3H+E(+"-*>5J?[8((!:Q.;M4UI]]??V G9
M=K?M];X0>SSSS#.>\0S=O9#?U(92#8]EP=6EN]%Z>^[[*M_0DJ@3L:4<3U9"
MED3C5JY]M964+*U16?A1$)SZ)6'<[76M;"I[7;'3!>-T*D'MRI+(IRM:B/VE
M&[H'P8RM-]H(_%YW2]9T3O7==BIQYS<H2U92KIC@(.GJTDW#\ZO$Z%N%>T;W
MZMD:3"0+(;Z9S6AYZ0:&$"UHK@T"P<\#[=.B,$!(XWN-Z38NC>'S]0']VL:.
ML2R(HGU1_,66>G/IGKFPI"NR*_1,[+_0.IZVP<M%H>PO[&O=P(5\I[0H:V-D
M4#)>?<EC?0\?,8AJ@\CRKAQ9E@.B2:\KQ1ZDT48TL["A6FLDQ[A)REQ+/&5H
MIWOWZ6R47MT,833.AK/A/(/A.!ME7^'XSS_.HBBXN!\-[2J\:,%Q1A8%5:VN
MK]&U ?#SVLU5Y29ZPTT8P:W@>J-@R)=T^1+ 1\X-\>A _"IZ%W% \Q.(0P^B
M( K>P8N;BX@M7OP&WD2N"6<_B*D5#_J"*U&P):E*AR]A*JFB7%<"L8)KQ@G/
M&2E@CD**=:H5_)TNE)98:?^\PRAI&"664?(&HWG_RW!PAZF97,-;:7HM$^^C
M9AOJY$3*)\;70$JQX]J$HS<4ZE2'G0L%1"F* 9G("T86K&":405[*BF>P4H4
M^)S5.7R$I(.YHN6"RB9?3G\G)=[8P<T1)&=>)^PT\N<^C]NQU^[$T'+&V*3P
MQ;&<:30Y3KRS]BF*_P/^W.D3M;&AY&9!O^_8 RELPHX@[GCQ6<?!]&X)6X(F
MC^@R#+TX#IQ,:,QO_G&NY\X$+U+"ECS9EV*=DCR7._KR'H\@]#X%R:_J]OK#
M"V!<4YF+<DOX$[1#[_3TTR]D7H+5-Y1^3J=#)\VFT)_,II-9FHTF8QA/LN'<
MR28H',\G-Z-!F@T'<#T:I^/^*+V!>8:"6TS5'(ZKF/(GASYBC\> E\@%[CC3
MN+*%KF" N2=2-1WB;GYTZ! >T,><;C76AP2^LTG!XE(;@F MB$^<_]=OD'%6
ME^2@!:9TJ^'!?B ='$P2GR.6,8)C$U:OUO'+>G6PE5N=KY3(JA?![^4S>8;\
M0/G.WG&<G&+*.LYG*92"K10K6X6)ER21<V-D*RG* ROL'Z9$P\#KM*.Z= NC
MA,(H\8(P@=9K/<)_ULI+*M=V8"G(S3NMNGHC;69B6HV"G^K50+TE<LV01D%7
M:!J<=-HNR&I(51LMMG8P+(3&,6.7&YSK5!H%/%\)H0\;XZ#YI]#[%U!+ P04
M    " #32W]23\9">:<%  !)#   &0   'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6R-5UEOVS@0?M>O(+S%P@&X,75+W22 KVX,Y%H[:5$L]D&6:)NH#I>4
M<^ROWX^4[-I-8O0E%H><;V:^.<B</57RFUIQ7I/G(B_5>6=5U^N/O9Y*5[Q(
MU&FUYB5V%I4LDAI+N>RIM>1)9I2*O.<P%O2*1)2=BS,CNY,79]6FSD7)[R11
MFZ)(Y,N Y]73><?N; 53L5S56M"[.%LG2S[C]</Z3F+5VZ%DHN"E$E5))%^<
M=_KVQX&OSYL#GP5_4GO?1$<RKZIO>C')SCM,.\1SGM8:(<'/(Q_R/-= <.-[
MB]G9F=2*^]];]$\F=L0R3Q0?5OD7D=6K\T[4(1E?))N\GE9/E[R-QSB85KDR
M?\E3<]:'Q72CZJIHE;$N1-G\)L\M#WL*$7M'P6D5'.-W8\AX.4KJY.),5D]$
MZM- TQ\F5*,-YT2IDS*K)78%].J+P</L9G(SGLW(\/9Z,+GIWT]N;TCW/IGG
M7)V<]6K8T"=[:8LW:/"<=_!LAUQ79;U29%QF/#L$Z,&YG8?.UL.!<Q1QQ--3
MXMJ4.,QA1_#<7<2NP7/?BWBC(%&*#*MB+LI$%X<B__3GJI:HD7^/F/!V)CQC
MPGO'Q.SA^KH__4IN/Y'^;#:^GY'^\.^'R70\(OV;$;F:] >3J\G]9#S3^P_7
MX]%;1!^UH9OUHUHG*3_OH!L5EX^\<W&_XM:BRM%IHER26B>Q;3?Q'U>D7G&2
M)E*^D,<DWW!2+8Q(9+RLQ4*8XXE2O%;HEN\;(7E&DC(C.;9$+FH!#.QO"LC1
M45K7G%/"=%B6U)Q:3RN1KM"OQJNR;JR6&"_KC4Q7:""REB*%)MQ,#?M;+*V_
M]6D?%Z+^[.J4M+1:OTZK-331?M;16HV.-=Q(";_:0'%"K<@'8E.'!=2+7>L6
MYB7\3[EX-%U 7)<Z-GMCXP^L<CB=D74B#3N.'5/;L:U)^0@;E=2RP YH%#'K
M#IPD(D-:GB%M#$8X:^0OA>%*LUT9.VT>7#NB3A!:]U6=Y!@(^[X3EP:,T3!V
M6M_:D.XD9K:L7PP:!X]K#4Y-$ES'IX$7P<$Z*9?B1\:;[8 &46"-^()+G?S&
M57.@V;=#ASH^:]TY\-1G'O4CK]UJA1^(1VWF4S<,K(/\(%^SR_YT?'E[-1I/
M9[__!B;"/\D8^;S_NLO17N%9_32M-IHCD&4J]9#]%VTKMFG@1%#7<Q.N97Q=
MH8@TVYJI@ 4M4RU&0WB2IG+##\O<83%E<? 3[P<GJ,MLZKI;,H[M:>I^;BR;
M1F",>0$Y,G'\W<3QCT^<X>5X]' UUB/G;GI+/MU.K_L$P_W5;']KTAS%?GO2
MD%^W:.'Z-#W]E2>RN1;($=%,/!]<(:C&E!=S)&U["9"?)';\6F)-.3H0,TY7
M8!"[- K=IAH#AJYC^$8E>VAY'_52J5I/&=GJ=*/0IR&+R GIAE%,/1;K3R_$
MI\W(B?67K'"!K&6U$&@I&J%)[<#'EQO:.&(CN6$0(KG1ME/0D)AU&,K\&>\I
MA1KI0L_%M(@\C>U3%MDTMD.]<*@71#1F#DQ-RA2E3+HY+)Z0A:R*+9B^MKJ.
M377\4())FU&?!<9KE%_D [FM=]&BM-9/FF[&8*&!Z\*5R$/%&D=L<!)X\2O+
M<XX7(-\"-8-!\Q?8GG:8Q1YH8!HA\B*XX0)AP$NN&0*U79#U*,Q3#C@GASB(
M B';VKZK!V@4$]L&?2RV;N"F.'#D W$]S$Z=01TS,A4X-M'R;HCL>[&.^K4:
M."-8%W! K1*IQP=><R(U$R 3^48/$G8*W-T?ZXMYT^E+\!&,+W&-;4R1(9Y]
M*$7PVE68IYE.\%NX\#G4I0:>O/#HZJU9T-M[WF&J+<TC5A$S#IN7WDZZ>R?W
MF^?AC^/-(_LZD4N!NLGY JKL-$3KR^;AVBSJ:FT>B_.JQ@@UGRN\];G4!["_
MJ*IZN] &=O\]7/P/4$L#!!0    ( --+?U+UP=UL<@(  'D%   9    >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;)54;6_:,!#^WE]Q\J9IDUKR A3*(%)X
MJ5JI+PAHIVG:!Y,<)*H39[8I[;^?[82,2H"T+\G=^>YY[BYYW-]R\2(31 5O
M&<OE@"1*%3W'D5&"&94-7F"N3U9<9%1I5ZP=60BDL2W*F..[[J63T30G0=_&
MIB+H\XUB:8Y3 7*3952\#Y'Q[8!X9!>8I>M$F8 3] NZQCFJIV(JM.?4*'&:
M82Y3GH/ U8"$7F_8,ODVX3G%K=RSP4RRY/S%.+?Q@+BF(608*8- ]>L51\B8
M =)M_*DP24UI"O?M'?JUG5W/LJ021YS]2&.5#$B70(PKNF%JQK<W6,W3-G@1
M9](^85OF7EX1B#92\:PJUAUD:5Z^Z5NUA[V"KGNDP*\*?-MW262['%-%@[[@
M6Q F6Z,9PXYJJW5S:6X^REP)?9KJ.A6$H]'CT\-B#K/):'+[' [O)A ^C.%0
M_,NGKN]YWW7H+EQ,QC -9XN?\'5!EPSEM[ZC=#\&U8DJ[F')[1_A]GRXY[E*
M)$SR&../ (X>I)[&WTTS]$\BCC%J0-,[!]_UW1-XS7H[38O7/((WPPC35SL?
M_ J74@G]%_T^ =RJ@5L6N'4$>#ZZF8R?]$X?KP^M>@X7'[=\:+DG&8R8>[*@
M$0Z(5JM$\8HD@/_E/0LE\!7HO6*V1%'O%@[&O:NS,(KX)E=2"W:W.O@,7L<_
M[[0[VKHXF+'[LP0RJC"&@@KUKGMI^^YYIWMYMN"*L@\XU0D<^A;.GAPR%&LK
M>@F6ME1&':WOE;"4T[_T\E*ZIV*=YA(8KG2IV^BT"8A2Z*6C>&'%M>1*2]6:
MB;X;49@$?;[B7.T<0U#?ML%?4$L#!!0    ( --+?U*AV[UK3 (  .P$   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;'U436_;, R]]U<0P@X;T-6.
MDVYID 1(FA0-L'Z@:;O#L(-BT[906?0DI6G__20Y\3*@R<4B*?+QD28UW)!^
M,26BA;=**C-BI;7U((I,6F+%S1G5J-Q-3KKBUJFZB$RMD6<AJ))1$L??HHH+
MQ<;#8+O7XR&MK10*[S68=55Q_3Y%29L1Z["=X4$4I?6&:#RL>8%+M$_UO79:
MU*)DHD)E!"G0F(_8I#.8]KQ_<'@6N#%[,OA*5D0O7EED(Q9[0B@QM1Z!N^,5
M+U%*#^1H_-EBLC:E#]R7=^A7H797RXH;O"3Y4V2V'+$^@PQSOI;V@3;7N*WG
MW..E)$WXPJ;Q[28,TK6Q5&V#'8-*J.;D;]L^[ 7TXP,!R38@";R;1('EC%L^
M'FK:@/;>#LT+H=00[<@)Y7_*TFIW*UR<'2]NG^>WCW</B_D2/C_RE43S91A9
MA^SOHW2+,FU0D@,HG01N2-G2P%QEF/T/$#E*+:]DQVN:'$6<87H&W<XI)'$2
M'\'KMG5V U[W4)WJ%94E_0XS85))9JT1?DU6QFHW&+^/9.BU&7HA0^] AN7E
M]7SV]&,.=U>PU]6/FGD4R*_AP-0\Q1%S>V90OR)K^0LT)RFYG3 6* =;(N0D
MW6H)50S@ (>3B?'.KJ=8K5"W?84/[9V+DRNAA)NI# JBS, G..]?G/8[/2=]
MA8]Z%>U-8(6Z"'MF(*6ULLTPMM9VE2?-!/]S;]Z!&ZX+H0Q(S%UH?/;]G(%N
M=JM1+-5AGE=DW78$L73/$6KOX.YS(KM3?(+V@1O_!5!+ P04    " #32W]2
MKTO?3( "   Z!0  &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6R-E%EO
MHS 0@-_S*T9H'W8E6JZ$'DJ0DD+52-L6)>T>CPX,P2I@UG::]M^O;1(VE9IH
M'X 9>^:; X_'6\9?1(DHX:VN&C&Q2BG;:\<168DU$>>LQ4;M%(S71"J5KQW1
M<B2Y<:HKQW?=T*D);:QH;-92'HW91E:TP92#V-0UX>\SK-AV8GG6?F%!UZ74
M"TXT;LD:ERB?VY0KS>DI.:VQ$90UP+&86%/O>C;4]L;@!\6M.)!!5[)B[$4K
M\WQBN3HAK#"3FD#4YQ5OL*HT2*7Q9\>T^I#:\5#>TV]-[:J6%1%XPZJ?-)?E
MQ+JT(,>";"JY8-L[W-4STKR,5<*\8=O9#GT+LHV0K-XYJPQJVG1?\K;KPX'#
MI7O$P=\Y^";O+I#),B:21&/.ML"UM:)IP91JO%5RM-$_92FYVJ7*3T;I(DFG
MO^^3AZ<E3!]BB)/T<3E7RM<GLJI0?!L[4H71QDZV0\XZI'\$Z?EPSQI9"DB:
M'/./ $?EUR?I[Y.<^2>),6;G$'@V^*[OGN %?=&!X07'BN;8DG=UM*2 :9-#
MC"T35(H3Z&&/'AKT\ AZ>7.7Q,_?$WB\!=/;>0S)KS1Y6"8?&_Q97T^B]7A>
MBY9D.+'4_ GDKVA%\-\!!U,!K #S'I@.T!SP34VW0 %?X$P]OAT.O<$",Z2O
MYO=#P5D-@F@QIT)RNMI(Q@4$(SMP?3@;['L'DJG);MN*HMKV0\]VPTOU#>W1
MR!\\,4DJ'> JM(,+5TOAE>U=!?!9SYV#\UPC7YNI%9"Q32.[H]VO]A?#M)N'
M?^;=K7)/^)HV BHLE*M[?C&R@'>3VBF2M68Z5DRJ63-BJ2XWY-I [1>,R;VB
M _379?074$L#!!0    ( --+?U)J8=,'X@(  .P%   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,S+GAM;'U476_;.@Q]SZ\@C.%B WSKCSA9DYL$2-L4&[!V
MN6VZ81CVH-AT+$R6/$ENNG]_*3GQ>H$V+[9(D8>'D@YG>Z5_F@K1PE,MI)D'
ME;7--(I,7F'-S)EJ4-).J73-+)EZ%YE&(RM\4BVB-(['4<VX#!8S[UOKQ4RU
M5G"):PVFK6NF?U^@4/MYD 1'QQW?5=8YHL6L83N\1_O0K#5948]2\!JEX4J"
MQG(>+)/I1>;B?< 7CGOS; VNDZU2/YWQL9@'L2.$ G/K$!C]'O$2A7! 1./7
M 3/H2[K$Y^LC^K7OG7K9,H.72GSEA:WFP7D !9:L%?9.[3_@H9^1P\N5,/X+
M^RXVHXIY:ZRJ#\EDUUQV?_9T.(=G">?Q*PGI(2'UO+M"GN45LVPQTVH/VD43
MFEOX5GTVD>/27<J]U;3+*<\NUG>?UZN[S3=8WE[!ZM^'C^N;U>TFA-O5!MYN
MV%:@>3>++%5R\5%^0+WH4--74),4;I2TE8&5++#X/T!$%'N>Z9'G17H2\0KS
M,Q@F(:1Q&I_ &_9]#SW>\+6^-;UK;7^'L!9,6F"R@-6OEC?TX"Q\7VZ-U?1B
M?IPHE?6E,E\J>Z74_>6'U=7#IQ5\OH83Q_W2*9\$=GJ=FH;E. ](D ;U(P9]
M8P/7$1X["D&2P'-%8C(65 FV0BB5($URN9O"D>/@-,?!TKADN@RLMZC["X$7
M_<ED<*GJIK7D<6Q46?(<_Y""-W">A-GP/2W^'ERW6G+;:H2_6-W\ R5_<I:!
M)!V'D_&80CXAZ:]2H@!>-UH]HD,QD"9QF$U<P!>L>"X0DC@-1^.,//?MUBK+
M!(Q2*C4>>A1CIC0.\K9N!;-8D(KI_'+._)QXFZ;#,!EE\(YB-S[W#:23\W 8
M3QQ1>.E)1,\46*/>^3ECZ,!;:3LQ]MY^E"T[!?\)[^;@#=,[+@T(+"DU/GL_
M"D!WLZ4SK&J\GK?*TG3PRXK&,6H70/NE4O9HN +]@%_\!U!+ P04    " #3
M2W]2*PG:J)4"  !M!0  &0   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q]
M5$UOXC 0O?,K1M$>6HEM0H!^($#BJRU2VZT*W3VL]F"2"8GJV*SM--W]]3MV
M(&4EX$(\XWEOWM@\]TNIWG2*:. CYT(/O-283<_W=91BSO2%W*"@G42JG!D*
MU=K7&X4L=J"<^V$07/HYRX0W[+O<LQKV96%X)O!9@2[RG*D_8^2R''@M;Y=X
MR=:IL0E_V-^P-2[0O&Z>%45^S1)G.0J=20$*DX$W:O7&'5OO"KYG6.J]-=A)
M5E*^V6 >#[S "D*.D;$,C#[O.$'.+1')^+WE].J6%KB_WK'?NMEIEA73.)'\
M1Q:;=.!=>Q!CP@IN7F1YC]MYNI8ODER[7RBKVF[;@ZC01N9;,"G(,U%]V<?V
M'/8 U\$10+@%A$YWU<BIG#+#AGTE2U"VFMCLPHWJT"0N$_92%D;1;D8X,YP_
M+4=/=_/QPPQ&B\5LN6C"TVP)9TNVXJC/^[ZA)K;4C[:$XXHP/$+8"N%1"I-J
MF(D8X_\)?%)72PQW$L?A2<8I1A?0;C4A#,+@!%^['KGM^-I'^.ZDC,N,<V B
MAKDP3*PS&A9&6J/1,,UTQ*4N%,+/T4H;17^<7R?:=NJV'=>V<Z3M8G(_F[[2
M.7^[A<.G?NBP3W):Q_;TAD4X\,B2&M4[>L//D1K,C=0$@:8)D20K:0,R 9,B
M))*3(S.Q[L%.6N.HM,9(6QQ=!>8K5/5UP,%\ZZ8QD?FF,)31,C$EH\/\ NUN
M\SIHT>)KXP&U[I$EHR(O.#,8 \NE,ME?YKQZ%MXT;ZZZ<$ZE2VD8)Q"!PTL+
MAD.7X>]9($>U=D;7-',A3.6&.EN_):/*0I_EU4/TR-0Z$QHX)@0-+JZZ'JC*
MW%5@Y,89:B4-V=,M4WH/4=D"VD^D-+O -JA?V.$_4$L#!!0    ( --+?U*K
M._8 Q (  -<%   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;(U4;6_:
M,!#^SJ\X1?O02HR\0: 5( %-5[315;QTGTUR(583.[,-=/OULQ,(3"JH7V+?
M^>YY[B5W_3T7;S)%5/">9TP.K%2IXMZV991B3F2+%\CT2\)%3I06Q<:6A4 2
METYY9GN.$]@YH<P:]DO=BQCV^59EE.&+ +G-<R+^C#'C^X'E6D?%G&Y2913V
ML%^0#2Y0K8H7H26[1HEICDQ2SD!@,K!&[OVX;>Q+@U>*>WEV!Y/)FO,W(TSC
M@>68@###2!D$HH\=3C#+#) .X_<!TZHIC>/Y_8C^6.:N<UD3B1.>_:*Q2@=6
MSX(8$[+-U)SOG_"03\?@13R3Y1?VE6U;&T=;J7A^<-81Y)15)WD_U.',H>=<
M</ .#EX9=T541OE %!GV!=^#,-8:S5S*5$MO'1QEIBD+)?0KU7YJ.'U^#1?+
M6?B\A.DSS$;S[^%R-/X1PB*<K.;3Y31<P,V2K#.4MWU;:4;C9T<']'&%[EU
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M"@HKP=,][!B5;X60Y:U)CCS!'(X\R<@Q3%C*M,(CG36W>>KI/;UE:.?T^)]
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ME56@[QLIS5FP#LJ=/_@74$L#!!0    ( --+?U+D 8-)R@4  "D;   9
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M-5VD2IZCWWU$<)Q:Z \;^D,[?0X-3$N<U?I+)26BC;4=95HLB9!J &OR*<N
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M0F^ ]17GZGF@+ZC5%\S@'U!+ P04    " #32W]2V7-$LA\#  #!#   &0
M 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6R]5VU/VS 0_BNG?-HD1.(46D!M
M):"IJ-1"1UNF:=H'TUP;BSC.;(>"M!\_.VF3(HT4ALJ7Q&_W/'=^[,NEO1+R
M046(&IYXG*B.$VF=GKFNFD?(J3H4*29F9B$DI]ITY=)5J40:YD8\=GW/:[J<
MLL3IMO.QL>RV1:9CEN!8@LHXI_+Y F.QZCC$V0S<LF6D[8#;;:=TB1/4LW0L
M3<\M44+&,5%,)"!QT7'.R=F%[UF#?,4=PY7::H,-Y5Z(!]L9A!W'LQYAC'-M
M(:AY/>(EQK%%,G[\7H,Z):<UW&YOT/MY\":8>ZKP4L3?6:BCCG/B0(@+FL7Z
M5JRN<!W0L<6;BUCE3U@5:UN&<9XI+?C:V/0Y2XHW?5IOQ)8!:;YBX*\-_-SO
M@BCWLD<U[;:E6(&TJPV:;>2AYM;&.998529:FEEF['1W<GD5]&;# &[Z$$RF
M@]'Y-.C!;!+T9T,8#NZ"B9T9W]Z,@]OI#SB_[D'P;388CX+K*7SIH:8L5E_;
MKC:^6$1WON:]*'C]5WB)#R.1Z$A!D(08O@1P31!E)/XFD@N_%K&'\T-HD /P
M/=^KP6N4.]/(\8Y>P;L4/,TT2@A^9RPU!U'#SQ'R>Y2_X ^,6,)XQLNA&L*C
MDO H)VR\0CB6YJY)_7P XY@:-IJ$V]Q#LQP&&KFJ(SLNR8YKHPN49N9,8P@S
MA8LLAB%;((@%;+QX2?\O@>L)CN$9J50UKC9+5YL?$8(^O56(5DG8VK\0)R79
MR;Z%J"=H[13BM'3UM!:IG\F$Z4QB[E*?/=FV^L];0;PJ0WG[EX-L)42R;T%V
M,#1W*D+\REO_HYJ\_8*0*C>2QB=H4F5&<K1W3>H9=M\24J564I_ZAFC*A$C$
M(0QX*L4C6I_4FP2H<B)I?H( 548DK?<*\&B.V?L4J*?(=PVF*'F=QU5:)?5I
M[PXC-H_Q;=M>94!RNO]M]ZO4YWO[/O<[&&H^T^Y65<E1+O/:6<%<9(DN"LQR
MM*S/SXNJM%I>%/<C*I<L41#CPIAZARUS@611+Q<=+=*\1KT7VE2\>3,R_Q@H
M[0(SOQ!";SJ6H/QKZ?X%4$L#!!0    ( --+?U)M.4"06P(  !T%   9
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MSU]8_D)VRC?C89+]!<_;6%=EG*T3R:,<K,ZC(-[^IR]Y(78 BJ<>@'( :@K
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M)QCHAXS&2: D[-%&;HJU5V/K5/)A;=G8O)1]4[Y>3E#Z1'61Y52FMCRLM+[
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M#N+Y\7!^(5F2'6<^,BE9E'U= 0F :P/U^X*IG51QH0<H#^DO_@%02P,$%
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M@J7%Y8J2!>7*0+Y?,B;>;U2 ^I1T^AM02P,$%     @ TTM_4GBN]QQ( @
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MM5W?/,#\STMNF(CU+V/'  /KQXE*M'F!1CO0ECRZ0R[Y@"BF>+,&7S^]\^(
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M1@#OET+H0\,$:*^=H_\ 4$L#!!0    ( --+?U*8$]K!5 4  +@8   9
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M"W'$;IM\=R)Y5FZZ7G,I>5(>AHS",E,7P.\WG,O'$[6/6_^S8OXO4$L#!!0
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M>F)=6:B$)=Y0.6>[.^C\!)JO8%28)]JUN:%GH6(C)*LZL%)0D;I]XWU7AR.
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MU^J_ 5PGJ/4E8_(PT*VI_Q/%_P%02P,$%     @ TTM_4OQ?L"%" P  20P
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M](.H/F&33\_R98(I]X6J]NU%'F0;I479@$T$)>7U2G9-'0X AN<X(&P X6M
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M,X]16@=SOQ1"[PTKT$[X^#=02P,$%     @ TTM_4@3N&*7; @  5@<  !D
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MUB!0!+SMXNU$LKIIA"],JK;:# MU\0'7 6H_9TR^3W1O[:[2\!]02P,$%
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MTDP.F NY3PJ 8KI/1%.IY19.9J'VZ</8=6W?'NJ'ZIS65="RH>N6LI, [3)
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MMJL!:<0C@:THC9%.9<;8LY[TYRW#THH@@E!J"JS^-M"%*-),2L>WG-0H]M3
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M><!)*&_8>D(*AS(#/1:*[#]8%V.M!O 2(5E4@)4%$8WS7_Q<!&(#H'BJ :@
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M8YWE G5CA$?=&:%NC=#<&XN,K1+N!>K!Q@=^PFF\3 N*LJJ^\J4@?%OV^QL
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M_VJ1GTBVRMZ!WS,I690=!@2KX*8#U/T'QN3K23I!^>UH^!]02P,$%     @
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MB90 +Y^3<B+9QG3D!9.JOYOA6KW P+6!VE\Q)M\FNLE7;WK\%U!+ P04
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M$T+/%HK2F$EA5%;5XG>YTPNE5 6JK2KJ[4"@XK)$R1:$V>L;%B5047GLWZA
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M#>#]E'/U=*._9)0?TX[^!U!+ P04    " #32W]2GD,>@P0%   N&   &0
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M7FH&'3$#P2V-A,?!,%J010%^8,8WRO##$OO(0&#)F.6!0V^!ZR$CXX"X5>#
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M>^FZ*^1O..'IX3T2N5Z(V?,N\!?J$.F6@,[?$I!N"<C<$CZ4[!+.TL:+=#M
M9LV\D]Y^7LI,4]+BBVKGSX]6952RE?] ?@8EG(9B+$&V6U7'G%G= )!9E7_*
MC8C<L:L$GY(>+=&H>?[T:&5&K3.DQ\Q9;Q_)SK $V*Q5X9&TFH$-^SUP/R"Z
M>2"S7&=IO=_24]+J:.EV[+.GU=$:[,#/3VL)9PT>2VL)$-6K[>*TE@"=]GM@
M&A!KY[!12N4J.7CF((EJ>NB2/\T/MZ^3(]V#YSUXV8<%SX?P<I0>76OZ]"3]
M%K.5_)D. K*4INQJ4RH.2P^GTQM!X^2H\XD*J>/)I4>P3+L:(-\O*15O-\I
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MHQK\)RUL:>$I6M!%"\^B#5K:X!2MWT4;G$4;MK3A*5K811N>18M:6O0I[;$
MW1HW"D07,_K [ 71,#H&';70T>=0KC US8&PFJ&J%EFA^Q3*#KX3 <\U$9!W
MI1I]>(/[43@,/J1R#[J,:=AS++:DE(C"1BN]RZ&V$$T3;":*5[;QK+G2;<P.
M"_W? &$VZ.L;SM7[Q/2R]D^4_ 502P,$%     @ TTM_4EPS;* * P  3PD
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M7$K%TPU8>Y!2EK_)RR80>P"_<000; #!KX#:$4!U ZB>"JAM #4;F5R*C<.
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M)F9U"$L :"" QKL!LK-E!"!-!-+L$%)J"/T')<MWS']H++6%0%KO!NGNHPQ
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MT+!#"[5TZA 3L]"0O -J'R*<=B2(B5EH2&VA%YG^8J  SZQ@%K([&+Z]/>N
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MCVGJJFM^-L^C[=,_>3S]@\J7_P!02P,$%     @ TTM_4GKM3FU6 @  CBT
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M<',O87!P+GAM;%!+ 0(4 Q0    ( --+?U(<,, Y[@   "L"   1
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M965T,BYX;6Q02P$"% ,4    " #32W]2F?FM9D\#  !'"P  &
M    @(%L%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
MTTM_4BXL^:[W!@  HQP  !@              ("!\1@  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( --+?U*)=YCYF 0  *H5   8
M          " @1X@  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    " #32W]2_C#62 8*  ";-@  &               @('L)   >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ TTM_4A)^P$%>"P  OQP
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( --+?U)'3HH51 (  .8$   9
M      " @71U  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ TTM_4GEL/@YY @  .P4  !D              ("![W<  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " #32W]210,L.O@"   ^!@
M&0              @(&?>@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( --+?U(;X7O'J0(  +H%   9              " @<Y]  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ TTM_4I*G^ =3
M P  /0<  !D              ("!KH   'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    " #32W]2#PF:';4#  !6"   &0
M@($XA   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( --+
M?U+E=_BQ&P,  $T&   9              " @22(  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ TTM_4G3$_F_>!   .P\  !D
M         ("!=HL  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    " #32W]2:[['/3,#  #P!@  &0              @(&+D   >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( --+?U)G$-Y85 H  'H9
M   9              " @?63  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ TTM_4J5M-.\^!0  [PL  !D              ("!@)X
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " #32W]2-&7R
M.^X+  !'&P  &0              @('UHP  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( --+?U*OYPC+!@,  $$&   9
M  " @1JP  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
MTTM_4E=9N:HH,@  X:X  !D              ("!5[,  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    " #32W]2+[3@V0,$  # "   &0
M            @(&VY0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( --+?U(LJ]W?G@8  !L/   9              " @?#I  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ TTM_4FY7PV#< P
M-0@  !D              ("!Q?   'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    " #32W]23\9">:<%  !)#   &0              @('8
M]   >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( --+?U+U
MP=UL<@(  'D%   9              " @;;Z  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ TTM_4J';O6M, @  [ 0  !D
M     ("!7_T  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( --+?U+%;KS2FP(  "8&   9              "
M@7D+ 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ TTM_
M4D.W1#:I @  F 4  !D              ("!2PX! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    " #32W]266BCI-T$  !5#@  &0
M        @($K$0$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( --+?U(*OOQA104  (,-   9              " @3\6 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ TTM_4G$\-6J$ P  _P<
M !D              ("!NQL! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    " #32W]2Y &#2<H%   I&P  &0              @(%V'P$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( --+?U(J0Z#>
MS@,  ,T,   9              " @7<E 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ TTM_4MES1+(? P  P0P  !D
M ("!?"D! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " #3
M2W]2;3E D%L"   =!0  &0              @('2+ $ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( --+?U(G/09VA@4  . <   9
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M970T.2YX;6Q02P$"% ,4    " #32W]2892AK\(#  " #   &0
M    @(&;1P$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M --+?U)<TK_<7 0  ((.   9              " @91+ 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ TTM_4I@3VL%4!0  N!@  !D
M             ("!)U ! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    " #32W]2 )G,,&4"    !@  &0              @(&R50$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( --+?U)D%$;2% (
M 'H$   9              " @4Y8 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ TTM_4LE@[CV+ @  E08  !D              ("!
MF5H! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " #32W]2
M_%^P(4(#  !)#   &0              @(%;70$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( --+?U)7US; ;P(  "L&   9
M      " @=1@ 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ TTM_4L4?^\5V @  (08  !D              ("!>F,! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " #32W]2D_!=OF<"  #M!0
M&0              @($G9@$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( --+?U($[ABEVP(  %8'   9              " @<5H 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ TTM_4CN7/1%_
M P  > P  !D              ("!UVL! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    " #32W]2^\2375<#  #K"P  &0
M@(&-;P$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( --+
M?U(=GZX.5P4  $<:   9              " @1MS 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ TTM_4@#F< +( @  WP<  !D
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M=#8X+GAM;%!+ 0(4 Q0    ( --+?U)&===I'P,  %\+   9
M  " @2.. 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @
MTTM_4N([6^NZ @  $@@  !D              ("!>9$! 'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6Q02P$"% ,4    " #32W]26>;-$RL#  !6"@  &0
M            @(%JE $ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4
M Q0    ( --+?U*;U'G)N 8  %@;   9              " @<R7 0!X;"]W
M;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ TTM_4IY#'H,$!0
M+A@  !D              ("!NYX! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6Q02P$"% ,4    " #32W]2\@H7)J("  #!!@  &0              @('V
MHP$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( --+?U*6
M^VJE<@(  )4&   9              " @<^F 0!X;"]W;W)K<VAE971S+W-H
M965T-S4N>&UL4$L! A0#%     @ TTM_4EPS;* * P  3PD  !D
M     ("!>*D! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( --+?U)Z[4YM5@(  (XM   :
M          "  ;*Z 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( --+?U)5J+EG$@(  ',L   3              "  4"] 0!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !5 %4 2A<  (._ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>225</ContextCount>
  <ElementCount>422</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>83</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OrganizationAndBusinessBackground</Role>
      <ShortName>ORGANIZATION AND BUSINESS BACKGROUND</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/VariableInterestEntityVie</Role>
      <ShortName>VARIABLE INTEREST ENTITY (???VIE???)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - BUSNINESS COMBINATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BusninessCombination</Role>
      <ShortName>BUSNINESS COMBINATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE ??? RELATED PARTY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty</Role>
      <ShortName>ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE ??? RELATED PARTY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - PREPAYMENTS AND DEPOSITS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PrepaymentsAndDeposits</Role>
      <ShortName>PREPAYMENTS AND DEPOSITS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IntangibleAssetsNet</Role>
      <ShortName>INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInMarketableSecurities</Role>
      <ShortName>INVESTMENT IN MARKETABLE SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInNon-marketableSecurities</Role>
      <ShortName>INVESTMENT IN NON-MARKETABLE SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities</Role>
      <ShortName>OTHER PAYABLES AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/RelatedPartyBalancesAndTransactions</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - CONCENTRATIONS OF RISKS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ConcentrationsOfRisks</Role>
      <ShortName>CONCENTRATIONS OF RISKS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables</Role>
      <ShortName>ORGANIZATION AND BUSINESS BACKGROUND (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/OrganizationAndBusinessBackground</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/VariableInterestEntityVieTables</Role>
      <ShortName>VARIABLE INTEREST ENTITY (???VIE???) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/VariableInterestEntityVie</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - BUSNINESS COMBINATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BusninessCombinationTables</Role>
      <ShortName>BUSNINESS COMBINATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/BusninessCombination</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE ??? RELATED PARTY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE ??? RELATED PARTY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/Inventories</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PrepaymentsAndDepositsTables</Role>
      <ShortName>PREPAYMENTS AND DEPOSITS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/PrepaymentsAndDeposits</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/IntangibleAssetsNet</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables</Role>
      <ShortName>INVESTMENT IN MARKETABLE SECURITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/InvestmentInMarketableSecurities</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables</Role>
      <ShortName>INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/InvestmentInNon-marketableSecurities</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables</Role>
      <ShortName>OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/RelatedPartyBalancesAndTransactions</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://agapeatp.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails</Role>
      <ShortName>SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative</Role>
      <ShortName>ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails</Role>
      <ShortName>SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails</Role>
      <ShortName>SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails</Role>
      <ShortName>SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails</Role>
      <ShortName>SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails</Role>
      <ShortName>SCHEDULE OF VARIABLE INTEREST ENTITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative</Role>
      <ShortName>VARIABLE INTEREST ENTITY (???VIE???) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/VariableInterestEntityVieTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails</Role>
      <ShortName>SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - BUSNINESS COMBINATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/BusninessCombinationDetailsNarrative</Role>
      <ShortName>BUSNINESS COMBINATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/BusninessCombinationTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails</Role>
      <ShortName>SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - SCHEDULE OF INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfInventoriesDetails</Role>
      <ShortName>SCHEDULE OF INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails</Role>
      <ShortName>SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails</Role>
      <ShortName>SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails</Role>
      <ShortName>SCHEDULE OF INTANGIBLE ASSETS, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative</Role>
      <ShortName>INTANGIBLE ASSETS, NET (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/IntangibleAssetsNetTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails</Role>
      <ShortName>SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative</Role>
      <ShortName>INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails</Role>
      <ShortName>SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative</Role>
      <ShortName>INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails</Role>
      <ShortName>SCHEDULE OF RELATED PARTIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/StockholdersEquity</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails</Role>
      <ShortName>SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails</Role>
      <ShortName>SCHEDULE OF PROVISION FOR INCOME TAX (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails</Role>
      <ShortName>SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical</Role>
      <ShortName>SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails</Role>
      <ShortName>SCHEDULE OF DEFERRED TAX ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/IncomeTaxesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative</Role>
      <ShortName>CONCENTRATIONS OF RISKS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/ConcentrationsOfRisks</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - SCHEDULE OF LEASE COMMITMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails</Role>
      <ShortName>SCHEDULE OF LEASE COMMITMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - SCHEDULE OF PURCHASE COMMITMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails</Role>
      <ShortName>SCHEDULE OF PURCHASE COMMITMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agapeatp.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://agapeatp.com/role/SubsequentEvents</ParentRole>
      <Position>77</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="form10-k.htm">form10-k.htm</File>
    <File>aatp-20201231.xsd</File>
    <File>aatp-20201231_cal.xml</File>
    <File>aatp-20201231_def.xml</File>
    <File>aatp-20201231_lab.xml</File>
    <File>aatp-20201231_pre.xml</File>
    <File>ex31-1.htm</File>
    <File>ex32-1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
    <File>image_007.jpg</File>
    <File>image_008.jpg</File>
    <File>image_009.jpg</File>
    <File>image_010.jpg</File>
    <File>image_011.jpg</File>
    <File>image_012.jpg</File>
    <File>image_013.jpg</File>
    <File>image_014.jpg</File>
    <File>image_015.jpg</File>
    <File>image_016.jpg</File>
    <File>image_017.jpg</File>
    <File>image_018.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>113
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form10-k.htm": {
   "axisCustom": 1,
   "axisStandard": 22,
   "contextCount": 225,
   "dts": {
    "calculationLink": {
     "local": [
      "aatp-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aatp-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "form10-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aatp-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aatp-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "aatp-20201231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 582,
   "entityCount": 1,
   "hidden": {
    "http://agapeatp.com/20201231": 30,
    "http://fasb.org/us-gaap/2020-01-31": 142,
    "http://xbrl.sec.gov/dei/2020-01-31": 9,
    "total": 181
   },
   "keyCustom": 72,
   "keyStandard": 350,
   "memberCustom": 58,
   "memberStandard": 23,
   "nsprefix": "AATP",
   "nsuri": "http://agapeatp.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://agapeatp.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - BUSNINESS COMBINATION",
     "role": "http://agapeatp.com/role/BusninessCombination",
     "shortName": "BUSNINESS COMBINATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY",
     "role": "http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty",
     "shortName": "ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - INVENTORIES",
     "role": "http://agapeatp.com/role/Inventories",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:PrepaymentsAndDepositsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - PREPAYMENTS AND DEPOSITS",
     "role": "http://agapeatp.com/role/PrepaymentsAndDeposits",
     "shortName": "PREPAYMENTS AND DEPOSITS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:PrepaymentsAndDepositsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET",
     "role": "http://agapeatp.com/role/PropertyAndEquipmentNet",
     "shortName": "PROPERTY AND EQUIPMENT, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - INTANGIBLE ASSETS, NET",
     "role": "http://agapeatp.com/role/IntangibleAssetsNet",
     "shortName": "INTANGIBLE ASSETS, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:InvestmentInMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES",
     "role": "http://agapeatp.com/role/InvestmentInMarketableSecurities",
     "shortName": "INVESTMENT IN MARKETABLE SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:InvestmentInMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES",
     "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecurities",
     "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES",
     "role": "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities",
     "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS",
     "role": "http://agapeatp.com/role/RelatedPartyBalancesAndTransactions",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "role": "http://agapeatp.com/role/BalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:NotesReceivableRelatedPartiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - STOCKHOLDERS\u2019 EQUITY",
     "role": "http://agapeatp.com/role/StockholdersEquity",
     "shortName": "STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - INCOME TAXES",
     "role": "http://agapeatp.com/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - CONCENTRATIONS OF RISKS",
     "role": "http://agapeatp.com/role/ConcentrationsOfRisks",
     "shortName": "CONCENTRATIONS OF RISKS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://agapeatp.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://agapeatp.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)",
     "role": "http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables",
     "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Tables)",
     "role": "http://agapeatp.com/role/VariableInterestEntityVieTables",
     "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - BUSNINESS COMBINATION (Tables)",
     "role": "http://agapeatp.com/role/BusninessCombinationTables",
     "shortName": "BUSNINESS COMBINATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://agapeatp.com/role/BalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY (Tables)",
     "role": "http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables",
     "shortName": "ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - INVENTORIES (Tables)",
     "role": "http://agapeatp.com/role/InventoriesTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)",
     "role": "http://agapeatp.com/role/PrepaymentsAndDepositsTables",
     "shortName": "PREPAYMENTS AND DEPOSITS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)",
     "role": "http://agapeatp.com/role/PropertyAndEquipmentNetTables",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - INTANGIBLE ASSETS, NET (Tables)",
     "role": "http://agapeatp.com/role/IntangibleAssetsNetTables",
     "shortName": "INTANGIBLE ASSETS, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)",
     "role": "http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables",
     "shortName": "INVESTMENT IN MARKETABLE SECURITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:NonMarketableSecuritiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)",
     "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables",
     "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:NonMarketableSecuritiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)",
     "role": "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables",
     "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "role": "http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://agapeatp.com/role/IncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)",
     "role": "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://agapeatp.com/role/CommitmentsAndContingenciesTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31_custom_SubsidiaryCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:NameOftheCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
     "shortName": "SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31_custom_SubsidiaryCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "AATP:NameOftheCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)",
     "role": "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
     "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-05-072020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
     "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails",
     "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
     "shortName": "SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-012020-12-31_custom_SurvivorSelectMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31_custom_PeriodEndMYRMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails",
     "shortName": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31_custom_PeriodEndMYRMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AllowanceForDoubtfulAccountsReceivable",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
     "shortName": "SCHEDULE OF VARIABLE INTEREST ENTITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31_us-gaap_VariableIncomeInterestRateMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31_custom_SubsidiaryCompanyThreeMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Details Narrative)",
     "role": "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative",
     "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2018-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity",
     "role": "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity",
     "shortName": "Consolidated Statements of Changes in Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2018-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)",
     "role": "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails",
     "shortName": "SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails",
     "shortName": "SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - BUSNINESS COMBINATION (Details Narrative)",
     "role": "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
     "shortName": "BUSNINESS COMBINATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:TimeDeposits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails",
     "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - SCHEDULE OF INVENTORIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfInventoriesDetails",
     "shortName": "SCHEDULE OF INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails",
     "shortName": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
       "AATP:PrepaymentsAndDepositsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails",
     "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)",
     "role": "http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CapitalizedComputerSoftwareGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails",
     "shortName": "SCHEDULE OF INTANGIBLE ASSETS, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CapitalizedComputerSoftwareGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)",
     "role": "http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative",
     "shortName": "INTANGIBLE ASSETS, NET (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://agapeatp.com/role/StatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtCost",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails",
     "shortName": "SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "AATP:InvestmentsIncomeDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtCost",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)",
     "role": "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
     "shortName": "INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2018-10-16_custom_GreenproCapitalCorpMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:InvestmentOwnedBalanceShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtCost",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
     "shortName": "SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "AATP:NonMarketableSecuritiesTableTextBlock",
       "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31_custom_PhoenixPlusCorpMember",
      "decimals": "0",
      "lang": null,
      "name": "AATP:InvestmentInNonMarketableSecuritiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "AATP:InvestmentInMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtCost",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)",
     "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
     "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "AATP:InvestmentInNonMarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-04-03_custom_PhoenixPlusCorpMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails",
     "shortName": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableRelatedParties",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails",
     "shortName": "SCHEDULE OF RELATED PARTIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "role": "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-06-292020-07-31_custom_AgapeSuperiorLivingMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
     "shortName": "SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails",
     "shortName": "SCHEDULE OF PROVISION FOR INCOME TAX (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000069 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails",
     "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND",
     "role": "http://agapeatp.com/role/OrganizationAndBusinessBackground",
     "shortName": "ORGANIZATION AND BUSINESS BACKGROUND",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000070 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)",
     "role": "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
     "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000071 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails",
     "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "AATP:DeferredTaxLiabilitiesDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2019-07-012019-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000072 - Disclosure - INCOME TAXES (Details Narrative)",
     "role": "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:TaxCutsAndJobsActOf2017OtherTaxEffectDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "AATP:CommissionExpensePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000073 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)",
     "role": "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
     "shortName": "CONCENTRATIONS OF RISKS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "AATP:CommissionExpensePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000074 - Disclosure - SCHEDULE OF LEASE COMMITMENTS (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails",
     "shortName": "SCHEDULE OF LEASE COMMITMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000075 - Disclosure - SCHEDULE OF PURCHASE COMMITMENTS (Details)",
     "role": "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails",
     "shortName": "SCHEDULE OF PURCHASE COMMITMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "AATP:ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000076 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000077 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "role": "http://agapeatp.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2019-12-31_custom_VettonsSdnBhdMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d)",
     "role": "http://agapeatp.com/role/VariableInterestEntityVie",
     "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 83,
   "tag": {
    "AATP_AccountsReceivableAndAccountsReceivableRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable and accounts receivable related parties.",
        "label": "Accounts receivable and accounts receivable related parties",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsReceivableAndAccountsReceivableRelatedParties",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_AccruedPromotionExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "AATP_OtherAccountPayableAndAccruedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued promotion expenses.",
        "label": "Promotion expenses"
       }
      }
     },
     "localname": "AccruedPromotionExpenses",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_AgapeATPAsiaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agape A T P Asia Limited [Member]"
       }
      }
     },
     "localname": "AgapeATPAsiaLimitedMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeATPCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agape ATP Corporation [Member]",
        "label": "Agape A T P Corporation [Member]"
       }
      }
     },
     "localname": "AgapeATPCorporationMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeATPInternationalHoldingLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agape ATP International Holding Limited [Member]",
        "label": "Agape ATP International Holding Limited [Member]"
       }
      }
     },
     "localname": "AgapeATPInternationalHoldingLimitedMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeSuperiorLivingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASL [Member]",
        "label": "ASL [Member]"
       }
      }
     },
     "localname": "AgapeSuperiorLivingMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeSuperiorLivingPtyLtdASLPLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agape Superior Living Pty Ltd ASLPL [Member]",
        "label": "Agape Superior Living Pty Ltd ASLPL [Member]"
       }
      }
     },
     "localname": "AgapeSuperiorLivingPtyLtdASLPLMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeSuperiorLivingPtyLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agape Superior Living Pty Ltd [Member]"
       }
      }
     },
     "localname": "AgapeSuperiorLivingPtyLtdMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AgapeSuperiorLivingSdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agape Superior Living Sdn Bhd [Member]",
        "label": "Agape Superior Living Sdn Bhd [Member]"
       }
      }
     },
     "localname": "AgapeSuperiorLivingSdnBhdMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_AllowanceForDoubtfulAccountsReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for doubtful accounts,",
        "label": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivablesCurrent",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount transferred from investment in investee company to investment in non-marketable securities.",
        "label": "Amount transferred from investment in investee company to non-marketable securities"
       }
      }
     },
     "localname": "AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BetaMaxxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BetaMaxx [Member]",
        "label": "BetaMaxx [Member]"
       }
      }
     },
     "localname": "BetaMaxxMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income (loss) per common share - basic and diluted.",
        "label": "Net income (loss) per common share - basic and diluted"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasicDiluted",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average number of common shares outstanding - basic and diluted.",
        "label": "Weighted average number of common shares outstanding - basic and diluted"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "AATP_BusinessAcquisitionsProFormaCostOfRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of revenue.",
        "label": "BusinessAcquisitionsProFormaCostOfRevenue",
        "verboseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaCostOfRevenue",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaGrossProfit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross profit.",
        "label": "BusinessAcquisitionsProFormaGrossProfit",
        "verboseLabel": "Gross profit"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaGrossProfit",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (loss) before income taxes.",
        "label": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Benefit of (Provision for) income taxes.",
        "label": "Benefit of (Provision for) income taxes"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaOperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total operating expenses.",
        "label": "Total operating expenses"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaOperatingExpenses",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other income (expense), net.",
        "label": "Other income (expense), net"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes",
        "verboseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other receivables - related parties"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_CommissionExpensePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission expense, percentage.",
        "label": "[custom:CommissionExpensePercentage-0]"
       }
      }
     },
     "localname": "CommissionExpensePercentage",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "AATP_ComputerAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer and Office Equipment [Member]",
        "label": "Computer and Office Equipment [Member]"
       }
      }
     },
     "localname": "ComputerAndOfficeEquipmentMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_DSwissIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "D Swiss Inc [Member]"
       }
      }
     },
     "localname": "DSwissIncMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_DeferredTaxLiabilitiesDepreciation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "DeferredTaxLiabilitiesDepreciation",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciation",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_DefinedContributionPlanPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan [Policy Text Block]",
        "label": "Defined contribution plan"
       }
      }
     },
     "localname": "DefinedContributionPlanPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_DepositForInsurance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposit for insurance.",
        "label": "Deposit for insurance"
       }
      }
     },
     "localname": "DepositForInsurance",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_DepositsToSupplier": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposits to supplier.",
        "label": "Deposits to suppliers"
       }
      }
     },
     "localname": "DepositsToSupplier",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_DirectorsOfUnreservedInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors of Unreserved Investments [Member]",
        "label": "Directors of Unreserved Investments [Member]"
       }
      }
     },
     "localname": "DirectorsOfUnreservedInvestmentMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_DisclosureInvestmentInMarketableSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Marketable Securities",
        "verboseLabel": "Schedule Of Investment In Marketable Securities"
       }
      }
     },
     "localname": "DisclosureInvestmentInMarketableSecuritiesAbstract",
     "nsuri": "http://agapeatp.com/20201231",
     "xbrltype": "stringItemType"
    },
    "AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Non-marketable Securities"
       }
      }
     },
     "localname": "DisclosureInvestmentInNonmarketableSecuritiesAbstract",
     "nsuri": "http://agapeatp.com/20201231",
     "xbrltype": "stringItemType"
    },
    "AATP_DisclosurePrepaymentsAndDepositsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments And Deposits",
        "verboseLabel": "Schedule Of Prepaid Expenses And Deposits"
       }
      }
     },
     "localname": "DisclosurePrepaymentsAndDepositsAbstract",
     "nsuri": "http://agapeatp.com/20201231",
     "xbrltype": "stringItemType"
    },
    "AATP_ECommerceCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E-commerce [Member].",
        "label": "E-commerce [Member]"
       }
      }
     },
     "localname": "ECommerceCompanyMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_EmployeesProvidentFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees Provident Fund [Member]",
        "label": "Employees Provident Fund [Member]"
       }
      }
     },
     "localname": "EmployeesProvidentFundMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_EmploymentInsuranceSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment Insurance System [Member]",
        "label": "Employment Insurance System [Member]"
       }
      }
     },
     "localname": "EmploymentInsuranceSystemMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_EnergetiqueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Energetique [Member]",
        "label": "Energetique [Member]"
       }
      }
     },
     "localname": "EnergetiqueMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_EnergizedMineralConcentrateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Energized Mineral Concentrate [Member]",
        "label": "Energized Mineral Concentrate [Member]"
       }
      }
     },
     "localname": "EnergizedMineralConcentrateMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_MarketableSecuritiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange rate effect.",
        "label": "Exchange rate effect"
       }
      }
     },
     "localname": "ExchangeRateEffectOnInvestmentInMarketableSecurites",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_ForeignCurrencyExchangeRateAverage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency exchange rate period average"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateAverage",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "AATP_ForfeitedCouponIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forfeited coupon income.",
        "label": "Forfeited coupon income"
       }
      }
     },
     "localname": "ForfeitedCouponIncome",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_GreenproCapitalCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Greenpro Capital Corp. [Member]",
        "label": "Greenpro Capital Corp. [Member]"
       }
      }
     },
     "localname": "GreenproCapitalCorpMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HealthAndWellnessProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health and Wellness Products [Member]",
        "label": "Health and Wellness Products [Member]"
       }
      }
     },
     "localname": "HealthAndWellnessProductsMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HostastaySdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hostastay Sdn Bhd [Member]"
       }
      }
     },
     "localname": "HostastaySdnBhdMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HostastaySdnBhdOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hostastay Sdn. Bhd.[Member]",
        "label": "Hostastay Sdn. Bhd [Member]"
       }
      }
     },
     "localname": "HostastaySdnBhdOneMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_HumanResourceDevelopmentFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Human Resource Development Fund [Member]",
        "label": "Human Resource Development Fund [Member]"
       }
      }
     },
     "localname": "HumanResourceDevelopmentFundMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_IfUnutilizedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "If Unutilized [Member]",
        "label": "If Unutilized [Member]"
       }
      }
     },
     "localname": "IfUnutilizedMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ImpairmentLossInEquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment loss in equity investments.",
        "label": "Impairment loss in equity investment",
        "negatedLabel": "Impairment loss in equity investment"
       }
      }
     },
     "localname": "ImpairmentLossInEquityInvestments",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in operating lease liabilities.",
        "label": "IncreaseDecreaseInOperatingLeaseLiabilities",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial recognition of right-of-use assets and lease liabilities.",
        "label": "Initial recognition of right-of-use assets and lease liabilities"
       }
      }
     },
     "localname": "InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InvestmentInMarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVESTMENT IN MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "InvestmentInMarketableSecuritiesTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_InvestmentInNonMarketableSecuritiesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in non-marketable securities.",
        "label": "Investment in non-marketable securities [Default Label]",
        "verboseLabel": "Investment in non-marketable securities"
       }
      }
     },
     "localname": "InvestmentInNonMarketableSecuritiesGross",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InvestmentInNonMarketableSecuritiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in non-marketable securities.",
        "label": "Investment in non-marketable securities",
        "verboseLabel": "Total investment in non-marketable securities"
       }
      }
     },
     "localname": "InvestmentInNonMarketableSecuritiesNoncurrent",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InvestmentInNonMarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVESTMENT IN NON-MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "InvestmentInNonMarketableSecuritiesTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_InvestmentInNonmarketableSecuritiesNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in non-marketable securities, net.",
        "label": "Investment in non-marketable securities, net",
        "verboseLabel": "Investment in non-marketable securities"
       }
      }
     },
     "localname": "InvestmentInNonmarketableSecuritiesNet",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_InvestmentsIncomeDividend": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_MarketableSecuritiesNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "InvestmentsIncomeDividend",
        "negatedLabel": "Dividend income from Greenpro Capital Corp."
       }
      }
     },
     "localname": "InvestmentsIncomeDividend",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_IonizedCalMagMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ionized Cal-Mag [Member]",
        "label": "Ionized Cal-Mag [Member]"
       }
      }
     },
     "localname": "IonizedCalMagMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_IronMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Iron [Member]",
        "label": "Iron [Member]"
       }
      }
     },
     "localname": "IronMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in exchange for acquisition payment of acquisition.",
        "label": "Issuance of common stock in exchange for acquisition of Agape Superior Living Sdn Bhd"
       }
      }
     },
     "localname": "IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_LabuanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Labuan [Member]",
        "label": "Labuan [Member]"
       }
      }
     },
     "localname": "LabuanMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Operating Lease Liability Payments Due After Rolling Year Three.",
        "label": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearThree",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_MYRCurrencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MYR Currency [Member]",
        "label": "MYR Currency [Member]"
       }
      }
     },
     "localname": "MYRCurrencyMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_MarketableSecuritiesUnrealizedHoldingLoss": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_MarketableSecuritiesNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized holding loss.",
        "label": "Unrealized holding gain (loss)"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedHoldingLoss",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_MitogizeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mitogize [Member]",
        "label": "Mitogize [Member]"
       }
      }
     },
     "localname": "MitogizeMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_MonthlySalary": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly salary.",
        "label": "Monthly salary"
       }
      }
     },
     "localname": "MonthlySalary",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_MrHowKokChoongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mr.How Kok Choong [Member]",
        "label": "Mr.How Kok Choong [Member]"
       }
      }
     },
     "localname": "MrHowKokChoongMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_NameOftheCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the company name.",
        "label": "Subsidiary company name"
       }
      }
     },
     "localname": "NameOftheCompany",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_NoCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No Customer [Member].",
        "label": "No Customer [Member]"
       }
      }
     },
     "localname": "NoCustomerMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_NoOneMEDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No. 1 MED [Member]",
        "label": "No. 1 MED [Member]"
       }
      }
     },
     "localname": "NoOneMEDMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_NoSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No Sales [Member]",
        "label": "No Sales [Member]"
       }
      }
     },
     "localname": "NoSalesMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_NonMarketableSecuritiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Marketable Securities [Policy Text Block]",
        "label": "Investment in non-marketable equity securities"
       }
      }
     },
     "localname": "NonMarketableSecuritiesPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_NonMarketableSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "NonMarketableSecuritiesTableTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_NoncontrollingInterestPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest [Policy Text Block]",
        "label": "Non-controlling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_OmegaBlendMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Omega Blend [Member]",
        "label": "Omega Blend [Member]"
       }
      }
     },
     "localname": "OmegaBlendMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_OneCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Customer [Member].",
        "label": "One Customer [Member]"
       }
      }
     },
     "localname": "OneCustomerMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_OperatingLeaseEffectiveInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease effective interest rate.",
        "label": "Operating lease effective interest rate"
       }
      }
     },
     "localname": "OperatingLeaseEffectiveInterestRate",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "AATP_OperatingLossCarryforwardsExpireYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards Expire Year.",
        "label": "Operating loss carryforwards expire year"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpireYear",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "gYearItemType"
    },
    "AATP_OrganicYouthCareCleansingBarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organic Youth Care Cleansing Bar [Member]",
        "label": "Organic Youth Care Cleansing Bar [Member]"
       }
      }
     },
     "localname": "OrganicYouthCareCleansingBarMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_OtherAccountPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "OtherAccountPayableAndAccruedLiabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherAccountPayableAndAccruedLiabilities",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_OtherPayablesRelatedPartyCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other payables - related party.",
        "label": "Other payables - intercompany"
       }
      }
     },
     "localname": "OtherPayablesRelatedPartyCurrent",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_ParticularsOfIssuedCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Particulars of issued capital.",
        "label": "Particulars of issued capital"
       }
      }
     },
     "localname": "ParticularsOfIssuedCapital",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_PaymentsToAcquireNonMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in non-marketable securities.",
        "label": "PaymentsToAcquireNonMarketableSecurities",
        "negatedLabel": "Investment in non-marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireNonMarketableSecurities",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_PercentageOfCommonStockIssuedAndOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of common stock issued and outstanding.",
        "label": "Percentage of common stock issued and outstanding"
       }
      }
     },
     "localname": "PercentageOfCommonStockIssuedAndOutstanding",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "AATP_PeriodAverageHKDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period-average HKD [Member]",
        "label": "Period-average HKD [Member]"
       }
      }
     },
     "localname": "PeriodAverageHKDMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PeriodAverageMYRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period-average MYR [Member]",
        "label": "Period-average MYR [Member]"
       }
      }
     },
     "localname": "PeriodAverageMYRMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PeriodEndHKDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period-end HKD [Member]",
        "label": "Period-end HKD [Member]"
       }
      }
     },
     "localname": "PeriodEndHKDMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PeriodEndMYRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period-end MYR [Member]",
        "label": "Period-end MYR [Member]"
       }
      }
     },
     "localname": "PeriodEndMYRMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PhoenixPlusCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phoenix Plus Corporation [Member]",
        "label": "Phoenix Plus Corporation [Member]"
       }
      }
     },
     "localname": "PhoenixPlusCorpMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_PlaceAndDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Place and date of incorporation.",
        "label": "Place and date of incorporation"
       }
      }
     },
     "localname": "PlaceAndDateOfIncorporation",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_PreferredStockDividendIncomeStatementImpact": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Dividend income from marketable securities",
        "negatedLabel": "Dividend income from marketable securities"
       }
      }
     },
     "localname": "PreferredStockDividendIncomeStatementImpact",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_PrepaidTaxesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Taxes [Policy Text Block]",
        "label": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxesPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_PrepaymentsAndDepositsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayments and Deposits [Policy Text Block]",
        "label": "PrepaymentsAndDepositsPolicyTextBlock",
        "verboseLabel": "Prepayments and deposits"
       }
      }
     },
     "localname": "PrepaymentsAndDepositsPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_PrepaymentsAndDepositsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PREPAYMENTS AND DEPOSITS"
       }
      }
     },
     "localname": "PrepaymentsAndDepositsTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/PrepaymentsAndDeposits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_PrincipalActivities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal activities.",
        "label": "Principal activities"
       }
      }
     },
     "localname": "PrincipalActivities",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of non-marketable securities to a related party.",
        "label": "Proceeds from sale of non-marketable securities to a related party",
        "verboseLabel": "Proceeds from investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_ReceivablesFromSalesDistributors": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables from sales distributors.",
        "label": "Receivables from sales distributors"
       }
      }
     },
     "localname": "ReceivablesFromSalesDistributors",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_RelatedPartiesNatureDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties nature, description.",
        "label": "Nature"
       }
      }
     },
     "localname": "RelatedPartiesNatureDescription",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_RelatedPartiesNatureDescriptionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties Nature Description [Axis]",
        "verboseLabel": "RelatedPartiesNatureDescriptionAxis [Axis]"
       }
      }
     },
     "localname": "RelatedPartiesNatureDescriptionAxis",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_RelatedPartiesNatureDescriptionDomain": {
     "auth_ref": [],
     "localname": "RelatedPartiesNatureDescriptionDomain",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_RelatedPartiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Parties [Policy Text Block]",
        "label": "Related parties"
       }
      }
     },
     "localname": "RelatedPartiesPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_RelatedPartiesRelationshipsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties, relationships, description.",
        "label": "Relationship"
       }
      }
     },
     "localname": "RelatedPartiesRelationshipsDescription",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "AATP_RepaymentsOfRelatedPartyDebts": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments from related parties.",
        "label": "Repayments from related parties",
        "negatedLabel": "Repayments from related parties"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebts",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_SalaryPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Salary percentage.",
        "label": "Salary percentage"
       }
      }
     },
     "localname": "SalaryPercentage",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "AATP_SaleOfInvestmentInNonmarketableSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of investment in non-marketable securities.",
        "label": "Less: Sale of investment in non-marketable securities"
       }
      }
     },
     "localname": "SaleOfInvestmentInNonmarketableSecurities",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of non-marketable securities to related party in exchange for acquisition.",
        "label": "Sale of non-marketable securities to a related party in exchange for acquisition payment of Agape Superior Living Sdn Bhd"
       }
      }
     },
     "localname": "SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_SalesCommissionsAndFees1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).",
        "label": "Commission expenses [Default Label]",
        "verboseLabel": "Commission expenses"
       }
      }
     },
     "localname": "SalesCommissionsAndFees1",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES"
       }
      }
     },
     "localname": "ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of purchase commitments [Table Text Block].",
        "label": "SCHEDULE OF PURCHASE COMMITMENTS"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES"
       }
      }
     },
     "localname": "ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS"
       }
      }
     },
     "localname": "ScheduleOfPrepaidExpensesAndDepositsTableTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/PrepaymentsAndDepositsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_SeaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sea [Member]"
       }
      }
     },
     "localname": "SeaMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SellersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sellers [Member]",
        "label": "Sellers [Member]"
       }
      }
     },
     "localname": "SellersMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ShareExchangeAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Exchange Agreement [Member]",
        "label": "Share Exchange Agreement [Member]"
       }
      }
     },
     "localname": "ShareExchangeAgreementMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_ShippingAndHandlingPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shipping and Handling [Policy Text Block]",
        "label": "Shipping and handling"
       }
      }
     },
     "localname": "ShippingAndHandlingPolicyTextBlock",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "AATP_SocialSecurityOrganizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Social Security Organization [Member]",
        "label": "Social Security Organization [Member]"
       }
      }
     },
     "localname": "SocialSecurityOrganizationMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company Four [Member]",
        "label": "Subsidiary Company Four [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyFourMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company [Member]",
        "label": "Subsidiary Company [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company One [Member]",
        "label": "Subsidiary Company One [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyOneMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company Three [Member]",
        "label": "Subsidiary Company Three [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyThreeMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SubsidiaryCompanyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Company Two [Member]",
        "label": "Subsidiary Company Two [Member]"
       }
      }
     },
     "localname": "SubsidiaryCompanyTwoMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_SurvivorSelectMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Survivor Select [Member]",
        "label": "Survivor Select [Member]"
       }
      }
     },
     "localname": "SurvivorSelectMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_THThreeTechnologySdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "T H Three Technology Sdn Bhd [Member]"
       }
      }
     },
     "localname": "THThreeTechnologySdnBhdMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_TrimPlusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trim+ [Member]",
        "label": "Trim+ [Member]"
       }
      }
     },
     "localname": "TrimPlusMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_UnreservedSdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unreserved Sdn Bhd [Member]",
        "label": "Unreserved Sdn Bhd [Member]"
       }
      }
     },
     "localname": "UnreservedSdnBhdMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VIE consolidated amount of cash and cash equivalents.",
        "label": "VIE consolidated amount of cash and cash equivalents"
       }
      }
     },
     "localname": "VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VIE consolidated amount of other payables and accrued liabilities.",
        "label": "VIE consolidated amount of other payables and accrued liabilities"
       }
      }
     },
     "localname": "VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VIE consolidated amount of Prepaid taxes .",
        "label": "VIE consolidated amount of prepaid taxes"
       }
      }
     },
     "localname": "VariableInterestEntityConsolidatedAmountOfPrepaidTaxes",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "AATP_VegeFruitFiberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vege Fruit Fiber [Member]",
        "label": "Vege Fruit Fiber [Member]"
       }
      }
     },
     "localname": "VegeFruitFiberMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VehicleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vehicle [Member]",
        "label": "Vehicle [Member]"
       }
      }
     },
     "localname": "VehicleMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VendorOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor One [Member]",
        "label": "Vendor One [Member]"
       }
      }
     },
     "localname": "VendorOneMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VendorTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor Two [Member]",
        "label": "Vendor Two [Member]"
       }
      }
     },
     "localname": "VendorTwoMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_VettonsSdnBhdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vettons Sdn Bhd [Member]",
        "label": "Vettons Sdn Bhd [Member]"
       }
      }
     },
     "localname": "VettonsSdnBhdMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "AATP_YoungFormulaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Young Formula [Member]",
        "label": "Young Formula [Member]"
       }
      }
     },
     "localname": "YoungFormulaMember",
     "nsuri": "http://agapeatp.com/20201231",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_HK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "HONG KONG"
       }
      }
     },
     "localname": "HK",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_MY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MALAYSIA"
       }
      }
     },
     "localname": "MY",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r489",
      "r491",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_CondensedCashFlowStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Cash Flow Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedCashFlowStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r323",
      "r324",
      "r330",
      "r331",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r323",
      "r324",
      "r330",
      "r331"
     ],
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r163",
      "r239",
      "r243",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r251",
      "r254",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r446",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r251",
      "r254",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r446",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r163",
      "r239",
      "r243",
      "r449"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r160",
      "r239",
      "r241",
      "r396",
      "r445",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r160",
      "r239",
      "r241",
      "r396",
      "r445",
      "r447"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r248",
      "r251",
      "r254",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r446",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r248",
      "r251",
      "r254",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r446",
      "r450"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r252"
     ],
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r161",
      "r162",
      "r239",
      "r242",
      "r448",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r161",
      "r162",
      "r239",
      "r242",
      "r448",
      "r464",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r217",
      "r252",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r164",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "AATP_OtherAccountPayableAndAccruedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.",
        "label": "Others"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "verboseLabel": "Other payables and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableMember": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations incurred and payable to vendors for goods and services received.",
        "label": "Accounts Payable [Member]"
       }
      }
     },
     "localname": "AccountsPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r11",
      "r44"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r165",
      "r166"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": {
       "order": 1.0,
       "parentTag": "AATP_AccountsReceivableAndAccountsReceivableRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r26",
      "r165",
      "r166"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable",
        "verboseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedParties": {
     "auth_ref": [
      "r25",
      "r108",
      "r376",
      "r379",
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.",
        "label": "Accounts receivable - related party"
       }
      }
     },
     "localname": "AccountsReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedPartiesCurrent": {
     "auth_ref": [
      "r51",
      "r113",
      "r376",
      "r379"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": {
       "order": 2.0,
       "parentTag": "AATP_AccountsReceivableAndAccountsReceivableRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.",
        "label": "Accounts receivable \u2013 related party"
       }
      }
     },
     "localname": "AccountsReceivableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "auth_ref": [
      "r11",
      "r46"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "AATP_OtherAccountPayableAndAccruedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Payroll"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r46"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "AATP_OtherAccountPayableAndAccruedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r46"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "AATP_OtherAccountPayableAndAccruedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Commission"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r42",
      "r206"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r61",
      "r63",
      "r64",
      "r430",
      "r455",
      "r456"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r60",
      "r64",
      "r65",
      "r116",
      "r117",
      "r118",
      "r328",
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r262"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r259",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income (loss) to net cash (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "verboseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r171",
      "r180",
      "r181",
      "r182"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r96",
      "r192",
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Potentially dilutive securities outstanding"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r106",
      "r149",
      "r152",
      "r158",
      "r178",
      "r323",
      "r330",
      "r349",
      "r413",
      "r429"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r9",
      "r58",
      "r106",
      "r178",
      "r323",
      "r330",
      "r349"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Total current assets",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r256",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r250",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r250",
      "r253",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business acquisition percentage of voting interests"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r304",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "SCHEDULE OF PRO FORMA BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": {
     "auth_ref": [
      "r304",
      "r305"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.",
        "label": "Income (loss) from operations"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r304",
      "r305"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Net income (loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r304",
      "r305"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r314",
      "r315",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Consideration amount",
        "verboseLabel": "Purchase consideration value"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r313",
      "r314",
      "r315",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Loan receivable",
        "verboseLabel": "Loan payable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "BUSNINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombination"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Total assets",
        "verboseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "verboseLabel": "Total current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Prepayments and other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Other receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "verboseLabel": "Total current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Accounts payable - related party"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "verboseLabel": "Customer deposits"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "verboseLabel": "Other payables and accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Deferred taxes asset, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r308",
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r308",
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Total net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Total other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r308",
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r1",
      "r115",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "ORGANIZATION AND BUSINESS BACKGROUND"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackground"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Computer software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r38",
      "r458",
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash in bank"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash acquired through acquisition of Agape superior Living Sdn Bhd"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r38",
      "r98"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents (Included $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2020)",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r17",
      "r99",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r92",
      "r98",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of end",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r92",
      "r350"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommissionsExpensePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commissions incurred in relation to revenue generating activities or operations.",
        "label": "Commission expenses"
       }
      }
     },
     "localname": "CommissionsExpensePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Ordinary shares no par value"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "verboseLabel": "Ordinary shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,452,047 and 376,275,500 shares issued and outstanding as of December 31, 2020 and December 31, 2019"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r67",
      "r69",
      "r76",
      "r321",
      "r337",
      "r423",
      "r440"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r193",
      "r196",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r163",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r163",
      "r347",
      "r348",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "CONCENTRATIONS OF RISKS"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisks"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r138",
      "r139",
      "r163",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentrations of risk percentage",
        "verboseLabel": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r329",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r228",
      "r229",
      "r240"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Customer deposits"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r82",
      "r396"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "COST OF REVENUE"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r112",
      "r286"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "- Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r286",
      "r293"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "- U.S."
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r49",
      "r110",
      "r221",
      "r222",
      "r223",
      "r224",
      "r360",
      "r361",
      "r362",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r43",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "verboseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r287",
      "r293"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "verboseLabel": "- Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r107",
      "r287",
      "r293",
      "r294",
      "r295"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred tax expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r268",
      "r269"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r57",
      "r190"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r287",
      "r293"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "- U.S."
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "negatedLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r284",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Net operating loss carry forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r284",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "verboseLabel": "Net operating loss carry forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined contribution plan expense"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r96",
      "r204"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r96",
      "r146"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueFromOfficersOrStockholdersCurrent": {
     "auth_ref": [
      "r51",
      "r113",
      "r376",
      "r378"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are usually due within 1 year (or 1 business cycle).",
        "label": "Amount due from director"
       }
      }
     },
     "localname": "DueFromOfficersOrStockholdersCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueFromRelatedParties": {
     "auth_ref": [
      "r113",
      "r376",
      "r416",
      "r437"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.",
        "label": "Due from Related Parties",
        "verboseLabel": "Amount due from related parties"
       }
      }
     },
     "localname": "DueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r44",
      "r113",
      "r376"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Amount due to a related party"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r113",
      "r376",
      "r418",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Amount due to a Related Party"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NET LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r130",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings (loss) per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r350"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective tax rate",
        "verboseLabel": "Effective Income Tax Rate Reconciliation, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r271",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "U.S. statutory rate",
        "verboseLabel": "Tax percentage"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r271",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r271",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Differential tax rate in Malaysia"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r271",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r271",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Permanent difference"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r120",
      "r125",
      "r127",
      "r133",
      "r179",
      "r220",
      "r225",
      "r259",
      "r260",
      "r261",
      "r289",
      "r290",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r451",
      "r452",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Proportional of ownership interest and voting power held",
        "terseLabel": "Equity interest percentage",
        "verboseLabel": "Ownership interest percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative",
      "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished."
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r102",
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Estimated useful lives of intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r193",
      "r194",
      "r197",
      "r199",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r193",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r197",
      "r397"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Change of year end"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyExchangeRateTranslation1": {
     "auth_ref": [
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.",
        "label": "Foreign Currency Exchange Rate, Translation"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateTranslation1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign currencies translation and transaction"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "auth_ref": [
      "r78",
      "r79",
      "r96",
      "r420",
      "r441"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.",
        "label": "Gain on deemed disposal of shares in Investee Company",
        "negatedLabel": "Gain on deemed disposal of shares in investee company"
       }
      }
     },
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedLabel": "GENERAL AND ADMINISTRATIVE"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r81",
      "r106",
      "r149",
      "r151",
      "r154",
      "r157",
      "r159",
      "r178",
      "r349"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross profit",
        "totalLabel": "GROSS PROFIT"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r96",
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r201",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment for long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r111",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Local"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r73",
      "r149",
      "r151",
      "r154",
      "r157",
      "r159",
      "r411",
      "r421",
      "r424",
      "r442"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Loss before income tax",
        "totalLabel": "INCOME (LOSS) BEFORE INCOME TAXES"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r111",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r74",
      "r96",
      "r147",
      "r176",
      "r419",
      "r438"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Loss from equity investment",
        "negatedLabel": "Loss from equity investment"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r272",
      "r276",
      "r281",
      "r291",
      "r298",
      "r300",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationDescription": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.",
        "label": "Income tax examination, description"
       }
      }
     },
     "localname": "IncomeTaxExaminationDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": {
     "auth_ref": [
      "r265",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.",
        "label": "Income Tax Examination, Likelihood of Unfavorable Settlement"
       }
      }
     },
     "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r126",
      "r127",
      "r148",
      "r270",
      "r292",
      "r299",
      "r443"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Tax benefit",
        "negatedLabel": "(PROVISION FOR) BENEFIT OF INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r70",
      "r102",
      "r266",
      "r267",
      "r276",
      "r277",
      "r280",
      "r288",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Accounts payable \u2013 related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Accounts Receivable, Related Parties",
        "negatedLabel": "Accounts receivable \u2013 related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "verboseLabel": "Customer deposits"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in related party receivables classified as other, due within one year or operating cycle, if longer.",
        "label": "Increase (Decrease) in Due from Other Related Parties, Current",
        "negatedLabel": "Amount due from related parties"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Increase (Decrease) in Other Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Other payables and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "negatedLabel": "Prepayments and deposits"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r102",
      "r196",
      "r393",
      "r394",
      "r395",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r191",
      "r195"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r91",
      "r93",
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r55"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r12",
      "r56",
      "r102",
      "r132",
      "r183",
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventories write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtCost": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_MarketableSecuritiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of the investment.",
        "label": "Cost of investment",
        "verboseLabel": "Investment amount"
       }
      }
     },
     "localname": "InvestmentOwnedAtCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails",
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "auth_ref": [
      "r461",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance held at close of period in number of shares.",
        "label": "Investment in securities, shares",
        "verboseLabel": "Shares purchased during period"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r45",
      "r106",
      "r153",
      "r178",
      "r324",
      "r330",
      "r331",
      "r349"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r106",
      "r178",
      "r349",
      "r415",
      "r433"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r106",
      "r178",
      "r324",
      "r330",
      "r331",
      "r349"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Total current liabilities",
        "negatedLabel": "Current liabilities",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r21",
      "r22",
      "r106",
      "r178",
      "r324",
      "r330",
      "r331",
      "r349"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Non-current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON-CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      },
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Investment in marketable securities",
        "totalLabel": "Investment in marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Investment in marketable equity securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Unrealized holding gain (loss) on marketable securities",
        "negatedLabel": "Unrealized holding (gain) loss on marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r53",
      "r106",
      "r178",
      "r349",
      "r414",
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "verboseLabel": "Non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders.",
        "label": "Noncontrolling interest, description"
       }
      }
     },
     "localname": "MinorityInterestDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r92",
      "r94",
      "r97"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r66",
      "r68",
      "r75",
      "r97",
      "r106",
      "r119",
      "r121",
      "r122",
      "r123",
      "r124",
      "r126",
      "r127",
      "r128",
      "r149",
      "r151",
      "r154",
      "r157",
      "r159",
      "r178",
      "r349",
      "r422",
      "r439"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income",
        "terseLabel": "Net loss",
        "totalLabel": "NET INCOME (LOSS)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
      "http://agapeatp.com/role/StatementsOfCashFlows",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL NON-CASH FLOWS INFORMATION"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r226",
      "r310",
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Non controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "TOTAL OTHER INCOME/(EXPENSES), NET"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INCOME/(EXPENSES)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesReceivableRelatedPartiesCurrent": {
     "auth_ref": [
      "r51",
      "r113",
      "r376"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle).",
        "label": "Amount due from related parties"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "TOTAL OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r149",
      "r151",
      "r154",
      "r157",
      "r159"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "LOSS FROM OPERATIONS",
        "verboseLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r366"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating lease, rent expenses"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r365"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Present value of lease liabilities",
        "verboseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r367",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating lease payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r364"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Amortization of operating right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r370",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating lease, weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Cumulative net operating loss"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "Other payables and accrued liabilities ($1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2020)"
       }
      }
     },
     "localname": "OtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r20",
      "r412",
      "r428"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "totalLabel": "Total other assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r321",
      "r322",
      "r327"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r270"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other current and other deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "Other Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "(Provision for) benefit of income taxes"
       }
      }
     },
     "localname": "OtherIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "OTHER PAYABLES AND ACCRUED LIABILITIES"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Income/(Expenses), Net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of interest-bearing domestic time deposit liabilities to total deposit liabilities.",
        "label": "Percentage of Interest rate for time deposits"
       }
      }
     },
     "localname": "PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PolicyholderAccountBalanceLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Policyholder Account Balance [Line Items]"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheetsParenthetical",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r36",
      "r37"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepayments and deposits",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r5",
      "r8",
      "r188",
      "r189"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r6",
      "r8",
      "r187",
      "r189"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid taxes (Included $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2020)",
        "verboseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDividendsReceived": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends received on equity and other investments during the current period.",
        "label": "ividend received"
       }
      }
     },
     "localname": "ProceedsFromDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.",
        "label": "Proceeds from (Repayments of) Related Party Debt",
        "verboseLabel": "Amount due to a related party"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfInvestmentProjects": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of investment projects held by an entity in hopes of getting a future return or interest from it.",
        "label": "Proceeds from sale of investment in marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfInvestmentProjects",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r42",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r210",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "PROPERTY AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/PropertyAndEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r102",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Estimated Useful Lives of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r41",
      "r205"
     ],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Subtotal"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r207",
      "r435"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      },
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r40",
      "r102",
      "r207",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/PropertyAndEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Estimated Useful Life of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "totalLabel": "Total minimum purchase commitments required"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueAfterFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "PurchaseObligationDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "PurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFourthYear": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "PurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year One",
        "verboseLabel": "2021"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Two",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "PurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "auth_ref": [],
     "calculation": {
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Three",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "PurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r249",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r249",
      "r375",
      "r379",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r373",
      "r374",
      "r376",
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY BALANCES AND TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/RelatedPartyBalancesAndTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r225",
      "r262",
      "r431",
      "r454",
      "r456"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r120",
      "r125",
      "r127",
      "r179",
      "r259",
      "r260",
      "r261",
      "r289",
      "r290",
      "r451",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r144",
      "r145",
      "r150",
      "r155",
      "r156",
      "r160",
      "r161",
      "r163",
      "r238",
      "r239",
      "r396"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "REVENUE",
        "terseLabel": "Operating revenues",
        "verboseLabel": "Revenue from sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r138",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "verboseLabel": "Customer deposits"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r80",
      "r462"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "REVENUE \u2013 RELATED PARTY",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r72",
      "r106",
      "r144",
      "r145",
      "r150",
      "r155",
      "r156",
      "r160",
      "r161",
      "r163",
      "r178",
      "r349",
      "r424"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Total revenues",
        "totalLabel": "TOTAL REVENUE"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesCommissionsAndFees": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).",
        "label": "Sales Commissions and Fees",
        "negatedLabel": "COMMISSION"
       }
      }
     },
     "localname": "SalesCommissionsAndFees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "SCHEDULE OF PROVISION FOR INCOME TAX"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r246",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "SCHEDULE OF DEFERRED TAX ASSETS"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "SCHEDULE OF EFFECTIVE INCOME TAX RATE"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r193",
      "r196",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r193",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "SCHEDULE OF INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.",
        "label": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES"
       }
      }
     },
     "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "SCHEDULE OF LEASE COMMITMENTS"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r12",
      "r33",
      "r34",
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "SCHEDULE OF INVENTORIES"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r42",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails",
      "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r109",
      "r377",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "SCHEDULE OF RELATED PARTIES"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r211",
      "r212",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership.",
        "label": "SCHEDULE OF SUBSIDIARIES AND ASSOCIATES"
       }
      }
     },
     "localname": "ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r332",
      "r333",
      "r334",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "SCHEDULE OF VARIABLE INTEREST ENTITY"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/VariableInterestEntityVieTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services.",
        "label": "Selling expenses",
        "negatedLabel": "SELLING"
       }
      }
     },
     "localname": "SellingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r255",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Purchased price per shares",
        "verboseLabel": "Shares Issued, Price Per Share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r50",
      "r116",
      "r117",
      "r118",
      "r120",
      "r125",
      "r127",
      "r133",
      "r179",
      "r220",
      "r225",
      "r259",
      "r260",
      "r261",
      "r289",
      "r290",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r451",
      "r452",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r133",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails",
      "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails",
      "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical",
      "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r23",
      "r24",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock issued during period acquisitions, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r23",
      "r24",
      "r220",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "ssuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares",
        "terseLabel": "Issuance of common stock shares",
        "verboseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r50",
      "r220",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock issued during period, value, acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r23",
      "r24",
      "r220",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd",
        "verboseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r30",
      "r31",
      "r106",
      "r173",
      "r178",
      "r349"
     ],
     "calculation": {
      "http://agapeatp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Net deficit",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets",
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails",
      "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r105",
      "r225",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r357",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r357",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r357",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r357",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r382",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASH FLOWS INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription": {
     "auth_ref": [
      "r62",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of other income tax effect related to application of Tax Cuts and Jobs Act that are reclassified from accumulated other comprehensive income to retained earnings.",
        "label": "Tax rate description"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017OtherTaxEffectDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimeDeposits": {
     "auth_ref": [
      "r417",
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of time deposit liabilities, including certificates of deposit.",
        "label": "Time deposits"
       }
      }
     },
     "localname": "TimeDeposits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts receivable and accounts receivable \u2013 related party"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradingActivitiesGainLossByTypeTable": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance by statement location, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit).",
        "label": "Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table]"
       }
      }
     },
     "localname": "TradingActivitiesGainLossByTypeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingActivityByTypeAxis": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of trading activity.",
        "label": "Trading Activity [Axis]"
       }
      }
     },
     "localname": "TradingActivityByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingActivityByTypeDomain": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit)."
       }
      }
     },
     "localname": "TradingActivityByTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingActivityGainsAndLossesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Trading Activity, Gains and Losses, Net [Line Items]"
       }
      }
     },
     "localname": "TradingActivityGainsAndLossesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/BusninessCombinationDetailsNarrative",
      "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r140",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableIncomeInterestRateMember": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading in a derivative or nonderivative instrument that provides a fluctuating return in the form of periodic payments of interest typically based on movement of a benchmark rate (for example, US Federal Funds Rate, LIBOR),  and eventual return of principal at maturity.",
        "label": "Variable Income Interest Rate [Member]"
       }
      }
     },
     "localname": "VariableIncomeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d)"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/VariableInterestEntityVie"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "verboseLabel": "Basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=27011391&loc=d3e105025-122735"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2611-110228"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=65877542&loc=d3e27249-109313"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5291-111683"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6228884-111685"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "184",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5634876-113961"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10(3))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.12)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r481": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r482": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r483": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r484": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r485": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r486": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r487": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r488": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r489": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r491": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r492": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r493": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r494": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r495": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r496": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r497": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r498": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL116659650-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659663-227067"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3337-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>114
<FILENAME>0001493152-21-007316-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-21-007316-xbrl.zip
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M(<P:M2U)WJ-GWS".=I<AIE<C5HA2"KH%ITTRGU%_/,A$FL_Z8[L_H#&L35F
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M5\;F=&;=I*_7;Z?F]>V@-[#NS#3?5G6*BR:>'@NOA9T(QCY.2)230VENE%<
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M4_",4HZHB=*:FQ2Y00*%C9S3#<M5RX-86/;MOC""CF?[4^ D(2(@BS_\=[H
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M0+>[,A+,?CPTP/(87?-I9ENQ^L=VL/!PY;\T(3++J/R);OV?&<//%BYPDZ5
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MB/4H2N44>10[\;8'L8,6YF%>;" ?3WI>%ZO(S:8Y,Q,C1U<UD6HL"-B 54I
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M[VP_26_GAH\N_KA2L0#0Y<[=1I; #W'[EFLDS)%3*)F\#H'CD1[:X)[LCMV
M18 7HA*HU^K*L3 $M&S#]([=@$^ %Q)\[]18_/*!ACRI43]>')KZ]N$5N?K=
M>B1#)1]7-'/?MC=79Y6YA8GT,8R S([JK8(B$%2N1$[A=".#Z?,:W:;>817?
M)K579C7D1:,JB)'$MF[J99E:5K9+<@\U"4H9\F:!HWE:4GGX:&EGE(EA<[9&
M29XNG+D$?<+_GR3T(M=SJ$$%><\%N:.BPMS,953A\:(SH>?NN#4/]+>V0096
M5:U;C[^IAQ"1="(N"MQ?W?=#"FH4]1R34O-0OC@F7QR3.BD,_]F.206A9C4\
MD[0(,=F%Q0?V]\2FAV;FF[2>J4A$@I7$D@19NR!XTT[>\S<:B_B 3+(Y1==$
M .<=\*'OR"1*5ZX774QYG#H@L$,/<BB.Q:9=5!JKF&W8!<.'QI:NVR!: \>;
M>\"EJBCDY@H5QDKA0AZB=5(6)2&AO;)8%ZU6GP59\]L@B3T?9\"EZC3EABH\
MCNPI#IDDDT3[4?_W)49\#1"MMH\G68((V10:DPU%$@:_/V_[+G"T<TL:UZ0I
MH];$BTCL)W%D!.[_P.^1X<2C.5K>']-:H^AO&??TRN_;H41'ZN!<J,>BGD9B
MLA3J.+,["":+F58,E?4]:]N';9<@0$)FINDI=>@@8%1.9-\2"*H.F7I$E!>"
M;\ F*3\\7;N$BAA/1,N:7H%TLL-4.X2G*%<D1-66PJE6UZJ2<HDJNE5C=!!?
M4>9(,*LM@9,["^S5-K<]EY;*Z-A!0+DX(MY7U03"HNF&BU=L)]IH/O&B'YPA
ML6\/0V+[HV'?',XFQLP:#=/$_A-K^E6WZ-@Q]#UGLX0^$KOAI";G2]O'NVD)
MWXKJE3R=5<<)=?)%O(B *U=?UY[%W]C_@F$_B6*T9X24-&-5[?1]"$_F2H<7
M\$-[!4;S HTT:S6E>?M^ XID(0_%&CD-9,&@J]/@.*A:]1@,X>[C5'_!83,%
M3]S94QO2Z96]#9$,$P'@$FFIG8I4:T)"K::8*%;)<KU#:BT,$0U4J1ZTNG^O
MN4RKZ"7>YQN1Z.P1<DCTN96*4A(U)%JDEWAU5FOY+UR^\,WK<G,) F>YLL,?
M]+=.[)Z:JHC<].MI]"_3O:.:]:R&W5/-\R=N)%@ 5@M"NP=1S2&HI3;:+,HZ
M/YF:@ <0)&!7"2*TG?@/+UXR=;-M?Z[NBIY/<2\^6(\E/??>K3DHF@ '> _X
M<&%A2.K1>J6QXW"CLD%<?>U;5R9VL !D0U;NSYHJ)T4BB9)5(UCB9-]1O6O0
MOFFJ+#1839I&-B@1F6IYLO/+O<53FM/R_>2MDA5-^(4F"HQ-5;,6DJEK8JLH
MO0)Q@9?)%OUP*%;TJ_L!6-A^FJZ=E"@#M2HUTG0KKB*5).5C(E>$I9P11+PK
MH";%%BWOQA2Y00*%C6S*#<M5RQU96/:M6OK-/EPA+=\!Z/_7=D#.1H!;5S=N
M76\FS57(12E1LK+3^$T?O2BR H<JTH-6K;^WX)!E%8DD(2I^7Y'%VCR?(0/\
M)2PVC@Q1A$Z:'H0\I!,=!CI"Q)=_B-A-99(HNOBY -/<.MH$9EJ>U<W@VK+K
M?FK[(&+X[7-M[L_;]MT)K05()9LDU7/%/CSS"<>*)EZTQ*SA"D+?8_HI1.ZA
M]Q'$XE2WR.0J>F?HHZS-C-5/S0G$E#X;K#+SVIT_S6"F\PDD%5>=_7$[+\;8
MWHCX;@K-E9U@G,NIVF]3P0+Y--,LOF&,K]9!;"_ N8!G/-?K_J+M?#Y'1Y*S
MV2'!IW:%C4/H .!&V,%[Y3UX+@C<K=-P_QZDXDT#K5L'X>/@A[C\U!Y^?R9>
MO+D!\1*Z5O  HCC=;!X#$$9+;[V?A91SD'>(#N(JR!M1PY%["\/F1R_"JL#V
M,305)B.MDTOLT254N%AIPC$FX92SHR7E-$-_[1(0);)E^\F(U6O6,/+B:QA:
M092$A"?:68F74LLN"9C* H?M54TIXP&P(Y NT'2?I%<R?D>K9#PPC:G9ZX]N
M;JS9C3DLU#'>,]D8(^,D=)8"O+RG\3*^G?2_*& G1[P1N-DC[P4('(^W ,V'
M\FO;/0/&\ J_OIU9P\_FL&]I5Y'&<-#9'0)T;&\EBA;; _YG; <+7!Q\5S>(
M^0!7?"25KW&?Y_ $:2MAXL1)B&!'$V "?#L&:!Y$,:MNC= @VKSCK8OXX:->
M<0DJ>?$K/#4NDPBQ'D6IG"*/[;LD=E!G-*Z!#>3C2<_[616YV31GVB<YNJHQ
M*[,@8 -6*0'M#,M-8J>S>5DROJTZ. VL14T3M"-Y,$3'!]I<J,Y.8GM%SS3X
M5POD9$+/?7&?,0=?.7;%'S?D%47HT/K34KFZ"HTKV09C9E(\3$(NP50,0G1&
M$[+*%O/'$7MV%1X1]KJPP/X WF*)U"OC ?UV 28 "W'WQQD(5Q1/C>A(7<7\
M&'9E&XZ;F -C>Y/:$GB1WK4_*3P+3.EI:3[8=S(C.2]HV^8GA5F>)PX[=:NF
MT^1[!/Y,T(PR'W)&1H9=[F/)VGA[.37_<6L.9SWSKF!>U,,6=\ FA\V-W$.E
M;:U(%,N(5ME:&VL9"Y-#JQB%]VZ8OPXY0-^CF[^('=29OV@@T/$ZX%8W=;."
M7):-A-)%C5V+)7(F0)K;LV1BI+/]2A*..@=&'A#-K.A<U5R1A8N];JCXM&S8
MXGJ</L/:W6B.E%X<.I;0*@03FFI](I');N7:6P\"G*4F]2GA'-5+;SV#C-?"
M55RR!FD_;08=" I@?/+0(LV&"BRU/,^:P[M5G\P4^#X(Z8_."FT4).^HNUX@
MA84F=L>3S_#!<1Z)Y/EH-9L*8U=ZR?/QDN>#6_:M[M!W(([1-C=U@\LEO0AH
M1<O6<U!S9*4@D4F\,[PD]55I[*J?VE=M!;*7U+[<[&AJ$WM)[?L?DMI78B;8
MJBG;P4RP%[0KBMK A59?-2JJ&2?HOQ/CAX2K;FMP".)^$H:YO8IG'>Y[=00\
M)@MZ.O4:>-G?#;R8+'"8=DAA*-O?X__Y;D< _>;_ U!+ P04    " #32W]2
M2 .4D6N$  #>.@< %0   &%A=' M,C R,#$R,S%?;&%B+GAM;.2];9/C-I8F
M^OU&['_ ]4SLM>-FVBY[9GMLS^R&4JFLTCI3TDBJ<GL=$PZF"&5RBB+5))55
MZE^_ /A.O%(2@9,U$SW=6>(YX'.(!V\'!P?_^K\^[T+T@I,TB*-_^^K-M]]_
MA7"TB?T@>OJWK]ZOKD>K\73Z%4HS+_*],([POWT5Q5_]K__YW_X?1/[O7__?
MZVMT%^#0_QG=QIOK:;2-?T$S;X=_1F]QA!,OBY-?T <O/-!?XKL@Q D:Q[M]
MB#-,'N0O_AG]\[=_\=#UM4&Q'W#DQ\G[Y;0J]CG+]C]_]]VG3Y^^C>(7[U.<
M?$R_W<0[L_)6F9<=TJJP[S]_7_Q?KOZO81!]_)G^UZ.78D2^5I3^_#D-_NVK
MQFL__?AMG#Q]]\/WW[_Y[J\/]ZO-,]YYUT%$O]H&?U5JT5)$>F]^^NFG[]C3
M4I23_/R8A.4[?ORNA%.53)X&"OD&DC3X.67P[N.-E[%*U[X&227HOZY+L6OZ
MT_6;'ZY_?//MY]3_JOSX[ LF<8B7>(N8F3]GQSTA4AI0'GQ5_/:<X*T83)@D
MWU'][R+\Y&78IR_ZB;[HS?^@+_J'XN=[[Q&'7R$J2>@AM>NG5EF%TG>VP2YP
M$L3^)#H-=5?;$7S2=I+L# .:^M9-6,>9%YX$OJEI'?8,G_;%:SW[7YKT\OBT
M+]W0' 1VQD/N_7G%WS6D/]Z3OUH0\>>,C%_8+T'2(A0],'L#&QB*LJO2XTVK
MW)#VYG$BM)T5N?721U;N(;U^\KP]*?^'[[_#89:6OUS37ZZ_?U-TW_]0_/PG
M'2#Q#D?9Y&^'(#O2P9M, Z(L'7T.TO*%S-I_^\I0Y[NN-51[E)0F><E&\UT*
MB>\V,1G5]MEUF-= KKY-XITQE.(CQH8*?X:/U7OR+T^@2 QJB24XC0_)!O>J
M^*95?;YP@7(7$BTZC\/1]?O55_\S%T6U+/J#2O_'OWY7O\$=SPBL71RMLGCS
M\0'O'G$BL5P@9Y-/4IA-#G%"8'@C0];E2BZ'F"#Z(Q<%0I21[P=TYNJ%"R_P
MI]'8VP=D0%:21J-CDT!&\)MD4BJ (98)RB[):AU$E<B*"15JP"BWQ)D71-B?
M>$E$5L:IDFLR89LD4P-NLDLL"8962GA=/I7"J)0&1J/19G/8'4(ZLYUGSSBA
M(W&"GW&4!B]X&FWB'5;W8N;Z5GNTOF:U>C=393"4[(N8Z_7FXRD:95D2/!XR
M[S'$*(M)_Y>0&=FP?$V3K,%5\J\N3\E/9((0I7$8^-2\2921_AF+9OIJ41OL
M,P%+B::2<\XI W#\S*P61Z7\A6;RGI?EG=>;'PI*C$;KQ9^C)V^/R1_3*,-)
MY.5#]KLXI%[B^V 7$"3"?JNOL@W:G&80)5(_3>?4.@DNUU=1?40*0*T24%$$
M*LH -LZNR0OFVU&2$%/8(EGAJI#(VAP_E7";8Z50T#G13-#QG5A(M..$\.F%
M\*O605[DM_[-AEB4/7MD;=!2&K3'6SV3\7CR>?-,<8R>$LS R#LYM;RU?LT$
M=M65J82=D\H489=83 65.JA2 C"S6@=92!K(-/*#E\ _>*%D6B61LS6G4L(L
M)U1"(>>DT2'KDH7)HGB+:NEANY6'Y%W\Z=?XX_@YCJ,G>7<BEK/6C:A@5MV'
M2,@Y W3(N@QX2+XELH@(HUSZ8OV$;& Y/*:!'W@)<]E[T7']*58,*PII>X.*
M%G(]I$A%83!#BX\;3BH%5&@@HF*=)#T8XIX>IMP 38R^K+#-B'DD=A5JI=WQ
M@H,LIT8E"I0=77P&!"$J]L<6(MZ')BUYA^,+#ULQPM3"0,G"(S099:B2=<+<
MD<_0@R]-<7=TX4'+V5++ B4+!]" *U0'F =ND<1[G&3'!<&>C2*?AI[LZ3K\
MYDC=1 I_G)&F3>]<#U.:OCH#-><4[(^UR\9[LF2ZO@]>L(_6Y/> [F:-TA1G
MT$*+]H<,)Y5=N@ CL;3E,",5Y$ZPD4@4#+O4^ 2!1TP:5>( 7'=+YH 4N^L:
MSVRYZ#@XI5NN>N"\\D5HN*$L\[(@S8*-%Z('[*6'I'#5#M=U&-7V0Q %N\-.
MV$D(GMNJ=2&LLN9;#T'4O@@1YW[+90"T\ ?OL[K.V\^MU;D(5E7GS8<PZER
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M E$\AM,'-B<U-9#FI.;]RGF=<U"X^,79=#VY1:OU:#U9 5BDKC8X\LCZ6K=
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M6YS0$Q!K_#F[(:_[J%B%&.C:7N$9F]-=\&D505"Q+UK9<C!%S0+0(XU$*XI
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M0"HLPV./;O$&4V<M^O'-%:(<_09&NRAV+,@B?X/)!WH,\0QG8C>-F8K5OM4
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M#+5,4'+3?JK#(F=:6N ZLC&MU2C+K_^@H,T[-#-5J_<I]3"F=<.,@1X8-O8
MRUWB,B=KSQE9=K(E)\W)LYRN?@72]]$LA$%6AJ>/V=TT3SC:]-GKZ%F&76Z>
M8%Z;I#T* ,36_J@YVM9EL!ZU50KD6:*1\?INME\AX$BMZ7K[E/"Z:*WOCA\>
MINOZ: WIGFE&M,D,3CJTU>$QQ7\[$#LG+P89SN3B=F_+4H-N7X\EE@7#- U
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M<,XIV]&6SOF?0[+)<WK! !O*^=:HFLW]9+2:T!7&PY0Y3(=WBK;L69!O]DR
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M8F6M!I^6'%;NSLXR13O*11&5I1[=LL@V4X&34Y1PON\G$Y<!@K J\XRH*RH
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MHSBI7 57L6>V5R)J+*]U*.W]N:TL<55 G,^7(5@O[!2.^4T[-'@P9K-H2)<
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M:00_Y8T@PD\4L,9/>$F[N!A'G*8_TY3]Y4NH'[MZB[.A5&*$)#6N2A[>X&F
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M%K7)(178)H5$<F 8I #7)5 MBI@LK(R)'4/N-0>LY>(.*<2!5M#H'MSY:0U
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M#WQ9=[/(CE>#T=_\\KAH"@/KCO2FU8C4(UR1<,W8@YOR$>R&,Q11.>!<M:[
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M%\Y #@U5-#Q=%Q2B*5E)J\(T4#/E!!I(E=(E0AD;67JG3PP%DTCK:+X%\MR
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M13RXWGK>$#\BFB$TX ' P0#&,%(3FY:V16:=4I^D\:@A?4C2$]2S 5I%FB$
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MF;[^1H'_IJKLO&P-E@*EC]?@:#QZ@[T.&5E55-5:BLJQ+I!Q#&1. ON:M]:
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MZRD[A'AXH^\P]?$0]ZLE#75&Q7X]=(XXU$?1-'G8Y?IG).3QK+Z6,5:"1G-
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M\$A-1G,,BG8<BHCS]3)X?.L2FC&'_7#*$_:KWX=D:7M66N5*<$JP5J5&5WI
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M%TPFX!LQ1\+1.Y(RJUW_,Z2RN]R=IK&4C 51X1(C:P> CV5J'H?Q'$7/5]9
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MI[Y5Q_')AZHPP'4:83>*!Y?\;W56W=GZY).<FKYI=A\YT[?0_P=02P,$%
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M7-ILWE[%UY(.Z5,2]"LV[\EK:W6X4NYQ2ASXMX7_^25@@4L/?WFO_@V_]FA
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M]8DWN.T*^@H.&QQQS^<N<V#^'.D+9]0?Z@\\>=BOVRLREM09[:DSS^8]^&=
M!?4#W&'E1D'$,VX%<3 )SP[8/=#]:9 $TT;9RJ0I>*V(F)GP:[!1.&P47).-
MF4QU9ZNZ'TN9+A'TY-'N$J]#FQU@M3@3(XD#X@M_^(W?'74YCQ)EH]^:'=*G
M-Z$D27R%M?(Z-X[WJ5OR:&T,0T#=9;LI!$X//B<MJ:9,73Z9!B@N;UG@ @EG
MG@.3ZX3$36<;9"Q,OCD.U]1%.7T%Z!W EO1\8F-&HO]ID/XE1=(,/+PHOY;
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M[<W)T;?KL]NSDYOUM>;%L77R[Z,OS8O/)];1Y?GYV<W-V>7%RPVA/M<0_B#
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ML%&6,D?B6REL3Z!C4RNM,"0PE@7?PG:1S':!A/CALC#_IF[6%8TV+I+>I_T
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MA5@??K@HBRQZ R_KCEKO1:U7*?W6 A2A?;6V1[N!Q5L"SP.:(U(=11S:8>I
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MN<SHUC 2%F#FJ8"4<BVW12Q-!%D8OD<KIFA3B=^,!;EO=;-'!3,MG7P($2Q
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M]NXU"3)MLE5%L;!X@>R3=A:=JW1>R=?B1^5LU#&1N;1]F3K=?"*#A9'0SWI
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MC[Q'/;14&AT9@V)YBT;C&I1ZYZ]J( )OC,\O7)M5UJ J08I/S0IHD62)2*#
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MI(G) NE5N!S6].=6);VX?]1#CB])TU%D\V5:QM_=E/O<E/?H83I&5.9BPAW
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M6N &2(^ZJK05&TH^VX"<I4),RJKPV%S[]55W*4+C#IY:SQ46H]$T-E6C28=
MP#\SH$D!/.S69^=SDW!1JLDJLQ0(N5S*U+0^[;_^FFXQP="!6)K9\FD^$UCS
M;B?8_N96\^$NT@5Z\8V+<IF4H[VL*+A'LW_)=@;<_$2DQ8?!CV*%:E<D\&ZG
M3*L/0BHK@.NEF22 <)_$43)#5P3!5Z=I<M?I)\E3IL=Y6?Q+BBHKX"7$KDLU
M-_ 3W'9N3SFF>X+W!O(>*>7+Q12;@!ZT$WKRR? I/4U:?#KG LI%R; OVGXY
MS4>T]26>&\D(BMSCFZ0RSHQ\\8F19\+Q<F-&7'PJC]2,21]W.RO=KWE;KQEQ
M0WM@ X-FA/:!XY2C7H-K?9EO%[T^JBP0XRRYCBT.H_X(\#^K/Y.[;G_:[>B/
M_6Q77S!$#K.6GV/):S^S':;7?B%'M?IC@ 2E>8V37IT0'7L1_-S-AKN,5ZL_
MGKF^B18!?^T1#X[?\AL!^O&3T/K7W "VZ,IN>&6WW$'^HT>!,M$B7WT$6"E)
MR><F"$]D!4ZN&;8H@^+H1]UT$RP&RY#N^X!A6)*JJDON8>FZL-YP";&_-):4
M /,M!PX#/</ 4&CSFZ -P'!8E_O1/XO:2@+N9 Y0EVZ'S-<:<H%L1V[P:U=Y
M W/8>C;X2+BU2OF-IUN1W/P@'<.E<IWAO=!6&U*;>>W"\A,@@#'SB;G;]WQA
M4<9HRK@U)?!]T+2..,S8H)5O%F"R=CMHPL$86PSPM4@^,#5Z8"_N-#SGCZ.T
M^H99,Y;6&-7P$4I)%G)5TG)8S[3;<-AX7%9#G-(NIZ$YZ,(P0C LMP 9"HJ7
M]*2N\Y ;RV>WG$RW7@L=--^\"0'\S17Z(YJE6\U._;\'=. DF1-?N'C_-GI6
ME'/=;[K;],I5,DJ(Z;N?1D]4Q*U +I.,>\KX#4C:E:?-*(!ZQFVW#.5RD4B3
M;!V>1@4V0K<C19\GCPX287OFUWZ4:IG!;IJ613V9,D#%<EI &T2/[1&:%E7I
M*$V@D_(@40LY6)B+HIPD.3<K)X'_*AG4F,CKEI9]6[8[C_/TXN:=:MGR&%BX
M#)Q'6NJ"=5: /+,=H$?&)C>R]RSLGNM\1./Y W^)G^;\601&?])17J4SV.F@
M 3O@ZIQ:>\UMV?YN^_F_(;7D=7(=G5EP\!!;AK-8>*]),4FB2ZZ">/Z[0,[0
M$99&K!4^Z=>D??]4+.E /D3/ID4!P_?9\S=:)B&PI)8=VP]@V"'K;-W.>7Q\
M?D#_/_&=SP0!+&8,5(]"#FJBO^+#>'].9MGO;-P19SD_WS\__]9^9B/=7=;$
MG5*:SZOT"L1V.<KWNYWOIZ-]J)?2ZGZ=WG;LYJ'83=O^1]A^)^LO+E\Y&0].
M0\;F3/UV+<R Y,U%/:&Y"1T?',8M>L#N^!Z$6UR2W24)J+U>&]-H',QO)LL8
M37B-TT?*Z"L<?MP\_-_H:7OZ$ "AVH!^Y59ON.&08\9+KLNJ-DU88WJ&&,:L
MX$Z 2SL],"G\8V"X1V$Z-KPWEI$ ?+#.P1,&U]T.O7^52A<1VS*=_1CJ+807
M!29#9$8I\;PTR<2K-RF3&?U-[47QZ]&6T<'@C>T]]&TGRFFQ9)BT9#CEKI'S
MHDK9W]4X77>F^]&O<VT;0S](R/BOIA:2'(07\W]AH9?L?,JR9%!HYT@6=,2:
M0%S#I"0*!,0X:;;=CJ-T>]*/C<W<4O_3V]7_/&S]3V]7__-UU_]L.]]DSZR5
MVF"1L-"=< 4.,M3]>4EB+9US%,?DDV1B_? F^LDD&;<]">3\2PTS<13(ORQ]
MM"! FQ8 MS@A9EK5\SDZ'J23Z=Z_ZP2AKVCJAU\&S'54(W2BPI:%,-[U?MFD
MJE+1]4'AT<P0H:"-^BQ&DPHR%<9$FF+D#K*B((6"_;:9=3F0[K^73+BG+_I5
MZ ?IW8IV'6&U(DIG4 %$L: _$>*RLZVN*X"4ZBJG]0Q!CV(D&VR;02\?NZS8
MHOEM<#^QS6!M!=;.1&NCH6ZB*_ZI/<HBJR7G8'255@7L4:?N2<OF89:R$[[;
M>1\HP$3TM-8T0P!A2*>-:V7& .WE^%JRX)8B["FAM1<S-,8*K<OH)>:Q]DUA
MB[;CG6M<]S;Z/T3AW8Y>QK="4:H]NV@U=D.7I337(&AII4TZ4X;ILX:*? R3
M5/AP4E<24YF3**@Y^)!?I661:T2\SF5HNLVCE"93LLF-Z(H$ _6W7@73(+/J
MX9+P(0]9MB%3E*;@A3YH[+T;A4>8%?G$7(FYWNT$I^(<CTP' ]N:ACXU*TC"
MY<091BE)/\/*.5 >\GI1^BP3G,!0NY]7'](L0PC</D$<AFGEKP4ZAQN$99)\
M=XT_?7XO<7@E6W,D#9"Z,"$RW]!F483%<)JD-$Z!J[/!@876ZU4]I.M3C6MN
M_C/4"&&;VXB[ 9!V'WO(ZDF!SC]CC2*R3/!6 ^=$+)#^H'TA61IQUPNXR'*3
M">?!+ ;&--\,;KQ%JB;+,B')U3L66.Y]MC3<RP7=48=ZO[HEE@]$33: D.J<
M[!@L 6Q(V5P$\[2>TP=X>Z:R:;PW52I-E8:D6<)[7UWGIIQ<;^IXZ?*OP!X&
M15$M-LV06P]E?+/\9@V3N4OFEJN?FV5&?,2=4V#L)\@4JU;]AW2N8\X#H.7-
M4I<_IOQQ:K(YI[:88HX,!C+;>&%-(8"_VG0*L#EKW],\?+87D4EIEI+2$[@3
MYD@X$M\ FD"A840ZJ+D%$P:WRHP3,&T/>3FPG!+U&_/!L6O:"V^Y;N_UW7;V
MTM!U1\:07&%"8-JHZ4X.HX3.ULB9YK<[ANABT:\E3X@E:#[5A!8C]&,)$70I
M1]GM;-8HOK/)AB7;<BM.-+K=ZK5@72+T6H3>"O:.WNBN@(!<[-30STU@S*I9
M 3%HV<"VE/@=>9M5*4.2(BP5;MN&-Z!U.74O-#[^MHF_Q\3G^@>][WYY_NY'
M^=O[E__[ZW-IW/#]\XM??\$_/_^QZ@_3'&E^]-#^<9I_W4>]2>#>IFE;53:0
M/YHE&;"9Y@NBCNL+5BLG"7UGM3RZHU;^4<JWT)C7OF_3MJU1Y8WUC]"[O8H-
MQHN-HL]7Z,K->8$SCD=4&FKTPG7'S^Y'Y*W,Q3*T@#Y@5]/!+[@^CTY[AKP[
M*^N@W#IM!B>*+%":,KI/^LXH\-7465)&&9%[IA:U?@F-WXFSEBGH73TKST4M
M?9U4'_2Q./KI.LEJHG\2YA?#=(2EU#,FBM<D[BH3O4@X;?]99HB23+DCC_N1
MAQ,PSJ[0 V._A['9Q*C7('N&))[6=> V.[N V JG[^9@%#0E4 4X8F1^GZ.5
M,J<E(X?=&H?:8KG;P5/$%<+T968 )DNOT+%9^ H]5<SHJ08]$HTQ.^0^JJ2A
M/S9*N"56T]_%:AXV5M/?Q6J^[EC-C5AMV\,,/B9?^9U4R;%3ZXUUT^R2E[_P
M*;PH2JY_N;G3GFO.MSN?ASB?NU^19AN0;5W0MF]XP_DAYBS,T5*V%VK?-ZZ3
MQQW:,N(^5%IX)D;P-ZZIPTVO=SNVAQ.J+Z$]PC\'IWT$>YH#OSFG:96PH7E>
M_;AWTH^/S@]0?M,,"O1.3O=/OA6CV"X%Y08T\(A4RER>"IM'RDVWXVM%IP]N
M;0HYPF4@-<W>'@J<\9&+2K#;:,!V]B*J)=H=D=%$TA,8+7/F]8V@XJ>$*Y8H
MUKLE5!&M1"I>V C&3<TVN?2*1^=RKUGRP<] (ZJV^2>"%JXLX'+_^?[%/O($
MD2882V%806\E*"9-JA0>-8D5(3L/)7]2N&W["8OQL','? &6^JRH%DR&.][Z
M,/-S&VI9T-WXYZRH\X4RS]/3X_CL^+B-J1X<Q&?]\]O&['9:F2J1@&>D1_VC
M^/ST:)V-'A[O'RD7'1;B[K9+\5X=^YM)48RJ*.P##EXP_,#!. S(Z;3MH]E%
M2,TD]Q,O2IXJ+VN==1.CQJ/L0T64! ,@P.)<B.R2E,0EKA]%Z@_"C.)N9(:<
M&4T07I]+!A;I/FTY&XT1,*\@*WG13"&1:M"UN*S( BZ_AGTH.4OAJ[0]A5]9
MAL';)L=4@J)H_0@_4R6<C<\>.S8^(5X*M!1FMVT*$4MW7F ,B)@EICXR<Y",
M%E:GTJ#:$/&[MRH5;[;',M*\#%H4,USI'D-U5(L=>_[\[/G'LH#K["UC3.QX
M\SWGI[LIB!V?P)A)(3X]01^G-=9\=AX?'O3OU,)\O]OA>>@B[S8-<*0FFSX]
MW3_^=G4>S4=.]L^_;1F^VUF?$S/H5J6;9CCAZ>JN82:S)(5"&+"C\''+MEKU
M9)> $B3OW*8F1_?3DIVV>Y,-@DRDI0F,(>5YD^"H*LDLRAC,0K%@--F4Z^6R
M:\>=P]D*IH=,T2KNP;FQF+J-:.PN-::81+.:?I85R[6)\GYCBK=JZ]W.JKKN
MQ%WEUK%C]9^?U:O/#XK3\]])0E<!7N:V+F[;-_]-31>\L!N+$!7O:YC*8>^S
M_5W,Q6.:F.9>"./^$O0FK31E+"=4+MGG=O>D#8%V*0BTGXY)<REGU.T8=S&^
M (K*PR]EVZ_+VCZS]G!W_>B0M*/CL_Z:=G0:GQV=W$DY:MJLR.?<Z D\/#F+
M3P]/U@W8H_CD_'S_]-L;E)H6MZ#795KL-Y6^* 6 G0G9J\8<(Q8U.8B5M@'6
MH4=!M"950VFBCS27\$W_^"@^.#CH=D@.<RXM#6!F\ZRX-D 4RPU4,?=!C=/;
M!UCKT()L2< 682X%"7?1-SG3>$U!J9*9B;@0G'V,SD4X2@6\:YI<"1"3GTB1
MAUJ(26:W' I;PW:;!<2L:'II6S;K\!![A011.A,D3HZ@9Y'Z:+/XD$\>N"[+
M)*^2H9R,4Y2<RA:OG@U1X<KWSOA[OC*9R8"/B%._O-1 [I-LRPQ9HD$I\20=
M+QKI6@U]TB)9VEDP'0KX&XDF1)>3W" E=(WVUG?G2'9'YE+!])?)$#W2-[4Z
MAM['-S$)Z^/X$EF(GT%6;(19NR4'XW"7@_&P.1B'NQR,KSP'XXMB&GX69O',
MJ?J/7K=\[*?1=A02?/SF[/ @/CD^9ZGXS4%#@;D]0P,:936WU9)W"C2SM'5?
MI:_1%=T_N$F?9(_XNM4(C:9=L8P:>N6*[ZO;R6F7@JHK=1K)P_/DN@J^UEZA
M9#.L:6+6]23*CQOU,8KWQVS#_BC> TG#W^ ^>*17]Y& V][E!#XA*-"+3_JG
M\<G)0;QF]QZ>G\0'1V>-08F[W<7TO2D'IA?WZ:637K\E>-OKW<RIB"4A ++!
M] T_ W^_Y'.3<3,VK;;%\?%Q8%RPH5,:Z#>,#5&R;WZY,E):S@#M6PPM3!L^
M_.O^Y3XS+H<1&")&9&;"305J.J(LEI8 %M;<H_O[^#'<>V1K)RBW:Y8GBZ7'
M\68@8UFH81[) >5Y4>00KBZ?/W/P9EDJ5;/^>Z-B6 <M"(I((<:-?#VY9K(
MF/7"UHFY#2$3WY:0N2@P!U$$X.(&V3&J77GQQ^1FK5CRW4YHRK/ K=E8ED#R
M^MDUL0_>KE!)(TC??K(Z3 -POMO1> O'J;4H<X7\5D?V.4X8[P::1Y["[;[;
M;F>3 V*C\$:YYLJ-.#D]E1OA_4-W^#9[.9H^(QOQT5A;HZ &Y$L#>I?UG;Q$
M4FQ!=W\HY1<[K_67C.[ >=/MO,SI($WTQ$9XGNY"//><7R-A>Q,/C-5YEO+V
MQ]")63FGZWH4'[5XK(\.SN)C^/CX-7_1\.*=(NH?(\T/SOKQ^5F+-.^?'._W
MOK5 "XO&(OA=G7ZW8[-:[RH3&NPDP%MU(Q^=QWW <JY]$L[/8QK&Y@PIXCUQ
M\$F2,FO\!BRP?XZ"5EIEQB#0%FM8GLG5#&'^Z@'_9?QCY V?:FTH*A6!="7?
M9V?MIE>[G6^(4N.#D_[JAH7.47>R3IK<:<MZY^&6K>W)27QX@+2[;_JD\)T=
M8X49PO'.N^R0;2WZ<NON\#LW[L[)67QX3C.BI=(JSO&PW5*@)( 4R1:<%Y7"
MH# @+R2V?-D8A['$QO3AR4E\=GC$1 !HRY*!%7D:VH9F;>([8?'YA<5;"TC!
MG3BB)]^K*"_&3R.5(.^3WW?Y 0];"%'B,'#W/1X([_X@V'V]] OL/BYA+SX^
MZ\E=>G(2GY\</_U8]U2W$_JG]J,?[L;!5[*5:$+,+G1^$O^3\@#HV54]^!<W
M*4%F50TY1._TC[YMK(=S18WKER6=M&QRKH;]_-9H73_^')FQ859*PVB3;-\)
MQB6ZUHM4N!V]+/FR,F;%_(:Y5+?#N;)OQ (0-COE]C%W9-*\*XZSVTW1\7DW
MM*D1T%6P!]HRA@_M5(XLMGU?7,"6S;%A0?+;:O]M*RYR$3DNVX39:.*EEQ"-
M4M-.Z?X"?/07L_ J]RLZCIVZ?=_Y\98J0;,&?7A\Q!FQ=W&<Q9%X6#0' M=%
M5!XHC:31]/JG=ZT7:W5A0:DN!'-$NU,B4V-07#TZ**Y;@M5'NV#UPP:KCW;!
MZJ\[6+WM?/7.,NU52A;9B&PRB6,\DR:>T3N;S;.3< _280?P-\U^&;\593:R
M\&%OI+V5^%%)8OWVTQN4UV7B0.+ZK++(D^@J+6ON-?CLS3]>_K#7.R?]&YE6
M9I8.]Z/W103 2XYLV.:#G)WF(N$D&>V;L0*<TGW.;?\#YP)/H9NR)3"C!_C7
MB$&41::UM"Z2\?K9&]^J R..T[):>$3A2->N^*R*[$1OD28^:NC$_ZZ3$NC;
M.3:/IDWV"WZ_*-.A>K!M&MO"S("-6%Y'0Y+W:&(+W\2B*-4K/2;&)Z"BS> "
MFV<R/TP ^@9WCASQ)@.L;R%'9Q*:L@!7+9;%WM*8#Y6:%W"TD.7!F+.]ODUO
M?",@M+W#\(3=-[B4D6VE9[:1-0(UK^W6/M.M?<,81W9GGP5;&TE'Z1FJ]%S1
M8,4]E32K@=%1Y3/:>DV[H\@&1F6=Z>Y<+NB_9*1T.ZY$ &&7H2&CB"/Z.3?%
MMF&1=@H1G]@SN\1Q7;)UA3#3[]RU*Q_9)GL>FM>1%XB*(T4:#'E'O(DAF6[9
MDG?!EL"T-;*KH*)R8OMD>@)WTRM-2A13^?@@]]_DZW"9#)(I+FM&FB2"@#_7
M-,OH53V;<__C4?2V)F+\5W*=!$3]AG:>6^ <!13P"R:/GYXVL(C720US)@$(
M#71B@+8WGT*BPK1.&%]>C>4D%YNU2G^7&;OZ'[[A0-E_[I&[Z7,,$XP>N>4"
MD,'^';?S3"M:(L_TT>W(!"WBL316E6; X^@MQ 1=B+<)%&W>CI^Q4T1"O.2_
M)WF->RB<K2<K_K&=IP17S9_XK;<@/'(',B@\1<V 7G,F_7 J]N-Y2,:.L28!
M'= <F(2N(X$NQ/E(Z'4V(#O?$M6^=#&:I8N%N#:''T;%,M=+&%"9!5G5,_#0
MA,/%VBG23<QU3<=V]G[D-)=[;X&<@S?7V MMUF,S3;9H?I?U -U[%ZF$D.F_
M-A5>:Q ERDR2$&KL>E\XD'#%NOX"UU%>9!0F'L?G[W/GZBS] %MS8 !Y22*5
MK[#@8^.GOMZ=?\[W')RUV?+8-=!V"@&D%C!H)50Q3UDW(&&+&'DCS,UIXUDQ
M0.27EE3,&.5;H\M$DQ<H1+>]T"U.GZO\DV7Q0J0 /.)*=%]J*1.,;9OY$7 =
MB[E/:T F1YJ3D)UI8@)6@J7+380?<Z)HVY@V":?$8816 / +NXDX;4@U!)N.
M#[Q3QB8/KG]2+Z9%D*>A.X6>?ZEDKVO'<8D#AAN[ &8TE[C+=M"Y9'PWE52T
MK*-$M/RZT 1X59SVH[<KFUE91A^33!?'*LH>;*>[12&MTTD1@6RGC?C;]EZ=
M]JOMC=/0&%TU5C]Z#0U;=:--^Y?_P0S*CQ^^Q<+]B[5"O57[T=,]V.\_("PR
MV<I;,*7SD]/SAYK30Y*CLQ!D/H&94(S'2([:8&&0B"[KN;7"JAKU+1;)7=$L
MJKA9WZ/LFOC9)-$6*G*]S2AL'B 3$;X)GI8&W>V).<[8;D&'U+!N1X=V\L&)
M@<:>L\]D*VA]&XC[*Z3FI9&)@!PX*3* 70[S0"0E.V7MA"C1]RERM!K$O8IZ
MP1Y&GQ@F73YJM,9QFH>G/9F"$""/ZC,EA]:J%7GJK$K5$KBYP8Y@_T0$RYW=
M,).0GXHFW6S>DQ439+\.*TO/)7NW/,&2H9.- @9HX:*#PL*@&G9%SXYE$C[Q
M%YCY^%-\:&XZ#%$$O8^3J&@]]9@^(E=%O$ :KH:ZF2))IPROR(@LXFN+.WV]
M=NET%OZ6<4YH9A(VVFS JO'*?MMM4:?X(U#[MF=^%QGI^O6$>Z_,3--Z9J1R
MQ WE9)H%LTAR8 ?XB/^.E"]Z(1]J)K.8YL@IYW:'XFF\*K(K8VW[1A.8,?<9
MY+P,(1G?(<(7Z,YAHR5#4S-_J]0> )@^6B_^3AH-"?[]Z#<C5I*=$4TT XR6
MDF&:AST+E21!;&1+@'1A:0R0K8!K //+5' 5<0_$&:Q?48X8?7^!RHZHFO(=
M' 1^UYV/X9/G]QO)<DV"04MK)RM]U\#07<<YWCEZ7\SAT96R:E$?U0]PP=XM
MR?!SCB6QN;6/6<*>HW3([148FI\X$IFQ1!2<HYDNU,<@*=SA!]X3E\XX8>9E
M/BJ(V>J4WB?I$AY HD7V -!K65'J_)CHK^#PVT-9F:%+1$_:9FXV6M'M2',V
MM/="$D^)-@\% _<+.W=:.;<18&6=2],'9K$$Q>;J2\$UJ8F'C]D[LM09$?%&
MC/0TUE*(E8L/Z]Y!(%F'.:V81D?D1&LH-G'EK:.J;:?Z[PVWJV%/*PZB)C93
MPL>RN"8:*+EXS'6.<PX7IZ%*7,FJFZH#!(B*H3[+945"0G.XX^SO[;#HG)/#
MSS(PFN!!8O4: &"<)DWW#0XUM*6E%7"8 X[=BEAQ-)$(%>)$<%:!.*3GB7,/
M,NU-RF()@BX-BBTB==!5Z8SN4MGM<(<3R4=A>N>_<=%,O[<CL4\7]0)UWY[9
MB%@CJE:UZ2"'N#E[.SXY.HY/^^<6PHFAV,;T3(6<19*4^0?-JN_U^G'O2!+)
M69*.#'>:KQ1'&GG4/>3.K^3^MWU6T;!/CF_[;/_P+#X_W/S1XX/C^%AJLH*U
M^\0F 0I%NF)E0>8R&_#GC9D5.6K?5- DV?5_E.EA)D6^-Y5?C$($&HL/0H/4
M[ Z?S5+.Y:[VHS?A%U!X;$;"HFDG9L;(I5G=DM)PMT?O&VZ!V"H&1";"\EGN
M#$BWH8OD&#[;Q54-?I\*^JOH;XPV,ZYU!:M?EOG9'+&<R#'J];$IBVGE@740
M#^6<]JJJ$XTR,HMX0>H9$>?>SX_MWMZ2#W:\RP=[V'RPXUT^V)\Q'^RC#N/N
MT[W;L:W$/U;/26YFB^]L_7A:=F5OG) Z<_VWC_>3K3BG]I8, HWY9,0V=)\<
MWV">\J#?]^NE7<./__LO)ZL7X@:^UC+G!]TPKC_$#"%X_@G5\#F2)C;L8.MV
MM4SR:S_!_K:>X&7Z>_1:U(GM.\<U-_R.1SP*"O-Z/J9I#9VM(JW= 7[L 0;-
MOW8'N#O KYJY?W9*V>+Y[I;_IU[^':]E&ZI:.1D\Z1\<Q7 *]H^/G[9<737_
MCF"TM]C@G[J.7\Q"/(*U9C<7OKD 9X6X)DD;6*#.J__M9Q(2S<_T'G;UW]R\
MJ-[)RN=*L/1[?._)\?%I?'[<N^6S#[O(I[N3>X"3.Z7K>=0[VYW<HSNY7N\P
M/C\Z_@-/[AZ2X3?!V[Q1DWLH$:")6EP?]D3EP5,%]+E=('Q64GS Y=YH$3TD
MX?7B_ND)&C'>X5N?8TV[ UGC!,#S^ORGL<JV=P>Q\J&]/^1&?%[]_'/JY)H@
M@S+-'?>]ZV7O]^.#\TV:]NZV?\&3.(J/3P]W!_&''\2C8[MW57X?WFW]7(MA
MQJB:9R0JK?+B?*%<V#/RF?@O2'*Z2C(D.7V,H_CS6F^WN]*_% U_W$SN2^6D
M<Y^?;;+V-CCLO]1.[,C@BY$!2?_#3=)_1P5_%BHXZVT5)_BR)LBZ6.S?D]+8
M,I'6%RBSX +L>TK"^T[I4XF?OQN-BGJ0F2_BW_S(6=Q;#)X>QKVC36IWZRG\
M<1QP1P2?APB>G!Z<Q4<G=TT@>G@JV!3!V!' %R( !#]ZA]M" *OUSMM?3K%%
M\_NO ?JGO?'Q^= 9B'9J]/NMG?RV;RZC5;<G0@1.U[LU?6.T:XWTLVK$"')M
M[9FX-*G(]_!A!Y9=Y%^X'TIDVZ'$+0VTAUQ96W&W-E+M!IE[Y9CT"\4:'1G_
MABVJ;1:T]>*C?B\^.SMQ0%[SY-H""08Y)QD/DZ7)P.)\\ML'Z!YW[MNUW'Y2
M. 3=\F(\1M&PHE[B]; CBZ"2\SJZ'7L8S?977"DW0PLWQ7'5VC4>X/@D/@<T
M8>.!<%'"Q/>*\1Y-V/4 X%6=Q,<G1#6V20!M?_)[$U_@F][I67S87]UG[=.2
M+XK2[A$]AR8_:\_1.N9).M*F CSDV1%<)&N/<KL_/1;7!(R/,&RQ9XMS47I^
MK5O8CX]/3SV*:]CM5##8:%0A'=[*X;"L:8354SX\/(E/Z92WETM\,2ZV.2UK
MA1O=UM&J=R[L2--7;F9';3#[<8-)A90_82 ]UT\H:F\G]-*V$[+=/81YH"=1
MO-9)LDE;+;Q';ESO+#X_.M KV[P30?\,1W/<#@DM5SR%AB^U,ZQ^[S0^/3J\
MC>6$4O@&GM.R?;[MTUKG))D -XBZ8_<G](9L:?_D;^1ZSZ;VKVJ?IW6VOHDU
MR%R/>O'A*>3'/5D 39L$Y_Z?^>I_&04&P,-:#'TCW]#D*44OO9%E=#O$P5'4
MWEN_V&U7&=B_O=YW+0*%R/[DH+]^6<.!E)RB)TXR 5<T&.FIT',_/CPXN_4Z
MMJI<=V^R%LZ2VZ3>?%M(G)_03MU77AX=Q6<GISMQ>4^+ZJ5/<-M95)^#(85Y
MA2Z;\-.L*I=39[$-!9P[C[0UFH/:L![I;B=P24MK7FF\('#C+;UZM6]V[R ^
M0VL#1EB2]L9#AI1 1;81#%"+(@%T1HOT!MYR@UP^)1OM]-#V=I81>1P[1B"/
MTYM83P]0XIZMS>MR.%4>B17/!1 Y%RS^))^D&",P/HY@M>QXQP/*VT\D;2=I
MN=FH4C7Z4H7-UD.:V$QAN^/\Y/DQ&%2WP^PD+VX^R]MUIRT^")%Y]CA:A=PM
M$#(G.PB9AX60.=E!R'S=$#)WN'-;QR%>V)SCG5;\>=6&MN3NC]"()<TYU(;;
MS/3 V>Z=S:0]&D:+':+1A?AQSN/C_G&@5P9V+*NIH8EM5=%^_S0^.CS:8J'W
MIZ$*JTQRRG5(%($VZ8Y4>KJ,R"!"MS'&6/SF.#[LG;6=_^;C/STZWAW]0RF>
M-Y[[HU8\M_T@&J_=U%?S&3'/E.[K"]>+T"UJ6]>V[7L/Z.Q1P3V2&.T3<:(A
M;W/8\1' _NP=389#= < J#/@5.7)'>E_?M)_,Q[O?9]D0$KM=BZG0'V]*$OD
M@\X:*9_;NM!M/XA;D(ZO6$2$?6%(4.\-Y$"BBL\C"<Y#P*SY/0 !EPU8;&U2
M1Y=(KERDV/4T@]*V=C-:!I-O:@MC^[1S1''C,PY$FT:VL+_QQL8> 8RQ!?,-
M0(FEBXB#%]9>QK+2A+5?Z=YAFW54BV+X 1&='<S[%Y*.*5O\W<Z%A.JX"6V1
MI;N.TP]EFO^J</L6V'YGEC^$%J[93]J+$G$D8D=P5R:-?F\1MWT5]HKDD8(;
M72*3@EMR_+I_N1_]>''QUD*?<]OE1!@R0Z4G'XP_.8GO5E4]D\Z\2.<!(Q.^
MJ]9:47+S@ID$OA$$ES .W@UCPMJ)5EOB5;H&7$".!6UXJ;*)B"/;,%?Z:=RV
M>!N\;IN@;ZI*#SF@]Z!%F71=0F\H4\')-]J/+KU8@\O)\0Z_5Z49:^1-FWYH
M2A$G$IQ^5]WIQ+3_,OINLM2$;87,Z\6XSEQV0<PM8H,G&LEV _J(J89PTL8P
MV/%FQEW9.$\&P@S92UBZC<2M/[<6E8N#)!T^AJS()WMX?N2>6)FV>G*0[^0>
MN3'M,/SU>J8E9NS:=V@N8E'Y]F]!$M%:H+(9E J"E?O1Q7!1BZQF<2]]OT8I
MG$\NA%H%=V(GI>\I'][)[4,^S+"8Y'R .Q%QW_F]H2OQ]SK3CN@]S5ZT68W)
MJ$ 3KRA0>B[I@H^2DKC<KW/N,V$;GU]<_NKZGM-(1WM(A=1#DQO!#=.YCS +
ME6>V3U&W\^3B\EGTOIBGP^CDX.1I)%WO,)-907<J-6B/LR@+SH9 /_N964P+
M:4 Z=*.RD%&7TX(]Q9EA%LZLZ>]U;J+# ]MGY#WZ88S2$9X%3>$:X\K3)B8C
M[*H5;?1A8APTC$G*G*951?4<K -;HS*5>VODM,434O&9D255*RM7"<+>3"7C
M_\!G/4C8HRW\7R2.E=7H,9BX].RA-A"2A#/.$;&E_+P9%3U:C:\#@<0-J[D'
M2-"09'OI<=OO"ZM40_0.FY/8'Z9$8FHGN$VWAQSP*4<D=$E$W#7H0T]4R"':
M<R,P09=&U0EYA6@]K\9&'-N3 NJ&=!CG!F#2%M)UHU1Z%H+2T5C;J)PZY.D+
MO7]<AU\[,R$Z\4H9:3J>L:K2[53U<.JH3R\4M[91'7%UA2C=P-Z[&POYN8%"
M-;V0C-X9W3V:EV$7F=T8:?%']\8$UPB-JQ*2[:G(;I*[["#@GE7X1QRY:[9$
M=S?M<QYMV$?=YTKB"79/)7-ZY5Z#?^C$T'%]5JE7XJ:96>_W*HNP&5/:<5$R
MV[.,&X?:1HF[^WN_^XM;Z P9;N^F:;C,Q,?$6/>JA9E#^)BL>3G+4*"Y''LG
M@X0\5D<(OI4LI+;!WHLGZ5-_,?1.\E B(_DG^I68'EY]>M/U<?T#93!^E=YU
M-THFP32><-="L#,H_KXBYBHI4TFL6.42>)6.Q%B>DB[0;XZ(<\#/BZW7<.BI
MXPV;5Z*6 FP"94DDY8:D4F-Z5T^9,0ZYKV';W'R@SVD!=UX];M$3^L+:.:*I
M(K&")W D5D\;'$M$::H4TOZIQW81;\F!.MWE0#UL#M3I+@?JZ\Z!>A3BSEES
MMLI$>H0W)8U7<40[:LBBM-*NB>JF6L(+DD_$6&2/C/.W:0Y%($FZ'9>90<('
M_AXDMXL42]$#M_&IJ;2C1!M>]G+5 VGR++GO#5$4"AU4Y\FCTAW8)K0_0B:]
M1?-[6Z9<C%E$FWT$3J963>4(BFSEE6M'5.,"]H^TJJ^]2C\DDD*(2\)=AB;X
MI/<48K>JDXJ$?;=CN/A;NEG"JO$A0=)&TFI1?1<]Z3_U3<1!2:Q>E(8$TY/#
MIZ3<2TMFT2>(?,;I[]++V2I&"6-5L+IP]-32D/@2K[N=M I#C7!PE_#Q-IP<
M53V?9YI$=),.'Z6A"T"W!\:5- -.JP^NG)+;D:HYPBENZJ2F'TO/=76(U]PR
M-="#5&,*;!?W ;FXU8=*>P\OV:6#H.4RISV?IG/W23: I&#+P!M$9M=U8UQ_
MMHU^]+ZD9/5Y[3"\:OI(\VN_G[I#)7*"4)&'.PZBZG80#Q"7-MPS=9F'7N1*
M]#U-JG"^G"":*G8@NW%\&,--8V"JQ4HL@TQ;N,F'&K25/O9R#@F[ K042)SJ
M6CTSLP$!ZPVR:68^CJ!6(E;X^;E4&_[64K HOU+VQ=(OP7T<)MX-LVZ?.<NB
M:<2'79&%NHD;>A^?.@\C[SL,31[-(."Z2;R\3*[7V":N7+IP?',_^K7I6<QO
M8+OFBC1U)J=@A(;/:8[P-'$MEO99MK8\B'U+K,-B;NSNP#IFEQ;B6%=I45>(
M-:G3EZ,ISCN[NI'RFN!1>&^H7!3$%!%G&<D]%/YE$P0E<();Y:RW>8+.]GD0
M> M7MQ/JGSR__Y^]+VUNVUC:_:XJ_0=<WY-;TBE(YJHESG$515$V8XF41<I.
M\L4%$D,1-@@P6+3XU]_NGADL)+B(FT 9>=^3V!()],QT]_3Z=(OK4-C7C^']
M]'7T?DHO_6G?WX/=G>L)@0D94TB*"*9W06G?\.DY+-!(E)V.J$DW:J&&^2/R
M@_!C80"=?A1\J\,X5$S<:A-QY*#(8*K5-V++45P\\L;IIA%:JFB:R60U?I*L
M:]$W3!;J'0,#CEP@UQ@8IN;PP#X0BB]*M([%S39BYBLM#/"/&2N30]I:S\.\
M!-XU$\/Z#@N%@ =+G<G6GC3"> $(]UVYN8HV7\3B.U2NQ0;#Z^$5=[!&2SG*
M*;KVQ-U=82;R6CU9W1>T.E,B$\L<1+_QH?(QL/C,)S5Z61E6]);G+"0>GMU)
M*XI3F*Y-OAJ550R%)Q,73,K\4DN\1]T>G#TX*W<#4P9MI. OXEF'8>(9G@!<
M!/;A$P?=2?JX"): E/@\&"W,D_'X-.%1C;DZ$1,?_8#HDZ0_P^6 ]_4'[?/<
MJDSJQY>$C0JDFX#Y@TE[,[8<GL@CHWB,HOE4V/C*R9.B=""7A\@G0B63F#D+
MR,)J79!=/#&JDI6N$^Y1T!]RJ-1[R252P8E*H]R'=6.</[ITTD^1Q\7OB0>>
M4@Q3!#Q8X?085>A*M@"E  ) 2HDO-I%I-)=TF%2>F698D[4JT[7II3_M^YM9
MJR]YU74UAU=?^AY=<%$W[,[1!FC8L7@I1:#T8C9E!UQO+,P@@U6H;[?K,&:1
MKXXA+8I6B=]A7^9@*-_"5?/D;T6NA.C79)B/Q^3Y;>+R8N/)I4?T*GC P'!1
MKN$Z$B9I]"TC-/!BW( 4# Q8HL[*&R..3$Q!!5SL,M& D5T)KX,?D='D,)S9
MT[I>$)L(K@41VXNL+"@1H;9CHEW&0V:2K\G8MZ;#!KC1.S>\PS#>2DL<75OL
M"EVA8X.%-$F>#=DYX0KD>0=U=52C0QLP[LFX<6*%31<<2Q+QNSNK=,LF,"W5
MWH5K$-8<EE6#!P?N@A(W@6C;TZM,%LGRGV19_M5F^4^R+/_KSO)O)=*)9C@1
MCS;L&S$LUW-\T=FZ'6O9EIWG^::P5EZF3>!NNH/_4,X;CD69?BHBQ,5SA9'/
M#YB&"6?^&9W!=_&^3WH"3[@$58=A]U20 )N#BCY(GPQGB%M\$SE*^J%AH=4&
M'SHL&];K]@02V$6>;N285(R%@IHT,.*%.(^,'9A@_Y@*3P-B+*9O,$=SNOTG
MWD85;YE+YB/.*,SJBX1FP">"=P1$#K9.CWU?&'A$BT*T</N0TT[. "_U^#V]
M)Y#,(>$M&[U51V_=9Z\A=NE.O)S?Q$=IS?_XA*LZ89K6L\G-'196*(-)(VPV
M3]+IT?'IJFA:)3M>HA1Q6O*@BX>^%]3PA&+.6Y]LT[Y[(GG[U[>#N+>K[/D6
M+WEA^CXO1R'_%RM7)$RJ$VN/Q!81T5-%C8Z16&7B;+>78L@T<.#K9KG"7"PG
M>XWC;$>]9R+=.*$E>XS1>)D6?R>G("C0LCL89"$U+/MDQKGW"2Y%@XJ\.-@7
MSB? \BOY-Y53%:L*)>/'-TTJ10W+@83]PZF(&$&9+/RBLE"<6_WZ5H19J8,L
MDAX6WPZ-IT2&"@:'I=XR2@]]%Z',1IT6H9UT/@&%D'^B^DC^*(8/X$30'L+.
MH1!R(89$Y&+(N:=U@]RR@^V@KA>$EH=#QWZDJH6HS=QA74TTF5$JMX\!X3#%
M2>43'>8],!&XE%E&F2;&W.JHBPB?,YR@*Q@SESCI00N #?COY9*YTJ51WQ*I
M@8$1GP&,;0 ]Z(9UV0C^!W")92,L108QMO*D6I^ZZ^\-]L!T4?F*^X_)(-?U
ML>.DXWM4)? $$L'1P, N496)Y\-3'1S*K\-, RX*84I0:8"LV*5<#LFJR!Q%
M'S'0GJB%.M+%SW6"%J)[(18)1R;#?$<"ZI@BK*$(RAC-7XDBC6VOXYT>^NIP
MEE=P8&$YX46E=2;XARJD\3<'N;+4^P;RB.)S2 PX6OR( ,AHV(?XZ:.#?%%5
M@GM+J8?JG%*ZA7<<@E.YM%U*C>YQ0(QBX6C_=^4J#-K@H<<^BOR2^-R ."Q0
MU/TNTT7OKF!! 49I\J=$+9M@!ML@_M[X-VPKPJ/BFA5?X#4#?'@@O@FQF#N:
M:U#'QM"DL(HHJA<UYG!U\V)$ZGF)$'.XN],F6 QFZ0%"E=A;L:\@@7CI!QOV
MC'U6Q1 H'1.[]U@Y2;<_)7%H1$KX7LI6\W"H3A8>%:*/D8*9S@"VA%R74*U0
M,=F]!GX26'P'\+<#JNK26<>+H O)<QOXN&N,?)I[0_?1A4'Y!K)=T6T2/Q!*
M?$;,#N!*DS!%^UJ +9)P(N2:88T:V3F47&WY'4_NY@&BID0,KO$=C?.C^&$E
MMDZLXU'.<9VM"(K2^,$23(;84CA5AY-ON]BWH/U@ O-0%$&@[8703I9+TV(H
M54_9=9P3)MO5#>"J>[M+/5O,E ADT1 X_RAM)X>)&F=KR:;PC B'PV$D;.BA
M<D%J&HDFQ PZ4DJF@[:BM#-5R'&-[N!]TN/(&<'(+-YZ(OS<>(P^P/V"3U.%
M!;]Y)J^?5&),D$/A,D9\]]%UPU)\!WUL6":;M08L_47>UYYX2:&LOG-%#-G%
M*89R0^C^PS3\4XAT,%7$0200@LO#?0I7FK ONSMPJ\HB ;#(:.KH@4 JB^S9
M(:@&4,[W')1TLJ87^OOT(!_,9P+:I:KOL]""",'F(M\CXG'Y0\>XQZ_0V5K$
M$V!/D'# >GH@/K9S![_@)KQP6 0_N@.0?0) 04>%H]N+I_ "5JE<N@+&V13*
MC?#0A)+K,_TNFF>04R ?1E8@8RXNXQ/?'(*2$7D P\58(F*U8^$%/(_J7'AI
MI41XW=W)EPGBM7 8O2OQ&>&;1@!0N&JT+ 2%X7$AM(D&D15+=+WPK7]J\'%'
M%*P7BB.H2U0-_R\\CVMB*G6=M(]/\6H5['?F?I,9=%K)"TO8:-%U(<=S/%IN
MN$7=Q]V=),B^S.M:RC23!\]1A)/-LT+N()<G+0.*3>*E$%=I0?EUPNTL!HA&
MYI+QIC9$*"L6\G+XF$0)=.7WQ7T<=L")!PFDLG#(([X())H_KQ@6M<7)""XB
MV\'6W$@Y%!$@&Q5TH>>3R<!WG.3+A\I77B_%A\D%X[>"K7"#V$-DE9)"=50U
MB_V4H)X65^E/ I0IJ >,!G%C!>$"AXIC1!E$CXCC\E)\D;SD+<ULUEX*!)=
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M$WW=NF:8<J RM>_WL&8_3(JH 9 0G_ORR'MI/E0JUS%0!K0QQ%UC2^03T?Z
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MPI/P7+M,]TFL.; )AYY " TW/"<2"3"CP'<? ]& 3\J./\*2Q*\&0C=1P75
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MO\D"_EG /POXIY7/L]A^%MM/!XU9;#^+[4^+[2>6O:TUX#_>S,:)DJ!5%?P
M_EXB5DW09*.$Q< [$@NQUVFF3MW'.1,*\Y)3>QPRRX5/##5#)XQ-W#/$%31F
M#$/.XLWSO*^@%@K'+QUMSLYNT;/+O_C9K2%3L+%VT0AVI=3(P>^>K9'3H897
MN$TMC)AJ+E,<G"4:Q,>"'=J(33-AN]>E?U8IGJ>GDT+#KV9ZXK8<Q:1$36I5
MXZ+6[+A:6G7\H/VQJ+19MV\!H7=AP_V4BI8Y:4JK!EW]%L9L6DX4&K;QG=W6
MJ/0Z5<+S*%EZ;NFDH:43V/>ETKL9"ZR-!>9-\&^$ S8P=GY<UQ76H9JGE>Z\
M$$D+&#XO1EE6ZK'Q4H\B6&+E-!5Z9"RP:1:8%FW):GWFJU9)#WTCE3\XYR(=
M?;M9,=#&,\S3RH.VTP)/9;U)5AJT-4>5E09EI4%9:5!6&I25!FV6WJPT*$W)
ME#65!HT/H<BJ?D85>V2&[E![&F "&A'"6Y><+ 2X8F.501%4P:R\9'W![ZPL
M*-WG5E1/RY-25Z^^+&CU5G%\;@BG:LKPD"SO/7DGV]?*M6-8?+0H[:/68:;2
M8_&A=ML4:7D]N<Y2>=X$1Y;O?JT\\%KRW7-8_%GJ.TM]9WG/E=X+6>+[53+
M-'\B2WPG9!PF@ES,@/ _S2#\PV#D*B#\3S,(_V=L<0;AOSD(?\_1+%?KTF!O
MBET^,<UQ%6;I3)\"Z*_2GV2LTS4>E0$0T9_P1?K\R 2 W9UL!,#F!^1,.?U@
M=:M;9(J*MI83F7MF^:,%(VG;G5^[Y@JOW$C5%-\B43JU:/W"M+F-*R2<%R/-
M%6I*I.AU5OY<V,\IE)GW'[RM_H8;3HD*<^=]#6\M_J.T5@TM60L4M:DR-ML8
MFT48*^55:9%"I=7QUY*Z=IVU7A?"=FV![7K%;5=^6%2_!30D;,RBI5NC#LTS
M2Z_B>SM[G' \W#+/MV=4Y<Q\TJ(/EH>Q=VMIOHZP-/NK?/QLNC>"X5],KMM)
MA.*?6&XP[=2E(9;\'@+#C^+@3\S%S_>6Q)?\9])#B\E%!0?/*@A(UBXO07=>
M+1R=J$?'N2VEOU0X58M'A86I?Y'>3W%'Q L@QFH?%C=MGDO(3(E:BT,Q+ULM
ME*G-GZBYHS&FGCO=NKQYF8YM*.35TE'^E]^&,>V\T ZL]W*=D'43>>VY,G3+
M*8/QARSWQH5R>F/Z?[&<W'SB/S&I]CKV0"V<YM1\<:;XO^YMF& A++0)XPG2
M5(7-TQ5F;H([ZNSNU*VN/<B"S6D.-J^TP3<6JM[.NL-41O:R+M^M.:KG!6&W
M,+BZY2V_&8=G'+YJ#E\TT9!Q^&OA\+',2\;G:^+S%09M4]R9O54T3@HSK4O!
MK;(.>^X799#2<VS2DKHIECK-3N07EX^7 Z=(3'*OOG4W /V/ 7ZO8&I"!-$B
MU=W1TW+]J]]N.7J!TX;S%S13,2A".7L00T)R.96AK,VB+<Q/SX04_A+ H2<G
M^07/:.,0&QFWO#"WS(&ZDG'*:^(4ON9U_/O5\6"&@)_! ,R9YL^ZP%<.?S[9
MBLF  'X)%I@7'28[_NSX,PR(]+<O_W=W)XY#JO0U5]&Z"'\/?Z 6<]MD6&X]
ML#WF8/5,!&-3<0U$4\!_#;&5^5#YR.@)ENTI'<8L_.*]@8WI^.F>[0SP"5WX
M-K-<#;^RNZ.Y\JFZYC'^9\-5''9GN![OI(:%P:\0 _0PO7NY^IJV-4 0W!OL
M0=W=J0SQ8#23P 1N8(][8*O13H_./U#:L4[U-#/SELC<!^.> =O;/O@P \TT
M%<3WH(,P^8!PI6=8FM4UX'@<YL+GNOCM!Y2L>T:BI>GVD#X( @6?&H*7V37@
MG?@0.-@NTWWX9H 2X?!C5S1YZI@Q=D9./8I(H"JNW^US#6"[()C,[3I&!\6X
M8]\S(,;P^@JN@#VRKN_!BN 1\#3F[+G[JG)N.*SKV?@7HLF%C:.76> 2>W;W
M1]\VX=YR#W=WOJ+Z\!A\R+,5YJ(R-]S^K)49%BVLYV.EF:K8J(7D!KD^4F(@
M8'"P??1]^BWL@8TOA*7 G86KU<S='4DPKMR&1VL>WX$82,># 8?5P1=TOL.G
MD> )NZN,;BYNU9FM.3K^)?(R^*B&*A"_.G0,U'^@'($+/,;PX0ZS>X?*K>49
MYJPM09B/H>_AU@S!#,!=@9<&[^+4=VV$WA33;HA>Y+PGX 8A\V/H%"E6N(OC
M+)5S&<[22G&6RKD,9^D7P5E:SQ4+'UV]=N#?-/3_O=$ZWW*Y_!M)<KU=N]K=
MR9<.E>N;>J-:OZY<*I5JM7G;:-<;'Y2+6JVE5!KG2JMV\Z5>K;72O]K5&Y^K
MIY$BGF![NH:F5%S7[N)]YRK7EVWE 9T N*X,2V=#1+*"RYN**^""E%;,OS[<
M3>""<*"K*\V!^SE$N?K3MYA2S*D1D*P6."4"2$#\''^\NP/NBN\X: '@&PA[
M6AH4'I*(=_1_\F6UG,L=*A>.P718C')Y>:T8LZE$%*])(%XJ?__\X%WO:!US
MT5LLE-5<$L&:"18-4NUIC^#9=7'BG89#[^:F."0 'Y'\^L()O3W=#+@-0G*&
MV&S H]SYUN[NP ]&LU"C486XUW0 ';#FN . -F"/N2Y9LHK+G'L##5X'3Q3/
MK/-$IP_6);@40W3Y AYPN1T/UN-0V+/X25-S@3N\!QO\$!?N/0Y,MY5'^V+-
M4B?/[Y5Z-4!!XX>[DAKG==;FKX/D##XJXXJ97+$*T*<UX1K-"2"T/FBBEP8/
M*A>2P8,"(VQ";<2\F$'/0I4IY))+1PHE,OM6AXFS4>I/R<A.$R3.W$4M;6$*
MOQ#DR&HP5TZ2>&<[,%=^&;25N>%05H6_\I(0&$O&M@K'1<[1LR_2UPTELN0^
M2KV\HFU<<:;^UPP,M/ML=Z>K>>S.=IXP#B :+T)[1'1>8+C&]'7,_S&1!$2W
M7K,L'[U__+@J@VGFDTA?\732>/3 L#!G9+$NS]6+>,&=;VH>DM$S3. &$4>@
MUM):-9H\9(KANKZ&J0">]P=J/. 0#][-7PE/=\'@V\[X0KIHG,0ATE09XX_%
M(T<\W G/Q5(.T\ #5O'ONSN:CD_A<4/\P- $Q@,>R<YW:1HKIKF[(TIE9A]=
M<L!/!GUY*%EDIH5J",L.@G(;E^?",;=L4?K9?-K="6IZX"WTK) M8NJ":P5\
MED_* EDB07?8&'V^T^[$"Y%"#$$JHQ%(Y8$Y3&:M]=T=P9X=F5;79:I[&UEM
M1KXZG^6K5YNOSF?YZJW(5Z\E+[RI%/;RX<*YQ\N,I+H+0:K[NG+3WMVI?PE6
MFF6RUU%;4!RM+2@?*K6_/M;/ZFU>2G!1;U0:U7KE4FFU*_"16J.MM*H?:^>W
MEUE]P<I.94_;W]VY".R85F#'9#N\,@^C!U>2_8  X&@6@A7':\6Q<C!2O#T$
M1^_W=*]F&W8\X.7=G2@SIYGD;=C6$49.]'R ERL?*M<U!8?65VUG*.[=0UXT
M3QR.'ZI'JH%NJ&F!7+!KOV,:7:7"G2-\RX7A#'B9KL,PYL&H%HE<*.&I7T@7
M'8U)-Y"FF^V5IM#ZC5J[H];PL]<1,X8G&LTC)1CS/SZQ>74LP/N,FVDE6SI'
MD+F3C*S[K$W-'1Z7#6NEEBRZ ]/;N%_CV<R_IA5N]3P]\TMM]H)IK+4?R!^:
MTG=8[W]O_B\:Y/G\F_>HF!__>*N]3]\I71SD-WQ$DQ+>F:#\VH*2*^-L6K0O
MW&<;,VF5K8(@)).P3,)>XD B3AM!Y8T[;K_V&662DH936*&DA#5)F%L(<A(K
MN9^.WKROVA8Y,]2A>J:95$_0ZC.&$I7.*ZBX92*UTA/,Q&S[Q.QX1,Q:L4!8
M<\AX\(L7[2#\A\/ZS'*Q\Y_/35+V+FW7W4^K0)8R@4S?L60".5D@3Z8*9+6O
M61@B-BSX10BH@?'C_/$[I?:O;^!4JW3*8GDK_;-,(G]QB3R=+I&:VU<N3/LA
MM3;I429VF=AMG=CE<V_>-VP$BO!L)29_R74>Z92]8TX(W<_Y=PHXB(D>8M B
ML17)W731B.4_G?W=G=ICW^@86<G/6BHEF-C<2.V/[<CRA9[O6(;;Q\FJO(P!
M <RP"'SEI0M9E<+*,^&1_'^A;%@+[W#Q,+\&!1RRL;P<^IXW=']_^_;AX>'0
M9=W#._O^;<7I]HU[YKYE^IWFO(5K0GN;/\X7"_G<VUPNES\ZS9T42OEC_',N
M_[8+&VCW#*M[V/<&P?D>P-,.X-6.U@5"!<,OWK2!9V0RD5SKAF5$__UOL$U:
M5A4Q__FGU,!ZB=TN'A:V1=0Z3Z;VX*Y1SL[H!9E094*UK%#EUWR!+>D4L<=B
M_B!/DO3^Q@>S)5_<T_8/\B7X]]M\>4\7?U:JN)]1$-JP(W ,M5> R<K?A_6P
MXO?_'?6K7L%!9V*U4;$JI%ZL"E*L6J)_-5\LYS8C1FOV^Y.B/P\\+I=^UW7U
MQ/\7>X30=97^Z68ZAK-3B)_"?Q$+5@011!_$C1CZ8'DBD^4&/R+Q"P)]"OSE
M L=)M [R2@5^HM-/&_;AB;*'AXM_5(K%XD&AD,N72OOXA6;7LQ%[K7!$V&O'
MK^K89W20%[(.\M5VD!>R#O)?M(-\$UIW5:WC08-R*6A0;M4_-"KMVYNL[7@U
M-%[[#D(<(6:R' CRKV\X86:8<)' 4G0,#^=VU!Z[5+RA5+K4/Y@_+994\45Y
M^]$0)=TWGY2NYKN(O!UVU6(>#*>0 /$8?8<SAM=T6%\S>P2*@D\B9 #^"97/
M$?$M^!H]4?.]ONV Y.LKO_^RL'QZ'*YI[FT" NO:Z:%>6DX"-=0V;ZZ;-Y5V
MO=DX?&6N;MIV?@]M%TX"3?>22F8_G?L>"&B9;+,4!'<D/>DBI[12>M)S_@LO
MZAQ\P]_Y:Z/300JKB3NEX>RS\T[_QJ:!ANQP5T+#V=/O4PE8'?C"4HZ>\?ZM
M^Y83%Q_F^L=;XWW,Q\M88U4TM W/9-.Y8^TT5/L&Z_'7UH),1)-G&E3EVF&N
M@7W<^/FNPSS->8(G.$QS?0<_($=#9MR1<AI2%NZ0Z2VLM!SANK%!)MM8UCHC
MD%[, NFK#:07LT!Z%DC?FD!Z/C)%M'%>^VMWI]U, O=<2W ]BZ]NE9VQ'>!L
MP.(<GVVMCD):L5IPC-QDN);XEJ2CF2B#;/EE3R$5 C,!/BQ##\L$+!.PU0M8
MAG^4B4\F/@N+3X9KE E:)F@;$+37C%>4R5@F8VF0L:U'(,H$*1.D% C2J\(4
M.M@XFM!JF7"NK&OI'=CJ9*C_C@^6'9I9 C:>';PX6"0%N[EAF $?1K@K9(CA
M5F8Q-SA0<A5S"XW!G>(ZW?^],0:PI]^P#?+[\.Z-HIG>_]X$_"VXJE@^&3XB
MCA..E0<Q+ \?WRAO-SY ,V20+<@08TA<;,M-[;J)XS>;%PHFBZ]K\*]&6[FI
M?:BWVK6;VKER?7MV6:\JE6JU>=MHUQL?E(OZS57J1Y.N/G,_@=';O*7J3 YY
MED5K%*]9YXNC7BJ-@KO3AFQT%-PZ"5@AST]2(IWWS:%A$:P!;[^>:0JA4=%9
MZX&O?]E?F=+7[L4(=&JMXR/,!\#+3YB<ZD9V87>G(^+M+L;;)W*"LA<9XU?E
MSQ(H>/LX'1-9EW79 -O/15M"CD*.A5S^5*4_\0Y D_8^3D)\**$=CUEV8S%+
M0\0L38Q9JDHW#+NX"6$71F$7_AAT'GOH//(3D(/B<?3Z[@[F]/0)*\!/N<;C
MP0!.J*\ <8:M*XE?2%JI16;X'II/:-/=,_,)?M=C#B8.P3K7< 0]V]V)[DCB
MO,;]0Z5NT41XFS,U[ZF<^3TYC5'I:89C/JFX5YII AN!@L2/PJ^'0)JK[N[@
M \-G#&W7D* @7'KHV)]UW*YO\E/%)LZ1D\4?A<<"IJ3#*< C2=[@A4X$U@N;
M!$\?("\@' :)@\C4"C031+"[8Q;09YI/NSOP 3;T0MR&6\L(XA%<70[@K5WM
M<+M5!6C(,\TU:.\5J2NW7P.V^\#Q<TB&YC#.<2@"\&FC8YC((W%^#Y Z@!*P
M*/&KATH3Y'#D6P9YV^P1Y0T97,II>/G$'Q?7@8D$=C27MT"CV),^/U1 O2,V
MJ:8,>=5!A)=[.(#5">L2B-?QU=?52O.,1 >_*OJW==%H;81%#;L[]!6A$131
M[RWE'A4'O,S1Z;X('GY[V#I4>DQ'V5'<L \<\>H"<=6&0R"6/%#'1V'#7P"I
MOBD4 M_SW9U((SE^)&@F!R(&ANOB?LIGTJJV7 *_$I_J?A>9-#CE"5M--Z6E
M@ZD8]-WS/5#:?1LX/ORM.&+XB.8I#TP9PAW/P9N8@YJ0GPF]"@[9[G@:O!%;
M)VR+SDAS7=^A=VL=VX=']!EVV7-IF4NPE)[#$#<JO&?P^.1'5/E$1?<9B8WC
M@ J"_^\Y0!8N*,)W+MZB =L2#@%:."K\V('5P<M@B<RZ ^DDIA:+Q'M(+%)<
M0 8Z!1;0 DOP'-M4['L@(5P"!R  43I4*N'$[^!85'P/*8VH"(G=@W=Q5 (\
M!)1&?.>\[U.5#NPRKE+:)4,?;"^7=E"H%)I('FB5W1VA5EBOQPT+"]7.!-7U
MG(43W\$?T5; ?14*S;(5U^_VY?NW7.Z:$5'KFCZ:#H)KN%%@=YGN.Q1 !6O
M=7$'Z*8PW!_N1+:6VS]30F;POQJ552!H=R=*$<HTOWMTKJ*13XBP0Z6%1Q3Y
M<+ Z]JC!DXC54(7"KK@>WB\&T,+NL9&J2P =&IT]UP\#O%A(#^_NZ(;;!:-;
M/'2^5?)KDF^S9KIVA)I[S?0U+WA3HCU&P""X$0CT01!U>$,!W<: S+"!IC.E
M\Q2YEU6T31\86+?PWY%W(,>CW2O,82UJV<ZQ$E#4'68:[)Y,!CB!4%G#=N,&
MPJ9&-&@GL*LB)ON6"PWOQ%0N'(/I\'7E\O*:MV!N\Z*DN^PRYQ[YS4U4H'32
MZ*" &@9!0<]BNY>-7_S;=GZHBOS3.M\VBE>PF9U;_/D\I@\?'\NET,]6'VD<
MBUJ?Q*+6;[<P7#HCXU7.DELK26YM#J<O2VZ]<!Y&0$R-P$MM ^4C&:2C((-4
M;39:S<OZ>:5=.]_=.:M<5AK5FM+Z6*NMI\-PU0O;J_J. P+W!(8I=Y1XT# >
M,#Q'_>*XRIX(H-^V_B.#YV!]/V*LD4Q%RZ?8)5BE;A_\3*S*37O*=5;GY31U
MC/SPJ#]^*^9.O^7S^6\__]6:?U:/>W]_/F&@K/T!T/U$'_D]@HQ[H$SI%UB@
MG7.^VV"DG7-4_?/;*%+Y$VMDCI?2'#R(='/'-O58QW,RCIK<IM+IR3>,@><+
M1=BKNX+;+?SMNT_5-Q,?GLSMT1CY\^A;V4)JW]""Y@NYK_]9-6I_/;H?V 97
M,E86-O-$E]^B<(J<-%[(L)ECY^8VCN;<.&2C47(3:4MXXE8N%]VU52PW9)N
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MN(YMPWXBCVSJOZQ;;9<H"K\+-!"&_P:8NM:_9[\!NITBC@P QOKIB_ B2^8
M-YW\B]\?0YX2A@7\S%([VM1&G@V_O%5>AN^9SWWX>G[B1IB%JB]":S("",JZ
MV)&[7X0ZL"^&SKJ&*,RZ7_K;>@O_XMQIZT;_]V_ M!?2=2(^G71H"X)_@#3Q
MJ#B:85\6CFV2<Q&2<_:CV=7=0"&P[+0#)US,T9-[DZTI][\=>P.=KY&^8P!I
M^:)\4ST^*K=NP-2]O6FP:8N' #E[$XTYL=-.)HL?+(@KC7JS<54[*X-%?WP$
M]GJK>EVMMYK4G+\LUR_ D*^!2=]J5+Y?-J[.JK?-__U_Q72J\$6H_KBKM7X>
MPNX_6LFFQT?D=032W2#8<%NX YD//]$6UH9PADQ(-X2/N,%T\LM=\S_TI]27
M3PF!O'8)? LNJ*!2%<5IU?LI\BCP%MO^6+;E ,B [9Y*9=O35+]?'%[F?KX4
M,2@\'@+8$_K(/X+="UPX$2INB6K_P4"T50:BVF<MCFDC7IP!073C?\619@!9
MT1Z7'S;'GS^I\F'6'8N=EQ5Q\@]H"2H\Z.V1\.<8VUK57Y6) WO 4_N_#^EY
MZ;E"0J_1.RUJJEN$_-^.+OR-'V4$[3,?91\HL-U1I^=MVQME4Q<C'4P.@L,$
M8BN_RD;;G<LYU%1*<=<$=]Z>UA[)?5=M:%?)7O#HO1%U&['/HC(F0>/U[4BL
M;(S$,GP232!1N1%EJ:96Q)%LBHJ%T)^3VUSZ83PLB8,-$.K)ZB+%04&(W)1K
M9R *YYB]$#DX*^6;6JM\-0?GYK03]@7.;DQ[M\04995(5L3$)CJMWGKH#>_R
M]R$PR7*E<G=]=X7ZD7!6/:]5:JWHW>/DYO>XVQT/QXIH19@\,BHM]#[?ZA6C
M5/AYKXKO[4[/Y,!'_F;/Y>A'_'Z?M:>]>OUR^"-52H\RP5_,529)$/?39^0^
M"KIA/GCL6J%<1'*$]<'E*WKR\K.S&EKL*!W7@.0O.NL"9<7SOK\3R!Y=\HJV
M!MAXJ[N#E;9__^-N:VS)A8&"R%I;[TMCBJV@*!)_A(V4]T7^L<$0]:NP.[/
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MHF888R*=C75L04ET69/N,1NA3E[H7XP%_<Q7!8*O_C#X 1KCT7J 8_1>PS<
M)"RT )RKA!WRBVP.!+'[>RP;U.N*CY?[XH@(S?$((=:%*_D9*R>;DBJ<#J1@
ME'\GY'.V'F<L5N$@;2=!H,EMN?+TZS[[T\C90:"04+H05/*ZG#X%9R9/Q=Q:
MFV^'3HE,,GJVJ&_8(VA'^X8]?<"P9PX8]G56TMMA]\H[R&R1=U!M3U_EZ;?O
M3Z?UTT"F^:S)+"@%+3W6) Q4=R,K^J>UNX><F7NXZZU-& @I2V!>B]Y?ED#
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M;EX*YU>-A^8A;/'-HVXCOTEOJ;SI,-M".Y5*MZ>IFQOI9E)N9)KY;8?9BL9
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M\/7\Q(TP"U5?A-9D!!"4=;$C=[\(: TS=-8U1&'!_=+?UEOX%X?@+'+[[]^
M:2^DZT1\.ND0N*BP]H@>%4<S[,O"L3TSV455#AV,9E=W X7 ,H!<Q$&))=@Q
MS&\E:>]YWZ,P0'W[Q.CR1?FF>GQ$Q]<U;F\:M^56K5$_!,CKC5:U>7S4:@#@
M]6;CJG96;E7/A/,:Z,N56OE*:+;@%]?5>JMY"-OY6!GK.MRYR?$1>1V!?F"
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M_D$J4/,)CGXSRTW-23/] %HI6'681:>/R8=YWRI +_?DKJB:Y6X7_1?H7]5
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M)5%RNG@1)POL$Z\>"SS3#W\6[F8C%>H*]FNEVTGN%3QBO:QUGTC=N[/;0R7
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ML3]*=BP(J ?'4E?NN&-YP6ZW.61CD>B=[-?&P[>?2386\S1A':IP&6WN<'=
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M$)I 11UJO5V(P:H0?ZF+?BW9T-*IWC3%Q+1L,?*ZI)^?X;>2E6!D?:0$K:?
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M*Z_?\,5;=;)L5U$?.MUK6CVVH[KJU@?@GF -Z'B-C553#"&R;@M9R&;2X%#
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MH!<T^Y-0S_E99V)$Q"C6(PZ.6BM=1;P;SWA#D3)=FND%>"A9&])($0[K4T
MT/(8K-;$=S)4.KA95M@7YQL$G!/&&)60IIC(^,[@A\9[3JK:%:REJLBXI53!
M\)V&M;E:2=NJX'Q]'3EX^?2X-;E7ZW+OBRCHZ_:\FVAD[Y^%!ZV: WM9OK!Q
M M0&X<5).X>Q8^YH$ ^2C&$4#3DL(K%7I3%LIGN\8W)]]YOGI<>KN34*PRG2
MIH,"213S:0'%P5;0NT*B,'[@<.94J^.QJGQ*(S+W-789X_[#?(\S2.%+ #1
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M&OP1/4J" #N.\4N:3L=D$K@Y4,,LB:-CD%26&6)R6>9[_ ?YF>D.T:/Q%4L
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M@^+--_JOK=3V#"_4;#KK0Y0GRW$%L\S"\QD[AA@V+M"P1QL:A&IH[RE0&!K
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MV3M?A#,^A,007'@OT0;FH<X"*#@ 6>\+,SR^.@F^?(]C(,+U-SG%Y+;A<=O
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MV(::H(M?G^ L)AGG 7%3?CAD!LA.'\Z8H83T&TQ@^A U?81'Q^ G(J8KR!%
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M#/D\CM;,:_.[N]^#DZQ$0%8 O7)76;%J"\T]CZ5M5Y1Q,5E7$(:.)T:KCD-
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MX/5L(J?SB>SOCS K6#TK_2JBIOW#\-8Z88*%N=!H:.Y=M.'WM8!?@6QPR 5
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M6#S0NH[UI:XL2"J8Q*;XAXK\E8=3/@>1FR;WN3;U@3_%[W)E<_N&8@M@O@[
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M-T[[FEK*OVW:UX/EXXSS/.OI5&+_U\#'*2/]/=U/X)+OXM7W*5Y]6-L#Z)!
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MYZ>G,5;266",Z!@X(I#"IEHF@(<3\VL 4#CN_FO!A$(P#,."BE+".'+OS:F
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MG1;,!$R7<[*IU@!YW=P8[3T'!#;C?<4[$<#&)F92M4Q#XG@GAQ&HMM#[GN"
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M=0'M4((L+1V0 WM\N<MP+L#DU I>EV)VL%[N*]XO6P(PX_>="=\KY?=X8AH
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MX,QE)W*_B[FS?@!2X<>V@]\;-'1+,_4/+OV#(PM)/!B.G^],>$,[]0T08S<
ML:"X:S$ YV-[H1Y!8*G&"5TI,Q5RXQL0>*QUIR_4\$?W+;T/C/87[L'XB5%!
M*GY+C]QSH$E^&#2BSO-'8%,10@U6C1AJX4&"RQ=!D:^((+B*C\40%0&KZ)<B
M^U$(93;>FDOGGA" &G$AB(2F+57X8LYB1P^4/4>U+Y0A24-Z?U,SV$N[&L;(
M [MTE]Z;6KJ^W+D_ZP8V^ V2YUUJKS%B;F&$*-9K/3*B)6NW8.0F0=-&F46.
M^NOY/K^&X'FLF(GBT6 D^HBC*GPI8#K "#/<7,',$D;0)I!O>[='J9T/M1I5
M;1G/I9G?(5C@%/Y:NXF?H]/T1R3%F2:]-^W88Z&*4T&"C-V]7;@?=K.778LA
M<'Z.!#O:Q+J^?^=SM8G_^!;%MXURD12][O+O3DB,Q(D@&8M>#<5'=">.OMLT
MI97'LTD]-J&>RY_[%6[^=V*H4<808B #E<18Y[-#X'E7]S"I 7S'3S597?$\
M1L/"\9N(7IAQP2\U2=^Y\7+<CF[U(E7'!'[!Z^[UV\\?*%F/E6G#D 0)WAD=
M.+?=5BN;JR/CU+ T>!#*;^@&U^"MGNG&.$_I"8]20IPT"C@\C%1&H6M>=@J,
M(@>/KB,+O( &U/@;37]+N.Q&(QAH$)Z[;@P,9N@XF5[>7(]V\_6[!]@$Q*#
M#.^F>U?9<P)IW(2R_<4%.R#!'# W=69I[JTLS%PZB)W CQX2GO:VG1>Y5[7
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M#V@#H/)AFY8NAM>O[Y.J2'WI<_(CC)^J=0OIEW#\*<^X?\Y*MR34:06Y.'C
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M8JGU- 5X+PM>"+L?+1U*FCQJ +9:3Q5FV_G-M;DUUU>LIF!%6K'@5H1QQ!6
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MVB.MX&3<]G>O/W\DE-6F6R#D4-JQ3K:GA2;B]& "/!MT& "(^)%'8-#+?^#
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M[S[JZ'M B"/SQTWSVB?%O3K?K61V4!/V=Z'_&>#^3\0WM&,@)9ZW$^(-J8H
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MY]G(/#_+,>%.V&3Z;"4SU,M KS>KA2'5MMJC9%MMT%V+R0Q9R>![H[%EX<L
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M2XOF!&66U^P)B\-Z0WA]%H7.^_1;IW!_>3"9H&U#,[]K]8?POVC+.9DC9U#
MXK4.;BM$3#E4.;]E1'?*%,LZ4._R*=L/GA07\'1V?@)HZ54/"RM*&JWF_9"U
M.,/: >'9F$_7XV@P:._"A_*PM#\*A-CQ_K&6<3Z)KSV5!X76A4<E=I_K+"Q9
M$P[J"5)8BZEOY;!UZ<1TCH?:?O:>7H] A[\H148/Q_UJ JUG.\0:")+Y:[G
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M _PHH>Y+'W'[K=#'X9$WZ0M:<1D'TGFH*)OT,1\:&FQ#\/Y,6L%0X=BENW*
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MB'DQ[2J#L0 ^)8B9 PM0/#E)"<BJ\A?!50'Y_@H5/<H:KP=;:D'AU07<'[]
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MG>#ES>&H:Z?M3SZ)B71D.?!2O0/9E_N-N$+?S+)O;"H51W_WFD!0.KEWCKM
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M/ 3N43?G6/S66<O7M=@*_!(][WQFC4+E\,WL13#D 2NMI[X5?>S&.+O^IP\
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M64588.RI\;(BTWB?N%9=H2T&-+$&>Y_4?>89<;C>!NLXL4]( >%_%^K<;@^
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M^Z<LURY:,PFDA1GU1@[.Q*DM&+ECEX-OG.YF'9HX#=6'R?P0Q<;&S]JYL3.
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M_Y)'%<UNF7:"T%Q9?U9Z95+3[T;>SN6I:!4&M,O<S#!(T:1*WE3B/Y5-2\,
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M"H(LO_HV.P':F/11TDE SR..X?WH+%@T;P(#I"A_\-8GO\J[<ES*_97,;$:
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M!J.X,C;M24A6/WAK:1L2?9&SL?S*-!?QIT"@E&E#BE@3B5=^*G)N?<3P>_I
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M$4[]Z!N'C[S>WU4J?KI'2&DQZ*H8SB%%L+(1K*A_DN&T&]=50#3 1M4T29-
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MU,HL\L#0+P##AW9=<BH?=(>><X54^!>8=#Z]=^JCTM),_PV;X3/_QN;Z#0R
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M!'E/:O9*V6:$EGKQ3Y&H7(_:3Z.Q5;3?DX<(%.)QSV\QS11SU]$E]62@IS!
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M3NA'Q0;X:92=AJB33]1O@B.ND.343^J@/.GGFY_Y;_]01>1-8J;]LZ%8XZ\
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MOZPXASM!4XGS?%2].Y8JY1H E; $%5=(V!*^ K#R?'TE*1^G(ET[EWRAD(*
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M@KH?S8\XQYML&<J3Q+#H7!04)=GB6' S39J6DF8O1I7U,)VX_XUH-KTD^\(
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MJ^F^Y-E\K"7\A)/]-2*3?:6"49)NK\JH*H6M0ZR_@2&AW_9K*8E6Q,&EKY0
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M""I.YQS^+F/&OT[8QW]#?4.GSPJK+L+@VDJ:SF(WV2*Q/7\W#C77G^.NY,T
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MGM0V]B)E(2",DCY$,N?^T#Q#':D2RU9@04,H[8L@FLR_U:Q=K _971:JGDV
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MKW#QR8@IR,F(24G?T+#2O:%BIB8EI>=A8'[/QLG)24'')\3++LC*P<G^STE
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MAOD$7$0CG9$D^*:",7M@I@LU0EO,L8E4<SSZ QHC57<DN5L11Z-YKU0>5"V
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M]PH&ZT_MX4=+S?X]]E1+ CY'BN+7[D&J:,R'2CJR3V$"^1"CE/N..X0:G#0
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MHK)>CM-V^^G^1:WLQP=\-=U3?"=6G8754WGKV0$*%.*-]1@L=LNLT>STS;9
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M!-GR2'B9@YQIF03PY21RB39&)@#%7&]O)#%;M#_:U=*O6\5& MA<WIV*2@E
M/FG#>7-S-[<S<PN^##PP=W##60(()NT&O@AUNYB0;.C=<63WN 2P1/RT6]RG
M\NL V)CSB*TYRJ]6NF@%34XZ#]Z(*=^&=P#WEA49/U1T4NWG+OFNZX#BSI4_
M27RO\HK?BY9'_#O1^C]#2L+\%U!+ P04    " #32W]2A$C7.JUB  #090
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MLC;A8_; R<).4TIR5'<TE3'OX!$JK-2-6_P*S#MZJOB8*^[1^HEAF82V/J>
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M2=YZX2U+(D*VF^JFY9BUL/E1+2&:B/S[LPDN[M^-LE[[7U36/\([,JCC!PC
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M%<?B]G6<)>FQ)UC7Z/V_IPR[-P2OS/+2D4O=>2B25NM)[O@UY+%K6Q0:N!V
MNRV_.9W3KMZF1*(5D&Y$,$FE;UC3CLOHV1,T&*6J%LNDYF0E,97ZQ*C\T*T:
M2^_WV=#&ZW5Y,:^^)BM&EY#T8=^" D9%/9_I,R=+_;7?Z2$7LX!2BG3J$B.@
M8AH_W_\_W9QE4!3@U_:74$(I!:4;*9%6.A1VZ<ZE2V*I96E!2E%J89&0[F99
MZ99N%@26;EA 4AKIU^?Y\,Q_GIEWWN_OA^O[?<^<N<[O.O?<IX&=Z@+?X$>8
MLND9E^I%0*NSE3%HRE*+]T&[POR$%&)W=!NL="M>_O>9I,<82-!+ZV&O>X],
MVZU_V@B#HJ*Z\;;5= ,BOSIDJN:E?$,<[#A696MR=H%KQ[>B7K7NV$I?;-1_
MH(S*N+@[]3<[<96L'&]66\,;72^[Z-@$ZQK1;88BN.@(;CR$F;M]";=()Q 2
M1I$_]S:'@3)S(X@?SP<5I*WS:E(CZXV\ZA/^!_GMHX#)N,CR69QP,;1'=>'&
M:P/F>@TG7[OC$;VJS)FUQ!"K1B#!N[<L1@-X[!<,)2]>?P-F))5N!&>1MB%=
MW[$V+KHQ6RU"XK_2)[';,^P8;0FH,5"'W0T@K<SZKC ;)>$Z,WMC74=PD,U<
MGL,;&4J&OK9:[<JVY[9 (Z(O;R6GVN.ZLV7^'<K^T5=]P]8)U!GFQ$D;ZDT.
M?OO4SVS<)KF/<]>X_CFU1PDCK'?-Z:@18...ME\@/SZ4 >]Y&?1[;A?>KGH6
M<]@&I*\<?0,?M0N&Q2+M34:QA6/MLBDE:YF&[I2VNOK67Q,8AG2Z:AC*3IB<
MC'*(&)>'KU)3WEBZ2G,K4Q?N*CKS2AJ5\1P$X(PB%>X!W&S9?51659I4=$#3
MD_9R,T,^$NXR96$)9_IX")ZV52BD'*+TW3(TB#;'+W]N!#>N/U"^L%B<,5'B
M"(1'C4!]M]SO=1H0DTF<ZX,\QL=7[*=>A$/U^5]:-45T :5&AA^20NS#7<S7
M/T-<WRC(DZ1^ZX!]2YTY:9A[8$,_#T34R6@]E"]9:2)[_2Z@;*G!;)U7> CY
M1WT@N3 =1(%_8JH9\<>[_/7@7S_2S7.JMK(= 1/09G.TM^DQ9-3 433027GA
MZ;=@ JMM\/CD<F5&>:S28= P7SL] 37*&L5W6-N6<%X*.HH\XSDH.HRGU%8T
M>O ?S\OT?^!: RO7AY+X;@,=*&H?#MQSE,>12OAA73Z99G7E+6\7^P,-02,#
MP9*&C)W$N373J\F.J=+EPM_5\)D*XK&6ES!-/8BCH4$]$+^)Q=5J[0TGW9<"
MH]I?'X?\7Q4TZM+;^[;W;>EOC)576,(A?C(CXZ_TF7)NR%0*8$4[WD-UNB)Q
M(3>OC(-XEDQ_J<Z]2YT7<2PU/VZ-V14WT/-YJU(#!ZUUWP/ 9AK8'BMF^:<J
MZTX@7I?'@<*GI:G<:+CP6'_9>,Q8G5POF39B/-*+SG2T9(+,GRB]LC)N7F3,
M<=3Y:U1Z/_4;]GAQF3:D#BDDJ(O/A6,12U&0XQ$Y/#6?J#1 S>6K(]T*D369
M2.W$-CU6Z(MUTK=!CH+P#!>QMDU2YB[]'F(66V8QQ14F\GC]]@?@)A-E(7>R
M %KLMPLTE#9%XEK*$%JU)=;/5ON>AB&=AO0=;(*J".7ZG(>0,PS]GCNN4T]L
MCI3XWQU.CF2[WY\&A8=DS";#;'&"R>1UZMZ&\_:IG18GV![#1IT2\UG>?FN4
M)E/9^/@^3RM><*[ FN(''5MCD2+DY7$L'W!BP9.*/4DC:E-HPV_SB_K<.9-0
M:X4 FSAQM@U^UI!(**46J9#R"FE-9?A[>IR_ZZ*LET+B!-&($QNQ$C7GMMQN
MVV0T<T &(<-N(>_Y=Z([EJGJE]GD<GG4G)MLU+O[AON;QQ$$U)RIY^YC6J%J
M)V4RCF8TY3W&<4=A0 \"*<Q5B[7 "W.<76/K<Q'S[&GE#%0I?P]%O%RI<.I\
M?;U1',YT8ZF_CFNP6M>?8YG$\F#K="]OH316JQ"U?1V5'0(JG(\\G'D_%$G;
M\P"8CY8WCFORT<2E+J:YW$I@).=PUCY.+X^C$OL*AB-<G VOU6L\L["2ZTWJ
MPN<.!I@REQUQ^[?;5?66R;UR[9:!, $:GI;4]N8C]E!3D]Q2>$'C+6\SK#2#
M-O$UL/ 'K:056Q4PK$S8)G*CHD67I.GRF<VPU8U]P1M=#.,ME:M9Y*'[\JII
M1=Y38W,7O7N D5#+%M7 USR?8;NHSL$$\0JS5@QGL_6)N!_=9\;$UE5U\>A=
M;O/T6_7W#A*439]6TS@)XOT-B[:;;+T%G %/H]\WCJLN@M)GRW+[ZJYF;.[
MQ*<\*Z>(&!U,T(2\V8:W[DSP_^YS_4>:C)23FK<2 S<QOC"!>/+%Z^E&W^QG
MAQ6E!+H0SKM02$=<UDO87&7Y<"F9><W09Q(\6UM2QQW';CLEZ=V81:2&'Q$*
M[_QT=''F]23ZD4ZZ:PT;6I+HJ^"!I/UX3KU1+42Q)DF> 2/%QKA6L2W!@2[X
MF^D398T7$ZT1)*]@HS^ESWP[)9*_A69(<5IR\**R#V=[,.>E.W8TOY0&\T"
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M]G3H^?>J_IZAC.:&SNMOY@&_YY>^9JR!@Z,D0Y[2]VI09DY..B:5VD B!"A
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M>WE?<47EGZDSJG']JZ?F[JF0//=\ZUH^MB8Y@'?[OBDL6>%4>JXRCW.X7F(
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M<(P/>8HZ]ZY:Y//HEC2]HEM_8D.0ZIW>MV:<6UV<[W6T13-Y5#L$)RJ*K%-
M[9Z#2 "6$1H1H$W8S4&7A3%,5T@NPX+,JXC^,G19#^%VK^.*2+)O/Q\C_XA;
MPI*3_ 7*DH7\WP"/.- X3/KO7#%)[-'FE#7-09J_VT9!S]OHNK<1SE%MMJWN
M%A*%^YH\[KO7ND%M\NT3>4087H4Z<B(!5/LJ2BI2V/]\H='EYV6AP]0*)]4
MOBGNS_,1-$<066WN$9O$1^"4,&@/ BL(6/A?/H^<[*:FJ(FE@OA5@S.)7P'"
MV"MX^:Z/@*D13&1* C)OE>C7>,9HU;NNPTQ:T&,8G?\VVF,]#2P&GB0VM>V2
MC77Q>0248YC-,H,51:?L)H^+T6BI6:?&U;- VA/:8\A0(V4C@!67XR7PDK]X
M:E**$/ZA_?YKUFWFAJU\@7'T=7*'WRCBBTV60%$.U.*_<P:"F*Q8*918-6<C
MQ'>GUS]&L6E816C,?69F+]2^S7Q/NXRIK+R"]#X"LR:_%@YNTC:C32:EU%!P
MLQ5L&Q/@6;G;(.)<E!"R/5;NQ!B]Y$>@7"I9G&W([GY/7C$W7PRB_*ZP\CQ+
M=G?J2P8+D)^3^*0PZT>D?YZ- UVACAK 71(\%155(,#6F18T;.;:K1LKWLLW
M1B[BF'\90Y^*_/Y/#>1B7[[)E4R;3!UC@W"^P?XU8I)D5K+-O.WH2%6N^=](
M0??,F68,D7[J,?KYZM:IZ#_-=I-'0/J^&W"^YE%K"D7)\(5_BF9F2LMTT]VI
MG>M+!'R@+O/$PK)!^GIRJ@&ZW]D+DW/MF#2*]O778:X1,7ZXXH#8^DDQ,NL>
M&BVA]T]40@VR@H<,L6U2OE42$5%_MP"OXG75+[9 Y,/11$%$]07M)%*W>'&C
M1 (M&*;^IQO@DO^]G2]IA48Q3&?A.X;\E[1  &E?>KN8*0Y+5!-%B2J0;[+Q
M#LN;;^(C,D].[H=B-5ZR+ PR6S]QC^4@1']6@3#?/D/J*F*W(&#FWZJ-+:36
M8^?JE1>2](.<>0GY'$BN!=72VQH*;-+3%O&_5P<1#]N(;#"MS"T**4G_>C[>
M6SC3S$^+T)UG+:C]T'A9'37-)=-;B (O)US12^Y'B=.FE^*>SR-B+<3S@4H!
MDS7R:"S( 8#-0A$6ZR]Z!2- 4*LY:8"AC3/ID 5)4-NQ\%O[/-$/3<0%H- <
M.4T;*6[S*;<.D.O/M>%G)OHZAB* -!,4.!$/M\G"F ^GN7X$: [A]M6,'T?^
M$NM:5@D!^@*!%7(EU[#U>M$LJ$#G(_#YI.^R(-1J_+>6'%'_?ZA;6(KLEEKF
M?CIL4M(<,Y+D)KD;!V$#;M:-P)=)HZ9+)8>P]? E87+1[X[99L&I>.A^O@C)
M=*U9).,"4(7/K#@OM;,IB9JM+U'QKSP.1E^)\'5<"CV]MQ43PL8H \E_[3,Z
MQ6@Z^2=E!@R",GQFA_)@:>0S52<2=?G$)/"(\9(BK. &6NH!%]"F8;-?Q&:2
M^0K$^]P6[E7YXOMU38GQP8O$Q"N6TN@D[A8:;6^:F(J0R35$_%[.WJ]#5LR?
MIY?-T9]C\7<-&Y4H3W\:1/]NS]Z5R6"/;;@.7_6>8YGJ #_LI$O=*W;;,4/Y
M2&AQK37Z=R0F4B3+V7E!RCG+G(<"<D+DE<1=VEE>&P8Z?1^$T0MPN&=@R7M:
MJHNLGM%&@!_14N=,=N./NMKHH:8F*!%--T,P33D0YTO"4A9VKY,MC9EP8<<3
M=!<'DHSI+[,;#<L@K_O:;*KRJ6-]$$J" SDJPY\I&:TJ^W3QH=9\<>1';&NG
MYO4H&!L)G*\AU,MD\\:2)@LW<Z2)2F7M*LSQAS'8S@J)D31GL<L#Y*^P@499
M-B]$?N3NI+/,!&>AM[&",42B&RZN(.VI.?ML=^.BJ/PA+BO4;*)$:Y!D<H8E
M[4:[#WL)Y)?MP5NS+[#OPG,PV;?ZWK[V6:'.#%:PCS@DEK;P CQ+- 5#T#@C
MTRLJUQV,NV+CT[M(FFX<UE8U)+M\&IP<1;".$"^ZM@ZV&#9.^T8W331"6C&+
M3*M'_<MMG&9QN [.J=K)+XYPC3K!GQ*/:15G>(#[DO38:MXN=<+HFL!I+3GB
ME([_2 C&FF23CJ$//$Z;^K;81]?'C8] A=I]$<IV)4%UZ\!^CP+_D$EDGO,L
M_X1=R;*_1V /]Z[)PWP@>1JR)_@1H.(?JQ<OD_P5\<N;/K1#B$KR=FK]JG?R
M=M*<;)V/JHH,+CL3H;=$_C+5N KZ!B_:F;PZ(P(;CX7?I;I)\;DV.]>.FJ]]
M!MKQP<_7\RY?((U_V[.$2F+ON<<V['--WX@_DWZ0+M)1H'05$7>,9E R=UKF
M=Q0M!FM5R]/(FB7^P3I?PT_R<VD_<I <TU58509CE\ N0A^!ZI+ML$G*0>QI
M!"B]/M=[?LOI[N\D[L54IK\WQ<,64QO1/3,SPN)I]B$] G=L>M=J^Z71]Z!'
MX&_15J *3="/1R#T'F4DUF#$=;1.G=%%V )"?N[E3[10R6/K(E@P%X"H\Y<,
M$5&D$9]>H+'2>F!+4*2?<?@:;=YQ:L"Q9UOV&[VMAR8T@R;2W]>;2:*2'7\3
M.A;ZRPBM\9>-0/F3(3+@07CA*7KA7*7IFK;C:IEB<M;.GIQ)3JBQ?3YLK. ;
MK(7OUY UM3?%IL*KLO>N,&J)K+-;@S'NGSB$7Z&,;ZB(Y8%":G9!28;AXI0!
M<QQ[;X&DX\]?*DOV:-X>)#T"5I*KICUQJZ84,B:_#>6K(:,&-YEGXA)!T"6F
M7+Z*$:QD:(*@):?.QY9'H '_2BSN9BO;IRI'\%ZMK_>^FEDRDN%YP5/G!9X:
MTO\#NB_:3U:=G\)CZ@UY1E;;(Q"-'7V[\:=O##1J=/W>[><WCKBX?9/I21>D
M P3QI%>@5),]98 B>E-J?I?M#8*V\3;(%!L\W[E+9-UX$[\=%1_[3+&OESK=
MAC0C?E?OBT)3()J+\ X/Y/9\9([0O1P7.])70_+\C ;QE2UPU\#-C+\%Y1'0
M>$J6.S(PEVO#\U?6@3I8@2)8*6JNF:_Z$[,%QQ6*Y*QZGRE'[&?<*8Z>%2-U
M,/-O^M.=4$U1<T[6\5(HV)%*Z&-*6#A]X.BC4G!2U3]G::ZV\>"JU--6RFAD
MG=XVNNJ:J]T_04\G,H#=O(^ ;@,9RQF9 TT+E6&WTT-9;V(6ND3E>7I/A!%Z
M>5S\!16PYSW:0376M9:>1?-[?._:19]/VI+0).^:2=-T+>G3(K^=C]MGNI1,
ML9_^AJ"[AI_;-U2'>J]?:59)%O,77KH[UM\-(=I5\A'KTY_O0G"KY[Z(>$<
MDHD:N[K #/ZW!I)O-AGJ D%GH%&SS.U]$Z?@5N\BDWVE0MN!T&&+P'H'2\>.
M1X"SIXV!/]A6._NUX<OB-O*J<NJ/@05P'37^$7NN*0=M?ODEUD#4!+LW-"=\
MS(B4#-O2,P,^C1L,FBM<+A$1EIR\_\B363_^$3;S'V&G+M".[KU,(+-,"/D
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MC8+SN;?<>20MQTVSQK$G[7EZ*_S 7NG[.-A#^VV (DJ&QB-@UHC+T3W]5V#
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MB([7:M'*&W=191$ :\'(4OMF#(TZZ]O7VHOB-K+X1@V7[)!#FKNG.1))8]&
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MOS?!P,/#([A'0$5(2,7WD.XAW__V<=L&D.!BZF R@#"8 $P2#! )QFTG  $
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MDZ1L$B?FRPR;;"CC$,XB^OI9UY0(RY/P6/H&FOD[4<]_B#;S<M6_NY%@U"I
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M?"M&!MU7ORW,&ZZ.C'Z2M>TN'*BF/O&LB;X%OJ0,K:+&WVW-;SQP%'<)G+(
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MK<NWP%06H?=_PR#":O>-J$^*?L\FBC-=FKK ^.R>Y+?"#H1:(,<';#?O$30
M1ZYFJZAMEK32W:L\S"V JV/"X2-2W2-*,L C,@TI[/]-P>'@L,G"RDX,5\?4
M4$*R8W#<Q0N^@>*=!;*1@,'?MP*ZN &K (;:D3,SYZ+6:R?8!>DD&0FE YA\
M^.P-1HGP<< ML'%')C+_S1,8C L5;H$'83MT0<YW*MCHS''F5E$_L7+Q.XH[
M1\4*]7B_OD>_(<&N,\<N#K\?[Y$S&I=W9V0K)*#(8<N.P9Z7'4"KH)K;!2)%
M&OVO).@_2@T0WW"G$'MV8@!I(M( 4#3 EE"O7% '20VH$1 R ^!E'?OC4S_#
M0 ,%_!<-&O+X!^T5^6(3^\3^O29J%PO^QX^*8]U*_!A$)EEN@3+P+?#,P-0=
MJB$#D/T7D>]!Q&WP2S%(%A3M3^:1TVB%*;_HGQ;@JW"HU=/L>I@HWM(1I,+9
M'HQ(T6/(CKYOWX-F4ZRRT-FPS?]9.09M"X+6K$5\0)AI2MV3Y6AI3:<MO%\3
MWY@=0!JN$8/BE<)#\OYU4T-VNBP[U0R'L^Q?"W6Q_A/+& "\=\HSYN9E!W[\
M#TO\C1IN;C;H)X4=&R [3\F6I7N<;8-S1U1Y(**-_4\6P0Y-#*,7$;G"@,/S
MW,[DI[&(I>=T%OA9<! -(??TZHV&@8:^#.Z"Y<5$CC)K ,V;PN2E7 %:=6S/
M/R5^]+= =&?F2=O?<-!F*<F@AQP(W8'U&.@6^,0-!6O^DV>T]W,/W2Y3_!L?
M"*T0ZA4;M%X%.MX"V_-JUUC#X(0\14[H%:>T\O/)#%Z4#74!_G,6NK')Y.P,
MB4),;0E.;4>#8+^:@S&R@#0>"1D&+<=Q\QQ587)&<7408;)#2+8=Y3&6=IM?
M J/D,4;BY&!K.X(IG)BI[NM21*%W8?:"V<*H:P]Y@_TGAT*.#VK!+45S!#XC
MJ E[7C79:T[6T=EJ?&"H-V^IC)[/9+IP,),'YC3,U$)5I!+?<4:#LL^'M/MS
M E%DYFEFT1[08#H/*('](^&2"SBYV4P *=(8O:D00E\(9(<+Y6'HG69A_AV1
M2UROS,+**\!EE2!IY72J3HLZL3]7Q_+Q'D%50"]#-FFUPG+G,L^MY,:'F1)E
MJ-'0D2?$QCD'17%2T2=.,'P<"PW#S:RLRU&:"A1W5:37E0TH!5]%Q-Q#G ,F
M;6Q@.UD4];.HI[!H$G<JF[@_FJ[8]@_QJ&")QD9U_3RCKDP-47MB ._R\#!=
M<]QQB?-FW<BQE%^MRQT94$!-D-C<'+E96-"01)0-!B%T+ (ZS!NA@8H>HPDD
MG],>^IL'SV\!9;6;][5PQ<;%D;N,%HG*U;N6@8+5_LFQ6NZQ.!_\U*XN>V$'
M8[HED"Z^<TG:SV;CP1IG%608:P>H>/?"Z-^<K]:2/V!TP<XU9<3A5*N;</P(
MA/0 (*[9Q>-1A,W(P+&4G)_!CK&40<3Q+@W< HC3..4CG;+ 2"?HB"([II1M
MVQBVL#HHF!L*'P8%+"6!1J/A2,"XY'I$"LD_(</-#@5"</W7DZ^*)(<P;H%$
MB\.BN^H%$U8M?0N(3QWF[%3X#PE<%2L: %$[P_Y#CZZ*_(9P[^;9G6O=@?Q7
M++U;0*<U05B.Z@9#24D*>'&S-%;1^O-E?QRT,0M[>=A/ZR^Q&HW\)_: :_S%
MX9IX@G^!%^'#O-PN3!K;_ S;_  JA&!!9>%, &-LC;@@;,R!.!OC8O+ML8!G
MQQB+]_L8(1RM<[6&=4C28?X_F]0H*LJATT/'(UD$]>Q\-YBJYT8<QKE=$G+V
M(5 P+B;C%>0"&W 9$1)3T3,HUF0.1R9R!-J_OQIOJR"R7<Z#:O:,1A.1':B0
M'1QG@='B?PV.T9[!D65U9]_VC,]C,L*^=R=I$K9@1:<L[+N)F&F\4D1DV=&:
MP0![ ;Z]L#HFTD!10QZ;;$M:D2.@1D-)"IO[$?<=4L.'[V!%2>K>7Y35D.'^
M=QA4DL*3X7YT9XN&'#("144/]BR<$:2!\O!##D+J7"B!;7Z<*G1,BD" FOQA
MH:6/D^@P$S619*WQZEM=I=!!!L$Y?AV//Q*(]/-[(*OW8"]'OKE9&=%W%"^(
M,+;?\<.U)=ANI"9A)_N0FW><JSS_A4D7)-DAG%.*C>)8*?&9A9!%XVNG7^1D
M$ +#6)%+@Z@KYUN@/<Z#1M>:^QX>,Q9#=LS"/)_HI8Y@6"%&F*W:H.3:VUO@
M9-N7MB$?A=A0@>[TQGH&+$GI2\AIZ#(G/**-"2)&6'6YKV@1V_3/+IE'[$K1
M8&; # 8-&S^UH20Z+K_=D'O<2RZ -#OY-M]HE6$MY=*- 06 #:8V]$#C"4):
MBI0X3U@36YP&\.!H3YUJ+&!O.\D"!ZIBHCC: ^@DBMI354%WY&N@Z'Z'U8QY
MN9BCPQP=*--'W$_8LS 38Q/O")K#YE\ ;\">=X<L'#;_1MO_TG[@WV*0U28[
M-@!?T>"Y5&=N7F%>AK"L<?NU"B \[K 5EF@*;M&TZ]O#,[3YW?K+_W>!G'4B
ML5@*G?<QN?C4]&,<W>0EWN";@X+'9G)%)T6GP50@I(6F/&YJH)[!ZE0232?Q
M]W4JM-AE[\[NC+X> %XW,FV(TQP/+^7)NLH9AKO4!<L*C9]R_V</:8W> BLD
M=S6WT8-;0)K<H33@?Z:K,MJE\BODY)W=SUHO0%.N1K"NE^?D6;= >=<M,,P0
M7\<)(Q7W4CW*"!<+ZA5HR=\6TWKN(25!H3IP<ESFQ*L#SM/3U:?,ZG$V0N0$
M#>\D"$ ];5FE>KPKT*BE'0&Q5*&97"7B/U2'DB%-2MR*]]K$&W$.)FC?<>63
M6TA$*HS&"T&O:IU[BP\W*WN?8[P3P=(J8A,NP9WP8!RZYV__QTCQ2]30-CR_
MD#(LU$#<G7D-LGRA$\!XH6XJ1\7)H8?3X8ZU$IJGPV@-')UKQ^@?;O(H38 7
ME2_I=T0.'3+I@WPZ3G+4!>04W5_=:WE&ZM-+*@5K\LC<UI0KZ6@F[8(:63].
M@>2K4%+GWCF_N*?00*'>OM/"N4WG-:E?@@W$VYR.7Y5L1(V>':/C+G!DA-WN
M$K0F?E$>.X_L76( 11HA%(XTA4$U[Y*/^U\Y^;?Y5Z10(!4-_JV,8_]776<
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MDXK+-,6;M_;7@,:"D#K/&U&/W7$M?A"N))_XB%P-VAJ?N*F324WO]7I=12#
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M052S/M3 /$.55P4T'Q^%X.&-4>QHR K<5!%?AQ[T8&7F/7QYM"U%$A32*RS
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MF54)_OP8CLJ87E+V'J>SRB3I#!M@WQ.L@4YEK&^J&7G?:-.L8^:"-U'3O=&
M+.Y2*GV-_&S=R@4J4NE]N(N+;\F36T ],SA\Y_GF9*1NP\M/M8_&[YOI_^[)
MVE=7*.05#C=].R6&^;D>+SPM9M N/TB5WI+E$M]Y=8N#;3CDWL>N]O[WU46]
M6):Z,C@E3NI>IY7+=(L7-^2J[)0^SK*82?:-H(+S+EL%^N ,DL4C2V8V9N=K
MQ)BC=C:3@DUN66_KDCXOJR%K1-/*TY>7:XENU9&4-@[4]%HQ#TB&%F01:F=)
M"MV3P2U>&C=D/W8SIBW3#QBB-D_RN&I]J63[9K7LV'Y"%-]LMQ4N7>:,D:W]
M#*Q96,\01>:@9N(?1A2XI?78#*6E@6+.+B:K)I\E*[=]J';-6+8=JC>8IN?5
M5!XME[[&?K$;A(2W,7AKL?Q92U"P-6<F59E^N2X/R1]3;]Z%7'M'#<RXHK[V
M_I!JT&7V\!Z36DN.*_$LBB]01XPJTP\7IP_( V0#/X:@W?%R?3"T20SK0&S,
M .L<$8+$DWKKF#:Y#_*9K#%;]W$S\6N2+OF\0%IO+8AM/5U2@8PK61RVSH"B
M\Y?EU80Z[ONXO<+Y"T7+!;4PD/BP)CTV8@1E7@Z-:-M$@7OE\D0:#8"//;VV
MR%2MM^/3YUZ%*XQ$")HMN*,IQ U.HBJ=0)WKF'2%,!@V=P&CV8[ROF:YE^YH
M=P<%#2C0FAZ,YDCX%DO)?O>$OE"N3"O/8U,T%Y1CRG"RRWZR1JAG$.*0-9Z=
M(GR.;3A-L4)O^Z4&;I4U+IM/XYS_0*;-06'S;JU&8PL=(P^!H%^?Z5F_#+U@
MAHQ61IG4MBQB#];T7%947LLXJKF*['AJ_;>1O;D4$T6^-=_Z.ND6>"X0K2JJ
M*[W\YBJ3:BLLLIKBZORF=C NTBZR;-V=.[I'_&1?E9Z3_YM6:,CS65"+Z<1
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M1?-<JW=#\I6*NX7;U] 8H?L;"NL9$ZE$S>Y4P!=9+D&Y)SL_MEQLRSP/<"#
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M<0F4JWXE/&O%5'A1%:_MU/B'L2_Y62N_=]P!CF_VKMIO$$U8T=76-_@V5'>
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MF\%!"5#[FK'2!Y^W>.4EGEJSH5R4UD4CLH+W<L7:<UR5/!J8_O3!E)=/BT:
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MODOBS;: L%T0*'0 015R@A?>E]CC.5LYR%*)U=R5.ELC3^[LGN$W](IW2^H
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MI\][I,5N4C7X7?/'*E3*YP?<0T":>B'Z<K+)2T_^"*P8I7A$IB)1'B\4LW]
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M!J#.#3A0^C]$-T(9HK\*/:M_F,Q;;=PKX<.V_?VJXN#7_!]"=SC@:-6JOB7
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MC#<JR@W/2MV_E 2ESI">FE_BMN,?2C%YQB6(12@CO-9N9FEO@4OE/%7RTT%
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M!?/\YQ 4+"PLG!<XI+BXI#QTE'0\_\?RW D@P$2)0J4 HM #4 E0@ 0HS[T
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M0Z3[;4;D14*RPF5I]!,6\A]0^_!OE1H4KOU:350?UQ,([JQUX+<3*?2J;&Z
M,=VN9P!VV]8PCTJ4_K(#/_8.&ZV-F-"!?%U%8_;J*S*:F$-CE*.JB1L*E($#
M/88SES@&Y[\RQ60C<IU!;,&+# 3I[YVNV.1)<%*\S>%OTEFN4&$FTOO9*Z_X
MUL\PX%QOO# Q\,1M%Q_V%\P6%&-3N1K]+;I&/8X*]L9GR'CWV1AR#+B[%5H*
M1Z.,^R32*L9^<;E\H2E\Z^Z\ME[RGC=I:+]"JNC'MU(Y:,T?$]H/Q\,.U/05
MG]E<MVQ?B3BP1QOR[:I]_LVZ<1LL\4NKZGM57[@595;%+NB\3V:@6X+8Z [E
M]Z1)NF^Z1FS$@4&F^]B$_%7QNQ@J14,.)/6?=H8[:,G&Z?G!+<J,ILG0F2?G
M"X@ ![XV17Z0IK%_X(-1;-XX>:M=A0<.SZ.LJUH'&VPBP=PX#\JN@;W=KLLT
MTD$;Y&]'<[M6E=(21(JCFM]4.$F#( =13689[[A6LK^<K+DB(7@&& RL9"/J
MC47SCMICU:PW4&7Z_/$C"O[DERP/GNR9!53',9@T4\5\ZZJ:ZU;?@7!^L09.
M\PVI+C2M>$[?PF#<#:C';T_41BT*+TL_UJ8I51WE>!HK>31,98ZE5(B 6XH2
MFQKM!\M>'FI1L@P) BMEO'Q(,I@4#0#L\<B&@.BOT06QE ;]$_YS8I]46':O
MK(>51#)%$:-)SM_'T/^BZ#,DM;,SR3.(DE^PCR3B@.PX Z!'[=P<";N3W_#6
MV7'XV;SL(&\QP]7LK"R8\=KR WOFD:%V@$^]=BNY%-H 0,LA*]S5\M=A1<N=
M^T);K++EOL7D*-L?DP@A"]B,28"&*O=KN4).+C?(2%F\FX[[2HD5?8R[)'F8
MSN:G?*J]V,K%@@,B?BRR/MM9\?RB<;%+_9>"AZ1$"XF+4@59.V:(CO9!<J:5
M@M5X?YV]0)?1>L%!LBZ2T0$G.%N%.5M8!EZRA)+WJT@Y3@8Q4NWV/K&!'9,)
M;RJL8BQKFG[95R2P1#?:RU$!:Q>,*ZW/R6,]G\84#+$8PA U[PII^B0-?CL:
M4-W4.Q@C)S?EZTLT4 9DH$/D2<VK<95"?*R"2YXAXQWD(9\,^R.Y4[4/D120
M<WY3GI@+>**N7$G'; %YAEV5/>IF.9W,EB NC(=7HZ1MM2;J/B2+-;I4LB>"
M/NL=W>$&&! V!D%5=DKK5[:+Z\ZCH!/Z2W0LN@E0-110T%E+RO;WR4KGC?\<
M$1VB*OL]@R2#WS,!3\U!CHO!20"G@.!!USI!3;>3F*U:3B2N.6]5YD7>\?)'
MQA%*8 C,7_N,@?]]E/X$E'H%@^&3@D< E'P,F/@=[8K-79*@;AF##$:&\3D[
MEGN#@ZJH$40;.#O$5$$*2B$P1>*MM8"[7.F;7N/#>BH!W$H%T'XL*:#],3IW
MGB(Q"K@4GIU>\^#@D5B"8J,EN5EW58AJ"7#[0G01R(*:8S H;OK+N=F.$'^V
M( N].8;#)>;!1:A??DT-ONBN5[\$DN:6M(XK+&>U&-(\D23@R_>+=+)(?6JE
MV9(;DK*T2O,0',X>3K%NBBI+3>#"4]!R/Y!$L&J^]^$,MKY /GU$(8:7>HR&
MRVZ-Y))19VAOIK"F^:F0RU+&]KJQ]8M+$MHP5QEG3.L)]0M@6@MN;I#E8*(D
MVFXNAV7P#&-*9+(I"I>E0@)V-D$2R:I;)UZ*SMH.55*@X$!T.2W1C,7A;\<_
M'QT 3JG&!G+G\HF_D3%G&B%H@P(+DCVD%)1N;)^Z,92'(TE'\)).. 464Q51
M=C')P"BJ;]]:+>4?N;<X60N]J?/4%Q]@PU]>4<W8V>ZB@LQ>A^)P]5_TF&?H
M9@1,S!/GOX:K-OI9^OH?+\C835.Q_4P74>DT[N/9/*TSWQ!UDX4HTTO'' _G
MRBGRF8D<0!1^@_T$]]W4Y.3W%&RL@DAJG:]]",Y?L[6%#'7NW2$;F_B[&-E%
MO[ *\82BKOZ=07HQT(7<DU.1])/) )$$"!\"#7 =P*(5*I5M-5>L[A#?T.F:
MM4SF/G^A*0ZW//DYM+!T7A!C5WK_=RK(MB!@V'2)UF7Q_'4,3B#+!):WL2H#
M732ZG&(_:$?S1ZJC,*5YZ8,L'\,/.6K37L_WOG0#R]0YL.(#(S8 *0#ER$ =
M7RZ(6(.,9^\(^QB'+"A9%^:W]B/R\-PB.EC>$FN[R<:-&-92Y?"'M;(W\BD
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M!)W"FY C9:CLVYI7I$X>Z/S\\*03C6+Q^DYO>27'=Z3CQ(62.[E%(E$3WW>
M"$E.=17W U7X2SF?CR<ZUC/KQK9)[.Z=I =ZYE[-#8I"761=N6!^!!699(C5
M<,@T6!%<4B&] X3Y3X&'N8,5J3-+_T9T__(M0H. ST/:G=$\Q_EL7*Q56#QU
M =XV]M [VV*L1(0T1V"=6[%CQO0&DEEWY.=LS@O-AI)$-TL%%\QB<_#Z+(6O
MAM2H<;0>3E\ K"'.U8ZD%9!?7*G&52R*G8XOX^R:W#K=MZ3F'4%V64%FQTJV
M.%NZ,"Q7#S78L757A+%K%R%DX@.VTT[Z>.3VKDJ6$G"E"B,&:.$RL(AR0\#*
MVT90#?,S@(KO;>UH*V78B2:DQR=Z[5I.XG:ORD2OC/WOR 6H=D%3EF36G&3P
MDY+&RDNGZY8OSX"-]=;[S2<&IF< YB#HX4'F&9 +A68#+\TM# 0=%0;WH'6X
M5O;G@_0L"MB1E+-UUEG^6MTCB!C#W*UL E(J9P"I"-M)3PTN,G)"]UT48^9G
M[AC<9,^UD>UC&X8&.XGU=]I93W=[$2UQA YD]+.\G7_G*_^VS"Z DD.Z83-=
M2\K7Z9%IFYLW%=_)EVIUYK3VAR<9M!N$<MVX85)%&[^<S$/4:$M0]$/,Z'Y%
M\J),5>ZZ\<V6M)@4?)JA"9IM5<>6BK).N[(R7BLM2]91#FV'Q6=&QTM@?[6Y
MB%_EV4#J%$ EI2BQ[_6\Z!2'ST;?G5ZHXEXX#VRH%0!XL"Z/#.<6 A2.1#UX
M!N7P1T.,&-?+S/XLSG=;M\2S'-8K,E:_#;U&(L:$Z!MU4M2Y(_W3*&M))39,
MQ&ZB778X4VKO%'^/?Q@NA:S0M87IAI)5DW_@.B]JH19&?*K5Y_'*#Z".(+)*
M$+D9%0JVH3W'=^ ]ARH=\J'3T@YV[H6I47$K*B=*$ORBV;)A #QT7M(7;#ZR
MY ON2>)::W5%;6HTH\7V7OQI8#G(F) 4\\M!'T"S(^X?= KK/% 78RW#'%.S
M)R"IW/2Q^&41K!T&AV8AB%SX5_$=J!HWPH9VJ$I0*:**DG(C-((IX; &B08
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M&FXS*;9R6R4:&9!VK@9H,&CT-0^=J  *TFP'73(^5F((]F*-.<+.XF*<'\2
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M\QI$IY1ZM@4>5(VU&V(@I8956O7K_&M>ED?\VQF1!/364/<8W9/(H]81S6=
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M9CD](3^$E2"FZH_<[Z].G#I IF1DPS&BJXT=[HU6<L\[UV4_8W/MXUHZ_"$
M+PLI1'KUA,IMTG!^KH]>&U4W;(%XI6=_7R""VSFYMSUNF*C'M+>=O#3>-7)B
MIW2O^:HI!V"N-"AD9?R(>!=3?5*<K=/!ZEPH5ZAIX,GP5R\R[,%4(,J+8I>:
MEB$:EP)?Y:;*;IVJ#.(OGEC<BS>O#1$ZF"XII\&J7,)5VJ'\5"+> <$2&!_V
M#RAQ/YF_U]8S[0L>VUJ%%HHA.]/T"-^XGY]+" ?7V;<ZS?EX''_4,OQZ<*1V
MXRUW(NLM83)W!&9GRMKJ=S\O\N/;\0YZ>84KT]OHCJ[IR-B%XSLF5:F*+YW=
MYQ\R>]6\>/CEN+')=C5.2XS=:+%K@1KNQU3NEC\J;R<W-B,9V.HN,V=%X]=V
M*;RJ:()4870BL?E@QFMH]/HK1\- "VS:^^T\*W-NI4=Y?" K@GD&;Q1 J8EP
M%&<-WE#%)HGV 6.,DN6@GZA:>N"Y@0ZD!/=473QX54!$?0+@7P_MGFH@J*25
M;\+Z]9_WS8A^(L:_[L%^0*1^V)"GP.+G23I7L/AA5DMU_I >%0J)G"F[:HOE
MM('D:%8E:>[^^]Q?QQ:WQB;M<Q_[C:,-S=VR.?K<JB^K(I8:VEF)1U.!U94J
MT*A<7>F250"KP3L3G"F%AH8OA*_<^#.L*D4OY"2))SL/$#DOBXX5-WT*!\U8
M%3<:Z$!00,S:(JV'2!;RMT%VD@N:#\F[SVP"7GM9$!3*Z:#>FG[B"]KMRET[
M:]A 347;5\H2Z<\:'H#*0%P?T/KW_5&M^9DVFF87=<:/A:U:DVPQCUM[5\4F
M[&!SMN.[R,^AZ:+AT@#>EN!2CN)R\?FH 8I_@_GI#JB;N^FFBDGB]HYFJH:O
M<=%IYS',%-23AGB';G3\),3D?LG#7>7U$)2Z;Z>=.S/Y;P*V)M'6(9MR!3UR
M!6TZ+.O,2&P2^3T#3&B> 5)@E,V%F:;,HA-0?,X<K\-6COT%]- 6U52PNDS_
MM4L;IPF-MIFM%;Z?\B"B59$GOSA9P*RH+M>R"02+-7[-<-/[=Y:\\9V-]N_R
M+%AIFMBWV??[PU@'4'B4A@*)WBMQHXVI F^+KBH0E:I0/2'X8EMV ,?=-#"#
M'?(R]O4+DQ\99WV^E;2"(.BA#Y"4UH[OR.;C$RM"6T^?VVNDCAXS]N*[>8C.
MX1P(5VN_FL(,  !XW2.5UOF!?#UINM?)'ZQ-K\#TR09UI:O8BG@,;.IFEW#:
M]Z-2WG_U@3^5-HN@B1.FXOC"![_&ASO8<\,C52X,&[E(.;J>^$E*T2PTB&YJ
M1P/\ D6XWT910U1/9;4TO 3+OZ!R*_8Q[5]5FU,+$G<OPG@UAU)6*;7E1TRN
MV"OC"6L7.AR!O8WR)I.<%;FN*R3#C[(.KSE^%8L$96+K8A!CKY5_^/#1^T?,
M7?_VPOKP6FX6,TQ'#+/OH[]>]7IZ&FY'%$+G;UMMYX/CO/7WAA9/QMDS$6^.
M'*2GGW?\=T:',J'N&#V2"W1'C^5O _AV+3OW[T*] ETL%V86!UPJ+^0J$V;V
MR&TC+?*,_80#6V7WYX<DM'7JJ=XKHT6\9PTU9O2N[*(?#$G:I):J5L=E9E/2
M6HZ#RUOT\(W=1O:R%O-(D6%H^9'NF1)FS*&LF_(K-$2VQH/A"ICC-P[<">Z%
M.90G7Z]T SDU8AG:CWF> 3V7&#7MG*VP?!'[:Y##F,^OC3I8P_2?V\\W>DWU
M-4W<;]JMMI-;XQSV+U691GK<Y5(F<0=>,!:?4-Y44?+Y$\1 !,J#3GL]E+2V
MP> @O-][</2F&.:J%93[>\0<##W:HX1"72)65FPU6/;\U06%*U59_^%<33[I
M'C%D K:MB5Y1MXD;99R5R3[R0%KG&]9_8]0QUNG<[]8Q?\I>>Y95\O$/KHE"
MF\&@: U^;C7_:4037G+QGPJZ3>1QFCR.@_ 4/"F[/5J"Z&1JQP1&^L?M*Y?[
M@:E\-U+VM!=6FN(8L21U,-7\X?4NS^XSP#+%^YV[:$#QF^\7VQW,:\NU3:>!
MI:MD+X0&6@J1:1\R&S]Z]HDH4+]C9\BUV=0G6O^6;72F&ADYYVF\\ZL9T[_D
M ''8(-)7.^W":1A\/I'=W_P!N/'$),Z$9.J,3YO)+II$0IVFU(X8.NP:ISGD
ME/K06$/F >R#GQPW!&:9^1M=]";5>"2@K;=?GH2:[>!95*^8NLM.[2363)X!
MO:/D/>H1W<J"5L&KN3JD@U0L]#X.CR^> =@,YY=_#R(%\5DT;[$OPT)Y',?%
M7WTP;H2[VQ)CY27Z7='>5$LS8M.;B!/3-TJ^^7YK6=>P[#\G7XO0AZM 6W3&
M&6?UFM93E/NFZK^\%HZ)! #/BUOXNF_GE!-5OC<&M*P$[ U!LB4X T$U>>L9
M]1/'GT!! 25[/@("(0/I0KXW01_O _2UQIM@V\W5*%BVI[&UC@F3Y8)LPB%9
MWZH:CNE#Q:8&OY)2$D+H\T_S7/*9&<1*!<D&M$U<OW[R@Q3U6];9(%9A.:?L
MREWW)]?'48D*JTMT["R7X.,WC,OPB2I 9YE_2KE=P2+9"9/!=,ZX?P,B='UV
M99>E.51(.B-X'P^7!^;KFZK1U@3YF/D*8K'YE?(+[B4HT00I07 %0M+7.S+J
M0Z2YQ.0%JQ4?EU@[%_*GVGL,0^<?5.LU26.5R_F[,D</% _MV,L=_$,3=*B_
M0+6X>.>(PVL$B0N;QQQB4<Z^,P:+;+<\JO<+JZ6V,&:(YM_JM;PC]NT^O]$4
M%D=@\TJD&+?PY=JMFM(OX/P9='$Y?9%J%:S>H!P8U9;2_^DG,9-C;..U<:H@
ML)1OU\@&.8=P>OV:VX]GL"WF<_+HKAG1U.&Q^ Q5Z05\;-;##53#-[OY,4]X
M7RO:&/H+,,074NJ8;9,X#.4:?2AW,%=RR_E+OE/]4-+$'-^_@\8>/@91;;,W
M<0Y4]4H1B>7$(G#;>G*:70G%&\(BK;)2B_#]V*RR+V7+")QMC<6,HTO/:D X
M5ZJ2UU?$4A2S$J["#/ "V5@7;R:J Y$'8^]E!)FDH!%[4($T#^S'"9$S*?O"
MZL:WC!*'^J:K,FU=Y(974=D/OG-$Z\R:5JQ++YPW]3U7HV+$L:9>7OWE:=H9
MOZI@>/#9_<G+%O%(K&F*(:7K1=>FU$Y=(_@,&% U*G'%.& =J'"24 )<L*3R
MEW#/H+OKLV[M\^!E\_F\Q+_\-P4OD_3OGQW-T !+JU0^N:IRZ_$<UYG #1Q^
M[IT_.GIOG.@)J5\.N/JOY]7;"7CZ@^AT G2J-ER9RF3:YF SX,@7_;@>S0Y:
M=C(YBQSQWZBD=CH<39>B%5YLQ)CK.M-A3FL#2RH>S=8*W3&%L&8[[)$Z7%\K
M?T_7*^7S?E=X2/!4)L5GL=UM($W,>\M&60N8^S+MJJ4M%X= M<YB$Z3[JSNK
M3!6MB9^!.9VXTE A6E(YMI)?Y5@4+EY1Z,?3^>$//<:J%\FGEX#M,F,F*7@S
M4Y'=/+?9-E6 \*?Q4E?-L<_FGBI^W!-(5>:.]R87B297[H&HO;%N95V>0R59
M&[=2)85>B^=7)37>82%9#5W"AS;)\7%)< 5K-LD7\>JB,_P2[;C9+FSFZF1[
M!R93Y>X%2IN$7&Z@0MT.\\GD)2E1G=Q^A3%5&<H/SNW]$CYD=W$=MGG[H[+X
M5M+]_12.@?G,;G=-E,@Z.LQ7 N>=8I$.B9 !$&IBE0?[?BXZ9LDU[X\F M+:
M)?P16%I)PPM2KQ<"H2;!/649!-KH_9)C8I"NVF"'0\162K>=T*MT?@29_,G+
MT["?&[*5$W)]@PS;_0H;XLE3)'KC5@<:HW:N//A\),%".[/MP]]DA1RQP,-:
MM<3HGWJ0F\!Q/GM=QH:_?+]47WJKD'2)LO YA0[O+P$[&:8Z6/J56)4]#$=O
M!WI\S!B_AZZL;-'J6(ZV$R'L(D0IBG8)"CJQ3A1Z5%9^]#1\-#2V/XN0T)XJ
MM%EJ_TSLPJD;D*5\IL4JU^#DQ\IHH+DH5*UT>E7^>_>5AC"'2WR)M5GP>ON?
M==D>,]^$L3[&X=#R8"$M5?_P# ]91TJGWD.-%C$UEOWWKRHSU'NCM[Y/3W4O
M-65^7(2&)<AJGNZ$\\7*=8]1F:DS*\=MO^I<RWX\<;@TK*BTRV1&8*X8/&W4
MA>KO:>5CF(0S',A&#OEX,W+).F/+8K/)A6&7<0&J]->9DIERU_H32.$K2W>1
M#-L#G_1U%'"P&"8T),UE %+[N-P-7E:=HD+K9 ]B)111DEX6#1,W)"O&^V:,
M9U]1)]72+29WQ(SW#DR+KU\EO;G R'2B$1I/89O'X-.-)=&AM,H9:& G(C56
M_N8O'\E1KQ#<.)ZU-")R?AZHZI9-5+668FP<^!O!<=PU3K-A5N2^9V:WCH^^
MGT5[9M-;WOA"-$9E1VBCAMB *5U/3BUD0RK/7G/A?0M<^5/:V+JZ40LD_U_5
M%6II^_FJAJCW4\K 5.OHNTY_\=3_TMQ;!;7A .^BP=VEN 6GN"4M7KQH<)?@
M'M)BQ2G00G"G. &"!&EQ::&X4Z X%'=IL6*%\_N?F3-S'N_#G3OWX9O9W<=]
M^/;;F14OI3ZGO"VQ$=\P,LW%YAET4;:N5QEH20UJX Q#K;X;1-Q\^7X>X'4J
M<3'V0U.L5I7LJ_OKC;DFTD\H2PO+X9U^L5-B'=R-(ZNDI ?YM^B#WUWIH8Y]
M@G_%$5&6 _F_OUZ;&K\^ZF_Q#4P4;8VXNJIRF<RH='FSE)34>.1$OGB;94#U
M?4#<7(ZQX^>97>J6?H3G5LH78N7@GI!#;<;>%]:Q=+3-ZT-!(P\-#^Y&66Y1
M%Z+,7^;BQ0T+(?#QP!HT2_$?37DA^2O &7"6M&E?F(]"O&'A65JAYGHGLRM+
M\::LKDF&ALN. "/6H*Q+YAS5*DLX:"-@L"YHX(]3R9UQM.R8Z06LD17MZ:,#
MFT0'#O;=W^I[HC&^BSP/.8R6=LD)(VO<_2EYV\08U:H@GO9OR[KHS]@I#:V4
M%G-_+.=UK?O&[J=K5M*:XT7WTETH,YZBE;M8'QI(7H7'68"C:4[*/Y0H>Q@6
MN/.1[HT!Q"MADI2 R2?(V"NA:K#JTT>.) HU]@2'QT?^.R2! %VW4.AYG$MQ
MOS])1[QP\,_ E,>IQ ^$$5'C.LOAMJWZ"]/B-;#4;:&0@T4,R2< ^9+P/>=<
M)@*_B3,LZ+/W,(D'P>3IN8"SQE CDP.5F5QYM>_LGGAW&_V*KKQF75B,:-3A
MN\V:UU$2#E?TW8]-2D<>7\KG]E>B;@QS@51]*L9+)X,0@'Q&D/=[11:R'SU'
MUZ!OEQ36)IM=/USG/?J"5Y)&NN"]?SX$@\L'7@C60)\ S#31\ENZVU 3N&H<
M;VV4".H4U[.,]9AU!V((?P*@TO[-/*"PQD[:FA%/@,\":?//O)"ZZ+>9[QG5
MD^XYVKZ1JSWFHA?B>FGKU 4\X'^Q!,T<16&%!N9_Z6BRV\0OIEOY!$F5'I2A
M!Q#IL=[$\M)XS$*>%<FTQ*+$<F8E@1!A-XI68L(!4G5GZ*C1.X=%<LX\@U$O
MKTX(6AKR8S]AI1;\RA<^KDW.L\T:/,/Q<<^6W'FMN4;B&\]>J+;V"R'S2R:.
M1:E"^WKNW9TDM#E_'7<_@/2F1&VY6^:ZO/3#Q_^(U\!*%*:S2M%54V.%HR^J
M)S.:ATN/,E\O#(KU@2:#J^L0$.-7RF5M/9+8M8;;+'R<\ /]M$EF@='TTYX/
MI.N*>-Q(XVZB C>.VPVUN4^ME9-T-9^P-17HKU!K!E_H'U14GK=A5U:AV5UI
M0?/P@I_\@@VK'/.Y/9A\*V,^&NAX7DI\)1Z>:H;!*(VV>\C+;R-@MC>U$=0<
M#YV$?S\_")2O['81>&VP"97Y4YSR,@'$M>WA_9*%Q$5Y5,MS7:*4ETAFC:M2
MB?=Z;"N*Y8S9?=\I>]\11Z,VVBB'#IIB9A I<P5 7,AQG/I]11=+%,^O(;K-
MV!YZGHAQNU]'D /_*F'!#U]"LPB&#!ZG3LSU;"RL5%D(ME+4)T?@.O_HI96?
M ,#$\*DQ&H*#" 4@TYM:]_Z@.]=F;4^,"V$>1F!"H,P4]S'LQ7.-FH?7_NW_
MUA-R50:U$C,.3QWP@^OI]BIT!%)^M\3N3=G&.7]T:&_WF%B=#2(\#N^N5,0_
M+\+:H9?/9S^:CW,8XHK>LE=PY%>7'%LZI.IU,M]5,Y78$VTS&#O)X_VGMF4H
MCN*D0L US"#N#1:W\?Y4/1RJG,O)?96@+99+-X:3@D_4,5;'?_@;E"&Z8SZ\
M]0P59=(Q6,!?N</-<].>^B>KJ;P/2$>R7EJ//^;2TGIFW3,Z&T!KY!36[IHJ
M17V0+P@5'+6#^))ET,.3&T>B\_(C#;9X,:Q-*R49OYIPT&\F[^J@GQ9+:M9&
M=FQF3311!%\9K\G%O)JK74 4>A@TLQIN<*37-YY?EVDK=PV2X+)K\?46>2:P
M0CR-2S*U6YH3O' =ZT@<>CY5!=4N.L>S-*"@6>E@D33R\PWH/C%(59]0*&]8
MAZ4=*7BG4PW.Q6.H66;B7[Z;E/V 4%JN#^QW"F!Y&= IBM&L@=DA3KF%DQ@T
M=]^_F_J97\+!MIIXMR NGLYTEC\QG!A#)=K3BW>]H/-N/N-!)P96V2,0?6XF
MDG=1<'6HHXGX3^/"K45^KWSE:/CHN6.Z^V$;CXGIA[TS(QKW1LV@,8Q@R6E3
MPB7-??O?M(#0$\"@XX_DWK53[NGSO_;O\FRA4T:>\AOM/1XZI2A-C</,![+'
M+C_:H) F=-7",HPX ( 5E^!IAUS;;J:M=[U.-E\:P*:HP[ZJCI%D2^GA 3-1
MO69R9[+#4Q =5W;BWG^U([?B( 6B,?[,R]41AZN2G#SF@\M/- HZ4[P@(NU]
M<!NK5^$SX'3KUU&455&KEQC02DL$\)0Q("Q0"&[\UU^HWQ,7-$T=,!WL4_]S
M+YP=E=RCPU8MG6L7%%7VXPV@IY?,>F74>BM^/93.XB?Z:*2>+LX?E74A3759
MN=$9>7@L(=REQ"2R'SAX655/<9WG>1I&JLWQ8^QF '+G.#D;<6O2Y,JWLS_'
M&X3N_-\$N"DGX9DIA(Q\#4]"ORLK(G(&,&.[R6M^3_K#_3"_#37P=>,M:2?^
M7EJ8S?D$>/,$X$]-B=D!SMJ'RS0//LK872T),/81W<]*MGB(>I3.Q/7/7W0)
MR.C^-C5:V!4606E#(L#/W58/]FB87K^GZ:5QR:O)%-45:(N<*=7#=7,1W,[X
M:"0SIPOKM_3:_-6A7UAFU3B]DQW9'7%@[O?"7!D+M#V'6F98)Z2&,CN\4<TR
M5G1UIFF$8N7F_*HO;ZS"XZ%1M?AI&5T"__H)^!J5UAG_'X4V_../LLKTY>_,
M<OR((BZ>U.^'3VCO-[,/S5!% LHT:'3<Q<#A(,[<1@L@&]6-,>GS,HZCD6)?
M;47.]21%O1/_)T"FYRU$@@HTTC>0B[PG&6YX]*=CYN=))R5[!1FLL&K8QL&;
M0P\B2QZFT]B9JP-L#[7WHRL_$?NNRBT85OE#+:3,@XU["<6V?0=J^C&CZ:Q*
M*NCT(ZR;&;$(K2^OH![D'D?#$J+CTGXZO)L=GUH_#&9S<28;M* J24D)J"&X
MJX6:R:32M-2=N6ZU:SB,,2==^QA*B/OI&1\LRA>Y1- F &<#YQ\)WR('NTC\
M(8ZVT4)<TS/*A=>RZ7&@<YO(T(SIO3A2_")MGK:^NMA.(XD8\!72(C1'\8+"
MXH5N=$WCXOAH8Y8)#_)+?G]H048K +O07!ICT/SY^Y+H(:Q<NH>*.T./F@=;
MG/*Z[$\M]<"&<GTV5B$R>?.)$);%&J=&QLA1]O0&,/N7O,>W116^47E1FBJ8
MX'%=M52CU%VSL1;!!NKWWZMB)D1/@V;]&20OZR3[8N@Y4P-L[%-Q^QZ9"D/=
MRR6F^59(W8ZTVE/7_N0"G-K:M<@5!>B >8^XZ)O()3/T"=)J ,1CQFE$STGZ
M!(@U7SS0,N97&O+5.,1YAB5T;_HEL2>?R]F+.E -FQ:$)XNW93IUV/)H.:4H
MQ^D^&PD$$A B'-O.K*"O*)1B)'F#(D&2>->>A05I@IUN^[Z$**8M:HP)[>JU
M89D1B!FP*5UY@QV45;Z5,D./%C@ZCA=X3> 74JX4HSBL@L5#?V8N6&'Q#[4B
M=.D'MDU4:K@"=DF=Z<3M !>"*SG"Q*3U_YHG%D^5!A*W.^7#?;/@R0WD%,OR
MTM"K2L\F"Q?(R\ ]03$<#:9*-C SP3Y!^9KKWZSF78):O<HWWAFBW6#@GRI@
M[[)0K;3*;K_,FM^%N-#,/,Z[<[Z(1F%/AU;WMP7B(H>?VBK4)""IP!0;9@5P
M+?3XKJ$K<G.7P&HCT>#\9+DS*8MNC]7\[=?"?P5OIH N9H+;[SYFA'V(Z+G:
MWON-Q--^/HSMR9G0]*QRP/5V\I4EPD"7.8]<=8(K\P]47("24W_8KB '"[?0
M&^5&Z=EQ_RH0;IU=\B$B,F=POJ&(-#]J+^9N.@<S&<GR;K.MPQ.JU]Z5".IS
MU.XMK<C4Z;.^;X<;RRB^Y=!VQ)3L)F-WQ?GVBQ_O"5 5+DD^(;3R=9(WH@4O
M-UD)W4D-D(:\G"/-0JEGAH;TP5=I4SH_5Q'Q8PUL'9G;+ >%+CN+VZX0#^"#
M.9(9+ $X["]5-;J1,NN8XIH*,@RVJ@[$H9 @YS+Q,8-()%1616S],Y_*RFL6
M]4-^D-0#JAHAC<7,9^G0'O72C9.="6=UT,-$VTVT K7<2BT3- _VC_F:8?$5
M[\"*6B#_)=1!:(R)!18W6ERU4ERF"@T'XC "[XN_M*3""BZ;UV]1_@(.5-T5
MB[J,YF++W3_4F&SYY?'*N*IQ3(9[H>>;*<4#-VU8_T6? .@<M=UNDV_*'>PJ
MEWH">V<TPX]I%77H,9L[NKIB 4+&\=N\*SFVDCB!HO"2.%ZL44\-D;#NI(N:
M!!_?F*:3@/"DZ_^<+G\B.K?<P\MLPX5M9QLQ7UE^904^?2)U#1H[Z## OY;
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M;?% !XUG?TO9W50?Q>-53<%M/=2\OEJPB8;8(!+0O5]S60<5!%B3L3?DA8K
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M%\.\UT:L!#8EZ4^8B[%UZY#=PUO0]7<?3AX*::%?$R83.+:K^2N&5D/RA([
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M&]44F(:@W+_>6PD>LH,U_J,RS9I:=UWJ'@4CI!#="K?E)(W*@[ 1O\"SAY]
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MU]E+ WSG"MA$ _C_\Q>!__-_ 5!+ P04    " #32W]2.51X4$%'  "[2@
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MW;!IQ&A;,TB*%O=!+H4+2B"PW=[35,^0F@:*T>_;A:@0,/TT]GZ.P'L**%!
M#:^E-#:[<3'E5E !63]/\T@3&T8G9FDEA1;QM8@T^W4) V41MY?N;$^6O1"]
MH];@N!^_4-SY/9*ORFN\^6.9C?Z%@L,D_2%X9J1.T22<PXN/"EA3HAU*"%51
MEI@G ,-=87 [OD#JE9.( M]%/.\%C?GXH;:^R/O81W^9AJ^% "10)YPMS?6.
M=S,Y>I%P>]FY$-.I5V$5_U5N7W8OM9#NN_+@W0;1)YK>1M!B.5XY\D@O9%3N
M:+A\P9)_40>:N4T7L"U)=.*@X"[79CLLN<1R5#0SI&L;!I,.@UH"<CSAQI%6
M8)(Y+N-?,&";.=B43L_+D!JCK<T-*;E41MU7T%!0U.&3@LSM7$RD/:U)RM*_
MK8#<%BYUT^< K.6L1W)<P-%!F$&NB(X2DI=*2*<+&*M !63^J(!\&]A50+(>
M%0H+Q>7K M(]Q7SZ>0;B!WED0M;$<Q-5-MXT$K%!H5_2!J+VY"*@YP]XL-DM
MHHVW=(I[;5.!1L=!3J,*H?U YN:S8="@< E,^[BH8Q @]2WJPPZ*!ZWK(;!
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MG=VN6(*BNE">#5+HH>SVFK:TIH!EJ(+-C7Q#5=RHE-E'2WG=:ZZ"&"*: P)
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M+(I(M>O!9$=OV&/U;M;=Z+^1[-C;<3-2*C\4>S9JR[$G.QY=1]'Z)8;=.7#
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M74#A0"?6DMP5.%ZI#P[D.Q@W)@"3?@BM>BDK924&GXC<?\3BJ,E^+=5Q',Q
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MB?PGS1G7Y\M(*'B_3Z$B.J1U6Z^A'%-,6_;KF'/A*/ (\BHT@"1/D4?EZX9
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M[Q=>(1M.\,G7(0TJZH-YI \<ZQ$5;*.QS[$@O+$@PP/W&'Z,:,X&(I[XOJ[
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MF_-<$+C_A>A4!=$+(;CM-.U,C_7V;6(ZHM1S@D?$V<U;,I3;V(9JJ>4&^?#
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M3B2C']('L[*-"A&1)W<0.<B7E8"A=#@;,7M*T^V).K<[>=6\Z68UVWH 3SQ
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M8F[ F"QZ$/Z(4_7,V^Z@;\7-<!7.FYB$1VK]=!Y1-V#<>MINFNC<$T?EK!=
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MZ1A2.H;N9N:.O__]?]]=W_KNNK%GG36SSZ[W/?M]WN?99U#3J"6 3$5!60'
MP,  S- ? #4'R 'W<''Q<''NX>'AX>/?(R"B("8B)"2B)7] 2L%(Q\S$2,?
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MK//.=,TVV>O\X6B<',3*F_+K[H/!*!XK9WRQ=KRIRAISQLR2]9]T]YJ_!9(
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M:G!GG7H'6%/?LN^FAHX(*" 0JM*1)IV 2%=ZDXZ@5.F]A2*@D8Z((A)ZZ(B
M%.D(H4J5+KTC)30I(7GQ?^XY][Q[SWWOO+?RS?<ELU?6WK/WS&]^,WMAI["+
MP#5-50U5  \/#[#!?0#L+* ,D! 3@XB)2$ @$"DI"1D%'24%.3D%XW5::CH6
M)C K"Q,S,QN7T!TV#@%.9F8>25Z!NR+BXN+@.]+R4J)R0F+BHG\6P2,E):4@
MIV"@I&0096=F%_U_'M@V@(8$[S$>/P$>!X!/@T= @X?]!H ! (\([Z\!_,?
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MT5@?#4+^0Q/VCSE_-*W_5?&//T6*&Z2I@*8,BAVSJ;'3_PM02P,$%     @
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MJ'UG@0Y#.,8LPK?5"*;YB?%=_.@C!)M N.QA$41R1]/"L0A>E.B? Y*+4)U
MV$K\/CTY4HZNO564D-$!5RE&!V>]&F9N,%KB(&_J2 8K3ADAS%T;7B,YIJ=Q
M/\UFD3SHX08ZRF$P!;\D9(0H%1T]J!U'.358KW'U55M!<-D<=WHK$E(Q1#K0
M[!Q_7HP$L5G,51,^UK\?;:MR=&?4MFR?*UZFN[=F$Y@Y(?Q-R8[)J8CA.23;
M!$;3=<V7:3SAR)DW( @@V3 NE%0KO(W@BY"\BI\QYXY0QJJ..V;^"\C)+6:Y
MH<Z]G-8RY_Y2DF#\?M']+V!*ZE[GM6S"I]5?5LM17-S#14.D+4\A/R_G/^IV
M+V(^^\/97Y"Q#KC\!?2*!^W5'BCS$3XX/6B9<\&4FML)[Q2&=#@/]/9F3_*T
MK=OU@'5\]\:+>!\\E.#.:?IEXV+3@=SK^4XE5G_*(L6O6Q 5W\,_(FG&R$L2
MU.,F[%OX@@3S*HF,>,O8N30<TR+*V@F798OD'3Y[&.,6NU"L92;O1S82[S'G
MSR52)MKBLU9G>&+B)B>QK-<SQA3$%WH9I9'!N_KSX!BLM$W ESH#/%E=]JA2
M4UNF+W)=FN-=G?VBA:<<QYM"79CB U'*M[]K8Q,0" GQ+\B'.J7W%LLV\C&V
M D45Z:3TS/2%QS(G4V\EO.!;20F&+>VC"L',:/.<S!WY$7:\9<Y*K%/O'+,6
M6/,2%Q\RM\_$].IEJ(DZ$PF$,>_U%!>,$'N<'DX^- U>GG'V=#D8+OGDI]A*
M7T4BOG! >U!NN_/XDUL>JG=I665AKVZSO*J=7+$/FL=HMCHO4H1MTO$^IC0X
MO])OM6]<!&9M4=!7,/P)"A/D2XN?#W!TG_J@IZ?#R26T3)*]MPA1V5@CVSEV
MJ?'"E6[A\4!Y9GH4A;POWN]3E6,G78W^D(#'N85L)B:5NO@TI6-">FZRK&!5
MD"WJ.&KD#,&VP&H'J)-@ O8R6^!I4"JGL,.)+^?R;&J-EO%$FP4YULUAQ4EO
M($F?,I,G7KJ%RZWZ#CK$\<EY[+Z;=@MD?<'S5G:FZDNI$UZ( ^TAUO/CE]:C
M":%&(IJ.%+"D&.'OBB2'FU>B@_TAW;X@6EXISLSE5U%'VF[,JD^.>EZPY#Y"
M*\/*8H<0,UKI#4R,J36)YXIN_*ZNJ@"K>ZF3'#5NEG>%:O,J;M^XWJSD#1BL
MJ.%2UM>?8+2_Y,WTA2524= FD^3"!&8:=8-146CPWRV_D&OTUVI9+EZ17P8,
M(6S:OBA08RTF-#>&%N!<G%A/E!Y=?DW.R+>]-Y-V<UK&"5VNF++!^U$H61-W
M6X\RM&>L57F\=JQ:.!Y'+\B89Q\O%K5(.W_G]9--,XV;C^4IWS2V<J.ESLK#
M.6$RSVH,% %<:;)2<H"6KU1W(3KD@[?]@D$?7W09Z$4C9D98#9<2EP]APWE#
M;-^JR6O^ I9)QTQ]33><#XH+V-W"';[KG&19\5,9W56J1M_?,!LLG)&\J;O7
M_I XG0-I%TT__5I'ZB[:"XL'36Z<LV$E*F4I)(6@A2AL&&L>:0Y_4>WP<2]N
MG9#]=KOH"'7Q1M7SQF^-<T8*5%N3O1?GOFAY;Z4Y5/9B:%P"3:?X<(P"@DXH
M8X+@JBY41,Z/+<$%$&WY%RNQNA<E!6_- M1$><M%4QSPSHU94VUQVGZ@;\'R
M,X QVRG-0Y2IWH-NF$:_^(VS=<PZ>7KL/&YL-AEUA7 / R=<(XJG.+QE1Y9H
MLO>B.("3!Z%$2TXO]@;A/-]D[I$NV1N@CB;;SDN.8#'7'YB'2IOM:[P;*6']
MJ ZU60I/)UMTZ;6&\]&O9=W+Y+J\A$G.29_F[UYV]M6_@SWHYR1MQ'@8= BR
M&?W@?C[Z4-"Q)MIG)!_J,KNLP;<1%.'^Z]FKW+5RS'M=KRNS,"$N>Q!Q6[5C
MI&8F\HS6J-,\@"_:]]O758W!P2IG9])H(XD@2&0<T:F<9,)N%%AA,IJNGQ#)
MW2_1.917/<*N/'G:J])1Y*;+N3;)>X\S7S^[OO>A/8L[ZVDQ7&!KE: I3LSJ
M3.GGPWZ$[5K"'K2\:VV58?;"N#+>NZNI=4AH^X)+SN<!78/1TNI5?X?DLN(/
MEZ<&H]1EO;"BW0 G POW#J48Z?,[O7%"Q\%F)C5#H('VC@]0SKS5=C40!O=^
MNVHE3%Z\13$\X$X9,T!>:FTEG/>+H!&PJ@7WECQT4$+K LC21Z.B.Z)LGRLD
M9_R)NM=M0^MBWJ'91\G11E4?V*NE<9!&F4:Y*CTUV>+[FDS;")B%JRM'/[$N
M@C%$_?<H"MWW*/+0E\&L*RI='LB8@R-);#BW0OKW1K_(U<U@/&W+.'ZP_:4.
M,AA/$Q*MM5OJH;1;6@W0GF<ORID;"XX9=<^_1W_F[W7\2+>0/]^?:Q6JRX,_
M+ ^\B/4;&>(_H'7TOU3:K0$Y>NUH6#*I*5Z*!H),ZK[K&^JCL*PWM<>?8"(,
M["YJPJEJ&?R(G\G8?H#()[6Z!]M!*\9JTD0TO8DDV^9;I/'EI$VSR\9U;;C9
M,R-S.?U_K/BG*RNB]&JOYT=Z!M(S<X/YH%J"RS(T'1)OMC OCTS$&WX%:JA+
M-\^MKF'L1U$,^"Q_"<?N;%'BB'JGZNB..1T*T7XZN1K>,:EPQ?IZH1JM <#;
MSBUV+&8= "]<ST>MZXM9<#S*V/LV=Y@$U3M:;'+8]J.)*+[.XV'F-:O>A$K?
MRY(A4]6\/CQVPOK:2 ,-Z[GO%\"PHL JEINUFMR74T15L09T>4(33C@+D+^
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M_+S7#+Z<X)CZLO%[;6NM@F(S/;U9[M8:-EW^Z'&7J?%Z7^"A4,6Q@M149H,
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M<+UK)GI>I):_TA1]0C.<'&%?]YV,VBK7S*]6!F'-[= @$J)(4SEP=LI>V^D
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MT<[K._WA@Y+[E)GQ0P'>P]O$1I4OP<L4[93A/Y5"58_^C 1\%PD$E5Q*1P,
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MA8HPM6Z=$(Z"_\CW]?% ,,@(IK8XJ3V[E:M[\0EPRI\B5LTW,*4S4FP_0G.
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M@M((0;P  1V(D Z$[P6X  !$#/HW@/\=( )"(F(24C)RBAO7@D9:@ !$2$A
M1$A,3$1TG8V\S@-$=,3T/))J) Q&]J2\?F"IF/0B,KY[=5\8C<?1_'<=_&/)
M*9B865C9;@D("MT6EH;(R,K)*]Q_H*ZAJ:6M\\C$U,S<PM+*T>FILXNKFWM
M8%#PLY#0L+CG\2\2$E\F962^R<K.>?LN]V-Q";RTK+RBLOY30V-3<TMK6W=/
M;U__P-?!;]\G)J>F9V9_S*VNK6]L;FWO[.YACD].L6?GN%\7?[E  "'HO^/_
MR$5WS45 1$1(1/J7"T3P[*^ CHB81Y*$7LV(U-Z/@5<JA@Q\+[VH[@LYWUUC
M-*.#_S@%$[_TZBW,7[1_R?[OP&+_O\C^ _8_7', )2'H^N,1T@%0X*<*#V[4
M$GW6ZN56BN*5][KLYA3KS4NW6$9G1VC@@4(_//!9(6UM]\;:@5)!FU@,]'P<
ML1HE$&)KXORKZ^@'TDA=(X7=[<3F1+ZU<E GN*Z/B_%2\[HN +;"$=:9#)GJ
M3W91/O9L"S&%L_3?9,=83$-IE13+E^\_]0H>5AJNEZP]]B@G:)6D#Q.D?E3Y
MW+C=N/7+I39&HV+US<2K7(SX!R?ZT/3#'1)HOK]?R, :1R_=,%7..W"<?YN5
M$YT5E TVZ;I\-'09']3)--W0$B$"[Q,H<L\0JR=Y)!5++5(J+-'3'Y'CO:WT
M/C]4_=L@.]&2' 8;&WINQL-C!S\@XWJ)V/[<*<TITI@MOVZ!+-QZ\+A-;4?=
M;CK"H$@-;BM]$5]=Z6B_*1J3[#?!N/V8U"$==;_<1C@K_LE<%+P%+-=?0Z[7
MDU6H;[*O(6S^\,Q%T62]%LF'3DO#'CCVG>4&;31M+9F]EK/P#2%Z!:/ #D*G
MH&,SHP4TI)<V8M _OV"G#$9Q</+OY1M-ZFN5.G=C#8(CJ>QLU_$ VWX4%P8L
MH^#1S1O"B,9XR_.G[=H5V_%@;+M#E@9'U6/(\4#GL$O,<Q>K[^8BK()LS_3[
M"G"Z4?S!M8)7"SMXX'G[FF:D?!>:NET-(]O#,C!O??4GM[$,][OG GXI8];L
M.?'--\DD9?I[ILYADE3*(SR04[U8'^I4VQP>WSO,EL/23RV/E,5LIP8MTO0.
MEKFETF2/BQ"Y-M/WSI3/)%_>PP,9^661W'A@;%^4DD=A]-UC#:_D-\4&BXX%
M?7B SM'XX,EGZJZ=0#<\P 0)U^U+MJI++;Y2KGOS.GRMXXTO*>,WW'J/6>YR
MPN%L=^PARS_I>J],7OGEMI@7W?8?(7]<EU=NFK25\F/,K2T546//L9DW)$V?
M4E43 */%[N,!ZAU)V]UAMF\3B8/ILI1/9I31/H9NTOM_E =[I<@?*<=AN=Y6
MX0$6?:7;(#Q0!K_2^"@7T@.NZ# ="K*I/?0(I[M4Q/0=)2(./8,L>>Z6T]!D
MO_?OV!\/L ,Y=*$30Y#W)F4+/BW>9R_C3)'H[LCI4^@Z@\8?!8%_[S(?_IE%
M0_/-I)Z;FO[,3LD3<_FYK+)SPL40H3<CIJ06Z5/:4=L0>R_],-E/;G]TNL-'
MJR7C1*.^-8?3LU:3;^6)4[1>Q+)?F4XGNZU51$YKFU )5HY5\ 1RZI/0M6$]
M =W_+OX','M[(5W1S3E,%U<E/YDC^=%C-(HWY/M13_V/'[M>S'.;0RU!B\]W
MH'=M3^O)'-WXN7ECM97C0SH36# #O?.I:H,>NL$G][K.S>.YIEO1KY.]@Y@2
MYQF,2HHX?LQ$*&+R!Q*G]V:,)?_4,[1XZ;4^+JM#X,R3[6AP]SI%^<=+YQ4_
M4I,2>J!A?'9C9;PIMG+].H96$+_5TCF_[)V1&>2MVK$C[Q5N74K1H?3T=#O;
M59\D\^-].C6$ML^9O,:RE-S93^679TA=C/EETES!GW#H,9)N[)+WBAOM=7#P
M<>MB.H+XZL*+**TF\,GN>#ZK0G(-PC&YPM0T*>:45\*7[ OI:X]1%7Y<NREZ
M>+J ,Q?#.\J>LN04WDH$2S7%/5WG"TXNW!-==D_A$M"X@G#U8!G?8ZJNH(&P
MBTWQ$ZLD.6\;G3*(?^7,5N$V4QCBG>+";G#F8)J4A=$\9XDS8CKJ)1[@5H9>
M=5QOLC%U5W/*K)*1KQ%"PC6G-<2IO16I@PQRH^6,[A5[L&/R#CR H(?Q/7A&
M'B%X SW?UX9\Z1U$AA5\^9PLY8-->%CF%>-.-^K92O,ES'T9^TU\RV.V*L*)
MC^)04H-%6]Y8+R$,7OGP[,)T >,88=B.B%3]6M68CX!]O6&(!Y!NT%,&BSX[
MK;DP]3Q8CP^C^X=;KW![!@RAMX)#_0[V[6*)0V6_^& 5RGZ/XP%A[*NI3AEA
MQ@6'ZI3:>O^2]\P=+A[/I'ZX-C=+K.A2BO-F2$D1NTYK7L-M6$YV[<\9_"&I
MC46EU^AQC]ZJP\6L1VI!9QV3UIUE?P6W]EFKW,$E16?7>M)<!)1=\G0UU-L^
M.I U_-):/+\E9X/%(@U@M&X44D&*#V$S04@-5#%Y2Z7KB5#?"(5Q^?CG$/,U
MTZFMAESG=K"O=(FH=Y))PBG?4AN4#I?M)8Q38V*Z!;(]BWU&J\5^]AD)P4"F
M$$B,%*OT/UJE(>;^-*B5E(*37;OVRAWR\I$<LGWV%4;1P1:ZB3($^=:G&@K#
M-TY3B":9GI$ X]0CEU8/K;8/6_\TSJKY9H!AXD6GT'3&"I.&WV2GOZ6;[XV0
MWEK8J,-"@EMLD45+2"\#>EQ;$<JVK&C'2_5OFZJ.X$6O&IW8X8'EHZO&@ +P
M3^_#".LR;1\/Z4IN0SNY0<)MR$^1<_-=6ZS'"-BM7-'5]U$QZW2!E-RB[.JK
M>+A[\/G90;!+S'GI+_^[O\Q=QOSTBS&(VY/YFJ&*^:_+6"*$CF&IT#UIG_/-
MJWM5.\OD/X-LF;[_P;*.(WCI&>E2**>64\R:97UW>>?F+)M0)3^-_3XCMKO]
M4%'@[^M9%"U-JFHL?$E'9\=ES]/X/K7+=:2X).9(*3$\0E]>'_X&9\'P+;&W
M;VCD-6X\@"6:=^!\-"<"]7B%I&NIVB.NG)\QC_I[D*[)QD-7N<<[)[Q)Y\5
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M;,UWUVRTRLGZ_0#!,[XM\[A@4":IO(\SSQCTH!Z60:C#&>W?VM_+$X=[8+J
M\+ ?V2TTF-:MO :^LF]G;&.<O1S2KVJEA ZVB1^U,(N$17WL!.86^Z*DK\<^
M$/!<X#SZMA[&WZ1:6GXBJ*X$B9GY+K4N,@?ZN+RI)FZ:>=L<<AS7J(U=F33&
M%5%>^+S=B%<4-8H&G(:TV'?D@X6@)?/O)Z]7^'V5N>E8;BK_Q"1<>DNK9-H8
M,4)F/KCYIES1A*]*W@TL&MJ'$T#1"U^P,&A."HR D,%O?,A18&&(]XX5 *U(
MLT3<3M<3;FL5E?C\Q#YIC=.Z:M(MB[+G.^<2S]S;_=ZL BM@925W>&0_BS2N
MKHQ9Q=@EJXNVD2]1:OJSHZ9=-=S:5#(5XG]^X]BG^<&K6KB#"!M2N@DJ6>U*
M#JJ .Y2>"PUX==@Z9_<DN55/'13V7  "32E<N7PG']W$CT/WZM'N"S62DVKA
MC=1D"^L;ZI/=-"+'J:=^WF#4EC0=-@4"48<>^CJPV>F4-G'G:QS1;<-%_RG4
MR,>Z>7Y_9#"FKF+1RBIG\'C0L6QKQ0WB4?_5MCS 6? !N^LB- ^[NUB[9R):
M4 EI02PBB9SBF$D11FQOP#:2:YEW\+8W7]Q\Q1W6,LA<N)L76R<3$[^28;CK
MG4X.JH$['">$9!;65&L[C:2U(=@/UM.A[!$.@=^O,4B2^[G3N74LY-2%50>=
MZ/>D0G0X.P35'SW'%!!__+S+K1WW4PRN1*!T-^!"_H!V1BBZ5>"L(!,=.]!8
MK,LZ$2_#QI-34@92Y*I8XW6,\=>I91B9U"_T\+>+^NY /@M>%]?P:&,\:2J<
M(Y&ARB#L5.ZI&BE9OQ+@M[E+E6F(IV!#>]7'*Y'.BOON!:!>PMN296EV_&!*
MR?V9>@9]GG]'>SWFZ, +H?*8.Z.O*Z!/S;$V7G.)>AX(R;>][%^ 0KVN.+&R
MV>.X+;\3$*QEJ2X=F@M95(CGEEQ8_QHY59)1)06]R?,*'S=EN1;(,%>%.U3V
MAN+$Y-],L]$Q^ :/2/FPM23<_T7>/0;+,=1X)JMZ1[.F[+E1O\:$Q_,[&BJ<
MS16D<?J-4JXL*9X2<,#)Z8%$YGJ9JVC=@4MFYG7JF:EI>"F*C8T*@P&P-7SH
M]IDVY:J_)L_I/>]W5H$S%X!BH)CV7-+FPU?5>S108X:G[QJ&YD#I!LK .EN^
M)(+JD<X%\&;6(@SG%7_KB,LGIR+\,LFI:ZTD?O)/0IUNQCW5]>0>/;#1N;EA
M"G&.'YH&T7!\*+T 1&C]Z,7!YMP]?-)TGA2I;ZQ0:\>J-:<6[3=PG9##M&34
MB#X_*8+^#(P0MK]_8T(X6?6&%_H%+P"T8M7S*&--B(\*K8.]O=@Y.1PFQB0<
M7264G>OF?,)NIHC=1>]F5,R:>)X;  E=Q*4Z6$QZ^HAQ(+,DZ<NMQWRWPS:J
MJ'KO2IP\&790*13?V;3JU^8[RE)Q3OU<&<(6?9O63E?2C$)[SGG1!>\@Y\H"
MX8T1<Y4C@GJ0PW467-^(1VZ+=>1052=L:.V[FALFZ22KG#8)W)XD81V:8A40
M9ZKUJ%5UE04\LF,V=?'VMZ2D_!\GY-+,I8(2COL[>!IZZ9>F*5)-\RPG0L/H
M4C_?J\PV(EGVGWH2D<FOZGI'I8);=9]3T'TFL[ ,DS4M$3-%XTO<QN,][LL>
M'Y(>O5",'M^D/&9@UV:Z4>CW!.QQ\"U+UWI"__-. ](#'"T:KWFOH\V@;3*/
M-OHK[6^XX.0A!,TC^U4OEDNJ"].@0E=$S *^R.Y$=FK&^3#.[;1_-M0:M<KT
M_C!F:5%D,--@D^_R/DG:)]VF+\:N736SHD<JT)E;=AZ)5DD6KKZJRZO-C.1F
M"C$0,.SH@!P>/((NA;^:L^[8\II$.F-V'R0G8HAUDWUW=#??DI_;Q.'[*B/^
M0.$"P/<.DEH1R_*>T_ .8]A..'(\]Z]T/<=F/1IV0!2S3BA4:"PW1</GK]LR
MW+6V>(N.QGWA\/$%7V>1,34$LXS.8UA?I6FBIPJLH%Y1%&BQ6!'L^9)/X\8+
M0_%#K"6T]_RM[>4S7*>M4P+$SIMSL@N R+O/]3*)]6\O !J)E!/>@ZA-QP>/
ML(:<KSM'[YZ/;K@4-A 6C"^X1<4S(WJ#IO@1VU%EM&8E3MYX*N]F'\X(QN]4
M"FZ)PI<D#Z*,U5P5E2!X03?14K]2QF'GR.R;,S%X=3"=CRMC=^MF(#-S$E[(
MR]M73[V,F.HWJM!.3WH#\X0VC!&5=2'L&QM,B6!^S$^P"+!DVL/3-8,CE5/8
M!2 S+78!8,2<6EP S^J:TO?I!NNVV:5:(\PENR3>>B0^B7BF)R;\0ISFJ:49
M]^LP$A_B%(AXN+R]O )C2K@UVQ&G02"^8<AYIZYU<AUZNH%3]63QR^O@3_$\
M]\D[.KX?TQ)QOO^OA?^K[('CUZ9+3?S?NR&TA]'DY>D:/K)%DU/NBJ8$T7)J
ML014[%COO[\D$PAOHG-)O]$UHM[A3M $ZUEIZ($M[K>87P"-!O.]QT2KLT?D
MZ8L*IS?.:2^ C,W4"\!7Z5S0 W;P>(-EJC.F,4%=\(%+\03Z&_IL^+/D4Y-6
MN9:B+%Q&'P66P9D/Q+A64:L"J^JSE@NC:DK8F[:\QOQBQ>Y0"4D'P,AECL%J
MY9<$4=NY%;@TG%_2D3<_: >/5GY'J,S"++Q=+J5>]NV#BR1!$A_-U%1CE. #
M5 EE5&PX*334-IC,'C<>,?R\?E77^Z]6[?^[C>E[/%]Z*!["*IZR+. OHBV%
MQ*"9@QLM>>]+ V*Z(APHI\8[R5CT;%9['\7=3)V;?J#D5%5:4^0Q*^F"E&2-
M$J]XYA&H0@FA2L!*DW<,W>GS_@7.EEX?N4)<1OI29:6F+%?)0-3 (WF,-@<<
M#P!'(DB(8M9'"+:AU2'D=,(>SC]YVO=TVU6QF=/G9#*E5+&7+N?#ST7_G&Y&
M/R#1Q<UZIZYDV'E#8V;B(;D>5<F)1\!X@!DQC+Z;"<* 5)[8(7Q7Z&U.2R,Q
M)3R??KAQ<[LK+>13Y_+HX#O1P0O@5R1YH$JTID)(Q [/K%H=E353<4;>LE!0
MRTGS#G4^S/,UMBAVS['%2W YF\=Q##67K![Q_B\R_LY4\>]MMT.V,P-F@PO0
M$K*=/=L(,)]<\63.RU)D+^NH_>KJPZ8F&G3 :5)XG+O)J-TA1X?S%?+=+PG=
M5 T],HM])T:EOV0E1RUZC-J!/);^C6]7+ 4#*P,WM=SX)%<Z4WB(ILA>]/"#
M6-(X7_?GWA*T5J$3(>W%VTNR#+JNY/G)]Y)?J3BI_U[U[S7'>XN)+>F_</9>
M00]--"^L=Z9M:F>5)%[E1D)06(1;LRSE$-?<Z\1! A,(NV*$K:.=5R^D]38O
ML^(;^'=C(A86/C\1<.AA?7[!S\M$__#LI_0@+P\]VUHV2"6&.#N.&$OJP>+8
M5LS^?GYR<Q+;Z%,1][<%L7Y.!"+Y]PW]![??_8HY>T9.8>\?K5T;M"QS0<'?
M/\Q+'2M_5B&G?V320 V-*A=W.OQ0YH45?@'<258M3Y&(K0QUY4KQZ^=2H>_R
M@XDY1OU*V*[>#KI7?"_+@&HI<.*&HIVZ2R*.-M#T3O99#[3C%$<R:^X]LB3U
MT818<^#NYI+[1KZ6^'>C^P3M3>4LC.>XV13%/]F(^K\NCP>51-@GW]YSGF;5
MF*:T84RBO\?E^FS%P[/I^W"8QUU/ ^DAP97/I!+#U9'/J4S86:@O$_7O/0LX
M(PBM1!*>A&J5N?2O'N?WEN(;&W,\EF7@\@_7E%Y^M9P6IX7 F='/&+ K,#QO
M";%\]^)3:%X#/[ZDQOBD[Y(4=!ESINR7#&K8/4^GJ[6[-(RTT5GH9E%!\.#L
MCKU]P<3_WL[!6,;';3E&UXMA@,=I>8AG*VUJ9G8*/U/7E)-L7M9'H .J%S/U
MB_G5&!;,DSU\6*7K$B+F\8*\+%[)B#M2Y\X&; VTXO;Y?M)Y8L[TA,Z$I8AP
MWR1[2^,=$ZTHH%YMO9V^YJSEX4]GD%4F=4E<'8;17.JFPLTPE*/UZ^>$N626
MAYP";_&>5F,Y3[PIFV&(NQ^AO /:$;"ZIK$Z.)'[3#K(S8)Y=3<\N7VM;867
MXP+XV;BX=ZERW*596X:?,GB\GYZJZC#4.F.^QJ]T5;"T*P-<[]AV)W1??&\@
MUHU#!4$BDZ-M5:;[)GIA_E5%I" 2DN/;9TXGM@\0Q?V"DQRE;@^*RQBC4,*O
M;J8Z.D,-^+^ DY,)!W$#U*X8$IU7)U5(!<5ON_G:+7.??4@W![]Y^6KW(. "
MJ T-.L?6^)7$-2<W'L^\8C98NS8B-2'\@FS\Y>/'U!SSSR.OIB<#ADZ'6:Q!
M0N5"F'DM[H;.STUB>L)>>[-\,H$3P*:COL@[SJ;AVJ;_RGDCQD+G<7^)&U?H
M:_,[U1&A=BY&7=)?^>]B6XVP_L)D[J[DO/HOH^_3;Z/O\D3\_*>D?OF=5+N0
MYG\YNSC\?G8I@QO]"X4NOU$X^4$T+GEF4H%,LK&XA9VUGU982OG-91NN@1?
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M,#(P,3(S,5]D968N>&UL4$L! A0#%     @ TTM_4D@#E)%KA   WCH' !4
M             ( !\6D  &%A=' M,C R,#$R,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( --+?U)LWR6[AEL  -B_!0 5              "  8_N  !A871P+3(P
M,C Q,C,Q7W!R92YX;6Q02P$"% ,4    " #32W]2'M!/L40(   2/0  "@
M            @ %(2@$ 97@S,2TQ+FAT;5!+ 0(4 Q0    ( --+?U*2B,Z+
M6 4  )8;   *              "  ;12 0!E>#,R+3$N:'1M4$L! A0#%
M  @ TTM_4O;H:QVB:P( _ZH7  P              ( !-%@! &9O<FTQ,"UK
M+FAT;5!+ 0(4 Q0    ( --+?U):VR5D"D<  "9*   -              "
M 0#$ P!I;6%G95\P,#$N:G!G4$L! A0#%     @ TTM_4KS\(1L,,0  HS0
M  T              ( !-0L$ &EM86=E7S P,BYJ<&=02P$"% ,4    " #3
M2W]24I; BR1$  !&1@  #0              @ %L/ 0 :6UA9V5?,# S+FIP
M9U!+ 0(4 Q0    ( --+?U+35HG+6D@  -U+   -              "  ;N
M! !I;6%G95\P,#0N:G!G4$L! A0#%     @ TTM_4DP%#$-420  94P   T
M             ( !0,D$ &EM86=E7S P-2YJ<&=02P$"% ,4    " #32W]2
MA$C7.JUB  #090  #0              @ &_$@4 :6UA9V5?,# V+FIP9U!+
M 0(4 Q0    ( --+?U)_C0L%7C4  $<Y   -              "  9=U!0!I
M;6%G95\P,#<N:G!G4$L! A0#%     @ TTM_4HJ!(!+;8   EF<   T
M         ( !(*L% &EM86=E7S P."YJ<&=02P$"% ,4    " #32W]2"?@'
M5U<(  #J"   #0              @ $F# 8 :6UA9V5?,# Y+FIP9U!+ 0(4
M Q0    ( --+?U+PTM;/IV0  %]G   -              "  :@4!@!I;6%G
M95\P,3 N:G!G4$L! A0#%     @ TTM_4K6+I"9=-@  73D   T
M     ( !>GD& &EM86=E7S Q,2YJ<&=02P$"% ,4    " #32W]2.51X4$%'
M  "[2@  #0              @ $"L 8 :6UA9V5?,#$R+FIP9U!+ 0(4 Q0
M   ( --+?U(DA%S8Q$   ,U$   -              "  6[W!@!I;6%G95\P
M,3,N:G!G4$L! A0#%     @ TTM_4ONA,J'#+@  F#    T
M ( !73@' &EM86=E7S Q-"YJ<&=02P$"% ,4    " #32W]272P4R30H  #D
M*@  #0              @ %+9P< :6UA9V5?,#$U+FIP9U!+ 0(4 Q0    (
M --+?U*3:I0G$T4  )]%   -              "  :J/!P!I;6%G95\P,38N
M:G!G4$L! A0#%     @ TTM_4E-DXI4D&0  [QD   T              ( !
MZ-0' &EM86=E7S Q-RYJ<&=02P$"% ,4    " #32W]24&K+?> ?  !7)P
M#0              @ $W[@< :6UA9V5?,#$X+FIP9U!+!08     &@ : !L&
(  !"#@@    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
